data_1u5s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1u5s _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.326 0.584 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.7 p -162.06 35.34 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -1.169 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.06 148.64 43.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.148 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.3 t -66.08 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.117 -0.99 . . . . 0.0 109.246 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.2 -54.26 2.01 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.417 ' O ' HG11 ' A' ' 9' ' ' VAL . 79.2 t -69.43 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 8' ' ' VAL . 3.2 m -145.23 131.51 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.426 -1.421 . . . . 0.0 111.665 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -99.98 129.26 46.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.4 m -63.37 154.28 32.45 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.518 1.152 . . . . 0.0 110.538 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 95.9 mt -114.23 -17.35 11.88 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.236 -1.394 . . . . 10.54 107.236 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.2 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.503 2.218 0 C-N-CA 119.463 -0.895 . . . . 18.39 110.699 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.5 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 121.436 1.424 . . . . 0.0 108.983 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.82 170.3 13.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.926 -1.109 . . . . 0.0 110.959 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.12 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.826 0.822 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.93 10.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.486 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 23.3 m -130.32 94.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.917 1.342 . . . . 0.0 109.187 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.606 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 4.0 m -144.51 -151.98 0.4 Allowed 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.596 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.606 ' H ' ' CG2' ' A' ' 19' ' ' THR . 49.8 tp10 -82.42 -54.28 5.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.906 -1.516 . . . . 55.13 106.906 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.443 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.6 mt-10 -109.36 29.12 7.85 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.342 -0.849 . . . . 0.0 110.739 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.41 151.02 22.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.827 -1.171 . . . . 0.0 109.783 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.44 111.38 22.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.38 -0.825 . . . . 11.68 110.773 -178.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.5 127.7 41.75 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.93 142.12 21.46 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.377 -1.452 . . . . 12.44 110.935 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.81 22.51 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 146.92 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.422 -0.911 . . . . 29.03 109.577 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.05 6.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.315 -1.514 . . . . 6.18 109.315 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.73 22.79 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.509 -0.995 . . . . 9.52 109.396 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.85 108.55 5.86 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.5 133.77 49.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 123.185 1.469 . . . . 0.0 110.523 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.89 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.401 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.49 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.92 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.576 -0.703 . . . . 0.0 111.491 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.515 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.7 mt -59.82 -50.33 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.921 -1.112 . . . . 0.0 110.246 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.607 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.34 157.65 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.941 -1.099 . . . . 0.0 110.774 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.607 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.16 65.63 64.83 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.766 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.72 165.32 31.79 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.702 1.601 . . . . 0.0 109.07 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.02 -46.5 7.77 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.4 m-20 57.69 -59.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.008 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.74 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.142 0 C-N-CA 122.625 2.217 . . . . 0.0 109.929 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 35.8 mm-40 131.83 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.78 0.832 . . . . 0.0 108.765 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 14.3 m0 -71.86 165.84 23.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.64 -1.287 . . . . 14.29 110.464 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.472 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.0 m0 -129.54 145.18 51.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.198 -0.667 . . . . 11.8 109.198 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.15 96.79 5.96 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -116.01 128.82 56.03 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.959 0.885 . . . . 0.0 110.361 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.67 150.4 26.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.775 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.62 43.48 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 117.324 -1.751 . . . . 0.0 107.229 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.51 -18.32 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 119.706 -1.871 . . . . 0.0 107.946 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.459 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.66 -4.64 4.41 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.654 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.687 0 CA-C-N 115.499 -0.773 . . . . 14.41 112.239 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.775 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.93 164.01 30.08 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 119.609 1.704 . . . . 0.0 111.727 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.65 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' N ' HD22 ' A' ' 23' ' ' LEU . . . 172.17 156.76 12.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.263 -1.535 . . . . 7.25 109.263 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.39 150.85 43.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.338 -1.095 . . . . 0.0 108.643 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.01 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.782 -1.199 . . . . 0.0 109.316 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.15 113.63 1.19 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.912 -1.226 . . . . 4.76 108.912 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HE3' HH22 ' B' ' 83' ' ' ARG . 64.3 pttt -60.52 3.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.671 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 57' ' ' PRO . 99.5 m-20 -102.05 -7.65 22.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.285 -0.884 . . . . 14.84 109.357 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.438 ' O ' HG11 ' A' ' 61' ' ' VAL . 3.2 m-85 -89.02 8.31 30.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 10.23 109.454 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 60' ' ' TYR . 35.4 m -147.48 156.51 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.094 -1.004 . . . . 6.97 109.487 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.76 160.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.403 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 11.5 p -107.59 134.29 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.43 -0.794 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.12 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.613 -0.679 . . . . 0.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 41.6 m -69.92 151.53 45.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.546 ' OD2' ' NH1' ' B' ' 84' ' ' ARG . 53.4 p-10 -146.63 152.73 39.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.35 1.48 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.356 1.371 . . . . 0.0 109.688 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.11 82.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.8 124.94 32.14 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 109.301 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.39 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.16 29.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -1.107 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.81 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.85 0.2 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.26 130.85 5.39 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.297 -1.119 . . . . 0.0 109.345 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.4 Cg_endo -74.29 163.53 36.2 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.031 1.821 . . . . 0.0 108.832 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.436 ' H ' HE21 ' B' ' 97' ' ' GLN . 76.2 mt -135.34 119.85 27.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 122.008 0.909 . . . . 0.0 109.365 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.541 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.809 0.814 . . . . 0.0 109.914 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.82 -0.16 4.86 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.541 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.7 -48.53 8.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.295 -1.121 . . . . 0.0 109.301 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.16 4.78 13.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . 0.444 HH22 ' HE3' ' A' ' 58' ' ' LYS . 83.8 mtt85 53.53 41.25 32.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . 0.546 ' NH1' ' OD2' ' A' ' 66' ' ' ASP . 17.3 mtp180 -115.79 143.39 30.64 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' B' ' 78' ' ' ILE . 5.7 Cg_exo -56.37 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.366 1.377 . . . . 0.0 110.615 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.451 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.6 mt -70.91 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.702 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.59 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.877 -1.14 . . . . 0.0 110.55 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.12 -101.8 0.15 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.76 120.63 42.17 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.83 158.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.648 0.737 . . . . 0.0 111.125 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.57 115.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.616 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.73 106.03 18.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.624 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.52 42.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.618 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.99 17.34 4.31 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.12 76.09 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.16 -154.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.787 0.803 . . . . 0.0 109.779 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.436 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.48 143.46 45.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.6 139.99 33.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.544 -1.347 . . . . 0.0 110.576 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.46 131.98 50.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.17 -14.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 108.365 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.97 15.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.823 -0.548 . . . . 0.0 110.594 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.05 -6.62 31.45 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.878 -1.139 . . . . 0.0 110.798 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -80.08 106.3 12.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.423 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.8 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.161 0.982 . . . . 0.0 111.192 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.8 148.58 46.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.314 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.78 28.67 1.73 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.77 -31.75 0.71 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.293 -0.879 . . . . 0.0 110.113 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.44 4.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.222 -0.924 . . . . 0.0 110.226 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.65 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.363 -0.836 . . . . 0.0 110.237 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.52 59.18 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -68.99 138.27 39.83 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.825 1.683 . . . . 0.0 112.059 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.8 57.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.132 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.19 1.69 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 108.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.25 30.98 2.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.566 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.86 4.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.504 -0.998 . . . . 0.0 109.993 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -94.35 145.3 24.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.33 169.45 9.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.78 47.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.26 28.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.85 . . . . 0.0 111.188 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.635 0.731 . . . . 0.0 110.334 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mttm 51.39 22.8 1.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.62 -0.675 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.618 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.94 20.4 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.7 mt -143.26 142.81 31.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.46 -1.023 . . . . 0.0 108.848 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.8 36.31 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 110.702 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.3 m-85 -153.96 140.28 18.61 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.53 177.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.439 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.594 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.76 -35.92 82.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -0.814 . . . . 0.0 109.353 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.5 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.9 m -86.75 -43.52 12.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.543 -0.723 . . . . 0.0 111.384 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.72 -43.82 83.24 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.738 -1.226 . . . . 0.0 108.126 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.65 -56.48 13.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.6 -44.8 89.46 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.05 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.53 -34.37 61.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.535 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.65 -35.26 45.61 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.427 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.51 16.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.34 51.42 15.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -1.124 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 1 C--O 0.476 -39.651 1 CA-C-O 70.943 -23.408 . . . . 0.0 109.45 -179.965 . . . . . . . . 2 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.98 0.12 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -1.217 . . . . 0.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.09 148.67 43.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.4 t -66.07 93.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.19 -54.42 2.0 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.39 74.09 1.38 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.65 158.05 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.39 131.51 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.511 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.01 129.28 46.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.0 m -63.39 154.37 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.456 1.122 . . . . 0.0 110.636 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.9 mt -114.38 -17.24 11.83 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.205 -1.406 . . . . 10.54 107.205 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.0 m-85 -149.51 144.98 18.41 Favored Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 119.474 -0.891 . . . . 18.39 110.793 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.01 81.39 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 121.524 1.482 . . . . 0.0 109.019 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.8 170.28 13.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.05 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.15 8.07 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.453 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.01 10.68 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 m -130.35 94.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 122.869 1.319 . . . . 0.0 109.177 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.54 -151.98 0.4 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.35 -1.296 . . . . 38.32 107.549 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -82.48 -54.32 5.29 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.849 -1.537 . . . . 55.13 106.849 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.35 29.15 7.81 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.402 -0.812 . . . . 0.0 110.762 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.4 150.84 22.21 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.839 -1.163 . . . . 0.0 109.7 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.37 22.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.385 -0.822 . . . . 11.68 110.764 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.46 127.7 41.72 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.88 142.17 21.54 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.374 -1.454 . . . . 12.44 110.947 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.09 155.77 22.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.38 146.84 18.58 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.267 -0.895 . . . . 29.03 109.602 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.71 44.07 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.275 -1.53 . . . . 6.18 109.275 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.33 114.75 22.85 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.513 -0.992 . . . . 9.52 109.454 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.04 108.59 6.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.43 133.69 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.153 1.454 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.82 103.12 15.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.39 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.492 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.516 -0.74 . . . . 0.0 111.392 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.3 mt -59.79 -50.46 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.971 -1.08 . . . . 0.0 110.121 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.606 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.17 157.58 43.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.983 -1.073 . . . . 0.0 110.814 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.606 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -134.97 65.54 65.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.39 31.64 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.635 1.556 . . . . 0.0 108.966 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.97 -46.56 7.75 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.52 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.268 0.556 . . . . 0.0 110.09 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.36 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.57 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 122.709 2.273 . . . . 0.0 109.914 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.75 9.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.816 0 C-N-CA 123.849 0.86 . . . . 0.0 108.849 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 12.7 m0 -71.89 165.82 23.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.593 -1.317 . . . . 14.29 110.481 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.9 m0 -129.53 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.356 -0.609 . . . . 11.8 109.356 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -79.01 96.62 5.82 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.65 55.92 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.379 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.47 150.35 27.08 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.766 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.35 128.49 43.32 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.322 -1.751 . . . . 0.0 107.295 177.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.41 0.98 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 119.643 -1.911 . . . . 0.0 108.03 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.68 -4.57 4.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.658 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.48 33.9 6.92 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.287 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.766 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.94 164.04 30.01 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 119.654 1.727 . . . . 0.0 111.77 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.64 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.274 1.035 . . . . 0.0 112.583 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.16 156.73 12.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.291 -1.524 . . . . 7.25 109.291 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.38 150.86 43.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.226 -1.161 . . . . 0.0 108.561 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.76 9.04 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.102 . . . . 0.0 109.297 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.28 113.53 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 N-CA-C 108.938 -1.216 . . . . 4.76 108.938 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.6 pttt -60.38 3.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 0.0 110.757 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.7 m-20 -102.03 -7.54 22.24 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.285 -0.885 . . . . 14.84 109.325 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.13 8.22 31.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 10.23 109.506 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.44 156.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.285 -0.885 . . . . 6.97 109.577 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -106.81 160.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.59 134.27 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.452 -0.78 . . . . 0.0 109.778 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.4 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 98.5 mt -105.13 -63.07 1.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 70.4 m -70.05 151.66 45.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.036 -1.04 . . . . 0.0 109.409 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 65' ' ' SER . 87.8 m-20 -146.6 152.69 39.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 109.311 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.29 1.48 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.299 1.332 . . . . 0.0 109.629 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.61 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.9 124.95 32.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.41 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.76 156.22 28.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -1.112 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.83 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.22 130.81 5.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 76' ' ' VAL . 5.5 Cg_endo -74.29 163.42 36.44 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.052 1.835 . . . . 0.0 108.83 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.438 ' H ' HE21 ' B' ' 97' ' ' GLN . 41.7 mt -135.22 119.85 27.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.983 0.896 . . . . 0.0 109.389 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.1 t -58.42 116.96 3.97 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.11 4.78 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.536 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.69 -48.57 8.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -1.067 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.72 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.132 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 53.54 41.3 32.12 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 64' ' ' LEU . 2.3 mmm180 -115.82 143.5 30.86 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.55 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.44 1.427 . . . . 0.0 110.542 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.444 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.5 mt -70.95 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.53 61.41 0.32 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.791 -1.193 . . . . 0.0 110.593 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.666 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.67 42.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.8 158.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 111.294 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.51 115.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.61 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.92 106.07 18.23 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 109.592 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.62 159.48 42.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.11 17.26 4.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.19 25.28 75.85 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.041 -2.024 . . . . 0.0 108.041 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.76 0.65 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.8 0.809 . . . . 0.0 109.732 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.35 143.52 46.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.58 139.91 33.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.488 -1.382 . . . . 0.0 110.648 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.54 131.99 50.26 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.21 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.846 -1.158 . . . . 0.0 108.377 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.89 -26.82 15.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.869 -0.519 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.23 -6.5 31.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.816 -1.177 . . . . 0.0 110.781 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -80.26 106.25 12.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.428 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.2 m -133.59 175.27 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.329 1.061 . . . . 0.0 111.1 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.87 148.7 46.41 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.37 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.61 1.74 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.82 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.42 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.74 -31.78 0.71 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.01 -15.38 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.79 47.5 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.36 109.64 59.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.6 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.05 138.27 39.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.748 1.632 . . . . 0.0 112.147 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.84 56.97 1.78 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.098 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.6 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.11 -55.25 1.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.12 30.91 2.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.93 4.14 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.474 -1.015 . . . . 0.0 109.977 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.41 145.33 24.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 109.412 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.411 -0.806 . . . . 0.0 109.511 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.696 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.61 47.17 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.98 148.36 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.218 -0.926 . . . . 0.0 111.18 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.556 0.693 . . . . 0.0 110.27 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.7 mttm 51.27 22.83 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.465 0.65 . . . . 0.0 109.526 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.46 30.92 20.54 Favored Glycine 0 N--CA 1.481 1.663 0 C-N-CA 119.396 -1.383 . . . . 0.0 109.785 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -143.26 142.8 31.48 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 108.79 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.4 152.79 36.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.7 m-85 -153.81 140.27 18.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.2 m -57.57 177.5 0.1 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.366 -1.334 . . . . 0.0 108.486 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.63 -36.06 82.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.417 -0.802 . . . . 0.0 109.349 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.534 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.5 m -86.54 -43.8 12.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.745 . . . . 0.0 111.338 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.456 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.87 83.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.722 -1.236 . . . . 0.0 108.089 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.38 14.07 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -64.55 -44.92 89.23 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.043 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.45 61.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.53 -35.28 46.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.501 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.114 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.43 31.36 16.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.0 m-20 48.59 51.26 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 70.968 -23.396 . . . . 0.0 109.468 179.977 . . . . . . . . 2 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.94 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.99 35.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -1.21 . . . . 0.0 109.583 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.02 148.68 43.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.48 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -66.08 93.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.255 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.25 -54.28 2.0 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.35 74.0 1.38 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.411 HG11 ' H ' ' A' ' 9' ' ' VAL . 47.0 t -69.53 158.09 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.411 ' H ' HG11 ' A' ' 8' ' ' VAL . 3.1 m -145.36 131.45 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.449 -1.407 . . . . 0.0 111.561 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.92 129.29 45.98 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.0 m -63.48 154.4 32.44 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.517 1.151 . . . . 0.0 110.594 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.7 mt -114.35 -17.24 11.84 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.23 -1.396 . . . . 10.54 107.23 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 13.9 m-85 -149.53 145.07 18.54 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.238 -0.914 . . . . 18.39 110.743 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.08 81.41 1.7 Allowed 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.356 1.371 . . . . 0.0 109.058 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.74 170.22 14.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.836 -1.165 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.59 111.11 8.03 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.725 0.774 . . . . 0.0 109.414 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -134.31 111.95 10.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.27 94.29 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 122.839 1.304 . . . . 0.0 109.13 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.546 ' HG1' ' CD ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -144.49 -152.09 0.4 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.578 -1.267 . . . . 38.32 107.578 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 58.0 mp0 -82.4 -54.31 5.32 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.857 -1.534 . . . . 55.13 106.857 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -109.28 29.16 7.79 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.383 -0.823 . . . . 0.0 110.746 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.546 ' CD ' ' HG1' ' A' ' 19' ' ' THR . 1.2 mp0 -100.52 150.88 22.21 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.823 -1.173 . . . . 0.0 109.678 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.42 111.38 22.37 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.416 -0.803 . . . . 11.68 110.756 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.67 41.58 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.9 142.16 21.52 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.42 -1.425 . . . . 12.44 110.918 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.12 155.82 22.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.93 18.27 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.268 -0.895 . . . . 29.03 109.595 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.1 6.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.345 -1.502 . . . . 6.18 109.345 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.3 114.83 22.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.589 -0.947 . . . . 9.52 109.415 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.99 108.59 5.98 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.41 133.7 49.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 123.154 1.454 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.78 103.08 15.83 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.919 -1.492 . . . . 0.0 107.395 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.485 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.502 -0.749 . . . . 0.0 111.468 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.3 mt -59.74 -50.43 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.917 -1.115 . . . . 0.0 110.201 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.608 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.23 157.6 43.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.947 -1.095 . . . . 0.0 110.714 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.608 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.08 65.58 65.24 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.77 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.75 165.32 31.76 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.61 1.54 . . . . 0.0 109.016 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.52 7.78 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.67 -59.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.324 0.583 . . . . 0.0 109.989 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.659 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.6 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.158 0 C-N-CA 122.714 2.276 . . . . 0.0 109.896 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.6 tp10 131.87 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.802 0.841 . . . . 0.0 108.771 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.508 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 16.8 m0 -71.93 165.94 23.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.674 -1.266 . . . . 14.29 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.59 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.3 m0 -129.56 145.05 51.51 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.32 -0.622 . . . . 11.8 109.32 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.02 96.62 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.93 128.7 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.921 0.867 . . . . 0.0 110.403 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.45 150.41 27.07 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.759 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.54 43.4 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 117.325 -1.75 . . . . 0.0 107.31 177.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 119.596 -1.94 . . . . 0.0 107.99 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.49 -4.6 4.17 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.661 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.41 33.81 6.99 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 115.307 -0.861 . . . . 14.41 112.329 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.759 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.1 29.81 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-N 119.603 1.701 . . . . 0.0 111.787 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.56 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.32 1.057 . . . . 0.0 112.468 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' N ' HD22 ' A' ' 23' ' ' LEU . . . 172.13 156.79 12.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.252 -1.539 . . . . 7.25 109.252 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.43 150.88 42.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -1.194 . . . . 0.0 108.608 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.7 8.97 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.955 -1.091 . . . . 0.0 109.297 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.968 -1.205 . . . . 4.76 108.968 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.59 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 16.0 pttp -60.46 3.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 110.648 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.5 m-20 -102.13 -7.52 22.17 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.179 -0.95 . . . . 14.84 109.319 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' O ' HG11 ' A' ' 61' ' ' VAL . 3.5 m-85 -89.09 8.19 31.19 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.242 -0.911 . . . . 10.23 109.427 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 60' ' ' TYR . 34.5 m -147.44 156.6 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 6.97 109.513 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 63' ' ' VAL . 12.6 p -106.81 160.72 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.441 ' N ' HG23 ' A' ' 62' ' ' VAL . 56.0 t -107.67 134.25 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.805 . . . . 0.0 109.834 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.2 mt -105.09 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.626 -0.671 . . . . 0.0 109.237 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.48 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 38.8 m -70.0 151.69 45.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.952 -1.092 . . . . 0.0 109.403 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 54.4 p-10 -146.72 152.63 39.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 109.317 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.08 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.59 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.302 1.335 . . . . 0.0 109.681 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.96 82.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.77 125.02 32.2 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.22 28.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -1.128 . . . . 0.0 109.52 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.96 0.2 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.28 130.65 5.29 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.261 -1.14 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.7 Cg_endo -74.19 163.65 36.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.912 1.741 . . . . 0.0 108.922 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.449 ' H ' HE21 ' B' ' 97' ' ' GLN . 64.2 mt -135.39 119.83 26.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 122.087 0.946 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.5 117.06 4.09 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.016 0.912 . . . . 0.0 109.89 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.513 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.05 4.89 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.76 -48.5 8.18 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.295 -1.12 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.88 13.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.573 -0.704 . . . . 0.0 109.107 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 53.55 41.14 32.14 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 6.8 mtp85 -115.79 143.41 30.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.39 113.25 1.37 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.485 1.457 . . . . 0.0 110.535 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.5 mt -70.75 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.63 61.55 0.31 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.824 -1.173 . . . . 0.0 110.663 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.07 -101.93 0.15 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.658 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.63 120.58 42.05 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.71 158.64 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.472 -0.767 . . . . 0.0 111.211 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.55 116.05 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.605 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.74 106.11 18.25 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 109.629 -179.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.61 159.54 42.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.02 17.28 4.31 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.25 75.92 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.25 -154.88 0.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.747 0.784 . . . . 0.0 109.748 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.449 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.31 143.51 46.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.513 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.528 -1.358 . . . . 0.0 110.594 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.473 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.0 m80 -56.59 131.92 50.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.07 -14.94 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 120.863 -1.148 . . . . 0.0 108.385 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.78 -26.89 15.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.828 -0.545 . . . . 0.0 110.71 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.06 -6.57 31.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.828 -1.17 . . . . 0.0 110.858 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.18 106.16 11.99 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.43 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.6 m -133.46 175.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.19 0.995 . . . . 0.0 111.203 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.75 148.74 45.86 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.303 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.9 28.69 1.75 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.111 -0.993 . . . . 0.0 109.667 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.83 -31.67 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.343 -0.848 . . . . 0.0 110.097 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.21 4.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.6 47.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 110.173 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.58 59.33 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.602 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.0 138.3 39.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.748 1.632 . . . . 0.0 112.13 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.312 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.83 56.94 1.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.159 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.602 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.32 1.62 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.34 -0.85 . . . . 0.0 109.01 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 31.07 2.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.564 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.32 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -1.048 . . . . 0.0 109.986 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.52 145.46 24.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.43 169.48 9.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.53 137.71 47.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.07 148.3 28.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.223 -0.923 . . . . 0.0 111.197 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.02 129.31 11.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.34 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.88 1.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.59 30.95 20.12 Favored Glycine 0 N--CA 1.483 1.775 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.713 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.36 142.74 31.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.535 -0.979 . . . . 0.0 108.82 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.47 152.73 36.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.4 m-85 -153.79 140.35 18.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.57 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.495 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.595 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.71 -35.92 82.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.486 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.72 -43.69 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.509 -0.744 . . . . 0.0 111.312 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.83 83.46 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.761 -1.212 . . . . 0.0 108.116 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.66 -56.44 13.65 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.51 -44.93 89.36 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.004 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.5 -34.28 61.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.77 -35.4 44.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.218 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 110.091 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.37 31.43 16.52 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.56 51.19 15.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.313 -1.11 . . . . 0.0 109.612 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.475 -39.667 1 CA-C-O 71.024 -23.37 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.76 0.13 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -161.87 35.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -1.194 . . . . 0.0 109.575 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.422 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -72.99 148.68 43.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.123 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.21 93.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.694 ' C ' ' HG ' ' A' ' 65' ' ' SER . 25.7 mt -121.28 -54.39 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.709 ' CA ' ' HG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.32 73.86 1.37 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' N ' ' OG ' ' A' ' 65' ' ' SER . 9.7 t -69.43 158.11 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.31 131.44 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.45 -1.406 . . . . 0.0 111.549 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -99.88 129.27 45.95 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.8 m -63.42 154.38 32.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.455 1.121 . . . . 0.0 110.602 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.6 mt -114.36 -17.23 11.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.186 -1.412 . . . . 10.54 107.186 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.2 m-85 -149.53 145.03 18.47 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.126 -0.984 . . . . 18.39 110.765 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 121.43 1.42 . . . . 0.0 109.037 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.79 170.3 13.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.965 -1.084 . . . . 0.0 110.984 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.58 111.01 7.96 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.739 0.78 . . . . 0.0 109.474 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.19 112.0 10.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.36 94.31 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-O 122.901 1.334 . . . . 0.0 109.126 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.427 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.45 -152.07 0.4 Allowed 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.38 -1.282 . . . . 38.32 107.579 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' H ' ' CG2' ' A' ' 19' ' ' THR . 96.2 mt-10 -82.47 -54.27 5.33 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.863 -1.532 . . . . 55.13 106.863 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.445 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.33 29.24 7.72 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.375 -0.828 . . . . 0.0 110.741 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.649 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.57 150.94 22.18 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.812 -1.18 . . . . 0.0 109.671 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.469 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.29 22.23 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.42 -0.8 . . . . 11.68 110.757 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.43 127.65 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.8 142.18 21.63 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.425 -1.422 . . . . 12.44 110.904 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.22 155.83 22.31 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 146.93 17.93 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.464 -0.894 . . . . 29.03 109.577 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.62 44.09 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.218 -1.553 . . . . 6.18 109.218 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.84 22.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.592 -0.946 . . . . 9.52 109.449 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.03 108.65 6.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.74 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.175 1.464 . . . . 0.0 110.53 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.81 102.99 15.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.368 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.494 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.507 -0.746 . . . . 0.0 111.607 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.518 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 81.9 mt -59.8 -50.34 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.593 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.985 -1.072 . . . . 0.0 110.83 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.593 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.09 65.52 64.99 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.785 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -74.83 165.38 31.58 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.618 1.545 . . . . 0.0 108.987 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.645 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.93 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.57 -59.27 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.237 0.541 . . . . 0.0 110.136 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.35 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.63 -59.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.693 2.262 . . . . 0.0 109.943 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 70.8 mt-10 131.78 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 123.805 0.842 . . . . 0.0 108.769 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.8 m0 -71.93 165.92 23.2 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.607 -1.308 . . . . 14.29 110.436 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.5 m0 -129.57 144.99 51.51 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.338 -0.616 . . . . 11.8 109.338 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -79.01 96.72 5.84 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.72 55.98 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.907 0.86 . . . . 0.0 110.38 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.52 150.35 27.02 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.38 128.47 43.34 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.286 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.41 -18.41 1.03 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 119.716 -1.865 . . . . 0.0 107.918 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.55 -4.56 4.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.665 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.39 33.95 6.93 Favored Glycine 0 N--CA 1.481 1.684 0 CA-C-N 115.28 -0.873 . . . . 14.41 112.258 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.76 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.05 29.98 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.648 1.724 . . . . 0.0 111.82 179.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.67 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 122.325 1.059 . . . . 0.0 112.401 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.06 156.79 12.67 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.274 -1.53 . . . . 7.25 109.274 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.39 150.79 43.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.214 -1.168 . . . . 0.0 108.672 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.91 136.77 9.08 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 120.949 -1.094 . . . . 0.0 109.329 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.21 113.52 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 N-CA-C 109.024 -1.183 . . . . 4.76 109.024 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.35 3.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 110.729 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.524 ' H ' ' C ' ' A' ' 57' ' ' PRO . 95.7 m-20 -101.9 -7.71 22.22 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.247 -0.908 . . . . 14.84 109.4 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.42 ' O ' HG11 ' A' ' 61' ' ' VAL . 3.6 m-85 -89.0 8.23 30.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.221 -0.925 . . . . 10.23 109.437 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 60' ' ' TYR . 33.5 m -147.48 156.48 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.096 -1.002 . . . . 6.97 109.494 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.74 160.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.5 t -107.74 134.3 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.372 -0.83 . . . . 0.0 109.701 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 mp -105.06 -63.24 1.25 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.562 -0.711 . . . . 0.0 109.254 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.709 ' HG ' ' CA ' ' A' ' 7' ' ' HIS . 11.5 p -70.01 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.024 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 109.372 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.2 1.48 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.53 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.257 1.305 . . . . 0.0 109.656 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.06 82.67 1.78 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.93 124.96 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.81 156.24 28.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -1.114 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.92 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.433 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.44 46.91 0.2 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.21 130.82 5.39 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.312 -1.111 . . . . 0.0 109.396 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.28 163.65 35.94 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.876 1.718 . . . . 0.0 108.936 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.451 ' H ' HE21 ' B' ' 97' ' ' GLN . 64.8 mt -135.38 119.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 122.053 0.93 . . . . 0.0 109.44 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 14.8 t -58.46 117.13 4.15 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.872 0.844 . . . . 0.0 109.883 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.518 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -65.0 -0.06 4.97 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.544 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.55 8.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.15 4.94 13.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -116.01 143.3 30.61 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.35 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.412 1.408 . . . . 0.0 110.495 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.4 mt -70.98 158.45 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.54 61.46 0.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.828 -1.17 . . . . 0.0 110.671 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.04 0.15 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.63 120.59 42.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.72 158.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.41 -0.806 . . . . 0.0 111.286 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.43 116.06 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.612 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.79 106.15 18.27 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.572 -179.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.47 42.74 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.19 4.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.16 76.03 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.19 -154.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.704 0.764 . . . . 0.0 109.747 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.47 143.5 45.9 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.518 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.6 140.07 33.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.506 -1.371 . . . . 0.0 110.614 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.5 m80 -56.36 131.98 49.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 t -53.33 -14.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 120.843 -1.161 . . . . 0.0 108.323 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.94 15.51 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.804 -0.56 . . . . 0.0 110.683 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.17 -6.52 31.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.936 -1.102 . . . . 0.0 110.835 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.13 106.3 12.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.432 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.8 m -133.67 175.22 11.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 111.092 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.7 148.65 45.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.263 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.85 28.72 1.73 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.57 0.71 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.354 -0.842 . . . . 0.0 110.056 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.4 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.15 -15.55 4.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.75 47.65 0.33 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.55 59.34 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.6 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.5 Cg_endo -68.96 138.29 40.03 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.788 1.659 . . . . 0.0 112.101 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.313 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.77 56.91 1.79 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.023 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.6 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.18 1.69 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 0.0 109.022 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 30.97 2.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.34 178.88 4.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -1.041 . . . . 0.0 110.066 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.31 145.41 24.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.509 -0.745 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.33 169.52 9.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 109.624 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.703 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.52 137.77 47.28 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.21 29.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.256 -0.902 . . . . 0.0 111.212 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.36 11.35 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.609 0.719 . . . . 0.0 110.35 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.07 22.92 1.36 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.578 -0.701 . . . . 0.0 109.536 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.37 31.15 20.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.792 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.45 142.74 31.31 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.549 -0.971 . . . . 0.0 108.803 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.42 152.86 36.08 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.725 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.511 ' HA ' ' SG ' ' B' ' 105' ' ' CYS . 58.3 m-85 -153.82 140.37 18.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.69 177.48 0.11 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.471 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.61 -36.04 82.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 109.294 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.465 ' O ' ' N ' ' B' ' 132' ' ' GLN . 53.7 m -86.66 -43.73 12.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 111.295 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.89 83.38 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.736 -1.228 . . . . 0.0 108.052 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.495 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.32 14.47 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -64.66 -44.75 89.42 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.161 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.48 -34.3 61.3 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.77 -35.22 44.81 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.351 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.66 -81.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.29 31.6 16.26 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 48.31 51.33 15.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 71.114 -23.327 . . . . 0.0 109.534 179.903 . . . . . . . . 2 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.422 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.422 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.39 74.93 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.98 35.32 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 109.619 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.08 148.7 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.049 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.12 93.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 0.0 109.394 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.28 2.0 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.38 73.82 1.37 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.39 158.09 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.39 131.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.485 -1.384 . . . . 0.0 111.529 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.92 129.21 45.97 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.7 m -63.52 154.45 32.44 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.521 1.153 . . . . 0.0 110.584 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.2 mt -114.39 -17.25 11.82 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.173 -1.417 . . . . 10.54 107.173 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.0 m-85 -149.49 145.03 18.49 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.198 -0.939 . . . . 18.39 110.791 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.04 81.43 1.68 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.385 1.39 . . . . 0.0 109.099 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CG ' ' N ' ' A' ' 16' ' ' SER . 27.8 t80 -71.61 170.23 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.962 -1.087 . . . . 0.0 110.937 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.6 111.09 8.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.776 0.798 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 111.89 10.59 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 17.6 m -130.25 94.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-O 122.883 1.325 . . . . 0.0 109.16 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.42 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.575 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -82.39 -54.34 5.3 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.904 -1.517 . . . . 55.13 106.904 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 17.4 pt-20 -109.26 29.09 7.86 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.451 -0.781 . . . . 0.0 110.703 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.62 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.41 150.89 22.15 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.921 -1.112 . . . . 0.0 109.741 -179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.33 111.4 22.42 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.402 -0.811 . . . . 11.68 110.739 -178.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.6 41.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.89 142.16 21.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.366 -1.459 . . . . 12.44 110.912 -178.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.19 155.8 22.36 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.97 18.2 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.465 -0.894 . . . . 29.03 109.591 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.54 44.2 6.6 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 6.18 109.298 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.37 114.8 22.9 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.725 -0.868 . . . . 9.52 109.389 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.98 108.67 6.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.54 133.66 49.92 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 123.112 1.434 . . . . 0.0 110.585 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.65 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.393 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.16 92.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 111.431 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.515 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.8 mt -59.71 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.894 -1.129 . . . . 0.0 110.259 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.602 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.916 -1.115 . . . . 0.0 110.79 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.602 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.07 65.53 65.13 Favored Pre-proline 0 N--CA 1.486 1.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.794 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.44 31.42 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.653 1.569 . . . . 0.0 108.982 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.06 -46.55 7.73 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.78 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.351 0.596 . . . . 0.0 110.052 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 122.664 2.243 . . . . 0.0 110.023 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 31.4 tt0 131.77 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 C-N-CA 123.814 0.846 . . . . 0.0 108.752 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.527 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 14.6 m0 -71.87 165.96 23.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.623 -1.298 . . . . 14.29 110.463 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.548 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.1 m0 -129.68 145.06 51.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.233 -0.654 . . . . 11.8 109.233 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.99 96.73 5.83 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.73 55.98 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.89 0.853 . . . . 0.0 110.428 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.52 150.33 27.03 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.769 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.47 128.51 43.47 Favored 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 117.25 -1.78 . . . . 0.0 107.212 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.3 -18.46 0.97 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.775 -1.828 . . . . 0.0 107.995 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.452 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.6 4.29 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.656 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.45 33.82 6.97 Favored Glycine 0 N--CA 1.482 1.761 0 CA-C-N 115.388 -0.824 . . . . 14.41 112.281 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.769 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.91 164.02 30.04 Favored 'General case' 0 N--CA 1.515 2.809 0 CA-C-N 119.796 1.798 . . . . 0.0 111.839 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.59 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 122.309 1.052 . . . . 0.0 112.522 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.11 156.64 12.53 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.255 -1.538 . . . . 7.25 109.255 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.3 150.85 43.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.13 -1.218 . . . . 0.0 108.768 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.62 8.92 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.895 -1.128 . . . . 0.0 109.271 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.048 -1.174 . . . . 4.76 109.048 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.548 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 33.9 pttt -60.38 3.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.8 m120 -102.09 -7.63 22.11 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.183 -0.948 . . . . 14.84 109.273 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.441 ' O ' HG12 ' A' ' 61' ' ' VAL . 3.2 m-85 -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 10.23 109.454 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 60' ' ' TYR . 35.3 m -147.48 156.64 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.149 -0.969 . . . . 6.97 109.521 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.3 p -106.77 160.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -107.63 134.36 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.5 -0.75 . . . . 0.0 109.767 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -105.11 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.619 -0.676 . . . . 0.0 109.227 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -69.91 151.58 45.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.0 109.435 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -146.54 152.72 39.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 0.0 109.377 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.29 1.48 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.47 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.338 1.358 . . . . 0.0 109.645 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.66 1.78 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.04 32.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.85 156.25 28.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.93 0.2 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.3 130.74 5.33 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.337 -1.096 . . . . 0.0 109.378 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.43 ' C ' HG13 ' B' ' 78' ' ' ILE . 5.6 Cg_endo -74.14 163.51 36.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.988 1.792 . . . . 0.0 108.87 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.441 ' H ' HE21 ' B' ' 97' ' ' GLN . 48.5 mt -135.35 119.89 27.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 122.081 0.943 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.42 117.01 4.01 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.831 0.824 . . . . 0.0 110.048 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.519 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.93 -0.09 4.91 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.58 -48.7 8.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -1.061 . . . . 0.0 109.375 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.84 13.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.568 -0.708 . . . . 0.0 109.106 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 53.51 41.33 32.11 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -115.89 143.51 30.92 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.54 113.31 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.5 1.467 . . . . 0.0 110.464 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.438 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.6 mt -70.78 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.57 61.48 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.809 -1.182 . . . . 0.0 110.646 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.0 0.15 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.5 120.56 42.06 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.74 158.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.66 0.743 . . . . 0.0 111.253 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.42 115.96 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.618 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.096 -1.003 . . . . 0.0 109.473 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.55 159.42 42.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.19 17.14 4.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.22 75.94 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.79 0.805 . . . . 0.0 109.754 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.441 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.36 143.52 46.12 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.519 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.58 140.0 33.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.66 -1.275 . . . . 0.0 110.58 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.54 132.02 50.37 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.39 -14.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.876 -1.14 . . . . 0.0 108.335 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.82 -26.94 15.45 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.806 -0.559 . . . . 0.0 110.651 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.08 -6.59 31.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.952 -1.092 . . . . 0.0 110.858 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.13 106.26 12.02 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.433 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.0 m -133.62 175.17 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.218 1.009 . . . . 0.0 111.18 -177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.82 148.67 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.259 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.78 1.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.85 -31.75 0.71 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.14 -15.37 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.248 -0.908 . . . . 0.0 110.175 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.66 47.69 0.34 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.851 . . . . 0.0 110.147 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.47 59.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.5 Cg_endo -69.02 138.23 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.706 1.604 . . . . 0.0 112.167 -177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.315 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.76 56.76 1.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.19 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.93 -55.27 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 0.0 109.07 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.08 2.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.562 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.33 178.96 4.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.469 -1.018 . . . . 0.0 109.953 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.45 145.36 24.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.404 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.6 137.64 47.13 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -107.08 148.26 28.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.23 -0.919 . . . . 0.0 111.233 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 129.4 11.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.614 0.721 . . . . 0.0 110.332 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.15 22.86 1.4 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 0.0 109.504 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.95 20.4 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.687 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -143.26 142.82 31.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.514 -0.992 . . . . 0.0 108.852 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.48 152.97 35.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.673 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.9 m-85 -153.92 140.28 18.65 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.61 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.399 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.0 tt0 -63.56 -36.11 82.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.402 -0.811 . . . . 0.0 109.475 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.515 ' O ' ' N ' ' B' ' 132' ' ' GLN . 58.2 m -86.51 -43.63 12.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.724 . . . . 0.0 111.466 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.77 -43.76 83.15 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.789 -1.194 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.4 13.95 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -64.6 -44.91 89.1 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.46 -34.28 61.22 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.7 -35.3 45.18 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.354 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.2 m-85 -158.51 -81.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 110.094 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.35 31.41 16.62 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.54 51.16 15.87 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -1.151 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.934 -23.412 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.44 74.92 0.12 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -161.94 35.24 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.253 -1.145 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.425 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.02 148.58 44.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.0 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.22 -54.26 2.0 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.435 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.41 73.94 1.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.601 ' H ' ' HG ' ' A' ' 65' ' ' SER . 79.1 t -69.38 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m -145.41 131.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.354 -1.466 . . . . 0.0 111.461 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -99.79 129.19 45.87 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.4 m -63.44 154.31 32.56 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.51 1.148 . . . . 0.0 110.537 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.3 mt -114.28 -17.25 11.88 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.225 -1.398 . . . . 10.54 107.225 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.6 m-85 -149.47 145.1 18.63 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.164 -0.96 . . . . 18.39 110.678 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -73.01 81.45 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.444 1.43 . . . . 0.0 109.107 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.78 170.32 13.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.98 -1.075 . . . . 0.0 110.861 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.72 111.1 7.96 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.805 0.812 . . . . 0.0 109.38 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 112.0 10.72 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 34.0 m -130.36 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 122.941 1.353 . . . . 0.0 109.222 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.504 ' CG2' ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.512 -1.292 . . . . 38.32 107.512 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 58.8 mp0 -82.38 -54.47 5.19 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.832 -1.544 . . . . 55.13 106.832 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -109.18 29.22 7.72 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.374 -0.829 . . . . 0.0 110.803 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.53 150.93 22.16 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.036 -1.04 . . . . 0.0 109.761 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.52 22.61 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.517 -0.739 . . . . 11.68 110.655 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.49 127.84 41.86 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.0 142.21 21.48 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.415 -1.428 . . . . 12.44 110.78 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.87 22.4 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 146.92 18.78 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.238 -0.913 . . . . 29.03 109.585 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 44.2 6.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.416 -1.474 . . . . 6.18 109.416 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.452 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.83 22.93 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.543 -0.974 . . . . 9.52 109.331 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.13 108.67 6.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.48 133.66 49.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.155 1.455 . . . . 0.0 110.584 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.78 103.14 15.88 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.41 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.19 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.489 -0.757 . . . . 0.0 111.491 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.4 mt -59.91 -50.31 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.957 -1.09 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.603 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.603 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.14 65.63 64.94 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.701 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.77 165.41 31.54 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.627 1.551 . . . . 0.0 109.049 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.1 -46.55 7.72 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.77 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.419 0.628 . . . . 0.0 110.059 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.51 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.65 -59.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.547 2.164 . . . . 0.0 109.975 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 71.6 mt-10 131.7 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 123.828 0.851 . . . . 0.0 108.837 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.511 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 20.2 m0 -71.87 166.0 22.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.696 -1.252 . . . . 14.29 110.497 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.462 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.4 m0 -129.64 144.97 51.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.668 -0.645 . . . . 11.8 109.355 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -78.98 96.68 5.81 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.76 56.0 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.889 0.852 . . . . 0.0 110.321 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.69 150.39 26.79 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.777 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.37 128.56 43.4 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 117.327 -1.749 . . . . 0.0 107.239 178.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.5 1.02 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 119.584 -1.948 . . . . 0.0 108.008 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.457 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.59 -4.57 4.26 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.662 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.47 33.81 6.97 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-N 115.403 -0.817 . . . . 14.41 112.284 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.777 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.1 29.8 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-N 119.724 1.762 . . . . 0.0 111.792 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.63 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-O 122.356 1.074 . . . . 0.0 112.541 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.71 12.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.294 -1.522 . . . . 7.25 109.294 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.3 150.78 43.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.278 -1.13 . . . . 0.0 108.596 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.04 136.77 9.02 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 109.269 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 N-CA-C 109.014 -1.187 . . . . 4.76 109.014 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.37 3.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.482 -0.761 . . . . 0.0 110.712 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.7 m-20 -102.01 -7.63 22.18 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.206 -0.934 . . . . 14.84 109.327 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.97 8.13 31.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 10.23 109.527 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.41 156.64 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.193 -0.942 . . . . 6.97 109.483 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.85 160.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.57 134.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.389 -0.819 . . . . 0.0 109.838 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 mp -105.2 -63.18 1.26 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.631 -0.668 . . . . 0.0 109.229 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' A' ' 8' ' ' VAL . 14.4 p -70.01 151.54 45.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.037 -1.039 . . . . 0.0 109.521 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 55.7 p-10 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.3 1.48 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.304 1.336 . . . . 0.0 109.667 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.02 82.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.09 32.33 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.71 156.1 29.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.278 -1.131 . . . . 0.0 109.57 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.4 mtt -49.7 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.74 0.2 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.22 130.86 5.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.301 -1.117 . . . . 0.0 109.378 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.41 163.66 35.74 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.85 1.7 . . . . 0.0 108.827 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.449 ' H ' HE21 ' B' ' 97' ' ' GLN . 74.6 mt -135.41 119.86 26.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.07 0.938 . . . . 0.0 109.338 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 14.9 t -58.43 116.98 3.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.824 0.821 . . . . 0.0 109.871 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.24 4.92 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.54 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.63 -48.65 8.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.361 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.09 4.77 13.72 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 53.57 41.36 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -115.89 143.43 30.77 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.43 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.442 1.428 . . . . 0.0 110.551 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.441 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.6 mt -70.94 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.44 61.54 0.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.918 -1.114 . . . . 0.0 110.583 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.08 -102.06 0.15 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.64 120.74 42.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.83 158.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.762 0.792 . . . . 0.0 111.141 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.45 115.91 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.613 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 109.548 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.5 42.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.15 17.23 4.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.1 25.42 75.64 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.27 -154.77 0.65 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.712 0.768 . . . . 0.0 109.821 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.449 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.46 143.37 45.85 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.8 m95 -141.48 140.1 33.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.41 -1.431 . . . . 0.0 110.634 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.452 ' C ' ' H ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.5 131.9 49.92 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 120.894 -1.129 . . . . 0.0 108.336 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.91 -26.94 15.4 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.71 -0.619 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.21 -6.42 31.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.806 -1.184 . . . . 0.0 110.899 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.29 106.19 12.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.432 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.9 m -133.53 175.25 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.288 1.042 . . . . 0.0 111.167 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.81 148.66 46.28 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.8 28.73 1.71 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.414 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.84 -31.62 0.71 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.349 -0.844 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.22 -15.27 4.19 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.332 -0.855 . . . . 0.0 110.138 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.66 47.67 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.319 -0.863 . . . . 0.0 110.148 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.52 59.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.5 Cg_endo -69.03 138.22 39.58 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.704 1.603 . . . . 0.0 112.168 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.309 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.79 56.96 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.157 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.01 -55.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 109.082 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.19 30.88 2.76 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.574 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.18 178.84 4.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.479 -1.012 . . . . 0.0 110.03 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.33 145.24 24.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.55 9.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 0.0 109.489 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.6 137.65 47.13 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.03 148.24 28.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.241 -0.912 . . . . 0.0 111.331 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.31 11.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.685 0.755 . . . . 0.0 110.257 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.38 22.83 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.506 -0.746 . . . . 0.0 109.414 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.87 20.59 Favored Glycine 0 N--CA 1.481 1.685 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.79 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.29 142.64 31.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.524 -0.986 . . . . 0.0 108.821 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.91 36.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.739 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.503 ' HA ' ' SG ' ' B' ' 105' ' ' CYS . 57.6 m-85 -154.01 140.26 18.54 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.7 m -57.61 177.4 0.1 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.453 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.81 . . . . 0.0 109.383 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.506 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.68 -43.79 12.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.434 -0.791 . . . . 0.0 111.354 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.74 83.91 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.867 -1.145 . . . . 0.0 108.213 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.46 13.58 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -64.52 -44.82 89.66 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.45 -34.49 61.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.541 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.64 -35.19 45.81 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.381 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.7 -81.64 0.05 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 110.085 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.44 31.43 16.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.55 51.28 15.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -1.103 . . . . 0.0 109.556 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.791 -23.48 . . . . 0.0 109.443 -179.981 . . . . . . . . 2 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.437 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.437 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.28 74.81 0.13 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.595 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.422 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.03 148.68 43.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.882 . . . . 0.0 109.099 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.11 93.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 109.238 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.31 -54.25 2.0 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.34 74.08 1.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.5 t -69.53 158.07 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.34 131.55 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.463 -1.398 . . . . 0.0 111.528 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.93 129.26 45.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.5 m -63.42 154.33 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.468 1.128 . . . . 0.0 110.633 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 74.4 mt -114.31 -17.34 11.84 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.219 -1.4 . . . . 10.54 107.219 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.4 m-85 -149.5 145.08 18.57 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.21 -0.931 . . . . 18.39 110.726 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 121.364 1.376 . . . . 0.0 109.042 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.85 170.23 14.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.972 -1.08 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.14 8.04 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.906 0.86 . . . . 0.0 109.358 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.07 10.73 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.44 94.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 123.039 1.399 . . . . 0.0 109.172 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.4 m -144.58 -152.11 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.321 -1.309 . . . . 38.32 107.593 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.452 ' H ' ' CG2' ' A' ' 19' ' ' THR . 79.1 mm-40 -82.37 -54.3 5.33 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.92 -1.511 . . . . 55.13 106.92 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 74.9 mt-10 -109.33 29.17 7.79 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.364 -0.835 . . . . 0.0 110.778 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.39 150.78 22.26 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.756 -1.215 . . . . 0.0 109.83 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.29 111.37 22.38 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.408 -0.807 . . . . 11.68 110.775 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.43 127.71 41.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.0 142.04 21.32 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.374 -1.454 . . . . 12.44 110.848 -178.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.07 155.85 22.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.92 18.49 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.482 -0.887 . . . . 29.03 109.539 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.12 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.284 -1.526 . . . . 6.18 109.284 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.4 114.84 22.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.584 -0.951 . . . . 9.52 109.424 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.07 108.68 6.1 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.54 133.83 49.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 123.231 1.491 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.05 15.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.328 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.99 92.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.527 -0.733 . . . . 0.0 111.485 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.6 mt -59.65 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.927 -1.108 . . . . 0.0 110.344 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.611 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.66 43.68 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.037 -1.039 . . . . 0.0 110.737 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.611 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.02 65.55 65.54 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.75 165.4 31.59 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.61 1.54 . . . . 0.0 109.003 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.641 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.07 -46.48 7.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.66 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.352 0.596 . . . . 0.0 110.025 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.8 -47.36 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.734 2.289 . . . . 0.0 109.961 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 67.5 mt-10 131.76 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 C-N-CA 123.881 0.872 . . . . 0.0 108.805 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.5 m0 -71.85 165.89 23.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.738 -1.226 . . . . 14.29 110.502 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.6 m0 -129.51 145.03 51.5 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.377 -0.601 . . . . 11.8 109.377 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -78.98 96.71 5.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.9 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.869 0.842 . . . . 0.0 110.429 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.79 150.47 26.61 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.759 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.53 43.4 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 117.28 -1.768 . . . . 0.0 107.325 178.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.56 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.45 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.618 -1.926 . . . . 0.0 107.951 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.455 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.71 -4.47 4.31 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.4 33.95 6.92 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 115.379 -0.828 . . . . 14.41 112.224 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.759 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.1 29.79 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.731 1.766 . . . . 0.0 111.87 179.12 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.02 154.65 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.323 1.059 . . . . 0.0 112.408 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.337 -1.505 . . . . 7.25 109.337 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.29 150.96 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.31 -1.112 . . . . 0.0 108.684 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.08 136.79 9.02 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.004 -1.06 . . . . 0.0 109.297 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.98 -1.2 . . . . 4.76 108.98 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.46 3.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 110.721 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -101.97 -7.67 22.18 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.147 -0.971 . . . . 14.84 109.391 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' O ' HG12 ' A' ' 61' ' ' VAL . 3.1 m-85 -89.06 8.33 30.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.919 . . . . 10.23 109.483 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 60' ' ' TYR . 32.7 m -147.46 156.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 6.97 109.454 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 3.8 p -106.76 160.82 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 45.6 t -107.71 134.26 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.403 -0.811 . . . . 0.0 109.714 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' O ' ' NH2' ' B' ' 84' ' ' ARG . 9.0 mp -105.14 -63.3 1.24 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -69.92 151.59 45.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 49.4 p30 -146.55 152.72 39.41 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.45 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 121.368 1.378 . . . . 0.0 109.7 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.03 82.59 1.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.93 125.14 32.41 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.514 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.09 28.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -1.073 . . . . 0.0 109.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.76 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.3 46.98 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.32 130.79 5.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.286 -1.126 . . . . 0.0 109.332 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.4 Cg_endo -74.21 163.6 36.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.912 1.741 . . . . 0.0 108.847 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.45 ' H ' HE21 ' B' ' 97' ' ' GLN . 30.6 mt -135.43 119.84 26.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 122.17 0.986 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.3 116.96 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.778 0.799 . . . . 0.0 109.897 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.508 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.23 4.91 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.543 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.59 -48.74 8.07 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 109.321 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.89 13.76 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 53.44 41.28 32.13 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . 0.423 ' NH2' ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -115.82 143.43 30.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -56.48 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.433 1.422 . . . . 0.0 110.56 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -70.91 158.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.51 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.0 110.577 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.71 42.46 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.8 158.62 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.669 0.747 . . . . 0.0 111.245 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.51 116.03 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.604 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.585 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.56 42.58 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 57.94 17.38 4.29 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.32 75.78 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.84 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.45 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.38 143.4 46.03 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.508 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.46 139.97 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.507 -1.371 . . . . 0.0 110.67 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.445 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.38 131.9 49.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.926 -1.109 . . . . 0.0 108.436 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.85 -26.98 15.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.781 -0.574 . . . . 0.0 110.624 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.1 -6.55 31.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.937 -1.102 . . . . 0.0 110.842 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -80.1 106.26 11.99 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.429 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.9 m -133.58 175.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.268 1.032 . . . . 0.0 111.172 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.75 148.71 45.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.31 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.66 1.74 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.78 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -128.98 -15.57 4.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.385 -0.822 . . . . 0.0 110.208 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.59 0.32 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.52 59.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.608 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.06 138.18 39.39 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.699 1.6 . . . . 0.0 112.184 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.326 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.67 56.85 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.194 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.608 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.08 -55.22 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.337 -0.852 . . . . 0.0 108.962 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.22 31.05 2.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.57 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.25 179.07 4.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.578 -0.954 . . . . 0.0 109.949 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.41 24.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 109.305 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.35 169.42 9.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.67 47.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.92 148.29 28.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.264 -0.898 . . . . 0.0 111.25 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.37 11.34 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.584 0.707 . . . . 0.0 110.295 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.14 22.92 1.41 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.664 -0.647 . . . . 0.0 109.448 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.35 31.08 20.39 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.443 -1.361 . . . . 0.0 109.742 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.32 142.71 31.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.547 -0.973 . . . . 0.0 108.778 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.26 152.85 36.38 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.641 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.9 m-85 -153.9 140.22 18.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.57 177.43 0.1 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.477 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.596 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.56 -36.03 82.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.387 -0.82 . . . . 0.0 109.357 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.491 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.2 m -86.61 -43.86 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 111.289 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.64 84.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 108.218 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.86 -56.37 14.42 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.55 -44.74 89.83 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.2 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.49 -34.37 61.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.538 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.77 -35.12 44.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.346 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.52 31.32 16.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.409 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.53 51.3 15.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.723 1 CA-C-O 70.819 -23.467 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.29 0.567 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.31 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.425 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.02 148.64 43.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.12 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.185 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.26 -54.35 2.0 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.444 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.34 74.0 1.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.514 ' N ' ' OG ' ' A' ' 65' ' ' SER . 10.1 t -69.51 158.13 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.33 131.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.487 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.414 HE21 ' HA2' ' A' ' 28' ' ' GLY . 56.7 tp60 -99.87 129.31 45.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.4 m -63.51 154.36 32.69 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.456 1.122 . . . . 0.0 110.625 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.9 mt -114.31 -17.23 11.86 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.224 -1.398 . . . . 10.54 107.224 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.1 m-85 -149.56 145.03 18.45 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.21 -0.931 . . . . 18.39 110.798 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.41 1.67 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 121.425 1.417 . . . . 0.0 109.01 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.71 170.26 13.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.948 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.13 8.06 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.741 0.782 . . . . 0.0 109.452 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.38 112.08 10.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.33 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.888 1.327 . . . . 0.0 109.193 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.509 -1.293 . . . . 38.32 107.509 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.49 -54.21 5.37 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.897 -1.52 . . . . 55.13 106.897 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.39 29.31 7.66 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.365 -0.834 . . . . 0.0 110.849 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.57 150.85 22.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.801 -1.187 . . . . 0.0 109.759 -179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.44 22.48 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.411 -0.806 . . . . 11.68 110.714 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.49 127.78 41.8 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.02 142.18 21.44 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.382 -1.449 . . . . 12.44 110.819 -178.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.24 155.77 22.32 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.28 146.96 17.83 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.282 -0.886 . . . . 29.03 109.521 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.414 ' HA2' HE21 ' A' ' 10' ' ' GLN . . . 84.48 44.11 6.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.35 -1.5 . . . . 6.18 109.35 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.26 114.83 23.01 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.493 -1.004 . . . . 9.52 109.451 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.09 108.63 6.09 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.49 133.64 49.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.179 1.466 . . . . 0.0 110.523 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 103.05 15.8 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.733 -1.576 . . . . 0.0 107.484 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.535 -0.728 . . . . 0.0 111.465 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.518 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.0 mt -59.69 -50.46 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.986 -1.072 . . . . 0.0 110.273 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.606 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.56 43.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.606 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -134.93 65.52 65.88 Favored Pre-proline 0 N--CA 1.486 1.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.791 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 45' ' ' LYS . 11.1 Cg_endo -74.69 165.42 31.59 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.625 1.55 . . . . 0.0 109.008 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.53 7.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.7 m-20 57.69 -59.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.33 0.586 . . . . 0.0 110.017 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 178.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.2 Cg_endo -68.73 -59.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.756 2.304 . . . . 0.0 109.776 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 16.8 pt-20 131.78 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 123.79 0.836 . . . . 0.0 108.784 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 14.7 m0 -72.0 165.92 23.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.756 -1.215 . . . . 14.29 110.407 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.479 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.3 m0 -129.58 145.07 51.51 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 109.276 -0.639 . . . . 11.8 109.276 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HZ2' ' HG3' ' A' ' 37' ' ' PRO . 66.0 mttp -79.03 96.63 5.83 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.97 128.86 56.08 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.942 0.877 . . . . 0.0 110.441 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -82.62 150.4 26.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.76 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.52 43.4 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 117.284 -1.766 . . . . 0.0 107.221 177.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.46 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 119.668 -1.895 . . . . 0.0 108.031 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.45 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.57 -4.61 4.27 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.665 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.45 33.89 6.94 Favored Glycine 0 N--CA 1.481 1.691 0 CA-C-N 115.303 -0.862 . . . . 14.41 112.271 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.76 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.12 29.77 Favored 'General case' 0 N--CA 1.515 2.812 0 CA-C-N 119.736 1.768 . . . . 0.0 111.843 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.302 1.048 . . . . 0.0 112.468 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.22 156.73 12.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.306 -1.518 . . . . 7.25 109.306 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.41 150.85 43.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.271 -1.135 . . . . 0.0 108.685 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.74 9.03 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.765 -1.209 . . . . 0.0 109.354 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.32 113.5 1.15 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.032 -1.18 . . . . 4.76 109.032 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.19 3.09 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.793 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 57' ' ' PRO . 10.5 m120 -102.03 -7.67 22.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.095 -1.003 . . . . 14.84 109.337 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -89.11 8.38 30.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.91 . . . . 10.23 109.455 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.48 156.53 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.101 -0.999 . . . . 6.97 109.431 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.79 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -107.67 134.23 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.35 -0.844 . . . . 0.0 109.753 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.17 -63.12 1.26 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.567 -0.708 . . . . 0.0 109.184 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.6 p -70.0 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 50.6 p30 -146.58 152.66 39.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 109.42 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.316 1.344 . . . . 0.0 109.638 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.5 1.75 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.12 32.36 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.434 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.27 28.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.98 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.17 46.82 0.2 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.3 130.72 5.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.24 163.64 36.02 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.975 1.783 . . . . 0.0 108.842 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.451 ' H ' HE21 ' B' ' 97' ' ' GLN . 6.4 mt -135.38 119.7 26.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.967 0.889 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.542 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.32 116.86 3.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.871 0.843 . . . . 0.0 109.917 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.72 -0.19 4.79 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.542 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.62 -48.53 8.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.993 . . . . 0.0 109.443 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.8 13.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 109.147 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 53.47 41.27 32.13 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . 0.503 ' NH2' ' CE1' ' B' ' 99' ' ' HIS . 8.9 mtm105 -115.95 143.39 30.74 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.42 113.32 1.4 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.409 1.406 . . . . 0.0 110.699 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.442 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.5 mt -70.86 158.47 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.56 61.54 0.32 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.858 -1.151 . . . . 0.0 110.593 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.645 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.7 120.69 42.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.83 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.686 0.755 . . . . 0.0 111.168 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.53 116.01 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.593 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.22 18.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.69 159.53 42.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.21 4.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.14 25.22 75.92 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.2 -154.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.728 0.775 . . . . 0.0 109.783 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.41 143.37 45.95 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.604 -1.31 . . . . 0.0 110.669 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.503 ' CE1' ' NH2' ' B' ' 84' ' ' ARG . 17.2 m80 -56.56 131.99 50.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 t -53.17 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 120.902 -1.124 . . . . 0.0 108.311 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.79 -27.02 15.43 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.848 -0.532 . . . . 0.0 110.62 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.04 -6.59 31.54 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.886 -1.134 . . . . 0.0 110.841 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -80.12 106.27 12.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.43 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.7 m -133.56 175.34 11.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.272 1.034 . . . . 0.0 111.081 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.75 148.68 46.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.312 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.5 1.77 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.7 -31.66 0.72 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.369 -0.832 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.17 -15.42 4.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.375 -0.828 . . . . 0.0 110.133 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.64 47.68 0.34 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.208 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.64 59.59 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.21 138.31 39.23 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.691 1.594 . . . . 0.0 112.126 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.294 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.87 56.95 1.77 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.21 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 108.997 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.97 2.74 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.574 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.25 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -1.011 . . . . 0.0 110.024 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.33 24.86 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.57 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.54 9.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.65 47.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.01 148.26 28.92 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.312 -0.867 . . . . 0.0 111.196 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.31 11.28 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.606 0.717 . . . . 0.0 110.413 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.3 22.84 1.49 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.579 -0.7 . . . . 0.0 109.482 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.47 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -143.26 142.74 31.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.487 -1.007 . . . . 0.0 108.762 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.28 152.79 36.37 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.802 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.8 m-85 -153.82 140.24 18.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.49 177.54 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.341 -1.343 . . . . 0.0 108.388 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.595 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.74 -35.99 82.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.382 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.4 m -86.67 -43.65 12.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 0.0 111.464 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.6 -43.76 83.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.797 -1.19 . . . . 0.0 108.255 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.54 13.17 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -64.39 -44.98 89.63 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.151 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.39 61.25 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.62 -35.24 45.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.387 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 110.09 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.48 16.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.413 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.4 51.28 15.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -1.099 . . . . 0.0 109.644 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.708 1 CA-C-O 71.096 -23.335 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.429 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.429 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.37 74.88 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.6 p -161.93 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.238 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.0 148.67 43.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 t -66.14 93.38 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.02 . . . . 0.0 109.19 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.21 -54.28 2.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.445 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.3 73.97 1.38 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.494 ' N ' ' OG ' ' A' ' 65' ' ' SER . 3.7 t -69.39 158.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.46 131.51 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.462 -1.399 . . . . 0.0 111.447 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.0 129.25 46.04 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.2 m -63.45 154.4 32.32 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.505 1.145 . . . . 0.0 110.544 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 84.2 mt -114.39 -17.34 11.8 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.202 -1.407 . . . . 10.54 107.202 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 13.9 m-85 -149.4 145.11 18.68 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.24 -0.913 . . . . 18.39 110.79 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.06 81.56 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 121.394 1.396 . . . . 0.0 109.022 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.86 170.39 13.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.853 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.85 0.833 . . . . 0.0 109.338 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.35 111.92 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 m -130.35 94.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 122.93 1.348 . . . . 0.0 109.145 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.458 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.52 -152.05 0.4 Allowed 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.392 -1.276 . . . . 38.32 107.611 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.458 ' H ' ' CG2' ' A' ' 19' ' ' THR . 97.0 mt-10 -82.47 -54.35 5.26 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.813 -1.551 . . . . 55.13 106.813 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.3 29.19 7.77 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.388 -0.82 . . . . 0.0 110.727 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -100.5 150.85 22.24 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.963 -1.086 . . . . 0.0 109.697 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.37 111.55 22.68 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.384 -0.823 . . . . 11.68 110.698 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.59 127.75 41.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.02 142.18 21.43 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.433 -1.417 . . . . 12.44 110.801 -178.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.85 22.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 146.85 18.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.228 -0.92 . . . . 29.03 109.516 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.53 44.26 6.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.302 -1.519 . . . . 6.18 109.302 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.71 22.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.476 -1.014 . . . . 9.52 109.432 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.57 5.95 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.42 133.7 49.74 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 123.088 1.423 . . . . 0.0 110.574 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.83 103.15 15.89 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.374 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.12 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.561 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.2 mt -59.79 -50.3 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.962 -1.086 . . . . 0.0 110.276 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.609 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.28 157.63 43.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.983 -1.073 . . . . 0.0 110.724 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.609 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.05 65.56 65.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.789 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.39 31.65 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.655 1.57 . . . . 0.0 109.004 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.646 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.09 -46.37 7.81 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.58 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 110.044 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.646 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.49 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.69 -59.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.107 0 C-N-CA 122.592 2.194 . . . . 0.0 109.922 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 54.2 tt0 131.7 9.38 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 123.882 0.873 . . . . 0.0 108.785 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.0 m0 -71.96 166.01 23.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.73 -1.231 . . . . 14.29 110.436 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.555 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.0 m0 -129.6 145.09 51.52 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.284 -0.635 . . . . 11.8 109.284 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.17 96.64 5.93 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.87 128.76 56.05 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.884 0.849 . . . . 0.0 110.45 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.69 150.36 26.81 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.762 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.35 128.5 43.33 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.297 178.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.41 0.99 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 119.632 -1.918 . . . . 0.0 107.991 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.64 -4.55 4.31 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.46 33.79 6.99 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 115.25 -0.886 . . . . 14.41 112.306 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.762 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.89 164.11 29.79 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.658 1.729 . . . . 0.0 111.847 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.55 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 122.294 1.045 . . . . 0.0 112.53 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.19 156.85 12.84 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.233 -1.547 . . . . 7.25 109.233 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.42 150.81 43.04 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -1.15 . . . . 0.0 108.644 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.71 9.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.89 -1.131 . . . . 0.0 109.299 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.532 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.18 113.57 1.17 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 108.971 -1.204 . . . . 4.76 108.971 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.507 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 15.9 pttt -60.41 3.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.479 -0.763 . . . . 0.0 110.679 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -102.16 -7.52 22.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.325 -0.86 . . . . 14.84 109.281 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.13 8.25 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.302 -0.874 . . . . 10.23 109.486 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.44 156.5 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.059 -1.026 . . . . 6.97 109.522 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 2.6 p -106.75 160.73 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.444 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 54.4 t -107.72 134.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.449 -0.782 . . . . 0.0 109.699 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.11 -63.21 1.25 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.264 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.521 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 15.7 p -70.01 151.67 45.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 109.415 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.521 ' OD1' ' O ' ' A' ' 65' ' ' SER . 90.2 m-20 -146.67 152.75 39.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.14 -67.44 1.47 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.41 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.364 1.376 . . . . 0.0 109.722 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.54 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.72 124.93 32.07 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.22 29.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -1.157 . . . . 0.0 109.431 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.84 167.85 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.3 -0.875 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.33 46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.31 130.74 5.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.306 -1.114 . . . . 0.0 109.312 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.19 163.69 35.97 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.932 1.754 . . . . 0.0 108.854 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.445 ' H ' HE21 ' B' ' 97' ' ' GLN . 27.6 mt -135.46 119.77 26.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 122.05 0.929 . . . . 0.0 109.377 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.542 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.37 117.02 4.0 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.771 0.796 . . . . 0.0 109.995 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.06 4.9 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.542 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.72 -48.55 8.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.07 4.72 13.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.497 -0.752 . . . . 0.0 109.068 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.243 -0.911 . . . . 0.0 108.564 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -115.89 143.39 30.71 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.47 113.37 1.42 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.496 1.464 . . . . 0.0 110.604 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.5 mt -71.03 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.49 61.44 0.32 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.898 -1.126 . . . . 0.0 110.733 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.81 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.69 120.56 41.94 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.69 158.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.444 -0.785 . . . . 0.0 111.25 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.57 116.07 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.602 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.86 106.03 18.2 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.042 -1.036 . . . . 0.0 109.466 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.57 42.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.29 4.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.08 25.3 75.79 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.82 0.66 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.821 0.819 . . . . 0.0 109.657 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.445 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.39 143.6 46.12 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.67 139.93 33.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.55 -1.343 . . . . 0.0 110.661 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.45 131.94 49.89 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.19 -14.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 120.922 -1.112 . . . . 0.0 108.399 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.77 -26.95 15.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.728 -0.607 . . . . 0.0 110.635 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.24 -6.42 31.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.839 -1.163 . . . . 0.0 110.799 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.32 106.42 12.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.425 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.3 m -133.72 175.26 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.259 1.028 . . . . 0.0 111.066 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.8 148.59 46.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.419 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.64 28.54 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.738 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.74 -31.62 0.72 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.075 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.06 -15.41 4.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 110.186 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.68 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.277 -0.89 . . . . 0.0 110.256 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.59 59.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.598 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -69.12 138.3 39.51 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.655 1.57 . . . . 0.0 112.102 -177.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.302 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.77 56.94 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.168 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.835 . . . . 0.0 109.023 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.15 31.13 2.73 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.35 178.95 4.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.587 -0.949 . . . . 0.0 109.901 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.43 145.3 24.87 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.558 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.28 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.49 137.69 47.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.96 148.27 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.253 -0.904 . . . . 0.0 111.189 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.0 129.45 11.38 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.692 0.758 . . . . 0.0 110.237 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 51.02 22.97 1.33 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.561 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.96 20.37 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.32 -1.419 . . . . 0.0 109.698 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.31 142.78 31.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.502 -0.999 . . . . 0.0 108.755 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.34 152.91 36.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.363 -0.836 . . . . 0.0 110.722 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.8 m-85 -153.99 140.3 18.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.54 177.38 0.1 Allowed 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.344 -1.343 . . . . 0.0 108.415 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.6 -35.98 82.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 109.341 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.496 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.6 m -86.66 -43.76 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 111.327 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.74 83.85 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.79 -1.193 . . . . 0.0 108.143 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.46 13.7 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -64.55 -44.7 89.95 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.102 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.58 -34.45 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.536 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.59 -35.24 46.07 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.443 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.6 -81.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.34 16.48 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.406 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.54 51.33 15.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -1.133 . . . . 0.0 109.561 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.801 1 CA-C-O 70.798 -23.477 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.436 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.274 0.559 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.436 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.39 74.99 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.212 -1.17 . . . . 0.0 109.542 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.65 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -66.11 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 109.146 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.31 -54.26 2.0 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.446 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.475 ' N ' ' OG ' ' A' ' 65' ' ' SER . 5.2 t -69.41 158.07 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.32 131.53 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.447 -1.408 . . . . 0.0 111.603 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.91 129.22 45.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.9 m -63.45 154.4 32.33 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.501 1.143 . . . . 0.0 110.546 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 8.6 mp -114.41 -17.22 11.82 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.222 -1.399 . . . . 10.54 107.222 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.3 m-85 -149.57 145.08 18.54 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.07 -1.019 . . . . 18.39 110.794 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.06 81.4 1.69 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.479 1.452 . . . . 0.0 109.054 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.77 170.31 13.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.993 -1.067 . . . . 0.0 110.854 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.64 111.13 8.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.839 0.828 . . . . 0.0 109.369 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 112.0 10.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 32.8 m -130.27 94.19 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 122.873 1.32 . . . . 0.0 109.238 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.43 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.385 -1.28 . . . . 38.32 107.634 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -82.42 -54.33 5.29 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.824 -1.547 . . . . 55.13 106.824 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.1 mt-10 -109.38 29.3 7.68 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.364 -0.835 . . . . 0.0 110.728 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.47 150.79 22.28 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.966 -1.084 . . . . 0.0 109.776 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.25 111.38 22.4 Favored 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.385 -0.822 . . . . 11.68 110.796 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.38 127.63 41.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.93 142.24 21.58 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.385 -1.447 . . . . 12.44 110.839 -178.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.15 155.9 22.36 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 146.95 19.15 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.251 -0.906 . . . . 29.03 109.515 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.11 6.59 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.306 -1.517 . . . . 6.18 109.306 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.68 22.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.47 -1.018 . . . . 9.52 109.385 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.69 6.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.52 133.68 49.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 123.154 1.454 . . . . 0.0 110.504 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.75 103.12 15.86 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.372 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.481 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.11 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.534 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.2 mt -59.72 -50.36 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.881 -1.137 . . . . 0.0 110.259 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.605 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.59 43.65 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.973 -1.079 . . . . 0.0 110.736 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.605 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.05 65.54 65.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.79 165.4 31.55 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.628 1.552 . . . . 0.0 108.973 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.631 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.52 7.76 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.73 -59.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.309 0.576 . . . . 0.0 110.041 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.631 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.78 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 122.621 2.214 . . . . 0.0 109.908 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 67.6 mt-10 131.75 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.853 0.861 . . . . 0.0 108.768 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 12.8 m0 -71.85 165.9 23.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.578 -1.326 . . . . 14.29 110.451 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.433 ' CD2' ' HB2' ' A' ' 58' ' ' LYS . 24.9 m0 -129.57 145.03 51.51 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.237 -0.653 . . . . 11.8 109.237 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.99 96.62 5.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.84 56.1 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.928 0.871 . . . . 0.0 110.326 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.69 150.28 26.85 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.758 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.33 128.54 43.35 Favored 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 117.15 -1.82 . . . . 0.0 107.223 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.33 0.99 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 119.579 -1.951 . . . . 0.0 108.045 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.466 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.67 -4.68 4.46 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.55 33.97 6.86 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 115.309 -0.859 . . . . 14.41 112.261 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.758 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -138.0 164.08 29.95 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 119.645 1.722 . . . . 0.0 111.803 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-O 122.381 1.086 . . . . 0.0 112.417 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.04 156.74 12.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.211 -1.556 . . . . 7.25 109.211 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.34 150.83 43.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.261 -1.141 . . . . 0.0 108.598 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.67 8.91 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.969 -1.082 . . . . 0.0 109.266 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.15 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 N-CA-C 109.09 -1.158 . . . . 4.76 109.09 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.568 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.29 3.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.768 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 57' ' ' PRO . 47.2 p30 -102.1 -7.65 22.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.256 -0.902 . . . . 14.84 109.354 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.181 -0.949 . . . . 10.23 109.497 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.47 156.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.14 -0.975 . . . . 6.97 109.456 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.78 160.75 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.67 134.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.49 -0.756 . . . . 0.0 109.765 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.12 -63.27 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.599 -0.688 . . . . 0.0 109.182 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.4 p -69.89 151.59 45.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.062 -1.024 . . . . 0.0 109.491 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -146.59 152.64 39.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.21 -67.36 1.47 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.33 93.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.393 1.395 . . . . 0.0 109.725 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.01 82.48 1.74 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.04 32.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.112 -0.993 . . . . 0.0 109.437 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.18 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -1.121 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.34 46.85 0.2 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.19 130.76 5.37 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.414 -1.051 . . . . 0.0 109.405 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.4 Cg_endo -74.3 163.57 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.915 1.743 . . . . 0.0 108.881 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.447 ' H ' HE21 ' B' ' 97' ' ' GLN . 29.9 mt -135.38 119.71 26.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-O 122.082 0.944 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.32 117.0 3.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.885 0.85 . . . . 0.0 109.983 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.29 4.96 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.539 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.54 -48.52 8.3 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.302 -1.116 . . . . 0.0 109.503 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.1 4.79 13.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 53.59 41.22 32.13 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -115.9 143.34 30.61 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.44 113.48 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.436 1.424 . . . . 0.0 110.542 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -70.93 158.36 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.47 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.872 -1.142 . . . . 0.0 110.687 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -101.96 0.15 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.662 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.6 42.14 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.82 158.68 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.736 0.779 . . . . 0.0 111.144 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.52 115.99 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.607 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.86 106.05 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 109.558 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.53 42.62 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.627 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.22 17.06 4.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.33 75.79 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.29 -154.7 0.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.63 0.729 . . . . 0.0 109.813 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.447 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.44 143.47 45.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.9 m95 -141.65 140.03 33.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.53 -1.356 . . . . 0.0 110.584 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.48 132.01 50.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.37 -14.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.968 -1.082 . . . . 0.0 108.315 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.83 -26.9 15.46 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.776 -0.577 . . . . 0.0 110.616 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.24 -6.47 31.1 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.94 -1.1 . . . . 0.0 110.787 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.427 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.4 m -133.64 175.31 11.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.232 1.015 . . . . 0.0 111.072 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.82 148.76 46.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.329 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.96 28.67 1.77 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 109.65 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.417 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.6 0.72 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.354 -0.841 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.14 -15.52 4.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.57 0.32 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.205 -0.934 . . . . 0.0 110.088 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.52 109.65 59.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.604 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -69.19 138.25 39.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.716 1.611 . . . . 0.0 112.099 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.321 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.74 56.94 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.151 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.604 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 0.0 109.072 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.27 30.96 2.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.567 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.18 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.58 -0.953 . . . . 0.0 110.04 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.38 145.44 24.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.37 169.48 9.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.47 137.69 47.32 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.14 148.35 28.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.213 -0.929 . . . . 0.0 111.174 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.595 0.712 . . . . 0.0 110.306 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.22 22.95 1.47 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.648 -0.657 . . . . 0.0 109.435 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.627 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.47 30.95 20.41 Favored Glycine 0 N--CA 1.482 1.75 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.31 142.64 31.39 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.534 -0.98 . . . . 0.0 108.873 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.38 152.76 36.2 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.793 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.2 m-85 -153.8 140.31 18.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.63 177.44 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.414 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.59 -35.9 82.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.4 m -86.65 -43.86 12.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 111.301 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.74 83.73 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.834 -1.167 . . . . 0.0 108.1 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.78 -56.38 14.24 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.64 -44.79 89.34 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.078 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.44 -34.32 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.74 -35.35 44.86 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.279 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.48 -81.64 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.095 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.42 31.42 16.41 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.7 m-20 48.56 51.17 15.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -1.103 . . . . 0.0 109.613 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.977 -23.392 . . . . 0.0 109.455 179.964 . . . . . . . . 2 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.35 74.81 0.12 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.9 35.25 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.057 -1.26 . . . . 0.0 109.58 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.11 148.67 43.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.142 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -66.06 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.105 -0.997 . . . . 0.0 109.275 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.23 -54.37 2.0 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.441 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.8 m-70 -145.2 73.88 1.38 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.623 ' H ' ' HG ' ' A' ' 65' ' ' SER . 38.6 t -69.38 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.36 131.47 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.458 -1.401 . . . . 0.0 111.549 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -99.8 129.29 45.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.5 m -63.44 154.45 32.16 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.483 1.135 . . . . 0.0 110.598 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 87.1 mt -114.37 -17.35 11.81 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.251 -1.388 . . . . 10.54 107.251 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.0 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.044 . . . . 18.39 110.783 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -73.06 81.55 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.438 1.425 . . . . 0.0 108.965 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.5 t80 -71.85 170.4 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.845 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.7 111.04 7.93 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.787 0.803 . . . . 0.0 109.472 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.32 111.93 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -130.43 94.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 123.056 1.408 . . . . 0.0 109.147 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.46 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.38 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.272 -1.331 . . . . 38.32 107.569 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' H ' ' CG2' ' A' ' 19' ' ' THR . 97.3 mt-10 -82.39 -54.39 5.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.923 -1.51 . . . . 55.13 106.923 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.442 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.17 29.01 7.91 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.4 -0.812 . . . . 0.0 110.762 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.629 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -100.4 150.9 22.14 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.863 -1.148 . . . . 0.0 109.787 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.36 111.39 22.4 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.419 -0.801 . . . . 11.68 110.756 -178.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.4 127.68 41.63 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.27 21.67 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.4 -1.437 . . . . 12.44 110.943 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.82 22.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.87 18.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.242 -0.911 . . . . 29.03 109.617 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.63 44.09 6.61 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.317 -1.513 . . . . 6.18 109.317 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.82 22.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.541 -0.976 . . . . 9.52 109.396 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.06 108.64 6.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.79 49.68 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.192 1.472 . . . . 0.0 110.527 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.477 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.49 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.07 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -0.782 . . . . 0.0 111.53 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.521 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.0 mt -59.76 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.968 -1.082 . . . . 0.0 110.267 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.599 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.63 43.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.933 -1.105 . . . . 0.0 110.844 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.03 65.5 65.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.836 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HG3' ' HZ1' ' A' ' 45' ' ' LYS . 11.0 Cg_endo -74.86 165.4 31.51 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.578 1.518 . . . . 0.0 108.96 177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.635 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.52 7.75 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.59 -59.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.391 0.615 . . . . 0.0 110.141 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.56 -59.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.583 2.188 . . . . 0.0 109.909 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 17.8 pt-20 131.83 9.27 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.892 0.877 . . . . 0.0 108.786 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.527 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.1 m0 -71.77 165.92 23.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.669 -1.27 . . . . 14.29 110.48 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.479 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.4 m0 -129.63 144.99 51.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.243 -0.651 . . . . 11.8 109.243 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HZ1' ' HG3' ' A' ' 37' ' ' PRO . 65.8 mttp -78.93 96.58 5.75 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.914 0.864 . . . . 0.0 110.373 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.72 150.37 26.75 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.775 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.261 -1.776 . . . . 0.0 107.163 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.37 1.0 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.675 -1.89 . . . . 0.0 108.011 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.448 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.68 -4.59 4.38 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.42 33.88 6.95 Favored Glycine 0 N--CA 1.48 1.627 0 CA-C-N 115.386 -0.825 . . . . 14.41 112.297 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.775 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.14 29.7 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.633 1.717 . . . . 0.0 111.849 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.59 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-O 122.362 1.077 . . . . 0.0 112.434 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.2 156.75 12.73 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.338 -1.505 . . . . 7.25 109.338 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.23 150.89 43.27 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.296 -1.12 . . . . 0.0 108.681 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.71 8.95 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.84 -1.162 . . . . 0.0 109.342 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.22 113.6 1.18 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.074 -1.164 . . . . 4.76 109.074 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.5 pttt -60.37 3.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.487 -0.758 . . . . 0.0 110.603 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.7 m-20 -102.05 -7.66 22.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.144 -0.973 . . . . 14.84 109.323 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.22 30.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 10.23 109.494 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.38 156.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 6.97 109.589 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.0 m -106.77 160.69 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.2 t -107.59 134.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.411 -0.806 . . . . 0.0 109.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.19 -63.28 1.25 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.623 ' HG ' ' H ' ' A' ' 8' ' ' VAL . 13.8 p -69.91 151.61 45.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.983 -1.073 . . . . 0.0 109.418 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -146.59 152.68 39.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.23 1.48 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.254 1.302 . . . . 0.0 109.732 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.7 1.79 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.9 125.09 32.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.86 156.21 28.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -1.181 . . . . 0.0 109.507 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.73 167.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.93 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.31 130.75 5.33 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.383 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.28 163.8 35.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.816 1.677 . . . . 0.0 108.828 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.451 ' H ' HE21 ' B' ' 97' ' ' GLN . 61.3 mt -135.52 119.75 26.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 122.072 0.939 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.541 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.29 116.94 3.92 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.819 0.818 . . . . 0.0 109.96 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.3 4.96 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.541 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.53 -48.62 8.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -1.057 . . . . 0.0 109.455 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.86 13.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -115.91 143.49 30.91 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.402 ' HA ' HG12 ' B' ' 78' ' ' ILE . 5.6 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.511 1.474 . . . . 0.0 110.494 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -70.96 158.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.52 61.48 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 110.615 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.0 -101.93 0.15 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.62 42.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.77 158.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.419 -0.801 . . . . 0.0 111.195 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.55 116.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.607 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.033 -1.042 . . . . 0.0 109.622 -179.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.51 42.68 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.637 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.15 4.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.38 25.11 76.16 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.16 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.788 0.804 . . . . 0.0 109.726 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.35 143.49 46.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.64 139.99 33.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.416 -1.428 . . . . 0.0 110.646 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.465 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.58 131.94 50.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.16 -14.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.909 -1.119 . . . . 0.0 108.348 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.465 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.83 -26.97 15.44 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 110.638 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.06 -6.6 31.46 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.93 -1.107 . . . . 0.0 110.787 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.24 106.34 12.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.431 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.3 m -133.64 175.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.267 1.032 . . . . 0.0 111.088 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.85 148.66 46.45 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.354 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.87 28.77 1.72 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.676 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.413 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.82 -31.62 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.309 -0.87 . . . . 0.0 110.086 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.24 -15.25 4.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.54 47.6 0.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.232 -0.918 . . . . 0.0 110.24 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.59 59.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.596 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.12 138.26 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.79 1.66 . . . . 0.0 112.006 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.325 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.038 0.0 OUTLIER -95.77 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.075 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.596 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.04 -55.24 1.61 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.001 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.98 2.75 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.57 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.36 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.416 -1.05 . . . . 0.0 109.958 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.53 145.41 24.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.797 . . . . 0.0 109.295 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.39 169.55 9.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.472 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.54 137.66 47.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.96 148.3 28.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.203 -0.936 . . . . 0.0 111.18 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.469 -0.77 . . . . 0.0 110.327 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.31 22.8 1.49 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.637 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 31.02 20.41 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.79 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.37 142.8 31.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.61 -0.936 . . . . 0.0 108.799 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.43 152.82 36.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.331 -0.855 . . . . 0.0 110.673 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.506 ' HA ' ' SG ' ' B' ' 105' ' ' CYS . 57.5 m-85 -153.84 140.36 18.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.3 m -57.72 177.55 0.1 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.441 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.67 -35.92 82.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.853 . . . . 0.0 109.436 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.528 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.1 m -86.61 -43.81 12.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 111.349 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.73 83.79 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.738 -1.226 . . . . 0.0 108.177 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.5 13.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.42 -44.92 89.72 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.184 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.43 -34.36 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.63 -35.35 45.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.384 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.7 m-85 -158.51 -81.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.054 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.46 31.44 16.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.39 51.37 15.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.327 -1.102 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.698 1 CA-C-O 70.992 -23.385 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.309 0.576 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.98 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.91 35.2 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -1.208 . . . . 0.0 109.666 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.62 43.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.296 -0.878 . . . . 0.0 109.139 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.5 t -65.92 93.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -121.26 -54.32 2.0 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.31 73.88 1.37 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.41 158.13 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -145.44 131.6 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.48 -1.387 . . . . 0.0 111.513 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -100.03 129.16 46.06 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.3 m -63.3 154.39 31.84 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.497 1.141 . . . . 0.0 110.617 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 93.1 mt -114.37 -17.28 11.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.211 -1.403 . . . . 10.54 107.211 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.3 m-85 -149.49 145.06 18.54 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 121.133 -0.979 . . . . 18.39 110.794 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -72.87 81.4 1.64 Allowed 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.468 1.445 . . . . 0.0 109.07 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.76 170.33 13.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.923 -1.111 . . . . 0.0 110.91 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.07 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.776 0.798 . . . . 0.0 109.431 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.31 111.96 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.29 94.25 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 122.9 1.333 . . . . 0.0 109.134 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.537 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 2.6 m -144.46 -151.98 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.362 -1.29 . . . . 38.32 107.581 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.537 ' H ' ' CG2' ' A' ' 19' ' ' THR . 76.7 mm-40 -82.5 -54.29 5.3 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.903 -1.518 . . . . 55.13 106.903 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.5 mt-10 -109.3 29.2 7.76 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.53 150.93 22.17 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.907 -1.12 . . . . 0.0 109.741 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.38 22.39 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.342 -0.849 . . . . 11.68 110.82 -178.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.36 127.7 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.03 142.22 21.47 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.327 -1.483 . . . . 12.44 110.851 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.521 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.87 22.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 146.93 18.91 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.255 -0.903 . . . . 29.03 109.492 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.14 6.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.273 -1.531 . . . . 6.18 109.273 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.29 114.79 22.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.652 -0.911 . . . . 9.52 109.436 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.99 108.57 5.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.65 49.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 123.21 1.481 . . . . 0.0 110.549 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.6 102.95 15.69 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.48 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.485 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 111.49 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.516 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.0 mt -59.85 -50.39 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 120.917 -1.114 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.603 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.16 157.62 43.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.99 -1.069 . . . . 0.0 110.831 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.603 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.04 65.52 65.35 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.28 31.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.721 1.614 . . . . 0.0 109.027 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.645 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.49 7.77 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.67 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.353 0.597 . . . . 0.0 110.037 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.89 -47.54 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.601 ' O ' ' HB3' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.64 -59.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.608 2.205 . . . . 0.0 109.996 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.9 pt-20 131.67 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 123.878 0.871 . . . . 0.0 108.806 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 11.7 m0 -71.79 165.91 23.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.712 -1.242 . . . . 14.29 110.527 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.466 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.1 m0 -129.46 145.12 51.47 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.633 -0.667 . . . . 11.8 109.302 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.17 96.61 5.92 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.6 p -115.92 128.81 56.06 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.966 0.888 . . . . 0.0 110.347 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.63 150.48 26.8 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.765 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.46 128.57 43.51 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 117.275 -1.77 . . . . 0.0 107.216 177.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.44 1.02 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.611 -1.931 . . . . 0.0 107.972 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.58 -4.77 4.43 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.655 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 34.04 6.85 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.438 -0.801 . . . . 14.41 112.215 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.765 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.96 164.11 29.84 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.628 1.714 . . . . 0.0 111.765 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.55 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.305 1.05 . . . . 0.0 112.507 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.14 156.69 12.61 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.324 -1.511 . . . . 7.25 109.324 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.29 150.76 43.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.171 -1.194 . . . . 0.0 108.674 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.98 136.75 9.04 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.954 -1.092 . . . . 0.0 109.289 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.12 113.46 1.11 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 N-CA-C 109.052 -1.172 . . . . 4.76 109.052 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.4 pttt -60.36 3.23 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.443 -0.786 . . . . 0.0 110.71 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.3 m120 -102.17 -7.48 22.17 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.3 -0.875 . . . . 14.84 109.326 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.05 8.16 31.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.089 -1.007 . . . . 10.23 109.343 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.45 156.62 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.219 -0.926 . . . . 6.97 109.561 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.445 HG21 ' H ' ' A' ' 63' ' ' VAL . 7.5 p -106.84 160.86 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.445 ' H ' HG21 ' A' ' 62' ' ' VAL . 5.5 p -107.72 134.31 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.2 -63.14 1.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.566 -0.709 . . . . 0.0 109.202 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 31.8 m -70.15 151.69 45.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.99 -1.069 . . . . 0.0 109.417 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -146.58 152.67 39.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.32 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.31 1.34 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.58 1.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.79 124.96 32.16 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.94 156.19 28.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -1.134 . . . . 0.0 109.41 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.83 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.28 46.88 0.2 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.27 130.76 5.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.0 109.463 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.15 163.65 36.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.024 1.816 . . . . 0.0 108.811 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.434 ' H ' HE21 ' B' ' 97' ' ' GLN . 74.8 mt -135.47 119.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.073 0.939 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.48 117.05 4.07 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.833 0.825 . . . . 0.0 109.962 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.13 4.97 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.538 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.64 -48.6 8.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.372 -1.075 . . . . 0.0 109.422 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.12 4.83 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 53.55 41.26 32.12 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . 0.418 HH11 ' HB3' ' B' ' 84' ' ' ARG . 2.0 mmm180 -115.98 143.55 31.08 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.407 ' HA ' HG12 ' B' ' 78' ' ' ILE . 5.7 Cg_exo -56.45 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.417 1.411 . . . . 0.0 110.611 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -70.89 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.6 61.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.877 -1.139 . . . . 0.0 110.667 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.08 0.15 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.71 42.51 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.82 158.72 3.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 111.155 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.6 116.16 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.612 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.89 106.15 18.28 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 109.534 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.53 159.5 42.67 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.23 4.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.22 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.851 -0.793 . . . . 0.0 109.856 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.448 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.48 143.54 45.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.5 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.526 -1.359 . . . . 0.0 110.646 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.455 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.61 132.12 50.82 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -53.36 -14.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.927 -1.108 . . . . 0.0 108.408 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.455 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.68 -27.18 15.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.778 -0.576 . . . . 0.0 110.589 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -97.94 -6.63 31.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.901 -1.124 . . . . 0.0 110.899 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.15 106.29 12.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.43 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.0 m -133.56 175.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.358 1.075 . . . . 0.0 111.073 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.95 148.7 46.72 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.2 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.65 1.74 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.837 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.43 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.47 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.321 -0.862 . . . . 0.0 110.196 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.23 -15.29 4.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.296 -0.878 . . . . 0.0 110.076 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.61 47.57 0.35 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.794 . . . . 0.0 110.267 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.5 59.05 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.07 138.23 39.5 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.73 1.62 . . . . 0.0 112.179 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.314 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.8 57.04 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.196 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.12 -55.29 1.64 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 108.997 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.07 31.0 2.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.576 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.31 178.98 4.13 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.611 -0.935 . . . . 0.0 109.94 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.37 145.3 24.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.564 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.25 169.57 9.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.5 m-85 -132.57 137.65 47.17 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.32 28.85 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.14 -0.975 . . . . 0.0 111.204 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.24 11.2 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.615 0.722 . . . . 0.0 110.324 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.36 22.74 1.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.96 20.32 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.741 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.7 mt -143.25 142.63 31.44 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.608 -0.937 . . . . 0.0 108.873 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.16 152.8 36.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.507 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.6 m-85 -153.87 140.34 18.76 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.6 m -57.74 177.44 0.11 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.299 -1.361 . . . . 0.0 108.401 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.58 -35.94 82.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.417 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.507 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.6 m -86.71 -43.66 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 111.311 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.466 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.83 -43.55 83.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.817 -1.177 . . . . 0.0 108.206 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.82 -56.37 14.37 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.6 -44.91 89.13 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.009 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.45 -34.35 61.32 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.63 -35.34 45.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.381 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.58 -81.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 110.096 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.4 31.34 16.69 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.48 51.24 15.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -1.084 . . . . 0.0 109.576 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.981 -23.39 . . . . 0.0 109.454 179.915 . . . . . . . . 2 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.84 0.12 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.95 35.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -1.172 . . . . 0.0 109.624 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -72.99 148.6 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.167 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -65.96 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.288 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.41 1.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.23 73.94 1.38 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.46 158.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m -145.34 131.45 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.416 -1.427 . . . . 0.0 111.564 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.92 129.22 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 m -63.41 154.43 32.1 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.487 1.136 . . . . 0.0 110.572 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 90.5 mt -114.31 -17.36 11.84 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.274 -1.38 . . . . 10.54 107.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 13.9 m-85 -149.51 144.96 18.39 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.16 -0.963 . . . . 18.39 110.803 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.97 81.54 1.65 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.392 1.395 . . . . 0.0 109.024 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.92 170.32 13.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.978 -1.077 . . . . 0.0 110.86 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.63 111.08 7.99 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.831 0.824 . . . . 0.0 109.47 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 111.86 10.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.2 t -130.23 94.35 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.938 1.352 . . . . 0.0 109.2 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.624 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 4.9 m -144.49 -151.97 0.39 Allowed 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.335 -1.302 . . . . 38.32 107.557 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.624 ' H ' ' CG2' ' A' ' 19' ' ' THR . 45.6 tp10 -82.41 -54.36 5.27 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.885 -1.524 . . . . 55.13 106.885 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.8 mt-10 -109.38 29.23 7.74 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.447 -0.783 . . . . 0.0 110.712 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.643 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -100.49 150.98 22.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.811 -1.181 . . . . 0.0 109.727 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.443 -0.786 . . . . 11.68 110.765 -178.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.53 127.69 41.77 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.83 142.25 21.68 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.352 -1.467 . . . . 12.44 110.876 -178.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.76 22.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 146.91 18.73 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.227 -0.921 . . . . 29.03 109.452 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.17 6.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.326 -1.51 . . . . 6.18 109.326 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.67 22.72 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.487 -1.008 . . . . 9.52 109.416 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.97 108.69 6.02 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.59 133.63 50.01 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.201 1.477 . . . . 0.0 110.532 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.71 103.05 15.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.466 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.0 92.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.573 -0.705 . . . . 0.0 111.496 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.509 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.4 mt -59.65 -50.52 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.94 -1.1 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.607 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.12 157.67 43.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.991 -1.068 . . . . 0.0 110.788 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.607 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.07 65.6 65.35 Favored Pre-proline 0 N--CA 1.486 1.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.761 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.74 165.34 31.71 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.715 1.61 . . . . 0.0 108.947 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.16 -46.3 7.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.5 m-20 57.62 -59.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.442 0.639 . . . . 0.0 110.054 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.71 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.6 ' O ' ' HB3' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.61 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.128 0 C-N-CA 122.597 2.198 . . . . 0.0 109.968 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.86 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 22.1 m0 -71.81 165.87 23.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.626 -1.296 . . . . 14.29 110.519 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.469 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.8 m0 -129.55 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.286 -0.635 . . . . 11.8 109.286 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.15 96.66 5.92 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.6 p -116.0 128.8 56.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.954 0.883 . . . . 0.0 110.378 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.6 150.44 26.86 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.766 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.45 128.58 43.52 Favored 'General case' 0 N--CA 1.509 2.487 0 C-N-CA 117.266 -1.773 . . . . 0.0 107.215 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.5 -18.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.734 -1.854 . . . . 0.0 107.913 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.447 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.67 -4.55 4.33 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.651 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.35 33.96 6.94 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 115.257 -0.883 . . . . 14.41 112.286 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.766 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.07 29.86 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.745 1.772 . . . . 0.0 111.829 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.97 154.58 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 122.335 1.064 . . . . 0.0 112.52 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' HD22 ' A' ' 23' ' ' LEU . . . 172.21 156.84 12.85 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.236 -1.546 . . . . 7.25 109.236 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.51 150.97 42.76 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.296 -1.12 . . . . 0.0 108.613 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.12 136.67 8.91 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.82 -1.175 . . . . 0.0 109.265 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.04 113.46 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 108.992 -1.195 . . . . 4.76 108.992 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 62.7 pttt -60.33 3.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 110.66 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.3 m-20 -102.01 -7.66 22.15 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.275 -0.891 . . . . 14.84 109.334 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.456 ' O ' HG13 ' A' ' 61' ' ' VAL . 3.4 m-85 -88.96 8.11 31.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.239 -0.913 . . . . 10.23 109.56 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 60' ' ' TYR . 32.0 m -147.32 156.57 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 6.97 109.542 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 63' ' ' VAL . 15.0 t -106.86 160.69 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 10.4 p -107.57 134.34 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.392 -0.818 . . . . 0.0 109.814 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.19 -63.15 1.26 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 33.9 m -70.05 151.68 45.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.956 -1.09 . . . . 0.0 109.503 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -146.75 152.69 39.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.27 1.48 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.52 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.209 1.273 . . . . 0.0 109.637 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.53 1.75 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.05 32.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 156.27 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 109.532 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.92 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.27 46.92 0.2 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.3 130.73 5.32 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.283 -1.128 . . . . 0.0 109.413 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.28 163.58 36.1 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.872 1.714 . . . . 0.0 108.848 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.442 ' H ' HE21 ' B' ' 97' ' ' GLN . 72.7 mt -135.33 119.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 122.001 0.905 . . . . 0.0 109.379 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.1 t -58.24 116.88 3.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.75 -0.1 4.73 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.78 -48.41 8.25 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.361 -1.082 . . . . 0.0 109.397 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.19 4.89 13.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.521 -0.737 . . . . 0.0 109.07 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -115.94 143.32 30.61 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.415 ' HA ' HG12 ' B' ' 78' ' ' ILE . 5.8 Cg_exo -56.33 113.25 1.36 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.49 1.46 . . . . 0.0 110.636 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.7 mt -70.9 158.53 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.642 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.6 61.44 0.32 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.873 -1.142 . . . . 0.0 110.615 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.96 -101.96 0.15 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.74 120.61 42.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.67 158.75 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.698 0.761 . . . . 0.0 111.186 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.59 115.92 47.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.611 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.81 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.48 42.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.32 4.35 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.3 75.82 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.8 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.747 0.784 . . . . 0.0 109.684 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.457 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.41 143.4 45.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.46 140.06 33.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.606 -1.309 . . . . 0.0 110.651 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.469 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.5 131.93 50.0 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 t -53.17 -14.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.988 -1.07 . . . . 0.0 108.465 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.469 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.8 -26.87 15.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.762 -0.586 . . . . 0.0 110.608 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.14 -6.51 31.37 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.909 -1.119 . . . . 0.0 110.804 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -80.27 106.31 12.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.425 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.4 m -133.58 175.39 11.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.153 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.83 148.69 46.3 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.375 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.74 1.73 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.428 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.83 -31.74 0.71 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 110.135 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.08 -15.32 4.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.104 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.63 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.69 59.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.595 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.14 138.35 39.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.636 1.558 . . . . 0.0 112.144 -177.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.81 56.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.172 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.595 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.98 -55.35 1.57 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.04 2.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.57 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.96 4.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.429 -1.042 . . . . 0.0 109.977 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.51 145.28 24.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.5 137.72 47.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.06 148.34 28.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.353 -0.842 . . . . 0.0 111.266 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.95 129.31 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.724 . . . . 0.0 110.424 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.97 1.43 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 30.94 20.63 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.77 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -143.27 142.66 31.43 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.968 . . . . 0.0 108.853 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.93 36.27 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.735 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.8 m-85 -153.99 140.28 18.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.1 m -57.54 177.46 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.404 -1.318 . . . . 0.0 108.508 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.64 -35.99 82.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.5 m -86.54 -43.79 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 111.426 -178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.85 83.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.812 -1.18 . . . . 0.0 108.155 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.75 -56.49 13.49 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.153 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.55 -34.29 61.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.71 -35.24 45.19 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.357 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.52 -81.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.45 31.37 16.45 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.57 51.2 15.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -1.09 . . . . 0.0 109.561 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.476 -39.647 1 CA-C-O 70.829 -23.462 . . . . 0.0 109.479 -179.975 . . . . . . . . 2 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.407 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.407 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.36 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.03 35.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -1.102 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.8 ttm-85 -73.01 148.62 44.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.127 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.05 93.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.3 mt -121.19 -54.27 2.01 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.32 74.04 1.38 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.55 157.97 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.2 131.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.365 -1.459 . . . . 0.0 111.553 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -99.9 129.27 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -63.47 154.35 32.57 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.499 1.142 . . . . 0.0 110.544 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 91.7 mt -114.3 -17.29 11.86 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.221 -1.4 . . . . 10.54 107.221 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.2 m-85 -149.48 145.07 18.56 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.154 -0.966 . . . . 18.39 110.768 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.98 81.51 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.345 1.363 . . . . 0.0 109.059 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.4 t80 -71.88 170.3 13.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.912 -1.117 . . . . 0.0 110.821 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.58 111.16 8.07 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.809 0.814 . . . . 0.0 109.389 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.27 111.89 10.61 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.37 94.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.904 1.335 . . . . 0.0 109.197 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.383 -1.28 . . . . 38.32 107.63 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.41 -54.31 5.31 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.936 -1.505 . . . . 55.13 106.936 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.6 mt-10 -109.25 29.21 7.74 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.47 -0.769 . . . . 0.0 110.827 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.616 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.61 150.92 22.21 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.861 -1.149 . . . . 0.0 109.682 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.42 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.43 22.49 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.39 -0.819 . . . . 11.68 110.71 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.45 127.68 41.69 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.92 142.27 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.436 -1.415 . . . . 12.44 110.798 -178.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.32 155.87 22.17 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.94 18.43 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.266 -0.896 . . . . 29.03 109.506 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 44.09 6.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.286 -1.526 . . . . 6.18 109.286 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.87 23.01 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.534 -0.98 . . . . 9.52 109.358 -179.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.22 108.74 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.56 133.75 49.81 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 123.228 1.49 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.86 103.11 15.86 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 113.745 -1.571 . . . . 0.0 107.351 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.495 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.521 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.0 mt -59.9 -50.43 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.145 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.6 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.17 157.6 43.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.026 -1.046 . . . . 0.0 110.786 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.6 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.01 65.57 65.7 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.767 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.43 31.56 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.567 1.512 . . . . 0.0 109.145 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.11 -46.42 7.78 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.63 -59.43 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.421 0.629 . . . . 0.0 110.071 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.624 2.216 . . . . 0.0 109.899 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 75.2 mt-10 131.86 9.31 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 12.8 m0 -71.85 165.91 23.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.619 -1.301 . . . . 14.29 110.385 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.539 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.1 m0 -129.64 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.287 -0.635 . . . . 11.8 109.287 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.99 96.58 5.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.69 55.98 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.91 0.862 . . . . 0.0 110.488 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.5 150.31 27.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.774 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 117.226 -1.789 . . . . 0.0 107.289 177.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.46 1.01 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.652 -1.905 . . . . 0.0 108.013 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.452 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.61 -4.55 4.26 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.655 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.42 33.95 6.92 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-N 115.355 -0.839 . . . . 14.41 112.253 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.774 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.06 29.96 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-N 119.71 1.755 . . . . 0.0 111.859 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.83 154.56 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.231 1.015 . . . . 0.0 112.601 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.24 -1.544 . . . . 7.25 109.24 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.29 150.87 43.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -1.182 . . . . 0.0 108.605 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.06 136.83 9.06 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.075 -1.016 . . . . 0.0 109.225 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.23 113.51 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 108.935 -1.217 . . . . 4.76 108.935 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 25.6 pttm -60.23 2.95 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.453 -0.78 . . . . 0.0 110.798 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.9 m120 -101.96 -7.56 22.29 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 14.84 109.297 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.11 8.34 30.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.289 -0.882 . . . . 10.23 109.481 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.1 m -147.51 156.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.239 -0.913 . . . . 6.97 109.389 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.82 160.78 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.405 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 73.1 t -107.62 134.22 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.435 -0.791 . . . . 0.0 109.834 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.436 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 97.9 mt -105.14 -63.08 1.26 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.636 -0.665 . . . . 0.0 109.207 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.491 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 19.4 m -70.11 151.55 45.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 65' ' ' SER . 85.6 m-20 -146.43 152.8 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.34 1.47 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.4 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.298 1.332 . . . . 0.0 109.669 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.6 1.77 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.83 124.93 32.15 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.121 -0.987 . . . . 0.0 109.395 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.19 28.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -1.137 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.78 167.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.444 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.39 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.31 130.84 5.37 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.346 -1.091 . . . . 0.0 109.291 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.4 Cg_endo -74.34 163.65 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.941 1.761 . . . . 0.0 108.875 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.44 ' H ' HE21 ' B' ' 97' ' ' GLN . 61.7 mt -135.42 119.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 122.054 0.93 . . . . 0.0 109.313 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.2 t -58.33 116.94 3.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 110.045 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.85 -0.16 4.91 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.537 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.55 -48.72 8.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -1.121 . . . . 0.0 109.33 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.01 4.81 13.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 53.62 41.25 32.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . 0.436 ' NH1' ' O ' ' A' ' 64' ' ' LEU . 5.3 mmm180 -115.95 143.46 30.89 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.416 1.411 . . . . 0.0 110.566 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.3 mt -70.87 158.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.58 61.57 0.32 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.885 -1.134 . . . . 0.0 110.648 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.16 -101.91 0.15 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.66 120.75 42.61 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.89 158.61 3.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.524 -0.735 . . . . 0.0 111.205 -177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.6 115.97 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.615 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.7 106.01 18.18 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.687 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.61 42.46 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.92 17.28 4.2 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.24 25.17 76.01 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.14 -154.75 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.776 0.798 . . . . 0.0 109.758 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.39 143.52 46.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.53 140.01 33.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.462 -1.399 . . . . 0.0 110.644 -177.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.51 131.89 49.9 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.16 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 120.866 -1.146 . . . . 0.0 108.343 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.11 15.41 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.848 -0.533 . . . . 0.0 110.61 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.13 -6.43 31.56 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 110.746 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.12 106.24 12.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.429 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.2 m -133.57 175.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 122.219 1.009 . . . . 0.0 111.143 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.82 148.71 46.18 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.222 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.7 1.74 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.072 -1.018 . . . . 0.0 109.596 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.8 0.71 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.407 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.36 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.407 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.59 47.75 0.34 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.314 -0.866 . . . . 0.0 110.131 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.57 109.62 59.67 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.6 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -69.08 138.32 39.67 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.656 1.57 . . . . 0.0 112.059 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.305 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.78 56.87 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.131 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.6 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.15 1.69 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.1 30.96 2.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.35 178.87 4.17 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.411 -1.052 . . . . 0.0 109.953 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.35 145.39 24.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.365 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.42 169.39 9.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 109.504 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.67 47.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.05 148.29 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.256 -0.902 . . . . 0.0 111.22 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.93 129.41 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.09 22.93 1.37 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.491 -0.756 . . . . 0.0 109.531 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.99 20.26 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -143.33 142.74 31.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.577 -0.955 . . . . 0.0 108.738 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.81 36.26 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.903 . . . . 0.0 110.721 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.7 m-85 -153.9 140.23 18.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.49 177.48 0.1 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.339 -1.344 . . . . 0.0 108.49 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.65 -36.06 82.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 109.301 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.531 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.5 m -86.65 -43.73 12.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.843 . . . . 0.0 111.325 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.72 83.67 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.698 -1.251 . . . . 0.0 108.187 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.7 -56.56 13.03 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.51 -44.75 89.93 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.46 -34.42 61.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.536 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.65 -35.22 45.7 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.39 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.62 -81.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.838 . . . . 0.0 110.075 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.33 31.47 16.49 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.422 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.42 51.3 15.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.245 -1.15 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.749 1 CA-C-O 71.145 -23.312 . . . . 0.0 109.454 179.98 . . . . . . . . 2 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.96 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -162.0 35.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.082 -1.246 . . . . 0.0 109.606 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -72.95 148.59 44.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.129 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.0 93.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.277 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 mt -121.37 -54.25 1.99 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.438 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.34 74.1 1.38 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.65 ' H ' ' HG ' ' A' ' 65' ' ' SER . 82.1 t -69.56 158.12 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.39 131.53 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.401 -1.437 . . . . 0.0 111.538 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -99.92 129.23 45.98 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.1 m -63.45 154.29 32.69 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.513 1.149 . . . . 0.0 110.614 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.3 mt -114.29 -17.3 11.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.155 -1.424 . . . . 10.54 107.155 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 13.9 m-85 -149.56 145.04 18.48 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.19 -0.944 . . . . 18.39 110.798 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -73.02 81.47 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.506 1.471 . . . . 0.0 109.036 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.2 t80 -71.78 170.31 13.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.125 . . . . 0.0 110.944 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.0 7.92 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.738 0.78 . . . . 0.0 109.459 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.0 10.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.33 94.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-O 122.907 1.337 . . . . 0.0 109.26 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.474 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.6 m -144.36 -151.93 0.39 Allowed 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.301 -1.318 . . . . 38.32 107.701 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.474 ' H ' ' CG2' ' A' ' 19' ' ' THR . 96.2 mt-10 -82.51 -54.42 5.2 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.84 -1.541 . . . . 55.13 106.84 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.46 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.4 mt-10 -109.3 29.28 7.69 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.357 -0.839 . . . . 0.0 110.759 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.43 150.89 22.16 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.812 -1.18 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.451 -0.78 . . . . 11.68 110.756 -178.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.39 127.72 41.67 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.99 142.16 21.44 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.386 -1.446 . . . . 12.44 110.905 -178.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.78 22.52 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 146.98 18.09 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.389 -0.924 . . . . 29.03 109.603 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.56 44.18 6.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.248 -1.541 . . . . 6.18 109.248 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.82 22.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.545 -0.973 . . . . 9.52 109.452 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.13 108.66 6.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.46 133.81 49.6 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 123.104 1.431 . . . . 0.0 110.588 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.09 15.84 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.304 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.488 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.518 -0.739 . . . . 0.0 111.504 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 83.1 mt -59.68 -50.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.979 -1.076 . . . . 0.0 110.259 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.597 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.55 43.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.03 -1.044 . . . . 0.0 110.844 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.597 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.03 65.72 65.91 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.86 165.36 31.58 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.665 1.577 . . . . 0.0 109.003 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.58 -59.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.349 0.595 . . . . 0.0 110.119 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.69 -47.41 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 178.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.68 -59.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 122.562 2.174 . . . . 0.0 110.022 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 29.7 mm-40 131.76 9.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 123.86 0.864 . . . . 0.0 108.729 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.9 m0 -71.79 165.88 23.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.718 -1.239 . . . . 14.29 110.546 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.1 m0 -129.62 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.661 -0.649 . . . . 11.8 109.263 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.0 96.69 5.83 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.94 128.74 56.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.866 0.841 . . . . 0.0 110.345 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -82.57 150.36 26.94 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.767 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.41 128.59 43.47 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.27 -1.772 . . . . 0.0 107.181 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.45 -18.37 1.04 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 119.751 -1.843 . . . . 0.0 107.917 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.449 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.67 -4.53 4.31 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.43 33.86 6.96 Favored Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.331 -0.85 . . . . 14.41 112.271 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.767 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.08 29.86 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.692 1.746 . . . . 0.0 111.762 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.62 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.369 1.081 . . . . 0.0 112.494 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.82 12.82 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.302 -1.519 . . . . 7.25 109.302 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.41 150.94 42.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.218 -1.166 . . . . 0.0 108.629 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.02 136.7 8.97 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.356 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.2 113.52 1.14 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 N-CA-C 109.002 -1.192 . . . . 4.76 109.002 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.515 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 63.7 pttt -60.3 3.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.842 . . . . 0.0 110.719 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.594 ' OD1' ' NH2' ' B' ' 83' ' ' ARG . 95.8 m-20 -102.07 -7.59 22.16 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.263 -0.898 . . . . 14.84 109.319 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.93 8.09 31.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.269 -0.894 . . . . 10.23 109.533 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.33 156.66 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 6.97 109.49 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 2.7 p -106.82 160.83 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.446 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 8.5 p -107.75 134.27 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.363 -0.836 . . . . 0.0 109.724 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.11 -63.1 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.665 -0.647 . . . . 0.0 109.275 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.65 ' HG ' ' H ' ' A' ' 8' ' ' VAL . 13.4 p -69.99 151.54 45.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.027 -1.046 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 44.2 p30 -146.54 152.78 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.221 -0.925 . . . . 0.0 109.337 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.43 1.47 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.338 1.359 . . . . 0.0 109.693 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.0 82.65 1.77 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.04 32.28 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.65 156.35 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.9 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.493 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.8 0.2 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.24 130.78 5.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.271 -1.135 . . . . 0.0 109.431 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.28 163.54 36.18 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.958 1.772 . . . . 0.0 108.805 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.451 ' H ' HE21 ' B' ' 97' ' ' GLN . 65.0 mt -135.33 119.78 26.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 122.068 0.937 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.2 t -58.43 117.09 4.1 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.949 0.881 . . . . 0.0 109.922 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.17 4.94 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.543 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.71 -48.56 8.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.372 -1.075 . . . . 0.0 109.306 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.78 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . 0.594 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 94.2 mtt-85 53.51 41.32 32.12 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -115.87 143.42 30.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.54 113.3 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.428 1.419 . . . . 0.0 110.596 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.447 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.6 mt -70.92 158.42 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.47 61.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 110.682 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.09 0.15 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.645 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.49 120.72 42.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 43.1 t -98.91 158.73 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.73 0.776 . . . . 0.0 111.105 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.64 116.01 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.594 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.89 105.97 18.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.09 -1.007 . . . . 0.0 109.528 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.52 159.64 42.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.22 4.27 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.26 75.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.17 -154.72 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.722 0.772 . . . . 0.0 109.796 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.5 143.45 45.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.9 m95 -141.58 140.07 33.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.516 -1.365 . . . . 0.0 110.596 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.454 ' C ' ' N ' ' B' ' 101' ' ' GLU . 16.9 m80 -56.66 131.99 50.6 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.15 -14.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.956 -1.09 . . . . 0.0 108.302 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.02 15.45 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.696 -0.627 . . . . 0.0 110.638 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.01 -6.6 31.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.818 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.12 106.22 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.431 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.9 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.204 1.002 . . . . 0.0 111.192 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.7 148.68 45.85 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.329 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.63 1.75 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.66 0.71 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.338 -0.851 . . . . 0.0 110.009 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.36 4.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.392 -0.817 . . . . 0.0 110.165 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.5 109.54 59.34 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.02 138.19 39.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.804 1.669 . . . . 0.0 112.078 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.78 56.98 1.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.138 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.21 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.9 2.75 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.568 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.2 178.99 4.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.465 -1.021 . . . . 0.0 109.906 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.62 145.37 24.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.761 . . . . 0.0 109.302 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.43 9.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.462 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.705 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.53 137.64 47.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.06 148.33 28.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.262 -0.899 . . . . 0.0 111.173 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.19 11.22 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.607 0.718 . . . . 0.0 110.291 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.39 22.77 1.53 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.4 31.06 20.32 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.729 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.3 mt -143.4 142.71 31.34 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.521 -0.988 . . . . 0.0 108.773 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.9 36.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 110.787 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.3 m-85 -153.97 140.42 18.75 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.6 177.51 0.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.446 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.73 -35.89 82.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 0.0 109.443 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.501 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.1 m -86.69 -43.7 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 111.384 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.7 -43.71 83.6 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.839 -1.163 . . . . 0.0 108.065 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.486 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.84 -56.45 13.9 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -64.4 -45.03 89.39 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.012 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.34 61.17 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.66 -35.25 45.57 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.361 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.57 -81.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.51 31.31 16.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.406 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.56 51.3 15.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -1.128 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.744 1 CA-C-O 70.872 -23.442 . . . . 0.0 109.455 179.941 . . . . . . . . 2 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.429 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.429 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.26 74.93 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -162.0 35.33 0.12 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -1.207 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.0 148.65 44.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.143 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.15 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -121.37 -54.35 1.99 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.34 74.11 1.38 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -69.52 158.04 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.32 131.48 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.42 -1.425 . . . . 0.0 111.557 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.9 129.25 45.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.4 m -63.44 154.29 32.64 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.591 1.186 . . . . 0.0 110.546 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 77.2 mt -114.28 -17.22 11.88 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.147 -1.427 . . . . 10.54 107.147 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.2 m-85 -149.55 145.09 18.57 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.24 -0.913 . . . . 18.39 110.694 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.06 81.53 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 121.372 1.381 . . . . 0.0 109.058 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.29 13.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.015 -1.053 . . . . 0.0 110.896 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.19 8.04 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.857 0.837 . . . . 0.0 109.389 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.97 10.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 29.7 m -130.34 94.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-O 122.911 1.339 . . . . 0.0 109.232 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.599 ' HG1' ' CG ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -144.44 -152.05 0.4 Allowed 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 114.377 -1.283 . . . . 38.32 107.618 178.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.47 -54.27 5.32 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.902 -1.518 . . . . 55.13 106.902 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -109.26 29.23 7.72 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.427 -0.795 . . . . 0.0 110.778 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.599 ' CG ' ' HG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER -100.32 150.92 22.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.81 -1.181 . . . . 0.0 109.766 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.51 111.45 22.48 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.401 -0.812 . . . . 11.68 110.695 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.44 127.67 41.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.26 21.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.35 -1.469 . . . . 12.44 110.881 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.28 155.77 22.27 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 146.95 17.92 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 121.262 -0.899 . . . . 29.03 109.542 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.08 6.65 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.316 -1.514 . . . . 6.18 109.316 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.25 114.78 22.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.522 -0.987 . . . . 9.52 109.54 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.05 108.62 6.04 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.43 133.65 49.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 123.172 1.463 . . . . 0.0 110.485 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.74 102.99 15.75 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.459 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.48 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.96 92.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.51 -0.744 . . . . 0.0 111.597 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.521 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.2 mt -59.78 -50.29 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.993 -1.067 . . . . 0.0 110.248 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.596 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.29 157.6 43.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.055 -1.028 . . . . 0.0 110.779 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.596 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.06 65.58 65.33 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.8 165.41 31.53 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.697 1.598 . . . . 0.0 108.901 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.09 -46.41 7.79 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.62 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.369 0.604 . . . . 0.0 110.069 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.53 0.0 OUTLIER Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.296 -2.185 0 C-N-CA 122.707 2.271 . . . . 0.0 109.874 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.7 pt-20 131.84 9.19 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.898 0 C-N-CA 123.894 0.878 . . . . 0.0 108.754 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.53 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.3 m0 -71.8 165.81 23.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.635 -1.291 . . . . 14.29 110.532 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.505 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 19.3 m0 -129.5 144.99 51.5 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.38 -0.6 . . . . 11.8 109.38 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.95 96.73 5.81 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.8 56.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.913 0.863 . . . . 0.0 110.381 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.56 150.44 26.91 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.752 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.46 128.55 43.49 Favored 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 117.282 -1.767 . . . . 0.0 107.203 177.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.41 1.01 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.701 -1.875 . . . . 0.0 107.934 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.8 -4.4 4.33 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.654 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.46 33.78 6.99 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-N 115.33 -0.85 . . . . 14.41 112.27 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.752 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.79 164.09 29.77 Favored 'General case' 0 N--CA 1.515 2.805 0 CA-C-N 119.783 1.792 . . . . 0.0 111.867 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.0 154.55 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.374 1.083 . . . . 0.0 112.504 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.66 12.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.267 -1.533 . . . . 7.25 109.267 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.28 150.83 43.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -1.201 . . . . 0.0 108.712 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.99 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.959 -1.088 . . . . 0.0 109.254 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 N-CA-C 108.997 -1.194 . . . . 4.76 108.997 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HZ1' ' HB2' ' A' ' 42' ' ' GLU . 23.8 pttm -60.31 3.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.544 -0.722 . . . . 0.0 110.742 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.657 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 1.0 OUTLIER -102.04 -7.57 22.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.177 -0.952 . . . . 14.84 109.342 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.01 8.27 30.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.255 -0.903 . . . . 10.23 109.487 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -147.59 156.52 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 6.97 109.582 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 p -106.71 160.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.8 p -107.66 134.26 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.07 -63.23 1.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -70.09 151.67 45.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.922 -1.112 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -146.61 152.74 39.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.196 -0.94 . . . . 0.0 109.385 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.3 1.47 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.27 1.313 . . . . 0.0 109.688 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.24 82.64 1.78 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.06 32.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.2 28.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -1.126 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.21 46.76 0.2 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.17 130.8 5.4 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.21 163.65 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.949 1.766 . . . . 0.0 108.924 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.465 HG13 ' C ' ' B' ' 77' ' ' PRO . 49.0 mt -135.41 119.89 26.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 122.032 0.92 . . . . 0.0 109.425 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.2 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.829 0.823 . . . . 0.0 110.019 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.89 -0.11 4.89 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.539 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.57 8.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -1.094 . . . . 0.0 109.356 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.17 4.77 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . 0.417 HH21 ' HE2' ' A' ' 58' ' ' LYS . 84.3 mtt85 53.62 41.28 32.12 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -115.88 143.48 30.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -56.51 113.47 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.425 1.417 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.5 mt -71.01 158.47 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.49 61.4 0.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.887 -1.133 . . . . 0.0 110.688 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.95 -101.88 0.15 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.65 120.64 42.23 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.89 158.7 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.755 0.788 . . . . 0.0 111.182 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.53 116.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.611 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.12 18.26 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.057 -1.027 . . . . 0.0 109.552 -179.085 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.63 42.49 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.634 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.06 17.24 4.32 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.33 75.77 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.35 -154.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.756 0.788 . . . . 0.0 109.658 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.28 143.5 46.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.7 m95 -141.61 140.18 33.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.51 -1.369 . . . . 0.0 110.596 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.446 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.65 132.01 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.24 -14.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.854 -1.153 . . . . 0.0 108.285 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.446 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.97 15.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.743 -0.598 . . . . 0.0 110.594 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.18 -6.47 31.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.903 -1.123 . . . . 0.0 110.769 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -80.24 106.28 12.14 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.434 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.4 m -133.52 175.31 11.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 122.369 1.08 . . . . 0.0 111.175 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.86 148.71 46.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.343 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.49 1.79 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.71 -31.67 0.72 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.392 -0.818 . . . . 0.0 110.079 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.2 -15.15 4.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.339 -0.851 . . . . 0.0 110.15 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.69 47.46 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.55 109.66 59.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.07 138.28 39.63 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.673 1.582 . . . . 0.0 112.168 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.327 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.72 56.9 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.212 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.606 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.15 -55.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.242 -0.911 . . . . 0.0 108.988 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.94 2.75 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.573 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.88 4.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.54 -0.976 . . . . 0.0 109.963 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.55 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.227 -0.921 . . . . 0.0 109.622 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.59 137.67 47.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.94 148.3 28.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 111.261 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.33 11.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.74 . . . . 0.0 110.318 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.17 22.78 1.39 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.634 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.61 30.8 20.44 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.766 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.21 142.76 31.51 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.56 -0.965 . . . . 0.0 108.851 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.92 35.99 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.6 m-85 -153.95 140.23 18.57 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.7 m -57.59 177.43 0.1 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.346 -1.342 . . . . 0.0 108.397 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.52 -36.11 82.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.376 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.9 m -86.57 -43.68 12.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.55 -0.719 . . . . 0.0 111.412 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.78 -43.74 83.18 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.748 -1.22 . . . . 0.0 108.078 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.73 -56.52 13.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.42 -44.85 89.94 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.101 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.57 -34.31 61.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.543 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.76 -35.18 44.95 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.366 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.59 -81.71 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.52 31.29 16.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.56 51.28 15.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.714 1 CA-C-O 70.897 -23.43 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.409 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.409 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.36 74.83 0.12 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.93 35.24 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -1.16 . . . . 0.0 109.581 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.07 148.69 43.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.106 -0.996 . . . . 0.0 109.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.13 93.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.268 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.16 -54.32 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.449 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.9 m-70 -145.26 73.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.703 ' H ' ' HG ' ' A' ' 65' ' ' SER . 19.6 t -69.47 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -145.3 131.44 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.458 -1.401 . . . . 0.0 111.52 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.83 129.28 45.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 m -63.38 154.32 32.36 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.585 1.183 . . . . 0.0 110.532 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.0 mt -114.32 -17.36 11.83 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.125 -1.435 . . . . 10.54 107.125 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.5 m-85 -149.45 145.03 18.52 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.052 -1.03 . . . . 18.39 110.748 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.95 81.38 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.414 1.409 . . . . 0.0 109.031 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.73 170.26 13.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.916 -1.115 . . . . 0.0 110.956 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.12 7.97 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.876 0.846 . . . . 0.0 109.327 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.17 111.91 10.68 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 34.0 m -130.38 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 122.983 1.373 . . . . 0.0 109.161 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.418 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.51 -152.01 0.4 Allowed 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.309 -1.314 . . . . 38.32 107.61 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.418 ' H ' ' CG2' ' A' ' 19' ' ' THR . 97.6 mt-10 -82.36 -54.36 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.967 -1.494 . . . . 55.13 106.967 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.22 29.24 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.424 -0.798 . . . . 0.0 110.769 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.47 150.88 22.19 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.915 -1.116 . . . . 0.0 109.83 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -111.34 111.35 22.33 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.317 -0.864 . . . . 11.68 110.765 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.5 127.64 41.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.96 142.16 21.47 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.36 -1.462 . . . . 12.44 110.861 -178.447 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.16 155.83 22.38 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.99 18.2 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.462 -0.895 . . . . 29.03 109.51 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.52 44.25 6.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.262 -1.535 . . . . 6.18 109.262 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.67 22.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.53 -0.982 . . . . 9.52 109.437 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.92 108.6 5.93 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.55 133.8 49.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.202 1.477 . . . . 0.0 110.561 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.83 103.04 15.8 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.384 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.499 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.588 -0.695 . . . . 0.0 111.543 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.509 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.2 mt -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.012 -1.055 . . . . 0.0 110.224 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.599 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.2 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 110.748 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.1 65.62 65.19 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.36 31.59 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.693 1.596 . . . . 0.0 108.94 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.08 -46.49 7.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.7 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.366 0.603 . . . . 0.0 110.005 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.55 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.615 2.21 . . . . 0.0 109.965 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 27.4 tt0 131.69 9.1 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.78 0.832 . . . . 0.0 108.795 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.557 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 12.9 m0 -71.75 165.88 23.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.586 -1.321 . . . . 14.29 110.537 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.534 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.3 m0 -129.58 145.1 51.51 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.321 -0.622 . . . . 11.8 109.321 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -78.99 96.59 5.8 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.6 p -115.97 128.77 56.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.011 0.91 . . . . 0.0 110.361 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.59 150.33 26.94 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.776 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.32 128.55 43.34 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 117.299 -1.76 . . . . 0.0 107.266 177.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.43 -18.41 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 119.656 -1.902 . . . . 0.0 107.912 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.69 -4.58 4.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.658 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.49 33.89 6.92 Favored Glycine 0 N--CA 1.481 1.683 0 CA-C-N 115.291 -0.868 . . . . 14.41 112.29 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.776 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.92 164.11 29.81 Favored 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.625 1.713 . . . . 0.0 111.883 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.54 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-O 122.315 1.055 . . . . 0.0 112.484 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.69 12.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 7.25 109.258 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.29 150.89 43.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.24 -1.153 . . . . 0.0 108.631 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.73 9.0 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.902 -1.124 . . . . 0.0 109.228 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.1 Cg_exo -51.16 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.217 -0.543 0 N-CA-C 109.061 -1.169 . . . . 4.76 109.061 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.518 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 31.3 pttt -60.25 3.01 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.453 -0.779 . . . . 0.0 110.758 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 57' ' ' PRO . 94.4 m-20 -102.03 -7.62 22.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 14.84 109.27 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.31 30.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.873 . . . . 10.23 109.476 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.47 156.69 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 6.97 109.499 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.88 160.69 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.61 134.23 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.13 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.613 -0.68 . . . . 0.0 109.239 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 8' ' ' VAL . 16.4 p -69.99 151.64 45.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 109.462 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -146.65 152.59 39.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.035 . . . . 0.0 109.427 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.36 1.48 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.27 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.464 1.442 . . . . 0.0 109.654 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.74 124.92 32.08 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.73 156.31 28.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.384 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.82 167.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.92 0.2 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.24 130.74 5.35 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.405 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.24 163.62 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.957 1.772 . . . . 0.0 108.873 178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.44 ' H ' HE21 ' B' ' 97' ' ' GLN . 25.4 mt -135.46 119.76 26.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 122.12 0.962 . . . . 0.0 109.455 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.541 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.1 t -58.32 117.01 3.98 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.869 0.843 . . . . 0.0 109.897 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.1 4.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.541 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.8 -48.48 8.18 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.245 -1.15 . . . . 0.0 109.368 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.13 4.87 13.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . 0.469 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 95.7 mtt-85 53.45 41.49 32.1 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -116.07 143.42 30.9 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.29 113.39 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.524 1.483 . . . . 0.0 110.592 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -71.01 158.4 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.5 61.45 0.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.849 -1.157 . . . . 0.0 110.663 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -102.01 0.15 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.58 120.7 42.47 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.98 158.74 3.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.507 -0.746 . . . . 0.0 111.151 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.63 115.94 47.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.613 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.72 106.09 18.23 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.57 42.58 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.12 17.12 4.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.09 25.37 75.7 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.77 0.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.857 0.837 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.44 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.45 143.5 45.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.5 140.05 33.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.655 -1.278 . . . . 0.0 110.598 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.45 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.53 131.93 50.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.22 -14.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 120.725 -1.234 . . . . 0.0 108.347 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.82 -27.03 15.42 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.886 -0.509 . . . . 0.0 110.595 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.17 -6.48 31.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.948 -1.095 . . . . 0.0 110.856 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.22 106.31 12.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.433 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.4 m -133.6 175.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.318 1.056 . . . . 0.0 111.065 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.92 148.76 46.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.264 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.89 28.74 1.74 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.428 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.81 -31.68 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.388 -0.82 . . . . 0.0 110.118 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.01 -15.52 4.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.57 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.378 -0.826 . . . . 0.0 110.238 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.5 59.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -69.13 138.24 39.32 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.676 1.584 . . . . 0.0 112.111 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.72 56.96 1.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.221 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.17 1.72 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 108.881 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.2 30.99 2.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.563 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 1.0 OUTLIER -116.29 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.352 -1.087 . . . . 0.0 109.935 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.478 -0.764 . . . . 0.0 109.334 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.39 9.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.84 47.34 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.19 148.31 29.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.22 11.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.604 0.716 . . . . 0.0 110.331 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.42 22.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.638 -0.664 . . . . 0.0 109.413 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.48 Favored Glycine 0 N--CA 1.483 1.815 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.689 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.7 mt -143.33 142.76 31.41 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.646 -0.914 . . . . 0.0 108.865 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.88 36.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.666 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.8 m-85 -153.92 140.32 18.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.3 m -57.64 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.282 -1.367 . . . . 0.0 108.448 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.97 82.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.494 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.6 m -86.78 -43.68 12.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.453 -0.78 . . . . 0.0 111.315 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.71 83.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.67 -1.269 . . . . 0.0 108.133 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.499 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.1 t80 -51.8 -56.5 13.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -64.58 -44.75 89.69 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.135 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.46 -34.32 61.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.542 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.77 -35.29 44.74 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.51 -81.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.026 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.48 16.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.42 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.7 m-20 48.35 51.31 15.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -1.063 . . . . 0.0 109.563 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.763 1 CA-C-O 70.976 -23.392 . . . . 0.0 109.443 179.971 . . . . . . . . 2 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.437 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.332 0.586 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.437 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.38 74.85 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -161.99 35.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -1.19 . . . . 0.0 109.494 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.07 148.63 43.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.156 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.4 t -66.02 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 0.0 109.282 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.23 -54.36 2.0 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -145.23 73.86 1.38 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.9 t -69.44 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.33 131.58 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.484 -1.385 . . . . 0.0 111.55 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -99.94 129.14 45.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.9 m -63.37 154.41 32.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.52 1.153 . . . . 0.0 110.598 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 87.8 mt -114.3 -17.38 11.84 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.173 -1.417 . . . . 10.54 107.173 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.5 m-85 -149.43 145.15 18.73 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.177 -0.952 . . . . 18.39 110.706 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.02 81.42 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 121.414 1.41 . . . . 0.0 109.054 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.32 13.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.94 -1.1 . . . . 0.0 110.865 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.449 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.6 111.01 7.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.771 0.796 . . . . 0.0 109.462 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.25 112.07 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.36 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 122.866 1.317 . . . . 0.0 109.071 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.429 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.6 -151.97 0.4 Allowed 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.357 -1.292 . . . . 38.32 107.518 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.429 ' H ' ' CG2' ' A' ' 19' ' ' THR . 95.9 mt-10 -82.47 -54.33 5.28 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.783 -1.562 . . . . 55.13 106.783 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 71.6 mm-40 -109.35 29.25 7.72 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.366 -0.834 . . . . 0.0 110.701 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.57 150.82 22.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.841 -1.162 . . . . 0.0 109.797 -179.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -111.32 111.36 22.36 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.295 -0.878 . . . . 11.68 110.804 -178.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.64 41.56 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.91 142.22 21.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.39 -1.443 . . . . 12.44 110.87 -178.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.82 22.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 146.95 18.5 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.221 -0.925 . . . . 29.03 109.497 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 43.99 6.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.277 -1.529 . . . . 6.18 109.277 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.79 22.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.56 -0.964 . . . . 9.52 109.419 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.06 108.73 6.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.68 49.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 123.179 1.466 . . . . 0.0 110.486 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.75 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.427 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 111.51 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.518 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.7 mt -59.73 -50.51 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.994 -1.066 . . . . 0.0 110.194 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.609 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.22 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.061 -1.025 . . . . 0.0 110.803 -177.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.609 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.02 65.54 65.5 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.83 165.42 31.48 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 109.0 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.13 -46.4 7.78 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.74 -59.53 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.436 0.636 . . . . 0.0 110.018 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.61 2.206 . . . . 0.0 109.922 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 62.2 mt-10 131.74 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 123.845 0.858 . . . . 0.0 108.738 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 14.1 m0 -71.74 165.83 23.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.526 -1.359 . . . . 14.29 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.479 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.8 m0 -129.6 145.11 51.52 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.38 -0.6 . . . . 11.8 109.38 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -79.08 96.74 5.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.4 p -115.93 128.76 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.855 0.836 . . . . 0.0 110.36 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -82.68 150.35 26.82 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.768 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.37 128.49 43.35 Favored 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.172 -1.811 . . . . 0.0 107.212 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.28 -18.45 0.96 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 119.687 -1.883 . . . . 0.0 107.998 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.465 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.61 -4.57 4.29 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.638 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.206 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.768 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.03 29.97 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.773 1.787 . . . . 0.0 111.815 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.303 1.049 . . . . 0.0 112.544 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.77 12.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.28 -1.528 . . . . 7.25 109.28 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.45 150.88 42.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -1.147 . . . . 0.0 108.657 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.72 9.01 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.029 -1.045 . . . . 0.0 109.27 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.54 ' CB ' HD22 ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.26 113.49 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.068 -1.166 . . . . 4.76 109.068 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.33 3.21 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 110.78 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.54 HD22 ' CB ' ' A' ' 57' ' ' PRO . 1.1 p30 -102.03 -7.57 22.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 14.84 109.335 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.04 8.21 30.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 10.23 109.536 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -147.44 156.57 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.942 . . . . 6.97 109.541 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -106.87 160.75 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' B' ' 82' ' ' CYS . 10.5 p -107.61 134.26 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.401 -0.812 . . . . 0.0 109.754 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.05 -63.31 1.24 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.682 . . . . 0.0 109.227 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.447 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 58.3 m -69.95 151.68 45.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.975 -1.078 . . . . 0.0 109.454 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 48.7 p30 -146.58 152.73 39.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 109.356 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.11 -67.28 1.48 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.317 1.344 . . . . 0.0 109.606 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.05 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.72 125.0 32.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.23 28.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.562 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.82 167.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.29 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.23 130.75 5.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 109.366 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.461 ' C ' HG13 ' B' ' 78' ' ' ILE . 5.6 Cg_endo -74.16 163.61 36.19 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.946 1.764 . . . . 0.0 108.914 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.461 HG13 ' C ' ' B' ' 77' ' ' PRO . 56.7 mt -135.43 119.74 26.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.081 0.943 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' CYS . . . . . 0.542 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.3 117.05 4.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.22 4.88 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.542 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.74 -48.51 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -1.099 . . . . 0.0 109.305 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' CYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 1.6 p -116.12 4.84 13.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 53.54 41.32 32.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 43.3 mtp180 -115.86 143.46 30.81 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.32 113.33 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.494 1.463 . . . . 0.0 110.623 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.4 mt -70.95 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.57 61.34 0.32 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.831 -1.168 . . . . 0.0 110.646 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.97 -101.97 0.15 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.73 42.57 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.81 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.641 0.734 . . . . 0.0 111.298 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.52 115.91 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' ASN . . . . . 0.607 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.81 106.17 18.29 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.062 -1.023 . . . . 0.0 109.481 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.6 159.54 42.63 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.07 17.25 4.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.18 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.724 0.773 . . . . 0.0 109.821 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' GLN . . . . . 0.443 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.43 143.42 45.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.0 m95 -141.44 140.0 33.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.561 -1.337 . . . . 0.0 110.682 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.4 m80 -56.56 131.94 50.18 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -53.2 -14.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.701 -1.25 . . . . 0.0 108.32 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.85 15.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.754 -0.591 . . . . 0.0 110.613 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.22 -6.53 31.04 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.26 106.31 12.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.433 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.9 m -133.63 175.25 11.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.287 1.041 . . . . 0.0 111.138 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.79 148.69 46.15 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.234 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.79 28.54 1.76 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.73 -31.62 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.432 -0.793 . . . . 0.0 110.149 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.08 -15.38 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 110.156 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.55 0.35 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.28 109.48 58.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.02 138.36 39.97 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.66 1.574 . . . . 0.0 112.077 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.82 56.91 1.78 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.133 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.594 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.21 -55.24 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.2 -0.937 . . . . 0.0 108.897 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.12 2.73 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' HIS . . . . . 0.567 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.27 178.88 4.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.483 -1.01 . . . . 0.0 109.987 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.5 145.43 24.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.38 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.563 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.35 169.48 9.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.528 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.6 137.7 47.15 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.96 148.28 28.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.232 -0.918 . . . . 0.0 111.234 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.05 129.34 11.26 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.604 0.716 . . . . 0.0 110.381 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.3 22.78 1.48 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.671 -0.643 . . . . 0.0 109.438 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.9 20.49 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.764 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -143.27 142.89 31.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.529 -0.983 . . . . 0.0 108.725 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.84 36.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.685 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' B' ' 118' ' ' TYR . 58.5 m-85 -153.89 140.31 18.71 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.65 177.55 0.1 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.26 -1.376 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.67 -36.05 82.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.374 -0.828 . . . . 0.0 109.285 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.465 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.7 m -86.61 -43.78 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 0.0 111.333 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.79 83.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.721 -1.237 . . . . 0.0 108.095 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.71 -56.47 13.58 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.211 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.48 -34.29 61.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.75 -35.23 44.96 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.335 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.33 31.42 16.64 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.53 51.17 15.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -1.109 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.725 1 CA-C-O 70.924 -23.417 . . . . 0.0 109.436 179.924 . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.326 0.584 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.7 p -162.06 35.34 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -1.169 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.06 148.64 43.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.148 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.3 t -66.08 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.117 -0.99 . . . . 0.0 109.246 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.2 -54.26 2.01 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.417 ' O ' HG11 ' A' ' 9' ' ' VAL . 79.2 t -69.43 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 8' ' ' VAL . 3.2 m -145.23 131.51 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.426 -1.421 . . . . 0.0 111.665 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -99.98 129.26 46.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.4 m -63.37 154.28 32.45 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.518 1.152 . . . . 0.0 110.538 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 95.9 mt -114.23 -17.35 11.88 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.236 -1.394 . . . . 10.54 107.236 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.2 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.503 2.218 0 C-N-CA 119.463 -0.895 . . . . 18.39 110.699 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.5 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 121.436 1.424 . . . . 0.0 108.983 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.82 170.3 13.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.926 -1.109 . . . . 0.0 110.959 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.12 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.826 0.822 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.93 10.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.486 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 23.3 m -130.32 94.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.917 1.342 . . . . 0.0 109.187 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.606 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 4.0 m -144.51 -151.98 0.4 Allowed 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.596 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.606 ' H ' ' CG2' ' A' ' 19' ' ' THR . 49.8 tp10 -82.42 -54.28 5.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.906 -1.516 . . . . 55.13 106.906 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.443 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.6 mt-10 -109.36 29.12 7.85 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.342 -0.849 . . . . 0.0 110.739 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.41 151.02 22.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.827 -1.171 . . . . 0.0 109.783 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.44 111.38 22.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.38 -0.825 . . . . 11.68 110.773 -178.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.5 127.7 41.75 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.93 142.12 21.46 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.377 -1.452 . . . . 12.44 110.935 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.81 22.51 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 146.92 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.422 -0.911 . . . . 29.03 109.577 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.05 6.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.315 -1.514 . . . . 6.18 109.315 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.73 22.79 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.509 -0.995 . . . . 9.52 109.396 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.85 108.55 5.86 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.5 133.77 49.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 123.185 1.469 . . . . 0.0 110.523 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.89 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.401 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.49 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.92 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.576 -0.703 . . . . 0.0 111.491 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.515 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.7 mt -59.82 -50.33 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.921 -1.112 . . . . 0.0 110.246 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.607 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.34 157.65 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.941 -1.099 . . . . 0.0 110.774 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.607 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.16 65.63 64.83 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.766 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.72 165.32 31.79 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.702 1.601 . . . . 0.0 109.07 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.02 -46.5 7.77 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.4 m-20 57.69 -59.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.008 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.74 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.142 0 C-N-CA 122.625 2.217 . . . . 0.0 109.929 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 35.8 mm-40 131.83 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.78 0.832 . . . . 0.0 108.765 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 14.3 m0 -71.86 165.84 23.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.64 -1.287 . . . . 14.29 110.464 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.472 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.0 m0 -129.54 145.18 51.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.198 -0.667 . . . . 11.8 109.198 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.15 96.79 5.96 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -116.01 128.82 56.03 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.959 0.885 . . . . 0.0 110.361 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.67 150.4 26.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.775 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.62 43.48 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 117.324 -1.751 . . . . 0.0 107.229 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.51 -18.32 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 119.706 -1.871 . . . . 0.0 107.946 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.459 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.66 -4.64 4.41 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.654 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.687 0 CA-C-N 115.499 -0.773 . . . . 14.41 112.239 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.775 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.93 164.01 30.08 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 119.609 1.704 . . . . 0.0 111.727 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.65 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' N ' HD22 ' A' ' 23' ' ' LEU . . . 172.17 156.76 12.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.263 -1.535 . . . . 7.25 109.263 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.39 150.85 43.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.338 -1.095 . . . . 0.0 108.643 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.01 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.782 -1.199 . . . . 0.0 109.316 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.15 113.63 1.19 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.912 -1.226 . . . . 4.76 108.912 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HE3' HH22 ' B' ' 83' ' ' ARG . 64.3 pttt -60.52 3.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.671 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 57' ' ' PRO . 99.5 m-20 -102.05 -7.65 22.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.285 -0.884 . . . . 14.84 109.357 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.438 ' O ' HG11 ' A' ' 61' ' ' VAL . 3.2 m-85 -89.02 8.31 30.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 10.23 109.454 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 60' ' ' TYR . 35.4 m -147.48 156.51 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.094 -1.004 . . . . 6.97 109.487 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.76 160.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.403 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 11.5 p -107.59 134.29 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.43 -0.794 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.12 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.613 -0.679 . . . . 0.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 41.6 m -69.92 151.53 45.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.546 ' OD2' ' NH1' ' B' ' 84' ' ' ARG . 53.4 p-10 -146.63 152.73 39.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.35 1.48 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.356 1.371 . . . . 0.0 109.688 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.11 82.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.8 124.94 32.14 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 109.301 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.39 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.16 29.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -1.107 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.81 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.85 0.2 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.26 130.85 5.39 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.297 -1.119 . . . . 0.0 109.345 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.4 Cg_endo -74.29 163.53 36.2 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.031 1.821 . . . . 0.0 108.832 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.436 ' H ' HE21 ' B' ' 97' ' ' GLN . 76.2 mt -135.34 119.85 27.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 122.008 0.909 . . . . 0.0 109.365 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.541 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.809 0.814 . . . . 0.0 109.914 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.82 -0.16 4.86 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.541 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.7 -48.53 8.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.295 -1.121 . . . . 0.0 109.301 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.16 4.78 13.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . 0.444 HH22 ' HE3' ' A' ' 58' ' ' LYS . 83.8 mtt85 53.53 41.25 32.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.546 ' NH1' ' OD2' ' A' ' 66' ' ' ASP . 17.3 mtp180 -115.79 143.39 30.64 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' B' ' 78' ' ' ILE . 5.7 Cg_exo -56.37 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.366 1.377 . . . . 0.0 110.615 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.451 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.6 mt -70.91 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.702 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.59 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.877 -1.14 . . . . 0.0 110.55 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.12 -101.8 0.15 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.76 120.63 42.17 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.83 158.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.648 0.737 . . . . 0.0 111.125 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.57 115.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.616 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.73 106.03 18.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.624 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.52 42.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.618 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.99 17.34 4.31 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.12 76.09 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.16 -154.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.787 0.803 . . . . 0.0 109.779 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.436 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.48 143.46 45.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.6 139.99 33.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.544 -1.347 . . . . 0.0 110.576 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.46 131.98 50.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.17 -14.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 108.365 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.97 15.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.823 -0.548 . . . . 0.0 110.594 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.05 -6.62 31.45 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.878 -1.139 . . . . 0.0 110.798 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -80.08 106.3 12.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.423 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.8 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.161 0.982 . . . . 0.0 111.192 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.8 148.58 46.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.314 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.78 28.67 1.73 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.77 -31.75 0.71 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.293 -0.879 . . . . 0.0 110.113 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.44 4.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.222 -0.924 . . . . 0.0 110.226 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.65 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.363 -0.836 . . . . 0.0 110.237 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.52 59.18 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -68.99 138.27 39.83 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.825 1.683 . . . . 0.0 112.059 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.8 57.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.132 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.19 1.69 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 108.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.25 30.98 2.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.566 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.86 4.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.504 -0.998 . . . . 0.0 109.993 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -94.35 145.3 24.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.33 169.45 9.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.78 47.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.26 28.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.85 . . . . 0.0 111.188 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.635 0.731 . . . . 0.0 110.334 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mttm 51.39 22.8 1.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.62 -0.675 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.618 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.94 20.4 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.7 mt -143.26 142.81 31.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.46 -1.023 . . . . 0.0 108.848 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.8 36.31 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 110.702 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.3 m-85 -153.96 140.28 18.61 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.53 177.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.439 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.594 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.76 -35.92 82.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -0.814 . . . . 0.0 109.353 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.5 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.9 m -86.75 -43.52 12.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.543 -0.723 . . . . 0.0 111.384 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.72 -43.82 83.24 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.738 -1.226 . . . . 0.0 108.126 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.65 -56.48 13.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.6 -44.8 89.46 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.05 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.53 -34.37 61.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.535 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.65 -35.26 45.61 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.427 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.51 16.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.34 51.42 15.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -1.124 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 1 C--O 0.476 -39.651 1 CA-C-O 70.943 -23.408 . . . . 0.0 109.45 -179.965 . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.98 0.12 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -1.217 . . . . 0.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.09 148.67 43.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.4 t -66.07 93.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.19 -54.42 2.0 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.39 74.09 1.38 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.65 158.05 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.39 131.51 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.511 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.01 129.28 46.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.0 m -63.39 154.37 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.456 1.122 . . . . 0.0 110.636 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.9 mt -114.38 -17.24 11.83 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.205 -1.406 . . . . 10.54 107.205 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.0 m-85 -149.51 144.98 18.41 Favored Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 119.474 -0.891 . . . . 18.39 110.793 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.01 81.39 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 121.524 1.482 . . . . 0.0 109.019 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.8 170.28 13.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.05 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.15 8.07 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.453 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.01 10.68 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 m -130.35 94.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 122.869 1.319 . . . . 0.0 109.177 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.54 -151.98 0.4 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.35 -1.296 . . . . 38.32 107.549 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -82.48 -54.32 5.29 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.849 -1.537 . . . . 55.13 106.849 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.35 29.15 7.81 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.402 -0.812 . . . . 0.0 110.762 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.4 150.84 22.21 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.839 -1.163 . . . . 0.0 109.7 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.37 22.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.385 -0.822 . . . . 11.68 110.764 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.46 127.7 41.72 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.88 142.17 21.54 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.374 -1.454 . . . . 12.44 110.947 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.09 155.77 22.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.38 146.84 18.58 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.267 -0.895 . . . . 29.03 109.602 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.71 44.07 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.275 -1.53 . . . . 6.18 109.275 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.33 114.75 22.85 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.513 -0.992 . . . . 9.52 109.454 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.04 108.59 6.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.43 133.69 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.153 1.454 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.82 103.12 15.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.39 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.492 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.516 -0.74 . . . . 0.0 111.392 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.3 mt -59.79 -50.46 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.971 -1.08 . . . . 0.0 110.121 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.606 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.17 157.58 43.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.983 -1.073 . . . . 0.0 110.814 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.606 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -134.97 65.54 65.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.39 31.64 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.635 1.556 . . . . 0.0 108.966 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.97 -46.56 7.75 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.52 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.268 0.556 . . . . 0.0 110.09 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.36 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.57 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 122.709 2.273 . . . . 0.0 109.914 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.75 9.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.816 0 C-N-CA 123.849 0.86 . . . . 0.0 108.849 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 12.7 m0 -71.89 165.82 23.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.593 -1.317 . . . . 14.29 110.481 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.9 m0 -129.53 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.356 -0.609 . . . . 11.8 109.356 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -79.01 96.62 5.82 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.65 55.92 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.379 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.47 150.35 27.08 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.766 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.35 128.49 43.32 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.322 -1.751 . . . . 0.0 107.295 177.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.41 0.98 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 119.643 -1.911 . . . . 0.0 108.03 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.68 -4.57 4.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.658 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.48 33.9 6.92 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.287 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.766 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.94 164.04 30.01 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 119.654 1.727 . . . . 0.0 111.77 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.64 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.274 1.035 . . . . 0.0 112.583 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.16 156.73 12.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.291 -1.524 . . . . 7.25 109.291 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.38 150.86 43.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.226 -1.161 . . . . 0.0 108.561 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.76 9.04 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.102 . . . . 0.0 109.297 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.28 113.53 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 N-CA-C 108.938 -1.216 . . . . 4.76 108.938 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.6 pttt -60.38 3.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 0.0 110.757 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.7 m-20 -102.03 -7.54 22.24 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.285 -0.885 . . . . 14.84 109.325 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.13 8.22 31.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 10.23 109.506 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.44 156.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.285 -0.885 . . . . 6.97 109.577 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -106.81 160.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.59 134.27 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.452 -0.78 . . . . 0.0 109.778 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.4 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 98.5 mt -105.13 -63.07 1.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 70.4 m -70.05 151.66 45.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.036 -1.04 . . . . 0.0 109.409 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 65' ' ' SER . 87.8 m-20 -146.6 152.69 39.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 109.311 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.29 1.48 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.299 1.332 . . . . 0.0 109.629 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.61 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.9 124.95 32.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.41 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.76 156.22 28.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -1.112 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.83 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.22 130.81 5.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 76' ' ' VAL . 5.5 Cg_endo -74.29 163.42 36.44 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.052 1.835 . . . . 0.0 108.83 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.438 ' H ' HE21 ' B' ' 97' ' ' GLN . 41.7 mt -135.22 119.85 27.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.983 0.896 . . . . 0.0 109.389 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.1 t -58.42 116.96 3.97 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.11 4.78 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.536 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.69 -48.57 8.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -1.067 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.72 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.132 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 53.54 41.3 32.12 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 64' ' ' LEU . 2.3 mmm180 -115.82 143.5 30.86 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.55 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.44 1.427 . . . . 0.0 110.542 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.444 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.5 mt -70.95 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.53 61.41 0.32 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.791 -1.193 . . . . 0.0 110.593 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.666 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.67 42.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.8 158.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 111.294 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.51 115.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.61 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.92 106.07 18.23 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 109.592 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.62 159.48 42.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.11 17.26 4.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.19 25.28 75.85 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.041 -2.024 . . . . 0.0 108.041 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.76 0.65 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.8 0.809 . . . . 0.0 109.732 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.35 143.52 46.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.58 139.91 33.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.488 -1.382 . . . . 0.0 110.648 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.54 131.99 50.26 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.21 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.846 -1.158 . . . . 0.0 108.377 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.89 -26.82 15.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.869 -0.519 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.23 -6.5 31.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.816 -1.177 . . . . 0.0 110.781 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -80.26 106.25 12.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.428 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.2 m -133.59 175.27 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.329 1.061 . . . . 0.0 111.1 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.87 148.7 46.41 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.37 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.61 1.74 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.82 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.42 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.74 -31.78 0.71 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.01 -15.38 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.79 47.5 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.36 109.64 59.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.6 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.05 138.27 39.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.748 1.632 . . . . 0.0 112.147 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.84 56.97 1.78 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.098 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.6 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.11 -55.25 1.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.12 30.91 2.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.93 4.14 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.474 -1.015 . . . . 0.0 109.977 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.41 145.33 24.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 109.412 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.411 -0.806 . . . . 0.0 109.511 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.696 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.61 47.17 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.98 148.36 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.218 -0.926 . . . . 0.0 111.18 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.556 0.693 . . . . 0.0 110.27 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.7 mttm 51.27 22.83 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.465 0.65 . . . . 0.0 109.526 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.46 30.92 20.54 Favored Glycine 0 N--CA 1.481 1.663 0 C-N-CA 119.396 -1.383 . . . . 0.0 109.785 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -143.26 142.8 31.48 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 108.79 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.4 152.79 36.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.7 m-85 -153.81 140.27 18.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.2 m -57.57 177.5 0.1 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.366 -1.334 . . . . 0.0 108.486 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.63 -36.06 82.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.417 -0.802 . . . . 0.0 109.349 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.534 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.5 m -86.54 -43.8 12.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.745 . . . . 0.0 111.338 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.456 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.87 83.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.722 -1.236 . . . . 0.0 108.089 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.38 14.07 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -64.55 -44.92 89.23 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.043 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.45 61.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.53 -35.28 46.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.501 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.114 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.43 31.36 16.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.0 m-20 48.59 51.26 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 70.968 -23.396 . . . . 0.0 109.468 179.977 . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.94 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.99 35.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -1.21 . . . . 0.0 109.583 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.02 148.68 43.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.48 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -66.08 93.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.255 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.25 -54.28 2.0 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.35 74.0 1.38 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.411 HG11 ' H ' ' A' ' 9' ' ' VAL . 47.0 t -69.53 158.09 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' H ' HG11 ' A' ' 8' ' ' VAL . 3.1 m -145.36 131.45 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.449 -1.407 . . . . 0.0 111.561 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.92 129.29 45.98 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.0 m -63.48 154.4 32.44 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.517 1.151 . . . . 0.0 110.594 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.7 mt -114.35 -17.24 11.84 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.23 -1.396 . . . . 10.54 107.23 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 13.9 m-85 -149.53 145.07 18.54 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.238 -0.914 . . . . 18.39 110.743 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.08 81.41 1.7 Allowed 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.356 1.371 . . . . 0.0 109.058 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.74 170.22 14.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.836 -1.165 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.59 111.11 8.03 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.725 0.774 . . . . 0.0 109.414 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -134.31 111.95 10.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.27 94.29 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 122.839 1.304 . . . . 0.0 109.13 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.546 ' HG1' ' CD ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -144.49 -152.09 0.4 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.578 -1.267 . . . . 38.32 107.578 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 58.0 mp0 -82.4 -54.31 5.32 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.857 -1.534 . . . . 55.13 106.857 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -109.28 29.16 7.79 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.383 -0.823 . . . . 0.0 110.746 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.546 ' CD ' ' HG1' ' A' ' 19' ' ' THR . 1.2 mp0 -100.52 150.88 22.21 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.823 -1.173 . . . . 0.0 109.678 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.42 111.38 22.37 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.416 -0.803 . . . . 11.68 110.756 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.67 41.58 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.9 142.16 21.52 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.42 -1.425 . . . . 12.44 110.918 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.12 155.82 22.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.93 18.27 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.268 -0.895 . . . . 29.03 109.595 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.1 6.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.345 -1.502 . . . . 6.18 109.345 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.3 114.83 22.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.589 -0.947 . . . . 9.52 109.415 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.99 108.59 5.98 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.41 133.7 49.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 123.154 1.454 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.78 103.08 15.83 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.919 -1.492 . . . . 0.0 107.395 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.485 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.502 -0.749 . . . . 0.0 111.468 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.3 mt -59.74 -50.43 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.917 -1.115 . . . . 0.0 110.201 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.608 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.23 157.6 43.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.947 -1.095 . . . . 0.0 110.714 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.08 65.58 65.24 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.77 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.75 165.32 31.76 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.61 1.54 . . . . 0.0 109.016 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.52 7.78 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.67 -59.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.324 0.583 . . . . 0.0 109.989 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.659 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.6 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.158 0 C-N-CA 122.714 2.276 . . . . 0.0 109.896 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.6 tp10 131.87 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.802 0.841 . . . . 0.0 108.771 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.508 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 16.8 m0 -71.93 165.94 23.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.674 -1.266 . . . . 14.29 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.59 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.3 m0 -129.56 145.05 51.51 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.32 -0.622 . . . . 11.8 109.32 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.02 96.62 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.93 128.7 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.921 0.867 . . . . 0.0 110.403 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.45 150.41 27.07 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.759 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.54 43.4 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 117.325 -1.75 . . . . 0.0 107.31 177.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 119.596 -1.94 . . . . 0.0 107.99 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.49 -4.6 4.17 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.661 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.41 33.81 6.99 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 115.307 -0.861 . . . . 14.41 112.329 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.759 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.1 29.81 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-N 119.603 1.701 . . . . 0.0 111.787 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.56 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.32 1.057 . . . . 0.0 112.468 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' N ' HD22 ' A' ' 23' ' ' LEU . . . 172.13 156.79 12.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.252 -1.539 . . . . 7.25 109.252 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.43 150.88 42.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -1.194 . . . . 0.0 108.608 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.7 8.97 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.955 -1.091 . . . . 0.0 109.297 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.968 -1.205 . . . . 4.76 108.968 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.59 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 16.0 pttp -60.46 3.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 110.648 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.5 m-20 -102.13 -7.52 22.17 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.179 -0.95 . . . . 14.84 109.319 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' O ' HG11 ' A' ' 61' ' ' VAL . 3.5 m-85 -89.09 8.19 31.19 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.242 -0.911 . . . . 10.23 109.427 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 60' ' ' TYR . 34.5 m -147.44 156.6 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 6.97 109.513 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 63' ' ' VAL . 12.6 p -106.81 160.72 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.441 ' N ' HG23 ' A' ' 62' ' ' VAL . 56.0 t -107.67 134.25 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.805 . . . . 0.0 109.834 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.2 mt -105.09 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.626 -0.671 . . . . 0.0 109.237 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.48 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 38.8 m -70.0 151.69 45.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.952 -1.092 . . . . 0.0 109.403 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 54.4 p-10 -146.72 152.63 39.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 109.317 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.08 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.59 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.302 1.335 . . . . 0.0 109.681 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.96 82.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.77 125.02 32.2 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.22 28.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -1.128 . . . . 0.0 109.52 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.96 0.2 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.28 130.65 5.29 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.261 -1.14 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.7 Cg_endo -74.19 163.65 36.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.912 1.741 . . . . 0.0 108.922 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.449 ' H ' HE21 ' B' ' 97' ' ' GLN . 64.2 mt -135.39 119.83 26.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 122.087 0.946 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.5 117.06 4.09 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.016 0.912 . . . . 0.0 109.89 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.513 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.05 4.89 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.76 -48.5 8.18 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.295 -1.12 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.88 13.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.573 -0.704 . . . . 0.0 109.107 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 53.55 41.14 32.14 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 6.8 mtp85 -115.79 143.41 30.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.39 113.25 1.37 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.485 1.457 . . . . 0.0 110.535 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.5 mt -70.75 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.63 61.55 0.31 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.824 -1.173 . . . . 0.0 110.663 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.07 -101.93 0.15 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.658 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.63 120.58 42.05 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.71 158.64 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.472 -0.767 . . . . 0.0 111.211 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.55 116.05 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.605 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.74 106.11 18.25 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 109.629 -179.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.61 159.54 42.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.02 17.28 4.31 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.25 75.92 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.25 -154.88 0.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.747 0.784 . . . . 0.0 109.748 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.449 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.31 143.51 46.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.513 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.528 -1.358 . . . . 0.0 110.594 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.473 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.0 m80 -56.59 131.92 50.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.07 -14.94 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 120.863 -1.148 . . . . 0.0 108.385 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.78 -26.89 15.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.828 -0.545 . . . . 0.0 110.71 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.06 -6.57 31.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.828 -1.17 . . . . 0.0 110.858 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.18 106.16 11.99 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.43 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.6 m -133.46 175.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.19 0.995 . . . . 0.0 111.203 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.75 148.74 45.86 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.303 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.9 28.69 1.75 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.111 -0.993 . . . . 0.0 109.667 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.83 -31.67 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.343 -0.848 . . . . 0.0 110.097 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.21 4.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.6 47.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 110.173 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.58 59.33 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.602 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.0 138.3 39.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.748 1.632 . . . . 0.0 112.13 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.312 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.83 56.94 1.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.159 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.602 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.32 1.62 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.34 -0.85 . . . . 0.0 109.01 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 31.07 2.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.564 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.32 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -1.048 . . . . 0.0 109.986 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.52 145.46 24.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.43 169.48 9.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.53 137.71 47.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.07 148.3 28.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.223 -0.923 . . . . 0.0 111.197 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.02 129.31 11.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.34 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.88 1.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.59 30.95 20.12 Favored Glycine 0 N--CA 1.483 1.775 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.713 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.36 142.74 31.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.535 -0.979 . . . . 0.0 108.82 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.47 152.73 36.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.4 m-85 -153.79 140.35 18.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.57 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.495 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.595 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.71 -35.92 82.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.486 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.72 -43.69 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.509 -0.744 . . . . 0.0 111.312 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.83 83.46 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.761 -1.212 . . . . 0.0 108.116 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.66 -56.44 13.65 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.51 -44.93 89.36 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.004 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.5 -34.28 61.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.77 -35.4 44.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.218 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 110.091 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.37 31.43 16.52 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.56 51.19 15.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.313 -1.11 . . . . 0.0 109.612 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.475 -39.667 1 CA-C-O 71.024 -23.37 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.76 0.13 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -161.87 35.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -1.194 . . . . 0.0 109.575 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.422 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -72.99 148.68 43.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.123 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.21 93.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.694 ' C ' ' HG ' ' A' ' 65' ' ' SER . 25.7 mt -121.28 -54.39 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.709 ' CA ' ' HG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.32 73.86 1.37 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' N ' ' OG ' ' A' ' 65' ' ' SER . 9.7 t -69.43 158.11 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.31 131.44 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.45 -1.406 . . . . 0.0 111.549 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -99.88 129.27 45.95 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.8 m -63.42 154.38 32.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.455 1.121 . . . . 0.0 110.602 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.6 mt -114.36 -17.23 11.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.186 -1.412 . . . . 10.54 107.186 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.2 m-85 -149.53 145.03 18.47 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.126 -0.984 . . . . 18.39 110.765 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 121.43 1.42 . . . . 0.0 109.037 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.79 170.3 13.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.965 -1.084 . . . . 0.0 110.984 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.58 111.01 7.96 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.739 0.78 . . . . 0.0 109.474 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.19 112.0 10.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.36 94.31 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-O 122.901 1.334 . . . . 0.0 109.126 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.427 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.45 -152.07 0.4 Allowed 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.38 -1.282 . . . . 38.32 107.579 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' H ' ' CG2' ' A' ' 19' ' ' THR . 96.2 mt-10 -82.47 -54.27 5.33 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.863 -1.532 . . . . 55.13 106.863 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.445 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.33 29.24 7.72 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.375 -0.828 . . . . 0.0 110.741 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.649 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.57 150.94 22.18 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.812 -1.18 . . . . 0.0 109.671 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.469 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.29 22.23 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.42 -0.8 . . . . 11.68 110.757 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.43 127.65 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.8 142.18 21.63 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.425 -1.422 . . . . 12.44 110.904 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.22 155.83 22.31 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 146.93 17.93 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.464 -0.894 . . . . 29.03 109.577 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.62 44.09 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.218 -1.553 . . . . 6.18 109.218 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.84 22.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.592 -0.946 . . . . 9.52 109.449 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.03 108.65 6.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.74 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.175 1.464 . . . . 0.0 110.53 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.81 102.99 15.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.368 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.494 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.507 -0.746 . . . . 0.0 111.607 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.518 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 81.9 mt -59.8 -50.34 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.593 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.985 -1.072 . . . . 0.0 110.83 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.593 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.09 65.52 64.99 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.785 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -74.83 165.38 31.58 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.618 1.545 . . . . 0.0 108.987 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.645 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.93 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.57 -59.27 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.237 0.541 . . . . 0.0 110.136 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.35 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.63 -59.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.693 2.262 . . . . 0.0 109.943 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 70.8 mt-10 131.78 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 123.805 0.842 . . . . 0.0 108.769 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.8 m0 -71.93 165.92 23.2 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.607 -1.308 . . . . 14.29 110.436 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.5 m0 -129.57 144.99 51.51 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.338 -0.616 . . . . 11.8 109.338 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -79.01 96.72 5.84 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.72 55.98 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.907 0.86 . . . . 0.0 110.38 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.52 150.35 27.02 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.38 128.47 43.34 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.286 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.41 -18.41 1.03 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 119.716 -1.865 . . . . 0.0 107.918 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.55 -4.56 4.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.665 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.39 33.95 6.93 Favored Glycine 0 N--CA 1.481 1.684 0 CA-C-N 115.28 -0.873 . . . . 14.41 112.258 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.76 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.05 29.98 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.648 1.724 . . . . 0.0 111.82 179.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.67 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 122.325 1.059 . . . . 0.0 112.401 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.06 156.79 12.67 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.274 -1.53 . . . . 7.25 109.274 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.39 150.79 43.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.214 -1.168 . . . . 0.0 108.672 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.91 136.77 9.08 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 120.949 -1.094 . . . . 0.0 109.329 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.21 113.52 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 N-CA-C 109.024 -1.183 . . . . 4.76 109.024 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.35 3.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 110.729 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.524 ' H ' ' C ' ' A' ' 57' ' ' PRO . 95.7 m-20 -101.9 -7.71 22.22 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.247 -0.908 . . . . 14.84 109.4 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.42 ' O ' HG11 ' A' ' 61' ' ' VAL . 3.6 m-85 -89.0 8.23 30.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.221 -0.925 . . . . 10.23 109.437 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 60' ' ' TYR . 33.5 m -147.48 156.48 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.096 -1.002 . . . . 6.97 109.494 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.74 160.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.5 t -107.74 134.3 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.372 -0.83 . . . . 0.0 109.701 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 mp -105.06 -63.24 1.25 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.562 -0.711 . . . . 0.0 109.254 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.709 ' HG ' ' CA ' ' A' ' 7' ' ' HIS . 11.5 p -70.01 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.024 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 109.372 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.2 1.48 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.53 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.257 1.305 . . . . 0.0 109.656 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.06 82.67 1.78 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.93 124.96 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.81 156.24 28.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -1.114 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.92 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.433 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.44 46.91 0.2 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.21 130.82 5.39 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.312 -1.111 . . . . 0.0 109.396 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.28 163.65 35.94 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.876 1.718 . . . . 0.0 108.936 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.451 ' H ' HE21 ' B' ' 97' ' ' GLN . 64.8 mt -135.38 119.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 122.053 0.93 . . . . 0.0 109.44 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 14.8 t -58.46 117.13 4.15 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.872 0.844 . . . . 0.0 109.883 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.518 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -65.0 -0.06 4.97 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.544 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.55 8.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.15 4.94 13.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -116.01 143.3 30.61 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.35 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.412 1.408 . . . . 0.0 110.495 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.4 mt -70.98 158.45 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.54 61.46 0.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.828 -1.17 . . . . 0.0 110.671 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.04 0.15 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.63 120.59 42.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.72 158.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.41 -0.806 . . . . 0.0 111.286 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.43 116.06 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.612 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.79 106.15 18.27 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.572 -179.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.47 42.74 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.19 4.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.16 76.03 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.19 -154.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.704 0.764 . . . . 0.0 109.747 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.47 143.5 45.9 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.518 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.6 140.07 33.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.506 -1.371 . . . . 0.0 110.614 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.5 m80 -56.36 131.98 49.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 t -53.33 -14.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 120.843 -1.161 . . . . 0.0 108.323 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.94 15.51 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.804 -0.56 . . . . 0.0 110.683 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.17 -6.52 31.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.936 -1.102 . . . . 0.0 110.835 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.13 106.3 12.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.432 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.8 m -133.67 175.22 11.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 111.092 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.7 148.65 45.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.263 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.85 28.72 1.73 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.57 0.71 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.354 -0.842 . . . . 0.0 110.056 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.4 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.15 -15.55 4.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.75 47.65 0.33 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.55 59.34 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.6 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.5 Cg_endo -68.96 138.29 40.03 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.788 1.659 . . . . 0.0 112.101 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.313 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.77 56.91 1.79 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.023 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.6 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.18 1.69 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 0.0 109.022 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 30.97 2.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.34 178.88 4.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -1.041 . . . . 0.0 110.066 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.31 145.41 24.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.509 -0.745 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.33 169.52 9.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 109.624 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.703 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.52 137.77 47.28 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.21 29.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.256 -0.902 . . . . 0.0 111.212 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.36 11.35 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.609 0.719 . . . . 0.0 110.35 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.07 22.92 1.36 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.578 -0.701 . . . . 0.0 109.536 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.37 31.15 20.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.792 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.45 142.74 31.31 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.549 -0.971 . . . . 0.0 108.803 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.42 152.86 36.08 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.725 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.511 ' HA ' ' SG ' ' B' ' 105' ' ' CYS . 58.3 m-85 -153.82 140.37 18.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.69 177.48 0.11 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.471 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.61 -36.04 82.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 109.294 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.465 ' O ' ' N ' ' B' ' 132' ' ' GLN . 53.7 m -86.66 -43.73 12.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 111.295 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.89 83.38 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.736 -1.228 . . . . 0.0 108.052 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.495 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.32 14.47 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -64.66 -44.75 89.42 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.161 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.48 -34.3 61.3 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.77 -35.22 44.81 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.351 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.66 -81.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.29 31.6 16.26 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 48.31 51.33 15.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 71.114 -23.327 . . . . 0.0 109.534 179.903 . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.422 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.39 74.93 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.98 35.32 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 109.619 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.08 148.7 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.049 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.12 93.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 0.0 109.394 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.28 2.0 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.38 73.82 1.37 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.39 158.09 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.39 131.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.485 -1.384 . . . . 0.0 111.529 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.92 129.21 45.97 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.7 m -63.52 154.45 32.44 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.521 1.153 . . . . 0.0 110.584 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.2 mt -114.39 -17.25 11.82 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.173 -1.417 . . . . 10.54 107.173 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.0 m-85 -149.49 145.03 18.49 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.198 -0.939 . . . . 18.39 110.791 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.04 81.43 1.68 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.385 1.39 . . . . 0.0 109.099 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CG ' ' N ' ' A' ' 16' ' ' SER . 27.8 t80 -71.61 170.23 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.962 -1.087 . . . . 0.0 110.937 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.6 111.09 8.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.776 0.798 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 111.89 10.59 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 17.6 m -130.25 94.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-O 122.883 1.325 . . . . 0.0 109.16 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.42 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.575 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -82.39 -54.34 5.3 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.904 -1.517 . . . . 55.13 106.904 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 17.4 pt-20 -109.26 29.09 7.86 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.451 -0.781 . . . . 0.0 110.703 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.62 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.41 150.89 22.15 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.921 -1.112 . . . . 0.0 109.741 -179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.33 111.4 22.42 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.402 -0.811 . . . . 11.68 110.739 -178.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.6 41.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.89 142.16 21.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.366 -1.459 . . . . 12.44 110.912 -178.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.19 155.8 22.36 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.97 18.2 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.465 -0.894 . . . . 29.03 109.591 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.54 44.2 6.6 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 6.18 109.298 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.37 114.8 22.9 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.725 -0.868 . . . . 9.52 109.389 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.98 108.67 6.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.54 133.66 49.92 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 123.112 1.434 . . . . 0.0 110.585 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.65 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.393 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.16 92.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 111.431 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.515 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.8 mt -59.71 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.894 -1.129 . . . . 0.0 110.259 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.602 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.916 -1.115 . . . . 0.0 110.79 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.602 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.07 65.53 65.13 Favored Pre-proline 0 N--CA 1.486 1.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.794 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.44 31.42 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.653 1.569 . . . . 0.0 108.982 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.06 -46.55 7.73 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.78 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.351 0.596 . . . . 0.0 110.052 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 122.664 2.243 . . . . 0.0 110.023 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 31.4 tt0 131.77 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 C-N-CA 123.814 0.846 . . . . 0.0 108.752 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.527 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 14.6 m0 -71.87 165.96 23.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.623 -1.298 . . . . 14.29 110.463 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.548 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.1 m0 -129.68 145.06 51.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.233 -0.654 . . . . 11.8 109.233 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.99 96.73 5.83 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.73 55.98 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.89 0.853 . . . . 0.0 110.428 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.52 150.33 27.03 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.769 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.47 128.51 43.47 Favored 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 117.25 -1.78 . . . . 0.0 107.212 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.3 -18.46 0.97 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.775 -1.828 . . . . 0.0 107.995 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.452 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.6 4.29 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.656 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.45 33.82 6.97 Favored Glycine 0 N--CA 1.482 1.761 0 CA-C-N 115.388 -0.824 . . . . 14.41 112.281 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.769 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.91 164.02 30.04 Favored 'General case' 0 N--CA 1.515 2.809 0 CA-C-N 119.796 1.798 . . . . 0.0 111.839 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.59 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 122.309 1.052 . . . . 0.0 112.522 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.11 156.64 12.53 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.255 -1.538 . . . . 7.25 109.255 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.3 150.85 43.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.13 -1.218 . . . . 0.0 108.768 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.62 8.92 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.895 -1.128 . . . . 0.0 109.271 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.048 -1.174 . . . . 4.76 109.048 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.548 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 33.9 pttt -60.38 3.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.8 m120 -102.09 -7.63 22.11 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.183 -0.948 . . . . 14.84 109.273 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.441 ' O ' HG12 ' A' ' 61' ' ' VAL . 3.2 m-85 -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 10.23 109.454 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 60' ' ' TYR . 35.3 m -147.48 156.64 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.149 -0.969 . . . . 6.97 109.521 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.3 p -106.77 160.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -107.63 134.36 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.5 -0.75 . . . . 0.0 109.767 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -105.11 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.619 -0.676 . . . . 0.0 109.227 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -69.91 151.58 45.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.0 109.435 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -146.54 152.72 39.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 0.0 109.377 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.29 1.48 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.47 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.338 1.358 . . . . 0.0 109.645 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.66 1.78 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.04 32.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.85 156.25 28.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.93 0.2 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.3 130.74 5.33 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.337 -1.096 . . . . 0.0 109.378 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.43 ' C ' HG13 ' B' ' 78' ' ' ILE . 5.6 Cg_endo -74.14 163.51 36.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.988 1.792 . . . . 0.0 108.87 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.441 ' H ' HE21 ' B' ' 97' ' ' GLN . 48.5 mt -135.35 119.89 27.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 122.081 0.943 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.42 117.01 4.01 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.831 0.824 . . . . 0.0 110.048 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.519 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.93 -0.09 4.91 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.58 -48.7 8.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -1.061 . . . . 0.0 109.375 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.84 13.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.568 -0.708 . . . . 0.0 109.106 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 53.51 41.33 32.11 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -115.89 143.51 30.92 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.54 113.31 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.5 1.467 . . . . 0.0 110.464 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.438 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.6 mt -70.78 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.57 61.48 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.809 -1.182 . . . . 0.0 110.646 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.0 0.15 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.5 120.56 42.06 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.74 158.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.66 0.743 . . . . 0.0 111.253 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.42 115.96 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.618 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.096 -1.003 . . . . 0.0 109.473 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.55 159.42 42.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.19 17.14 4.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.22 75.94 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.79 0.805 . . . . 0.0 109.754 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.441 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.36 143.52 46.12 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.519 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.58 140.0 33.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.66 -1.275 . . . . 0.0 110.58 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.54 132.02 50.37 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.39 -14.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.876 -1.14 . . . . 0.0 108.335 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.82 -26.94 15.45 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.806 -0.559 . . . . 0.0 110.651 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.08 -6.59 31.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.952 -1.092 . . . . 0.0 110.858 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.13 106.26 12.02 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.433 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.0 m -133.62 175.17 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.218 1.009 . . . . 0.0 111.18 -177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.82 148.67 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.259 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.78 1.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.85 -31.75 0.71 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.14 -15.37 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.248 -0.908 . . . . 0.0 110.175 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.66 47.69 0.34 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.851 . . . . 0.0 110.147 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.47 59.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.5 Cg_endo -69.02 138.23 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.706 1.604 . . . . 0.0 112.167 -177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.315 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.76 56.76 1.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.19 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.93 -55.27 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 0.0 109.07 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.08 2.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.562 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.33 178.96 4.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.469 -1.018 . . . . 0.0 109.953 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.45 145.36 24.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.404 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.6 137.64 47.13 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -107.08 148.26 28.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.23 -0.919 . . . . 0.0 111.233 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 129.4 11.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.614 0.721 . . . . 0.0 110.332 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.15 22.86 1.4 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 0.0 109.504 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.95 20.4 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.687 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -143.26 142.82 31.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.514 -0.992 . . . . 0.0 108.852 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.48 152.97 35.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.673 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.9 m-85 -153.92 140.28 18.65 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.61 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.399 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.0 tt0 -63.56 -36.11 82.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.402 -0.811 . . . . 0.0 109.475 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.515 ' O ' ' N ' ' B' ' 132' ' ' GLN . 58.2 m -86.51 -43.63 12.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.724 . . . . 0.0 111.466 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.77 -43.76 83.15 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.789 -1.194 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.4 13.95 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -64.6 -44.91 89.1 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.46 -34.28 61.22 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.7 -35.3 45.18 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.354 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.2 m-85 -158.51 -81.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 110.094 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.35 31.41 16.62 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.54 51.16 15.87 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -1.151 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.934 -23.412 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.44 74.92 0.12 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -161.94 35.24 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.253 -1.145 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.425 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.02 148.58 44.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.0 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.22 -54.26 2.0 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.435 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.41 73.94 1.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.601 ' H ' ' HG ' ' A' ' 65' ' ' SER . 79.1 t -69.38 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m -145.41 131.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.354 -1.466 . . . . 0.0 111.461 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -99.79 129.19 45.87 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.4 m -63.44 154.31 32.56 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.51 1.148 . . . . 0.0 110.537 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.3 mt -114.28 -17.25 11.88 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.225 -1.398 . . . . 10.54 107.225 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.6 m-85 -149.47 145.1 18.63 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.164 -0.96 . . . . 18.39 110.678 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -73.01 81.45 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.444 1.43 . . . . 0.0 109.107 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.78 170.32 13.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.98 -1.075 . . . . 0.0 110.861 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.72 111.1 7.96 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.805 0.812 . . . . 0.0 109.38 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 112.0 10.72 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 34.0 m -130.36 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 122.941 1.353 . . . . 0.0 109.222 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.504 ' CG2' ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.512 -1.292 . . . . 38.32 107.512 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 58.8 mp0 -82.38 -54.47 5.19 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.832 -1.544 . . . . 55.13 106.832 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -109.18 29.22 7.72 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.374 -0.829 . . . . 0.0 110.803 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.53 150.93 22.16 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.036 -1.04 . . . . 0.0 109.761 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.52 22.61 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.517 -0.739 . . . . 11.68 110.655 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.49 127.84 41.86 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.0 142.21 21.48 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.415 -1.428 . . . . 12.44 110.78 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.87 22.4 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 146.92 18.78 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.238 -0.913 . . . . 29.03 109.585 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 44.2 6.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.416 -1.474 . . . . 6.18 109.416 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.452 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.83 22.93 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.543 -0.974 . . . . 9.52 109.331 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.13 108.67 6.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.48 133.66 49.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.155 1.455 . . . . 0.0 110.584 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.78 103.14 15.88 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.41 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.19 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.489 -0.757 . . . . 0.0 111.491 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.4 mt -59.91 -50.31 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.957 -1.09 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.603 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.603 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.14 65.63 64.94 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.701 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.77 165.41 31.54 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.627 1.551 . . . . 0.0 109.049 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.1 -46.55 7.72 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.77 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.419 0.628 . . . . 0.0 110.059 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.51 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.65 -59.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.547 2.164 . . . . 0.0 109.975 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 71.6 mt-10 131.7 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 123.828 0.851 . . . . 0.0 108.837 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.511 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 20.2 m0 -71.87 166.0 22.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.696 -1.252 . . . . 14.29 110.497 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.462 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.4 m0 -129.64 144.97 51.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.668 -0.645 . . . . 11.8 109.355 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -78.98 96.68 5.81 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.76 56.0 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.889 0.852 . . . . 0.0 110.321 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.69 150.39 26.79 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.777 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.37 128.56 43.4 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 117.327 -1.749 . . . . 0.0 107.239 178.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.5 1.02 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 119.584 -1.948 . . . . 0.0 108.008 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.457 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.59 -4.57 4.26 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.662 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.47 33.81 6.97 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-N 115.403 -0.817 . . . . 14.41 112.284 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.777 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.1 29.8 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-N 119.724 1.762 . . . . 0.0 111.792 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.63 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-O 122.356 1.074 . . . . 0.0 112.541 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.71 12.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.294 -1.522 . . . . 7.25 109.294 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.3 150.78 43.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.278 -1.13 . . . . 0.0 108.596 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.04 136.77 9.02 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 109.269 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 N-CA-C 109.014 -1.187 . . . . 4.76 109.014 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.37 3.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.482 -0.761 . . . . 0.0 110.712 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.7 m-20 -102.01 -7.63 22.18 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.206 -0.934 . . . . 14.84 109.327 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.97 8.13 31.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 10.23 109.527 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.41 156.64 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.193 -0.942 . . . . 6.97 109.483 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.85 160.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.57 134.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.389 -0.819 . . . . 0.0 109.838 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 mp -105.2 -63.18 1.26 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.631 -0.668 . . . . 0.0 109.229 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' A' ' 8' ' ' VAL . 14.4 p -70.01 151.54 45.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.037 -1.039 . . . . 0.0 109.521 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 55.7 p-10 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.3 1.48 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.304 1.336 . . . . 0.0 109.667 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.02 82.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.09 32.33 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.71 156.1 29.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.278 -1.131 . . . . 0.0 109.57 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.4 mtt -49.7 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.74 0.2 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.22 130.86 5.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.301 -1.117 . . . . 0.0 109.378 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.41 163.66 35.74 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.85 1.7 . . . . 0.0 108.827 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.449 ' H ' HE21 ' B' ' 97' ' ' GLN . 74.6 mt -135.41 119.86 26.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.07 0.938 . . . . 0.0 109.338 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 14.9 t -58.43 116.98 3.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.824 0.821 . . . . 0.0 109.871 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.24 4.92 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.54 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.63 -48.65 8.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.361 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.09 4.77 13.72 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 53.57 41.36 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -115.89 143.43 30.77 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.43 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.442 1.428 . . . . 0.0 110.551 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.441 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.6 mt -70.94 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.44 61.54 0.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.918 -1.114 . . . . 0.0 110.583 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.08 -102.06 0.15 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.64 120.74 42.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.83 158.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.762 0.792 . . . . 0.0 111.141 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.45 115.91 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.613 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 109.548 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.5 42.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.15 17.23 4.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.1 25.42 75.64 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.27 -154.77 0.65 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.712 0.768 . . . . 0.0 109.821 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.449 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.46 143.37 45.85 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.8 m95 -141.48 140.1 33.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.41 -1.431 . . . . 0.0 110.634 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.452 ' C ' ' H ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.5 131.9 49.92 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 120.894 -1.129 . . . . 0.0 108.336 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.91 -26.94 15.4 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.71 -0.619 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.21 -6.42 31.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.806 -1.184 . . . . 0.0 110.899 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.29 106.19 12.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.432 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.9 m -133.53 175.25 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.288 1.042 . . . . 0.0 111.167 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.81 148.66 46.28 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.8 28.73 1.71 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.414 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.84 -31.62 0.71 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.349 -0.844 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.22 -15.27 4.19 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.332 -0.855 . . . . 0.0 110.138 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.66 47.67 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.319 -0.863 . . . . 0.0 110.148 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.52 59.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.5 Cg_endo -69.03 138.22 39.58 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.704 1.603 . . . . 0.0 112.168 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.309 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.79 56.96 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.157 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.01 -55.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 109.082 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.19 30.88 2.76 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.574 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.18 178.84 4.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.479 -1.012 . . . . 0.0 110.03 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.33 145.24 24.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.55 9.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 0.0 109.489 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.6 137.65 47.13 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.03 148.24 28.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.241 -0.912 . . . . 0.0 111.331 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.31 11.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.685 0.755 . . . . 0.0 110.257 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.38 22.83 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.506 -0.746 . . . . 0.0 109.414 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.87 20.59 Favored Glycine 0 N--CA 1.481 1.685 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.79 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.29 142.64 31.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.524 -0.986 . . . . 0.0 108.821 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.91 36.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.739 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.503 ' HA ' ' SG ' ' B' ' 105' ' ' CYS . 57.6 m-85 -154.01 140.26 18.54 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.7 m -57.61 177.4 0.1 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.453 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.81 . . . . 0.0 109.383 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.506 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.68 -43.79 12.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.434 -0.791 . . . . 0.0 111.354 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.74 83.91 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.867 -1.145 . . . . 0.0 108.213 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.46 13.58 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -64.52 -44.82 89.66 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.45 -34.49 61.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.541 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.64 -35.19 45.81 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.381 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.7 -81.64 0.05 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 110.085 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.44 31.43 16.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.55 51.28 15.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -1.103 . . . . 0.0 109.556 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.791 -23.48 . . . . 0.0 109.443 -179.981 . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.437 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.437 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.28 74.81 0.13 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.595 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.422 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.03 148.68 43.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.882 . . . . 0.0 109.099 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.11 93.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 109.238 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.31 -54.25 2.0 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.34 74.08 1.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.5 t -69.53 158.07 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.34 131.55 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.463 -1.398 . . . . 0.0 111.528 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.93 129.26 45.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.5 m -63.42 154.33 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.468 1.128 . . . . 0.0 110.633 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 74.4 mt -114.31 -17.34 11.84 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.219 -1.4 . . . . 10.54 107.219 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.4 m-85 -149.5 145.08 18.57 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.21 -0.931 . . . . 18.39 110.726 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 121.364 1.376 . . . . 0.0 109.042 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.85 170.23 14.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.972 -1.08 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.14 8.04 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.906 0.86 . . . . 0.0 109.358 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.07 10.73 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.44 94.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 123.039 1.399 . . . . 0.0 109.172 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.4 m -144.58 -152.11 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.321 -1.309 . . . . 38.32 107.593 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.452 ' H ' ' CG2' ' A' ' 19' ' ' THR . 79.1 mm-40 -82.37 -54.3 5.33 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.92 -1.511 . . . . 55.13 106.92 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 74.9 mt-10 -109.33 29.17 7.79 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.364 -0.835 . . . . 0.0 110.778 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.39 150.78 22.26 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.756 -1.215 . . . . 0.0 109.83 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.29 111.37 22.38 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.408 -0.807 . . . . 11.68 110.775 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.43 127.71 41.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.0 142.04 21.32 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.374 -1.454 . . . . 12.44 110.848 -178.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.07 155.85 22.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.92 18.49 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.482 -0.887 . . . . 29.03 109.539 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.12 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.284 -1.526 . . . . 6.18 109.284 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.4 114.84 22.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.584 -0.951 . . . . 9.52 109.424 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.07 108.68 6.1 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.54 133.83 49.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 123.231 1.491 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.05 15.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.328 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.99 92.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.527 -0.733 . . . . 0.0 111.485 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.6 mt -59.65 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.927 -1.108 . . . . 0.0 110.344 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.611 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.66 43.68 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.037 -1.039 . . . . 0.0 110.737 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.611 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.02 65.55 65.54 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.75 165.4 31.59 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.61 1.54 . . . . 0.0 109.003 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.641 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.07 -46.48 7.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.66 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.352 0.596 . . . . 0.0 110.025 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.8 -47.36 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.734 2.289 . . . . 0.0 109.961 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 67.5 mt-10 131.76 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 C-N-CA 123.881 0.872 . . . . 0.0 108.805 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.5 m0 -71.85 165.89 23.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.738 -1.226 . . . . 14.29 110.502 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.6 m0 -129.51 145.03 51.5 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.377 -0.601 . . . . 11.8 109.377 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -78.98 96.71 5.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.9 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.869 0.842 . . . . 0.0 110.429 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.79 150.47 26.61 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.759 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.53 43.4 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 117.28 -1.768 . . . . 0.0 107.325 178.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.56 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.45 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.618 -1.926 . . . . 0.0 107.951 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.455 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.71 -4.47 4.31 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.4 33.95 6.92 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 115.379 -0.828 . . . . 14.41 112.224 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.759 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.1 29.79 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.731 1.766 . . . . 0.0 111.87 179.12 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.02 154.65 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.323 1.059 . . . . 0.0 112.408 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.337 -1.505 . . . . 7.25 109.337 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.29 150.96 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.31 -1.112 . . . . 0.0 108.684 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.08 136.79 9.02 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.004 -1.06 . . . . 0.0 109.297 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.98 -1.2 . . . . 4.76 108.98 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.46 3.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 110.721 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -101.97 -7.67 22.18 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.147 -0.971 . . . . 14.84 109.391 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' O ' HG12 ' A' ' 61' ' ' VAL . 3.1 m-85 -89.06 8.33 30.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.919 . . . . 10.23 109.483 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 60' ' ' TYR . 32.7 m -147.46 156.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 6.97 109.454 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 3.8 p -106.76 160.82 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 45.6 t -107.71 134.26 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.403 -0.811 . . . . 0.0 109.714 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' O ' ' NH2' ' B' ' 84' ' ' ARG . 9.0 mp -105.14 -63.3 1.24 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -69.92 151.59 45.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 49.4 p30 -146.55 152.72 39.41 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.45 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 121.368 1.378 . . . . 0.0 109.7 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.03 82.59 1.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.93 125.14 32.41 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.514 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.09 28.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -1.073 . . . . 0.0 109.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.76 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.3 46.98 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.32 130.79 5.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.286 -1.126 . . . . 0.0 109.332 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.4 Cg_endo -74.21 163.6 36.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.912 1.741 . . . . 0.0 108.847 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.45 ' H ' HE21 ' B' ' 97' ' ' GLN . 30.6 mt -135.43 119.84 26.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 122.17 0.986 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.3 116.96 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.778 0.799 . . . . 0.0 109.897 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.508 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.23 4.91 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.543 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.59 -48.74 8.07 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 109.321 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.89 13.76 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 53.44 41.28 32.13 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.423 ' NH2' ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -115.82 143.43 30.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -56.48 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.433 1.422 . . . . 0.0 110.56 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -70.91 158.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.51 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.0 110.577 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.71 42.46 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.8 158.62 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.669 0.747 . . . . 0.0 111.245 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.51 116.03 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.604 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.585 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.56 42.58 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 57.94 17.38 4.29 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.32 75.78 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.84 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.45 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.38 143.4 46.03 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.508 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.46 139.97 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.507 -1.371 . . . . 0.0 110.67 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.445 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.38 131.9 49.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.926 -1.109 . . . . 0.0 108.436 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.85 -26.98 15.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.781 -0.574 . . . . 0.0 110.624 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.1 -6.55 31.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.937 -1.102 . . . . 0.0 110.842 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -80.1 106.26 11.99 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.429 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.9 m -133.58 175.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.268 1.032 . . . . 0.0 111.172 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.75 148.71 45.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.31 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.66 1.74 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.78 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -128.98 -15.57 4.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.385 -0.822 . . . . 0.0 110.208 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.59 0.32 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.52 59.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.608 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.06 138.18 39.39 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.699 1.6 . . . . 0.0 112.184 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.326 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.67 56.85 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.194 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.608 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.08 -55.22 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.337 -0.852 . . . . 0.0 108.962 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.22 31.05 2.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.57 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.25 179.07 4.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.578 -0.954 . . . . 0.0 109.949 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.41 24.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 109.305 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.35 169.42 9.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.67 47.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.92 148.29 28.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.264 -0.898 . . . . 0.0 111.25 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.37 11.34 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.584 0.707 . . . . 0.0 110.295 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.14 22.92 1.41 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.664 -0.647 . . . . 0.0 109.448 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.35 31.08 20.39 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.443 -1.361 . . . . 0.0 109.742 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.32 142.71 31.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.547 -0.973 . . . . 0.0 108.778 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.26 152.85 36.38 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.641 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.9 m-85 -153.9 140.22 18.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.57 177.43 0.1 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.477 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.596 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.56 -36.03 82.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.387 -0.82 . . . . 0.0 109.357 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.491 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.2 m -86.61 -43.86 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 111.289 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.64 84.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 108.218 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.86 -56.37 14.42 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.55 -44.74 89.83 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.2 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.49 -34.37 61.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.538 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.77 -35.12 44.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.346 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.52 31.32 16.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.409 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.53 51.3 15.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.723 1 CA-C-O 70.819 -23.467 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.29 0.567 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.31 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.425 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.02 148.64 43.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.12 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.185 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.26 -54.35 2.0 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.444 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.34 74.0 1.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' N ' ' OG ' ' A' ' 65' ' ' SER . 10.1 t -69.51 158.13 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.33 131.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.487 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.414 HE21 ' HA2' ' A' ' 28' ' ' GLY . 56.7 tp60 -99.87 129.31 45.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.4 m -63.51 154.36 32.69 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.456 1.122 . . . . 0.0 110.625 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.9 mt -114.31 -17.23 11.86 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.224 -1.398 . . . . 10.54 107.224 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.1 m-85 -149.56 145.03 18.45 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.21 -0.931 . . . . 18.39 110.798 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.41 1.67 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 121.425 1.417 . . . . 0.0 109.01 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.71 170.26 13.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.948 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.13 8.06 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.741 0.782 . . . . 0.0 109.452 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.38 112.08 10.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.33 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.888 1.327 . . . . 0.0 109.193 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.509 -1.293 . . . . 38.32 107.509 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.49 -54.21 5.37 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.897 -1.52 . . . . 55.13 106.897 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.39 29.31 7.66 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.365 -0.834 . . . . 0.0 110.849 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.57 150.85 22.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.801 -1.187 . . . . 0.0 109.759 -179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.44 22.48 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.411 -0.806 . . . . 11.68 110.714 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.49 127.78 41.8 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.02 142.18 21.44 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.382 -1.449 . . . . 12.44 110.819 -178.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.24 155.77 22.32 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.28 146.96 17.83 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.282 -0.886 . . . . 29.03 109.521 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.414 ' HA2' HE21 ' A' ' 10' ' ' GLN . . . 84.48 44.11 6.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.35 -1.5 . . . . 6.18 109.35 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.26 114.83 23.01 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.493 -1.004 . . . . 9.52 109.451 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.09 108.63 6.09 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.49 133.64 49.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.179 1.466 . . . . 0.0 110.523 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 103.05 15.8 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.733 -1.576 . . . . 0.0 107.484 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.535 -0.728 . . . . 0.0 111.465 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.518 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.0 mt -59.69 -50.46 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.986 -1.072 . . . . 0.0 110.273 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.606 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.56 43.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.606 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -134.93 65.52 65.88 Favored Pre-proline 0 N--CA 1.486 1.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.791 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 45' ' ' LYS . 11.1 Cg_endo -74.69 165.42 31.59 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.625 1.55 . . . . 0.0 109.008 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.53 7.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.7 m-20 57.69 -59.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.33 0.586 . . . . 0.0 110.017 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 178.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.2 Cg_endo -68.73 -59.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.756 2.304 . . . . 0.0 109.776 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 16.8 pt-20 131.78 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 123.79 0.836 . . . . 0.0 108.784 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 14.7 m0 -72.0 165.92 23.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.756 -1.215 . . . . 14.29 110.407 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.479 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.3 m0 -129.58 145.07 51.51 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 109.276 -0.639 . . . . 11.8 109.276 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HZ2' ' HG3' ' A' ' 37' ' ' PRO . 66.0 mttp -79.03 96.63 5.83 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.97 128.86 56.08 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.942 0.877 . . . . 0.0 110.441 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -82.62 150.4 26.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.76 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.52 43.4 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 117.284 -1.766 . . . . 0.0 107.221 177.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.46 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 119.668 -1.895 . . . . 0.0 108.031 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.45 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.57 -4.61 4.27 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.665 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.45 33.89 6.94 Favored Glycine 0 N--CA 1.481 1.691 0 CA-C-N 115.303 -0.862 . . . . 14.41 112.271 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.76 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.12 29.77 Favored 'General case' 0 N--CA 1.515 2.812 0 CA-C-N 119.736 1.768 . . . . 0.0 111.843 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.302 1.048 . . . . 0.0 112.468 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.22 156.73 12.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.306 -1.518 . . . . 7.25 109.306 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.41 150.85 43.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.271 -1.135 . . . . 0.0 108.685 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.74 9.03 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.765 -1.209 . . . . 0.0 109.354 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.32 113.5 1.15 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.032 -1.18 . . . . 4.76 109.032 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.19 3.09 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.793 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 57' ' ' PRO . 10.5 m120 -102.03 -7.67 22.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.095 -1.003 . . . . 14.84 109.337 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -89.11 8.38 30.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.91 . . . . 10.23 109.455 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.48 156.53 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.101 -0.999 . . . . 6.97 109.431 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.79 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -107.67 134.23 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.35 -0.844 . . . . 0.0 109.753 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.17 -63.12 1.26 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.567 -0.708 . . . . 0.0 109.184 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.6 p -70.0 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 50.6 p30 -146.58 152.66 39.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 109.42 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.316 1.344 . . . . 0.0 109.638 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.5 1.75 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.12 32.36 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.434 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.27 28.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.98 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.17 46.82 0.2 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.3 130.72 5.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.24 163.64 36.02 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.975 1.783 . . . . 0.0 108.842 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.451 ' H ' HE21 ' B' ' 97' ' ' GLN . 6.4 mt -135.38 119.7 26.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.967 0.889 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.542 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.32 116.86 3.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.871 0.843 . . . . 0.0 109.917 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.72 -0.19 4.79 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.542 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.62 -48.53 8.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.993 . . . . 0.0 109.443 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.8 13.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 109.147 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 53.47 41.27 32.13 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.503 ' NH2' ' CE1' ' B' ' 99' ' ' HIS . 8.9 mtm105 -115.95 143.39 30.74 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.42 113.32 1.4 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.409 1.406 . . . . 0.0 110.699 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.442 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.5 mt -70.86 158.47 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.56 61.54 0.32 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.858 -1.151 . . . . 0.0 110.593 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.645 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.7 120.69 42.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.83 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.686 0.755 . . . . 0.0 111.168 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.53 116.01 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.593 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.22 18.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.69 159.53 42.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.21 4.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.14 25.22 75.92 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.2 -154.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.728 0.775 . . . . 0.0 109.783 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.41 143.37 45.95 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.604 -1.31 . . . . 0.0 110.669 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.503 ' CE1' ' NH2' ' B' ' 84' ' ' ARG . 17.2 m80 -56.56 131.99 50.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 t -53.17 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 120.902 -1.124 . . . . 0.0 108.311 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.79 -27.02 15.43 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.848 -0.532 . . . . 0.0 110.62 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.04 -6.59 31.54 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.886 -1.134 . . . . 0.0 110.841 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -80.12 106.27 12.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.43 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.7 m -133.56 175.34 11.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.272 1.034 . . . . 0.0 111.081 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.75 148.68 46.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.312 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.5 1.77 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.7 -31.66 0.72 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.369 -0.832 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.17 -15.42 4.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.375 -0.828 . . . . 0.0 110.133 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.64 47.68 0.34 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.208 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.64 59.59 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.21 138.31 39.23 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.691 1.594 . . . . 0.0 112.126 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.294 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.87 56.95 1.77 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.21 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 108.997 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.97 2.74 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.574 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.25 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -1.011 . . . . 0.0 110.024 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.33 24.86 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.57 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.54 9.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.65 47.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.01 148.26 28.92 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.312 -0.867 . . . . 0.0 111.196 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.31 11.28 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.606 0.717 . . . . 0.0 110.413 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.3 22.84 1.49 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.579 -0.7 . . . . 0.0 109.482 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.47 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -143.26 142.74 31.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.487 -1.007 . . . . 0.0 108.762 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.28 152.79 36.37 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.802 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.8 m-85 -153.82 140.24 18.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.49 177.54 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.341 -1.343 . . . . 0.0 108.388 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.595 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.74 -35.99 82.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.382 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.4 m -86.67 -43.65 12.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 0.0 111.464 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.6 -43.76 83.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.797 -1.19 . . . . 0.0 108.255 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.54 13.17 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -64.39 -44.98 89.63 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.151 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.39 61.25 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.62 -35.24 45.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.387 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 110.09 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.48 16.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.413 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.4 51.28 15.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -1.099 . . . . 0.0 109.644 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.708 1 CA-C-O 71.096 -23.335 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.429 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.429 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.37 74.88 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.6 p -161.93 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.238 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.0 148.67 43.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 t -66.14 93.38 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.02 . . . . 0.0 109.19 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.21 -54.28 2.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.445 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.3 73.97 1.38 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.494 ' N ' ' OG ' ' A' ' 65' ' ' SER . 3.7 t -69.39 158.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.46 131.51 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.462 -1.399 . . . . 0.0 111.447 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.0 129.25 46.04 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.2 m -63.45 154.4 32.32 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.505 1.145 . . . . 0.0 110.544 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 84.2 mt -114.39 -17.34 11.8 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.202 -1.407 . . . . 10.54 107.202 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 13.9 m-85 -149.4 145.11 18.68 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.24 -0.913 . . . . 18.39 110.79 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.06 81.56 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 121.394 1.396 . . . . 0.0 109.022 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.86 170.39 13.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.853 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.85 0.833 . . . . 0.0 109.338 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.35 111.92 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 m -130.35 94.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 122.93 1.348 . . . . 0.0 109.145 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.458 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.52 -152.05 0.4 Allowed 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.392 -1.276 . . . . 38.32 107.611 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.458 ' H ' ' CG2' ' A' ' 19' ' ' THR . 97.0 mt-10 -82.47 -54.35 5.26 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.813 -1.551 . . . . 55.13 106.813 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.3 29.19 7.77 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.388 -0.82 . . . . 0.0 110.727 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -100.5 150.85 22.24 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.963 -1.086 . . . . 0.0 109.697 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.37 111.55 22.68 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.384 -0.823 . . . . 11.68 110.698 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.59 127.75 41.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.02 142.18 21.43 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.433 -1.417 . . . . 12.44 110.801 -178.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.85 22.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 146.85 18.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.228 -0.92 . . . . 29.03 109.516 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.53 44.26 6.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.302 -1.519 . . . . 6.18 109.302 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.71 22.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.476 -1.014 . . . . 9.52 109.432 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.57 5.95 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.42 133.7 49.74 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 123.088 1.423 . . . . 0.0 110.574 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.83 103.15 15.89 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.374 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.12 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.561 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.2 mt -59.79 -50.3 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.962 -1.086 . . . . 0.0 110.276 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.609 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.28 157.63 43.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.983 -1.073 . . . . 0.0 110.724 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.609 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.05 65.56 65.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.789 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.39 31.65 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.655 1.57 . . . . 0.0 109.004 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.646 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.09 -46.37 7.81 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.58 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 110.044 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.646 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.49 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.69 -59.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.107 0 C-N-CA 122.592 2.194 . . . . 0.0 109.922 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 54.2 tt0 131.7 9.38 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 123.882 0.873 . . . . 0.0 108.785 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.0 m0 -71.96 166.01 23.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.73 -1.231 . . . . 14.29 110.436 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.555 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.0 m0 -129.6 145.09 51.52 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.284 -0.635 . . . . 11.8 109.284 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.17 96.64 5.93 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.87 128.76 56.05 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.884 0.849 . . . . 0.0 110.45 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.69 150.36 26.81 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.762 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.35 128.5 43.33 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.297 178.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.41 0.99 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 119.632 -1.918 . . . . 0.0 107.991 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.64 -4.55 4.31 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.46 33.79 6.99 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 115.25 -0.886 . . . . 14.41 112.306 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.762 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.89 164.11 29.79 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.658 1.729 . . . . 0.0 111.847 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.55 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 122.294 1.045 . . . . 0.0 112.53 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.19 156.85 12.84 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.233 -1.547 . . . . 7.25 109.233 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.42 150.81 43.04 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -1.15 . . . . 0.0 108.644 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.71 9.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.89 -1.131 . . . . 0.0 109.299 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.532 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.18 113.57 1.17 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 108.971 -1.204 . . . . 4.76 108.971 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.507 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 15.9 pttt -60.41 3.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.479 -0.763 . . . . 0.0 110.679 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -102.16 -7.52 22.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.325 -0.86 . . . . 14.84 109.281 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.13 8.25 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.302 -0.874 . . . . 10.23 109.486 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.44 156.5 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.059 -1.026 . . . . 6.97 109.522 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 2.6 p -106.75 160.73 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.444 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 54.4 t -107.72 134.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.449 -0.782 . . . . 0.0 109.699 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.11 -63.21 1.25 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.264 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.521 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 15.7 p -70.01 151.67 45.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 109.415 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.521 ' OD1' ' O ' ' A' ' 65' ' ' SER . 90.2 m-20 -146.67 152.75 39.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.14 -67.44 1.47 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.41 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.364 1.376 . . . . 0.0 109.722 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.54 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.72 124.93 32.07 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.22 29.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -1.157 . . . . 0.0 109.431 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.84 167.85 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.3 -0.875 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.33 46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.31 130.74 5.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.306 -1.114 . . . . 0.0 109.312 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.19 163.69 35.97 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.932 1.754 . . . . 0.0 108.854 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.445 ' H ' HE21 ' B' ' 97' ' ' GLN . 27.6 mt -135.46 119.77 26.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 122.05 0.929 . . . . 0.0 109.377 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.542 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.37 117.02 4.0 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.771 0.796 . . . . 0.0 109.995 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.06 4.9 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.542 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.72 -48.55 8.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.07 4.72 13.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.497 -0.752 . . . . 0.0 109.068 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.243 -0.911 . . . . 0.0 108.564 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -115.89 143.39 30.71 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.47 113.37 1.42 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.496 1.464 . . . . 0.0 110.604 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.5 mt -71.03 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.49 61.44 0.32 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.898 -1.126 . . . . 0.0 110.733 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.81 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.69 120.56 41.94 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.69 158.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.444 -0.785 . . . . 0.0 111.25 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.57 116.07 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.602 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.86 106.03 18.2 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.042 -1.036 . . . . 0.0 109.466 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.57 42.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.29 4.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.08 25.3 75.79 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.82 0.66 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.821 0.819 . . . . 0.0 109.657 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.445 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.39 143.6 46.12 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.67 139.93 33.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.55 -1.343 . . . . 0.0 110.661 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.45 131.94 49.89 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.19 -14.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 120.922 -1.112 . . . . 0.0 108.399 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.77 -26.95 15.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.728 -0.607 . . . . 0.0 110.635 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.24 -6.42 31.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.839 -1.163 . . . . 0.0 110.799 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.32 106.42 12.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.425 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.3 m -133.72 175.26 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.259 1.028 . . . . 0.0 111.066 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.8 148.59 46.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.419 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.64 28.54 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.738 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.74 -31.62 0.72 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.075 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.06 -15.41 4.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 110.186 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.68 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.277 -0.89 . . . . 0.0 110.256 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.59 59.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.598 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -69.12 138.3 39.51 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.655 1.57 . . . . 0.0 112.102 -177.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.302 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.77 56.94 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.168 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.835 . . . . 0.0 109.023 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.15 31.13 2.73 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.35 178.95 4.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.587 -0.949 . . . . 0.0 109.901 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.43 145.3 24.87 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.558 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.28 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.49 137.69 47.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.96 148.27 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.253 -0.904 . . . . 0.0 111.189 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.0 129.45 11.38 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.692 0.758 . . . . 0.0 110.237 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 51.02 22.97 1.33 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.561 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.96 20.37 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.32 -1.419 . . . . 0.0 109.698 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.31 142.78 31.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.502 -0.999 . . . . 0.0 108.755 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.34 152.91 36.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.363 -0.836 . . . . 0.0 110.722 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.8 m-85 -153.99 140.3 18.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.54 177.38 0.1 Allowed 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.344 -1.343 . . . . 0.0 108.415 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.6 -35.98 82.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 109.341 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.496 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.6 m -86.66 -43.76 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 111.327 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.74 83.85 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.79 -1.193 . . . . 0.0 108.143 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.46 13.7 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -64.55 -44.7 89.95 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.102 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.58 -34.45 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.536 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.59 -35.24 46.07 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.443 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.6 -81.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.34 16.48 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.406 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.54 51.33 15.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -1.133 . . . . 0.0 109.561 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.801 1 CA-C-O 70.798 -23.477 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.436 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.274 0.559 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.436 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.39 74.99 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.212 -1.17 . . . . 0.0 109.542 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.65 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -66.11 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 109.146 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.31 -54.26 2.0 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.446 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.475 ' N ' ' OG ' ' A' ' 65' ' ' SER . 5.2 t -69.41 158.07 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.32 131.53 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.447 -1.408 . . . . 0.0 111.603 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.91 129.22 45.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.9 m -63.45 154.4 32.33 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.501 1.143 . . . . 0.0 110.546 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 8.6 mp -114.41 -17.22 11.82 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.222 -1.399 . . . . 10.54 107.222 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.3 m-85 -149.57 145.08 18.54 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.07 -1.019 . . . . 18.39 110.794 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.06 81.4 1.69 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.479 1.452 . . . . 0.0 109.054 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.77 170.31 13.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.993 -1.067 . . . . 0.0 110.854 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.64 111.13 8.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.839 0.828 . . . . 0.0 109.369 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 112.0 10.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 32.8 m -130.27 94.19 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 122.873 1.32 . . . . 0.0 109.238 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.43 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.385 -1.28 . . . . 38.32 107.634 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -82.42 -54.33 5.29 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.824 -1.547 . . . . 55.13 106.824 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.1 mt-10 -109.38 29.3 7.68 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.364 -0.835 . . . . 0.0 110.728 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.47 150.79 22.28 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.966 -1.084 . . . . 0.0 109.776 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.25 111.38 22.4 Favored 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.385 -0.822 . . . . 11.68 110.796 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.38 127.63 41.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.93 142.24 21.58 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.385 -1.447 . . . . 12.44 110.839 -178.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.15 155.9 22.36 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 146.95 19.15 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.251 -0.906 . . . . 29.03 109.515 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.11 6.59 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.306 -1.517 . . . . 6.18 109.306 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.68 22.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.47 -1.018 . . . . 9.52 109.385 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.69 6.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.52 133.68 49.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 123.154 1.454 . . . . 0.0 110.504 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.75 103.12 15.86 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.372 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.481 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.11 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.534 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.2 mt -59.72 -50.36 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.881 -1.137 . . . . 0.0 110.259 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.605 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.59 43.65 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.973 -1.079 . . . . 0.0 110.736 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.605 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.05 65.54 65.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.79 165.4 31.55 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.628 1.552 . . . . 0.0 108.973 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.631 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.52 7.76 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.73 -59.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.309 0.576 . . . . 0.0 110.041 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.631 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.78 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 122.621 2.214 . . . . 0.0 109.908 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 67.6 mt-10 131.75 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.853 0.861 . . . . 0.0 108.768 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 12.8 m0 -71.85 165.9 23.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.578 -1.326 . . . . 14.29 110.451 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.433 ' CD2' ' HB2' ' A' ' 58' ' ' LYS . 24.9 m0 -129.57 145.03 51.51 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.237 -0.653 . . . . 11.8 109.237 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.99 96.62 5.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.84 56.1 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.928 0.871 . . . . 0.0 110.326 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.69 150.28 26.85 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.758 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.33 128.54 43.35 Favored 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 117.15 -1.82 . . . . 0.0 107.223 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.33 0.99 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 119.579 -1.951 . . . . 0.0 108.045 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.466 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.67 -4.68 4.46 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.55 33.97 6.86 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 115.309 -0.859 . . . . 14.41 112.261 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.758 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -138.0 164.08 29.95 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 119.645 1.722 . . . . 0.0 111.803 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-O 122.381 1.086 . . . . 0.0 112.417 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.04 156.74 12.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.211 -1.556 . . . . 7.25 109.211 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.34 150.83 43.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.261 -1.141 . . . . 0.0 108.598 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.67 8.91 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.969 -1.082 . . . . 0.0 109.266 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.15 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 N-CA-C 109.09 -1.158 . . . . 4.76 109.09 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.568 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.29 3.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.768 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 57' ' ' PRO . 47.2 p30 -102.1 -7.65 22.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.256 -0.902 . . . . 14.84 109.354 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.181 -0.949 . . . . 10.23 109.497 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.47 156.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.14 -0.975 . . . . 6.97 109.456 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.78 160.75 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.67 134.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.49 -0.756 . . . . 0.0 109.765 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.12 -63.27 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.599 -0.688 . . . . 0.0 109.182 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.4 p -69.89 151.59 45.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.062 -1.024 . . . . 0.0 109.491 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -146.59 152.64 39.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.21 -67.36 1.47 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.33 93.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.393 1.395 . . . . 0.0 109.725 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.01 82.48 1.74 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.04 32.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.112 -0.993 . . . . 0.0 109.437 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.18 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -1.121 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.34 46.85 0.2 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.19 130.76 5.37 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.414 -1.051 . . . . 0.0 109.405 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.4 Cg_endo -74.3 163.57 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.915 1.743 . . . . 0.0 108.881 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.447 ' H ' HE21 ' B' ' 97' ' ' GLN . 29.9 mt -135.38 119.71 26.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-O 122.082 0.944 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.32 117.0 3.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.885 0.85 . . . . 0.0 109.983 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.29 4.96 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.539 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.54 -48.52 8.3 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.302 -1.116 . . . . 0.0 109.503 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.1 4.79 13.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 53.59 41.22 32.13 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -115.9 143.34 30.61 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.44 113.48 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.436 1.424 . . . . 0.0 110.542 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -70.93 158.36 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.47 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.872 -1.142 . . . . 0.0 110.687 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -101.96 0.15 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.662 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.6 42.14 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.82 158.68 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.736 0.779 . . . . 0.0 111.144 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.52 115.99 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.607 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.86 106.05 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 109.558 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.53 42.62 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.627 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.22 17.06 4.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.33 75.79 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.29 -154.7 0.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.63 0.729 . . . . 0.0 109.813 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.447 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.44 143.47 45.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.9 m95 -141.65 140.03 33.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.53 -1.356 . . . . 0.0 110.584 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.48 132.01 50.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.37 -14.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.968 -1.082 . . . . 0.0 108.315 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.83 -26.9 15.46 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.776 -0.577 . . . . 0.0 110.616 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.24 -6.47 31.1 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.94 -1.1 . . . . 0.0 110.787 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.427 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.4 m -133.64 175.31 11.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.232 1.015 . . . . 0.0 111.072 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.82 148.76 46.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.329 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.96 28.67 1.77 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 109.65 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.417 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.6 0.72 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.354 -0.841 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.14 -15.52 4.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.57 0.32 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.205 -0.934 . . . . 0.0 110.088 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.52 109.65 59.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.604 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -69.19 138.25 39.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.716 1.611 . . . . 0.0 112.099 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.321 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.74 56.94 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.151 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.604 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 0.0 109.072 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.27 30.96 2.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.567 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.18 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.58 -0.953 . . . . 0.0 110.04 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.38 145.44 24.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.37 169.48 9.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.47 137.69 47.32 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.14 148.35 28.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.213 -0.929 . . . . 0.0 111.174 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.595 0.712 . . . . 0.0 110.306 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.22 22.95 1.47 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.648 -0.657 . . . . 0.0 109.435 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.627 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.47 30.95 20.41 Favored Glycine 0 N--CA 1.482 1.75 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.31 142.64 31.39 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.534 -0.98 . . . . 0.0 108.873 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.38 152.76 36.2 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.793 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.2 m-85 -153.8 140.31 18.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.63 177.44 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.414 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.59 -35.9 82.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.4 m -86.65 -43.86 12.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 111.301 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.74 83.73 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.834 -1.167 . . . . 0.0 108.1 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.78 -56.38 14.24 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.64 -44.79 89.34 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.078 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.44 -34.32 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.74 -35.35 44.86 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.279 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.48 -81.64 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.095 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.42 31.42 16.41 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.7 m-20 48.56 51.17 15.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -1.103 . . . . 0.0 109.613 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.977 -23.392 . . . . 0.0 109.455 179.964 . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.35 74.81 0.12 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.9 35.25 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.057 -1.26 . . . . 0.0 109.58 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.11 148.67 43.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.142 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -66.06 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.105 -0.997 . . . . 0.0 109.275 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.23 -54.37 2.0 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.8 m-70 -145.2 73.88 1.38 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.623 ' H ' ' HG ' ' A' ' 65' ' ' SER . 38.6 t -69.38 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.36 131.47 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.458 -1.401 . . . . 0.0 111.549 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -99.8 129.29 45.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.5 m -63.44 154.45 32.16 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.483 1.135 . . . . 0.0 110.598 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 87.1 mt -114.37 -17.35 11.81 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.251 -1.388 . . . . 10.54 107.251 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.0 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.044 . . . . 18.39 110.783 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -73.06 81.55 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.438 1.425 . . . . 0.0 108.965 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.5 t80 -71.85 170.4 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.845 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.7 111.04 7.93 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.787 0.803 . . . . 0.0 109.472 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.32 111.93 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -130.43 94.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 123.056 1.408 . . . . 0.0 109.147 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.46 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.38 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.272 -1.331 . . . . 38.32 107.569 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' H ' ' CG2' ' A' ' 19' ' ' THR . 97.3 mt-10 -82.39 -54.39 5.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.923 -1.51 . . . . 55.13 106.923 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.442 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.17 29.01 7.91 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.4 -0.812 . . . . 0.0 110.762 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.629 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -100.4 150.9 22.14 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.863 -1.148 . . . . 0.0 109.787 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.36 111.39 22.4 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.419 -0.801 . . . . 11.68 110.756 -178.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.4 127.68 41.63 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.27 21.67 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.4 -1.437 . . . . 12.44 110.943 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.82 22.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.87 18.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.242 -0.911 . . . . 29.03 109.617 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.63 44.09 6.61 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.317 -1.513 . . . . 6.18 109.317 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.82 22.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.541 -0.976 . . . . 9.52 109.396 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.06 108.64 6.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.79 49.68 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.192 1.472 . . . . 0.0 110.527 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.477 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.49 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.07 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -0.782 . . . . 0.0 111.53 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.521 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.0 mt -59.76 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.968 -1.082 . . . . 0.0 110.267 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.599 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.63 43.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.933 -1.105 . . . . 0.0 110.844 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.03 65.5 65.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.836 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HG3' ' HZ1' ' A' ' 45' ' ' LYS . 11.0 Cg_endo -74.86 165.4 31.51 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.578 1.518 . . . . 0.0 108.96 177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.635 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.52 7.75 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.59 -59.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.391 0.615 . . . . 0.0 110.141 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.56 -59.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.583 2.188 . . . . 0.0 109.909 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 17.8 pt-20 131.83 9.27 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.892 0.877 . . . . 0.0 108.786 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.527 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.1 m0 -71.77 165.92 23.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.669 -1.27 . . . . 14.29 110.48 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.479 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.4 m0 -129.63 144.99 51.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.243 -0.651 . . . . 11.8 109.243 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HZ1' ' HG3' ' A' ' 37' ' ' PRO . 65.8 mttp -78.93 96.58 5.75 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.914 0.864 . . . . 0.0 110.373 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.72 150.37 26.75 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.775 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.261 -1.776 . . . . 0.0 107.163 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.37 1.0 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.675 -1.89 . . . . 0.0 108.011 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.448 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.68 -4.59 4.38 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.42 33.88 6.95 Favored Glycine 0 N--CA 1.48 1.627 0 CA-C-N 115.386 -0.825 . . . . 14.41 112.297 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.775 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.14 29.7 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.633 1.717 . . . . 0.0 111.849 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.59 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-O 122.362 1.077 . . . . 0.0 112.434 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.2 156.75 12.73 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.338 -1.505 . . . . 7.25 109.338 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.23 150.89 43.27 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.296 -1.12 . . . . 0.0 108.681 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.71 8.95 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.84 -1.162 . . . . 0.0 109.342 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.22 113.6 1.18 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.074 -1.164 . . . . 4.76 109.074 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.5 pttt -60.37 3.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.487 -0.758 . . . . 0.0 110.603 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.7 m-20 -102.05 -7.66 22.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.144 -0.973 . . . . 14.84 109.323 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.22 30.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 10.23 109.494 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.38 156.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 6.97 109.589 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.0 m -106.77 160.69 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.2 t -107.59 134.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.411 -0.806 . . . . 0.0 109.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.19 -63.28 1.25 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.623 ' HG ' ' H ' ' A' ' 8' ' ' VAL . 13.8 p -69.91 151.61 45.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.983 -1.073 . . . . 0.0 109.418 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -146.59 152.68 39.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.23 1.48 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.254 1.302 . . . . 0.0 109.732 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.7 1.79 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.9 125.09 32.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.86 156.21 28.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -1.181 . . . . 0.0 109.507 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.73 167.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.93 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.31 130.75 5.33 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.383 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.28 163.8 35.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.816 1.677 . . . . 0.0 108.828 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.451 ' H ' HE21 ' B' ' 97' ' ' GLN . 61.3 mt -135.52 119.75 26.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 122.072 0.939 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.541 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.29 116.94 3.92 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.819 0.818 . . . . 0.0 109.96 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.3 4.96 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.541 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.53 -48.62 8.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -1.057 . . . . 0.0 109.455 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.86 13.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -115.91 143.49 30.91 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.402 ' HA ' HG12 ' B' ' 78' ' ' ILE . 5.6 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.511 1.474 . . . . 0.0 110.494 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -70.96 158.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.52 61.48 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 110.615 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.0 -101.93 0.15 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.62 42.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.77 158.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.419 -0.801 . . . . 0.0 111.195 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.55 116.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.607 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.033 -1.042 . . . . 0.0 109.622 -179.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.51 42.68 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.637 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.15 4.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.38 25.11 76.16 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.16 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.788 0.804 . . . . 0.0 109.726 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.35 143.49 46.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.64 139.99 33.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.416 -1.428 . . . . 0.0 110.646 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.465 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.58 131.94 50.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.16 -14.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.909 -1.119 . . . . 0.0 108.348 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.465 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.83 -26.97 15.44 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 110.638 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.06 -6.6 31.46 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.93 -1.107 . . . . 0.0 110.787 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.24 106.34 12.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.431 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.3 m -133.64 175.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.267 1.032 . . . . 0.0 111.088 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.85 148.66 46.45 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.354 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.87 28.77 1.72 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.676 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.413 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.82 -31.62 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.309 -0.87 . . . . 0.0 110.086 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.24 -15.25 4.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.54 47.6 0.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.232 -0.918 . . . . 0.0 110.24 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.59 59.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.596 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.12 138.26 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.79 1.66 . . . . 0.0 112.006 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.325 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.038 0.0 OUTLIER -95.77 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.075 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.596 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.04 -55.24 1.61 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.001 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.98 2.75 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.57 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.36 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.416 -1.05 . . . . 0.0 109.958 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.53 145.41 24.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.797 . . . . 0.0 109.295 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.39 169.55 9.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.472 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.54 137.66 47.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.96 148.3 28.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.203 -0.936 . . . . 0.0 111.18 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.469 -0.77 . . . . 0.0 110.327 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.31 22.8 1.49 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.637 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 31.02 20.41 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.79 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.37 142.8 31.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.61 -0.936 . . . . 0.0 108.799 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.43 152.82 36.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.331 -0.855 . . . . 0.0 110.673 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.506 ' HA ' ' SG ' ' B' ' 105' ' ' CYS . 57.5 m-85 -153.84 140.36 18.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.3 m -57.72 177.55 0.1 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.441 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.67 -35.92 82.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.853 . . . . 0.0 109.436 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.528 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.1 m -86.61 -43.81 12.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 111.349 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.73 83.79 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.738 -1.226 . . . . 0.0 108.177 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.5 13.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.42 -44.92 89.72 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.184 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.43 -34.36 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.63 -35.35 45.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.384 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.7 m-85 -158.51 -81.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.054 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.46 31.44 16.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.39 51.37 15.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.327 -1.102 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.698 1 CA-C-O 70.992 -23.385 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.309 0.576 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.98 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.91 35.2 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -1.208 . . . . 0.0 109.666 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.62 43.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.296 -0.878 . . . . 0.0 109.139 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.5 t -65.92 93.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -121.26 -54.32 2.0 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.31 73.88 1.37 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.41 158.13 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -145.44 131.6 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.48 -1.387 . . . . 0.0 111.513 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -100.03 129.16 46.06 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.3 m -63.3 154.39 31.84 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.497 1.141 . . . . 0.0 110.617 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 93.1 mt -114.37 -17.28 11.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.211 -1.403 . . . . 10.54 107.211 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.3 m-85 -149.49 145.06 18.54 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 121.133 -0.979 . . . . 18.39 110.794 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -72.87 81.4 1.64 Allowed 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.468 1.445 . . . . 0.0 109.07 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.76 170.33 13.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.923 -1.111 . . . . 0.0 110.91 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.07 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.776 0.798 . . . . 0.0 109.431 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.31 111.96 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.29 94.25 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 122.9 1.333 . . . . 0.0 109.134 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.537 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 2.6 m -144.46 -151.98 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.362 -1.29 . . . . 38.32 107.581 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.537 ' H ' ' CG2' ' A' ' 19' ' ' THR . 76.7 mm-40 -82.5 -54.29 5.3 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.903 -1.518 . . . . 55.13 106.903 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.5 mt-10 -109.3 29.2 7.76 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.53 150.93 22.17 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.907 -1.12 . . . . 0.0 109.741 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.38 22.39 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.342 -0.849 . . . . 11.68 110.82 -178.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.36 127.7 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.03 142.22 21.47 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.327 -1.483 . . . . 12.44 110.851 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.521 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.87 22.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 146.93 18.91 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.255 -0.903 . . . . 29.03 109.492 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.14 6.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.273 -1.531 . . . . 6.18 109.273 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.29 114.79 22.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.652 -0.911 . . . . 9.52 109.436 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.99 108.57 5.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.65 49.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 123.21 1.481 . . . . 0.0 110.549 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.6 102.95 15.69 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.48 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.485 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 111.49 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.516 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.0 mt -59.85 -50.39 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 120.917 -1.114 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.603 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.16 157.62 43.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.99 -1.069 . . . . 0.0 110.831 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.603 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.04 65.52 65.35 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.28 31.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.721 1.614 . . . . 0.0 109.027 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.645 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.49 7.77 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.67 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.353 0.597 . . . . 0.0 110.037 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.89 -47.54 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.601 ' O ' ' HB3' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.64 -59.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.608 2.205 . . . . 0.0 109.996 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.9 pt-20 131.67 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 123.878 0.871 . . . . 0.0 108.806 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 11.7 m0 -71.79 165.91 23.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.712 -1.242 . . . . 14.29 110.527 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.466 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.1 m0 -129.46 145.12 51.47 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.633 -0.667 . . . . 11.8 109.302 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.17 96.61 5.92 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.6 p -115.92 128.81 56.06 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.966 0.888 . . . . 0.0 110.347 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.63 150.48 26.8 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.765 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.46 128.57 43.51 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 117.275 -1.77 . . . . 0.0 107.216 177.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.44 1.02 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.611 -1.931 . . . . 0.0 107.972 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.58 -4.77 4.43 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.655 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 34.04 6.85 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.438 -0.801 . . . . 14.41 112.215 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.765 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.96 164.11 29.84 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.628 1.714 . . . . 0.0 111.765 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.55 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.305 1.05 . . . . 0.0 112.507 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.14 156.69 12.61 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.324 -1.511 . . . . 7.25 109.324 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.29 150.76 43.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.171 -1.194 . . . . 0.0 108.674 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.98 136.75 9.04 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.954 -1.092 . . . . 0.0 109.289 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.12 113.46 1.11 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 N-CA-C 109.052 -1.172 . . . . 4.76 109.052 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.4 pttt -60.36 3.23 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.443 -0.786 . . . . 0.0 110.71 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.3 m120 -102.17 -7.48 22.17 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.3 -0.875 . . . . 14.84 109.326 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.05 8.16 31.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.089 -1.007 . . . . 10.23 109.343 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.45 156.62 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.219 -0.926 . . . . 6.97 109.561 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.445 HG21 ' H ' ' A' ' 63' ' ' VAL . 7.5 p -106.84 160.86 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.445 ' H ' HG21 ' A' ' 62' ' ' VAL . 5.5 p -107.72 134.31 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.2 -63.14 1.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.566 -0.709 . . . . 0.0 109.202 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 31.8 m -70.15 151.69 45.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.99 -1.069 . . . . 0.0 109.417 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -146.58 152.67 39.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.32 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.31 1.34 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.58 1.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.79 124.96 32.16 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.94 156.19 28.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -1.134 . . . . 0.0 109.41 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.83 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.28 46.88 0.2 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.27 130.76 5.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.0 109.463 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.15 163.65 36.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.024 1.816 . . . . 0.0 108.811 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.434 ' H ' HE21 ' B' ' 97' ' ' GLN . 74.8 mt -135.47 119.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.073 0.939 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.48 117.05 4.07 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.833 0.825 . . . . 0.0 109.962 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.13 4.97 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.538 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.64 -48.6 8.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.372 -1.075 . . . . 0.0 109.422 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.12 4.83 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 53.55 41.26 32.12 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.418 HH11 ' HB3' ' B' ' 84' ' ' ARG . 2.0 mmm180 -115.98 143.55 31.08 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.407 ' HA ' HG12 ' B' ' 78' ' ' ILE . 5.7 Cg_exo -56.45 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.417 1.411 . . . . 0.0 110.611 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -70.89 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.6 61.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.877 -1.139 . . . . 0.0 110.667 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.08 0.15 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.71 42.51 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.82 158.72 3.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 111.155 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.6 116.16 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.612 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.89 106.15 18.28 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 109.534 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.53 159.5 42.67 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.23 4.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.22 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.851 -0.793 . . . . 0.0 109.856 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.448 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.48 143.54 45.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.5 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.526 -1.359 . . . . 0.0 110.646 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.455 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.61 132.12 50.82 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -53.36 -14.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.927 -1.108 . . . . 0.0 108.408 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.455 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.68 -27.18 15.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.778 -0.576 . . . . 0.0 110.589 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -97.94 -6.63 31.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.901 -1.124 . . . . 0.0 110.899 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.15 106.29 12.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.43 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.0 m -133.56 175.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.358 1.075 . . . . 0.0 111.073 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.95 148.7 46.72 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.2 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.65 1.74 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.837 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.43 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.47 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.321 -0.862 . . . . 0.0 110.196 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.23 -15.29 4.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.296 -0.878 . . . . 0.0 110.076 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.61 47.57 0.35 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.794 . . . . 0.0 110.267 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.5 59.05 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.07 138.23 39.5 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.73 1.62 . . . . 0.0 112.179 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.314 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.8 57.04 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.196 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.12 -55.29 1.64 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 108.997 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.07 31.0 2.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.576 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.31 178.98 4.13 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.611 -0.935 . . . . 0.0 109.94 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.37 145.3 24.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.564 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.25 169.57 9.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.5 m-85 -132.57 137.65 47.17 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.32 28.85 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.14 -0.975 . . . . 0.0 111.204 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.24 11.2 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.615 0.722 . . . . 0.0 110.324 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.36 22.74 1.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.96 20.32 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.741 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.7 mt -143.25 142.63 31.44 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.608 -0.937 . . . . 0.0 108.873 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.16 152.8 36.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.507 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.6 m-85 -153.87 140.34 18.76 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.6 m -57.74 177.44 0.11 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.299 -1.361 . . . . 0.0 108.401 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.58 -35.94 82.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.417 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.507 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.6 m -86.71 -43.66 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 111.311 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.466 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.83 -43.55 83.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.817 -1.177 . . . . 0.0 108.206 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.82 -56.37 14.37 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.6 -44.91 89.13 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.009 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.45 -34.35 61.32 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.63 -35.34 45.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.381 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.58 -81.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 110.096 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.4 31.34 16.69 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.48 51.24 15.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -1.084 . . . . 0.0 109.576 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.981 -23.39 . . . . 0.0 109.454 179.915 . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.84 0.12 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.95 35.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -1.172 . . . . 0.0 109.624 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -72.99 148.6 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.167 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -65.96 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.288 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.41 1.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.23 73.94 1.38 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.46 158.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m -145.34 131.45 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.416 -1.427 . . . . 0.0 111.564 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.92 129.22 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 m -63.41 154.43 32.1 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.487 1.136 . . . . 0.0 110.572 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 90.5 mt -114.31 -17.36 11.84 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.274 -1.38 . . . . 10.54 107.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 13.9 m-85 -149.51 144.96 18.39 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.16 -0.963 . . . . 18.39 110.803 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.97 81.54 1.65 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.392 1.395 . . . . 0.0 109.024 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.92 170.32 13.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.978 -1.077 . . . . 0.0 110.86 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.63 111.08 7.99 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.831 0.824 . . . . 0.0 109.47 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 111.86 10.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.2 t -130.23 94.35 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.938 1.352 . . . . 0.0 109.2 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.624 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 4.9 m -144.49 -151.97 0.39 Allowed 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.335 -1.302 . . . . 38.32 107.557 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.624 ' H ' ' CG2' ' A' ' 19' ' ' THR . 45.6 tp10 -82.41 -54.36 5.27 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.885 -1.524 . . . . 55.13 106.885 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.8 mt-10 -109.38 29.23 7.74 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.447 -0.783 . . . . 0.0 110.712 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.643 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -100.49 150.98 22.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.811 -1.181 . . . . 0.0 109.727 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.443 -0.786 . . . . 11.68 110.765 -178.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.53 127.69 41.77 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.83 142.25 21.68 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.352 -1.467 . . . . 12.44 110.876 -178.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.76 22.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 146.91 18.73 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.227 -0.921 . . . . 29.03 109.452 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.17 6.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.326 -1.51 . . . . 6.18 109.326 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.67 22.72 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.487 -1.008 . . . . 9.52 109.416 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.97 108.69 6.02 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.59 133.63 50.01 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.201 1.477 . . . . 0.0 110.532 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.71 103.05 15.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.466 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.0 92.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.573 -0.705 . . . . 0.0 111.496 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.509 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.4 mt -59.65 -50.52 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.94 -1.1 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.607 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.12 157.67 43.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.991 -1.068 . . . . 0.0 110.788 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.607 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.07 65.6 65.35 Favored Pre-proline 0 N--CA 1.486 1.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.761 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.74 165.34 31.71 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.715 1.61 . . . . 0.0 108.947 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.16 -46.3 7.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.5 m-20 57.62 -59.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.442 0.639 . . . . 0.0 110.054 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.71 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.6 ' O ' ' HB3' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.61 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.128 0 C-N-CA 122.597 2.198 . . . . 0.0 109.968 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.86 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 22.1 m0 -71.81 165.87 23.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.626 -1.296 . . . . 14.29 110.519 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.469 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.8 m0 -129.55 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.286 -0.635 . . . . 11.8 109.286 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.15 96.66 5.92 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.6 p -116.0 128.8 56.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.954 0.883 . . . . 0.0 110.378 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.6 150.44 26.86 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.766 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.45 128.58 43.52 Favored 'General case' 0 N--CA 1.509 2.487 0 C-N-CA 117.266 -1.773 . . . . 0.0 107.215 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.5 -18.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.734 -1.854 . . . . 0.0 107.913 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.447 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.67 -4.55 4.33 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.651 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.35 33.96 6.94 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 115.257 -0.883 . . . . 14.41 112.286 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.766 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.07 29.86 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.745 1.772 . . . . 0.0 111.829 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.97 154.58 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 122.335 1.064 . . . . 0.0 112.52 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' HD22 ' A' ' 23' ' ' LEU . . . 172.21 156.84 12.85 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.236 -1.546 . . . . 7.25 109.236 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.51 150.97 42.76 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.296 -1.12 . . . . 0.0 108.613 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.12 136.67 8.91 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.82 -1.175 . . . . 0.0 109.265 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.04 113.46 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 108.992 -1.195 . . . . 4.76 108.992 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 62.7 pttt -60.33 3.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 110.66 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.3 m-20 -102.01 -7.66 22.15 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.275 -0.891 . . . . 14.84 109.334 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.456 ' O ' HG13 ' A' ' 61' ' ' VAL . 3.4 m-85 -88.96 8.11 31.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.239 -0.913 . . . . 10.23 109.56 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 60' ' ' TYR . 32.0 m -147.32 156.57 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 6.97 109.542 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 63' ' ' VAL . 15.0 t -106.86 160.69 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 10.4 p -107.57 134.34 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.392 -0.818 . . . . 0.0 109.814 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.19 -63.15 1.26 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 33.9 m -70.05 151.68 45.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.956 -1.09 . . . . 0.0 109.503 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -146.75 152.69 39.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.27 1.48 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.52 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.209 1.273 . . . . 0.0 109.637 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.53 1.75 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.05 32.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 156.27 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 109.532 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.92 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.27 46.92 0.2 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.3 130.73 5.32 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.283 -1.128 . . . . 0.0 109.413 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.28 163.58 36.1 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.872 1.714 . . . . 0.0 108.848 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.442 ' H ' HE21 ' B' ' 97' ' ' GLN . 72.7 mt -135.33 119.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 122.001 0.905 . . . . 0.0 109.379 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.1 t -58.24 116.88 3.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.75 -0.1 4.73 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.78 -48.41 8.25 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.361 -1.082 . . . . 0.0 109.397 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.19 4.89 13.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.521 -0.737 . . . . 0.0 109.07 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -115.94 143.32 30.61 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.415 ' HA ' HG12 ' B' ' 78' ' ' ILE . 5.8 Cg_exo -56.33 113.25 1.36 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.49 1.46 . . . . 0.0 110.636 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.7 mt -70.9 158.53 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.642 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.6 61.44 0.32 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.873 -1.142 . . . . 0.0 110.615 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.96 -101.96 0.15 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.74 120.61 42.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.67 158.75 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.698 0.761 . . . . 0.0 111.186 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.59 115.92 47.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.611 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.81 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.48 42.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.32 4.35 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.3 75.82 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.8 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.747 0.784 . . . . 0.0 109.684 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.457 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.41 143.4 45.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.46 140.06 33.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.606 -1.309 . . . . 0.0 110.651 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.469 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.5 131.93 50.0 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 t -53.17 -14.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.988 -1.07 . . . . 0.0 108.465 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.469 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.8 -26.87 15.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.762 -0.586 . . . . 0.0 110.608 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.14 -6.51 31.37 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.909 -1.119 . . . . 0.0 110.804 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -80.27 106.31 12.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.425 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.4 m -133.58 175.39 11.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.153 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.83 148.69 46.3 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.375 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.74 1.73 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.428 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.83 -31.74 0.71 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 110.135 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.08 -15.32 4.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.104 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.63 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.69 59.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.595 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.14 138.35 39.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.636 1.558 . . . . 0.0 112.144 -177.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.81 56.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.172 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.595 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.98 -55.35 1.57 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.04 2.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.57 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.96 4.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.429 -1.042 . . . . 0.0 109.977 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.51 145.28 24.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.5 137.72 47.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.06 148.34 28.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.353 -0.842 . . . . 0.0 111.266 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.95 129.31 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.724 . . . . 0.0 110.424 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.97 1.43 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 30.94 20.63 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.77 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.9 mt -143.27 142.66 31.43 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.968 . . . . 0.0 108.853 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.93 36.27 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.735 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.8 m-85 -153.99 140.28 18.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.1 m -57.54 177.46 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.404 -1.318 . . . . 0.0 108.508 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.64 -35.99 82.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.5 m -86.54 -43.79 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 111.426 -178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.85 83.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.812 -1.18 . . . . 0.0 108.155 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.75 -56.49 13.49 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.153 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.55 -34.29 61.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.71 -35.24 45.19 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.357 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.52 -81.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.45 31.37 16.45 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.57 51.2 15.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -1.09 . . . . 0.0 109.561 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.476 -39.647 1 CA-C-O 70.829 -23.462 . . . . 0.0 109.479 -179.975 . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.407 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.407 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.36 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.03 35.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -1.102 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.8 ttm-85 -73.01 148.62 44.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.127 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.05 93.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.3 mt -121.19 -54.27 2.01 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.32 74.04 1.38 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.55 157.97 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.2 131.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.365 -1.459 . . . . 0.0 111.553 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -99.9 129.27 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -63.47 154.35 32.57 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.499 1.142 . . . . 0.0 110.544 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 91.7 mt -114.3 -17.29 11.86 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.221 -1.4 . . . . 10.54 107.221 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.2 m-85 -149.48 145.07 18.56 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.154 -0.966 . . . . 18.39 110.768 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.98 81.51 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.345 1.363 . . . . 0.0 109.059 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.4 t80 -71.88 170.3 13.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.912 -1.117 . . . . 0.0 110.821 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.58 111.16 8.07 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.809 0.814 . . . . 0.0 109.389 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.27 111.89 10.61 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.37 94.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.904 1.335 . . . . 0.0 109.197 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.383 -1.28 . . . . 38.32 107.63 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.41 -54.31 5.31 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.936 -1.505 . . . . 55.13 106.936 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.6 mt-10 -109.25 29.21 7.74 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.47 -0.769 . . . . 0.0 110.827 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.616 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.61 150.92 22.21 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.861 -1.149 . . . . 0.0 109.682 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.42 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.43 22.49 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.39 -0.819 . . . . 11.68 110.71 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.45 127.68 41.69 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.92 142.27 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.436 -1.415 . . . . 12.44 110.798 -178.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.32 155.87 22.17 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.94 18.43 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.266 -0.896 . . . . 29.03 109.506 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 44.09 6.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.286 -1.526 . . . . 6.18 109.286 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.87 23.01 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.534 -0.98 . . . . 9.52 109.358 -179.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.22 108.74 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.56 133.75 49.81 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 123.228 1.49 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.86 103.11 15.86 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 113.745 -1.571 . . . . 0.0 107.351 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.495 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.521 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.0 mt -59.9 -50.43 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.145 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.6 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.17 157.6 43.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.026 -1.046 . . . . 0.0 110.786 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.6 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.01 65.57 65.7 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.767 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.43 31.56 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.567 1.512 . . . . 0.0 109.145 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.11 -46.42 7.78 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.63 -59.43 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.421 0.629 . . . . 0.0 110.071 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.624 2.216 . . . . 0.0 109.899 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 75.2 mt-10 131.86 9.31 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 12.8 m0 -71.85 165.91 23.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.619 -1.301 . . . . 14.29 110.385 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.539 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.1 m0 -129.64 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.287 -0.635 . . . . 11.8 109.287 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.99 96.58 5.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.69 55.98 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.91 0.862 . . . . 0.0 110.488 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.5 150.31 27.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.774 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 117.226 -1.789 . . . . 0.0 107.289 177.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.46 1.01 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.652 -1.905 . . . . 0.0 108.013 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.452 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.61 -4.55 4.26 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.655 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.42 33.95 6.92 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-N 115.355 -0.839 . . . . 14.41 112.253 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.774 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.06 29.96 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-N 119.71 1.755 . . . . 0.0 111.859 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.83 154.56 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.231 1.015 . . . . 0.0 112.601 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.24 -1.544 . . . . 7.25 109.24 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.29 150.87 43.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -1.182 . . . . 0.0 108.605 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.06 136.83 9.06 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.075 -1.016 . . . . 0.0 109.225 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.23 113.51 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 108.935 -1.217 . . . . 4.76 108.935 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 25.6 pttm -60.23 2.95 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.453 -0.78 . . . . 0.0 110.798 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.9 m120 -101.96 -7.56 22.29 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 14.84 109.297 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.11 8.34 30.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.289 -0.882 . . . . 10.23 109.481 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.1 m -147.51 156.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.239 -0.913 . . . . 6.97 109.389 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.82 160.78 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 73.1 t -107.62 134.22 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.435 -0.791 . . . . 0.0 109.834 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.436 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 97.9 mt -105.14 -63.08 1.26 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.636 -0.665 . . . . 0.0 109.207 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.491 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 19.4 m -70.11 151.55 45.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 65' ' ' SER . 85.6 m-20 -146.43 152.8 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.34 1.47 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.4 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.298 1.332 . . . . 0.0 109.669 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.6 1.77 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.83 124.93 32.15 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.121 -0.987 . . . . 0.0 109.395 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.19 28.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -1.137 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.78 167.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.444 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.39 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 2.2 t -155.31 130.84 5.37 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.346 -1.091 . . . . 0.0 109.291 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.4 Cg_endo -74.34 163.65 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.941 1.761 . . . . 0.0 108.875 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.44 ' H ' HE21 ' B' ' 97' ' ' GLN . 61.7 mt -135.42 119.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 122.054 0.93 . . . . 0.0 109.313 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.2 t -58.33 116.94 3.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 110.045 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.85 -0.16 4.91 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.537 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.55 -48.72 8.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -1.121 . . . . 0.0 109.33 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.01 4.81 13.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 53.62 41.25 32.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.436 ' NH1' ' O ' ' A' ' 64' ' ' LEU . 5.3 mmm180 -115.95 143.46 30.89 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.416 1.411 . . . . 0.0 110.566 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.3 mt -70.87 158.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.58 61.57 0.32 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.885 -1.134 . . . . 0.0 110.648 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.16 -101.91 0.15 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.66 120.75 42.61 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.89 158.61 3.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.524 -0.735 . . . . 0.0 111.205 -177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.6 115.97 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.615 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.7 106.01 18.18 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.687 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.61 42.46 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.92 17.28 4.2 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.24 25.17 76.01 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.14 -154.75 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.776 0.798 . . . . 0.0 109.758 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.39 143.52 46.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.53 140.01 33.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.462 -1.399 . . . . 0.0 110.644 -177.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.51 131.89 49.9 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.16 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 120.866 -1.146 . . . . 0.0 108.343 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.11 15.41 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.848 -0.533 . . . . 0.0 110.61 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.13 -6.43 31.56 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 110.746 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.12 106.24 12.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.429 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.2 m -133.57 175.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 122.219 1.009 . . . . 0.0 111.143 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.82 148.71 46.18 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.222 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.7 1.74 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.072 -1.018 . . . . 0.0 109.596 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.8 0.71 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.407 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.36 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.407 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.59 47.75 0.34 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.314 -0.866 . . . . 0.0 110.131 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.57 109.62 59.67 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.6 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -69.08 138.32 39.67 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.656 1.57 . . . . 0.0 112.059 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.305 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.78 56.87 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.131 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.6 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.15 1.69 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.1 30.96 2.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.572 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.35 178.87 4.17 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.411 -1.052 . . . . 0.0 109.953 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.35 145.39 24.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.365 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.42 169.39 9.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 109.504 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.67 47.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.05 148.29 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.256 -0.902 . . . . 0.0 111.22 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.93 129.41 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.09 22.93 1.37 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.491 -0.756 . . . . 0.0 109.531 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.99 20.26 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -143.33 142.74 31.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.577 -0.955 . . . . 0.0 108.738 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.81 36.26 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.903 . . . . 0.0 110.721 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.7 m-85 -153.9 140.23 18.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.49 177.48 0.1 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.339 -1.344 . . . . 0.0 108.49 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.65 -36.06 82.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 109.301 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.531 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.5 m -86.65 -43.73 12.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.843 . . . . 0.0 111.325 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.72 83.67 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.698 -1.251 . . . . 0.0 108.187 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.7 -56.56 13.03 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.51 -44.75 89.93 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.46 -34.42 61.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.536 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.65 -35.22 45.7 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.39 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.62 -81.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.838 . . . . 0.0 110.075 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.33 31.47 16.49 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.422 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.42 51.3 15.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.245 -1.15 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.749 1 CA-C-O 71.145 -23.312 . . . . 0.0 109.454 179.98 . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.96 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -162.0 35.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.082 -1.246 . . . . 0.0 109.606 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -72.95 148.59 44.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.129 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.0 93.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.277 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 mt -121.37 -54.25 1.99 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.438 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.34 74.1 1.38 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.65 ' H ' ' HG ' ' A' ' 65' ' ' SER . 82.1 t -69.56 158.12 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.39 131.53 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.401 -1.437 . . . . 0.0 111.538 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -99.92 129.23 45.98 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.1 m -63.45 154.29 32.69 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.513 1.149 . . . . 0.0 110.614 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.3 mt -114.29 -17.3 11.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.155 -1.424 . . . . 10.54 107.155 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 13.9 m-85 -149.56 145.04 18.48 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.19 -0.944 . . . . 18.39 110.798 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -73.02 81.47 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.506 1.471 . . . . 0.0 109.036 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.2 t80 -71.78 170.31 13.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.125 . . . . 0.0 110.944 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.0 7.92 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.738 0.78 . . . . 0.0 109.459 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.0 10.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.33 94.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-O 122.907 1.337 . . . . 0.0 109.26 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.474 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.6 m -144.36 -151.93 0.39 Allowed 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.301 -1.318 . . . . 38.32 107.701 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.474 ' H ' ' CG2' ' A' ' 19' ' ' THR . 96.2 mt-10 -82.51 -54.42 5.2 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.84 -1.541 . . . . 55.13 106.84 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.4 mt-10 -109.3 29.28 7.69 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.357 -0.839 . . . . 0.0 110.759 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.43 150.89 22.16 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.812 -1.18 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.451 -0.78 . . . . 11.68 110.756 -178.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.39 127.72 41.67 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.99 142.16 21.44 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.386 -1.446 . . . . 12.44 110.905 -178.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.78 22.52 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 146.98 18.09 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.389 -0.924 . . . . 29.03 109.603 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.56 44.18 6.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.248 -1.541 . . . . 6.18 109.248 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.82 22.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.545 -0.973 . . . . 9.52 109.452 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.13 108.66 6.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.46 133.81 49.6 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 123.104 1.431 . . . . 0.0 110.588 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.09 15.84 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.304 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.488 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.518 -0.739 . . . . 0.0 111.504 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 83.1 mt -59.68 -50.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.979 -1.076 . . . . 0.0 110.259 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.597 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.55 43.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.03 -1.044 . . . . 0.0 110.844 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.597 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.03 65.72 65.91 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.86 165.36 31.58 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.665 1.577 . . . . 0.0 109.003 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.58 -59.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.349 0.595 . . . . 0.0 110.119 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.69 -47.41 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 178.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.68 -59.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 122.562 2.174 . . . . 0.0 110.022 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 29.7 mm-40 131.76 9.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 123.86 0.864 . . . . 0.0 108.729 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.9 m0 -71.79 165.88 23.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.718 -1.239 . . . . 14.29 110.546 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.1 m0 -129.62 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.661 -0.649 . . . . 11.8 109.263 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.0 96.69 5.83 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.94 128.74 56.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.866 0.841 . . . . 0.0 110.345 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -82.57 150.36 26.94 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.767 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.41 128.59 43.47 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.27 -1.772 . . . . 0.0 107.181 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.45 -18.37 1.04 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 119.751 -1.843 . . . . 0.0 107.917 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.449 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.67 -4.53 4.31 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.43 33.86 6.96 Favored Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.331 -0.85 . . . . 14.41 112.271 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.767 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.08 29.86 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.692 1.746 . . . . 0.0 111.762 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.62 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.369 1.081 . . . . 0.0 112.494 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.82 12.82 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.302 -1.519 . . . . 7.25 109.302 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.41 150.94 42.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.218 -1.166 . . . . 0.0 108.629 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.02 136.7 8.97 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.356 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.2 113.52 1.14 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 N-CA-C 109.002 -1.192 . . . . 4.76 109.002 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.515 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 63.7 pttt -60.3 3.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.842 . . . . 0.0 110.719 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.594 ' OD1' ' NH2' ' B' ' 83' ' ' ARG . 95.8 m-20 -102.07 -7.59 22.16 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.263 -0.898 . . . . 14.84 109.319 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.93 8.09 31.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.269 -0.894 . . . . 10.23 109.533 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.33 156.66 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 6.97 109.49 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 2.7 p -106.82 160.83 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.446 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 8.5 p -107.75 134.27 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.363 -0.836 . . . . 0.0 109.724 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.11 -63.1 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.665 -0.647 . . . . 0.0 109.275 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.65 ' HG ' ' H ' ' A' ' 8' ' ' VAL . 13.4 p -69.99 151.54 45.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.027 -1.046 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 44.2 p30 -146.54 152.78 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.221 -0.925 . . . . 0.0 109.337 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.43 1.47 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.338 1.359 . . . . 0.0 109.693 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.0 82.65 1.77 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.04 32.28 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.65 156.35 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.9 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.493 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.8 0.2 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.24 130.78 5.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.271 -1.135 . . . . 0.0 109.431 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.28 163.54 36.18 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.958 1.772 . . . . 0.0 108.805 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.451 ' H ' HE21 ' B' ' 97' ' ' GLN . 65.0 mt -135.33 119.78 26.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 122.068 0.937 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.2 t -58.43 117.09 4.1 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.949 0.881 . . . . 0.0 109.922 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.17 4.94 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.543 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.71 -48.56 8.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.372 -1.075 . . . . 0.0 109.306 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.78 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . 0.594 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 94.2 mtt-85 53.51 41.32 32.12 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -115.87 143.42 30.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.54 113.3 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.428 1.419 . . . . 0.0 110.596 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.447 HG13 ' H ' ' B' ' 79' ' ' CYS . 21.6 mt -70.92 158.42 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.47 61.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 110.682 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.09 0.15 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.645 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.49 120.72 42.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 43.1 t -98.91 158.73 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.73 0.776 . . . . 0.0 111.105 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.64 116.01 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.594 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.89 105.97 18.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.09 -1.007 . . . . 0.0 109.528 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.52 159.64 42.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.22 4.27 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.26 75.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.17 -154.72 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.722 0.772 . . . . 0.0 109.796 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.451 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.5 143.45 45.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.9 m95 -141.58 140.07 33.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.516 -1.365 . . . . 0.0 110.596 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.454 ' C ' ' N ' ' B' ' 101' ' ' GLU . 16.9 m80 -56.66 131.99 50.6 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.15 -14.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.956 -1.09 . . . . 0.0 108.302 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.02 15.45 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.696 -0.627 . . . . 0.0 110.638 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.01 -6.6 31.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.818 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.12 106.22 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.431 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.9 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.204 1.002 . . . . 0.0 111.192 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.7 148.68 45.85 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.329 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.63 1.75 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.66 0.71 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.338 -0.851 . . . . 0.0 110.009 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.36 4.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.392 -0.817 . . . . 0.0 110.165 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.5 109.54 59.34 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.02 138.19 39.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.804 1.669 . . . . 0.0 112.078 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.78 56.98 1.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.138 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.21 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.9 2.75 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.568 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.2 178.99 4.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.465 -1.021 . . . . 0.0 109.906 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.62 145.37 24.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.761 . . . . 0.0 109.302 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.43 9.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.462 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.705 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.53 137.64 47.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.06 148.33 28.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.262 -0.899 . . . . 0.0 111.173 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.19 11.22 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.607 0.718 . . . . 0.0 110.291 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.39 22.77 1.53 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.4 31.06 20.32 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.729 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.3 mt -143.4 142.71 31.34 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.521 -0.988 . . . . 0.0 108.773 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.9 36.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 110.787 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.3 m-85 -153.97 140.42 18.75 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.6 177.51 0.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.446 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.73 -35.89 82.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 0.0 109.443 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.501 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.1 m -86.69 -43.7 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 111.384 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.7 -43.71 83.6 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.839 -1.163 . . . . 0.0 108.065 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.486 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.84 -56.45 13.9 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -64.4 -45.03 89.39 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.012 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.34 61.17 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.66 -35.25 45.57 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.361 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.57 -81.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.51 31.31 16.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.406 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.56 51.3 15.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -1.128 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.744 1 CA-C-O 70.872 -23.442 . . . . 0.0 109.455 179.941 . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.429 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.429 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.26 74.93 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -162.0 35.33 0.12 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -1.207 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.0 148.65 44.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.143 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.15 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -121.37 -54.35 1.99 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.34 74.11 1.38 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -69.52 158.04 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.32 131.48 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.42 -1.425 . . . . 0.0 111.557 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.9 129.25 45.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.4 m -63.44 154.29 32.64 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.591 1.186 . . . . 0.0 110.546 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 77.2 mt -114.28 -17.22 11.88 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.147 -1.427 . . . . 10.54 107.147 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.2 m-85 -149.55 145.09 18.57 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.24 -0.913 . . . . 18.39 110.694 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.06 81.53 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 121.372 1.381 . . . . 0.0 109.058 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.29 13.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.015 -1.053 . . . . 0.0 110.896 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.19 8.04 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.857 0.837 . . . . 0.0 109.389 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.97 10.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 29.7 m -130.34 94.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-O 122.911 1.339 . . . . 0.0 109.232 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.599 ' HG1' ' CG ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -144.44 -152.05 0.4 Allowed 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 114.377 -1.283 . . . . 38.32 107.618 178.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.47 -54.27 5.32 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.902 -1.518 . . . . 55.13 106.902 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -109.26 29.23 7.72 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.427 -0.795 . . . . 0.0 110.778 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.599 ' CG ' ' HG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER -100.32 150.92 22.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.81 -1.181 . . . . 0.0 109.766 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.51 111.45 22.48 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.401 -0.812 . . . . 11.68 110.695 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.44 127.67 41.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.26 21.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.35 -1.469 . . . . 12.44 110.881 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.28 155.77 22.27 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 146.95 17.92 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 121.262 -0.899 . . . . 29.03 109.542 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.08 6.65 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.316 -1.514 . . . . 6.18 109.316 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.25 114.78 22.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.522 -0.987 . . . . 9.52 109.54 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.05 108.62 6.04 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.43 133.65 49.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 123.172 1.463 . . . . 0.0 110.485 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.74 102.99 15.75 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.459 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.48 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.96 92.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.51 -0.744 . . . . 0.0 111.597 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.521 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.2 mt -59.78 -50.29 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.993 -1.067 . . . . 0.0 110.248 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.596 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.29 157.6 43.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.055 -1.028 . . . . 0.0 110.779 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.596 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.06 65.58 65.33 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.8 165.41 31.53 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.697 1.598 . . . . 0.0 108.901 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.09 -46.41 7.79 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.62 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.369 0.604 . . . . 0.0 110.069 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.53 0.0 OUTLIER Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.296 -2.185 0 C-N-CA 122.707 2.271 . . . . 0.0 109.874 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.7 pt-20 131.84 9.19 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.898 0 C-N-CA 123.894 0.878 . . . . 0.0 108.754 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.53 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 13.3 m0 -71.8 165.81 23.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.635 -1.291 . . . . 14.29 110.532 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.505 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 19.3 m0 -129.5 144.99 51.5 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.38 -0.6 . . . . 11.8 109.38 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.95 96.73 5.81 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.8 56.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.913 0.863 . . . . 0.0 110.381 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -82.56 150.44 26.91 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.752 ' N ' ' O ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.46 128.55 43.49 Favored 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 117.282 -1.767 . . . . 0.0 107.203 177.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.41 1.01 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.701 -1.875 . . . . 0.0 107.934 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.8 -4.4 4.33 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.654 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.46 33.78 6.99 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-N 115.33 -0.85 . . . . 14.41 112.27 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.752 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.79 164.09 29.77 Favored 'General case' 0 N--CA 1.515 2.805 0 CA-C-N 119.783 1.792 . . . . 0.0 111.867 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.0 154.55 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.374 1.083 . . . . 0.0 112.504 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.66 12.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.267 -1.533 . . . . 7.25 109.267 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.28 150.83 43.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -1.201 . . . . 0.0 108.712 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.99 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.959 -1.088 . . . . 0.0 109.254 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 N-CA-C 108.997 -1.194 . . . . 4.76 108.997 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HZ1' ' HB2' ' A' ' 42' ' ' GLU . 23.8 pttm -60.31 3.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.544 -0.722 . . . . 0.0 110.742 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.657 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 1.0 OUTLIER -102.04 -7.57 22.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.177 -0.952 . . . . 14.84 109.342 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.01 8.27 30.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.255 -0.903 . . . . 10.23 109.487 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -147.59 156.52 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 6.97 109.582 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 p -106.71 160.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.8 p -107.66 134.26 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.07 -63.23 1.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -70.09 151.67 45.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.922 -1.112 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -146.61 152.74 39.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.196 -0.94 . . . . 0.0 109.385 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.3 1.47 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.27 1.313 . . . . 0.0 109.688 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.24 82.64 1.78 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.06 32.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.2 28.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -1.126 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.21 46.76 0.2 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.17 130.8 5.4 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.21 163.65 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.949 1.766 . . . . 0.0 108.924 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.465 HG13 ' C ' ' B' ' 77' ' ' PRO . 49.0 mt -135.41 119.89 26.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 122.032 0.92 . . . . 0.0 109.425 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.2 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.829 0.823 . . . . 0.0 110.019 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.89 -0.11 4.89 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.539 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.57 8.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -1.094 . . . . 0.0 109.356 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.17 4.77 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . 0.417 HH21 ' HE2' ' A' ' 58' ' ' LYS . 84.3 mtt85 53.62 41.28 32.12 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -115.88 143.48 30.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -56.51 113.47 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.425 1.417 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.5 mt -71.01 158.47 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.49 61.4 0.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.887 -1.133 . . . . 0.0 110.688 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.95 -101.88 0.15 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.665 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.65 120.64 42.23 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.89 158.7 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.755 0.788 . . . . 0.0 111.182 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.53 116.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.611 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.12 18.26 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.057 -1.027 . . . . 0.0 109.552 -179.085 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.63 42.49 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.634 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.06 17.24 4.32 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.33 75.77 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.35 -154.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.756 0.788 . . . . 0.0 109.658 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' B' ' 97' ' ' GLN . 2.8 mt-30 -135.28 143.5 46.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.7 m95 -141.61 140.18 33.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.51 -1.369 . . . . 0.0 110.596 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.446 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.65 132.01 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.24 -14.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.854 -1.153 . . . . 0.0 108.285 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.446 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.97 15.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.743 -0.598 . . . . 0.0 110.594 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.18 -6.47 31.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.903 -1.123 . . . . 0.0 110.769 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -80.24 106.28 12.14 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.434 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.4 m -133.52 175.31 11.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 122.369 1.08 . . . . 0.0 111.175 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.86 148.71 46.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.343 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.49 1.79 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.71 -31.67 0.72 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.392 -0.818 . . . . 0.0 110.079 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.2 -15.15 4.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.339 -0.851 . . . . 0.0 110.15 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.69 47.46 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.55 109.66 59.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.07 138.28 39.63 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.673 1.582 . . . . 0.0 112.168 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.327 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.72 56.9 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.212 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.606 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.15 -55.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.242 -0.911 . . . . 0.0 108.988 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.94 2.75 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.573 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.88 4.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.54 -0.976 . . . . 0.0 109.963 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.55 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.227 -0.921 . . . . 0.0 109.622 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.59 137.67 47.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.94 148.3 28.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 111.261 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.33 11.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.74 . . . . 0.0 110.318 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.17 22.78 1.39 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.634 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.61 30.8 20.44 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.766 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.21 142.76 31.51 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.56 -0.965 . . . . 0.0 108.851 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.92 35.99 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.6 m-85 -153.95 140.23 18.57 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.7 m -57.59 177.43 0.1 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.346 -1.342 . . . . 0.0 108.397 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.52 -36.11 82.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.376 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.9 m -86.57 -43.68 12.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.55 -0.719 . . . . 0.0 111.412 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.78 -43.74 83.18 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.748 -1.22 . . . . 0.0 108.078 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.73 -56.52 13.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.42 -44.85 89.94 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.101 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.57 -34.31 61.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.543 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.76 -35.18 44.95 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.366 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.59 -81.71 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.52 31.29 16.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.56 51.28 15.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.714 1 CA-C-O 70.897 -23.43 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.409 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.409 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.36 74.83 0.12 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.93 35.24 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -1.16 . . . . 0.0 109.581 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.07 148.69 43.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.106 -0.996 . . . . 0.0 109.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.13 93.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.268 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.16 -54.32 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.449 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.9 m-70 -145.26 73.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.703 ' H ' ' HG ' ' A' ' 65' ' ' SER . 19.6 t -69.47 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -145.3 131.44 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.458 -1.401 . . . . 0.0 111.52 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.83 129.28 45.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 m -63.38 154.32 32.36 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.585 1.183 . . . . 0.0 110.532 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.0 mt -114.32 -17.36 11.83 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.125 -1.435 . . . . 10.54 107.125 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.5 m-85 -149.45 145.03 18.52 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.052 -1.03 . . . . 18.39 110.748 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.95 81.38 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.414 1.409 . . . . 0.0 109.031 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.73 170.26 13.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.916 -1.115 . . . . 0.0 110.956 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.12 7.97 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.876 0.846 . . . . 0.0 109.327 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.17 111.91 10.68 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 34.0 m -130.38 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 122.983 1.373 . . . . 0.0 109.161 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.418 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.51 -152.01 0.4 Allowed 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.309 -1.314 . . . . 38.32 107.61 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.418 ' H ' ' CG2' ' A' ' 19' ' ' THR . 97.6 mt-10 -82.36 -54.36 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.967 -1.494 . . . . 55.13 106.967 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.22 29.24 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.424 -0.798 . . . . 0.0 110.769 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.47 150.88 22.19 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.915 -1.116 . . . . 0.0 109.83 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -111.34 111.35 22.33 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.317 -0.864 . . . . 11.68 110.765 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.5 127.64 41.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.96 142.16 21.47 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.36 -1.462 . . . . 12.44 110.861 -178.447 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.16 155.83 22.38 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.99 18.2 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.462 -0.895 . . . . 29.03 109.51 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.52 44.25 6.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.262 -1.535 . . . . 6.18 109.262 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.67 22.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.53 -0.982 . . . . 9.52 109.437 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.92 108.6 5.93 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.55 133.8 49.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.202 1.477 . . . . 0.0 110.561 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.83 103.04 15.8 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.384 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.499 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.588 -0.695 . . . . 0.0 111.543 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.509 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.2 mt -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.012 -1.055 . . . . 0.0 110.224 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.599 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.2 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 110.748 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.9 mptp? -135.1 65.62 65.19 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.36 31.59 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.693 1.596 . . . . 0.0 108.94 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.08 -46.49 7.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.7 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.366 0.603 . . . . 0.0 110.005 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.55 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.615 2.21 . . . . 0.0 109.965 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 27.4 tt0 131.69 9.1 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.78 0.832 . . . . 0.0 108.795 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.557 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 12.9 m0 -71.75 165.88 23.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.586 -1.321 . . . . 14.29 110.537 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.534 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.3 m0 -129.58 145.1 51.51 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.321 -0.622 . . . . 11.8 109.321 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -78.99 96.59 5.8 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.6 p -115.97 128.77 56.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.011 0.91 . . . . 0.0 110.361 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -82.59 150.33 26.94 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.776 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.32 128.55 43.34 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 117.299 -1.76 . . . . 0.0 107.266 177.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.43 -18.41 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 119.656 -1.902 . . . . 0.0 107.912 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' C ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.69 -4.58 4.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.658 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.49 33.89 6.92 Favored Glycine 0 N--CA 1.481 1.683 0 CA-C-N 115.291 -0.868 . . . . 14.41 112.29 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.776 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.92 164.11 29.81 Favored 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.625 1.713 . . . . 0.0 111.883 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.54 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-O 122.315 1.055 . . . . 0.0 112.484 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.69 12.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 7.25 109.258 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.29 150.89 43.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.24 -1.153 . . . . 0.0 108.631 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.73 9.0 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.902 -1.124 . . . . 0.0 109.228 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.1 Cg_exo -51.16 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.217 -0.543 0 N-CA-C 109.061 -1.169 . . . . 4.76 109.061 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.518 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 31.3 pttt -60.25 3.01 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.453 -0.779 . . . . 0.0 110.758 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 57' ' ' PRO . 94.4 m-20 -102.03 -7.62 22.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 14.84 109.27 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.31 30.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.873 . . . . 10.23 109.476 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.47 156.69 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 6.97 109.499 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.88 160.69 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.61 134.23 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.13 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.613 -0.68 . . . . 0.0 109.239 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 8' ' ' VAL . 16.4 p -69.99 151.64 45.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 109.462 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -146.65 152.59 39.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.035 . . . . 0.0 109.427 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.36 1.48 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.27 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.464 1.442 . . . . 0.0 109.654 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.74 124.92 32.08 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.73 156.31 28.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.384 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.82 167.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.92 0.2 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.24 130.74 5.35 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.405 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' B' ' 86' ' ' ILE . 5.5 Cg_endo -74.24 163.62 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.957 1.772 . . . . 0.0 108.873 178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.44 ' H ' HE21 ' B' ' 97' ' ' GLN . 25.4 mt -135.46 119.76 26.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 122.12 0.962 . . . . 0.0 109.455 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.541 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.1 t -58.32 117.01 3.98 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.869 0.843 . . . . 0.0 109.897 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.1 4.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.541 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.8 -48.48 8.18 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.245 -1.15 . . . . 0.0 109.368 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.13 4.87 13.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . 0.469 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 95.7 mtt-85 53.45 41.49 32.1 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -116.07 143.42 30.9 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.29 113.39 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.524 1.483 . . . . 0.0 110.592 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.6 mt -71.01 158.4 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -160.5 61.45 0.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.849 -1.157 . . . . 0.0 110.663 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -102.01 0.15 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.58 120.7 42.47 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.98 158.74 3.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.507 -0.746 . . . . 0.0 111.151 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.63 115.94 47.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.613 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.72 106.09 18.23 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.57 42.58 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.12 17.12 4.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.09 25.37 75.7 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.77 0.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.857 0.837 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.44 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.45 143.5 45.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.5 140.05 33.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.655 -1.278 . . . . 0.0 110.598 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.45 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.53 131.93 50.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.22 -14.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 120.725 -1.234 . . . . 0.0 108.347 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.82 -27.03 15.42 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.886 -0.509 . . . . 0.0 110.595 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.17 -6.48 31.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.948 -1.095 . . . . 0.0 110.856 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.22 106.31 12.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.433 HG11 ' N ' ' B' ' 111' ' ' PRO . 27.4 m -133.6 175.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.318 1.056 . . . . 0.0 111.065 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.92 148.76 46.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.264 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.89 28.74 1.74 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.428 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.81 -31.68 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.388 -0.82 . . . . 0.0 110.118 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.01 -15.52 4.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.57 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.378 -0.826 . . . . 0.0 110.238 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.5 59.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.3 Cg_endo -69.13 138.24 39.32 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.676 1.584 . . . . 0.0 112.111 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.72 56.96 1.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.221 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.17 1.72 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 108.881 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.2 30.99 2.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.563 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 1.0 OUTLIER -116.29 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.352 -1.087 . . . . 0.0 109.935 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.478 -0.764 . . . . 0.0 109.334 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.39 9.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.84 47.34 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.19 148.31 29.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.22 11.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.604 0.716 . . . . 0.0 110.331 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.42 22.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.638 -0.664 . . . . 0.0 109.413 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.48 Favored Glycine 0 N--CA 1.483 1.815 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.689 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.7 mt -143.33 142.76 31.41 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.646 -0.914 . . . . 0.0 108.865 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.88 36.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.666 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' B' ' 118' ' ' TYR . 57.8 m-85 -153.92 140.32 18.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.3 m -57.64 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.282 -1.367 . . . . 0.0 108.448 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.97 82.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.494 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.6 m -86.78 -43.68 12.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.453 -0.78 . . . . 0.0 111.315 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.71 83.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.67 -1.269 . . . . 0.0 108.133 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.499 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.1 t80 -51.8 -56.5 13.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -64.58 -44.75 89.69 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.135 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.46 -34.32 61.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.542 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.7 mp -78.77 -35.29 44.74 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.51 -81.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.026 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.48 16.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.42 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.7 m-20 48.35 51.31 15.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -1.063 . . . . 0.0 109.563 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.763 1 CA-C-O 70.976 -23.392 . . . . 0.0 109.443 179.971 . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.437 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 32.6 mt-30 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.332 0.586 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.437 ' H ' ' H3 ' ' A' ' 1' ' ' GLN . . . -168.38 74.85 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -161.99 35.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -1.19 . . . . 0.0 109.494 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.07 148.63 43.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.156 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.4 t -66.02 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 0.0 109.282 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.23 -54.36 2.0 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -145.23 73.86 1.38 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.9 t -69.44 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.33 131.58 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.484 -1.385 . . . . 0.0 111.55 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -99.94 129.14 45.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.9 m -63.37 154.41 32.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.52 1.153 . . . . 0.0 110.598 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 87.8 mt -114.3 -17.38 11.84 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.173 -1.417 . . . . 10.54 107.173 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 12' ' ' LEU . 14.5 m-85 -149.43 145.15 18.73 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.177 -0.952 . . . . 18.39 110.706 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.02 81.42 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 121.414 1.41 . . . . 0.0 109.054 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.32 13.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.94 -1.1 . . . . 0.0 110.865 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.449 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.6 111.01 7.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.771 0.796 . . . . 0.0 109.462 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.25 112.07 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.36 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 122.866 1.317 . . . . 0.0 109.071 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.429 ' CG2' ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.6 -151.97 0.4 Allowed 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.357 -1.292 . . . . 38.32 107.518 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' H ' ' CG2' ' A' ' 19' ' ' THR . 95.9 mt-10 -82.47 -54.33 5.28 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.783 -1.562 . . . . 55.13 106.783 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 71.6 mm-40 -109.35 29.25 7.72 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.366 -0.834 . . . . 0.0 110.701 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.57 150.82 22.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.841 -1.162 . . . . 0.0 109.797 -179.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -111.32 111.36 22.36 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.295 -0.878 . . . . 11.68 110.804 -178.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.64 41.56 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.91 142.22 21.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.39 -1.443 . . . . 12.44 110.87 -178.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.82 22.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 146.95 18.5 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.221 -0.925 . . . . 29.03 109.497 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 43.99 6.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.277 -1.529 . . . . 6.18 109.277 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.79 22.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.56 -0.964 . . . . 9.52 109.419 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.06 108.73 6.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.68 49.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 123.179 1.466 . . . . 0.0 110.486 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.75 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.427 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 111.51 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.518 ' C ' ' HZ1' ' A' ' 36' ' ' LYS . 82.7 mt -59.73 -50.51 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.994 -1.066 . . . . 0.0 110.194 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.609 ' C ' ' HZ2' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.22 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.061 -1.025 . . . . 0.0 110.803 -177.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.609 ' HZ2' ' C ' ' A' ' 35' ' ' GLU . 1.8 mptp? -135.02 65.54 65.5 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.83 165.42 31.48 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 109.0 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.13 -46.4 7.78 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.74 -59.53 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.436 0.636 . . . . 0.0 110.018 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.61 2.206 . . . . 0.0 109.922 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 62.2 mt-10 131.74 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 123.845 0.858 . . . . 0.0 108.738 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 43' ' ' TRP . 14.1 m0 -71.74 165.83 23.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.526 -1.359 . . . . 14.29 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.479 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.8 m0 -129.6 145.11 51.52 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.38 -0.6 . . . . 11.8 109.38 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -79.08 96.74 5.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 15.4 p -115.93 128.76 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.855 0.836 . . . . 0.0 110.36 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -82.68 150.35 26.82 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.768 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.37 128.49 43.35 Favored 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.172 -1.811 . . . . 0.0 107.212 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.28 -18.45 0.96 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 119.687 -1.883 . . . . 0.0 107.998 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.465 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.61 -4.57 4.29 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.638 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.206 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.768 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.03 29.97 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.773 1.787 . . . . 0.0 111.815 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.303 1.049 . . . . 0.0 112.544 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.77 12.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.28 -1.528 . . . . 7.25 109.28 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.45 150.88 42.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -1.147 . . . . 0.0 108.657 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.72 9.01 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.029 -1.045 . . . . 0.0 109.27 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.54 ' CB ' HD22 ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.26 113.49 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.068 -1.166 . . . . 4.76 109.068 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.33 3.21 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 110.78 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.54 HD22 ' CB ' ' A' ' 57' ' ' PRO . 1.1 p30 -102.03 -7.57 22.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 14.84 109.335 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.04 8.21 30.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 10.23 109.536 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.0 m -147.44 156.57 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.942 . . . . 6.97 109.541 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -106.87 160.75 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' B' ' 82' ' ' CYS . 10.5 p -107.61 134.26 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.401 -0.812 . . . . 0.0 109.754 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.05 -63.31 1.24 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.682 . . . . 0.0 109.227 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.447 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 58.3 m -69.95 151.68 45.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.975 -1.078 . . . . 0.0 109.454 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 48.7 p30 -146.58 152.73 39.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 109.356 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.11 -67.28 1.48 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.317 1.344 . . . . 0.0 109.606 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.05 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.72 125.0 32.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.23 28.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.562 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.82 167.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.29 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.23 130.75 5.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 109.366 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.461 ' C ' HG13 ' B' ' 78' ' ' ILE . 5.6 Cg_endo -74.16 163.61 36.19 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.946 1.764 . . . . 0.0 108.914 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.461 HG13 ' C ' ' B' ' 77' ' ' PRO . 56.7 mt -135.43 119.74 26.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.081 0.943 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' CYS . . . . . 0.542 ' SG ' ' CB ' ' B' ' 81' ' ' ALA . 15.0 t -58.3 117.05 4.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.22 4.88 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.542 ' CB ' ' SG ' ' B' ' 79' ' ' CYS . . . -86.74 -48.51 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -1.099 . . . . 0.0 109.305 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' CYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 1.6 p -116.12 4.84 13.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 53.54 41.32 32.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 43.3 mtp180 -115.86 143.46 30.81 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.32 113.33 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.494 1.463 . . . . 0.0 110.623 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' B' ' 77' ' ' PRO . 21.4 mt -70.95 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.57 61.34 0.32 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.831 -1.168 . . . . 0.0 110.646 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.97 -101.97 0.15 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.73 42.57 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -98.81 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.641 0.734 . . . . 0.0 111.298 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.52 115.91 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ASN . . . . . 0.607 HD21 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.81 106.17 18.29 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.062 -1.023 . . . . 0.0 109.481 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.6 159.54 42.63 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.07 17.25 4.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.18 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.724 0.773 . . . . 0.0 109.821 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' GLN . . . . . 0.443 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.43 143.42 45.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.0 m95 -141.44 140.0 33.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.561 -1.337 . . . . 0.0 110.682 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.4 m80 -56.56 131.94 50.18 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 t -53.2 -14.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.701 -1.25 . . . . 0.0 108.32 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.85 15.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.754 -0.591 . . . . 0.0 110.613 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.22 -6.53 31.04 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.26 106.31 12.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.433 HG11 ' N ' ' B' ' 111' ' ' PRO . 26.9 m -133.63 175.25 11.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.287 1.041 . . . . 0.0 111.138 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.79 148.69 46.15 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.234 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.79 28.54 1.76 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.73 -31.62 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.432 -0.793 . . . . 0.0 110.149 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.08 -15.38 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 110.156 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.55 0.35 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.28 109.48 58.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' B' ' 113' ' ' LEU . 5.4 Cg_endo -69.02 138.36 39.97 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.66 1.574 . . . . 0.0 112.077 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.82 56.91 1.78 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.133 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.594 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.21 -55.24 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.2 -0.937 . . . . 0.0 108.897 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.12 2.73 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.567 ' O ' ' CB ' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.27 178.88 4.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.483 -1.01 . . . . 0.0 109.987 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.5 145.43 24.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.38 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.563 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.35 169.48 9.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.528 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.6 137.7 47.15 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.96 148.28 28.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.232 -0.918 . . . . 0.0 111.234 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.05 129.34 11.26 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.604 0.716 . . . . 0.0 110.381 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.3 22.78 1.48 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.671 -0.643 . . . . 0.0 109.438 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.9 20.49 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.764 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -143.27 142.89 31.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.529 -0.983 . . . . 0.0 108.725 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.84 36.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.685 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' B' ' 118' ' ' TYR . 58.5 m-85 -153.89 140.31 18.71 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.65 177.55 0.1 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.26 -1.376 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.67 -36.05 82.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.374 -0.828 . . . . 0.0 109.285 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.465 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.7 m -86.61 -43.78 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 0.0 111.333 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.79 83.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.721 -1.237 . . . . 0.0 108.095 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.71 -56.47 13.58 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.211 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.48 -34.29 61.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' B' ' 134' ' ' PHE . 1.8 mp -78.75 -35.23 44.96 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.335 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.33 31.42 16.64 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.53 51.17 15.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -1.109 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.725 1 CA-C-O 70.924 -23.417 . . . . 0.0 109.436 179.924 . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.326 0.584 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.7 p -162.06 35.34 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -1.169 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.06 148.64 43.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.148 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.3 t -66.08 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.117 -0.99 . . . . 0.0 109.246 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.2 -54.26 2.01 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 9' ' ' VAL . 79.2 t -69.43 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 9' ' ' VAL . 3.2 m -145.23 131.51 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.426 -1.421 . . . . 0.0 111.665 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -99.98 129.26 46.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.646 HG22 ' H ' ' A' ' 13' ' ' TYR . 52.4 m -63.37 154.28 32.45 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.518 1.152 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 95.9 mt -114.23 -17.35 11.88 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.236 -1.394 . . . . 10.539999999999999 107.236 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.646 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.503 2.218 0 C-N-CA 119.463 -0.895 . . . . 18.390000000000001 110.699 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.5 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 121.436 1.424 . . . . 0.0 108.983 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.82 170.3 13.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.926 -1.109 . . . . 0.0 110.959 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.12 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.826 0.822 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.93 10.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 18' ' ' VAL . 23.3 m -130.32 94.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.917 1.342 . . . . 0.0 109.187 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.905 HG22 ' H ' ' A' ' 20' ' ' GLU . 4.0 m -144.51 -151.98 0.4 Allowed 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.596 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.905 ' H ' HG22 ' A' ' 19' ' ' THR . 49.8 tp10 -82.42 -54.28 5.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.906 -1.516 . . . . 55.130000000000003 106.906 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.443 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.6 mt-10 -109.36 29.12 7.85 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.342 -0.849 . . . . 0.0 110.739 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.41 151.02 22.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.827 -1.171 . . . . 0.0 109.783 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.44 111.38 22.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.38 -0.825 . . . . 11.68 110.773 -178.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.5 127.7 41.75 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' HD2' ' HG1' ' A' ' 11' ' ' THR . 0.8 OUTLIER -152.93 142.12 21.46 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.377 -1.452 . . . . 12.44 110.935 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.598 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.81 22.51 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 146.92 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.422 -0.911 . . . . 29.030000000000001 109.577 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 11' ' ' THR . . . 84.64 44.05 6.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.315 -1.514 . . . . 6.1799999999999997 109.315 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.73 22.79 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.509 -0.995 . . . . 9.5199999999999996 109.396 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.85 108.55 5.86 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.406 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.5 133.77 49.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 123.185 1.469 . . . . 0.0 110.523 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.89 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.401 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.558 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.92 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.576 -0.703 . . . . 0.0 111.491 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.7 mt -59.82 -50.33 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.921 -1.112 . . . . 0.0 110.246 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.34 157.65 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.941 -1.099 . . . . 0.0 110.774 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.558 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.16 65.63 64.83 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.766 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.72 165.32 31.79 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.702 1.601 . . . . 0.0 109.07 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.02 -46.5 7.77 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.4 m-20 57.69 -59.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.008 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.74 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.142 0 C-N-CA 122.625 2.217 . . . . 0.0 109.929 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 35.8 mm-40 131.83 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.78 0.832 . . . . 0.0 108.765 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.556 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.3 m0 -71.86 165.84 23.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.64 -1.287 . . . . 14.289999999999999 110.464 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.0 m0 -129.54 145.18 51.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.198 -0.667 . . . . 11.800000000000001 109.198 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.15 96.79 5.96 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -116.01 128.82 56.03 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.959 0.885 . . . . 0.0 110.361 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.67 150.4 26.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.765 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.39 128.62 43.48 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 117.324 -1.751 . . . . 0.0 107.229 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.51 -18.32 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 119.706 -1.871 . . . . 0.0 107.946 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.459 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.66 -4.64 4.41 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.687 0 CA-C-N 115.499 -0.773 . . . . 14.41 112.239 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.765 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.93 164.01 30.08 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 119.609 1.704 . . . . 0.0 111.727 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.65 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.76 12.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.263 -1.535 . . . . 7.25 109.263 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.39 150.85 43.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.338 -1.095 . . . . 0.0 108.643 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.01 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.782 -1.199 . . . . 0.0 109.316 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.15 113.63 1.19 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.912 -1.226 . . . . 4.7599999999999998 108.912 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.3 pttt -60.52 3.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.671 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.48 ' H ' ' C ' ' A' ' 57' ' ' PRO . 99.5 m-20 -102.05 -7.65 22.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.285 -0.884 . . . . 14.84 109.357 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.02 8.31 30.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 10.23 109.454 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.4 m -147.48 156.51 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.094 -1.004 . . . . 6.9699999999999998 109.487 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.76 160.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' HG22 ' A' ' 62' ' ' VAL . 11.5 p -107.59 134.29 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.43 -0.794 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.12 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.613 -0.679 . . . . 0.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 41.6 m -69.92 151.53 45.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.546 ' OD2' ' NH1' ' B' ' 84' ' ' ARG . 53.4 p-10 -146.63 152.73 39.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.35 1.48 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.356 1.371 . . . . 0.0 109.688 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.11 82.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.8 124.94 32.14 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 109.301 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.39 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.16 29.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -1.107 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.81 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.85 0.2 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.26 130.85 5.39 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.297 -1.119 . . . . 0.0 109.345 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.29 163.53 36.2 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.031 1.821 . . . . 0.0 108.832 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.507 HG23 ' C ' ' B' ' 84' ' ' ARG . 76.2 mt -135.34 119.85 27.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 122.008 0.909 . . . . 0.0 109.365 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.84 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.809 0.814 . . . . 0.0 109.914 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.82 -0.16 4.86 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.84 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.7 -48.53 8.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.295 -1.121 . . . . 0.0 109.301 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.16 4.78 13.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ARG . . . . . 0.456 HH22 ' HE3' ' A' ' 58' ' ' LYS . 83.8 mtt85 53.53 41.25 32.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.546 ' NH1' ' OD2' ' A' ' 66' ' ' ASP . 17.3 mtp180 -115.79 143.39 30.64 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.631 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.37 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.366 1.377 . . . . 0.0 110.615 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.665 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.91 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.702 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.422 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.59 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.877 -1.14 . . . . 0.0 110.55 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.12 -101.8 0.15 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.673 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.76 120.63 42.17 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.665 HG22 HG21 ' B' ' 86' ' ' ILE . 42.6 t -98.83 158.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.648 0.737 . . . . 0.0 111.125 -177.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.57 115.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.73 106.03 18.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.624 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.52 42.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.618 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.99 17.34 4.31 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.12 76.09 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.16 -154.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.787 0.803 . . . . 0.0 109.779 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.467 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.48 143.46 45.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.6 139.99 33.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.544 -1.347 . . . . 0.0 110.576 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.46 131.98 50.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.7 t -53.17 -14.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 108.365 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.97 15.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.823 -0.548 . . . . 0.0 110.594 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.05 -6.62 31.45 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.878 -1.139 . . . . 0.0 110.798 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.472 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.1 t80 -80.08 106.3 12.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.8 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.161 0.982 . . . . 0.0 111.192 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.8 148.58 46.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.314 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.78 28.67 1.73 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.77 -31.75 0.71 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.293 -0.879 . . . . 0.0 110.113 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.44 4.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.222 -0.924 . . . . 0.0 110.226 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.65 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.363 -0.836 . . . . 0.0 110.237 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.52 59.18 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -68.99 138.27 39.83 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.825 1.683 . . . . 0.0 112.059 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.8 57.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.132 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.632 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.19 1.69 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 108.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.25 30.98 2.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.954 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.21 178.86 4.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.504 -0.998 . . . . 0.0 109.993 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -94.35 145.3 24.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.33 169.45 9.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.78 47.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.26 28.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.85 . . . . 0.0 111.188 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.635 0.731 . . . . 0.0 110.334 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mttm 51.39 22.8 1.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.62 -0.675 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.618 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.94 20.4 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.7 mt -143.26 142.81 31.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.46 -1.023 . . . . 0.0 108.848 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.8 36.31 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 110.702 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.555 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.3 m-85 -153.96 140.28 18.61 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.53 177.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.439 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.76 -35.92 82.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -0.814 . . . . 0.0 109.353 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.456 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.9 m -86.75 -43.52 12.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.543 -0.723 . . . . 0.0 111.384 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.72 -43.82 83.24 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.738 -1.226 . . . . 0.0 108.126 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.65 -56.48 13.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.421 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.6 -44.8 89.46 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.05 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.53 -34.37 61.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.65 -35.26 45.61 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.427 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.36 31.51 16.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.34 51.42 15.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -1.124 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 1 C--O 0.476 -39.651 1 CA-C-O 70.943 -23.408 . . . . 0.0 109.45 -179.965 . . . . . . . . 2 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.98 0.12 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -1.217 . . . . 0.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.09 148.67 43.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.4 t -66.07 93.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.19 -54.42 2.0 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.39 74.09 1.38 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.65 158.05 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.39 131.51 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.511 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.01 129.28 46.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 13' ' ' TYR . 30.0 m -63.39 154.37 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.456 1.122 . . . . 0.0 110.636 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.9 mt -114.38 -17.24 11.83 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.205 -1.406 . . . . 10.539999999999999 107.205 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.666 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.51 144.98 18.41 Favored Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 119.474 -0.891 . . . . 18.390000000000001 110.793 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.01 81.39 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 121.524 1.482 . . . . 0.0 109.019 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.8 170.28 13.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.05 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.15 8.07 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.453 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.01 10.68 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 18' ' ' VAL . 9.4 m -130.35 94.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 122.869 1.319 . . . . 0.0 109.177 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -144.54 -151.98 0.4 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.35 -1.296 . . . . 38.32 107.549 177.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 19' ' ' THR . 96.7 mt-10 -82.48 -54.32 5.29 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.849 -1.537 . . . . 55.130000000000003 106.849 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.35 29.15 7.81 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.402 -0.812 . . . . 0.0 110.762 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.4 150.84 22.21 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.839 -1.163 . . . . 0.0 109.7 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.37 22.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.385 -0.822 . . . . 11.68 110.764 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.46 127.7 41.72 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.88 142.17 21.54 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.374 -1.454 . . . . 12.44 110.947 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.09 155.77 22.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.38 146.84 18.58 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.267 -0.895 . . . . 29.030000000000001 109.602 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.71 44.07 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.275 -1.53 . . . . 6.1799999999999997 109.275 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.33 114.75 22.85 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.513 -0.992 . . . . 9.5199999999999996 109.454 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.04 108.59 6.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.43 133.69 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.153 1.454 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.82 103.12 15.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.39 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.516 -0.74 . . . . 0.0 111.392 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.3 mt -59.79 -50.46 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.971 -1.08 . . . . 0.0 110.121 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.53 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.17 157.58 43.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.983 -1.073 . . . . 0.0 110.814 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -134.97 65.54 65.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.39 31.64 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.635 1.556 . . . . 0.0 108.966 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.97 -46.56 7.75 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.52 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.268 0.556 . . . . 0.0 110.09 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.36 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 122.709 2.273 . . . . 0.0 109.914 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.75 9.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.816 0 C-N-CA 123.849 0.86 . . . . 0.0 108.849 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.7 m0 -71.89 165.82 23.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.593 -1.317 . . . . 14.289999999999999 110.481 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.494 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.9 m0 -129.53 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.356 -0.609 . . . . 11.800000000000001 109.356 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -79.01 96.62 5.82 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.504 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.65 55.92 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.379 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.47 150.35 27.08 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.766 ' N ' ' O ' ' A' ' 52' ' ' GLN . 14.9 p30 -96.35 128.49 43.32 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.322 -1.751 . . . . 0.0 107.295 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.41 0.98 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 119.643 -1.911 . . . . 0.0 108.03 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.68 -4.57 4.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.48 33.9 6.92 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.287 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.766 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.94 164.04 30.01 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 119.654 1.727 . . . . 0.0 111.77 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.64 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.274 1.035 . . . . 0.0 112.583 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.16 156.73 12.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.291 -1.524 . . . . 7.25 109.291 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.38 150.86 43.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.226 -1.161 . . . . 0.0 108.561 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.76 9.04 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.102 . . . . 0.0 109.297 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.28 113.53 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 N-CA-C 108.938 -1.216 . . . . 4.7599999999999998 108.938 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.6 pttt -60.38 3.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 0.0 110.757 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.7 m-20 -102.03 -7.54 22.24 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.285 -0.885 . . . . 14.84 109.325 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.13 8.22 31.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 10.23 109.506 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.44 156.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.285 -0.885 . . . . 6.9699999999999998 109.577 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.586 HG11 HD13 ' B' ' 78' ' ' ILE . 29.4 m -106.81 160.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.59 134.27 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.452 -0.78 . . . . 0.0 109.778 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.4 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 98.5 mt -105.13 -63.07 1.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 70.4 m -70.05 151.66 45.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.036 -1.04 . . . . 0.0 109.409 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 65' ' ' SER . 87.8 m-20 -146.6 152.69 39.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 109.311 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.29 1.48 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.299 1.332 . . . . 0.0 109.629 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.61 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.9 124.95 32.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.41 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.76 156.22 28.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -1.112 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.83 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.22 130.81 5.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.29 163.42 36.44 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.052 1.835 . . . . 0.0 108.83 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.596 HG23 ' C ' ' B' ' 84' ' ' ARG . 41.7 mt -135.22 119.85 27.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.983 0.896 . . . . 0.0 109.389 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.42 116.96 3.97 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.11 4.78 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.69 -48.57 8.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -1.067 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.72 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.132 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 53.54 41.3 32.12 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.596 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.3 mmm180 -115.82 143.5 30.86 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.55 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.44 1.427 . . . . 0.0 110.542 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.67 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.95 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.53 61.41 0.32 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.791 -1.193 . . . . 0.0 110.593 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.677 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.67 42.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.67 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.8 158.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 111.294 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.51 115.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.92 106.07 18.23 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 109.592 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.62 159.48 42.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.11 17.26 4.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.19 25.28 75.85 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.041 -2.024 . . . . 0.0 108.041 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.76 0.65 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.8 0.809 . . . . 0.0 109.732 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.483 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.35 143.52 46.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.58 139.91 33.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.488 -1.382 . . . . 0.0 110.648 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.54 131.99 50.26 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.457 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.21 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.846 -1.158 . . . . 0.0 108.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.89 -26.82 15.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.869 -0.519 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.23 -6.5 31.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.816 -1.177 . . . . 0.0 110.781 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.26 106.25 12.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.818 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.2 m -133.59 175.27 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.329 1.061 . . . . 0.0 111.1 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.87 148.7 46.41 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.37 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.61 1.74 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.82 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.74 -31.78 0.71 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.01 -15.38 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.79 47.5 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.36 109.64 59.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.818 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.05 138.27 39.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.748 1.632 . . . . 0.0 112.147 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.84 56.97 1.78 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.098 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.11 -55.25 1.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.12 30.91 2.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.906 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.21 178.93 4.14 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.474 -1.015 . . . . 0.0 109.977 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.41 145.33 24.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 109.412 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.411 -0.806 . . . . 0.0 109.511 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.696 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.61 47.17 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.98 148.36 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.218 -0.926 . . . . 0.0 111.18 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.556 0.693 . . . . 0.0 110.27 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.7 mttm 51.27 22.83 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.465 0.65 . . . . 0.0 109.526 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.46 30.92 20.54 Favored Glycine 0 N--CA 1.481 1.663 0 C-N-CA 119.396 -1.383 . . . . 0.0 109.785 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.6 mt -143.26 142.8 31.48 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 108.79 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.4 152.79 36.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.7 m-85 -153.81 140.27 18.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.2 m -57.57 177.5 0.1 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.366 -1.334 . . . . 0.0 108.486 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.63 -36.06 82.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.417 -0.802 . . . . 0.0 109.349 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.5 m -86.54 -43.8 12.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.745 . . . . 0.0 111.338 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.456 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.87 83.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.722 -1.236 . . . . 0.0 108.089 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.38 14.07 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.55 -44.92 89.23 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.043 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.45 61.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.53 -35.28 46.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.501 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.114 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.43 31.36 16.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.0 m-20 48.59 51.26 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 70.968 -23.396 . . . . 0.0 109.468 179.977 . . . . . . . . 2 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.94 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.99 35.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -1.21 . . . . 0.0 109.583 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.02 148.68 43.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.48 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -66.08 93.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.255 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.25 -54.28 2.0 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.35 74.0 1.38 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.53 158.09 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.36 131.45 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.449 -1.407 . . . . 0.0 111.561 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.92 129.29 45.98 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 13' ' ' TYR . 34.0 m -63.48 154.4 32.44 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.517 1.151 . . . . 0.0 110.594 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.7 mt -114.35 -17.24 11.84 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.23 -1.396 . . . . 10.539999999999999 107.23 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.53 145.07 18.54 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.238 -0.914 . . . . 18.390000000000001 110.743 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.08 81.41 1.7 Allowed 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.356 1.371 . . . . 0.0 109.058 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.74 170.22 14.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.836 -1.165 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.59 111.11 8.03 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.725 0.774 . . . . 0.0 109.414 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -134.31 111.95 10.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 18' ' ' VAL . 16.1 m -130.27 94.29 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 122.839 1.304 . . . . 0.0 109.13 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.977 HG22 ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.49 -152.09 0.4 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.578 -1.267 . . . . 38.32 107.578 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.977 ' OE1' HG22 ' A' ' 19' ' ' THR . 58.0 mp0 -82.4 -54.31 5.32 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.857 -1.534 . . . . 55.130000000000003 106.857 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -109.28 29.16 7.79 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.383 -0.823 . . . . 0.0 110.746 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.52 150.88 22.21 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.823 -1.173 . . . . 0.0 109.678 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.42 111.38 22.37 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.416 -0.803 . . . . 11.68 110.756 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.35 127.67 41.58 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.9 142.16 21.52 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.42 -1.425 . . . . 12.44 110.918 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.609 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.12 155.82 22.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.93 18.27 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.268 -0.895 . . . . 29.030000000000001 109.595 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.1 6.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.345 -1.502 . . . . 6.1799999999999997 109.345 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.3 114.83 22.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.589 -0.947 . . . . 9.5199999999999996 109.415 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.99 108.59 5.98 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.41 133.7 49.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 123.154 1.454 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.78 103.08 15.83 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.919 -1.492 . . . . 0.0 107.395 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.502 -0.749 . . . . 0.0 111.468 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.486 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.3 mt -59.74 -50.43 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.917 -1.115 . . . . 0.0 110.201 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.23 157.6 43.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.947 -1.095 . . . . 0.0 110.714 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.55 ' HB3' ' NE1' ' A' ' 44' ' ' TRP . 1.8 mptp? -135.08 65.58 65.24 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.77 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.75 165.32 31.76 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.61 1.54 . . . . 0.0 109.016 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.52 7.78 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.67 -59.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.324 0.583 . . . . 0.0 109.989 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.673 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.6 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.158 0 C-N-CA 122.714 2.276 . . . . 0.0 109.896 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.673 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.6 tp10 131.87 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.802 0.841 . . . . 0.0 108.771 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.536 ' HB2' HD12 ' A' ' 55' ' ' LEU . 16.8 m0 -71.93 165.94 23.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.674 -1.266 . . . . 14.289999999999999 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.3 m0 -129.56 145.05 51.51 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.32 -0.622 . . . . 11.800000000000001 109.32 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.02 96.62 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.93 128.7 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.921 0.867 . . . . 0.0 110.403 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.45 150.41 27.07 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.756 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.39 128.54 43.4 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 117.325 -1.75 . . . . 0.0 107.31 177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 119.596 -1.94 . . . . 0.0 107.99 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.49 -4.6 4.17 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.41 33.81 6.99 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 115.307 -0.861 . . . . 14.41 112.329 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.756 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.1 29.81 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-N 119.603 1.701 . . . . 0.0 111.787 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.56 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.32 1.057 . . . . 0.0 112.468 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.79 12.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.252 -1.539 . . . . 7.25 109.252 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.43 150.88 42.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -1.194 . . . . 0.0 108.608 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.7 8.97 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.955 -1.091 . . . . 0.0 109.297 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.968 -1.205 . . . . 4.7599999999999998 108.968 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.607 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 16.0 pttp -60.46 3.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 110.648 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.5 m-20 -102.13 -7.52 22.17 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.179 -0.95 . . . . 14.84 109.319 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.09 8.19 31.19 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.242 -0.911 . . . . 10.23 109.427 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 11' ' ' THR . 34.5 m -147.44 156.6 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 6.9699999999999998 109.513 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.476 HG22 ' N ' ' A' ' 63' ' ' VAL . 12.6 p -106.81 160.72 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 62' ' ' VAL . 56.0 t -107.67 134.25 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.805 . . . . 0.0 109.834 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.2 mt -105.09 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.626 -0.671 . . . . 0.0 109.237 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.48 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 38.8 m -70.0 151.69 45.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.952 -1.092 . . . . 0.0 109.403 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 54.4 p-10 -146.72 152.63 39.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 109.317 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.08 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.59 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.302 1.335 . . . . 0.0 109.681 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.96 82.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.77 125.02 32.2 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.22 28.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -1.128 . . . . 0.0 109.52 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.96 0.2 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.28 130.65 5.29 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.261 -1.14 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.7 Cg_endo -74.19 163.65 36.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.912 1.741 . . . . 0.0 108.922 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.532 HG23 ' C ' ' B' ' 84' ' ' ARG . 64.2 mt -135.39 119.83 26.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 122.087 0.946 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.827 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.5 117.06 4.09 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.016 0.912 . . . . 0.0 109.89 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.513 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.05 4.89 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.827 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.76 -48.5 8.18 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.295 -1.12 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.88 13.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.573 -0.704 . . . . 0.0 109.107 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 53.55 41.14 32.14 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.532 ' C ' HG23 ' B' ' 78' ' ' ILE . 6.8 mtp85 -115.79 143.41 30.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.646 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.39 113.25 1.37 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.485 1.457 . . . . 0.0 110.535 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.669 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.75 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.63 61.55 0.31 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.824 -1.173 . . . . 0.0 110.663 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.07 -101.93 0.15 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.673 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.63 120.58 42.05 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.669 HG22 HG21 ' B' ' 86' ' ' ILE . 42.4 t -98.71 158.64 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.472 -0.767 . . . . 0.0 111.211 -177.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.55 116.05 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.74 106.11 18.25 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 109.629 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.61 159.54 42.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.02 17.28 4.31 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.25 75.92 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.25 -154.88 0.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.747 0.784 . . . . 0.0 109.748 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.479 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.31 143.51 46.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.513 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.528 -1.358 . . . . 0.0 110.594 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.473 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.0 m80 -56.59 131.92 50.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.07 -14.94 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 120.863 -1.148 . . . . 0.0 108.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.78 -26.89 15.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.828 -0.545 . . . . 0.0 110.71 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.06 -6.57 31.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.828 -1.17 . . . . 0.0 110.858 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.471 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.18 106.16 11.99 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.6 m -133.46 175.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.19 0.995 . . . . 0.0 111.203 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.74 45.86 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.303 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.9 28.69 1.75 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.111 -0.993 . . . . 0.0 109.667 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.421 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.83 -31.67 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.343 -0.848 . . . . 0.0 110.097 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.21 4.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.6 47.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 110.173 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.58 59.33 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.0 138.3 39.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.748 1.632 . . . . 0.0 112.13 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.312 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.83 56.94 1.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.159 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.32 1.62 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.34 -0.85 . . . . 0.0 109.01 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 31.07 2.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.946 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.32 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -1.048 . . . . 0.0 109.986 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.52 145.46 24.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.43 169.48 9.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.685 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.53 137.71 47.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.07 148.3 28.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.223 -0.923 . . . . 0.0 111.197 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.02 129.31 11.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.34 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.88 1.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.59 30.95 20.12 Favored Glycine 0 N--CA 1.483 1.775 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.713 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.36 142.74 31.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.535 -0.979 . . . . 0.0 108.82 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.47 152.73 36.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.4 m-85 -153.79 140.35 18.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.57 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.495 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.71 -35.92 82.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.4 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.72 -43.69 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.509 -0.744 . . . . 0.0 111.312 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.83 83.46 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.761 -1.212 . . . . 0.0 108.116 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.66 -56.44 13.65 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.7 m-80 -64.51 -44.93 89.36 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.004 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.5 -34.28 61.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.77 -35.4 44.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.218 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 110.091 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.37 31.43 16.52 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.56 51.19 15.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.313 -1.11 . . . . 0.0 109.612 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.475 -39.667 1 CA-C-O 71.024 -23.37 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.76 0.13 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -161.87 35.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -1.194 . . . . 0.0 109.575 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.439 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -72.99 148.68 43.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.123 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.21 93.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.28 -54.39 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.423 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.32 73.86 1.37 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.563 ' N ' ' OG ' ' A' ' 65' ' ' SER . 9.7 t -69.43 158.11 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 31' ' ' MET . 3.3 m -145.31 131.44 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.45 -1.406 . . . . 0.0 111.549 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -99.88 129.27 45.95 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.677 HG22 ' H ' ' A' ' 13' ' ' TYR . 31.8 m -63.42 154.38 32.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.455 1.121 . . . . 0.0 110.602 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.6 mt -114.36 -17.23 11.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.186 -1.412 . . . . 10.539999999999999 107.186 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.677 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.53 145.03 18.47 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.126 -0.984 . . . . 18.390000000000001 110.765 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 121.43 1.42 . . . . 0.0 109.037 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.79 170.3 13.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.965 -1.084 . . . . 0.0 110.984 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.58 111.01 7.96 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.739 0.78 . . . . 0.0 109.474 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.19 112.0 10.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 18' ' ' VAL . 15.9 m -130.36 94.31 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-O 122.901 1.334 . . . . 0.0 109.126 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.45 -152.07 0.4 Allowed 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.38 -1.282 . . . . 38.32 107.579 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 19' ' ' THR . 96.2 mt-10 -82.47 -54.27 5.33 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.863 -1.532 . . . . 55.130000000000003 106.863 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.445 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.33 29.24 7.72 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.375 -0.828 . . . . 0.0 110.741 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.649 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.57 150.94 22.18 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.812 -1.18 . . . . 0.0 109.671 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.469 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.29 22.23 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.42 -0.8 . . . . 11.68 110.757 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.43 127.65 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.8 142.18 21.63 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.425 -1.422 . . . . 12.44 110.904 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.22 155.83 22.31 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 146.93 17.93 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.464 -0.894 . . . . 29.030000000000001 109.577 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.62 44.09 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.218 -1.553 . . . . 6.1799999999999997 109.218 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.84 22.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.592 -0.946 . . . . 9.5199999999999996 109.449 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.03 108.65 6.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.51 133.74 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.175 1.464 . . . . 0.0 110.53 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.81 102.99 15.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.368 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.507 -0.746 . . . . 0.0 111.607 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' A' ' 47' ' ' LYS . 81.9 mt -59.8 -50.34 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.985 -1.072 . . . . 0.0 110.83 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.09 65.52 64.99 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.785 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -74.83 165.38 31.58 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.618 1.545 . . . . 0.0 108.987 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.93 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.57 -59.27 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.237 0.541 . . . . 0.0 110.136 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.35 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.63 -59.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.693 2.262 . . . . 0.0 109.943 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 70.8 mt-10 131.78 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 123.805 0.842 . . . . 0.0 108.769 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.556 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.8 m0 -71.93 165.92 23.2 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.607 -1.308 . . . . 14.289999999999999 110.436 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.467 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.5 m0 -129.57 144.99 51.51 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.338 -0.616 . . . . 11.800000000000001 109.338 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -79.01 96.72 5.84 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.493 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.72 55.98 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.907 0.86 . . . . 0.0 110.38 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.52 150.35 27.02 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.758 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.38 128.47 43.34 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.286 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.41 -18.41 1.03 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 119.716 -1.865 . . . . 0.0 107.918 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.55 -4.56 4.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.39 33.95 6.93 Favored Glycine 0 N--CA 1.481 1.684 0 CA-C-N 115.28 -0.873 . . . . 14.41 112.258 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.758 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.05 29.98 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.648 1.724 . . . . 0.0 111.82 179.14 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.67 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 122.325 1.059 . . . . 0.0 112.401 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.06 156.79 12.67 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.274 -1.53 . . . . 7.25 109.274 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.39 150.79 43.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.214 -1.168 . . . . 0.0 108.672 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.91 136.77 9.08 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 120.949 -1.094 . . . . 0.0 109.329 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.21 113.52 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 N-CA-C 109.024 -1.183 . . . . 4.7599999999999998 109.024 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.449 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.35 3.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 110.729 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 57' ' ' PRO . 95.7 m-20 -101.9 -7.71 22.22 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.247 -0.908 . . . . 14.84 109.4 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.0 8.23 30.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.221 -0.925 . . . . 10.23 109.437 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 11' ' ' THR . 33.5 m -147.48 156.48 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.096 -1.002 . . . . 6.9699999999999998 109.494 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG11 HD13 ' B' ' 78' ' ' ILE . 33.6 m -106.74 160.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.5 t -107.74 134.3 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.372 -0.83 . . . . 0.0 109.701 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 mp -105.06 -63.24 1.25 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.562 -0.711 . . . . 0.0 109.254 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.563 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 11.5 p -70.01 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.024 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 109.372 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.2 1.48 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.53 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.257 1.305 . . . . 0.0 109.656 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.06 82.67 1.78 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.93 124.96 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.81 156.24 28.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -1.114 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.92 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.433 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.44 46.91 0.2 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.21 130.82 5.39 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.312 -1.111 . . . . 0.0 109.396 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.65 35.94 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.876 1.718 . . . . 0.0 108.936 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.496 HG23 ' C ' ' B' ' 84' ' ' ARG . 64.8 mt -135.38 119.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 122.053 0.93 . . . . 0.0 109.44 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 14.8 t -58.46 117.13 4.15 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.872 0.844 . . . . 0.0 109.883 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.518 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -65.0 -0.06 4.97 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.829 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.55 8.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.15 4.94 13.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.496 ' C ' HG23 ' B' ' 78' ' ' ILE . 3.4 mtt180 -116.01 143.3 30.61 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.35 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.412 1.408 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.667 HG21 HG22 ' B' ' 90' ' ' VAL . 21.4 mt -70.98 158.45 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.426 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.54 61.46 0.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.828 -1.17 . . . . 0.0 110.671 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.04 0.15 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.658 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.63 120.59 42.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.667 HG22 HG21 ' B' ' 86' ' ' ILE . 42.2 t -98.72 158.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.41 -0.806 . . . . 0.0 111.286 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.47 HG23 HG22 ' B' ' 100' ' ' VAL . 5.0 t -122.43 116.06 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.79 106.15 18.27 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.572 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.47 42.74 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.19 4.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.16 76.03 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.19 -154.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.704 0.764 . . . . 0.0 109.747 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.47 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.47 143.5 45.9 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.518 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.6 140.07 33.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.506 -1.371 . . . . 0.0 110.614 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.5 m80 -56.36 131.98 49.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 91' ' ' VAL . 7.4 t -53.33 -14.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 120.843 -1.161 . . . . 0.0 108.323 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.94 15.51 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.804 -0.56 . . . . 0.0 110.683 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.17 -6.52 31.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.936 -1.102 . . . . 0.0 110.835 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.13 106.3 12.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.8 m -133.67 175.22 11.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 111.092 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.526 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.7 148.65 45.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.263 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.85 28.72 1.73 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.57 0.71 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.354 -0.842 . . . . 0.0 110.056 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.4 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.15 -15.55 4.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.75 47.65 0.33 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.55 59.34 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -68.96 138.29 40.03 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.788 1.659 . . . . 0.0 112.101 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.313 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.77 56.91 1.79 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.023 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.18 1.69 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 0.0 109.022 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 30.97 2.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.945 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.34 178.88 4.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -1.041 . . . . 0.0 110.066 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.31 145.41 24.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.509 -0.745 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.33 169.52 9.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 109.624 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.703 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.52 137.77 47.28 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.21 29.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.256 -0.902 . . . . 0.0 111.212 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.36 11.35 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.609 0.719 . . . . 0.0 110.35 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.07 22.92 1.36 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.578 -0.701 . . . . 0.0 109.536 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.37 31.15 20.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.792 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.45 142.74 31.31 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.549 -0.971 . . . . 0.0 108.803 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.42 152.86 36.08 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.725 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.557 ' CE1' HD22 ' B' ' 133' ' ' LEU . 58.3 m-85 -153.82 140.37 18.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.69 177.48 0.11 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.471 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.61 -36.04 82.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 109.294 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 53.7 m -86.66 -43.73 12.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 111.295 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.89 83.38 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.736 -1.228 . . . . 0.0 108.052 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.32 14.47 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.419 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.2 m-80 -64.66 -44.75 89.42 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.48 -34.3 61.3 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.22 44.81 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.351 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.66 -81.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.29 31.6 16.26 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 48.31 51.33 15.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 71.114 -23.327 . . . . 0.0 109.534 179.903 . . . . . . . . 2 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.93 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.98 35.32 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 109.619 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.435 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.08 148.7 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.049 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.12 93.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 0.0 109.394 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.28 2.0 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.38 73.82 1.37 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.39 158.09 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.2 m -145.39 131.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.485 -1.384 . . . . 0.0 111.529 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.92 129.21 45.97 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 13' ' ' TYR . 30.7 m -63.52 154.45 32.44 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.521 1.153 . . . . 0.0 110.584 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.2 mt -114.39 -17.25 11.82 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.173 -1.417 . . . . 10.539999999999999 107.173 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.675 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.49 145.03 18.49 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.198 -0.939 . . . . 18.390000000000001 110.791 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.04 81.43 1.68 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.385 1.39 . . . . 0.0 109.099 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CG ' ' N ' ' A' ' 16' ' ' SER . 27.8 t80 -71.61 170.23 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.962 -1.087 . . . . 0.0 110.937 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.6 111.09 8.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.776 0.798 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 111.89 10.59 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 18' ' ' VAL . 17.6 m -130.25 94.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-O 122.883 1.325 . . . . 0.0 109.16 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.54 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -144.42 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.575 177.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.54 ' H ' HG22 ' A' ' 19' ' ' THR . 97.5 mt-10 -82.39 -54.34 5.3 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.904 -1.517 . . . . 55.130000000000003 106.904 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 17.4 pt-20 -109.26 29.09 7.86 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.451 -0.781 . . . . 0.0 110.703 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.62 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.41 150.89 22.15 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.921 -1.112 . . . . 0.0 109.741 -179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.33 111.4 22.42 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.402 -0.811 . . . . 11.68 110.739 -178.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.35 127.6 41.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.89 142.16 21.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.366 -1.459 . . . . 12.44 110.912 -178.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.19 155.8 22.36 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.97 18.2 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.465 -0.894 . . . . 29.030000000000001 109.591 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.54 44.2 6.6 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 6.1799999999999997 109.298 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.37 114.8 22.9 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.725 -0.868 . . . . 9.5199999999999996 109.389 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.98 108.67 6.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.54 133.66 49.92 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 123.112 1.434 . . . . 0.0 110.585 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.65 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.393 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.16 92.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 111.431 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.48 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.8 mt -59.71 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.894 -1.129 . . . . 0.0 110.259 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.474 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.916 -1.115 . . . . 0.0 110.79 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.555 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.07 65.53 65.13 Favored Pre-proline 0 N--CA 1.486 1.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.794 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.44 31.42 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.653 1.569 . . . . 0.0 108.982 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.06 -46.55 7.73 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.78 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.351 0.596 . . . . 0.0 110.052 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 122.664 2.243 . . . . 0.0 110.023 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 31.4 tt0 131.77 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 C-N-CA 123.814 0.846 . . . . 0.0 108.752 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.548 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.6 m0 -71.87 165.96 23.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.623 -1.298 . . . . 14.289999999999999 110.463 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.561 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.1 m0 -129.68 145.06 51.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.233 -0.654 . . . . 11.800000000000001 109.233 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.99 96.73 5.83 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.73 55.98 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.89 0.853 . . . . 0.0 110.428 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.52 150.33 27.03 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.756 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.1 p30 -96.47 128.51 43.47 Favored 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 117.25 -1.78 . . . . 0.0 107.212 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.3 -18.46 0.97 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.775 -1.828 . . . . 0.0 107.995 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.476 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.6 4.29 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.45 33.82 6.97 Favored Glycine 0 N--CA 1.482 1.761 0 CA-C-N 115.388 -0.824 . . . . 14.41 112.281 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.756 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.91 164.02 30.04 Favored 'General case' 0 N--CA 1.515 2.809 0 CA-C-N 119.796 1.798 . . . . 0.0 111.839 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.59 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 122.309 1.052 . . . . 0.0 112.522 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.11 156.64 12.53 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.255 -1.538 . . . . 7.25 109.255 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.3 150.85 43.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.13 -1.218 . . . . 0.0 108.768 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.62 8.92 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.895 -1.128 . . . . 0.0 109.271 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.048 -1.174 . . . . 4.7599999999999998 109.048 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.561 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 33.9 pttt -60.38 3.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.9 m-20 -102.09 -7.63 22.11 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.183 -0.948 . . . . 14.84 109.273 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 10.23 109.454 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.3 m -147.48 156.64 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.149 -0.969 . . . . 6.9699999999999998 109.521 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 63' ' ' VAL . 11.3 p -106.77 160.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.435 ' N ' HG22 ' A' ' 62' ' ' VAL . 48.5 t -107.63 134.36 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.5 -0.75 . . . . 0.0 109.767 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -105.11 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.619 -0.676 . . . . 0.0 109.227 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -69.91 151.58 45.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.0 109.435 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -146.54 152.72 39.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 0.0 109.377 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.29 1.48 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.47 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.338 1.358 . . . . 0.0 109.645 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.66 1.78 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.04 32.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.85 156.25 28.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.93 0.2 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.74 5.33 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.337 -1.096 . . . . 0.0 109.378 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.6 Cg_endo -74.14 163.51 36.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.988 1.792 . . . . 0.0 108.87 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.59 HG23 ' C ' ' B' ' 84' ' ' ARG . 48.5 mt -135.35 119.89 27.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 122.081 0.943 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.42 117.01 4.01 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.831 0.824 . . . . 0.0 110.048 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.519 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.93 -0.09 4.91 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.58 -48.7 8.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -1.061 . . . . 0.0 109.375 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.84 13.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.568 -0.708 . . . . 0.0 109.106 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 53.51 41.33 32.11 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.59 ' C ' HG23 ' B' ' 78' ' ' ILE . 42.7 mtp180 -115.89 143.51 30.92 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.54 113.31 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.5 1.467 . . . . 0.0 110.464 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.678 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.78 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.57 61.48 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.809 -1.182 . . . . 0.0 110.646 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.0 0.15 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.674 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.5 120.56 42.06 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.678 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.74 158.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.66 0.743 . . . . 0.0 111.253 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' B' ' 103' ' ' PHE . 5.0 t -122.42 115.96 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.096 -1.003 . . . . 0.0 109.473 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.55 159.42 42.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.19 17.14 4.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.22 75.94 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.79 0.805 . . . . 0.0 109.754 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.36 143.52 46.12 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.519 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.58 140.0 33.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.66 -1.275 . . . . 0.0 110.58 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.54 132.02 50.37 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.39 -14.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.876 -1.14 . . . . 0.0 108.335 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.82 -26.94 15.45 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.806 -0.559 . . . . 0.0 110.651 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.08 -6.59 31.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.952 -1.092 . . . . 0.0 110.858 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.13 106.26 12.02 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.0 m -133.62 175.17 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.218 1.009 . . . . 0.0 111.18 -177.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.525 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.67 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.259 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.78 1.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.85 -31.75 0.71 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.14 -15.37 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.248 -0.908 . . . . 0.0 110.175 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.66 47.69 0.34 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.851 . . . . 0.0 110.147 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.47 59.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -69.02 138.23 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.706 1.604 . . . . 0.0 112.167 -177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.315 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.76 56.76 1.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.19 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.93 -55.27 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 0.0 109.07 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.08 2.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.93 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.33 178.96 4.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.469 -1.018 . . . . 0.0 109.953 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.45 145.36 24.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.404 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.6 137.64 47.13 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -107.08 148.26 28.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.23 -0.919 . . . . 0.0 111.233 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 129.4 11.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.614 0.721 . . . . 0.0 110.332 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.15 22.86 1.4 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 0.0 109.504 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.95 20.4 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.687 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.4 mt -143.26 142.82 31.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.514 -0.992 . . . . 0.0 108.852 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.48 152.97 35.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.673 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.554 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.9 m-85 -153.92 140.28 18.65 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.61 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.399 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.0 tt0 -63.56 -36.11 82.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.402 -0.811 . . . . 0.0 109.475 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.2 m -86.51 -43.63 12.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.724 . . . . 0.0 111.466 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.77 -43.76 83.15 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.789 -1.194 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.4 13.95 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.6 -44.91 89.1 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.074 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.28 61.22 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.554 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.7 -35.3 45.18 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.354 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.2 m-85 -158.51 -81.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 110.094 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.35 31.41 16.62 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.54 51.16 15.87 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -1.151 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.934 -23.412 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.44 74.92 0.12 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -161.94 35.24 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.253 -1.145 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.442 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.02 148.58 44.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.0 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.22 -54.26 2.0 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.435 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.41 73.94 1.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' N ' ' OG ' ' A' ' 65' ' ' SER . 79.1 t -69.38 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 31' ' ' MET . 3.9 m -145.41 131.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.354 -1.466 . . . . 0.0 111.461 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -99.79 129.19 45.87 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 13' ' ' TYR . 35.4 m -63.44 154.31 32.56 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.51 1.148 . . . . 0.0 110.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.3 mt -114.28 -17.25 11.88 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.225 -1.398 . . . . 10.539999999999999 107.225 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.662 ' H ' HG22 ' A' ' 11' ' ' THR . 14.6 m-85 -149.47 145.1 18.63 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.164 -0.96 . . . . 18.390000000000001 110.678 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -73.01 81.45 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.444 1.43 . . . . 0.0 109.107 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.78 170.32 13.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.98 -1.075 . . . . 0.0 110.861 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.72 111.1 7.96 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.805 0.812 . . . . 0.0 109.38 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 112.0 10.72 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 18' ' ' VAL . 34.0 m -130.36 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 122.941 1.353 . . . . 0.0 109.222 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 1.031 HG22 ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.512 -1.292 . . . . 38.32 107.512 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 1.031 ' OE1' HG22 ' A' ' 19' ' ' THR . 58.8 mp0 -82.38 -54.47 5.19 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.832 -1.544 . . . . 55.130000000000003 106.832 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -109.18 29.22 7.72 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.374 -0.829 . . . . 0.0 110.803 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.53 150.93 22.16 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.036 -1.04 . . . . 0.0 109.761 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.52 22.61 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.517 -0.739 . . . . 11.68 110.655 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.49 127.84 41.86 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.0 142.21 21.48 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.415 -1.428 . . . . 12.44 110.78 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.87 22.4 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 146.92 18.78 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.238 -0.913 . . . . 29.030000000000001 109.585 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 44.2 6.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.416 -1.474 . . . . 6.1799999999999997 109.416 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.452 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.83 22.93 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.543 -0.974 . . . . 9.5199999999999996 109.331 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.13 108.67 6.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.48 133.66 49.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.155 1.455 . . . . 0.0 110.584 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.78 103.14 15.88 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.41 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.19 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.489 -0.757 . . . . 0.0 111.491 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.4 mt -59.91 -50.31 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.957 -1.09 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.14 65.63 64.94 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.701 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.77 165.41 31.54 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.627 1.551 . . . . 0.0 109.049 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.1 -46.55 7.72 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.77 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.419 0.628 . . . . 0.0 110.059 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.51 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.65 -59.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.547 2.164 . . . . 0.0 109.975 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 71.6 mt-10 131.7 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 123.828 0.851 . . . . 0.0 108.837 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.522 ' HB2' HD12 ' A' ' 55' ' ' LEU . 20.2 m0 -71.87 166.0 22.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.696 -1.252 . . . . 14.289999999999999 110.497 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.4 m0 -129.64 144.97 51.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.668 -0.645 . . . . 11.800000000000001 109.355 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -78.98 96.68 5.81 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.76 56.0 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.889 0.852 . . . . 0.0 110.321 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.69 150.39 26.79 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.754 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.37 128.56 43.4 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 117.327 -1.749 . . . . 0.0 107.239 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.5 1.02 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 119.584 -1.948 . . . . 0.0 108.008 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.472 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.57 4.26 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.47 33.81 6.97 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-N 115.403 -0.817 . . . . 14.41 112.284 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.754 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.1 29.8 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-N 119.724 1.762 . . . . 0.0 111.792 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.63 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-O 122.356 1.074 . . . . 0.0 112.541 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.71 12.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.294 -1.522 . . . . 7.25 109.294 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.522 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.3 150.78 43.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.278 -1.13 . . . . 0.0 108.596 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.04 136.77 9.02 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 109.269 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 N-CA-C 109.014 -1.187 . . . . 4.7599999999999998 109.014 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.37 3.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.482 -0.761 . . . . 0.0 110.712 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.7 m-20 -102.01 -7.63 22.18 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.206 -0.934 . . . . 14.84 109.327 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.97 8.13 31.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 10.23 109.527 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.41 156.64 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.193 -0.942 . . . . 6.9699999999999998 109.483 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.738 HG11 HD13 ' B' ' 78' ' ' ILE . 27.7 m -106.85 160.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.57 134.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.389 -0.819 . . . . 0.0 109.838 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 mp -105.2 -63.18 1.26 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.631 -0.668 . . . . 0.0 109.229 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 14.4 p -70.01 151.54 45.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.037 -1.039 . . . . 0.0 109.521 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 55.7 p-10 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.3 1.48 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.304 1.336 . . . . 0.0 109.667 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.02 82.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.09 32.33 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.71 156.1 29.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.278 -1.131 . . . . 0.0 109.57 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.4 mtt -49.7 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.74 0.2 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.22 130.86 5.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.301 -1.117 . . . . 0.0 109.378 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.41 163.66 35.74 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.85 1.7 . . . . 0.0 108.827 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.738 HD13 HG11 ' A' ' 62' ' ' VAL . 74.6 mt -135.41 119.86 26.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.07 0.938 . . . . 0.0 109.338 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 14.9 t -58.43 116.98 3.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.824 0.821 . . . . 0.0 109.871 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.24 4.92 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.63 -48.65 8.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.361 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.09 4.77 13.72 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 53.57 41.36 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.469 ' C ' HG23 ' B' ' 78' ' ' ILE . 19.7 mtp180 -115.89 143.43 30.77 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.644 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.43 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.442 1.428 . . . . 0.0 110.551 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.661 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.94 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.425 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.44 61.54 0.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.918 -1.114 . . . . 0.0 110.583 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.08 -102.06 0.15 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.661 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.64 120.74 42.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.661 HG22 HG21 ' B' ' 86' ' ' ILE . 42.7 t -98.83 158.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.762 0.792 . . . . 0.0 111.141 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.45 115.91 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 109.548 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.5 42.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.15 17.23 4.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.1 25.42 75.64 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.27 -154.77 0.65 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.712 0.768 . . . . 0.0 109.821 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.472 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.46 143.37 45.85 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.8 m95 -141.48 140.1 33.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.41 -1.431 . . . . 0.0 110.634 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.449 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.5 131.9 49.92 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.6 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 120.894 -1.129 . . . . 0.0 108.336 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.449 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.91 -26.94 15.4 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.71 -0.619 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.21 -6.42 31.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.806 -1.184 . . . . 0.0 110.899 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.29 106.19 12.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.824 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.53 175.25 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.288 1.042 . . . . 0.0 111.167 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.81 148.66 46.28 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.8 28.73 1.71 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.414 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.84 -31.62 0.71 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.349 -0.844 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.22 -15.27 4.19 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.332 -0.855 . . . . 0.0 110.138 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.66 47.67 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.319 -0.863 . . . . 0.0 110.148 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.52 59.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.824 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -69.03 138.22 39.58 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.704 1.603 . . . . 0.0 112.168 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.309 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.79 56.96 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.157 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.01 -55.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 109.082 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.19 30.88 2.76 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.966 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.18 178.84 4.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.479 -1.012 . . . . 0.0 110.03 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.33 145.24 24.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.55 9.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 0.0 109.489 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.6 137.65 47.13 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.03 148.24 28.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.241 -0.912 . . . . 0.0 111.331 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.31 11.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.685 0.755 . . . . 0.0 110.257 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.38 22.83 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.506 -0.746 . . . . 0.0 109.414 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.87 20.59 Favored Glycine 0 N--CA 1.481 1.685 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.79 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.29 142.64 31.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.524 -0.986 . . . . 0.0 108.821 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.91 36.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.739 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.543 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -154.01 140.26 18.54 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.7 m -57.61 177.4 0.1 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.453 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.81 . . . . 0.0 109.383 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.68 -43.79 12.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.434 -0.791 . . . . 0.0 111.354 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.74 83.91 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.867 -1.145 . . . . 0.0 108.213 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.46 13.58 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.4 m-80 -64.52 -44.82 89.66 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.45 -34.49 61.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.543 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.64 -35.19 45.81 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.381 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.7 -81.64 0.05 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 110.085 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.44 31.43 16.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.55 51.28 15.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -1.103 . . . . 0.0 109.556 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.791 -23.48 . . . . 0.0 109.443 -179.981 . . . . . . . . 2 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.81 0.13 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.595 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.03 148.68 43.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.882 . . . . 0.0 109.099 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.11 93.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 109.238 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.31 -54.25 2.0 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.34 74.08 1.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.5 t -69.53 158.07 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.34 131.55 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.463 -1.398 . . . . 0.0 111.528 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.93 129.26 45.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 13' ' ' TYR . 38.5 m -63.42 154.33 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.468 1.128 . . . . 0.0 110.633 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 74.4 mt -114.31 -17.34 11.84 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.219 -1.4 . . . . 10.539999999999999 107.219 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.648 ' H ' HG22 ' A' ' 11' ' ' THR . 14.4 m-85 -149.5 145.08 18.57 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.21 -0.931 . . . . 18.390000000000001 110.726 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 121.364 1.376 . . . . 0.0 109.042 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.85 170.23 14.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.972 -1.08 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.14 8.04 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.906 0.86 . . . . 0.0 109.358 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.07 10.73 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 18' ' ' VAL . 15.4 m -130.44 94.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 123.039 1.399 . . . . 0.0 109.172 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.672 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.4 m -144.58 -152.11 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.321 -1.309 . . . . 38.32 107.593 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.672 ' H ' HG22 ' A' ' 19' ' ' THR . 79.1 mm-40 -82.37 -54.3 5.33 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.92 -1.511 . . . . 55.130000000000003 106.92 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 74.9 mt-10 -109.33 29.17 7.79 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.364 -0.835 . . . . 0.0 110.778 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.39 150.78 22.26 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.756 -1.215 . . . . 0.0 109.83 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.29 111.37 22.38 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.408 -0.807 . . . . 11.68 110.775 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.43 127.71 41.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.0 142.04 21.32 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.374 -1.454 . . . . 12.44 110.848 -178.296 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.07 155.85 22.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.92 18.49 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.482 -0.887 . . . . 29.030000000000001 109.539 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.12 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.284 -1.526 . . . . 6.1799999999999997 109.284 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.4 114.84 22.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.584 -0.951 . . . . 9.5199999999999996 109.424 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.07 108.68 6.1 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.54 133.83 49.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 123.231 1.491 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.05 15.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.328 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.545 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.99 92.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.527 -0.733 . . . . 0.0 111.485 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.487 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.6 mt -59.65 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.927 -1.108 . . . . 0.0 110.344 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.66 43.68 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.037 -1.039 . . . . 0.0 110.737 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.02 65.55 65.54 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.75 165.4 31.59 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.61 1.54 . . . . 0.0 109.003 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.07 -46.48 7.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.66 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.352 0.596 . . . . 0.0 110.025 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.8 -47.36 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.734 2.289 . . . . 0.0 109.961 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 67.5 mt-10 131.76 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 C-N-CA 123.881 0.872 . . . . 0.0 108.805 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.551 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.5 m0 -71.85 165.89 23.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.738 -1.226 . . . . 14.289999999999999 110.502 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.491 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.6 m0 -129.51 145.03 51.5 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.377 -0.601 . . . . 11.800000000000001 109.377 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -78.98 96.71 5.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.9 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.869 0.842 . . . . 0.0 110.429 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.79 150.47 26.61 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.758 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.39 128.53 43.4 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 117.28 -1.768 . . . . 0.0 107.325 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.45 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.618 -1.926 . . . . 0.0 107.951 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.71 -4.47 4.31 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.4 33.95 6.92 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 115.379 -0.828 . . . . 14.41 112.224 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.758 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.1 29.79 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.731 1.766 . . . . 0.0 111.87 179.12 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.02 154.65 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.323 1.059 . . . . 0.0 112.408 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.337 -1.505 . . . . 7.25 109.337 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.96 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.31 -1.112 . . . . 0.0 108.684 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.08 136.79 9.02 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.004 -1.06 . . . . 0.0 109.297 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.98 -1.2 . . . . 4.7599999999999998 108.98 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.46 3.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 110.721 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -101.97 -7.67 22.18 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.147 -0.971 . . . . 14.84 109.391 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.06 8.33 30.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.919 . . . . 10.23 109.483 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.7 m -147.46 156.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 6.9699999999999998 109.454 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 63' ' ' VAL . 3.8 p -106.76 160.82 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' N ' HG22 ' A' ' 62' ' ' VAL . 45.6 t -107.71 134.26 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.403 -0.811 . . . . 0.0 109.714 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' O ' ' NH2' ' B' ' 84' ' ' ARG . 9.0 mp -105.14 -63.3 1.24 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -69.92 151.59 45.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 49.4 p30 -146.55 152.72 39.41 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.45 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 121.368 1.378 . . . . 0.0 109.7 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.03 82.59 1.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.93 125.14 32.41 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.514 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.09 28.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -1.073 . . . . 0.0 109.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.76 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.3 46.98 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.32 130.79 5.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.286 -1.126 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.21 163.6 36.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.912 1.741 . . . . 0.0 108.847 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 30.6 mt -135.43 119.84 26.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 122.17 0.986 . . . . 0.0 109.429 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.3 116.96 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.778 0.799 . . . . 0.0 109.897 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.508 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.23 4.91 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.59 -48.74 8.07 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 109.321 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.89 13.76 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 53.44 41.28 32.13 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.459 ' HE ' ' HB3' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -115.82 143.43 30.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.64 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.5 Cg_exo -56.48 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.433 1.422 . . . . 0.0 110.56 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.67 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.91 158.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.426 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.51 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.0 110.577 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.668 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.71 42.46 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.67 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.8 158.62 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.669 0.747 . . . . 0.0 111.245 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.51 116.03 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.585 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.56 42.58 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 57.94 17.38 4.29 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.32 75.78 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.84 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.474 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.38 143.4 46.03 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.508 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.46 139.97 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.507 -1.371 . . . . 0.0 110.67 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.445 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.38 131.9 49.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.926 -1.109 . . . . 0.0 108.436 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.85 -26.98 15.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.781 -0.574 . . . . 0.0 110.624 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.1 -6.55 31.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.937 -1.102 . . . . 0.0 110.842 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' B' ' 91' ' ' VAL . 24.9 t80 -80.1 106.26 11.99 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.58 175.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.268 1.032 . . . . 0.0 111.172 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.71 45.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.31 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.66 1.74 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.78 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -128.98 -15.57 4.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.385 -0.822 . . . . 0.0 110.208 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.59 0.32 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.52 59.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.06 138.18 39.39 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.699 1.6 . . . . 0.0 112.184 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.326 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.67 56.85 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.194 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.634 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.08 -55.22 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.337 -0.852 . . . . 0.0 108.962 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.22 31.05 2.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.938 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.25 179.07 4.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.578 -0.954 . . . . 0.0 109.949 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.41 24.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 109.305 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.35 169.42 9.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.684 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.67 47.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.92 148.29 28.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.264 -0.898 . . . . 0.0 111.25 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.37 11.34 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.584 0.707 . . . . 0.0 110.295 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.14 22.92 1.41 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.664 -0.647 . . . . 0.0 109.448 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.35 31.08 20.39 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.443 -1.361 . . . . 0.0 109.742 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.32 142.71 31.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.547 -0.973 . . . . 0.0 108.778 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.26 152.85 36.38 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.641 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.547 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.9 m-85 -153.9 140.22 18.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.57 177.43 0.1 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.477 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.56 -36.03 82.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.387 -0.82 . . . . 0.0 109.357 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.2 m -86.61 -43.86 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 111.289 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.64 84.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 108.218 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.86 -56.37 14.42 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.55 -44.74 89.83 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.2 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -54.49 -34.37 61.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.547 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.12 44.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.346 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.52 31.32 16.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.409 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.53 51.3 15.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.723 1 CA-C-O 70.819 -23.467 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.29 0.567 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.31 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.02 148.64 43.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.12 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.185 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.26 -54.35 2.0 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.444 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.34 74.0 1.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.514 ' N ' ' OG ' ' A' ' 65' ' ' SER . 10.1 t -69.51 158.13 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.9 m -145.33 131.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.487 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -99.87 129.31 45.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.4 m -63.51 154.36 32.69 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.456 1.122 . . . . 0.0 110.625 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.9 mt -114.31 -17.23 11.86 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.224 -1.398 . . . . 10.539999999999999 107.224 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' H ' HG22 ' A' ' 11' ' ' THR . 14.1 m-85 -149.56 145.03 18.45 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.21 -0.931 . . . . 18.390000000000001 110.798 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.41 1.67 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 121.425 1.417 . . . . 0.0 109.01 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.71 170.26 13.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.948 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.13 8.06 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.741 0.782 . . . . 0.0 109.452 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.38 112.08 10.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.33 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.888 1.327 . . . . 0.0 109.193 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.509 -1.293 . . . . 38.32 107.509 177.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 19' ' ' THR . 84.2 tt0 -82.49 -54.21 5.37 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.897 -1.52 . . . . 55.130000000000003 106.897 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.39 29.31 7.66 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.365 -0.834 . . . . 0.0 110.849 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.57 150.85 22.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.801 -1.187 . . . . 0.0 109.759 -179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -111.34 111.44 22.48 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.411 -0.806 . . . . 11.68 110.714 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.49 127.78 41.8 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.484 ' HE2' ' HG1' ' A' ' 11' ' ' THR . 0.8 OUTLIER -153.02 142.18 21.44 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.382 -1.449 . . . . 12.44 110.819 -178.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.24 155.77 22.32 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.28 146.96 17.83 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.282 -0.886 . . . . 29.030000000000001 109.521 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.48 44.11 6.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.35 -1.5 . . . . 6.1799999999999997 109.35 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.26 114.83 23.01 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.493 -1.004 . . . . 9.5199999999999996 109.451 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.09 108.63 6.09 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.49 133.64 49.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.179 1.466 . . . . 0.0 110.523 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 103.05 15.8 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.733 -1.576 . . . . 0.0 107.484 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.535 -0.728 . . . . 0.0 111.465 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.493 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.69 -50.46 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.986 -1.072 . . . . 0.0 110.273 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.56 43.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -134.93 65.52 65.88 Favored Pre-proline 0 N--CA 1.486 1.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.791 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.69 165.42 31.59 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.625 1.55 . . . . 0.0 109.008 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.53 7.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.7 m-20 57.69 -59.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.33 0.586 . . . . 0.0 110.017 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 178.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.2 Cg_endo -68.73 -59.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.756 2.304 . . . . 0.0 109.776 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 16.8 pt-20 131.78 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 123.79 0.836 . . . . 0.0 108.784 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.553 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.7 m0 -72.0 165.92 23.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.756 -1.215 . . . . 14.289999999999999 110.407 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.3 m0 -129.58 145.07 51.51 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 109.276 -0.639 . . . . 11.800000000000001 109.276 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -79.03 96.63 5.83 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.97 128.86 56.08 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.942 0.877 . . . . 0.0 110.441 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.62 150.4 26.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.76 ' N ' ' O ' ' A' ' 52' ' ' GLN . 14.9 p30 -96.4 128.52 43.4 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 117.284 -1.766 . . . . 0.0 107.221 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.46 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 119.668 -1.895 . . . . 0.0 108.031 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.57 -4.61 4.27 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.45 33.89 6.94 Favored Glycine 0 N--CA 1.481 1.691 0 CA-C-N 115.303 -0.862 . . . . 14.41 112.271 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.76 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.12 29.77 Favored 'General case' 0 N--CA 1.515 2.812 0 CA-C-N 119.736 1.768 . . . . 0.0 111.843 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.302 1.048 . . . . 0.0 112.468 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.44 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.22 156.73 12.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.306 -1.518 . . . . 7.25 109.306 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.41 150.85 43.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.271 -1.135 . . . . 0.0 108.685 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.74 9.03 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.765 -1.209 . . . . 0.0 109.354 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.32 113.5 1.15 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.032 -1.18 . . . . 4.7599999999999998 109.032 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.483 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.19 3.09 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.793 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.7 m-20 -102.03 -7.67 22.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.095 -1.003 . . . . 14.84 109.337 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -89.11 8.38 30.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.91 . . . . 10.23 109.455 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.48 156.53 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.101 -0.999 . . . . 6.9699999999999998 109.431 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 63' ' ' VAL . 8.4 p -106.79 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.505 ' N ' HG22 ' A' ' 62' ' ' VAL . 46.6 t -107.67 134.23 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.35 -0.844 . . . . 0.0 109.753 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.17 -63.12 1.26 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.567 -0.708 . . . . 0.0 109.184 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.6 p -70.0 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 50.6 p30 -146.58 152.66 39.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 109.42 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.316 1.344 . . . . 0.0 109.638 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.5 1.75 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.12 32.36 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.434 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.27 28.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.98 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.17 46.82 0.2 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.72 5.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.24 163.64 36.02 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.975 1.783 . . . . 0.0 108.842 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.566 HG23 ' C ' ' B' ' 84' ' ' ARG . 6.4 mt -135.38 119.7 26.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.967 0.889 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.32 116.86 3.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.871 0.843 . . . . 0.0 109.917 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.72 -0.19 4.79 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.62 -48.53 8.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.993 . . . . 0.0 109.443 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.8 13.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 109.147 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 53.47 41.27 32.13 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.566 ' C ' HG23 ' B' ' 78' ' ' ILE . 8.9 mtm105 -115.95 143.39 30.74 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.639 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.42 113.32 1.4 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.409 1.406 . . . . 0.0 110.699 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.668 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.86 158.47 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.56 61.54 0.32 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.858 -1.151 . . . . 0.0 110.593 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.658 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.7 120.69 42.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.668 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.83 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.686 0.755 . . . . 0.0 111.168 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.53 116.01 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.87 106.22 18.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.69 159.53 42.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.21 4.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.14 25.22 75.92 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.2 -154.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.728 0.775 . . . . 0.0 109.783 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.465 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.41 143.37 45.95 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.604 -1.31 . . . . 0.0 110.669 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.503 ' CE1' ' NH2' ' B' ' 84' ' ' ARG . 17.2 m80 -56.56 131.99 50.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG23 ' B' ' 91' ' ' VAL . 7.9 t -53.17 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 120.902 -1.124 . . . . 0.0 108.311 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.79 -27.02 15.43 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.848 -0.532 . . . . 0.0 110.62 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.04 -6.59 31.54 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.886 -1.134 . . . . 0.0 110.841 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.468 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.1 t80 -80.12 106.27 12.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.7 m -133.56 175.34 11.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.272 1.034 . . . . 0.0 111.081 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.68 46.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.312 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.5 1.77 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.7 -31.66 0.72 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.369 -0.832 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.17 -15.42 4.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.375 -0.828 . . . . 0.0 110.133 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.64 47.68 0.34 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.208 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.64 59.59 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.21 138.31 39.23 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.691 1.594 . . . . 0.0 112.126 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.294 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.87 56.95 1.77 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.21 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 108.997 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.97 2.74 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.967 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.25 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -1.011 . . . . 0.0 110.024 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.33 24.86 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.57 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.54 9.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.65 47.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.01 148.26 28.92 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.312 -0.867 . . . . 0.0 111.196 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.31 11.28 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.606 0.717 . . . . 0.0 110.413 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.3 22.84 1.49 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.579 -0.7 . . . . 0.0 109.482 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.47 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.6 mt -143.26 142.74 31.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.487 -1.007 . . . . 0.0 108.762 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.28 152.79 36.37 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.802 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.546 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.82 140.24 18.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.49 177.54 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.341 -1.343 . . . . 0.0 108.388 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.74 -35.99 82.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.382 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.4 m -86.67 -43.65 12.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 0.0 111.464 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.6 -43.76 83.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.797 -1.19 . . . . 0.0 108.255 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.521 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.54 13.17 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.4 m-80 -64.39 -44.98 89.63 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.39 61.25 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.546 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.62 -35.24 45.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.387 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 110.09 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.36 31.48 16.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.413 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.4 51.28 15.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -1.099 . . . . 0.0 109.644 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.708 1 CA-C-O 71.096 -23.335 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.37 74.88 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.6 p -161.93 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.238 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.0 148.67 43.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 t -66.14 93.38 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.02 . . . . 0.0 109.19 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.21 -54.28 2.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.445 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.3 73.97 1.38 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' N ' ' OG ' ' A' ' 65' ' ' SER . 3.7 t -69.39 158.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.46 131.51 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.462 -1.399 . . . . 0.0 111.447 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.0 129.25 46.04 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.2 m -63.45 154.4 32.32 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.505 1.145 . . . . 0.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 84.2 mt -114.39 -17.34 11.8 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.202 -1.407 . . . . 10.539999999999999 107.202 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.662 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.4 145.11 18.68 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.24 -0.913 . . . . 18.390000000000001 110.79 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.06 81.56 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 121.394 1.396 . . . . 0.0 109.022 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.86 170.39 13.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.853 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.85 0.833 . . . . 0.0 109.338 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.35 111.92 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 18' ' ' VAL . 14.3 m -130.35 94.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 122.93 1.348 . . . . 0.0 109.145 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.52 -152.05 0.4 Allowed 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.392 -1.276 . . . . 38.32 107.611 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.676 ' H ' HG22 ' A' ' 19' ' ' THR . 97.0 mt-10 -82.47 -54.35 5.26 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.813 -1.551 . . . . 55.130000000000003 106.813 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.3 29.19 7.77 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.388 -0.82 . . . . 0.0 110.727 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -100.5 150.85 22.24 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.963 -1.086 . . . . 0.0 109.697 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.37 111.55 22.68 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.384 -0.823 . . . . 11.68 110.698 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -95.59 127.75 41.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.02 142.18 21.43 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.433 -1.417 . . . . 12.44 110.801 -178.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.85 22.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 146.85 18.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.228 -0.92 . . . . 29.030000000000001 109.516 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.53 44.26 6.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.302 -1.519 . . . . 6.1799999999999997 109.302 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.71 22.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.476 -1.014 . . . . 9.5199999999999996 109.432 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.57 5.95 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.42 133.7 49.74 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 123.088 1.423 . . . . 0.0 110.574 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.83 103.15 15.89 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.374 -178.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.12 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.561 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.2 mt -59.79 -50.3 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.962 -1.086 . . . . 0.0 110.276 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.537 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.28 157.63 43.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.983 -1.073 . . . . 0.0 110.724 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HB3' ' NE1' ' A' ' 44' ' ' TRP . 1.9 mptp? -135.05 65.56 65.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.789 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.39 31.65 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.655 1.57 . . . . 0.0 109.004 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.09 -46.37 7.81 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.58 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 110.044 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.49 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.69 -59.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.107 0 C-N-CA 122.592 2.194 . . . . 0.0 109.922 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 54.2 tt0 131.7 9.38 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 123.882 0.873 . . . . 0.0 108.785 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.0 m0 -71.96 166.01 23.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.73 -1.231 . . . . 14.289999999999999 110.436 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.562 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.0 m0 -129.6 145.09 51.52 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.284 -0.635 . . . . 11.800000000000001 109.284 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.17 96.64 5.93 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.87 128.76 56.05 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.884 0.849 . . . . 0.0 110.45 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.69 150.36 26.81 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.762 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.35 128.5 43.33 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.297 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.41 0.99 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 119.632 -1.918 . . . . 0.0 107.991 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.465 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.64 -4.55 4.31 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.46 33.79 6.99 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 115.25 -0.886 . . . . 14.41 112.306 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.762 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.89 164.11 29.79 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.658 1.729 . . . . 0.0 111.847 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.55 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 122.294 1.045 . . . . 0.0 112.53 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.19 156.85 12.84 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.233 -1.547 . . . . 7.25 109.233 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.42 150.81 43.04 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -1.15 . . . . 0.0 108.644 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.71 9.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.89 -1.131 . . . . 0.0 109.299 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.18 113.57 1.17 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 108.971 -1.204 . . . . 4.7599999999999998 108.971 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HD2' ' CE2' ' A' ' 44' ' ' TRP . 15.9 pttt -60.41 3.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.479 -0.763 . . . . 0.0 110.679 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -102.16 -7.52 22.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.325 -0.86 . . . . 14.84 109.281 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.13 8.25 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.302 -0.874 . . . . 10.23 109.486 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.44 156.5 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.059 -1.026 . . . . 6.9699999999999998 109.522 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 63' ' ' VAL . 2.6 p -106.75 160.73 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' HG22 ' A' ' 62' ' ' VAL . 54.4 t -107.72 134.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.449 -0.782 . . . . 0.0 109.699 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.11 -63.21 1.25 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.264 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.7 p -70.01 151.67 45.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 109.415 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.521 ' OD1' ' O ' ' A' ' 65' ' ' SER . 90.2 m-20 -146.67 152.75 39.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.14 -67.44 1.47 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.41 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.364 1.376 . . . . 0.0 109.722 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.54 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.72 124.93 32.07 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.22 29.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -1.157 . . . . 0.0 109.431 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.84 167.85 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.3 -0.875 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.33 46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.74 5.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.306 -1.114 . . . . 0.0 109.312 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.19 163.69 35.97 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.932 1.754 . . . . 0.0 108.854 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 27.6 mt -135.46 119.77 26.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 122.05 0.929 . . . . 0.0 109.377 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.825 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.37 117.02 4.0 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.771 0.796 . . . . 0.0 109.995 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.06 4.9 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.825 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.72 -48.55 8.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.07 4.72 13.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.497 -0.752 . . . . 0.0 109.068 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.243 -0.911 . . . . 0.0 108.564 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -115.89 143.39 30.71 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.47 113.37 1.42 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.496 1.464 . . . . 0.0 110.604 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.663 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -71.03 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.49 61.44 0.32 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.898 -1.126 . . . . 0.0 110.733 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.81 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.682 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.69 120.56 41.94 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.663 HG22 HG21 ' B' ' 86' ' ' ILE . 42.4 t -98.69 158.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.444 -0.785 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.57 116.07 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.86 106.03 18.2 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.042 -1.036 . . . . 0.0 109.466 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.57 42.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.29 4.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.08 25.3 75.79 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.82 0.66 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.821 0.819 . . . . 0.0 109.657 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.485 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.39 143.6 46.12 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.67 139.93 33.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.55 -1.343 . . . . 0.0 110.661 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.45 131.94 49.89 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.19 -14.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 120.922 -1.112 . . . . 0.0 108.399 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.77 -26.95 15.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.728 -0.607 . . . . 0.0 110.635 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.24 -6.42 31.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.839 -1.163 . . . . 0.0 110.799 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.32 106.42 12.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.3 m -133.72 175.26 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.259 1.028 . . . . 0.0 111.066 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.8 148.59 46.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.419 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.64 28.54 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.738 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.74 -31.62 0.72 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.075 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.06 -15.41 4.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 110.186 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.68 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.277 -0.89 . . . . 0.0 110.256 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.59 59.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.12 138.3 39.51 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.655 1.57 . . . . 0.0 112.102 -177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.302 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.77 56.94 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.168 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.835 . . . . 0.0 109.023 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.15 31.13 2.73 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.921 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.35 178.95 4.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.587 -0.949 . . . . 0.0 109.901 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.43 145.3 24.87 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.558 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.28 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.694 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.49 137.69 47.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.96 148.27 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.253 -0.904 . . . . 0.0 111.189 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.0 129.45 11.38 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.692 0.758 . . . . 0.0 110.237 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 51.02 22.97 1.33 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.561 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.96 20.37 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.32 -1.419 . . . . 0.0 109.698 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.31 142.78 31.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.502 -0.999 . . . . 0.0 108.755 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.34 152.91 36.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.363 -0.836 . . . . 0.0 110.722 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.552 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.99 140.3 18.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.54 177.38 0.1 Allowed 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.344 -1.343 . . . . 0.0 108.415 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.6 -35.98 82.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 109.341 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.66 -43.76 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 111.327 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.74 83.85 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.79 -1.193 . . . . 0.0 108.143 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.52 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.46 13.7 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.424 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.55 -44.7 89.95 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.58 -34.45 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.552 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.59 -35.24 46.07 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.443 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.6 -81.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.47 31.34 16.48 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.406 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.54 51.33 15.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -1.133 . . . . 0.0 109.561 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.801 1 CA-C-O 70.798 -23.477 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.274 0.559 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.99 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.212 -1.17 . . . . 0.0 109.542 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.65 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -66.11 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 109.146 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.31 -54.26 2.0 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.446 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' N ' ' OG ' ' A' ' 65' ' ' SER . 5.2 t -69.41 158.07 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.9 m -145.32 131.53 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.447 -1.408 . . . . 0.0 111.603 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.91 129.22 45.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.9 m -63.45 154.4 32.33 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.501 1.143 . . . . 0.0 110.546 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 8.6 mp -114.41 -17.22 11.82 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.222 -1.399 . . . . 10.539999999999999 107.222 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.661 ' H ' HG22 ' A' ' 11' ' ' THR . 14.3 m-85 -149.57 145.08 18.54 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.07 -1.019 . . . . 18.390000000000001 110.794 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.06 81.4 1.69 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.479 1.452 . . . . 0.0 109.054 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.77 170.31 13.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.993 -1.067 . . . . 0.0 110.854 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.64 111.13 8.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.839 0.828 . . . . 0.0 109.369 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 112.0 10.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 18' ' ' VAL . 32.8 m -130.27 94.19 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 122.873 1.32 . . . . 0.0 109.238 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -144.43 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.385 -1.28 . . . . 38.32 107.634 177.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.566 ' H ' HG22 ' A' ' 19' ' ' THR . 83.8 tt0 -82.42 -54.33 5.29 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.824 -1.547 . . . . 55.130000000000003 106.824 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.1 mt-10 -109.38 29.3 7.68 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.364 -0.835 . . . . 0.0 110.728 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.47 150.79 22.28 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.966 -1.084 . . . . 0.0 109.776 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.25 111.38 22.4 Favored 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.385 -0.822 . . . . 11.68 110.796 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.38 127.63 41.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.93 142.24 21.58 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.385 -1.447 . . . . 12.44 110.839 -178.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.15 155.9 22.36 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 146.95 19.15 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.251 -0.906 . . . . 29.030000000000001 109.515 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.11 6.59 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.306 -1.517 . . . . 6.1799999999999997 109.306 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.68 22.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.47 -1.018 . . . . 9.5199999999999996 109.385 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.69 6.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.52 133.68 49.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 123.154 1.454 . . . . 0.0 110.504 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.75 103.12 15.86 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.372 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.11 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.534 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.474 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.72 -50.36 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.881 -1.137 . . . . 0.0 110.259 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.51 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.59 43.65 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.973 -1.079 . . . . 0.0 110.736 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.547 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.05 65.54 65.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.79 165.4 31.55 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.628 1.552 . . . . 0.0 108.973 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.52 7.76 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.73 -59.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.309 0.576 . . . . 0.0 110.041 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.78 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 122.621 2.214 . . . . 0.0 109.908 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 67.6 mt-10 131.75 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.853 0.861 . . . . 0.0 108.768 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.558 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.8 m0 -71.85 165.9 23.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.578 -1.326 . . . . 14.289999999999999 110.451 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.445 ' C ' HD13 ' A' ' 55' ' ' LEU . 24.9 m0 -129.57 145.03 51.51 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.237 -0.653 . . . . 11.800000000000001 109.237 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.99 96.62 5.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.84 56.1 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.928 0.871 . . . . 0.0 110.326 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.69 150.28 26.85 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.757 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.33 128.54 43.35 Favored 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 117.15 -1.82 . . . . 0.0 107.223 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.33 0.99 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 119.579 -1.951 . . . . 0.0 108.045 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.68 4.46 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.55 33.97 6.86 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 115.309 -0.859 . . . . 14.41 112.261 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.757 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -138.0 164.08 29.95 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 119.645 1.722 . . . . 0.0 111.803 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-O 122.381 1.086 . . . . 0.0 112.417 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.04 156.74 12.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.211 -1.556 . . . . 7.25 109.211 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.34 150.83 43.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.261 -1.141 . . . . 0.0 108.598 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.67 8.91 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.969 -1.082 . . . . 0.0 109.266 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.15 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 N-CA-C 109.09 -1.158 . . . . 4.7599999999999998 109.09 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.568 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.29 3.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.768 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' PRO . 47.2 p30 -102.1 -7.65 22.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.256 -0.902 . . . . 14.84 109.354 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.181 -0.949 . . . . 10.23 109.497 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.47 156.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.14 -0.975 . . . . 6.9699999999999998 109.456 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 63' ' ' VAL . 7.5 p -106.78 160.75 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.521 ' N ' HG22 ' A' ' 62' ' ' VAL . 46.5 t -107.67 134.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.49 -0.756 . . . . 0.0 109.765 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.12 -63.27 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.599 -0.688 . . . . 0.0 109.182 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.4 p -69.89 151.59 45.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.062 -1.024 . . . . 0.0 109.491 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -146.59 152.64 39.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.21 -67.36 1.47 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.33 93.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.393 1.395 . . . . 0.0 109.725 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.01 82.48 1.74 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.04 32.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.112 -0.993 . . . . 0.0 109.437 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.18 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -1.121 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.34 46.85 0.2 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.19 130.76 5.37 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.414 -1.051 . . . . 0.0 109.405 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.3 163.57 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.915 1.743 . . . . 0.0 108.881 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 29.9 mt -135.38 119.71 26.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-O 122.082 0.944 . . . . 0.0 109.394 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.32 117.0 3.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.885 0.85 . . . . 0.0 109.983 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.29 4.96 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.54 -48.52 8.3 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.302 -1.116 . . . . 0.0 109.503 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.1 4.79 13.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 53.59 41.22 32.13 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -115.9 143.34 30.61 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.642 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.44 113.48 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.436 1.424 . . . . 0.0 110.542 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.672 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.93 158.36 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.47 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.872 -1.142 . . . . 0.0 110.687 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -101.96 0.15 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.6 42.14 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.672 HG22 HG21 ' B' ' 86' ' ' ILE . 42.6 t -98.82 158.68 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.736 0.779 . . . . 0.0 111.144 -177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.52 115.99 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.86 106.05 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 109.558 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.53 42.62 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.627 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.22 17.06 4.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.33 75.79 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.29 -154.7 0.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.63 0.729 . . . . 0.0 109.813 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.44 143.47 45.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.9 m95 -141.65 140.03 33.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.53 -1.356 . . . . 0.0 110.584 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.48 132.01 50.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.7 t -53.37 -14.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.968 -1.082 . . . . 0.0 108.315 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.83 -26.9 15.46 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.776 -0.577 . . . . 0.0 110.616 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.24 -6.47 31.1 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.94 -1.1 . . . . 0.0 110.787 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.64 175.31 11.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.232 1.015 . . . . 0.0 111.072 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.76 46.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.329 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.96 28.67 1.77 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 109.65 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.417 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.6 0.72 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.354 -0.841 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.14 -15.52 4.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.57 0.32 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.205 -0.934 . . . . 0.0 110.088 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.52 109.65 59.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.19 138.25 39.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.716 1.611 . . . . 0.0 112.099 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.321 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.74 56.94 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.151 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 0.0 109.072 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.27 30.96 2.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.921 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.18 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.58 -0.953 . . . . 0.0 110.04 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.38 145.44 24.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.37 169.48 9.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.693 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.47 137.69 47.32 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.14 148.35 28.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.213 -0.929 . . . . 0.0 111.174 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.595 0.712 . . . . 0.0 110.306 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.22 22.95 1.47 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.648 -0.657 . . . . 0.0 109.435 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.627 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.47 30.95 20.41 Favored Glycine 0 N--CA 1.482 1.75 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.499 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.31 142.64 31.39 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.534 -0.98 . . . . 0.0 108.873 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.38 152.76 36.2 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.793 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.2 m-85 -153.8 140.31 18.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.63 177.44 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.414 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.59 -35.9 82.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.4 m -86.65 -43.86 12.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 111.301 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.74 83.73 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.834 -1.167 . . . . 0.0 108.1 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.78 -56.38 14.24 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.64 -44.79 89.34 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.078 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.44 -34.32 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.74 -35.35 44.86 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.279 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.48 -81.64 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.095 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.42 31.42 16.41 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.7 m-20 48.56 51.17 15.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -1.103 . . . . 0.0 109.613 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.977 -23.392 . . . . 0.0 109.455 179.964 . . . . . . . . 2 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.35 74.81 0.12 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.9 35.25 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.057 -1.26 . . . . 0.0 109.58 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.442 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.11 148.67 43.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.142 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -66.06 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.105 -0.997 . . . . 0.0 109.275 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.23 -54.37 2.0 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.441 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.8 m-70 -145.2 73.88 1.38 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.552 ' N ' ' OG ' ' A' ' 65' ' ' SER . 38.6 t -69.38 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.36 131.47 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.458 -1.401 . . . . 0.0 111.549 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -99.8 129.29 45.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 13' ' ' TYR . 35.5 m -63.44 154.45 32.16 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.483 1.135 . . . . 0.0 110.598 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 HG13 ' A' ' 62' ' ' VAL . 87.1 mt -114.37 -17.35 11.81 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.251 -1.388 . . . . 10.539999999999999 107.251 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.666 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.044 . . . . 18.390000000000001 110.783 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -73.06 81.55 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.438 1.425 . . . . 0.0 108.965 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.5 t80 -71.85 170.4 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.845 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.7 111.04 7.93 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.787 0.803 . . . . 0.0 109.472 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.32 111.93 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 18' ' ' VAL . 10.7 m -130.43 94.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 123.056 1.408 . . . . 0.0 109.147 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.38 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.272 -1.331 . . . . 38.32 107.569 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.693 ' H ' HG22 ' A' ' 19' ' ' THR . 97.3 mt-10 -82.39 -54.39 5.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.923 -1.51 . . . . 55.130000000000003 106.923 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.442 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.17 29.01 7.91 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.4 -0.812 . . . . 0.0 110.762 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.629 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -100.4 150.9 22.14 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.863 -1.148 . . . . 0.0 109.787 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.36 111.39 22.4 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.419 -0.801 . . . . 11.68 110.756 -178.385 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -95.4 127.68 41.63 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.27 21.67 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.4 -1.437 . . . . 12.44 110.943 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.82 22.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.87 18.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.242 -0.911 . . . . 29.030000000000001 109.617 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.63 44.09 6.61 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.317 -1.513 . . . . 6.1799999999999997 109.317 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.82 22.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.541 -0.976 . . . . 9.5199999999999996 109.396 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.06 108.64 6.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.79 49.68 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.192 1.472 . . . . 0.0 110.527 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.477 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.539 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.07 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -0.782 . . . . 0.0 111.53 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.497 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.76 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.968 -1.082 . . . . 0.0 110.267 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.63 43.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.933 -1.105 . . . . 0.0 110.844 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.539 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.03 65.5 65.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.836 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.4 31.51 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.578 1.518 . . . . 0.0 108.96 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.52 7.75 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.59 -59.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.391 0.615 . . . . 0.0 110.141 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.56 -59.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.583 2.188 . . . . 0.0 109.909 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 17.8 pt-20 131.83 9.27 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.892 0.877 . . . . 0.0 108.786 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.571 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.1 m0 -71.77 165.92 23.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.669 -1.27 . . . . 14.289999999999999 110.48 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.486 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.4 m0 -129.63 144.99 51.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.243 -0.651 . . . . 11.800000000000001 109.243 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -78.93 96.58 5.75 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.498 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.914 0.864 . . . . 0.0 110.373 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.72 150.37 26.75 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.759 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.2 p30 -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.261 -1.776 . . . . 0.0 107.163 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.37 1.0 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.675 -1.89 . . . . 0.0 108.011 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.68 -4.59 4.38 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.42 33.88 6.95 Favored Glycine 0 N--CA 1.48 1.627 0 CA-C-N 115.386 -0.825 . . . . 14.41 112.297 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.759 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.14 29.7 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.633 1.717 . . . . 0.0 111.849 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.59 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-O 122.362 1.077 . . . . 0.0 112.434 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.2 156.75 12.73 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.338 -1.505 . . . . 7.25 109.338 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.23 150.89 43.27 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.296 -1.12 . . . . 0.0 108.681 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.71 8.95 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.84 -1.162 . . . . 0.0 109.342 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.22 113.6 1.18 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.074 -1.164 . . . . 4.7599999999999998 109.074 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.5 pttt -60.37 3.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.487 -0.758 . . . . 0.0 110.603 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.7 m-20 -102.05 -7.66 22.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.144 -0.973 . . . . 14.84 109.323 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.22 30.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 10.23 109.494 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.38 156.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 6.9699999999999998 109.589 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 12' ' ' LEU . 29.0 m -106.77 160.69 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.2 t -107.59 134.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.411 -0.806 . . . . 0.0 109.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.19 -63.28 1.25 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 13.8 p -69.91 151.61 45.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.983 -1.073 . . . . 0.0 109.418 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -146.59 152.68 39.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.23 1.48 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.254 1.302 . . . . 0.0 109.732 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.7 1.79 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.9 125.09 32.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.86 156.21 28.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -1.181 . . . . 0.0 109.507 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.73 167.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.93 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.75 5.33 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.383 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.522 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.8 35.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.816 1.677 . . . . 0.0 108.828 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.559 HG23 ' C ' ' B' ' 84' ' ' ARG . 61.3 mt -135.52 119.75 26.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 122.072 0.939 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.29 116.94 3.92 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.819 0.818 . . . . 0.0 109.96 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.3 4.96 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.53 -48.62 8.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -1.057 . . . . 0.0 109.455 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.86 13.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.559 ' C ' HG23 ' B' ' 78' ' ' ILE . 29.1 mtp180 -115.91 143.49 30.91 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.511 1.474 . . . . 0.0 110.494 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.655 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.96 158.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.424 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.52 61.48 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 110.615 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.0 -101.93 0.15 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.663 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.62 42.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 86' ' ' ILE . 42.5 t -98.77 158.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.419 -0.801 . . . . 0.0 111.195 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.47 ' N ' HG12 ' B' ' 90' ' ' VAL . 5.0 t -122.55 116.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.033 -1.042 . . . . 0.0 109.622 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.51 42.68 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.637 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.15 4.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.38 25.11 76.16 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.16 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.788 0.804 . . . . 0.0 109.726 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.476 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.35 143.49 46.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.64 139.99 33.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.416 -1.428 . . . . 0.0 110.646 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.465 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.58 131.94 50.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG23 ' B' ' 91' ' ' VAL . 7.8 t -53.16 -14.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.909 -1.119 . . . . 0.0 108.348 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.465 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.83 -26.97 15.44 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 110.638 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.06 -6.6 31.46 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.93 -1.107 . . . . 0.0 110.787 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.24 106.34 12.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.3 m -133.64 175.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.267 1.032 . . . . 0.0 111.088 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.85 148.66 46.45 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.354 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.87 28.77 1.72 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.676 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.413 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.82 -31.62 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.309 -0.87 . . . . 0.0 110.086 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.24 -15.25 4.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.54 47.6 0.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.232 -0.918 . . . . 0.0 110.24 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.59 59.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.12 138.26 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.79 1.66 . . . . 0.0 112.006 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.325 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.038 0.0 OUTLIER -95.77 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.075 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.04 -55.24 1.61 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.001 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.98 2.75 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.947 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.36 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.416 -1.05 . . . . 0.0 109.958 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.53 145.41 24.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.797 . . . . 0.0 109.295 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.39 169.55 9.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.472 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.54 137.66 47.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.96 148.3 28.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.203 -0.936 . . . . 0.0 111.18 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.469 -0.77 . . . . 0.0 110.327 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.31 22.8 1.49 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.637 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 31.02 20.41 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.79 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.37 142.8 31.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.61 -0.936 . . . . 0.0 108.799 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.43 152.82 36.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.331 -0.855 . . . . 0.0 110.673 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.5 m-85 -153.84 140.36 18.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.3 m -57.72 177.55 0.1 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.441 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.67 -35.92 82.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.853 . . . . 0.0 109.436 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.445 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.1 m -86.61 -43.81 12.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 111.349 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.73 83.79 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.738 -1.226 . . . . 0.0 108.177 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.5 13.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.419 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.42 -44.92 89.72 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.184 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.43 -34.36 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.63 -35.35 45.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.384 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.7 m-85 -158.51 -81.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.054 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.46 31.44 16.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.39 51.37 15.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.327 -1.102 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.698 1 CA-C-O 70.992 -23.385 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.309 0.576 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.98 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.91 35.2 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -1.208 . . . . 0.0 109.666 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.62 43.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.296 -0.878 . . . . 0.0 109.139 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.5 t -65.92 93.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -121.26 -54.32 2.0 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.31 73.88 1.37 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 8' ' ' VAL . 3.4 t -69.41 158.13 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 31' ' ' MET . 4.8 m -145.44 131.6 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.48 -1.387 . . . . 0.0 111.513 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -100.03 129.16 46.06 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 13' ' ' TYR . 34.3 m -63.3 154.39 31.84 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.497 1.141 . . . . 0.0 110.617 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 93.1 mt -114.37 -17.28 11.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.211 -1.403 . . . . 10.539999999999999 107.211 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.671 ' H ' HG22 ' A' ' 11' ' ' THR . 14.3 m-85 -149.49 145.06 18.54 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 121.133 -0.979 . . . . 18.390000000000001 110.794 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -72.87 81.4 1.64 Allowed 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.468 1.445 . . . . 0.0 109.07 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.76 170.33 13.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.923 -1.111 . . . . 0.0 110.91 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.07 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.776 0.798 . . . . 0.0 109.431 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.31 111.96 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 18' ' ' VAL . 19.7 m -130.29 94.25 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 122.9 1.333 . . . . 0.0 109.134 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.817 HG22 ' H ' ' A' ' 20' ' ' GLU . 2.6 m -144.46 -151.98 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.362 -1.29 . . . . 38.32 107.581 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.817 ' H ' HG22 ' A' ' 19' ' ' THR . 76.7 mm-40 -82.5 -54.29 5.3 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.903 -1.518 . . . . 55.130000000000003 106.903 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.5 mt-10 -109.3 29.2 7.76 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.53 150.93 22.17 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.907 -1.12 . . . . 0.0 109.741 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.38 22.39 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.342 -0.849 . . . . 11.68 110.82 -178.419 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.36 127.7 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.03 142.22 21.47 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.327 -1.483 . . . . 12.44 110.851 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.87 22.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 146.93 18.91 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.255 -0.903 . . . . 29.030000000000001 109.492 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.14 6.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.273 -1.531 . . . . 6.1799999999999997 109.273 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.29 114.79 22.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.652 -0.911 . . . . 9.5199999999999996 109.436 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.459 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.99 108.57 5.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.489 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.51 133.65 49.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 123.21 1.481 . . . . 0.0 110.549 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.6 102.95 15.69 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.48 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 111.49 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.48 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.85 -50.39 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 120.917 -1.114 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.16 157.62 43.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.99 -1.069 . . . . 0.0 110.831 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.04 65.52 65.35 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.28 31.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.721 1.614 . . . . 0.0 109.027 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.49 7.77 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.67 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.353 0.597 . . . . 0.0 110.037 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.89 -47.54 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.608 2.205 . . . . 0.0 109.996 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.9 pt-20 131.67 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 123.878 0.871 . . . . 0.0 108.806 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.582 ' HB2' HD12 ' A' ' 55' ' ' LEU . 11.7 m0 -71.79 165.91 23.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.712 -1.242 . . . . 14.289999999999999 110.527 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.1 m0 -129.46 145.12 51.47 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.633 -0.667 . . . . 11.800000000000001 109.302 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.17 96.61 5.92 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -115.92 128.81 56.06 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.966 0.888 . . . . 0.0 110.347 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.63 150.48 26.8 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.765 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.46 128.57 43.51 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 117.275 -1.77 . . . . 0.0 107.216 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.44 1.02 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.611 -1.931 . . . . 0.0 107.972 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.58 -4.77 4.43 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.5 34.04 6.85 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.438 -0.801 . . . . 14.41 112.215 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.765 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.96 164.11 29.84 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.628 1.714 . . . . 0.0 111.765 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.55 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.305 1.05 . . . . 0.0 112.507 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.14 156.69 12.61 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.324 -1.511 . . . . 7.25 109.324 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.76 43.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.171 -1.194 . . . . 0.0 108.674 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.98 136.75 9.04 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.954 -1.092 . . . . 0.0 109.289 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.12 113.46 1.11 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 N-CA-C 109.052 -1.172 . . . . 4.7599999999999998 109.052 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.4 pttt -60.36 3.23 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.443 -0.786 . . . . 0.0 110.71 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.4 m-20 -102.17 -7.48 22.17 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.3 -0.875 . . . . 14.84 109.326 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.05 8.16 31.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.089 -1.007 . . . . 10.23 109.343 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.45 156.62 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.219 -0.926 . . . . 6.9699999999999998 109.561 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 63' ' ' VAL . 7.5 p -106.84 160.86 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.506 ' N ' HG22 ' A' ' 62' ' ' VAL . 5.5 p -107.72 134.31 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 64' ' ' LEU . 11.2 mp -105.2 -63.14 1.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.566 -0.709 . . . . 0.0 109.202 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 31.8 m -70.15 151.69 45.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.99 -1.069 . . . . 0.0 109.417 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -146.58 152.67 39.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.32 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.31 1.34 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.58 1.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.79 124.96 32.16 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.94 156.19 28.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -1.134 . . . . 0.0 109.41 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.83 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.28 46.88 0.2 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.27 130.76 5.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.0 109.463 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.15 163.65 36.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.024 1.816 . . . . 0.0 108.811 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.474 HG23 ' C ' ' B' ' 84' ' ' ARG . 74.8 mt -135.47 119.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.073 0.939 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.48 117.05 4.07 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.833 0.825 . . . . 0.0 109.962 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.13 4.97 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.64 -48.6 8.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.372 -1.075 . . . . 0.0 109.422 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.12 4.83 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 53.55 41.26 32.12 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.474 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.0 mmm180 -115.98 143.55 31.08 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.45 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.417 1.411 . . . . 0.0 110.611 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.658 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.89 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.422 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.6 61.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.877 -1.139 . . . . 0.0 110.667 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.08 0.15 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.68 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.71 42.51 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.658 HG22 HG21 ' B' ' 86' ' ' ILE . 43.2 t -98.82 158.72 3.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 111.155 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.6 116.16 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.89 106.15 18.28 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 109.534 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.53 159.5 42.67 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.23 4.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.22 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.851 -0.793 . . . . 0.0 109.856 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.48 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.48 143.54 45.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.5 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.526 -1.359 . . . . 0.0 110.646 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.455 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.61 132.12 50.82 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.6 t -53.36 -14.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.927 -1.108 . . . . 0.0 108.408 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.455 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.68 -27.18 15.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.778 -0.576 . . . . 0.0 110.589 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -97.94 -6.63 31.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.901 -1.124 . . . . 0.0 110.899 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.15 106.29 12.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.821 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.0 m -133.56 175.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.358 1.075 . . . . 0.0 111.073 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.95 148.7 46.72 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.2 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.65 1.74 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.837 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.43 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.47 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.321 -0.862 . . . . 0.0 110.196 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.23 -15.29 4.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.296 -0.878 . . . . 0.0 110.076 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.61 47.57 0.35 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.794 . . . . 0.0 110.267 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.5 59.05 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.821 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.07 138.23 39.5 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.73 1.62 . . . . 0.0 112.179 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.314 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.8 57.04 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.196 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.629 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.12 -55.29 1.64 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 108.997 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.07 31.0 2.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.922 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.31 178.98 4.13 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.611 -0.935 . . . . 0.0 109.94 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.37 145.3 24.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.564 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.25 169.57 9.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.694 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.5 m-85 -132.57 137.65 47.17 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.32 28.85 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.14 -0.975 . . . . 0.0 111.204 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.24 11.2 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.615 0.722 . . . . 0.0 110.324 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.36 22.74 1.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.96 20.32 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.741 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.7 mt -143.25 142.63 31.44 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.608 -0.937 . . . . 0.0 108.873 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.16 152.8 36.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -153.87 140.34 18.76 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.6 m -57.74 177.44 0.11 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.299 -1.361 . . . . 0.0 108.401 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.58 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.58 -35.94 82.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.417 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.71 -43.66 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 111.311 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.466 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.83 -43.55 83.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.817 -1.177 . . . . 0.0 108.206 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.82 -56.37 14.37 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.7 m-80 -64.6 -44.91 89.13 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.009 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.45 -34.35 61.32 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.63 -35.34 45.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.381 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.58 -81.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 110.096 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.4 31.34 16.69 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.48 51.24 15.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -1.084 . . . . 0.0 109.576 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.981 -23.39 . . . . 0.0 109.454 179.915 . . . . . . . . 2 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.84 0.12 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.95 35.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -1.172 . . . . 0.0 109.624 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -72.99 148.6 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.167 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -65.96 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.288 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.41 1.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.23 73.94 1.38 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.46 158.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 31' ' ' MET . 3.9 m -145.34 131.45 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.416 -1.427 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.92 129.22 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.8 m -63.41 154.43 32.1 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.487 1.136 . . . . 0.0 110.572 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.534 HD11 HG23 ' A' ' 62' ' ' VAL . 90.5 mt -114.31 -17.36 11.84 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.274 -1.38 . . . . 10.539999999999999 107.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.678 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.51 144.96 18.39 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.16 -0.963 . . . . 18.390000000000001 110.803 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.97 81.54 1.65 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.392 1.395 . . . . 0.0 109.024 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.92 170.32 13.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.978 -1.077 . . . . 0.0 110.86 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.63 111.08 7.99 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.831 0.824 . . . . 0.0 109.47 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 111.86 10.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.2 t -130.23 94.35 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.938 1.352 . . . . 0.0 109.2 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.949 HG22 ' H ' ' A' ' 20' ' ' GLU . 4.9 m -144.49 -151.97 0.39 Allowed 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.335 -1.302 . . . . 38.32 107.557 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.949 ' H ' HG22 ' A' ' 19' ' ' THR . 45.6 tp10 -82.41 -54.36 5.27 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.885 -1.524 . . . . 55.130000000000003 106.885 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.8 mt-10 -109.38 29.23 7.74 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.447 -0.783 . . . . 0.0 110.712 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.643 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -100.49 150.98 22.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.811 -1.181 . . . . 0.0 109.727 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.443 -0.786 . . . . 11.68 110.765 -178.403 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.53 127.69 41.77 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.83 142.25 21.68 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.352 -1.467 . . . . 12.44 110.876 -178.394 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.76 22.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 146.91 18.73 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.227 -0.921 . . . . 29.030000000000001 109.452 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.17 6.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.326 -1.51 . . . . 6.1799999999999997 109.326 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.67 22.72 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.487 -1.008 . . . . 9.5199999999999996 109.416 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.97 108.69 6.02 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.452 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.59 133.63 50.01 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.201 1.477 . . . . 0.0 110.532 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.71 103.05 15.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.466 -178.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.0 92.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.573 -0.705 . . . . 0.0 111.496 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.4 mt -59.65 -50.52 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.94 -1.1 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.478 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.12 157.67 43.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.991 -1.068 . . . . 0.0 110.788 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.547 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.07 65.6 65.35 Favored Pre-proline 0 N--CA 1.486 1.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.761 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.74 165.34 31.71 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.715 1.61 . . . . 0.0 108.947 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.16 -46.3 7.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.5 m-20 57.62 -59.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.442 0.639 . . . . 0.0 110.054 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.71 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.61 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.128 0 C-N-CA 122.597 2.198 . . . . 0.0 109.968 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.86 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.51 ' HB2' HD12 ' A' ' 55' ' ' LEU . 22.1 m0 -71.81 165.87 23.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.626 -1.296 . . . . 14.289999999999999 110.519 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.487 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.8 m0 -129.55 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.286 -0.635 . . . . 11.800000000000001 109.286 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.15 96.66 5.92 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -116.0 128.8 56.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.954 0.883 . . . . 0.0 110.378 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.6 150.44 26.86 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.766 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.1 p30 -96.45 128.58 43.52 Favored 'General case' 0 N--CA 1.509 2.487 0 C-N-CA 117.266 -1.773 . . . . 0.0 107.215 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.5 -18.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.734 -1.854 . . . . 0.0 107.913 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.55 4.33 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.35 33.96 6.94 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 115.257 -0.883 . . . . 14.41 112.286 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.766 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.07 29.86 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.745 1.772 . . . . 0.0 111.829 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.97 154.58 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 122.335 1.064 . . . . 0.0 112.52 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.84 12.85 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.236 -1.546 . . . . 7.25 109.236 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.51 150.97 42.76 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.296 -1.12 . . . . 0.0 108.613 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.12 136.67 8.91 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.82 -1.175 . . . . 0.0 109.265 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.04 113.46 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 108.992 -1.195 . . . . 4.7599999999999998 108.992 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 62.7 pttt -60.33 3.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 110.66 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.3 m-20 -102.01 -7.66 22.15 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.275 -0.891 . . . . 14.84 109.334 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.96 8.11 31.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.239 -0.913 . . . . 10.23 109.56 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 11' ' ' THR . 32.0 m -147.32 156.57 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 6.9699999999999998 109.542 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.534 HG23 HD11 ' A' ' 12' ' ' LEU . 15.0 t -106.86 160.69 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 10.4 p -107.57 134.34 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.392 -0.818 . . . . 0.0 109.814 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.19 -63.15 1.26 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 33.9 m -70.05 151.68 45.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.956 -1.09 . . . . 0.0 109.503 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -146.75 152.69 39.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.27 1.48 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.52 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.209 1.273 . . . . 0.0 109.637 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.53 1.75 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.05 32.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 156.27 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 109.532 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.92 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.27 46.92 0.2 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.73 5.32 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.283 -1.128 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.519 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.58 36.1 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.872 1.714 . . . . 0.0 108.848 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 62' ' ' VAL . 72.7 mt -135.33 119.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 122.001 0.905 . . . . 0.0 109.379 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.83 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.24 116.88 3.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.75 -0.1 4.73 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.83 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.78 -48.41 8.25 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.361 -1.082 . . . . 0.0 109.397 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.19 4.89 13.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.521 -0.737 . . . . 0.0 109.07 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.487 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.6 mtp-105 -115.94 143.32 30.61 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.8 Cg_exo -56.33 113.25 1.36 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.49 1.46 . . . . 0.0 110.636 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.668 HG21 HG22 ' B' ' 90' ' ' VAL . 21.7 mt -70.9 158.53 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.642 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.425 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.6 61.44 0.32 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.873 -1.142 . . . . 0.0 110.615 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.96 -101.96 0.15 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.677 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.74 120.61 42.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.668 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.67 158.75 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.698 0.761 . . . . 0.0 111.186 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.59 115.92 47.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.81 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.48 42.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.32 4.35 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.3 75.82 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.8 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.747 0.784 . . . . 0.0 109.684 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.48 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.8 mt-30 -135.41 143.4 45.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.46 140.06 33.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.606 -1.309 . . . . 0.0 110.651 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.469 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.5 131.93 50.0 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.9 t -53.17 -14.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.988 -1.07 . . . . 0.0 108.465 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.469 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.8 -26.87 15.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.762 -0.586 . . . . 0.0 110.608 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.14 -6.51 31.37 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.909 -1.119 . . . . 0.0 110.804 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.27 106.31 12.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.58 175.39 11.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.153 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.83 148.69 46.3 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.375 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.74 1.73 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.83 -31.74 0.71 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 110.135 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.08 -15.32 4.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.104 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.63 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.69 59.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.14 138.35 39.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.636 1.558 . . . . 0.0 112.144 -177.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.81 56.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.172 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.621 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.98 -55.35 1.57 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.04 2.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.934 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.21 178.96 4.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.429 -1.042 . . . . 0.0 109.977 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.51 145.28 24.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.683 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.5 137.72 47.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.06 148.34 28.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.353 -0.842 . . . . 0.0 111.266 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.95 129.31 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.724 . . . . 0.0 110.424 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.97 1.43 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 30.94 20.63 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.77 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.9 mt -143.27 142.66 31.43 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.968 . . . . 0.0 108.853 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.93 36.27 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.735 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.555 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.99 140.28 18.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.1 m -57.54 177.46 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.404 -1.318 . . . . 0.0 108.508 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.64 -35.99 82.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 56.5 m -86.54 -43.79 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 111.426 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.85 83.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.812 -1.18 . . . . 0.0 108.155 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.75 -56.49 13.49 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.2 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.153 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -54.55 -34.29 61.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.71 -35.24 45.19 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.357 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.52 -81.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.45 31.37 16.45 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.57 51.2 15.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -1.09 . . . . 0.0 109.561 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.476 -39.647 1 CA-C-O 70.829 -23.462 . . . . 0.0 109.479 -179.975 . . . . . . . . 2 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.03 35.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -1.102 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.8 ttm-85 -73.01 148.62 44.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.127 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.05 93.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.3 mt -121.19 -54.27 2.01 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.32 74.04 1.38 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.55 157.97 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.2 131.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.365 -1.459 . . . . 0.0 111.553 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -99.9 129.27 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 13' ' ' TYR . 28.3 m -63.47 154.35 32.57 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.499 1.142 . . . . 0.0 110.544 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 91.7 mt -114.3 -17.29 11.86 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.221 -1.4 . . . . 10.539999999999999 107.221 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.669 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.48 145.07 18.56 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.154 -0.966 . . . . 18.390000000000001 110.768 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.98 81.51 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.345 1.363 . . . . 0.0 109.059 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.4 t80 -71.88 170.3 13.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.912 -1.117 . . . . 0.0 110.821 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.58 111.16 8.07 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.809 0.814 . . . . 0.0 109.389 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.27 111.89 10.61 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 18' ' ' VAL . 23.2 m -130.37 94.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.904 1.335 . . . . 0.0 109.197 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -144.46 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.383 -1.28 . . . . 38.32 107.63 177.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.565 ' H ' HG22 ' A' ' 19' ' ' THR . 97.3 mt-10 -82.41 -54.31 5.31 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.936 -1.505 . . . . 55.130000000000003 106.936 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.6 mt-10 -109.25 29.21 7.74 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.47 -0.769 . . . . 0.0 110.827 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.616 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.61 150.92 22.21 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.861 -1.149 . . . . 0.0 109.682 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -111.31 111.43 22.49 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.39 -0.819 . . . . 11.68 110.71 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.45 127.68 41.69 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.92 142.27 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.436 -1.415 . . . . 12.44 110.798 -178.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.32 155.87 22.17 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.94 18.43 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.266 -0.896 . . . . 29.030000000000001 109.506 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 44.09 6.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.286 -1.526 . . . . 6.1799999999999997 109.286 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.87 23.01 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.534 -0.98 . . . . 9.5199999999999996 109.358 -179.594 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.22 108.74 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.56 133.75 49.81 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 123.228 1.49 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.86 103.11 15.86 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 113.745 -1.571 . . . . 0.0 107.351 -178.591 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.495 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.467 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.9 -50.43 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.145 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.17 157.6 43.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.026 -1.046 . . . . 0.0 110.786 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.552 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.01 65.57 65.7 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.767 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.43 31.56 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.567 1.512 . . . . 0.0 109.145 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.11 -46.42 7.78 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.63 -59.43 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.421 0.629 . . . . 0.0 110.071 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.624 2.216 . . . . 0.0 109.899 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 75.2 mt-10 131.86 9.31 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.559 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.8 m0 -71.85 165.91 23.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.619 -1.301 . . . . 14.289999999999999 110.385 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.544 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.1 m0 -129.64 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.287 -0.635 . . . . 11.800000000000001 109.287 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.99 96.58 5.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.69 55.98 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.91 0.862 . . . . 0.0 110.488 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.5 150.31 27.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.755 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.1 p30 -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 117.226 -1.789 . . . . 0.0 107.289 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.46 1.01 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.652 -1.905 . . . . 0.0 108.013 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.61 -4.55 4.26 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.42 33.95 6.92 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-N 115.355 -0.839 . . . . 14.41 112.253 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.755 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.06 29.96 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-N 119.71 1.755 . . . . 0.0 111.859 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.83 154.56 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.231 1.015 . . . . 0.0 112.601 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.17 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.24 -1.544 . . . . 7.25 109.24 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.87 43.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -1.182 . . . . 0.0 108.605 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.06 136.83 9.06 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.075 -1.016 . . . . 0.0 109.225 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.23 113.51 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 108.935 -1.217 . . . . 4.7599999999999998 108.935 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 25.6 pttm -60.23 2.95 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.453 -0.78 . . . . 0.0 110.798 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.6 m-20 -101.96 -7.56 22.29 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 14.84 109.297 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.11 8.34 30.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.289 -0.882 . . . . 10.23 109.481 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.1 m -147.51 156.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.239 -0.913 . . . . 6.9699999999999998 109.389 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.512 HG22 ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.82 160.78 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.512 ' N ' HG22 ' A' ' 62' ' ' VAL . 73.1 t -107.62 134.22 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.435 -0.791 . . . . 0.0 109.834 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.436 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 97.9 mt -105.14 -63.08 1.26 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.636 -0.665 . . . . 0.0 109.207 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.491 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 19.4 m -70.11 151.55 45.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 65' ' ' SER . 85.6 m-20 -146.43 152.8 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.34 1.47 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.4 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.298 1.332 . . . . 0.0 109.669 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.6 1.77 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.83 124.93 32.15 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.121 -0.987 . . . . 0.0 109.395 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.19 28.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -1.137 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.78 167.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.444 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.39 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.84 5.37 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.346 -1.091 . . . . 0.0 109.291 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.34 163.65 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.941 1.761 . . . . 0.0 108.875 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.556 HG23 ' C ' ' B' ' 84' ' ' ARG . 61.7 mt -135.42 119.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 122.054 0.93 . . . . 0.0 109.313 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.33 116.94 3.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 110.045 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.85 -0.16 4.91 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.55 -48.72 8.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -1.121 . . . . 0.0 109.33 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.01 4.81 13.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 53.62 41.25 32.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.556 ' C ' HG23 ' B' ' 78' ' ' ILE . 5.3 mmm180 -115.95 143.46 30.89 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.416 1.411 . . . . 0.0 110.566 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.667 HG21 HG22 ' B' ' 90' ' ' VAL . 21.3 mt -70.87 158.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.58 61.57 0.32 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.885 -1.134 . . . . 0.0 110.648 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.16 -101.91 0.15 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.66 120.75 42.61 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.667 HG22 HG21 ' B' ' 86' ' ' ILE . 42.7 t -98.89 158.61 3.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.524 -0.735 . . . . 0.0 111.205 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.475 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.6 115.97 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.7 106.01 18.18 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.687 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.61 42.46 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.92 17.28 4.2 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.24 25.17 76.01 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.14 -154.75 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.776 0.798 . . . . 0.0 109.758 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.482 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.39 143.52 46.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.53 140.01 33.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.462 -1.399 . . . . 0.0 110.644 -177.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.51 131.89 49.9 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.457 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.16 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 120.866 -1.146 . . . . 0.0 108.343 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.11 15.41 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.848 -0.533 . . . . 0.0 110.61 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.13 -6.43 31.56 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 110.746 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.475 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.12 106.24 12.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.821 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.2 m -133.57 175.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 122.219 1.009 . . . . 0.0 111.143 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.71 46.18 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.222 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.7 1.74 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.072 -1.018 . . . . 0.0 109.596 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.8 0.71 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.407 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.36 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.407 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.59 47.75 0.34 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.314 -0.866 . . . . 0.0 110.131 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.57 109.62 59.67 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.821 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.08 138.32 39.67 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.656 1.57 . . . . 0.0 112.059 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.305 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.78 56.87 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.131 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.15 1.69 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.1 30.96 2.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.907 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.35 178.87 4.17 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.411 -1.052 . . . . 0.0 109.953 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.35 145.39 24.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.365 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.42 169.39 9.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 109.504 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.693 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.67 47.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.05 148.29 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.256 -0.902 . . . . 0.0 111.22 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.93 129.41 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.09 22.93 1.37 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.491 -0.756 . . . . 0.0 109.531 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.99 20.26 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.4 mt -143.33 142.74 31.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.577 -0.955 . . . . 0.0 108.738 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.81 36.26 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.903 . . . . 0.0 110.721 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.7 m-85 -153.9 140.23 18.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.49 177.48 0.1 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.339 -1.344 . . . . 0.0 108.49 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.65 -36.06 82.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 109.301 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.5 m -86.65 -43.73 12.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.843 . . . . 0.0 111.325 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.72 83.67 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.698 -1.251 . . . . 0.0 108.187 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.7 -56.56 13.03 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.413 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.51 -44.75 89.93 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.139 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.42 61.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.65 -35.22 45.7 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.39 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.62 -81.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.838 . . . . 0.0 110.075 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.33 31.47 16.49 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.422 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.42 51.3 15.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.245 -1.15 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.749 1 CA-C-O 71.145 -23.312 . . . . 0.0 109.454 179.98 . . . . . . . . 2 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.96 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -162.0 35.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.082 -1.246 . . . . 0.0 109.606 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -72.95 148.59 44.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.129 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.0 93.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.277 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 mt -121.37 -54.25 1.99 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.438 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.34 74.1 1.38 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.502 ' N ' ' OG ' ' A' ' 65' ' ' SER . 82.1 t -69.56 158.12 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.39 131.53 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.401 -1.437 . . . . 0.0 111.538 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -99.92 129.23 45.98 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.665 HG22 ' H ' ' A' ' 13' ' ' TYR . 44.1 m -63.45 154.29 32.69 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.513 1.149 . . . . 0.0 110.614 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.3 mt -114.29 -17.3 11.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.155 -1.424 . . . . 10.539999999999999 107.155 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.665 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.56 145.04 18.48 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.19 -0.944 . . . . 18.390000000000001 110.798 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -73.02 81.47 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.506 1.471 . . . . 0.0 109.036 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.2 t80 -71.78 170.31 13.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.125 . . . . 0.0 110.944 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.0 7.92 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.738 0.78 . . . . 0.0 109.459 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.0 10.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 18' ' ' VAL . 7.5 m -130.33 94.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-O 122.907 1.337 . . . . 0.0 109.26 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.6 m -144.36 -151.93 0.39 Allowed 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.301 -1.318 . . . . 38.32 107.701 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.705 ' H ' HG22 ' A' ' 19' ' ' THR . 96.2 mt-10 -82.51 -54.42 5.2 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.84 -1.541 . . . . 55.130000000000003 106.84 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.46 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.4 mt-10 -109.3 29.28 7.69 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.357 -0.839 . . . . 0.0 110.759 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.43 150.89 22.16 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.812 -1.18 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.451 -0.78 . . . . 11.68 110.756 -178.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -95.39 127.72 41.67 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.99 142.16 21.44 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.386 -1.446 . . . . 12.44 110.905 -178.46 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.78 22.52 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 146.98 18.09 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.389 -0.924 . . . . 29.030000000000001 109.603 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.56 44.18 6.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.248 -1.541 . . . . 6.1799999999999997 109.248 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.82 22.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.545 -0.973 . . . . 9.5199999999999996 109.452 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.13 108.66 6.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.46 133.81 49.6 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 123.104 1.431 . . . . 0.0 110.588 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.09 15.84 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.304 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.518 -0.739 . . . . 0.0 111.504 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.486 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 83.1 mt -59.68 -50.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.979 -1.076 . . . . 0.0 110.259 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.55 43.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.03 -1.044 . . . . 0.0 110.844 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.03 65.72 65.91 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.86 165.36 31.58 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.665 1.577 . . . . 0.0 109.003 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.58 -59.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.349 0.595 . . . . 0.0 110.119 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.69 -47.41 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 178.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.68 -59.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 122.562 2.174 . . . . 0.0 110.022 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 29.7 mm-40 131.76 9.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 123.86 0.864 . . . . 0.0 108.729 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.9 m0 -71.79 165.88 23.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.718 -1.239 . . . . 14.289999999999999 110.546 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.492 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.1 m0 -129.62 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.661 -0.649 . . . . 11.800000000000001 109.263 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.0 96.69 5.83 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.94 128.74 56.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.866 0.841 . . . . 0.0 110.345 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.57 150.36 26.94 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.754 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.41 128.59 43.47 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.27 -1.772 . . . . 0.0 107.181 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.45 -18.37 1.04 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 119.751 -1.843 . . . . 0.0 107.917 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.462 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.53 4.31 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.43 33.86 6.96 Favored Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.331 -0.85 . . . . 14.41 112.271 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.754 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.08 29.86 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.692 1.746 . . . . 0.0 111.762 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.62 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.369 1.081 . . . . 0.0 112.494 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.82 12.82 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.302 -1.519 . . . . 7.25 109.302 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.41 150.94 42.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.218 -1.166 . . . . 0.0 108.629 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.02 136.7 8.97 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.356 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.2 113.52 1.14 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 N-CA-C 109.002 -1.192 . . . . 4.7599999999999998 109.002 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.3 3.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.842 . . . . 0.0 110.719 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.594 ' OD1' ' NH2' ' B' ' 83' ' ' ARG . 95.8 m-20 -102.07 -7.59 22.16 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.263 -0.898 . . . . 14.84 109.319 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.93 8.09 31.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.269 -0.894 . . . . 10.23 109.533 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.33 156.66 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 6.9699999999999998 109.49 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 63' ' ' VAL . 2.7 p -106.82 160.83 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 62' ' ' VAL . 8.5 p -107.75 134.27 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.363 -0.836 . . . . 0.0 109.724 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.11 -63.1 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.665 -0.647 . . . . 0.0 109.275 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 13.4 p -69.99 151.54 45.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.027 -1.046 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 44.2 p30 -146.54 152.78 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.221 -0.925 . . . . 0.0 109.337 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.43 1.47 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.338 1.359 . . . . 0.0 109.693 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.0 82.65 1.77 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.04 32.28 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.65 156.35 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.9 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.493 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.8 0.2 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.24 130.78 5.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.271 -1.135 . . . . 0.0 109.431 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.54 36.18 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.958 1.772 . . . . 0.0 108.805 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.527 HG23 ' C ' ' B' ' 84' ' ' ARG . 65.0 mt -135.33 119.78 26.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 122.068 0.937 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.826 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.43 117.09 4.1 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.949 0.881 . . . . 0.0 109.922 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.17 4.94 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.826 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.71 -48.56 8.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.372 -1.075 . . . . 0.0 109.306 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.78 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ARG . . . . . 0.594 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 94.2 mtt-85 53.51 41.32 32.12 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.527 ' C ' HG23 ' B' ' 78' ' ' ILE . 3.9 mmm180 -115.87 143.42 30.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.634 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.54 113.3 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.428 1.419 . . . . 0.0 110.596 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.671 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.92 158.42 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.47 61.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 110.682 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.09 0.15 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.661 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.49 120.72 42.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.671 HG22 HG21 ' B' ' 86' ' ' ILE . 43.1 t -98.91 158.73 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.73 0.776 . . . . 0.0 111.105 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.64 116.01 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.89 105.97 18.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.09 -1.007 . . . . 0.0 109.528 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.52 159.64 42.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.22 4.27 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.26 75.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.17 -154.72 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.722 0.772 . . . . 0.0 109.796 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.466 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.4 mt-30 -135.5 143.45 45.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.9 m95 -141.58 140.07 33.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.516 -1.365 . . . . 0.0 110.596 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.454 ' C ' ' N ' ' B' ' 101' ' ' GLU . 16.9 m80 -56.66 131.99 50.6 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.15 -14.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.956 -1.09 . . . . 0.0 108.302 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.02 15.45 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.696 -0.627 . . . . 0.0 110.638 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.01 -6.6 31.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.818 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.471 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.12 106.22 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.83 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.204 1.002 . . . . 0.0 111.192 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.7 148.68 45.85 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.329 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.63 1.75 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.66 0.71 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.338 -0.851 . . . . 0.0 110.009 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.36 4.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.392 -0.817 . . . . 0.0 110.165 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.5 109.54 59.34 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.83 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.02 138.19 39.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.804 1.669 . . . . 0.0 112.078 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.78 56.98 1.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.138 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.21 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.9 2.75 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.965 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.2 178.99 4.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.465 -1.021 . . . . 0.0 109.906 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.62 145.37 24.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.761 . . . . 0.0 109.302 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.43 9.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.462 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.705 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.53 137.64 47.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.06 148.33 28.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.262 -0.899 . . . . 0.0 111.173 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.19 11.22 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.607 0.718 . . . . 0.0 110.291 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.39 22.77 1.53 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.4 31.06 20.32 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.729 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.3 mt -143.4 142.71 31.34 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.521 -0.988 . . . . 0.0 108.773 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.9 36.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 110.787 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.548 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.3 m-85 -153.97 140.42 18.75 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.6 177.51 0.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.446 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.73 -35.89 82.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 0.0 109.443 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.1 m -86.69 -43.7 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 111.384 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.7 -43.71 83.6 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.839 -1.163 . . . . 0.0 108.065 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.512 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.84 -56.45 13.9 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.0 m-80 -64.4 -45.03 89.39 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.012 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.34 61.17 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.548 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.66 -35.25 45.57 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.361 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.57 -81.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.51 31.31 16.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.405 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.56 51.3 15.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -1.128 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.744 1 CA-C-O 70.872 -23.442 . . . . 0.0 109.455 179.941 . . . . . . . . 2 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.26 74.93 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -162.0 35.33 0.12 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -1.207 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.434 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.0 148.65 44.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.143 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.15 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -121.37 -54.35 1.99 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.34 74.11 1.38 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -69.52 158.04 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 31' ' ' MET . 3.5 m -145.32 131.48 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.42 -1.425 . . . . 0.0 111.557 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.9 129.25 45.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 13' ' ' TYR . 36.4 m -63.44 154.29 32.64 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.591 1.186 . . . . 0.0 110.546 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 77.2 mt -114.28 -17.22 11.88 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.147 -1.427 . . . . 10.539999999999999 107.147 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.661 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.55 145.09 18.57 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.24 -0.913 . . . . 18.390000000000001 110.694 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.06 81.53 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 121.372 1.381 . . . . 0.0 109.058 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.29 13.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.015 -1.053 . . . . 0.0 110.896 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.19 8.04 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.857 0.837 . . . . 0.0 109.389 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.97 10.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 18' ' ' VAL . 29.7 m -130.34 94.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-O 122.911 1.339 . . . . 0.0 109.232 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -144.44 -152.05 0.4 Allowed 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 114.377 -1.283 . . . . 38.32 107.618 178.031 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 19' ' ' THR . 97.2 mt-10 -82.47 -54.27 5.32 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.902 -1.518 . . . . 55.130000000000003 106.902 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -109.26 29.23 7.72 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.427 -0.795 . . . . 0.0 110.778 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.569 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.32 150.92 22.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.81 -1.181 . . . . 0.0 109.766 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.51 111.45 22.48 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.401 -0.812 . . . . 11.68 110.695 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.44 127.67 41.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.26 21.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.35 -1.469 . . . . 12.44 110.881 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.605 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.28 155.77 22.27 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 146.95 17.92 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 121.262 -0.899 . . . . 29.030000000000001 109.542 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.08 6.65 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.316 -1.514 . . . . 6.1799999999999997 109.316 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.25 114.78 22.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.522 -0.987 . . . . 9.5199999999999996 109.54 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.05 108.62 6.04 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.43 133.65 49.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 123.172 1.463 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.74 102.99 15.75 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.459 -178.762 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.96 92.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.51 -0.744 . . . . 0.0 111.597 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.482 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.78 -50.29 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.993 -1.067 . . . . 0.0 110.248 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.486 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.29 157.6 43.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.055 -1.028 . . . . 0.0 110.779 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.555 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.06 65.58 65.33 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.8 165.41 31.53 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.697 1.598 . . . . 0.0 108.901 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.09 -46.41 7.79 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.62 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.369 0.604 . . . . 0.0 110.069 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.53 0.0 OUTLIER Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.296 -2.185 0 C-N-CA 122.707 2.271 . . . . 0.0 109.874 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.7 pt-20 131.84 9.19 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.898 0 C-N-CA 123.894 0.878 . . . . 0.0 108.754 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.561 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.3 m0 -71.8 165.81 23.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.635 -1.291 . . . . 14.289999999999999 110.532 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 19.3 m0 -129.5 144.99 51.5 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.38 -0.6 . . . . 11.800000000000001 109.38 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.95 96.73 5.81 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.8 56.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.913 0.863 . . . . 0.0 110.381 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.56 150.44 26.91 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.752 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.46 128.55 43.49 Favored 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 117.282 -1.767 . . . . 0.0 107.203 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.41 1.01 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.701 -1.875 . . . . 0.0 107.934 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.8 -4.4 4.33 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.46 33.78 6.99 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-N 115.33 -0.85 . . . . 14.41 112.27 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.752 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.79 164.09 29.77 Favored 'General case' 0 N--CA 1.515 2.805 0 CA-C-N 119.783 1.792 . . . . 0.0 111.867 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.0 154.55 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.374 1.083 . . . . 0.0 112.504 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.18 156.66 12.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.267 -1.533 . . . . 7.25 109.267 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.28 150.83 43.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -1.201 . . . . 0.0 108.712 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.99 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.959 -1.088 . . . . 0.0 109.254 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 N-CA-C 108.997 -1.194 . . . . 4.7599999999999998 108.997 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.501 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 23.8 pttm -60.31 3.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.544 -0.722 . . . . 0.0 110.742 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.657 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 1.0 OUTLIER -102.04 -7.57 22.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.177 -0.952 . . . . 14.84 109.342 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.01 8.27 30.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.255 -0.903 . . . . 10.23 109.487 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -147.59 156.52 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 6.9699999999999998 109.582 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 63' ' ' VAL . 10.0 p -106.71 160.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 62' ' ' VAL . 11.8 p -107.66 134.26 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.07 -63.23 1.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -70.09 151.67 45.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.922 -1.112 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -146.61 152.74 39.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.196 -0.94 . . . . 0.0 109.385 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.3 1.47 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.27 1.313 . . . . 0.0 109.688 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.24 82.64 1.78 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.06 32.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.2 28.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -1.126 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.21 46.76 0.2 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.17 130.8 5.4 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.21 163.65 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.949 1.766 . . . . 0.0 108.924 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.485 HG23 ' C ' ' B' ' 84' ' ' ARG . 49.0 mt -135.41 119.89 26.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 122.032 0.92 . . . . 0.0 109.425 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.834 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.829 0.823 . . . . 0.0 110.019 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.89 -0.11 4.89 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.834 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.57 8.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -1.094 . . . . 0.0 109.356 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.17 4.77 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ARG . . . . . 0.456 HH21 ' HE2' ' A' ' 58' ' ' LYS . 84.3 mtt85 53.62 41.28 32.12 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.485 ' C ' HG23 ' B' ' 78' ' ' ILE . 8.7 mmm180 -115.88 143.48 30.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.646 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.5 Cg_exo -56.51 113.47 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.425 1.417 . . . . 0.0 110.515 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.645 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -71.01 158.47 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.42 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.49 61.4 0.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.887 -1.133 . . . . 0.0 110.688 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.95 -101.88 0.15 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.676 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.65 120.64 42.23 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.645 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.89 158.7 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.755 0.788 . . . . 0.0 111.182 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.53 116.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.87 106.12 18.26 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.057 -1.027 . . . . 0.0 109.552 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.63 42.49 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.634 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.06 17.24 4.32 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.33 75.77 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.35 -154.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.756 0.788 . . . . 0.0 109.658 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.28 143.5 46.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.7 m95 -141.61 140.18 33.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.51 -1.369 . . . . 0.0 110.596 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.446 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.65 132.01 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.466 HG22 HG23 ' B' ' 91' ' ' VAL . 7.8 t -53.24 -14.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.854 -1.153 . . . . 0.0 108.285 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.446 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.97 15.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.743 -0.598 . . . . 0.0 110.594 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.18 -6.47 31.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.903 -1.123 . . . . 0.0 110.769 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.24 106.28 12.14 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.828 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.4 m -133.52 175.31 11.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 122.369 1.08 . . . . 0.0 111.175 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.86 148.71 46.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.343 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.49 1.79 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.71 -31.67 0.72 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.392 -0.818 . . . . 0.0 110.079 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.2 -15.15 4.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.339 -0.851 . . . . 0.0 110.15 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.69 47.46 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.55 109.66 59.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.828 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.07 138.28 39.63 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.673 1.582 . . . . 0.0 112.168 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.327 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.72 56.9 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.212 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.15 -55.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.242 -0.911 . . . . 0.0 108.988 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.94 2.75 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.943 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.21 178.88 4.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.54 -0.976 . . . . 0.0 109.963 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.55 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.227 -0.921 . . . . 0.0 109.622 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.59 137.67 47.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.94 148.3 28.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 111.261 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.33 11.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.74 . . . . 0.0 110.318 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.17 22.78 1.39 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.634 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.61 30.8 20.44 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.766 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.21 142.76 31.51 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.56 -0.965 . . . . 0.0 108.851 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.92 35.99 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -153.95 140.23 18.57 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.7 m -57.59 177.43 0.1 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.346 -1.342 . . . . 0.0 108.397 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.52 -36.11 82.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.376 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.9 m -86.57 -43.68 12.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.55 -0.719 . . . . 0.0 111.412 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.78 -43.74 83.18 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.748 -1.22 . . . . 0.0 108.078 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.73 -56.52 13.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.42 -44.85 89.94 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.101 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.57 -34.31 61.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.76 -35.18 44.95 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.366 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.59 -81.71 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.52 31.29 16.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.56 51.28 15.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.714 1 CA-C-O 70.897 -23.43 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.83 0.12 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.93 35.24 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -1.16 . . . . 0.0 109.581 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.07 148.69 43.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.106 -0.996 . . . . 0.0 109.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.13 93.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.268 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.16 -54.32 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.449 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.9 m-70 -145.26 73.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.53 ' N ' ' OG ' ' A' ' 65' ' ' SER . 19.6 t -69.47 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.8 m -145.3 131.44 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.458 -1.401 . . . . 0.0 111.52 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.83 129.28 45.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 13' ' ' TYR . 33.2 m -63.38 154.32 32.36 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.585 1.183 . . . . 0.0 110.532 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.0 mt -114.32 -17.36 11.83 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.125 -1.435 . . . . 10.539999999999999 107.125 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.671 ' H ' HG22 ' A' ' 11' ' ' THR . 14.5 m-85 -149.45 145.03 18.52 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.052 -1.03 . . . . 18.390000000000001 110.748 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.95 81.38 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.414 1.409 . . . . 0.0 109.031 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.73 170.26 13.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.916 -1.115 . . . . 0.0 110.956 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.12 7.97 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.876 0.846 . . . . 0.0 109.327 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.17 111.91 10.68 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 18' ' ' VAL . 34.0 m -130.38 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 122.983 1.373 . . . . 0.0 109.161 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.635 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.51 -152.01 0.4 Allowed 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.309 -1.314 . . . . 38.32 107.61 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.635 ' H ' HG22 ' A' ' 19' ' ' THR . 97.6 mt-10 -82.36 -54.36 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.967 -1.494 . . . . 55.130000000000003 106.967 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.22 29.24 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.424 -0.798 . . . . 0.0 110.769 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.47 150.88 22.19 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.915 -1.116 . . . . 0.0 109.83 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.455 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -111.34 111.35 22.33 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.317 -0.864 . . . . 11.68 110.765 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -95.5 127.64 41.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.96 142.16 21.47 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.36 -1.462 . . . . 12.44 110.861 -178.447 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.16 155.83 22.38 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.99 18.2 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.462 -0.895 . . . . 29.030000000000001 109.51 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.52 44.25 6.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.262 -1.535 . . . . 6.1799999999999997 109.262 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.67 22.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.53 -0.982 . . . . 9.5199999999999996 109.437 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.92 108.6 5.93 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.55 133.8 49.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.202 1.477 . . . . 0.0 110.561 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.83 103.04 15.8 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.384 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.556 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.588 -0.695 . . . . 0.0 111.543 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.012 -1.055 . . . . 0.0 110.224 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.2 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 110.748 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.556 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.1 65.62 65.19 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.36 31.59 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.693 1.596 . . . . 0.0 108.94 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.08 -46.49 7.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.7 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.366 0.603 . . . . 0.0 110.005 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.55 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.615 2.21 . . . . 0.0 109.965 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 27.4 tt0 131.69 9.1 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.78 0.832 . . . . 0.0 108.795 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.568 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.9 m0 -71.75 165.88 23.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.586 -1.321 . . . . 14.289999999999999 110.537 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.536 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.3 m0 -129.58 145.1 51.51 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.321 -0.622 . . . . 11.800000000000001 109.321 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -78.99 96.59 5.8 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -115.97 128.77 56.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.011 0.91 . . . . 0.0 110.361 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.59 150.33 26.94 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.756 ' N ' ' O ' ' A' ' 52' ' ' GLN . 14.9 p30 -96.32 128.55 43.34 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 117.299 -1.76 . . . . 0.0 107.266 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.43 -18.41 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 119.656 -1.902 . . . . 0.0 107.912 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.473 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.69 -4.58 4.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.49 33.89 6.92 Favored Glycine 0 N--CA 1.481 1.683 0 CA-C-N 115.291 -0.868 . . . . 14.41 112.29 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.756 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.92 164.11 29.81 Favored 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.625 1.713 . . . . 0.0 111.883 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.54 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-O 122.315 1.055 . . . . 0.0 112.484 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.69 12.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 7.25 109.258 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.89 43.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.24 -1.153 . . . . 0.0 108.631 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.73 9.0 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.902 -1.124 . . . . 0.0 109.228 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.1 Cg_exo -51.16 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.217 -0.543 0 N-CA-C 109.061 -1.169 . . . . 4.7599999999999998 109.061 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 31.3 pttt -60.25 3.01 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.453 -0.779 . . . . 0.0 110.758 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 94.4 m-20 -102.03 -7.62 22.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 14.84 109.27 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.31 30.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.873 . . . . 10.23 109.476 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.47 156.69 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 6.9699999999999998 109.499 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 63' ' ' VAL . 13.8 p -106.88 160.69 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' N ' HG22 ' A' ' 62' ' ' VAL . 41.7 t -107.61 134.23 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.13 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.613 -0.68 . . . . 0.0 109.239 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 16.4 p -69.99 151.64 45.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 109.462 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -146.65 152.59 39.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.035 . . . . 0.0 109.427 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.36 1.48 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.27 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.464 1.442 . . . . 0.0 109.654 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.74 124.92 32.08 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.73 156.31 28.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.384 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.82 167.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.92 0.2 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.633 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.24 130.74 5.35 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.405 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.24 163.62 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.957 1.772 . . . . 0.0 108.873 178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 mt -135.46 119.76 26.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 122.12 0.962 . . . . 0.0 109.455 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.826 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.32 117.01 3.98 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.869 0.843 . . . . 0.0 109.897 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.1 4.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.826 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.8 -48.48 8.18 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.245 -1.15 . . . . 0.0 109.368 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.13 4.87 13.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ARG . . . . . 0.469 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 95.7 mtt-85 53.45 41.49 32.1 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -116.07 143.42 30.9 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.633 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.29 113.39 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.524 1.483 . . . . 0.0 110.592 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.675 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -71.01 158.4 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.429 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.5 61.45 0.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.849 -1.157 . . . . 0.0 110.663 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -102.01 0.15 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.659 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.58 120.7 42.47 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.675 HG22 HG21 ' B' ' 86' ' ' ILE . 43.2 t -98.98 158.74 3.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.507 -0.746 . . . . 0.0 111.151 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.63 115.94 47.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.72 106.09 18.23 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.57 42.58 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.12 17.12 4.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.09 25.37 75.7 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.77 0.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.857 0.837 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.462 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.45 143.5 45.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.5 140.05 33.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.655 -1.278 . . . . 0.0 110.598 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.45 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.53 131.93 50.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.22 -14.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 120.725 -1.234 . . . . 0.0 108.347 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.82 -27.03 15.42 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.886 -0.509 . . . . 0.0 110.595 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.17 -6.48 31.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.948 -1.095 . . . . 0.0 110.856 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.22 106.31 12.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.829 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.6 175.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.318 1.056 . . . . 0.0 111.065 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.92 148.76 46.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.264 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.89 28.74 1.74 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.428 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.81 -31.68 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.388 -0.82 . . . . 0.0 110.118 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.01 -15.52 4.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.57 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.378 -0.826 . . . . 0.0 110.238 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.5 59.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.829 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.13 138.24 39.32 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.676 1.584 . . . . 0.0 112.111 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.72 56.96 1.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.221 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.17 1.72 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 108.881 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.2 30.99 2.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.944 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.29 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.352 -1.087 . . . . 0.0 109.935 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.478 -0.764 . . . . 0.0 109.334 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.39 9.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.685 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.84 47.34 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.19 148.31 29.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.22 11.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.604 0.716 . . . . 0.0 110.331 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.42 22.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.638 -0.664 . . . . 0.0 109.413 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.48 Favored Glycine 0 N--CA 1.483 1.815 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.689 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.7 mt -143.33 142.76 31.41 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.646 -0.914 . . . . 0.0 108.865 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.88 36.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.666 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.552 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.92 140.32 18.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.3 m -57.64 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.282 -1.367 . . . . 0.0 108.448 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.97 82.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.78 -43.68 12.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.453 -0.78 . . . . 0.0 111.315 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.71 83.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.67 -1.269 . . . . 0.0 108.133 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.1 t80 -51.8 -56.5 13.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.423 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.0 m-80 -64.58 -44.75 89.69 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.135 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.32 61.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.552 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.29 44.74 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.51 -81.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.026 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.47 31.48 16.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.42 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.7 m-20 48.35 51.31 15.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -1.063 . . . . 0.0 109.563 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.763 1 CA-C-O 70.976 -23.392 . . . . 0.0 109.443 179.971 . . . . . . . . 2 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.332 0.586 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.85 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -161.99 35.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -1.19 . . . . 0.0 109.494 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.07 148.63 43.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.156 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.4 t -66.02 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 0.0 109.282 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.23 -54.36 2.0 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -145.23 73.86 1.38 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.9 t -69.44 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.33 131.58 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.484 -1.385 . . . . 0.0 111.55 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -99.94 129.14 45.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 13' ' ' TYR . 48.9 m -63.37 154.41 32.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.52 1.153 . . . . 0.0 110.598 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 87.8 mt -114.3 -17.38 11.84 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.173 -1.417 . . . . 10.539999999999999 107.173 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.651 ' H ' HG22 ' A' ' 11' ' ' THR . 14.5 m-85 -149.43 145.15 18.73 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.177 -0.952 . . . . 18.390000000000001 110.706 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.02 81.42 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 121.414 1.41 . . . . 0.0 109.054 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.32 13.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.94 -1.1 . . . . 0.0 110.865 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.449 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.6 111.01 7.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.771 0.796 . . . . 0.0 109.462 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.25 112.07 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.36 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 122.866 1.317 . . . . 0.0 109.071 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.64 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.6 -151.97 0.4 Allowed 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.357 -1.292 . . . . 38.32 107.518 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.64 ' H ' HG22 ' A' ' 19' ' ' THR . 95.9 mt-10 -82.47 -54.33 5.28 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.783 -1.562 . . . . 55.130000000000003 106.783 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 71.6 mm-40 -109.35 29.25 7.72 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.366 -0.834 . . . . 0.0 110.701 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.57 150.82 22.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.841 -1.162 . . . . 0.0 109.797 -179.344 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.32 111.36 22.36 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.295 -0.878 . . . . 11.68 110.804 -178.363 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -95.35 127.64 41.56 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.476 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.91 142.22 21.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.39 -1.443 . . . . 12.44 110.87 -178.472 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.82 22.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 146.95 18.5 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.221 -0.925 . . . . 29.030000000000001 109.497 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 43.99 6.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.277 -1.529 . . . . 6.1799999999999997 109.277 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.79 22.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.56 -0.964 . . . . 9.5199999999999996 109.419 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.06 108.73 6.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.68 49.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 123.179 1.466 . . . . 0.0 110.486 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.75 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.427 -178.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 111.51 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.7 mt -59.73 -50.51 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.994 -1.066 . . . . 0.0 110.194 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.22 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.061 -1.025 . . . . 0.0 110.803 -177.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.02 65.54 65.5 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.83 165.42 31.48 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 109.0 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.13 -46.4 7.78 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.74 -59.53 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.436 0.636 . . . . 0.0 110.018 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.61 2.206 . . . . 0.0 109.922 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 62.2 mt-10 131.74 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 123.845 0.858 . . . . 0.0 108.738 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.545 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.1 m0 -71.74 165.83 23.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.526 -1.359 . . . . 14.289999999999999 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.482 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.8 m0 -129.6 145.11 51.52 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.38 -0.6 . . . . 11.800000000000001 109.38 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -79.08 96.74 5.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.4 p -115.93 128.76 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.855 0.836 . . . . 0.0 110.36 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.68 150.35 26.82 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.756 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.1 p30 -96.37 128.49 43.35 Favored 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.172 -1.811 . . . . 0.0 107.212 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.28 -18.45 0.96 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 119.687 -1.883 . . . . 0.0 107.998 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.465 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.61 -4.57 4.29 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.638 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.206 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.756 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.03 29.97 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.773 1.787 . . . . 0.0 111.815 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.303 1.049 . . . . 0.0 112.544 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.21 156.77 12.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.28 -1.528 . . . . 7.25 109.28 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.45 150.88 42.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -1.147 . . . . 0.0 108.657 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.72 9.01 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.029 -1.045 . . . . 0.0 109.27 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.26 113.49 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.068 -1.166 . . . . 4.7599999999999998 109.068 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.443 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.33 3.21 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 110.78 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 57' ' ' PRO . 8.3 p-10 -102.03 -7.57 22.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 14.84 109.335 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.04 8.21 30.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 10.23 109.536 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.0 m -147.44 156.57 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.942 . . . . 6.9699999999999998 109.541 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -106.87 160.75 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' B' ' 82' ' ' CYS . 10.5 p -107.61 134.26 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.401 -0.812 . . . . 0.0 109.754 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.05 -63.31 1.24 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.682 . . . . 0.0 109.227 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.447 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 58.3 m -69.95 151.68 45.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.975 -1.078 . . . . 0.0 109.454 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 48.7 p30 -146.58 152.73 39.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 109.356 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.11 -67.28 1.48 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.317 1.344 . . . . 0.0 109.606 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.05 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.72 125.0 32.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.23 28.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.562 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.82 167.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.29 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.23 130.75 5.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 109.366 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.6 Cg_endo -74.16 163.61 36.19 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.946 1.764 . . . . 0.0 108.914 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.512 HG23 ' C ' ' B' ' 84' ' ' ARG . 56.7 mt -135.43 119.74 26.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.081 0.943 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.3 117.05 4.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.22 4.88 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.74 -48.51 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -1.099 . . . . 0.0 109.305 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' CYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 1.6 p -116.12 4.84 13.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 53.54 41.32 32.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.512 ' C ' HG23 ' B' ' 78' ' ' ILE . 43.3 mtp180 -115.86 143.46 30.81 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.64 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.8 Cg_exo -56.32 113.33 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.494 1.463 . . . . 0.0 110.623 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.669 HG21 HG22 ' B' ' 90' ' ' VAL . 21.4 mt -70.95 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.57 61.34 0.32 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.831 -1.168 . . . . 0.0 110.646 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.97 -101.97 0.15 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.656 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.73 42.57 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.669 HG22 HG21 ' B' ' 86' ' ' ILE . 42.5 t -98.81 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.641 0.734 . . . . 0.0 111.298 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.52 115.91 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.81 106.17 18.29 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.062 -1.023 . . . . 0.0 109.481 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.6 159.54 42.63 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.07 17.25 4.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.18 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.724 0.773 . . . . 0.0 109.821 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' GLN . . . . . 0.468 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.4 mt-30 -135.43 143.42 45.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.0 m95 -141.44 140.0 33.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.561 -1.337 . . . . 0.0 110.682 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.4 m80 -56.56 131.94 50.18 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 91' ' ' VAL . 7.6 t -53.2 -14.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.701 -1.25 . . . . 0.0 108.32 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.85 15.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.754 -0.591 . . . . 0.0 110.613 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.22 -6.53 31.04 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.26 106.31 12.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.63 175.25 11.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.287 1.041 . . . . 0.0 111.138 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.79 148.69 46.15 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.234 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.79 28.54 1.76 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.73 -31.62 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.432 -0.793 . . . . 0.0 110.149 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.08 -15.38 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 110.156 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.55 0.35 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.28 109.48 58.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.02 138.36 39.97 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.66 1.574 . . . . 0.0 112.077 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.82 56.91 1.78 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.133 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.21 -55.24 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.2 -0.937 . . . . 0.0 108.897 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.12 2.73 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 115' ' ' HIS . . . . . 0.956 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.27 178.88 4.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.483 -1.01 . . . . 0.0 109.987 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.5 145.43 24.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.38 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.563 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.35 169.48 9.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.528 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.695 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.6 137.7 47.15 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.96 148.28 28.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.232 -0.918 . . . . 0.0 111.234 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.05 129.34 11.26 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.604 0.716 . . . . 0.0 110.381 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.3 22.78 1.48 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.671 -0.643 . . . . 0.0 109.438 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.9 20.49 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.764 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.4 mt -143.27 142.89 31.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.529 -0.983 . . . . 0.0 108.725 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.84 36.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.685 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.547 ' CE1' HD22 ' B' ' 133' ' ' LEU . 58.5 m-85 -153.89 140.31 18.71 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.65 177.55 0.1 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.26 -1.376 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.67 -36.05 82.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.374 -0.828 . . . . 0.0 109.285 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.7 m -86.61 -43.78 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 0.0 111.333 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.79 83.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.721 -1.237 . . . . 0.0 108.095 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.71 -56.47 13.58 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 131' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.211 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.48 -34.29 61.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.547 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.75 -35.23 44.96 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.335 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.33 31.42 16.64 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.53 51.17 15.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -1.109 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.725 1 CA-C-O 70.924 -23.417 . . . . 0.0 109.436 179.924 . . . . . . . . 2 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.326 0.584 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.7 p -162.06 35.34 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -1.169 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.06 148.64 43.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.148 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.3 t -66.08 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.117 -0.99 . . . . 0.0 109.246 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.2 -54.26 2.01 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 9' ' ' VAL . 79.2 t -69.43 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 9' ' ' VAL . 3.2 m -145.23 131.51 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.426 -1.421 . . . . 0.0 111.665 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -99.98 129.26 46.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.646 HG22 ' H ' ' A' ' 13' ' ' TYR . 52.4 m -63.37 154.28 32.45 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.518 1.152 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 95.9 mt -114.23 -17.35 11.88 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.236 -1.394 . . . . 10.539999999999999 107.236 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.646 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.503 2.218 0 C-N-CA 119.463 -0.895 . . . . 18.390000000000001 110.699 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.5 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 121.436 1.424 . . . . 0.0 108.983 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.82 170.3 13.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.926 -1.109 . . . . 0.0 110.959 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.12 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.826 0.822 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.93 10.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 18' ' ' VAL . 23.3 m -130.32 94.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.917 1.342 . . . . 0.0 109.187 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.905 HG22 ' H ' ' A' ' 20' ' ' GLU . 4.0 m -144.51 -151.98 0.4 Allowed 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.596 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.905 ' H ' HG22 ' A' ' 19' ' ' THR . 49.8 tp10 -82.42 -54.28 5.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.906 -1.516 . . . . 55.130000000000003 106.906 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.443 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.6 mt-10 -109.36 29.12 7.85 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.342 -0.849 . . . . 0.0 110.739 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.41 151.02 22.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.827 -1.171 . . . . 0.0 109.783 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.44 111.38 22.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.38 -0.825 . . . . 11.68 110.773 -178.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.5 127.7 41.75 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' HD2' ' HG1' ' A' ' 11' ' ' THR . 0.8 OUTLIER -152.93 142.12 21.46 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.377 -1.452 . . . . 12.44 110.935 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.598 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.81 22.51 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 146.92 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.422 -0.911 . . . . 29.030000000000001 109.577 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 11' ' ' THR . . . 84.64 44.05 6.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.315 -1.514 . . . . 6.1799999999999997 109.315 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.73 22.79 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.509 -0.995 . . . . 9.5199999999999996 109.396 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.85 108.55 5.86 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.406 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.5 133.77 49.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 123.185 1.469 . . . . 0.0 110.523 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.89 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.401 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.558 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.92 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.576 -0.703 . . . . 0.0 111.491 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.7 mt -59.82 -50.33 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.921 -1.112 . . . . 0.0 110.246 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.34 157.65 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.941 -1.099 . . . . 0.0 110.774 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.558 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.16 65.63 64.83 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.766 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.72 165.32 31.79 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.702 1.601 . . . . 0.0 109.07 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.02 -46.5 7.77 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.4 m-20 57.69 -59.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.008 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.74 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.142 0 C-N-CA 122.625 2.217 . . . . 0.0 109.929 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 35.8 mm-40 131.83 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.78 0.832 . . . . 0.0 108.765 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.556 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.3 m0 -71.86 165.84 23.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.64 -1.287 . . . . 14.289999999999999 110.464 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.0 m0 -129.54 145.18 51.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.198 -0.667 . . . . 11.800000000000001 109.198 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.15 96.79 5.96 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -116.01 128.82 56.03 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.959 0.885 . . . . 0.0 110.361 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.67 150.4 26.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.765 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.39 128.62 43.48 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 117.324 -1.751 . . . . 0.0 107.229 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.51 -18.32 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 119.706 -1.871 . . . . 0.0 107.946 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.459 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.66 -4.64 4.41 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.687 0 CA-C-N 115.499 -0.773 . . . . 14.41 112.239 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.765 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.93 164.01 30.08 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 119.609 1.704 . . . . 0.0 111.727 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.65 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.76 12.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.263 -1.535 . . . . 7.25 109.263 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.39 150.85 43.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.338 -1.095 . . . . 0.0 108.643 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.01 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.782 -1.199 . . . . 0.0 109.316 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.15 113.63 1.19 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.912 -1.226 . . . . 4.7599999999999998 108.912 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.3 pttt -60.52 3.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.671 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.48 ' H ' ' C ' ' A' ' 57' ' ' PRO . 99.5 m-20 -102.05 -7.65 22.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.285 -0.884 . . . . 14.84 109.357 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.02 8.31 30.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 10.23 109.454 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.4 m -147.48 156.51 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.094 -1.004 . . . . 6.9699999999999998 109.487 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.76 160.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' HG22 ' A' ' 62' ' ' VAL . 11.5 p -107.59 134.29 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.43 -0.794 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.12 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.613 -0.679 . . . . 0.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 41.6 m -69.92 151.53 45.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.546 ' OD2' ' NH1' ' B' ' 84' ' ' ARG . 53.4 p-10 -146.63 152.73 39.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.35 1.48 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.356 1.371 . . . . 0.0 109.688 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.11 82.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.8 124.94 32.14 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 109.301 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.39 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.16 29.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -1.107 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.81 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.85 0.2 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.26 130.85 5.39 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.297 -1.119 . . . . 0.0 109.345 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.29 163.53 36.2 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.031 1.821 . . . . 0.0 108.832 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.507 HG23 ' C ' ' B' ' 84' ' ' ARG . 76.2 mt -135.34 119.85 27.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 122.008 0.909 . . . . 0.0 109.365 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.84 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.809 0.814 . . . . 0.0 109.914 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.82 -0.16 4.86 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.84 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.7 -48.53 8.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.295 -1.121 . . . . 0.0 109.301 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.16 4.78 13.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ARG . . . . . 0.456 HH22 ' HE3' ' A' ' 58' ' ' LYS . 83.8 mtt85 53.53 41.25 32.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.546 ' NH1' ' OD2' ' A' ' 66' ' ' ASP . 17.3 mtp180 -115.79 143.39 30.64 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.631 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.37 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.366 1.377 . . . . 0.0 110.615 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.665 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.91 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.702 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.422 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.59 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.877 -1.14 . . . . 0.0 110.55 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.12 -101.8 0.15 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.673 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.76 120.63 42.17 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.665 HG22 HG21 ' B' ' 86' ' ' ILE . 42.6 t -98.83 158.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.648 0.737 . . . . 0.0 111.125 -177.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.57 115.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.73 106.03 18.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.624 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.52 42.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.618 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.99 17.34 4.31 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.12 76.09 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.16 -154.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.787 0.803 . . . . 0.0 109.779 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.467 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.48 143.46 45.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.6 139.99 33.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.544 -1.347 . . . . 0.0 110.576 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.46 131.98 50.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.7 t -53.17 -14.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 108.365 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.97 15.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.823 -0.548 . . . . 0.0 110.594 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.05 -6.62 31.45 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.878 -1.139 . . . . 0.0 110.798 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.472 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.1 t80 -80.08 106.3 12.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.8 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.161 0.982 . . . . 0.0 111.192 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.8 148.58 46.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.314 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.78 28.67 1.73 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.77 -31.75 0.71 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.293 -0.879 . . . . 0.0 110.113 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.44 4.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.222 -0.924 . . . . 0.0 110.226 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.65 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.363 -0.836 . . . . 0.0 110.237 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.52 59.18 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -68.99 138.27 39.83 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.825 1.683 . . . . 0.0 112.059 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.8 57.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.132 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.632 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.19 1.69 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 108.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.25 30.98 2.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.954 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.21 178.86 4.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.504 -0.998 . . . . 0.0 109.993 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -94.35 145.3 24.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.33 169.45 9.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.78 47.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.26 28.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.85 . . . . 0.0 111.188 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.635 0.731 . . . . 0.0 110.334 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mttm 51.39 22.8 1.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.62 -0.675 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.618 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.94 20.4 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.7 mt -143.26 142.81 31.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.46 -1.023 . . . . 0.0 108.848 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.8 36.31 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 110.702 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.555 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.3 m-85 -153.96 140.28 18.61 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.53 177.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.439 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.76 -35.92 82.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -0.814 . . . . 0.0 109.353 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.456 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.9 m -86.75 -43.52 12.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.543 -0.723 . . . . 0.0 111.384 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.72 -43.82 83.24 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.738 -1.226 . . . . 0.0 108.126 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.65 -56.48 13.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.421 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.6 -44.8 89.46 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.05 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.53 -34.37 61.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.65 -35.26 45.61 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.427 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.36 31.51 16.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.34 51.42 15.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -1.124 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 1 C--O 0.476 -39.651 1 CA-C-O 70.943 -23.408 . . . . 0.0 109.45 -179.965 . . . . . . . . 2 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.98 0.12 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -1.217 . . . . 0.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.09 148.67 43.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.4 t -66.07 93.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.19 -54.42 2.0 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.39 74.09 1.38 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.65 158.05 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.39 131.51 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.511 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.01 129.28 46.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 13' ' ' TYR . 30.0 m -63.39 154.37 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.456 1.122 . . . . 0.0 110.636 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.9 mt -114.38 -17.24 11.83 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.205 -1.406 . . . . 10.539999999999999 107.205 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.666 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.51 144.98 18.41 Favored Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 119.474 -0.891 . . . . 18.390000000000001 110.793 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.01 81.39 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 121.524 1.482 . . . . 0.0 109.019 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.8 170.28 13.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.05 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.15 8.07 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.453 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.01 10.68 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 18' ' ' VAL . 9.4 m -130.35 94.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 122.869 1.319 . . . . 0.0 109.177 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -144.54 -151.98 0.4 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.35 -1.296 . . . . 38.32 107.549 177.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 19' ' ' THR . 96.7 mt-10 -82.48 -54.32 5.29 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.849 -1.537 . . . . 55.130000000000003 106.849 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.35 29.15 7.81 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.402 -0.812 . . . . 0.0 110.762 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.4 150.84 22.21 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.839 -1.163 . . . . 0.0 109.7 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.37 22.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.385 -0.822 . . . . 11.68 110.764 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.46 127.7 41.72 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.88 142.17 21.54 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.374 -1.454 . . . . 12.44 110.947 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.09 155.77 22.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.38 146.84 18.58 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.267 -0.895 . . . . 29.030000000000001 109.602 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.71 44.07 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.275 -1.53 . . . . 6.1799999999999997 109.275 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.33 114.75 22.85 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.513 -0.992 . . . . 9.5199999999999996 109.454 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.04 108.59 6.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.43 133.69 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.153 1.454 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.82 103.12 15.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.39 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.516 -0.74 . . . . 0.0 111.392 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.3 mt -59.79 -50.46 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.971 -1.08 . . . . 0.0 110.121 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.53 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.17 157.58 43.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.983 -1.073 . . . . 0.0 110.814 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -134.97 65.54 65.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.39 31.64 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.635 1.556 . . . . 0.0 108.966 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.97 -46.56 7.75 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.52 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.268 0.556 . . . . 0.0 110.09 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.36 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 122.709 2.273 . . . . 0.0 109.914 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.75 9.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.816 0 C-N-CA 123.849 0.86 . . . . 0.0 108.849 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.7 m0 -71.89 165.82 23.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.593 -1.317 . . . . 14.289999999999999 110.481 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.494 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.9 m0 -129.53 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.356 -0.609 . . . . 11.800000000000001 109.356 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -79.01 96.62 5.82 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.504 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.65 55.92 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.379 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.47 150.35 27.08 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.766 ' N ' ' O ' ' A' ' 52' ' ' GLN . 14.9 p30 -96.35 128.49 43.32 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.322 -1.751 . . . . 0.0 107.295 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.41 0.98 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 119.643 -1.911 . . . . 0.0 108.03 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.68 -4.57 4.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.48 33.9 6.92 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.287 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.766 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.94 164.04 30.01 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 119.654 1.727 . . . . 0.0 111.77 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.64 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.274 1.035 . . . . 0.0 112.583 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.16 156.73 12.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.291 -1.524 . . . . 7.25 109.291 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.38 150.86 43.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.226 -1.161 . . . . 0.0 108.561 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.76 9.04 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.102 . . . . 0.0 109.297 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.28 113.53 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 N-CA-C 108.938 -1.216 . . . . 4.7599999999999998 108.938 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.6 pttt -60.38 3.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 0.0 110.757 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.7 m-20 -102.03 -7.54 22.24 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.285 -0.885 . . . . 14.84 109.325 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.13 8.22 31.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 10.23 109.506 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.44 156.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.285 -0.885 . . . . 6.9699999999999998 109.577 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.586 HG11 HD13 ' B' ' 78' ' ' ILE . 29.4 m -106.81 160.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.59 134.27 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.452 -0.78 . . . . 0.0 109.778 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.4 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 98.5 mt -105.13 -63.07 1.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 70.4 m -70.05 151.66 45.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.036 -1.04 . . . . 0.0 109.409 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 65' ' ' SER . 87.8 m-20 -146.6 152.69 39.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 109.311 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.29 1.48 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.299 1.332 . . . . 0.0 109.629 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.61 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.9 124.95 32.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.41 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.76 156.22 28.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -1.112 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.83 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.22 130.81 5.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.29 163.42 36.44 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.052 1.835 . . . . 0.0 108.83 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.596 HG23 ' C ' ' B' ' 84' ' ' ARG . 41.7 mt -135.22 119.85 27.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.983 0.896 . . . . 0.0 109.389 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.42 116.96 3.97 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.11 4.78 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.69 -48.57 8.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -1.067 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.72 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.132 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 53.54 41.3 32.12 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.596 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.3 mmm180 -115.82 143.5 30.86 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.55 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.44 1.427 . . . . 0.0 110.542 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.67 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.95 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.53 61.41 0.32 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.791 -1.193 . . . . 0.0 110.593 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.677 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.67 42.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.67 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.8 158.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 111.294 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.51 115.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.92 106.07 18.23 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 109.592 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.62 159.48 42.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.11 17.26 4.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.19 25.28 75.85 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.041 -2.024 . . . . 0.0 108.041 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.76 0.65 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.8 0.809 . . . . 0.0 109.732 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.483 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.35 143.52 46.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.58 139.91 33.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.488 -1.382 . . . . 0.0 110.648 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.54 131.99 50.26 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.457 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.21 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.846 -1.158 . . . . 0.0 108.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.89 -26.82 15.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.869 -0.519 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.23 -6.5 31.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.816 -1.177 . . . . 0.0 110.781 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.26 106.25 12.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.818 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.2 m -133.59 175.27 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.329 1.061 . . . . 0.0 111.1 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.87 148.7 46.41 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.37 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.61 1.74 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.82 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.74 -31.78 0.71 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.01 -15.38 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.79 47.5 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.36 109.64 59.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.818 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.05 138.27 39.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.748 1.632 . . . . 0.0 112.147 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.84 56.97 1.78 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.098 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.11 -55.25 1.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.12 30.91 2.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.906 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.21 178.93 4.14 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.474 -1.015 . . . . 0.0 109.977 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.41 145.33 24.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 109.412 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.411 -0.806 . . . . 0.0 109.511 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.696 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.61 47.17 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.98 148.36 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.218 -0.926 . . . . 0.0 111.18 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.556 0.693 . . . . 0.0 110.27 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.7 mttm 51.27 22.83 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.465 0.65 . . . . 0.0 109.526 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.46 30.92 20.54 Favored Glycine 0 N--CA 1.481 1.663 0 C-N-CA 119.396 -1.383 . . . . 0.0 109.785 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.6 mt -143.26 142.8 31.48 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 108.79 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.4 152.79 36.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.7 m-85 -153.81 140.27 18.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.2 m -57.57 177.5 0.1 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.366 -1.334 . . . . 0.0 108.486 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.63 -36.06 82.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.417 -0.802 . . . . 0.0 109.349 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.5 m -86.54 -43.8 12.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.745 . . . . 0.0 111.338 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.456 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.87 83.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.722 -1.236 . . . . 0.0 108.089 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.38 14.07 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.55 -44.92 89.23 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.043 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.45 61.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.53 -35.28 46.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.501 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.114 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.43 31.36 16.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.0 m-20 48.59 51.26 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 70.968 -23.396 . . . . 0.0 109.468 179.977 . . . . . . . . 2 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.94 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.99 35.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -1.21 . . . . 0.0 109.583 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.02 148.68 43.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.48 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -66.08 93.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.255 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.25 -54.28 2.0 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.35 74.0 1.38 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.53 158.09 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.36 131.45 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.449 -1.407 . . . . 0.0 111.561 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.92 129.29 45.98 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 13' ' ' TYR . 34.0 m -63.48 154.4 32.44 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.517 1.151 . . . . 0.0 110.594 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.7 mt -114.35 -17.24 11.84 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.23 -1.396 . . . . 10.539999999999999 107.23 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.53 145.07 18.54 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.238 -0.914 . . . . 18.390000000000001 110.743 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.08 81.41 1.7 Allowed 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.356 1.371 . . . . 0.0 109.058 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.74 170.22 14.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.836 -1.165 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.59 111.11 8.03 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.725 0.774 . . . . 0.0 109.414 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -134.31 111.95 10.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 18' ' ' VAL . 16.1 m -130.27 94.29 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 122.839 1.304 . . . . 0.0 109.13 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.977 HG22 ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.49 -152.09 0.4 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.578 -1.267 . . . . 38.32 107.578 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.977 ' OE1' HG22 ' A' ' 19' ' ' THR . 58.0 mp0 -82.4 -54.31 5.32 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.857 -1.534 . . . . 55.130000000000003 106.857 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -109.28 29.16 7.79 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.383 -0.823 . . . . 0.0 110.746 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.52 150.88 22.21 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.823 -1.173 . . . . 0.0 109.678 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.42 111.38 22.37 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.416 -0.803 . . . . 11.68 110.756 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.35 127.67 41.58 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.9 142.16 21.52 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.42 -1.425 . . . . 12.44 110.918 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.609 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.12 155.82 22.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.93 18.27 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.268 -0.895 . . . . 29.030000000000001 109.595 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.1 6.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.345 -1.502 . . . . 6.1799999999999997 109.345 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.3 114.83 22.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.589 -0.947 . . . . 9.5199999999999996 109.415 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.99 108.59 5.98 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.41 133.7 49.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 123.154 1.454 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.78 103.08 15.83 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.919 -1.492 . . . . 0.0 107.395 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.502 -0.749 . . . . 0.0 111.468 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.486 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.3 mt -59.74 -50.43 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.917 -1.115 . . . . 0.0 110.201 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.23 157.6 43.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.947 -1.095 . . . . 0.0 110.714 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.55 ' HB3' ' NE1' ' A' ' 44' ' ' TRP . 1.8 mptp? -135.08 65.58 65.24 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.77 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.75 165.32 31.76 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.61 1.54 . . . . 0.0 109.016 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.52 7.78 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.67 -59.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.324 0.583 . . . . 0.0 109.989 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.673 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.6 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.158 0 C-N-CA 122.714 2.276 . . . . 0.0 109.896 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.673 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.6 tp10 131.87 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.802 0.841 . . . . 0.0 108.771 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.536 ' HB2' HD12 ' A' ' 55' ' ' LEU . 16.8 m0 -71.93 165.94 23.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.674 -1.266 . . . . 14.289999999999999 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.3 m0 -129.56 145.05 51.51 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.32 -0.622 . . . . 11.800000000000001 109.32 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.02 96.62 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.93 128.7 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.921 0.867 . . . . 0.0 110.403 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.45 150.41 27.07 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.756 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.39 128.54 43.4 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 117.325 -1.75 . . . . 0.0 107.31 177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 119.596 -1.94 . . . . 0.0 107.99 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.49 -4.6 4.17 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.41 33.81 6.99 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 115.307 -0.861 . . . . 14.41 112.329 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.756 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.1 29.81 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-N 119.603 1.701 . . . . 0.0 111.787 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.56 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.32 1.057 . . . . 0.0 112.468 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.79 12.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.252 -1.539 . . . . 7.25 109.252 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.43 150.88 42.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -1.194 . . . . 0.0 108.608 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.7 8.97 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.955 -1.091 . . . . 0.0 109.297 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.968 -1.205 . . . . 4.7599999999999998 108.968 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.607 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 16.0 pttp -60.46 3.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 110.648 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.5 m-20 -102.13 -7.52 22.17 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.179 -0.95 . . . . 14.84 109.319 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.09 8.19 31.19 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.242 -0.911 . . . . 10.23 109.427 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 11' ' ' THR . 34.5 m -147.44 156.6 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 6.9699999999999998 109.513 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.476 HG22 ' N ' ' A' ' 63' ' ' VAL . 12.6 p -106.81 160.72 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 62' ' ' VAL . 56.0 t -107.67 134.25 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.805 . . . . 0.0 109.834 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.2 mt -105.09 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.626 -0.671 . . . . 0.0 109.237 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.48 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 38.8 m -70.0 151.69 45.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.952 -1.092 . . . . 0.0 109.403 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 54.4 p-10 -146.72 152.63 39.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 109.317 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.08 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.59 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.302 1.335 . . . . 0.0 109.681 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.96 82.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.77 125.02 32.2 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.22 28.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -1.128 . . . . 0.0 109.52 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.96 0.2 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.28 130.65 5.29 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.261 -1.14 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.7 Cg_endo -74.19 163.65 36.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.912 1.741 . . . . 0.0 108.922 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.532 HG23 ' C ' ' B' ' 84' ' ' ARG . 64.2 mt -135.39 119.83 26.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 122.087 0.946 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.827 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.5 117.06 4.09 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.016 0.912 . . . . 0.0 109.89 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.513 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.05 4.89 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.827 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.76 -48.5 8.18 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.295 -1.12 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.88 13.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.573 -0.704 . . . . 0.0 109.107 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 53.55 41.14 32.14 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.532 ' C ' HG23 ' B' ' 78' ' ' ILE . 6.8 mtp85 -115.79 143.41 30.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.646 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.39 113.25 1.37 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.485 1.457 . . . . 0.0 110.535 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.669 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.75 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.63 61.55 0.31 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.824 -1.173 . . . . 0.0 110.663 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.07 -101.93 0.15 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.673 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.63 120.58 42.05 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.669 HG22 HG21 ' B' ' 86' ' ' ILE . 42.4 t -98.71 158.64 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.472 -0.767 . . . . 0.0 111.211 -177.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.55 116.05 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.74 106.11 18.25 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 109.629 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.61 159.54 42.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.02 17.28 4.31 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.25 75.92 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.25 -154.88 0.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.747 0.784 . . . . 0.0 109.748 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.479 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.31 143.51 46.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.513 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.528 -1.358 . . . . 0.0 110.594 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.473 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.0 m80 -56.59 131.92 50.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.07 -14.94 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 120.863 -1.148 . . . . 0.0 108.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.78 -26.89 15.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.828 -0.545 . . . . 0.0 110.71 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.06 -6.57 31.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.828 -1.17 . . . . 0.0 110.858 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.471 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.18 106.16 11.99 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.6 m -133.46 175.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.19 0.995 . . . . 0.0 111.203 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.74 45.86 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.303 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.9 28.69 1.75 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.111 -0.993 . . . . 0.0 109.667 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.421 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.83 -31.67 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.343 -0.848 . . . . 0.0 110.097 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.21 4.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.6 47.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 110.173 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.58 59.33 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.0 138.3 39.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.748 1.632 . . . . 0.0 112.13 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.312 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.83 56.94 1.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.159 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.32 1.62 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.34 -0.85 . . . . 0.0 109.01 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 31.07 2.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.946 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.32 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -1.048 . . . . 0.0 109.986 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.52 145.46 24.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.43 169.48 9.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.685 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.53 137.71 47.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.07 148.3 28.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.223 -0.923 . . . . 0.0 111.197 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.02 129.31 11.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.34 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.88 1.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.59 30.95 20.12 Favored Glycine 0 N--CA 1.483 1.775 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.713 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.36 142.74 31.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.535 -0.979 . . . . 0.0 108.82 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.47 152.73 36.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.4 m-85 -153.79 140.35 18.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.57 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.495 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.71 -35.92 82.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.4 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.72 -43.69 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.509 -0.744 . . . . 0.0 111.312 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.83 83.46 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.761 -1.212 . . . . 0.0 108.116 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.66 -56.44 13.65 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.7 m-80 -64.51 -44.93 89.36 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.004 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.5 -34.28 61.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.77 -35.4 44.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.218 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 110.091 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.37 31.43 16.52 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.56 51.19 15.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.313 -1.11 . . . . 0.0 109.612 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.475 -39.667 1 CA-C-O 71.024 -23.37 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.76 0.13 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -161.87 35.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -1.194 . . . . 0.0 109.575 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.439 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -72.99 148.68 43.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.123 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.21 93.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.28 -54.39 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.423 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.32 73.86 1.37 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.563 ' N ' ' OG ' ' A' ' 65' ' ' SER . 9.7 t -69.43 158.11 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 31' ' ' MET . 3.3 m -145.31 131.44 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.45 -1.406 . . . . 0.0 111.549 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -99.88 129.27 45.95 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.677 HG22 ' H ' ' A' ' 13' ' ' TYR . 31.8 m -63.42 154.38 32.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.455 1.121 . . . . 0.0 110.602 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.6 mt -114.36 -17.23 11.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.186 -1.412 . . . . 10.539999999999999 107.186 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.677 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.53 145.03 18.47 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.126 -0.984 . . . . 18.390000000000001 110.765 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 121.43 1.42 . . . . 0.0 109.037 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.79 170.3 13.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.965 -1.084 . . . . 0.0 110.984 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.58 111.01 7.96 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.739 0.78 . . . . 0.0 109.474 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.19 112.0 10.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 18' ' ' VAL . 15.9 m -130.36 94.31 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-O 122.901 1.334 . . . . 0.0 109.126 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.45 -152.07 0.4 Allowed 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.38 -1.282 . . . . 38.32 107.579 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 19' ' ' THR . 96.2 mt-10 -82.47 -54.27 5.33 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.863 -1.532 . . . . 55.130000000000003 106.863 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.445 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.33 29.24 7.72 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.375 -0.828 . . . . 0.0 110.741 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.649 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.57 150.94 22.18 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.812 -1.18 . . . . 0.0 109.671 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.469 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.29 22.23 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.42 -0.8 . . . . 11.68 110.757 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.43 127.65 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.8 142.18 21.63 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.425 -1.422 . . . . 12.44 110.904 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.22 155.83 22.31 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 146.93 17.93 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.464 -0.894 . . . . 29.030000000000001 109.577 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.62 44.09 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.218 -1.553 . . . . 6.1799999999999997 109.218 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.84 22.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.592 -0.946 . . . . 9.5199999999999996 109.449 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.03 108.65 6.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.51 133.74 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.175 1.464 . . . . 0.0 110.53 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.81 102.99 15.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.368 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.507 -0.746 . . . . 0.0 111.607 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' A' ' 47' ' ' LYS . 81.9 mt -59.8 -50.34 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.985 -1.072 . . . . 0.0 110.83 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.09 65.52 64.99 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.785 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -74.83 165.38 31.58 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.618 1.545 . . . . 0.0 108.987 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.93 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.57 -59.27 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.237 0.541 . . . . 0.0 110.136 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.35 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.63 -59.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.693 2.262 . . . . 0.0 109.943 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 70.8 mt-10 131.78 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 123.805 0.842 . . . . 0.0 108.769 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.556 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.8 m0 -71.93 165.92 23.2 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.607 -1.308 . . . . 14.289999999999999 110.436 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.467 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.5 m0 -129.57 144.99 51.51 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.338 -0.616 . . . . 11.800000000000001 109.338 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -79.01 96.72 5.84 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.493 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.72 55.98 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.907 0.86 . . . . 0.0 110.38 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.52 150.35 27.02 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.758 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.38 128.47 43.34 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.286 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.41 -18.41 1.03 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 119.716 -1.865 . . . . 0.0 107.918 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.55 -4.56 4.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.39 33.95 6.93 Favored Glycine 0 N--CA 1.481 1.684 0 CA-C-N 115.28 -0.873 . . . . 14.41 112.258 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.758 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.05 29.98 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.648 1.724 . . . . 0.0 111.82 179.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.67 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 122.325 1.059 . . . . 0.0 112.401 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.06 156.79 12.67 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.274 -1.53 . . . . 7.25 109.274 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.39 150.79 43.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.214 -1.168 . . . . 0.0 108.672 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.91 136.77 9.08 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 120.949 -1.094 . . . . 0.0 109.329 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.21 113.52 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 N-CA-C 109.024 -1.183 . . . . 4.7599999999999998 109.024 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.449 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.35 3.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 110.729 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 57' ' ' PRO . 95.7 m-20 -101.9 -7.71 22.22 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.247 -0.908 . . . . 14.84 109.4 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.0 8.23 30.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.221 -0.925 . . . . 10.23 109.437 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 11' ' ' THR . 33.5 m -147.48 156.48 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.096 -1.002 . . . . 6.9699999999999998 109.494 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG11 HD13 ' B' ' 78' ' ' ILE . 33.6 m -106.74 160.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.5 t -107.74 134.3 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.372 -0.83 . . . . 0.0 109.701 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 mp -105.06 -63.24 1.25 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.562 -0.711 . . . . 0.0 109.254 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.563 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 11.5 p -70.01 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.024 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 109.372 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.2 1.48 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.53 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.257 1.305 . . . . 0.0 109.656 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.06 82.67 1.78 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.93 124.96 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.81 156.24 28.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -1.114 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.92 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.433 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.44 46.91 0.2 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.21 130.82 5.39 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.312 -1.111 . . . . 0.0 109.396 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.65 35.94 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.876 1.718 . . . . 0.0 108.936 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.496 HG23 ' C ' ' B' ' 84' ' ' ARG . 64.8 mt -135.38 119.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 122.053 0.93 . . . . 0.0 109.44 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 14.8 t -58.46 117.13 4.15 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.872 0.844 . . . . 0.0 109.883 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.518 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -65.0 -0.06 4.97 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.829 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.55 8.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.15 4.94 13.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.496 ' C ' HG23 ' B' ' 78' ' ' ILE . 3.4 mtt180 -116.01 143.3 30.61 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.35 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.412 1.408 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.667 HG21 HG22 ' B' ' 90' ' ' VAL . 21.4 mt -70.98 158.45 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.426 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.54 61.46 0.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.828 -1.17 . . . . 0.0 110.671 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.04 0.15 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.658 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.63 120.59 42.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.667 HG22 HG21 ' B' ' 86' ' ' ILE . 42.2 t -98.72 158.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.41 -0.806 . . . . 0.0 111.286 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.47 HG23 HG22 ' B' ' 100' ' ' VAL . 5.0 t -122.43 116.06 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.79 106.15 18.27 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.572 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.47 42.74 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.19 4.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.16 76.03 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.19 -154.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.704 0.764 . . . . 0.0 109.747 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.47 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.47 143.5 45.9 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.518 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.6 140.07 33.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.506 -1.371 . . . . 0.0 110.614 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.5 m80 -56.36 131.98 49.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 91' ' ' VAL . 7.4 t -53.33 -14.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 120.843 -1.161 . . . . 0.0 108.323 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.94 15.51 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.804 -0.56 . . . . 0.0 110.683 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.17 -6.52 31.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.936 -1.102 . . . . 0.0 110.835 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.13 106.3 12.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.8 m -133.67 175.22 11.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 111.092 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.526 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.7 148.65 45.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.263 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.85 28.72 1.73 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.57 0.71 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.354 -0.842 . . . . 0.0 110.056 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.4 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.15 -15.55 4.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.75 47.65 0.33 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.55 59.34 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -68.96 138.29 40.03 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.788 1.659 . . . . 0.0 112.101 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.313 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.77 56.91 1.79 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.023 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.18 1.69 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 0.0 109.022 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 30.97 2.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.945 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.34 178.88 4.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -1.041 . . . . 0.0 110.066 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.31 145.41 24.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.509 -0.745 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.33 169.52 9.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 109.624 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.703 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.52 137.77 47.28 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.21 29.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.256 -0.902 . . . . 0.0 111.212 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.36 11.35 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.609 0.719 . . . . 0.0 110.35 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.07 22.92 1.36 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.578 -0.701 . . . . 0.0 109.536 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.37 31.15 20.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.792 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.45 142.74 31.31 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.549 -0.971 . . . . 0.0 108.803 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.42 152.86 36.08 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.725 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.557 ' CE1' HD22 ' B' ' 133' ' ' LEU . 58.3 m-85 -153.82 140.37 18.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.69 177.48 0.11 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.471 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.61 -36.04 82.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 109.294 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 53.7 m -86.66 -43.73 12.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 111.295 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.89 83.38 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.736 -1.228 . . . . 0.0 108.052 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.32 14.47 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.419 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.2 m-80 -64.66 -44.75 89.42 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.48 -34.3 61.3 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.22 44.81 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.351 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.66 -81.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.29 31.6 16.26 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 48.31 51.33 15.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 71.114 -23.327 . . . . 0.0 109.534 179.903 . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.93 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.98 35.32 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 109.619 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.435 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.08 148.7 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.049 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.12 93.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 0.0 109.394 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.28 2.0 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.38 73.82 1.37 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.39 158.09 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.2 m -145.39 131.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.485 -1.384 . . . . 0.0 111.529 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.92 129.21 45.97 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 13' ' ' TYR . 30.7 m -63.52 154.45 32.44 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.521 1.153 . . . . 0.0 110.584 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.2 mt -114.39 -17.25 11.82 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.173 -1.417 . . . . 10.539999999999999 107.173 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.675 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.49 145.03 18.49 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.198 -0.939 . . . . 18.390000000000001 110.791 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.04 81.43 1.68 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.385 1.39 . . . . 0.0 109.099 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CG ' ' N ' ' A' ' 16' ' ' SER . 27.8 t80 -71.61 170.23 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.962 -1.087 . . . . 0.0 110.937 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.6 111.09 8.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.776 0.798 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 111.89 10.59 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 18' ' ' VAL . 17.6 m -130.25 94.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-O 122.883 1.325 . . . . 0.0 109.16 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.54 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -144.42 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.575 177.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.54 ' H ' HG22 ' A' ' 19' ' ' THR . 97.5 mt-10 -82.39 -54.34 5.3 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.904 -1.517 . . . . 55.130000000000003 106.904 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 17.4 pt-20 -109.26 29.09 7.86 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.451 -0.781 . . . . 0.0 110.703 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.62 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.41 150.89 22.15 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.921 -1.112 . . . . 0.0 109.741 -179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.33 111.4 22.42 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.402 -0.811 . . . . 11.68 110.739 -178.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.35 127.6 41.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.89 142.16 21.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.366 -1.459 . . . . 12.44 110.912 -178.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.19 155.8 22.36 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.97 18.2 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.465 -0.894 . . . . 29.030000000000001 109.591 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.54 44.2 6.6 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 6.1799999999999997 109.298 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.37 114.8 22.9 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.725 -0.868 . . . . 9.5199999999999996 109.389 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.98 108.67 6.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.54 133.66 49.92 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 123.112 1.434 . . . . 0.0 110.585 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.65 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.393 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.16 92.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 111.431 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.48 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.8 mt -59.71 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.894 -1.129 . . . . 0.0 110.259 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.474 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.916 -1.115 . . . . 0.0 110.79 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.07 65.53 65.13 Favored Pre-proline 0 N--CA 1.486 1.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.794 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.44 31.42 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.653 1.569 . . . . 0.0 108.982 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.06 -46.55 7.73 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.78 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.351 0.596 . . . . 0.0 110.052 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 122.664 2.243 . . . . 0.0 110.023 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 31.4 tt0 131.77 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 C-N-CA 123.814 0.846 . . . . 0.0 108.752 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.548 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.6 m0 -71.87 165.96 23.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.623 -1.298 . . . . 14.289999999999999 110.463 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.561 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.1 m0 -129.68 145.06 51.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.233 -0.654 . . . . 11.800000000000001 109.233 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.99 96.73 5.83 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.73 55.98 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.89 0.853 . . . . 0.0 110.428 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.52 150.33 27.03 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.756 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.1 p30 -96.47 128.51 43.47 Favored 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 117.25 -1.78 . . . . 0.0 107.212 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.3 -18.46 0.97 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.775 -1.828 . . . . 0.0 107.995 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.476 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.6 4.29 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.45 33.82 6.97 Favored Glycine 0 N--CA 1.482 1.761 0 CA-C-N 115.388 -0.824 . . . . 14.41 112.281 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.756 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.91 164.02 30.04 Favored 'General case' 0 N--CA 1.515 2.809 0 CA-C-N 119.796 1.798 . . . . 0.0 111.839 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.59 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 122.309 1.052 . . . . 0.0 112.522 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.11 156.64 12.53 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.255 -1.538 . . . . 7.25 109.255 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.3 150.85 43.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.13 -1.218 . . . . 0.0 108.768 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.62 8.92 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.895 -1.128 . . . . 0.0 109.271 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.048 -1.174 . . . . 4.7599999999999998 109.048 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.561 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 33.9 pttt -60.38 3.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.9 m-20 -102.09 -7.63 22.11 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.183 -0.948 . . . . 14.84 109.273 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 10.23 109.454 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.3 m -147.48 156.64 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.149 -0.969 . . . . 6.9699999999999998 109.521 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 63' ' ' VAL . 11.3 p -106.77 160.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.435 ' N ' HG22 ' A' ' 62' ' ' VAL . 48.5 t -107.63 134.36 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.5 -0.75 . . . . 0.0 109.767 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -105.11 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.619 -0.676 . . . . 0.0 109.227 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -69.91 151.58 45.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.0 109.435 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -146.54 152.72 39.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 0.0 109.377 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.29 1.48 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.47 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.338 1.358 . . . . 0.0 109.645 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.66 1.78 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.04 32.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.85 156.25 28.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.93 0.2 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.74 5.33 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.337 -1.096 . . . . 0.0 109.378 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.6 Cg_endo -74.14 163.51 36.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.988 1.792 . . . . 0.0 108.87 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.59 HG23 ' C ' ' B' ' 84' ' ' ARG . 48.5 mt -135.35 119.89 27.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 122.081 0.943 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.42 117.01 4.01 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.831 0.824 . . . . 0.0 110.048 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.519 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.93 -0.09 4.91 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.58 -48.7 8.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -1.061 . . . . 0.0 109.375 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.84 13.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.568 -0.708 . . . . 0.0 109.106 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 53.51 41.33 32.11 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.59 ' C ' HG23 ' B' ' 78' ' ' ILE . 42.7 mtp180 -115.89 143.51 30.92 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.54 113.31 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.5 1.467 . . . . 0.0 110.464 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.678 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.78 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.57 61.48 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.809 -1.182 . . . . 0.0 110.646 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.0 0.15 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.674 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.5 120.56 42.06 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.678 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.74 158.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.66 0.743 . . . . 0.0 111.253 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' B' ' 103' ' ' PHE . 5.0 t -122.42 115.96 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.096 -1.003 . . . . 0.0 109.473 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.55 159.42 42.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.19 17.14 4.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.22 75.94 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.79 0.805 . . . . 0.0 109.754 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.36 143.52 46.12 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.519 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.58 140.0 33.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.66 -1.275 . . . . 0.0 110.58 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.54 132.02 50.37 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.39 -14.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.876 -1.14 . . . . 0.0 108.335 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.82 -26.94 15.45 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.806 -0.559 . . . . 0.0 110.651 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.08 -6.59 31.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.952 -1.092 . . . . 0.0 110.858 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.13 106.26 12.02 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.0 m -133.62 175.17 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.218 1.009 . . . . 0.0 111.18 -177.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.525 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.67 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.259 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.78 1.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.85 -31.75 0.71 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.14 -15.37 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.248 -0.908 . . . . 0.0 110.175 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.66 47.69 0.34 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.851 . . . . 0.0 110.147 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.47 59.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -69.02 138.23 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.706 1.604 . . . . 0.0 112.167 -177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.315 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.76 56.76 1.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.19 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.93 -55.27 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 0.0 109.07 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.08 2.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.93 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.33 178.96 4.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.469 -1.018 . . . . 0.0 109.953 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.45 145.36 24.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.404 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.6 137.64 47.13 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -107.08 148.26 28.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.23 -0.919 . . . . 0.0 111.233 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 129.4 11.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.614 0.721 . . . . 0.0 110.332 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.15 22.86 1.4 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 0.0 109.504 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.95 20.4 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.687 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.4 mt -143.26 142.82 31.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.514 -0.992 . . . . 0.0 108.852 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.48 152.97 35.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.673 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.554 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.9 m-85 -153.92 140.28 18.65 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.61 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.399 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.0 tt0 -63.56 -36.11 82.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.402 -0.811 . . . . 0.0 109.475 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.2 m -86.51 -43.63 12.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.724 . . . . 0.0 111.466 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.77 -43.76 83.15 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.789 -1.194 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.4 13.95 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.6 -44.91 89.1 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.074 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.28 61.22 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.554 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.7 -35.3 45.18 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.354 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.2 m-85 -158.51 -81.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 110.094 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.35 31.41 16.62 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.54 51.16 15.87 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -1.151 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.934 -23.412 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.44 74.92 0.12 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -161.94 35.24 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.253 -1.145 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.02 148.58 44.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.0 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.22 -54.26 2.0 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.435 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.41 73.94 1.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' N ' ' OG ' ' A' ' 65' ' ' SER . 79.1 t -69.38 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 31' ' ' MET . 3.9 m -145.41 131.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.354 -1.466 . . . . 0.0 111.461 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -99.79 129.19 45.87 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 13' ' ' TYR . 35.4 m -63.44 154.31 32.56 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.51 1.148 . . . . 0.0 110.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.3 mt -114.28 -17.25 11.88 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.225 -1.398 . . . . 10.539999999999999 107.225 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.662 ' H ' HG22 ' A' ' 11' ' ' THR . 14.6 m-85 -149.47 145.1 18.63 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.164 -0.96 . . . . 18.390000000000001 110.678 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -73.01 81.45 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.444 1.43 . . . . 0.0 109.107 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.78 170.32 13.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.98 -1.075 . . . . 0.0 110.861 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.72 111.1 7.96 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.805 0.812 . . . . 0.0 109.38 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 112.0 10.72 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 18' ' ' VAL . 34.0 m -130.36 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 122.941 1.353 . . . . 0.0 109.222 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 1.031 HG22 ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.512 -1.292 . . . . 38.32 107.512 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 1.031 ' OE1' HG22 ' A' ' 19' ' ' THR . 58.8 mp0 -82.38 -54.47 5.19 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.832 -1.544 . . . . 55.130000000000003 106.832 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -109.18 29.22 7.72 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.374 -0.829 . . . . 0.0 110.803 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.53 150.93 22.16 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.036 -1.04 . . . . 0.0 109.761 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.52 22.61 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.517 -0.739 . . . . 11.68 110.655 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.49 127.84 41.86 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.0 142.21 21.48 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.415 -1.428 . . . . 12.44 110.78 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.87 22.4 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 146.92 18.78 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.238 -0.913 . . . . 29.030000000000001 109.585 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 44.2 6.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.416 -1.474 . . . . 6.1799999999999997 109.416 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.452 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.83 22.93 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.543 -0.974 . . . . 9.5199999999999996 109.331 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.13 108.67 6.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.48 133.66 49.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.155 1.455 . . . . 0.0 110.584 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.78 103.14 15.88 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.41 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.19 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.489 -0.757 . . . . 0.0 111.491 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.4 mt -59.91 -50.31 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.957 -1.09 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.14 65.63 64.94 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.701 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.77 165.41 31.54 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.627 1.551 . . . . 0.0 109.049 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.1 -46.55 7.72 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.77 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.419 0.628 . . . . 0.0 110.059 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.51 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.65 -59.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.547 2.164 . . . . 0.0 109.975 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 71.6 mt-10 131.7 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 123.828 0.851 . . . . 0.0 108.837 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.522 ' HB2' HD12 ' A' ' 55' ' ' LEU . 20.2 m0 -71.87 166.0 22.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.696 -1.252 . . . . 14.289999999999999 110.497 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.4 m0 -129.64 144.97 51.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.668 -0.645 . . . . 11.800000000000001 109.355 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -78.98 96.68 5.81 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.76 56.0 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.889 0.852 . . . . 0.0 110.321 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.69 150.39 26.79 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.754 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.37 128.56 43.4 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 117.327 -1.749 . . . . 0.0 107.239 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.5 1.02 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 119.584 -1.948 . . . . 0.0 108.008 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.472 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.57 4.26 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.47 33.81 6.97 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-N 115.403 -0.817 . . . . 14.41 112.284 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.754 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.1 29.8 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-N 119.724 1.762 . . . . 0.0 111.792 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.63 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-O 122.356 1.074 . . . . 0.0 112.541 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.71 12.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.294 -1.522 . . . . 7.25 109.294 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.522 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.3 150.78 43.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.278 -1.13 . . . . 0.0 108.596 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.04 136.77 9.02 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 109.269 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 N-CA-C 109.014 -1.187 . . . . 4.7599999999999998 109.014 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.37 3.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.482 -0.761 . . . . 0.0 110.712 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.7 m-20 -102.01 -7.63 22.18 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.206 -0.934 . . . . 14.84 109.327 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.97 8.13 31.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 10.23 109.527 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.41 156.64 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.193 -0.942 . . . . 6.9699999999999998 109.483 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.738 HG11 HD13 ' B' ' 78' ' ' ILE . 27.7 m -106.85 160.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.57 134.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.389 -0.819 . . . . 0.0 109.838 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 mp -105.2 -63.18 1.26 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.631 -0.668 . . . . 0.0 109.229 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 14.4 p -70.01 151.54 45.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.037 -1.039 . . . . 0.0 109.521 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 55.7 p-10 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.3 1.48 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.304 1.336 . . . . 0.0 109.667 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.02 82.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.09 32.33 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.71 156.1 29.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.278 -1.131 . . . . 0.0 109.57 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.4 mtt -49.7 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.74 0.2 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.22 130.86 5.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.301 -1.117 . . . . 0.0 109.378 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.41 163.66 35.74 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.85 1.7 . . . . 0.0 108.827 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.738 HD13 HG11 ' A' ' 62' ' ' VAL . 74.6 mt -135.41 119.86 26.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.07 0.938 . . . . 0.0 109.338 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 14.9 t -58.43 116.98 3.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.824 0.821 . . . . 0.0 109.871 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.24 4.92 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.63 -48.65 8.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.361 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.09 4.77 13.72 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 53.57 41.36 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.469 ' C ' HG23 ' B' ' 78' ' ' ILE . 19.7 mtp180 -115.89 143.43 30.77 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.644 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.43 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.442 1.428 . . . . 0.0 110.551 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.661 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.94 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.425 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.44 61.54 0.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.918 -1.114 . . . . 0.0 110.583 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.08 -102.06 0.15 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.661 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.64 120.74 42.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.661 HG22 HG21 ' B' ' 86' ' ' ILE . 42.7 t -98.83 158.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.762 0.792 . . . . 0.0 111.141 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.45 115.91 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 109.548 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.5 42.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.15 17.23 4.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.1 25.42 75.64 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.27 -154.77 0.65 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.712 0.768 . . . . 0.0 109.821 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.472 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.46 143.37 45.85 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.8 m95 -141.48 140.1 33.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.41 -1.431 . . . . 0.0 110.634 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.449 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.5 131.9 49.92 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.6 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 120.894 -1.129 . . . . 0.0 108.336 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.449 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.91 -26.94 15.4 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.71 -0.619 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.21 -6.42 31.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.806 -1.184 . . . . 0.0 110.899 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.29 106.19 12.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.824 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.53 175.25 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.288 1.042 . . . . 0.0 111.167 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.81 148.66 46.28 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.8 28.73 1.71 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.414 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.84 -31.62 0.71 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.349 -0.844 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.22 -15.27 4.19 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.332 -0.855 . . . . 0.0 110.138 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.66 47.67 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.319 -0.863 . . . . 0.0 110.148 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.52 59.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.824 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -69.03 138.22 39.58 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.704 1.603 . . . . 0.0 112.168 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.309 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.79 56.96 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.157 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.01 -55.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 109.082 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.19 30.88 2.76 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.966 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.18 178.84 4.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.479 -1.012 . . . . 0.0 110.03 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.33 145.24 24.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.55 9.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 0.0 109.489 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.6 137.65 47.13 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.03 148.24 28.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.241 -0.912 . . . . 0.0 111.331 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.31 11.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.685 0.755 . . . . 0.0 110.257 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.38 22.83 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.506 -0.746 . . . . 0.0 109.414 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.87 20.59 Favored Glycine 0 N--CA 1.481 1.685 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.79 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.29 142.64 31.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.524 -0.986 . . . . 0.0 108.821 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.91 36.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.739 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.543 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -154.01 140.26 18.54 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.7 m -57.61 177.4 0.1 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.453 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.81 . . . . 0.0 109.383 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.68 -43.79 12.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.434 -0.791 . . . . 0.0 111.354 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.74 83.91 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.867 -1.145 . . . . 0.0 108.213 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.46 13.58 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.4 m-80 -64.52 -44.82 89.66 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.45 -34.49 61.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.543 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.64 -35.19 45.81 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.381 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.7 -81.64 0.05 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 110.085 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.44 31.43 16.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.55 51.28 15.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -1.103 . . . . 0.0 109.556 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.791 -23.48 . . . . 0.0 109.443 -179.981 . . . . . . . . 2 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.81 0.13 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.595 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.03 148.68 43.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.882 . . . . 0.0 109.099 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.11 93.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 109.238 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.31 -54.25 2.0 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.34 74.08 1.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.5 t -69.53 158.07 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.34 131.55 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.463 -1.398 . . . . 0.0 111.528 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.93 129.26 45.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 13' ' ' TYR . 38.5 m -63.42 154.33 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.468 1.128 . . . . 0.0 110.633 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 74.4 mt -114.31 -17.34 11.84 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.219 -1.4 . . . . 10.539999999999999 107.219 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.648 ' H ' HG22 ' A' ' 11' ' ' THR . 14.4 m-85 -149.5 145.08 18.57 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.21 -0.931 . . . . 18.390000000000001 110.726 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 121.364 1.376 . . . . 0.0 109.042 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.85 170.23 14.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.972 -1.08 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.14 8.04 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.906 0.86 . . . . 0.0 109.358 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.07 10.73 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 18' ' ' VAL . 15.4 m -130.44 94.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 123.039 1.399 . . . . 0.0 109.172 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.672 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.4 m -144.58 -152.11 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.321 -1.309 . . . . 38.32 107.593 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.672 ' H ' HG22 ' A' ' 19' ' ' THR . 79.1 mm-40 -82.37 -54.3 5.33 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.92 -1.511 . . . . 55.130000000000003 106.92 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 74.9 mt-10 -109.33 29.17 7.79 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.364 -0.835 . . . . 0.0 110.778 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.39 150.78 22.26 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.756 -1.215 . . . . 0.0 109.83 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.29 111.37 22.38 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.408 -0.807 . . . . 11.68 110.775 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.43 127.71 41.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.0 142.04 21.32 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.374 -1.454 . . . . 12.44 110.848 -178.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.07 155.85 22.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.92 18.49 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.482 -0.887 . . . . 29.030000000000001 109.539 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.12 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.284 -1.526 . . . . 6.1799999999999997 109.284 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.4 114.84 22.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.584 -0.951 . . . . 9.5199999999999996 109.424 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.07 108.68 6.1 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.54 133.83 49.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 123.231 1.491 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.05 15.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.328 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.545 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.99 92.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.527 -0.733 . . . . 0.0 111.485 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.487 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.6 mt -59.65 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.927 -1.108 . . . . 0.0 110.344 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.66 43.68 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.037 -1.039 . . . . 0.0 110.737 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.02 65.55 65.54 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.75 165.4 31.59 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.61 1.54 . . . . 0.0 109.003 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.07 -46.48 7.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.66 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.352 0.596 . . . . 0.0 110.025 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.8 -47.36 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.734 2.289 . . . . 0.0 109.961 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 67.5 mt-10 131.76 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 C-N-CA 123.881 0.872 . . . . 0.0 108.805 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.551 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.5 m0 -71.85 165.89 23.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.738 -1.226 . . . . 14.289999999999999 110.502 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.491 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.6 m0 -129.51 145.03 51.5 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.377 -0.601 . . . . 11.800000000000001 109.377 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -78.98 96.71 5.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.9 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.869 0.842 . . . . 0.0 110.429 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.79 150.47 26.61 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.758 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.39 128.53 43.4 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 117.28 -1.768 . . . . 0.0 107.325 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.45 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.618 -1.926 . . . . 0.0 107.951 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.71 -4.47 4.31 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.4 33.95 6.92 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 115.379 -0.828 . . . . 14.41 112.224 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.758 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.1 29.79 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.731 1.766 . . . . 0.0 111.87 179.12 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.02 154.65 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.323 1.059 . . . . 0.0 112.408 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.337 -1.505 . . . . 7.25 109.337 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.96 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.31 -1.112 . . . . 0.0 108.684 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.08 136.79 9.02 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.004 -1.06 . . . . 0.0 109.297 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.98 -1.2 . . . . 4.7599999999999998 108.98 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.46 3.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 110.721 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -101.97 -7.67 22.18 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.147 -0.971 . . . . 14.84 109.391 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.06 8.33 30.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.919 . . . . 10.23 109.483 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.7 m -147.46 156.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 6.9699999999999998 109.454 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 63' ' ' VAL . 3.8 p -106.76 160.82 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' N ' HG22 ' A' ' 62' ' ' VAL . 45.6 t -107.71 134.26 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.403 -0.811 . . . . 0.0 109.714 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' O ' ' NH2' ' B' ' 84' ' ' ARG . 9.0 mp -105.14 -63.3 1.24 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -69.92 151.59 45.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 49.4 p30 -146.55 152.72 39.41 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.45 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 121.368 1.378 . . . . 0.0 109.7 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.03 82.59 1.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.93 125.14 32.41 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.514 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.09 28.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -1.073 . . . . 0.0 109.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.76 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.3 46.98 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.32 130.79 5.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.286 -1.126 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.21 163.6 36.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.912 1.741 . . . . 0.0 108.847 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 30.6 mt -135.43 119.84 26.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 122.17 0.986 . . . . 0.0 109.429 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.3 116.96 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.778 0.799 . . . . 0.0 109.897 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.508 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.23 4.91 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.59 -48.74 8.07 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 109.321 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.89 13.76 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 53.44 41.28 32.13 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.459 ' HE ' ' HB3' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -115.82 143.43 30.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.64 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.5 Cg_exo -56.48 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.433 1.422 . . . . 0.0 110.56 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.67 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.91 158.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.426 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.51 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.0 110.577 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.668 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.71 42.46 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.67 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.8 158.62 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.669 0.747 . . . . 0.0 111.245 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.51 116.03 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.585 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.56 42.58 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 57.94 17.38 4.29 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.32 75.78 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.84 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.474 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.38 143.4 46.03 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.508 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.46 139.97 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.507 -1.371 . . . . 0.0 110.67 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.445 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.38 131.9 49.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.926 -1.109 . . . . 0.0 108.436 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.85 -26.98 15.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.781 -0.574 . . . . 0.0 110.624 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.1 -6.55 31.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.937 -1.102 . . . . 0.0 110.842 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' B' ' 91' ' ' VAL . 24.9 t80 -80.1 106.26 11.99 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.58 175.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.268 1.032 . . . . 0.0 111.172 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.71 45.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.31 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.66 1.74 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.78 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -128.98 -15.57 4.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.385 -0.822 . . . . 0.0 110.208 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.59 0.32 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.52 59.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.06 138.18 39.39 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.699 1.6 . . . . 0.0 112.184 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.326 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.67 56.85 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.194 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.634 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.08 -55.22 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.337 -0.852 . . . . 0.0 108.962 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.22 31.05 2.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.938 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.25 179.07 4.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.578 -0.954 . . . . 0.0 109.949 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.41 24.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 109.305 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.35 169.42 9.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.684 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.67 47.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.92 148.29 28.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.264 -0.898 . . . . 0.0 111.25 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.37 11.34 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.584 0.707 . . . . 0.0 110.295 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.14 22.92 1.41 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.664 -0.647 . . . . 0.0 109.448 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.35 31.08 20.39 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.443 -1.361 . . . . 0.0 109.742 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.32 142.71 31.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.547 -0.973 . . . . 0.0 108.778 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.26 152.85 36.38 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.641 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.547 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.9 m-85 -153.9 140.22 18.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.57 177.43 0.1 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.477 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.56 -36.03 82.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.387 -0.82 . . . . 0.0 109.357 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.2 m -86.61 -43.86 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 111.289 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.64 84.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 108.218 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.86 -56.37 14.42 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.55 -44.74 89.83 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.2 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -54.49 -34.37 61.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.547 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.12 44.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.346 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.52 31.32 16.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.409 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.53 51.3 15.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.723 1 CA-C-O 70.819 -23.467 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.29 0.567 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.31 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.02 148.64 43.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.12 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.185 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.26 -54.35 2.0 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.444 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.34 74.0 1.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' N ' ' OG ' ' A' ' 65' ' ' SER . 10.1 t -69.51 158.13 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.9 m -145.33 131.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.487 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -99.87 129.31 45.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.4 m -63.51 154.36 32.69 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.456 1.122 . . . . 0.0 110.625 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.9 mt -114.31 -17.23 11.86 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.224 -1.398 . . . . 10.539999999999999 107.224 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' H ' HG22 ' A' ' 11' ' ' THR . 14.1 m-85 -149.56 145.03 18.45 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.21 -0.931 . . . . 18.390000000000001 110.798 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.41 1.67 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 121.425 1.417 . . . . 0.0 109.01 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.71 170.26 13.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.948 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.13 8.06 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.741 0.782 . . . . 0.0 109.452 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.38 112.08 10.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.33 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.888 1.327 . . . . 0.0 109.193 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.509 -1.293 . . . . 38.32 107.509 177.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 19' ' ' THR . 84.2 tt0 -82.49 -54.21 5.37 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.897 -1.52 . . . . 55.130000000000003 106.897 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.39 29.31 7.66 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.365 -0.834 . . . . 0.0 110.849 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.57 150.85 22.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.801 -1.187 . . . . 0.0 109.759 -179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -111.34 111.44 22.48 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.411 -0.806 . . . . 11.68 110.714 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.49 127.78 41.8 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.484 ' HE2' ' HG1' ' A' ' 11' ' ' THR . 0.8 OUTLIER -153.02 142.18 21.44 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.382 -1.449 . . . . 12.44 110.819 -178.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.24 155.77 22.32 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.28 146.96 17.83 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.282 -0.886 . . . . 29.030000000000001 109.521 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.48 44.11 6.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.35 -1.5 . . . . 6.1799999999999997 109.35 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.26 114.83 23.01 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.493 -1.004 . . . . 9.5199999999999996 109.451 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.09 108.63 6.09 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.49 133.64 49.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.179 1.466 . . . . 0.0 110.523 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 103.05 15.8 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.733 -1.576 . . . . 0.0 107.484 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.535 -0.728 . . . . 0.0 111.465 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.493 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.69 -50.46 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.986 -1.072 . . . . 0.0 110.273 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.56 43.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -134.93 65.52 65.88 Favored Pre-proline 0 N--CA 1.486 1.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.791 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.69 165.42 31.59 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.625 1.55 . . . . 0.0 109.008 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.53 7.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.7 m-20 57.69 -59.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.33 0.586 . . . . 0.0 110.017 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 178.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.2 Cg_endo -68.73 -59.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.756 2.304 . . . . 0.0 109.776 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 16.8 pt-20 131.78 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 123.79 0.836 . . . . 0.0 108.784 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.553 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.7 m0 -72.0 165.92 23.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.756 -1.215 . . . . 14.289999999999999 110.407 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.3 m0 -129.58 145.07 51.51 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 109.276 -0.639 . . . . 11.800000000000001 109.276 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -79.03 96.63 5.83 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.97 128.86 56.08 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.942 0.877 . . . . 0.0 110.441 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.62 150.4 26.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.76 ' N ' ' O ' ' A' ' 52' ' ' GLN . 14.9 p30 -96.4 128.52 43.4 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 117.284 -1.766 . . . . 0.0 107.221 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.46 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 119.668 -1.895 . . . . 0.0 108.031 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.57 -4.61 4.27 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.45 33.89 6.94 Favored Glycine 0 N--CA 1.481 1.691 0 CA-C-N 115.303 -0.862 . . . . 14.41 112.271 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.76 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.12 29.77 Favored 'General case' 0 N--CA 1.515 2.812 0 CA-C-N 119.736 1.768 . . . . 0.0 111.843 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.302 1.048 . . . . 0.0 112.468 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.44 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.22 156.73 12.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.306 -1.518 . . . . 7.25 109.306 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.41 150.85 43.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.271 -1.135 . . . . 0.0 108.685 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.74 9.03 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.765 -1.209 . . . . 0.0 109.354 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.32 113.5 1.15 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.032 -1.18 . . . . 4.7599999999999998 109.032 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.19 3.09 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.793 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.7 m-20 -102.03 -7.67 22.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.095 -1.003 . . . . 14.84 109.337 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -89.11 8.38 30.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.91 . . . . 10.23 109.455 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.48 156.53 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.101 -0.999 . . . . 6.9699999999999998 109.431 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 63' ' ' VAL . 8.4 p -106.79 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.505 ' N ' HG22 ' A' ' 62' ' ' VAL . 46.6 t -107.67 134.23 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.35 -0.844 . . . . 0.0 109.753 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.17 -63.12 1.26 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.567 -0.708 . . . . 0.0 109.184 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.6 p -70.0 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 50.6 p30 -146.58 152.66 39.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 109.42 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.316 1.344 . . . . 0.0 109.638 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.5 1.75 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.12 32.36 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.434 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.27 28.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.98 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.17 46.82 0.2 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.72 5.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.24 163.64 36.02 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.975 1.783 . . . . 0.0 108.842 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.566 HG23 ' C ' ' B' ' 84' ' ' ARG . 6.4 mt -135.38 119.7 26.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.967 0.889 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.32 116.86 3.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.871 0.843 . . . . 0.0 109.917 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.72 -0.19 4.79 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.62 -48.53 8.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.993 . . . . 0.0 109.443 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.8 13.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 109.147 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 53.47 41.27 32.13 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.566 ' C ' HG23 ' B' ' 78' ' ' ILE . 8.9 mtm105 -115.95 143.39 30.74 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.639 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.42 113.32 1.4 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.409 1.406 . . . . 0.0 110.699 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.668 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.86 158.47 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.56 61.54 0.32 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.858 -1.151 . . . . 0.0 110.593 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.658 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.7 120.69 42.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.668 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.83 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.686 0.755 . . . . 0.0 111.168 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.53 116.01 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.87 106.22 18.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.69 159.53 42.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.21 4.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.14 25.22 75.92 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.2 -154.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.728 0.775 . . . . 0.0 109.783 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.465 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.41 143.37 45.95 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.604 -1.31 . . . . 0.0 110.669 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.503 ' CE1' ' NH2' ' B' ' 84' ' ' ARG . 17.2 m80 -56.56 131.99 50.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG23 ' B' ' 91' ' ' VAL . 7.9 t -53.17 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 120.902 -1.124 . . . . 0.0 108.311 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.79 -27.02 15.43 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.848 -0.532 . . . . 0.0 110.62 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.04 -6.59 31.54 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.886 -1.134 . . . . 0.0 110.841 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.468 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.1 t80 -80.12 106.27 12.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.7 m -133.56 175.34 11.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.272 1.034 . . . . 0.0 111.081 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.68 46.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.312 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.5 1.77 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.7 -31.66 0.72 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.369 -0.832 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.17 -15.42 4.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.375 -0.828 . . . . 0.0 110.133 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.64 47.68 0.34 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.208 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.64 59.59 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.21 138.31 39.23 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.691 1.594 . . . . 0.0 112.126 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.294 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.87 56.95 1.77 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.21 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 108.997 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.97 2.74 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.967 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.25 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -1.011 . . . . 0.0 110.024 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.33 24.86 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.57 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.54 9.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.65 47.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.01 148.26 28.92 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.312 -0.867 . . . . 0.0 111.196 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.31 11.28 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.606 0.717 . . . . 0.0 110.413 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.3 22.84 1.49 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.579 -0.7 . . . . 0.0 109.482 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.47 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.6 mt -143.26 142.74 31.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.487 -1.007 . . . . 0.0 108.762 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.28 152.79 36.37 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.802 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.546 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.82 140.24 18.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.49 177.54 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.341 -1.343 . . . . 0.0 108.388 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.74 -35.99 82.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.382 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.4 m -86.67 -43.65 12.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 0.0 111.464 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.6 -43.76 83.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.797 -1.19 . . . . 0.0 108.255 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.521 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.54 13.17 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.4 m-80 -64.39 -44.98 89.63 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.39 61.25 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.546 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.62 -35.24 45.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.387 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 110.09 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.36 31.48 16.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.413 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.4 51.28 15.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -1.099 . . . . 0.0 109.644 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.708 1 CA-C-O 71.096 -23.335 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.37 74.88 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.6 p -161.93 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.238 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.0 148.67 43.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 t -66.14 93.38 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.02 . . . . 0.0 109.19 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.21 -54.28 2.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.445 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.3 73.97 1.38 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' N ' ' OG ' ' A' ' 65' ' ' SER . 3.7 t -69.39 158.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.46 131.51 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.462 -1.399 . . . . 0.0 111.447 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.0 129.25 46.04 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.2 m -63.45 154.4 32.32 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.505 1.145 . . . . 0.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 84.2 mt -114.39 -17.34 11.8 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.202 -1.407 . . . . 10.539999999999999 107.202 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.662 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.4 145.11 18.68 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.24 -0.913 . . . . 18.390000000000001 110.79 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.06 81.56 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 121.394 1.396 . . . . 0.0 109.022 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.86 170.39 13.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.853 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.85 0.833 . . . . 0.0 109.338 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.35 111.92 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 18' ' ' VAL . 14.3 m -130.35 94.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 122.93 1.348 . . . . 0.0 109.145 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.52 -152.05 0.4 Allowed 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.392 -1.276 . . . . 38.32 107.611 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.676 ' H ' HG22 ' A' ' 19' ' ' THR . 97.0 mt-10 -82.47 -54.35 5.26 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.813 -1.551 . . . . 55.130000000000003 106.813 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.3 29.19 7.77 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.388 -0.82 . . . . 0.0 110.727 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -100.5 150.85 22.24 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.963 -1.086 . . . . 0.0 109.697 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.37 111.55 22.68 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.384 -0.823 . . . . 11.68 110.698 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -95.59 127.75 41.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.02 142.18 21.43 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.433 -1.417 . . . . 12.44 110.801 -178.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.85 22.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 146.85 18.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.228 -0.92 . . . . 29.030000000000001 109.516 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.53 44.26 6.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.302 -1.519 . . . . 6.1799999999999997 109.302 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.71 22.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.476 -1.014 . . . . 9.5199999999999996 109.432 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.57 5.95 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.42 133.7 49.74 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 123.088 1.423 . . . . 0.0 110.574 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.83 103.15 15.89 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.374 -178.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.12 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.561 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.2 mt -59.79 -50.3 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.962 -1.086 . . . . 0.0 110.276 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.537 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.28 157.63 43.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.983 -1.073 . . . . 0.0 110.724 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HB3' ' NE1' ' A' ' 44' ' ' TRP . 1.9 mptp? -135.05 65.56 65.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.789 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.39 31.65 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.655 1.57 . . . . 0.0 109.004 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.09 -46.37 7.81 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.58 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 110.044 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.49 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.69 -59.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.107 0 C-N-CA 122.592 2.194 . . . . 0.0 109.922 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 54.2 tt0 131.7 9.38 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 123.882 0.873 . . . . 0.0 108.785 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.0 m0 -71.96 166.01 23.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.73 -1.231 . . . . 14.289999999999999 110.436 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.562 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.0 m0 -129.6 145.09 51.52 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.284 -0.635 . . . . 11.800000000000001 109.284 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.17 96.64 5.93 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.87 128.76 56.05 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.884 0.849 . . . . 0.0 110.45 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.69 150.36 26.81 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.762 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.35 128.5 43.33 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.297 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.41 0.99 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 119.632 -1.918 . . . . 0.0 107.991 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.465 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.64 -4.55 4.31 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.46 33.79 6.99 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 115.25 -0.886 . . . . 14.41 112.306 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.762 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.89 164.11 29.79 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.658 1.729 . . . . 0.0 111.847 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.55 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 122.294 1.045 . . . . 0.0 112.53 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.19 156.85 12.84 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.233 -1.547 . . . . 7.25 109.233 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.42 150.81 43.04 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -1.15 . . . . 0.0 108.644 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.71 9.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.89 -1.131 . . . . 0.0 109.299 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.18 113.57 1.17 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 108.971 -1.204 . . . . 4.7599999999999998 108.971 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HD2' ' CE2' ' A' ' 44' ' ' TRP . 15.9 pttt -60.41 3.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.479 -0.763 . . . . 0.0 110.679 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -102.16 -7.52 22.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.325 -0.86 . . . . 14.84 109.281 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.13 8.25 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.302 -0.874 . . . . 10.23 109.486 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.44 156.5 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.059 -1.026 . . . . 6.9699999999999998 109.522 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 63' ' ' VAL . 2.6 p -106.75 160.73 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' HG22 ' A' ' 62' ' ' VAL . 54.4 t -107.72 134.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.449 -0.782 . . . . 0.0 109.699 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.11 -63.21 1.25 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.264 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.7 p -70.01 151.67 45.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 109.415 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.521 ' OD1' ' O ' ' A' ' 65' ' ' SER . 90.2 m-20 -146.67 152.75 39.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.14 -67.44 1.47 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.41 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.364 1.376 . . . . 0.0 109.722 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.54 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.72 124.93 32.07 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.22 29.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -1.157 . . . . 0.0 109.431 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.84 167.85 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.3 -0.875 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.33 46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.74 5.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.306 -1.114 . . . . 0.0 109.312 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.19 163.69 35.97 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.932 1.754 . . . . 0.0 108.854 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 27.6 mt -135.46 119.77 26.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 122.05 0.929 . . . . 0.0 109.377 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.825 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.37 117.02 4.0 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.771 0.796 . . . . 0.0 109.995 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.06 4.9 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.825 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.72 -48.55 8.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.07 4.72 13.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.497 -0.752 . . . . 0.0 109.068 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.243 -0.911 . . . . 0.0 108.564 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -115.89 143.39 30.71 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.47 113.37 1.42 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.496 1.464 . . . . 0.0 110.604 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.663 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -71.03 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.49 61.44 0.32 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.898 -1.126 . . . . 0.0 110.733 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.81 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.682 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.69 120.56 41.94 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.663 HG22 HG21 ' B' ' 86' ' ' ILE . 42.4 t -98.69 158.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.444 -0.785 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.57 116.07 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.86 106.03 18.2 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.042 -1.036 . . . . 0.0 109.466 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.57 42.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.29 4.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.08 25.3 75.79 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.82 0.66 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.821 0.819 . . . . 0.0 109.657 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.485 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.39 143.6 46.12 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.67 139.93 33.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.55 -1.343 . . . . 0.0 110.661 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.45 131.94 49.89 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.19 -14.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 120.922 -1.112 . . . . 0.0 108.399 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.77 -26.95 15.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.728 -0.607 . . . . 0.0 110.635 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.24 -6.42 31.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.839 -1.163 . . . . 0.0 110.799 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.32 106.42 12.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.3 m -133.72 175.26 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.259 1.028 . . . . 0.0 111.066 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.8 148.59 46.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.419 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.64 28.54 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.738 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.74 -31.62 0.72 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.075 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.06 -15.41 4.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 110.186 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.68 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.277 -0.89 . . . . 0.0 110.256 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.59 59.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.12 138.3 39.51 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.655 1.57 . . . . 0.0 112.102 -177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.302 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.77 56.94 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.168 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.835 . . . . 0.0 109.023 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.15 31.13 2.73 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.921 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.35 178.95 4.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.587 -0.949 . . . . 0.0 109.901 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.43 145.3 24.87 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.558 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.28 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.694 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.49 137.69 47.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.96 148.27 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.253 -0.904 . . . . 0.0 111.189 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.0 129.45 11.38 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.692 0.758 . . . . 0.0 110.237 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 51.02 22.97 1.33 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.561 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.96 20.37 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.32 -1.419 . . . . 0.0 109.698 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.31 142.78 31.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.502 -0.999 . . . . 0.0 108.755 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.34 152.91 36.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.363 -0.836 . . . . 0.0 110.722 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.552 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.99 140.3 18.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.54 177.38 0.1 Allowed 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.344 -1.343 . . . . 0.0 108.415 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.6 -35.98 82.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 109.341 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.66 -43.76 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 111.327 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.74 83.85 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.79 -1.193 . . . . 0.0 108.143 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.52 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.46 13.7 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.424 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.55 -44.7 89.95 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.58 -34.45 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.552 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.59 -35.24 46.07 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.443 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.6 -81.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.47 31.34 16.48 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.406 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.54 51.33 15.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -1.133 . . . . 0.0 109.561 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.801 1 CA-C-O 70.798 -23.477 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.274 0.559 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.99 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.212 -1.17 . . . . 0.0 109.542 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.65 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -66.11 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 109.146 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.31 -54.26 2.0 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.446 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' N ' ' OG ' ' A' ' 65' ' ' SER . 5.2 t -69.41 158.07 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.9 m -145.32 131.53 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.447 -1.408 . . . . 0.0 111.603 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.91 129.22 45.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.9 m -63.45 154.4 32.33 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.501 1.143 . . . . 0.0 110.546 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 8.6 mp -114.41 -17.22 11.82 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.222 -1.399 . . . . 10.539999999999999 107.222 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.661 ' H ' HG22 ' A' ' 11' ' ' THR . 14.3 m-85 -149.57 145.08 18.54 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.07 -1.019 . . . . 18.390000000000001 110.794 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.06 81.4 1.69 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.479 1.452 . . . . 0.0 109.054 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.77 170.31 13.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.993 -1.067 . . . . 0.0 110.854 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.64 111.13 8.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.839 0.828 . . . . 0.0 109.369 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 112.0 10.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 18' ' ' VAL . 32.8 m -130.27 94.19 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 122.873 1.32 . . . . 0.0 109.238 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -144.43 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.385 -1.28 . . . . 38.32 107.634 177.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.566 ' H ' HG22 ' A' ' 19' ' ' THR . 83.8 tt0 -82.42 -54.33 5.29 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.824 -1.547 . . . . 55.130000000000003 106.824 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.1 mt-10 -109.38 29.3 7.68 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.364 -0.835 . . . . 0.0 110.728 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.47 150.79 22.28 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.966 -1.084 . . . . 0.0 109.776 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.25 111.38 22.4 Favored 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.385 -0.822 . . . . 11.68 110.796 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.38 127.63 41.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.93 142.24 21.58 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.385 -1.447 . . . . 12.44 110.839 -178.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.15 155.9 22.36 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 146.95 19.15 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.251 -0.906 . . . . 29.030000000000001 109.515 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.11 6.59 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.306 -1.517 . . . . 6.1799999999999997 109.306 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.68 22.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.47 -1.018 . . . . 9.5199999999999996 109.385 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.69 6.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.52 133.68 49.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 123.154 1.454 . . . . 0.0 110.504 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.75 103.12 15.86 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.372 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.11 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.534 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.474 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.72 -50.36 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.881 -1.137 . . . . 0.0 110.259 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.59 43.65 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.973 -1.079 . . . . 0.0 110.736 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.05 65.54 65.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.79 165.4 31.55 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.628 1.552 . . . . 0.0 108.973 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.52 7.76 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.73 -59.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.309 0.576 . . . . 0.0 110.041 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.78 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 122.621 2.214 . . . . 0.0 109.908 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 67.6 mt-10 131.75 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.853 0.861 . . . . 0.0 108.768 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.558 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.8 m0 -71.85 165.9 23.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.578 -1.326 . . . . 14.289999999999999 110.451 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.445 ' C ' HD13 ' A' ' 55' ' ' LEU . 24.9 m0 -129.57 145.03 51.51 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.237 -0.653 . . . . 11.800000000000001 109.237 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.99 96.62 5.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.84 56.1 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.928 0.871 . . . . 0.0 110.326 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.69 150.28 26.85 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.757 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.33 128.54 43.35 Favored 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 117.15 -1.82 . . . . 0.0 107.223 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.33 0.99 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 119.579 -1.951 . . . . 0.0 108.045 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.68 4.46 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.55 33.97 6.86 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 115.309 -0.859 . . . . 14.41 112.261 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.757 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -138.0 164.08 29.95 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 119.645 1.722 . . . . 0.0 111.803 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-O 122.381 1.086 . . . . 0.0 112.417 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.04 156.74 12.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.211 -1.556 . . . . 7.25 109.211 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.34 150.83 43.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.261 -1.141 . . . . 0.0 108.598 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.67 8.91 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.969 -1.082 . . . . 0.0 109.266 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.15 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 N-CA-C 109.09 -1.158 . . . . 4.7599999999999998 109.09 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.568 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.29 3.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.768 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' PRO . 47.2 p30 -102.1 -7.65 22.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.256 -0.902 . . . . 14.84 109.354 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.181 -0.949 . . . . 10.23 109.497 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.47 156.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.14 -0.975 . . . . 6.9699999999999998 109.456 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 63' ' ' VAL . 7.5 p -106.78 160.75 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.521 ' N ' HG22 ' A' ' 62' ' ' VAL . 46.5 t -107.67 134.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.49 -0.756 . . . . 0.0 109.765 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.12 -63.27 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.599 -0.688 . . . . 0.0 109.182 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.4 p -69.89 151.59 45.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.062 -1.024 . . . . 0.0 109.491 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -146.59 152.64 39.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.21 -67.36 1.47 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.33 93.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.393 1.395 . . . . 0.0 109.725 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.01 82.48 1.74 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.04 32.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.112 -0.993 . . . . 0.0 109.437 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.18 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -1.121 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.34 46.85 0.2 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.19 130.76 5.37 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.414 -1.051 . . . . 0.0 109.405 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.3 163.57 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.915 1.743 . . . . 0.0 108.881 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 29.9 mt -135.38 119.71 26.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-O 122.082 0.944 . . . . 0.0 109.394 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.32 117.0 3.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.885 0.85 . . . . 0.0 109.983 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.29 4.96 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.54 -48.52 8.3 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.302 -1.116 . . . . 0.0 109.503 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.1 4.79 13.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 53.59 41.22 32.13 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -115.9 143.34 30.61 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.642 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.44 113.48 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.436 1.424 . . . . 0.0 110.542 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.672 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.93 158.36 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.47 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.872 -1.142 . . . . 0.0 110.687 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -101.96 0.15 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.6 42.14 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.672 HG22 HG21 ' B' ' 86' ' ' ILE . 42.6 t -98.82 158.68 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.736 0.779 . . . . 0.0 111.144 -177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.52 115.99 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.86 106.05 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 109.558 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.53 42.62 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.627 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.22 17.06 4.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.33 75.79 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.29 -154.7 0.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.63 0.729 . . . . 0.0 109.813 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.44 143.47 45.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.9 m95 -141.65 140.03 33.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.53 -1.356 . . . . 0.0 110.584 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.48 132.01 50.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.7 t -53.37 -14.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.968 -1.082 . . . . 0.0 108.315 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.83 -26.9 15.46 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.776 -0.577 . . . . 0.0 110.616 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.24 -6.47 31.1 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.94 -1.1 . . . . 0.0 110.787 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.64 175.31 11.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.232 1.015 . . . . 0.0 111.072 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.76 46.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.329 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.96 28.67 1.77 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 109.65 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.417 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.6 0.72 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.354 -0.841 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.14 -15.52 4.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.57 0.32 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.205 -0.934 . . . . 0.0 110.088 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.52 109.65 59.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.19 138.25 39.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.716 1.611 . . . . 0.0 112.099 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.321 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.74 56.94 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.151 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 0.0 109.072 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.27 30.96 2.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.921 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.18 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.58 -0.953 . . . . 0.0 110.04 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.38 145.44 24.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.37 169.48 9.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.693 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.47 137.69 47.32 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.14 148.35 28.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.213 -0.929 . . . . 0.0 111.174 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.595 0.712 . . . . 0.0 110.306 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.22 22.95 1.47 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.648 -0.657 . . . . 0.0 109.435 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.627 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.47 30.95 20.41 Favored Glycine 0 N--CA 1.482 1.75 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.499 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.31 142.64 31.39 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.534 -0.98 . . . . 0.0 108.873 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.38 152.76 36.2 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.793 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.2 m-85 -153.8 140.31 18.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.63 177.44 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.414 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.59 -35.9 82.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.4 m -86.65 -43.86 12.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 111.301 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.74 83.73 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.834 -1.167 . . . . 0.0 108.1 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.78 -56.38 14.24 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.64 -44.79 89.34 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.078 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.44 -34.32 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.74 -35.35 44.86 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.279 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.48 -81.64 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.095 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.42 31.42 16.41 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.7 m-20 48.56 51.17 15.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -1.103 . . . . 0.0 109.613 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.977 -23.392 . . . . 0.0 109.455 179.964 . . . . . . . . 2 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.35 74.81 0.12 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.9 35.25 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.057 -1.26 . . . . 0.0 109.58 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.11 148.67 43.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.142 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -66.06 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.105 -0.997 . . . . 0.0 109.275 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.23 -54.37 2.0 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.8 m-70 -145.2 73.88 1.38 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.552 ' N ' ' OG ' ' A' ' 65' ' ' SER . 38.6 t -69.38 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.36 131.47 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.458 -1.401 . . . . 0.0 111.549 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -99.8 129.29 45.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 13' ' ' TYR . 35.5 m -63.44 154.45 32.16 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.483 1.135 . . . . 0.0 110.598 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 HG13 ' A' ' 62' ' ' VAL . 87.1 mt -114.37 -17.35 11.81 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.251 -1.388 . . . . 10.539999999999999 107.251 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.666 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.044 . . . . 18.390000000000001 110.783 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -73.06 81.55 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.438 1.425 . . . . 0.0 108.965 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.5 t80 -71.85 170.4 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.845 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.7 111.04 7.93 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.787 0.803 . . . . 0.0 109.472 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.32 111.93 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 18' ' ' VAL . 10.7 m -130.43 94.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 123.056 1.408 . . . . 0.0 109.147 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.38 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.272 -1.331 . . . . 38.32 107.569 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.693 ' H ' HG22 ' A' ' 19' ' ' THR . 97.3 mt-10 -82.39 -54.39 5.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.923 -1.51 . . . . 55.130000000000003 106.923 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.442 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.17 29.01 7.91 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.4 -0.812 . . . . 0.0 110.762 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.629 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -100.4 150.9 22.14 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.863 -1.148 . . . . 0.0 109.787 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.36 111.39 22.4 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.419 -0.801 . . . . 11.68 110.756 -178.385 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -95.4 127.68 41.63 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.27 21.67 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.4 -1.437 . . . . 12.44 110.943 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.82 22.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.87 18.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.242 -0.911 . . . . 29.030000000000001 109.617 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.63 44.09 6.61 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.317 -1.513 . . . . 6.1799999999999997 109.317 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.82 22.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.541 -0.976 . . . . 9.5199999999999996 109.396 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.06 108.64 6.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.79 49.68 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.192 1.472 . . . . 0.0 110.527 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.477 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.539 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.07 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -0.782 . . . . 0.0 111.53 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.497 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.76 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.968 -1.082 . . . . 0.0 110.267 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.63 43.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.933 -1.105 . . . . 0.0 110.844 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.539 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.03 65.5 65.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.836 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.4 31.51 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.578 1.518 . . . . 0.0 108.96 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.52 7.75 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.59 -59.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.391 0.615 . . . . 0.0 110.141 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.56 -59.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.583 2.188 . . . . 0.0 109.909 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 17.8 pt-20 131.83 9.27 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.892 0.877 . . . . 0.0 108.786 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.571 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.1 m0 -71.77 165.92 23.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.669 -1.27 . . . . 14.289999999999999 110.48 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.486 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.4 m0 -129.63 144.99 51.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.243 -0.651 . . . . 11.800000000000001 109.243 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -78.93 96.58 5.75 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.498 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.914 0.864 . . . . 0.0 110.373 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.72 150.37 26.75 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.759 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.2 p30 -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.261 -1.776 . . . . 0.0 107.163 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.37 1.0 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.675 -1.89 . . . . 0.0 108.011 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.68 -4.59 4.38 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.42 33.88 6.95 Favored Glycine 0 N--CA 1.48 1.627 0 CA-C-N 115.386 -0.825 . . . . 14.41 112.297 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.759 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.14 29.7 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.633 1.717 . . . . 0.0 111.849 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.59 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-O 122.362 1.077 . . . . 0.0 112.434 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.2 156.75 12.73 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.338 -1.505 . . . . 7.25 109.338 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.23 150.89 43.27 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.296 -1.12 . . . . 0.0 108.681 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.71 8.95 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.84 -1.162 . . . . 0.0 109.342 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.22 113.6 1.18 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.074 -1.164 . . . . 4.7599999999999998 109.074 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.5 pttt -60.37 3.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.487 -0.758 . . . . 0.0 110.603 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.7 m-20 -102.05 -7.66 22.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.144 -0.973 . . . . 14.84 109.323 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.22 30.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 10.23 109.494 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.38 156.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 6.9699999999999998 109.589 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 12' ' ' LEU . 29.0 m -106.77 160.69 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.2 t -107.59 134.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.411 -0.806 . . . . 0.0 109.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.19 -63.28 1.25 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 13.8 p -69.91 151.61 45.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.983 -1.073 . . . . 0.0 109.418 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -146.59 152.68 39.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.23 1.48 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.254 1.302 . . . . 0.0 109.732 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.7 1.79 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.9 125.09 32.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.86 156.21 28.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -1.181 . . . . 0.0 109.507 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.73 167.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.93 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.75 5.33 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.383 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.522 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.8 35.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.816 1.677 . . . . 0.0 108.828 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.559 HG23 ' C ' ' B' ' 84' ' ' ARG . 61.3 mt -135.52 119.75 26.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 122.072 0.939 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.29 116.94 3.92 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.819 0.818 . . . . 0.0 109.96 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.3 4.96 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.53 -48.62 8.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -1.057 . . . . 0.0 109.455 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.86 13.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.559 ' C ' HG23 ' B' ' 78' ' ' ILE . 29.1 mtp180 -115.91 143.49 30.91 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.511 1.474 . . . . 0.0 110.494 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.655 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.96 158.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.424 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.52 61.48 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 110.615 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.0 -101.93 0.15 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.663 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.62 42.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 86' ' ' ILE . 42.5 t -98.77 158.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.419 -0.801 . . . . 0.0 111.195 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.47 ' N ' HG12 ' B' ' 90' ' ' VAL . 5.0 t -122.55 116.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.033 -1.042 . . . . 0.0 109.622 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.51 42.68 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.637 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.15 4.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.38 25.11 76.16 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.16 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.788 0.804 . . . . 0.0 109.726 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.476 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.35 143.49 46.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.64 139.99 33.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.416 -1.428 . . . . 0.0 110.646 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.465 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.58 131.94 50.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG23 ' B' ' 91' ' ' VAL . 7.8 t -53.16 -14.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.909 -1.119 . . . . 0.0 108.348 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.465 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.83 -26.97 15.44 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 110.638 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.06 -6.6 31.46 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.93 -1.107 . . . . 0.0 110.787 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.24 106.34 12.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.3 m -133.64 175.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.267 1.032 . . . . 0.0 111.088 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.85 148.66 46.45 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.354 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.87 28.77 1.72 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.676 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.413 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.82 -31.62 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.309 -0.87 . . . . 0.0 110.086 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.24 -15.25 4.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.54 47.6 0.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.232 -0.918 . . . . 0.0 110.24 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.59 59.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.12 138.26 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.79 1.66 . . . . 0.0 112.006 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.325 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.038 0.0 OUTLIER -95.77 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.075 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.04 -55.24 1.61 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.001 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.98 2.75 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.947 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.36 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.416 -1.05 . . . . 0.0 109.958 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.53 145.41 24.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.797 . . . . 0.0 109.295 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.39 169.55 9.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.472 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.54 137.66 47.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.96 148.3 28.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.203 -0.936 . . . . 0.0 111.18 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.469 -0.77 . . . . 0.0 110.327 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.31 22.8 1.49 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.637 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 31.02 20.41 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.79 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.37 142.8 31.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.61 -0.936 . . . . 0.0 108.799 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.43 152.82 36.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.331 -0.855 . . . . 0.0 110.673 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.5 m-85 -153.84 140.36 18.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.3 m -57.72 177.55 0.1 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.441 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.67 -35.92 82.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.853 . . . . 0.0 109.436 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.445 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.1 m -86.61 -43.81 12.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 111.349 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.73 83.79 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.738 -1.226 . . . . 0.0 108.177 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.5 13.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.419 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.42 -44.92 89.72 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.184 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.43 -34.36 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.63 -35.35 45.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.384 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.7 m-85 -158.51 -81.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.054 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.46 31.44 16.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.39 51.37 15.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.327 -1.102 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.698 1 CA-C-O 70.992 -23.385 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.309 0.576 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.98 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.91 35.2 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -1.208 . . . . 0.0 109.666 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.62 43.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.296 -0.878 . . . . 0.0 109.139 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.5 t -65.92 93.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -121.26 -54.32 2.0 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.31 73.88 1.37 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 8' ' ' VAL . 3.4 t -69.41 158.13 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 31' ' ' MET . 4.8 m -145.44 131.6 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.48 -1.387 . . . . 0.0 111.513 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -100.03 129.16 46.06 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 13' ' ' TYR . 34.3 m -63.3 154.39 31.84 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.497 1.141 . . . . 0.0 110.617 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 93.1 mt -114.37 -17.28 11.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.211 -1.403 . . . . 10.539999999999999 107.211 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.671 ' H ' HG22 ' A' ' 11' ' ' THR . 14.3 m-85 -149.49 145.06 18.54 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 121.133 -0.979 . . . . 18.390000000000001 110.794 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -72.87 81.4 1.64 Allowed 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.468 1.445 . . . . 0.0 109.07 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.76 170.33 13.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.923 -1.111 . . . . 0.0 110.91 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.07 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.776 0.798 . . . . 0.0 109.431 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.31 111.96 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 18' ' ' VAL . 19.7 m -130.29 94.25 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 122.9 1.333 . . . . 0.0 109.134 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.817 HG22 ' H ' ' A' ' 20' ' ' GLU . 2.6 m -144.46 -151.98 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.362 -1.29 . . . . 38.32 107.581 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.817 ' H ' HG22 ' A' ' 19' ' ' THR . 76.7 mm-40 -82.5 -54.29 5.3 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.903 -1.518 . . . . 55.130000000000003 106.903 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.5 mt-10 -109.3 29.2 7.76 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.53 150.93 22.17 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.907 -1.12 . . . . 0.0 109.741 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.38 22.39 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.342 -0.849 . . . . 11.68 110.82 -178.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.36 127.7 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.03 142.22 21.47 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.327 -1.483 . . . . 12.44 110.851 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.87 22.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 146.93 18.91 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.255 -0.903 . . . . 29.030000000000001 109.492 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.14 6.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.273 -1.531 . . . . 6.1799999999999997 109.273 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.29 114.79 22.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.652 -0.911 . . . . 9.5199999999999996 109.436 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.459 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.99 108.57 5.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.489 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.51 133.65 49.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 123.21 1.481 . . . . 0.0 110.549 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.6 102.95 15.69 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.48 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 111.49 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.48 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.85 -50.39 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 120.917 -1.114 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.16 157.62 43.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.99 -1.069 . . . . 0.0 110.831 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.04 65.52 65.35 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.28 31.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.721 1.614 . . . . 0.0 109.027 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.49 7.77 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.67 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.353 0.597 . . . . 0.0 110.037 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.89 -47.54 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.608 2.205 . . . . 0.0 109.996 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.9 pt-20 131.67 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 123.878 0.871 . . . . 0.0 108.806 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.582 ' HB2' HD12 ' A' ' 55' ' ' LEU . 11.7 m0 -71.79 165.91 23.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.712 -1.242 . . . . 14.289999999999999 110.527 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.1 m0 -129.46 145.12 51.47 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.633 -0.667 . . . . 11.800000000000001 109.302 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.17 96.61 5.92 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -115.92 128.81 56.06 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.966 0.888 . . . . 0.0 110.347 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.63 150.48 26.8 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.765 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.46 128.57 43.51 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 117.275 -1.77 . . . . 0.0 107.216 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.44 1.02 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.611 -1.931 . . . . 0.0 107.972 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.471 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.58 -4.77 4.43 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.5 34.04 6.85 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.438 -0.801 . . . . 14.41 112.215 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.765 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.96 164.11 29.84 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.628 1.714 . . . . 0.0 111.765 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.55 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.305 1.05 . . . . 0.0 112.507 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.14 156.69 12.61 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.324 -1.511 . . . . 7.25 109.324 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.76 43.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.171 -1.194 . . . . 0.0 108.674 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.98 136.75 9.04 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.954 -1.092 . . . . 0.0 109.289 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.12 113.46 1.11 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 N-CA-C 109.052 -1.172 . . . . 4.7599999999999998 109.052 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.4 pttt -60.36 3.23 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.443 -0.786 . . . . 0.0 110.71 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.4 m-20 -102.17 -7.48 22.17 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.3 -0.875 . . . . 14.84 109.326 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.05 8.16 31.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.089 -1.007 . . . . 10.23 109.343 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.45 156.62 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.219 -0.926 . . . . 6.9699999999999998 109.561 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 63' ' ' VAL . 7.5 p -106.84 160.86 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.506 ' N ' HG22 ' A' ' 62' ' ' VAL . 5.5 p -107.72 134.31 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 64' ' ' LEU . 11.2 mp -105.2 -63.14 1.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.566 -0.709 . . . . 0.0 109.202 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 31.8 m -70.15 151.69 45.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.99 -1.069 . . . . 0.0 109.417 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -146.58 152.67 39.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.32 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.31 1.34 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.58 1.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.79 124.96 32.16 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.94 156.19 28.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -1.134 . . . . 0.0 109.41 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.83 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.28 46.88 0.2 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.27 130.76 5.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.0 109.463 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.15 163.65 36.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.024 1.816 . . . . 0.0 108.811 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.474 HG23 ' C ' ' B' ' 84' ' ' ARG . 74.8 mt -135.47 119.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.073 0.939 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.48 117.05 4.07 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.833 0.825 . . . . 0.0 109.962 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.13 4.97 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.64 -48.6 8.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.372 -1.075 . . . . 0.0 109.422 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.12 4.83 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 53.55 41.26 32.12 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.474 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.0 mmm180 -115.98 143.55 31.08 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.45 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.417 1.411 . . . . 0.0 110.611 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.658 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.89 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.422 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.6 61.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.877 -1.139 . . . . 0.0 110.667 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.08 0.15 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.68 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.71 42.51 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.658 HG22 HG21 ' B' ' 86' ' ' ILE . 43.2 t -98.82 158.72 3.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 111.155 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.6 116.16 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.89 106.15 18.28 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 109.534 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.53 159.5 42.67 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.23 4.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.22 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.851 -0.793 . . . . 0.0 109.856 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.48 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.7 mt-30 -135.48 143.54 45.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.5 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.526 -1.359 . . . . 0.0 110.646 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.455 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.61 132.12 50.82 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.6 t -53.36 -14.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.927 -1.108 . . . . 0.0 108.408 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.455 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.68 -27.18 15.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.778 -0.576 . . . . 0.0 110.589 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -97.94 -6.63 31.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.901 -1.124 . . . . 0.0 110.899 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.15 106.29 12.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.821 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.0 m -133.56 175.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.358 1.075 . . . . 0.0 111.073 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.95 148.7 46.72 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.2 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.65 1.74 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.837 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.43 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.47 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.321 -0.862 . . . . 0.0 110.196 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.23 -15.29 4.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.296 -0.878 . . . . 0.0 110.076 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.61 47.57 0.35 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.794 . . . . 0.0 110.267 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.5 59.05 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.821 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.07 138.23 39.5 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.73 1.62 . . . . 0.0 112.179 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.314 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.8 57.04 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.196 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.629 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.12 -55.29 1.64 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 108.997 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.07 31.0 2.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.922 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.31 178.98 4.13 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.611 -0.935 . . . . 0.0 109.94 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.37 145.3 24.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.564 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.25 169.57 9.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.694 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.5 m-85 -132.57 137.65 47.17 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.32 28.85 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.14 -0.975 . . . . 0.0 111.204 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.24 11.2 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.615 0.722 . . . . 0.0 110.324 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.36 22.74 1.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.96 20.32 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.741 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.7 mt -143.25 142.63 31.44 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.608 -0.937 . . . . 0.0 108.873 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.16 152.8 36.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -153.87 140.34 18.76 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.6 m -57.74 177.44 0.11 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.299 -1.361 . . . . 0.0 108.401 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.58 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.58 -35.94 82.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.417 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.71 -43.66 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 111.311 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.466 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.83 -43.55 83.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.817 -1.177 . . . . 0.0 108.206 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.82 -56.37 14.37 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.7 m-80 -64.6 -44.91 89.13 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.009 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.45 -34.35 61.32 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.63 -35.34 45.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.381 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.58 -81.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 110.096 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.4 31.34 16.69 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.48 51.24 15.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -1.084 . . . . 0.0 109.576 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.981 -23.39 . . . . 0.0 109.454 179.915 . . . . . . . . 2 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.84 0.12 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.95 35.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -1.172 . . . . 0.0 109.624 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -72.99 148.6 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.167 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -65.96 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.288 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.41 1.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.23 73.94 1.38 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.46 158.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 31' ' ' MET . 3.9 m -145.34 131.45 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.416 -1.427 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.92 129.22 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.8 m -63.41 154.43 32.1 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.487 1.136 . . . . 0.0 110.572 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.534 HD11 HG23 ' A' ' 62' ' ' VAL . 90.5 mt -114.31 -17.36 11.84 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.274 -1.38 . . . . 10.539999999999999 107.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.678 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.51 144.96 18.39 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.16 -0.963 . . . . 18.390000000000001 110.803 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.97 81.54 1.65 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.392 1.395 . . . . 0.0 109.024 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.92 170.32 13.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.978 -1.077 . . . . 0.0 110.86 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.63 111.08 7.99 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.831 0.824 . . . . 0.0 109.47 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 111.86 10.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.2 t -130.23 94.35 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.938 1.352 . . . . 0.0 109.2 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.949 HG22 ' H ' ' A' ' 20' ' ' GLU . 4.9 m -144.49 -151.97 0.39 Allowed 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.335 -1.302 . . . . 38.32 107.557 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.949 ' H ' HG22 ' A' ' 19' ' ' THR . 45.6 tp10 -82.41 -54.36 5.27 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.885 -1.524 . . . . 55.130000000000003 106.885 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.8 mt-10 -109.38 29.23 7.74 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.447 -0.783 . . . . 0.0 110.712 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.643 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -100.49 150.98 22.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.811 -1.181 . . . . 0.0 109.727 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.443 -0.786 . . . . 11.68 110.765 -178.403 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.53 127.69 41.77 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.83 142.25 21.68 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.352 -1.467 . . . . 12.44 110.876 -178.394 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.76 22.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 146.91 18.73 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.227 -0.921 . . . . 29.030000000000001 109.452 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.17 6.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.326 -1.51 . . . . 6.1799999999999997 109.326 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.67 22.72 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.487 -1.008 . . . . 9.5199999999999996 109.416 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.97 108.69 6.02 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.452 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.59 133.63 50.01 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.201 1.477 . . . . 0.0 110.532 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.71 103.05 15.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.466 -178.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.0 92.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.573 -0.705 . . . . 0.0 111.496 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.4 mt -59.65 -50.52 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.94 -1.1 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.12 157.67 43.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.991 -1.068 . . . . 0.0 110.788 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.07 65.6 65.35 Favored Pre-proline 0 N--CA 1.486 1.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.761 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.74 165.34 31.71 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.715 1.61 . . . . 0.0 108.947 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.16 -46.3 7.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.5 m-20 57.62 -59.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.442 0.639 . . . . 0.0 110.054 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.71 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.61 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.128 0 C-N-CA 122.597 2.198 . . . . 0.0 109.968 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.86 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.51 ' HB2' HD12 ' A' ' 55' ' ' LEU . 22.1 m0 -71.81 165.87 23.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.626 -1.296 . . . . 14.289999999999999 110.519 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.487 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.8 m0 -129.55 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.286 -0.635 . . . . 11.800000000000001 109.286 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.15 96.66 5.92 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -116.0 128.8 56.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.954 0.883 . . . . 0.0 110.378 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.6 150.44 26.86 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.766 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.1 p30 -96.45 128.58 43.52 Favored 'General case' 0 N--CA 1.509 2.487 0 C-N-CA 117.266 -1.773 . . . . 0.0 107.215 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.5 -18.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.734 -1.854 . . . . 0.0 107.913 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.55 4.33 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.35 33.96 6.94 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 115.257 -0.883 . . . . 14.41 112.286 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.766 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.07 29.86 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.745 1.772 . . . . 0.0 111.829 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.97 154.58 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 122.335 1.064 . . . . 0.0 112.52 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.84 12.85 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.236 -1.546 . . . . 7.25 109.236 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.51 150.97 42.76 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.296 -1.12 . . . . 0.0 108.613 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.12 136.67 8.91 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.82 -1.175 . . . . 0.0 109.265 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.04 113.46 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 108.992 -1.195 . . . . 4.7599999999999998 108.992 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 62.7 pttt -60.33 3.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 110.66 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.3 m-20 -102.01 -7.66 22.15 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.275 -0.891 . . . . 14.84 109.334 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.96 8.11 31.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.239 -0.913 . . . . 10.23 109.56 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 11' ' ' THR . 32.0 m -147.32 156.57 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 6.9699999999999998 109.542 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.534 HG23 HD11 ' A' ' 12' ' ' LEU . 15.0 t -106.86 160.69 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 10.4 p -107.57 134.34 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.392 -0.818 . . . . 0.0 109.814 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.19 -63.15 1.26 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 33.9 m -70.05 151.68 45.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.956 -1.09 . . . . 0.0 109.503 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -146.75 152.69 39.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.27 1.48 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.52 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.209 1.273 . . . . 0.0 109.637 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.53 1.75 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.05 32.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 156.27 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 109.532 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.92 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.27 46.92 0.2 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.73 5.32 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.283 -1.128 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.519 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.58 36.1 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.872 1.714 . . . . 0.0 108.848 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 62' ' ' VAL . 72.7 mt -135.33 119.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 122.001 0.905 . . . . 0.0 109.379 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.83 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.24 116.88 3.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.75 -0.1 4.73 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.83 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.78 -48.41 8.25 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.361 -1.082 . . . . 0.0 109.397 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.19 4.89 13.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.521 -0.737 . . . . 0.0 109.07 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.487 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.6 mtp-105 -115.94 143.32 30.61 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.8 Cg_exo -56.33 113.25 1.36 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.49 1.46 . . . . 0.0 110.636 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.668 HG21 HG22 ' B' ' 90' ' ' VAL . 21.7 mt -70.9 158.53 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.642 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.425 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.6 61.44 0.32 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.873 -1.142 . . . . 0.0 110.615 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.96 -101.96 0.15 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.677 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.74 120.61 42.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.668 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.67 158.75 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.698 0.761 . . . . 0.0 111.186 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.59 115.92 47.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.81 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.48 42.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.32 4.35 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.3 75.82 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.8 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.747 0.784 . . . . 0.0 109.684 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.48 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.8 mt-30 -135.41 143.4 45.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.46 140.06 33.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.606 -1.309 . . . . 0.0 110.651 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.469 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.5 131.93 50.0 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.9 t -53.17 -14.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.988 -1.07 . . . . 0.0 108.465 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.469 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.8 -26.87 15.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.762 -0.586 . . . . 0.0 110.608 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.14 -6.51 31.37 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.909 -1.119 . . . . 0.0 110.804 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.27 106.31 12.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.58 175.39 11.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.153 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.83 148.69 46.3 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.375 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.74 1.73 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.83 -31.74 0.71 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 110.135 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.08 -15.32 4.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.104 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.63 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.69 59.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.14 138.35 39.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.636 1.558 . . . . 0.0 112.144 -177.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.81 56.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.172 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.621 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.98 -55.35 1.57 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.04 2.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.934 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.21 178.96 4.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.429 -1.042 . . . . 0.0 109.977 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.51 145.28 24.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.683 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.5 137.72 47.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.06 148.34 28.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.353 -0.842 . . . . 0.0 111.266 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.95 129.31 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.724 . . . . 0.0 110.424 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.97 1.43 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 30.94 20.63 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.77 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.9 mt -143.27 142.66 31.43 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.968 . . . . 0.0 108.853 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.93 36.27 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.735 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.555 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.99 140.28 18.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.1 m -57.54 177.46 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.404 -1.318 . . . . 0.0 108.508 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.64 -35.99 82.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 56.5 m -86.54 -43.79 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 111.426 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.85 83.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.812 -1.18 . . . . 0.0 108.155 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.75 -56.49 13.49 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.2 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.153 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -54.55 -34.29 61.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.71 -35.24 45.19 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.357 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.52 -81.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.45 31.37 16.45 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.57 51.2 15.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -1.09 . . . . 0.0 109.561 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.476 -39.647 1 CA-C-O 70.829 -23.462 . . . . 0.0 109.479 -179.975 . . . . . . . . 2 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.03 35.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -1.102 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.8 ttm-85 -73.01 148.62 44.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.127 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.05 93.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.3 mt -121.19 -54.27 2.01 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.32 74.04 1.38 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.55 157.97 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.2 131.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.365 -1.459 . . . . 0.0 111.553 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -99.9 129.27 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 13' ' ' TYR . 28.3 m -63.47 154.35 32.57 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.499 1.142 . . . . 0.0 110.544 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 91.7 mt -114.3 -17.29 11.86 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.221 -1.4 . . . . 10.539999999999999 107.221 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.669 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.48 145.07 18.56 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.154 -0.966 . . . . 18.390000000000001 110.768 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.98 81.51 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.345 1.363 . . . . 0.0 109.059 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.4 t80 -71.88 170.3 13.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.912 -1.117 . . . . 0.0 110.821 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.58 111.16 8.07 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.809 0.814 . . . . 0.0 109.389 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.27 111.89 10.61 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 18' ' ' VAL . 23.2 m -130.37 94.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.904 1.335 . . . . 0.0 109.197 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -144.46 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.383 -1.28 . . . . 38.32 107.63 177.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.565 ' H ' HG22 ' A' ' 19' ' ' THR . 97.3 mt-10 -82.41 -54.31 5.31 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.936 -1.505 . . . . 55.130000000000003 106.936 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.6 mt-10 -109.25 29.21 7.74 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.47 -0.769 . . . . 0.0 110.827 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.616 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.61 150.92 22.21 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.861 -1.149 . . . . 0.0 109.682 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -111.31 111.43 22.49 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.39 -0.819 . . . . 11.68 110.71 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.45 127.68 41.69 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.92 142.27 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.436 -1.415 . . . . 12.44 110.798 -178.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.32 155.87 22.17 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.94 18.43 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.266 -0.896 . . . . 29.030000000000001 109.506 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 44.09 6.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.286 -1.526 . . . . 6.1799999999999997 109.286 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.87 23.01 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.534 -0.98 . . . . 9.5199999999999996 109.358 -179.594 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.22 108.74 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.56 133.75 49.81 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 123.228 1.49 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.86 103.11 15.86 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 113.745 -1.571 . . . . 0.0 107.351 -178.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.495 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.9 -50.43 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.145 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.17 157.6 43.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.026 -1.046 . . . . 0.0 110.786 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.552 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.01 65.57 65.7 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.767 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.43 31.56 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.567 1.512 . . . . 0.0 109.145 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.11 -46.42 7.78 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.63 -59.43 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.421 0.629 . . . . 0.0 110.071 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.624 2.216 . . . . 0.0 109.899 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 75.2 mt-10 131.86 9.31 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.559 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.8 m0 -71.85 165.91 23.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.619 -1.301 . . . . 14.289999999999999 110.385 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.544 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.1 m0 -129.64 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.287 -0.635 . . . . 11.800000000000001 109.287 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.99 96.58 5.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.69 55.98 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.91 0.862 . . . . 0.0 110.488 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.5 150.31 27.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.755 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.1 p30 -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 117.226 -1.789 . . . . 0.0 107.289 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.46 1.01 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.652 -1.905 . . . . 0.0 108.013 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.61 -4.55 4.26 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.42 33.95 6.92 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-N 115.355 -0.839 . . . . 14.41 112.253 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.755 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.06 29.96 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-N 119.71 1.755 . . . . 0.0 111.859 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.83 154.56 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.231 1.015 . . . . 0.0 112.601 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.17 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.24 -1.544 . . . . 7.25 109.24 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.87 43.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -1.182 . . . . 0.0 108.605 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.06 136.83 9.06 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.075 -1.016 . . . . 0.0 109.225 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.23 113.51 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 108.935 -1.217 . . . . 4.7599999999999998 108.935 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 25.6 pttm -60.23 2.95 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.453 -0.78 . . . . 0.0 110.798 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.6 m-20 -101.96 -7.56 22.29 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 14.84 109.297 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.11 8.34 30.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.289 -0.882 . . . . 10.23 109.481 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.1 m -147.51 156.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.239 -0.913 . . . . 6.9699999999999998 109.389 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.512 HG22 ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.82 160.78 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.512 ' N ' HG22 ' A' ' 62' ' ' VAL . 73.1 t -107.62 134.22 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.435 -0.791 . . . . 0.0 109.834 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.436 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 97.9 mt -105.14 -63.08 1.26 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.636 -0.665 . . . . 0.0 109.207 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.491 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 19.4 m -70.11 151.55 45.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 65' ' ' SER . 85.6 m-20 -146.43 152.8 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.34 1.47 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.4 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.298 1.332 . . . . 0.0 109.669 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.6 1.77 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.83 124.93 32.15 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.121 -0.987 . . . . 0.0 109.395 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.19 28.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -1.137 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.78 167.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.444 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.39 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.84 5.37 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.346 -1.091 . . . . 0.0 109.291 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.34 163.65 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.941 1.761 . . . . 0.0 108.875 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.556 HG23 ' C ' ' B' ' 84' ' ' ARG . 61.7 mt -135.42 119.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 122.054 0.93 . . . . 0.0 109.313 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.33 116.94 3.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 110.045 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.85 -0.16 4.91 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.55 -48.72 8.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -1.121 . . . . 0.0 109.33 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.01 4.81 13.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 53.62 41.25 32.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.556 ' C ' HG23 ' B' ' 78' ' ' ILE . 5.3 mmm180 -115.95 143.46 30.89 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.416 1.411 . . . . 0.0 110.566 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.667 HG21 HG22 ' B' ' 90' ' ' VAL . 21.3 mt -70.87 158.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.58 61.57 0.32 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.885 -1.134 . . . . 0.0 110.648 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.16 -101.91 0.15 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.66 120.75 42.61 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.667 HG22 HG21 ' B' ' 86' ' ' ILE . 42.7 t -98.89 158.61 3.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.524 -0.735 . . . . 0.0 111.205 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.475 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.6 115.97 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.7 106.01 18.18 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.687 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.61 42.46 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.92 17.28 4.2 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.24 25.17 76.01 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.14 -154.75 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.776 0.798 . . . . 0.0 109.758 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.482 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.39 143.52 46.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.53 140.01 33.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.462 -1.399 . . . . 0.0 110.644 -177.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.51 131.89 49.9 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.457 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.16 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 120.866 -1.146 . . . . 0.0 108.343 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.11 15.41 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.848 -0.533 . . . . 0.0 110.61 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.13 -6.43 31.56 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 110.746 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.475 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.12 106.24 12.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.821 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.2 m -133.57 175.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 122.219 1.009 . . . . 0.0 111.143 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.71 46.18 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.222 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.7 1.74 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.072 -1.018 . . . . 0.0 109.596 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.8 0.71 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.407 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.36 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.407 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.59 47.75 0.34 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.314 -0.866 . . . . 0.0 110.131 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.57 109.62 59.67 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.821 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.08 138.32 39.67 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.656 1.57 . . . . 0.0 112.059 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.305 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.78 56.87 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.131 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.15 1.69 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.1 30.96 2.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.907 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.35 178.87 4.17 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.411 -1.052 . . . . 0.0 109.953 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.35 145.39 24.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.365 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.42 169.39 9.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 109.504 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.693 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.67 47.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.05 148.29 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.256 -0.902 . . . . 0.0 111.22 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.93 129.41 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.09 22.93 1.37 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.491 -0.756 . . . . 0.0 109.531 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.99 20.26 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.4 mt -143.33 142.74 31.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.577 -0.955 . . . . 0.0 108.738 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.81 36.26 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.903 . . . . 0.0 110.721 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.7 m-85 -153.9 140.23 18.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.49 177.48 0.1 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.339 -1.344 . . . . 0.0 108.49 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.65 -36.06 82.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 109.301 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.5 m -86.65 -43.73 12.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.843 . . . . 0.0 111.325 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.72 83.67 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.698 -1.251 . . . . 0.0 108.187 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.7 -56.56 13.03 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.413 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.51 -44.75 89.93 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.139 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.42 61.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.65 -35.22 45.7 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.39 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.62 -81.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.838 . . . . 0.0 110.075 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.33 31.47 16.49 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.422 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.42 51.3 15.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.245 -1.15 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.749 1 CA-C-O 71.145 -23.312 . . . . 0.0 109.454 179.98 . . . . . . . . 2 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.96 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -162.0 35.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.082 -1.246 . . . . 0.0 109.606 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -72.95 148.59 44.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.129 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.0 93.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.277 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 mt -121.37 -54.25 1.99 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.438 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.34 74.1 1.38 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.502 ' N ' ' OG ' ' A' ' 65' ' ' SER . 82.1 t -69.56 158.12 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.39 131.53 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.401 -1.437 . . . . 0.0 111.538 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -99.92 129.23 45.98 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.665 HG22 ' H ' ' A' ' 13' ' ' TYR . 44.1 m -63.45 154.29 32.69 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.513 1.149 . . . . 0.0 110.614 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.3 mt -114.29 -17.3 11.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.155 -1.424 . . . . 10.539999999999999 107.155 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.665 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.56 145.04 18.48 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.19 -0.944 . . . . 18.390000000000001 110.798 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -73.02 81.47 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.506 1.471 . . . . 0.0 109.036 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.2 t80 -71.78 170.31 13.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.125 . . . . 0.0 110.944 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.0 7.92 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.738 0.78 . . . . 0.0 109.459 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.0 10.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 18' ' ' VAL . 7.5 m -130.33 94.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-O 122.907 1.337 . . . . 0.0 109.26 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.6 m -144.36 -151.93 0.39 Allowed 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.301 -1.318 . . . . 38.32 107.701 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.705 ' H ' HG22 ' A' ' 19' ' ' THR . 96.2 mt-10 -82.51 -54.42 5.2 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.84 -1.541 . . . . 55.130000000000003 106.84 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.4 mt-10 -109.3 29.28 7.69 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.357 -0.839 . . . . 0.0 110.759 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.43 150.89 22.16 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.812 -1.18 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.451 -0.78 . . . . 11.68 110.756 -178.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -95.39 127.72 41.67 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.99 142.16 21.44 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.386 -1.446 . . . . 12.44 110.905 -178.46 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.78 22.52 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 146.98 18.09 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.389 -0.924 . . . . 29.030000000000001 109.603 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.56 44.18 6.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.248 -1.541 . . . . 6.1799999999999997 109.248 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.82 22.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.545 -0.973 . . . . 9.5199999999999996 109.452 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.13 108.66 6.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.46 133.81 49.6 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 123.104 1.431 . . . . 0.0 110.588 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.09 15.84 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.304 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.518 -0.739 . . . . 0.0 111.504 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.486 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 83.1 mt -59.68 -50.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.979 -1.076 . . . . 0.0 110.259 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.55 43.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.03 -1.044 . . . . 0.0 110.844 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.03 65.72 65.91 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.86 165.36 31.58 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.665 1.577 . . . . 0.0 109.003 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.58 -59.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.349 0.595 . . . . 0.0 110.119 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.69 -47.41 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 178.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.68 -59.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 122.562 2.174 . . . . 0.0 110.022 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 29.7 mm-40 131.76 9.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 123.86 0.864 . . . . 0.0 108.729 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.9 m0 -71.79 165.88 23.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.718 -1.239 . . . . 14.289999999999999 110.546 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.492 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.1 m0 -129.62 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.661 -0.649 . . . . 11.800000000000001 109.263 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.0 96.69 5.83 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.94 128.74 56.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.866 0.841 . . . . 0.0 110.345 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.57 150.36 26.94 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.754 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.41 128.59 43.47 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.27 -1.772 . . . . 0.0 107.181 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.45 -18.37 1.04 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 119.751 -1.843 . . . . 0.0 107.917 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.462 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.53 4.31 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.43 33.86 6.96 Favored Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.331 -0.85 . . . . 14.41 112.271 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.754 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.08 29.86 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.692 1.746 . . . . 0.0 111.762 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.62 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.369 1.081 . . . . 0.0 112.494 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.82 12.82 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.302 -1.519 . . . . 7.25 109.302 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.41 150.94 42.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.218 -1.166 . . . . 0.0 108.629 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.02 136.7 8.97 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.356 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.2 113.52 1.14 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 N-CA-C 109.002 -1.192 . . . . 4.7599999999999998 109.002 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.3 3.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.842 . . . . 0.0 110.719 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.594 ' OD1' ' NH2' ' B' ' 83' ' ' ARG . 95.8 m-20 -102.07 -7.59 22.16 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.263 -0.898 . . . . 14.84 109.319 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.93 8.09 31.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.269 -0.894 . . . . 10.23 109.533 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.33 156.66 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 6.9699999999999998 109.49 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 63' ' ' VAL . 2.7 p -106.82 160.83 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 62' ' ' VAL . 8.5 p -107.75 134.27 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.363 -0.836 . . . . 0.0 109.724 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.11 -63.1 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.665 -0.647 . . . . 0.0 109.275 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 13.4 p -69.99 151.54 45.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.027 -1.046 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 44.2 p30 -146.54 152.78 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.221 -0.925 . . . . 0.0 109.337 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.43 1.47 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.338 1.359 . . . . 0.0 109.693 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.0 82.65 1.77 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.04 32.28 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.65 156.35 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.9 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.493 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.8 0.2 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.24 130.78 5.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.271 -1.135 . . . . 0.0 109.431 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.54 36.18 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.958 1.772 . . . . 0.0 108.805 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.527 HG23 ' C ' ' B' ' 84' ' ' ARG . 65.0 mt -135.33 119.78 26.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 122.068 0.937 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.826 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.43 117.09 4.1 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.949 0.881 . . . . 0.0 109.922 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.17 4.94 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.826 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.71 -48.56 8.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.372 -1.075 . . . . 0.0 109.306 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.78 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ARG . . . . . 0.594 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 94.2 mtt-85 53.51 41.32 32.12 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.527 ' C ' HG23 ' B' ' 78' ' ' ILE . 3.9 mmm180 -115.87 143.42 30.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.634 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.54 113.3 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.428 1.419 . . . . 0.0 110.596 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.671 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.92 158.42 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.47 61.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 110.682 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.09 0.15 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.661 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.49 120.72 42.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.671 HG22 HG21 ' B' ' 86' ' ' ILE . 43.1 t -98.91 158.73 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.73 0.776 . . . . 0.0 111.105 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.64 116.01 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.89 105.97 18.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.09 -1.007 . . . . 0.0 109.528 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.52 159.64 42.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.22 4.27 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.26 75.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.17 -154.72 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.722 0.772 . . . . 0.0 109.796 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.466 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.4 mt-30 -135.5 143.45 45.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.9 m95 -141.58 140.07 33.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.516 -1.365 . . . . 0.0 110.596 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.454 ' C ' ' N ' ' B' ' 101' ' ' GLU . 16.9 m80 -56.66 131.99 50.6 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.15 -14.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.956 -1.09 . . . . 0.0 108.302 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.02 15.45 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.696 -0.627 . . . . 0.0 110.638 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.01 -6.6 31.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.818 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.471 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.12 106.22 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.83 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.204 1.002 . . . . 0.0 111.192 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.7 148.68 45.85 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.329 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.63 1.75 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.66 0.71 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.338 -0.851 . . . . 0.0 110.009 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.36 4.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.392 -0.817 . . . . 0.0 110.165 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.5 109.54 59.34 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.83 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.02 138.19 39.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.804 1.669 . . . . 0.0 112.078 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.78 56.98 1.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.138 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.21 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.9 2.75 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.965 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.2 178.99 4.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.465 -1.021 . . . . 0.0 109.906 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.62 145.37 24.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.761 . . . . 0.0 109.302 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.43 9.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.462 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.705 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.53 137.64 47.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.06 148.33 28.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.262 -0.899 . . . . 0.0 111.173 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.19 11.22 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.607 0.718 . . . . 0.0 110.291 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.39 22.77 1.53 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.4 31.06 20.32 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.729 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.3 mt -143.4 142.71 31.34 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.521 -0.988 . . . . 0.0 108.773 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.9 36.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 110.787 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.548 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.3 m-85 -153.97 140.42 18.75 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.6 177.51 0.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.446 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.73 -35.89 82.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 0.0 109.443 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.1 m -86.69 -43.7 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 111.384 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.7 -43.71 83.6 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.839 -1.163 . . . . 0.0 108.065 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.512 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.84 -56.45 13.9 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.0 m-80 -64.4 -45.03 89.39 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.012 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.34 61.17 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.548 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.66 -35.25 45.57 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.361 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.57 -81.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.51 31.31 16.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.405 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.56 51.3 15.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -1.128 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.744 1 CA-C-O 70.872 -23.442 . . . . 0.0 109.455 179.941 . . . . . . . . 2 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.26 74.93 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -162.0 35.33 0.12 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -1.207 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.434 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.0 148.65 44.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.143 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.15 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -121.37 -54.35 1.99 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.34 74.11 1.38 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -69.52 158.04 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 31' ' ' MET . 3.5 m -145.32 131.48 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.42 -1.425 . . . . 0.0 111.557 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.9 129.25 45.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 13' ' ' TYR . 36.4 m -63.44 154.29 32.64 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.591 1.186 . . . . 0.0 110.546 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 77.2 mt -114.28 -17.22 11.88 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.147 -1.427 . . . . 10.539999999999999 107.147 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.661 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.55 145.09 18.57 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.24 -0.913 . . . . 18.390000000000001 110.694 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.06 81.53 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 121.372 1.381 . . . . 0.0 109.058 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.29 13.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.015 -1.053 . . . . 0.0 110.896 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.19 8.04 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.857 0.837 . . . . 0.0 109.389 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.97 10.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 18' ' ' VAL . 29.7 m -130.34 94.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-O 122.911 1.339 . . . . 0.0 109.232 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -144.44 -152.05 0.4 Allowed 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 114.377 -1.283 . . . . 38.32 107.618 178.031 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 19' ' ' THR . 97.2 mt-10 -82.47 -54.27 5.32 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.902 -1.518 . . . . 55.130000000000003 106.902 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -109.26 29.23 7.72 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.427 -0.795 . . . . 0.0 110.778 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.569 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.32 150.92 22.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.81 -1.181 . . . . 0.0 109.766 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.51 111.45 22.48 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.401 -0.812 . . . . 11.68 110.695 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -95.44 127.67 41.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.26 21.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.35 -1.469 . . . . 12.44 110.881 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.605 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.28 155.77 22.27 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 146.95 17.92 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 121.262 -0.899 . . . . 29.030000000000001 109.542 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.08 6.65 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.316 -1.514 . . . . 6.1799999999999997 109.316 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.25 114.78 22.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.522 -0.987 . . . . 9.5199999999999996 109.54 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.05 108.62 6.04 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.43 133.65 49.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 123.172 1.463 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.74 102.99 15.75 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.459 -178.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.96 92.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.51 -0.744 . . . . 0.0 111.597 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.482 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.78 -50.29 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.993 -1.067 . . . . 0.0 110.248 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.486 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.29 157.6 43.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.055 -1.028 . . . . 0.0 110.779 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.06 65.58 65.33 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.8 165.41 31.53 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.697 1.598 . . . . 0.0 108.901 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.09 -46.41 7.79 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.62 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.369 0.604 . . . . 0.0 110.069 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.53 0.0 OUTLIER Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.296 -2.185 0 C-N-CA 122.707 2.271 . . . . 0.0 109.874 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.7 pt-20 131.84 9.19 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.898 0 C-N-CA 123.894 0.878 . . . . 0.0 108.754 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.561 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.3 m0 -71.8 165.81 23.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.635 -1.291 . . . . 14.289999999999999 110.532 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 19.3 m0 -129.5 144.99 51.5 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.38 -0.6 . . . . 11.800000000000001 109.38 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.95 96.73 5.81 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.8 56.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.913 0.863 . . . . 0.0 110.381 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.56 150.44 26.91 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.752 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.0 p30 -96.46 128.55 43.49 Favored 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 117.282 -1.767 . . . . 0.0 107.203 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.41 1.01 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.701 -1.875 . . . . 0.0 107.934 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.8 -4.4 4.33 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.46 33.78 6.99 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-N 115.33 -0.85 . . . . 14.41 112.27 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.752 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.79 164.09 29.77 Favored 'General case' 0 N--CA 1.515 2.805 0 CA-C-N 119.783 1.792 . . . . 0.0 111.867 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.0 154.55 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.374 1.083 . . . . 0.0 112.504 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.18 156.66 12.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.267 -1.533 . . . . 7.25 109.267 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.28 150.83 43.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -1.201 . . . . 0.0 108.712 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.99 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.959 -1.088 . . . . 0.0 109.254 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 N-CA-C 108.997 -1.194 . . . . 4.7599999999999998 108.997 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.501 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 23.8 pttm -60.31 3.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.544 -0.722 . . . . 0.0 110.742 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.657 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 1.0 OUTLIER -102.04 -7.57 22.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.177 -0.952 . . . . 14.84 109.342 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.01 8.27 30.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.255 -0.903 . . . . 10.23 109.487 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -147.59 156.52 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 6.9699999999999998 109.582 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 63' ' ' VAL . 10.0 p -106.71 160.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 62' ' ' VAL . 11.8 p -107.66 134.26 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.07 -63.23 1.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -70.09 151.67 45.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.922 -1.112 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -146.61 152.74 39.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.196 -0.94 . . . . 0.0 109.385 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.3 1.47 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.27 1.313 . . . . 0.0 109.688 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.24 82.64 1.78 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.06 32.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.2 28.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -1.126 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.21 46.76 0.2 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.17 130.8 5.4 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.21 163.65 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.949 1.766 . . . . 0.0 108.924 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.485 HG23 ' C ' ' B' ' 84' ' ' ARG . 49.0 mt -135.41 119.89 26.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 122.032 0.92 . . . . 0.0 109.425 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.834 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.829 0.823 . . . . 0.0 110.019 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.89 -0.11 4.89 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.834 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.57 8.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -1.094 . . . . 0.0 109.356 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.17 4.77 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ARG . . . . . 0.456 HH21 ' HE2' ' A' ' 58' ' ' LYS . 84.3 mtt85 53.62 41.28 32.12 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.485 ' C ' HG23 ' B' ' 78' ' ' ILE . 8.7 mmm180 -115.88 143.48 30.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.646 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.5 Cg_exo -56.51 113.47 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.425 1.417 . . . . 0.0 110.515 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.645 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -71.01 158.47 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.42 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.49 61.4 0.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.887 -1.133 . . . . 0.0 110.688 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.95 -101.88 0.15 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.676 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.65 120.64 42.23 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.645 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.89 158.7 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.755 0.788 . . . . 0.0 111.182 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.53 116.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.87 106.12 18.26 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.057 -1.027 . . . . 0.0 109.552 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.63 42.49 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.634 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.06 17.24 4.32 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.33 75.77 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.35 -154.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.756 0.788 . . . . 0.0 109.658 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.28 143.5 46.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.7 m95 -141.61 140.18 33.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.51 -1.369 . . . . 0.0 110.596 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.446 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.65 132.01 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.466 HG22 HG23 ' B' ' 91' ' ' VAL . 7.8 t -53.24 -14.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.854 -1.153 . . . . 0.0 108.285 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.446 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.97 15.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.743 -0.598 . . . . 0.0 110.594 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.18 -6.47 31.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.903 -1.123 . . . . 0.0 110.769 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.24 106.28 12.14 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.828 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.4 m -133.52 175.31 11.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 122.369 1.08 . . . . 0.0 111.175 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.86 148.71 46.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.343 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.49 1.79 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.71 -31.67 0.72 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.392 -0.818 . . . . 0.0 110.079 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.2 -15.15 4.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.339 -0.851 . . . . 0.0 110.15 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.69 47.46 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.55 109.66 59.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.828 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.07 138.28 39.63 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.673 1.582 . . . . 0.0 112.168 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.327 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.72 56.9 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.212 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.15 -55.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.242 -0.911 . . . . 0.0 108.988 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.94 2.75 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.943 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.21 178.88 4.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.54 -0.976 . . . . 0.0 109.963 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.55 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.227 -0.921 . . . . 0.0 109.622 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.59 137.67 47.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.94 148.3 28.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 111.261 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.33 11.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.74 . . . . 0.0 110.318 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.17 22.78 1.39 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.634 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.61 30.8 20.44 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.766 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.21 142.76 31.51 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.56 -0.965 . . . . 0.0 108.851 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.92 35.99 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -153.95 140.23 18.57 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.7 m -57.59 177.43 0.1 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.346 -1.342 . . . . 0.0 108.397 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.52 -36.11 82.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.376 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.9 m -86.57 -43.68 12.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.55 -0.719 . . . . 0.0 111.412 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.78 -43.74 83.18 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.748 -1.22 . . . . 0.0 108.078 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.73 -56.52 13.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.42 -44.85 89.94 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.101 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.57 -34.31 61.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.76 -35.18 44.95 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.366 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.59 -81.71 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.52 31.29 16.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.56 51.28 15.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.714 1 CA-C-O 70.897 -23.43 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.83 0.12 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.93 35.24 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -1.16 . . . . 0.0 109.581 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.07 148.69 43.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.106 -0.996 . . . . 0.0 109.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.13 93.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.268 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.16 -54.32 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.449 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.9 m-70 -145.26 73.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.53 ' N ' ' OG ' ' A' ' 65' ' ' SER . 19.6 t -69.47 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.8 m -145.3 131.44 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.458 -1.401 . . . . 0.0 111.52 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.83 129.28 45.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 13' ' ' TYR . 33.2 m -63.38 154.32 32.36 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.585 1.183 . . . . 0.0 110.532 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.0 mt -114.32 -17.36 11.83 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.125 -1.435 . . . . 10.539999999999999 107.125 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.671 ' H ' HG22 ' A' ' 11' ' ' THR . 14.5 m-85 -149.45 145.03 18.52 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.052 -1.03 . . . . 18.390000000000001 110.748 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.95 81.38 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.414 1.409 . . . . 0.0 109.031 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.73 170.26 13.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.916 -1.115 . . . . 0.0 110.956 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.12 7.97 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.876 0.846 . . . . 0.0 109.327 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.17 111.91 10.68 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 18' ' ' VAL . 34.0 m -130.38 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 122.983 1.373 . . . . 0.0 109.161 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.635 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.51 -152.01 0.4 Allowed 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.309 -1.314 . . . . 38.32 107.61 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.635 ' H ' HG22 ' A' ' 19' ' ' THR . 97.6 mt-10 -82.36 -54.36 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.967 -1.494 . . . . 55.130000000000003 106.967 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.22 29.24 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.424 -0.798 . . . . 0.0 110.769 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.47 150.88 22.19 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.915 -1.116 . . . . 0.0 109.83 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.455 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -111.34 111.35 22.33 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.317 -0.864 . . . . 11.68 110.765 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -95.5 127.64 41.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.96 142.16 21.47 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.36 -1.462 . . . . 12.44 110.861 -178.447 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.16 155.83 22.38 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.99 18.2 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.462 -0.895 . . . . 29.030000000000001 109.51 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.52 44.25 6.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.262 -1.535 . . . . 6.1799999999999997 109.262 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.67 22.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.53 -0.982 . . . . 9.5199999999999996 109.437 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.92 108.6 5.93 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.55 133.8 49.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.202 1.477 . . . . 0.0 110.561 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.83 103.04 15.8 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.384 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.556 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.588 -0.695 . . . . 0.0 111.543 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.012 -1.055 . . . . 0.0 110.224 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.2 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 110.748 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.556 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.1 65.62 65.19 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.36 31.59 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.693 1.596 . . . . 0.0 108.94 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.08 -46.49 7.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.7 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.366 0.603 . . . . 0.0 110.005 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.55 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.615 2.21 . . . . 0.0 109.965 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 27.4 tt0 131.69 9.1 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.78 0.832 . . . . 0.0 108.795 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.568 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.9 m0 -71.75 165.88 23.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.586 -1.321 . . . . 14.289999999999999 110.537 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.536 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.3 m0 -129.58 145.1 51.51 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.321 -0.622 . . . . 11.800000000000001 109.321 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -78.99 96.59 5.8 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -115.97 128.77 56.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.011 0.91 . . . . 0.0 110.361 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.59 150.33 26.94 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.756 ' N ' ' O ' ' A' ' 52' ' ' GLN . 14.9 p30 -96.32 128.55 43.34 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 117.299 -1.76 . . . . 0.0 107.266 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.43 -18.41 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 119.656 -1.902 . . . . 0.0 107.912 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.473 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.69 -4.58 4.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.49 33.89 6.92 Favored Glycine 0 N--CA 1.481 1.683 0 CA-C-N 115.291 -0.868 . . . . 14.41 112.29 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.756 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.92 164.11 29.81 Favored 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.625 1.713 . . . . 0.0 111.883 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.54 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-O 122.315 1.055 . . . . 0.0 112.484 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.69 12.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 7.25 109.258 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.89 43.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.24 -1.153 . . . . 0.0 108.631 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.73 9.0 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.902 -1.124 . . . . 0.0 109.228 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.1 Cg_exo -51.16 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.217 -0.543 0 N-CA-C 109.061 -1.169 . . . . 4.7599999999999998 109.061 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 31.3 pttt -60.25 3.01 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.453 -0.779 . . . . 0.0 110.758 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 94.4 m-20 -102.03 -7.62 22.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 14.84 109.27 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.31 30.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.873 . . . . 10.23 109.476 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.47 156.69 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 6.9699999999999998 109.499 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 63' ' ' VAL . 13.8 p -106.88 160.69 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' N ' HG22 ' A' ' 62' ' ' VAL . 41.7 t -107.61 134.23 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.13 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.613 -0.68 . . . . 0.0 109.239 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 16.4 p -69.99 151.64 45.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 109.462 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -146.65 152.59 39.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.035 . . . . 0.0 109.427 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.36 1.48 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.27 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.464 1.442 . . . . 0.0 109.654 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.74 124.92 32.08 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.73 156.31 28.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.384 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.82 167.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.92 0.2 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.633 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.24 130.74 5.35 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.405 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.24 163.62 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.957 1.772 . . . . 0.0 108.873 178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 mt -135.46 119.76 26.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 122.12 0.962 . . . . 0.0 109.455 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.826 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.32 117.01 3.98 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.869 0.843 . . . . 0.0 109.897 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.1 4.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.826 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.8 -48.48 8.18 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.245 -1.15 . . . . 0.0 109.368 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.13 4.87 13.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ARG . . . . . 0.469 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 95.7 mtt-85 53.45 41.49 32.1 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -116.07 143.42 30.9 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.633 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.29 113.39 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.524 1.483 . . . . 0.0 110.592 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.675 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -71.01 158.4 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.429 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.5 61.45 0.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.849 -1.157 . . . . 0.0 110.663 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -102.01 0.15 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.659 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.58 120.7 42.47 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.675 HG22 HG21 ' B' ' 86' ' ' ILE . 43.2 t -98.98 158.74 3.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.507 -0.746 . . . . 0.0 111.151 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.63 115.94 47.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.72 106.09 18.23 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.57 42.58 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.12 17.12 4.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.09 25.37 75.7 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.77 0.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.857 0.837 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.462 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.6 mt-30 -135.45 143.5 45.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.5 140.05 33.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.655 -1.278 . . . . 0.0 110.598 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.45 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.53 131.93 50.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.22 -14.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 120.725 -1.234 . . . . 0.0 108.347 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.82 -27.03 15.42 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.886 -0.509 . . . . 0.0 110.595 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.17 -6.48 31.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.948 -1.095 . . . . 0.0 110.856 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.22 106.31 12.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.829 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.6 175.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.318 1.056 . . . . 0.0 111.065 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.92 148.76 46.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.264 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.89 28.74 1.74 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.428 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.81 -31.68 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.388 -0.82 . . . . 0.0 110.118 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.01 -15.52 4.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.57 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.378 -0.826 . . . . 0.0 110.238 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.5 59.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.829 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.13 138.24 39.32 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.676 1.584 . . . . 0.0 112.111 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.72 56.96 1.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.221 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.17 1.72 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 108.881 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.2 30.99 2.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.944 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.29 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.352 -1.087 . . . . 0.0 109.935 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.478 -0.764 . . . . 0.0 109.334 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.39 9.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.685 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.84 47.34 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.19 148.31 29.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.22 11.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.604 0.716 . . . . 0.0 110.331 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.42 22.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.638 -0.664 . . . . 0.0 109.413 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.48 Favored Glycine 0 N--CA 1.483 1.815 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.689 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.7 mt -143.33 142.76 31.41 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.646 -0.914 . . . . 0.0 108.865 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.88 36.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.666 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.552 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.92 140.32 18.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.3 m -57.64 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.282 -1.367 . . . . 0.0 108.448 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.97 82.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.78 -43.68 12.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.453 -0.78 . . . . 0.0 111.315 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.71 83.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.67 -1.269 . . . . 0.0 108.133 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.1 t80 -51.8 -56.5 13.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.423 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.0 m-80 -64.58 -44.75 89.69 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.135 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.32 61.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.552 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.29 44.74 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.51 -81.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.026 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.47 31.48 16.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.42 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.7 m-20 48.35 51.31 15.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -1.063 . . . . 0.0 109.563 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.763 1 CA-C-O 70.976 -23.392 . . . . 0.0 109.443 179.971 . . . . . . . . 2 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.332 0.586 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.85 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -161.99 35.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -1.19 . . . . 0.0 109.494 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.07 148.63 43.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.156 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.4 t -66.02 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 0.0 109.282 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.23 -54.36 2.0 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -145.23 73.86 1.38 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.9 t -69.44 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.33 131.58 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.484 -1.385 . . . . 0.0 111.55 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -99.94 129.14 45.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 13' ' ' TYR . 48.9 m -63.37 154.41 32.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.52 1.153 . . . . 0.0 110.598 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 87.8 mt -114.3 -17.38 11.84 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.173 -1.417 . . . . 10.539999999999999 107.173 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.651 ' H ' HG22 ' A' ' 11' ' ' THR . 14.5 m-85 -149.43 145.15 18.73 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.177 -0.952 . . . . 18.390000000000001 110.706 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.02 81.42 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 121.414 1.41 . . . . 0.0 109.054 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.32 13.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.94 -1.1 . . . . 0.0 110.865 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.449 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.6 111.01 7.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.771 0.796 . . . . 0.0 109.462 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.25 112.07 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.36 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 122.866 1.317 . . . . 0.0 109.071 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.64 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.6 -151.97 0.4 Allowed 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.357 -1.292 . . . . 38.32 107.518 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.64 ' H ' HG22 ' A' ' 19' ' ' THR . 95.9 mt-10 -82.47 -54.33 5.28 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.783 -1.562 . . . . 55.130000000000003 106.783 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 71.6 mm-40 -109.35 29.25 7.72 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.366 -0.834 . . . . 0.0 110.701 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.57 150.82 22.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.841 -1.162 . . . . 0.0 109.797 -179.344 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.32 111.36 22.36 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.295 -0.878 . . . . 11.68 110.804 -178.363 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -95.35 127.64 41.56 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.91 142.22 21.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.39 -1.443 . . . . 12.44 110.87 -178.472 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.82 22.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 146.95 18.5 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.221 -0.925 . . . . 29.030000000000001 109.497 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 43.99 6.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.277 -1.529 . . . . 6.1799999999999997 109.277 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.79 22.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.56 -0.964 . . . . 9.5199999999999996 109.419 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.06 108.73 6.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.68 49.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 123.179 1.466 . . . . 0.0 110.486 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.75 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.427 -178.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 111.51 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.7 mt -59.73 -50.51 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.994 -1.066 . . . . 0.0 110.194 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.22 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.061 -1.025 . . . . 0.0 110.803 -177.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.02 65.54 65.5 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.83 165.42 31.48 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 109.0 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.13 -46.4 7.78 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.74 -59.53 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.436 0.636 . . . . 0.0 110.018 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.61 2.206 . . . . 0.0 109.922 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 62.2 mt-10 131.74 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 123.845 0.858 . . . . 0.0 108.738 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.545 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.1 m0 -71.74 165.83 23.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.526 -1.359 . . . . 14.289999999999999 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.482 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.8 m0 -129.6 145.11 51.52 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.38 -0.6 . . . . 11.800000000000001 109.38 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -79.08 96.74 5.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.4 p -115.93 128.76 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.855 0.836 . . . . 0.0 110.36 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.68 150.35 26.82 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.756 ' N ' ' O ' ' A' ' 52' ' ' GLN . 15.1 p30 -96.37 128.49 43.35 Favored 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.172 -1.811 . . . . 0.0 107.212 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.28 -18.45 0.96 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 119.687 -1.883 . . . . 0.0 107.998 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.465 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.61 -4.57 4.29 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.638 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.206 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.756 ' O ' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.03 29.97 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.773 1.787 . . . . 0.0 111.815 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.303 1.049 . . . . 0.0 112.544 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.21 156.77 12.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.28 -1.528 . . . . 7.25 109.28 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.45 150.88 42.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -1.147 . . . . 0.0 108.657 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.72 9.01 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.029 -1.045 . . . . 0.0 109.27 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.26 113.49 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.068 -1.166 . . . . 4.7599999999999998 109.068 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.443 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.33 3.21 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 110.78 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 57' ' ' PRO . 8.3 p-10 -102.03 -7.57 22.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 14.84 109.335 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.04 8.21 30.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 10.23 109.536 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.0 m -147.44 156.57 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.942 . . . . 6.9699999999999998 109.541 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -106.87 160.75 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' B' ' 82' ' ' CYS . 10.5 p -107.61 134.26 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.401 -0.812 . . . . 0.0 109.754 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.05 -63.31 1.24 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.682 . . . . 0.0 109.227 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.447 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 58.3 m -69.95 151.68 45.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.975 -1.078 . . . . 0.0 109.454 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 48.7 p30 -146.58 152.73 39.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 109.356 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.11 -67.28 1.48 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.317 1.344 . . . . 0.0 109.606 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.05 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.72 125.0 32.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.23 28.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.562 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.82 167.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.29 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.23 130.75 5.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 109.366 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.6 Cg_endo -74.16 163.61 36.19 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.946 1.764 . . . . 0.0 108.914 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.512 HG23 ' C ' ' B' ' 84' ' ' ARG . 56.7 mt -135.43 119.74 26.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.081 0.943 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.3 117.05 4.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.22 4.88 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.74 -48.51 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -1.099 . . . . 0.0 109.305 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' CYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 1.6 p -116.12 4.84 13.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 53.54 41.32 32.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.512 ' C ' HG23 ' B' ' 78' ' ' ILE . 43.3 mtp180 -115.86 143.46 30.81 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.64 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.8 Cg_exo -56.32 113.33 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.494 1.463 . . . . 0.0 110.623 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.669 HG21 HG22 ' B' ' 90' ' ' VAL . 21.4 mt -70.95 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.57 61.34 0.32 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.831 -1.168 . . . . 0.0 110.646 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.97 -101.97 0.15 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.656 HH11 ' CG ' ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.73 42.57 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.669 HG22 HG21 ' B' ' 86' ' ' ILE . 42.5 t -98.81 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.641 0.734 . . . . 0.0 111.298 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.52 115.91 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.81 106.17 18.29 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.062 -1.023 . . . . 0.0 109.481 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.6 159.54 42.63 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.07 17.25 4.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.18 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.724 0.773 . . . . 0.0 109.821 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' GLN . . . . . 0.468 ' HG2' HG11 ' B' ' 90' ' ' VAL . 20.4 mt-30 -135.43 143.42 45.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.0 m95 -141.44 140.0 33.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.561 -1.337 . . . . 0.0 110.682 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.4 m80 -56.56 131.94 50.18 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 91' ' ' VAL . 7.6 t -53.2 -14.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.701 -1.25 . . . . 0.0 108.32 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.85 15.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.754 -0.591 . . . . 0.0 110.613 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.22 -6.53 31.04 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.26 106.31 12.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.63 175.25 11.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.287 1.041 . . . . 0.0 111.138 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.79 148.69 46.15 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.234 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.79 28.54 1.76 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.73 -31.62 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.432 -0.793 . . . . 0.0 110.149 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.08 -15.38 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 110.156 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.55 0.35 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.28 109.48 58.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.02 138.36 39.97 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.66 1.574 . . . . 0.0 112.077 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.82 56.91 1.78 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.133 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.21 -55.24 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.2 -0.937 . . . . 0.0 108.897 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.12 2.73 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.956 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.6 m-70 -116.27 178.88 4.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.483 -1.01 . . . . 0.0 109.987 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.5 145.43 24.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.38 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.563 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.35 169.48 9.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.528 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.695 ' N ' ' CD1' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.6 137.7 47.15 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.96 148.28 28.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.232 -0.918 . . . . 0.0 111.234 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.05 129.34 11.26 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.604 0.716 . . . . 0.0 110.381 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.3 22.78 1.48 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.671 -0.643 . . . . 0.0 109.438 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.9 20.49 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.764 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.4 mt -143.27 142.89 31.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.529 -0.983 . . . . 0.0 108.725 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.84 36.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.685 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.547 ' CE1' HD22 ' B' ' 133' ' ' LEU . 58.5 m-85 -153.89 140.31 18.71 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.65 177.55 0.1 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.26 -1.376 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.67 -36.05 82.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.374 -0.828 . . . . 0.0 109.285 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.7 m -86.61 -43.78 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 0.0 111.333 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.79 83.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.721 -1.237 . . . . 0.0 108.095 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.71 -56.47 13.58 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 131' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.211 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.48 -34.29 61.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.547 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.75 -35.23 44.96 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.335 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.33 31.42 16.64 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.53 51.17 15.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -1.109 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.725 1 CA-C-O 70.924 -23.417 . . . . 0.0 109.436 179.924 . . . . . . . . 2 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.326 0.584 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.7 p -162.06 35.34 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -1.169 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.06 148.64 43.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.148 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.3 t -66.08 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.117 -0.99 . . . . 0.0 109.246 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.2 -54.26 2.01 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 9' ' ' VAL . 79.2 t -69.43 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 9' ' ' VAL . 3.2 m -145.23 131.51 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.426 -1.421 . . . . 0.0 111.665 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -99.98 129.26 46.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.646 HG22 ' H ' ' A' ' 13' ' ' TYR . 52.4 m -63.37 154.28 32.45 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.518 1.152 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 95.9 mt -114.23 -17.35 11.88 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.236 -1.394 . . . . 10.54 107.236 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.646 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.503 2.218 0 C-N-CA 119.463 -0.895 . . . . 18.39 110.699 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.5 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 121.436 1.424 . . . . 0.0 108.983 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.82 170.3 13.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.926 -1.109 . . . . 0.0 110.959 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.12 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.826 0.822 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.93 10.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 18' ' ' VAL . 23.3 m -130.32 94.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.917 1.342 . . . . 0.0 109.187 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.905 HG22 ' H ' ' A' ' 20' ' ' GLU . 4.0 m -144.51 -151.98 0.4 Allowed 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.596 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.905 ' H ' HG22 ' A' ' 19' ' ' THR . 49.8 tp10 -82.42 -54.28 5.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.906 -1.516 . . . . 55.13 106.906 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.443 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.6 mt-10 -109.36 29.12 7.85 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.342 -0.849 . . . . 0.0 110.739 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.41 151.02 22.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.827 -1.171 . . . . 0.0 109.783 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.44 111.38 22.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.38 -0.825 . . . . 11.68 110.773 -178.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.5 127.7 41.75 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' HD2' ' HG1' ' A' ' 11' ' ' THR . 0.8 OUTLIER -152.93 142.12 21.46 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.377 -1.452 . . . . 12.44 110.935 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.81 22.51 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 146.92 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.422 -0.911 . . . . 29.03 109.577 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 11' ' ' THR . . . 84.64 44.05 6.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.315 -1.514 . . . . 6.18 109.315 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.73 22.79 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.509 -0.995 . . . . 9.52 109.396 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.85 108.55 5.86 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.406 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.5 133.77 49.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 123.185 1.469 . . . . 0.0 110.523 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.89 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.401 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.558 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.92 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.576 -0.703 . . . . 0.0 111.491 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.7 mt -59.82 -50.33 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.921 -1.112 . . . . 0.0 110.246 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.34 157.65 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.941 -1.099 . . . . 0.0 110.774 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.558 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.16 65.63 64.83 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.766 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.72 165.32 31.79 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.702 1.601 . . . . 0.0 109.07 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.02 -46.5 7.77 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.4 m-20 57.69 -59.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.008 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.74 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.142 0 C-N-CA 122.625 2.217 . . . . 0.0 109.929 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 35.8 mm-40 131.83 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.78 0.832 . . . . 0.0 108.765 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.556 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.3 m0 -71.86 165.84 23.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.64 -1.287 . . . . 14.29 110.464 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.0 m0 -129.54 145.18 51.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.198 -0.667 . . . . 11.8 109.198 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.15 96.79 5.96 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -116.01 128.82 56.03 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.959 0.885 . . . . 0.0 110.361 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.67 150.4 26.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.792 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.62 43.48 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 117.324 -1.751 . . . . 0.0 107.229 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.51 -18.32 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 119.706 -1.871 . . . . 0.0 107.946 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.459 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.66 -4.64 4.41 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.654 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.687 0 CA-C-N 115.499 -0.773 . . . . 14.41 112.239 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.792 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.93 164.01 30.08 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 119.609 1.704 . . . . 0.0 111.727 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.65 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.76 12.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.263 -1.535 . . . . 7.25 109.263 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.39 150.85 43.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.338 -1.095 . . . . 0.0 108.643 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.01 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.782 -1.199 . . . . 0.0 109.316 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.15 113.63 1.19 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.912 -1.226 . . . . 4.76 108.912 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.3 pttt -60.52 3.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.671 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.48 ' H ' ' C ' ' A' ' 57' ' ' PRO . 99.5 m-20 -102.05 -7.65 22.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.285 -0.884 . . . . 14.84 109.357 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.02 8.31 30.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 10.23 109.454 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.4 m -147.48 156.51 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.094 -1.004 . . . . 6.97 109.487 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.76 160.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' HG22 ' A' ' 62' ' ' VAL . 11.5 p -107.59 134.29 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.43 -0.794 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.12 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.613 -0.679 . . . . 0.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 41.6 m -69.92 151.53 45.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.546 ' OD2' ' NH1' ' B' ' 84' ' ' ARG . 53.4 p-10 -146.63 152.73 39.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.35 1.48 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.356 1.371 . . . . 0.0 109.688 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.11 82.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.8 124.94 32.14 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 109.301 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.39 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.16 29.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -1.107 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.81 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.85 0.2 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.26 130.85 5.39 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.297 -1.119 . . . . 0.0 109.345 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.29 163.53 36.2 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.031 1.821 . . . . 0.0 108.832 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.507 HG23 ' C ' ' B' ' 84' ' ' ARG . 76.2 mt -135.34 119.85 27.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 122.008 0.909 . . . . 0.0 109.365 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.84 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.809 0.814 . . . . 0.0 109.914 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.82 -0.16 4.86 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.84 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.7 -48.53 8.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.295 -1.121 . . . . 0.0 109.301 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.16 4.78 13.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . 0.456 HH22 ' HE3' ' A' ' 58' ' ' LYS . 83.8 mtt85 53.53 41.25 32.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.546 ' NH1' ' OD2' ' A' ' 66' ' ' ASP . 17.3 mtp180 -115.79 143.39 30.64 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.631 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.37 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.366 1.377 . . . . 0.0 110.615 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.665 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.91 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.702 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.422 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.59 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.877 -1.14 . . . . 0.0 110.55 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.12 -101.8 0.15 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.76 120.63 42.17 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.665 HG22 HG21 ' B' ' 86' ' ' ILE . 42.6 t -98.83 158.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.648 0.737 . . . . 0.0 111.125 -177.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.57 115.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.646 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.73 106.03 18.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.624 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.52 42.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.618 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.99 17.34 4.31 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.12 76.09 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.16 -154.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.787 0.803 . . . . 0.0 109.779 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.479 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.48 143.46 45.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.6 139.99 33.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.544 -1.347 . . . . 0.0 110.576 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.46 131.98 50.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.7 t -53.17 -14.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 108.365 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.97 15.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.823 -0.548 . . . . 0.0 110.594 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.05 -6.62 31.45 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.878 -1.139 . . . . 0.0 110.798 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.472 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.1 t80 -80.08 106.3 12.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.8 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.161 0.982 . . . . 0.0 111.192 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.8 148.58 46.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.314 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.78 28.67 1.73 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.77 -31.75 0.71 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.293 -0.879 . . . . 0.0 110.113 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.44 4.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.222 -0.924 . . . . 0.0 110.226 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.65 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.363 -0.836 . . . . 0.0 110.237 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.52 59.18 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -68.99 138.27 39.83 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.825 1.683 . . . . 0.0 112.059 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.8 57.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.132 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.632 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.19 1.69 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 108.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.25 30.98 2.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.954 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.86 4.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.504 -0.998 . . . . 0.0 109.993 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -94.35 145.3 24.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.33 169.45 9.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.78 47.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.26 28.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.85 . . . . 0.0 111.188 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.635 0.731 . . . . 0.0 110.334 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mttm 51.39 22.8 1.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.62 -0.675 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.618 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.94 20.4 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.7 mt -143.26 142.81 31.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.46 -1.023 . . . . 0.0 108.848 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.8 36.31 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 110.702 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.555 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.3 m-85 -153.96 140.28 18.61 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.53 177.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.439 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.76 -35.92 82.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -0.814 . . . . 0.0 109.353 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.456 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.9 m -86.75 -43.52 12.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.543 -0.723 . . . . 0.0 111.384 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.72 -43.82 83.24 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.738 -1.226 . . . . 0.0 108.126 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.65 -56.48 13.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.421 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.6 -44.8 89.46 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.05 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.53 -34.37 61.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.65 -35.26 45.61 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.427 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.36 31.51 16.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.34 51.42 15.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -1.124 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 1 C--O 0.476 -39.651 1 CA-C-O 70.943 -23.408 . . . . 0.0 109.45 -179.965 . . . . . . . . 2 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.98 0.12 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -1.217 . . . . 0.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.09 148.67 43.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.4 t -66.07 93.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.19 -54.42 2.0 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.39 74.09 1.38 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.65 158.05 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.39 131.51 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.511 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.01 129.28 46.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 13' ' ' TYR . 30.0 m -63.39 154.37 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.456 1.122 . . . . 0.0 110.636 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.9 mt -114.38 -17.24 11.83 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.205 -1.406 . . . . 10.54 107.205 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.666 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.51 144.98 18.41 Favored Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 119.474 -0.891 . . . . 18.39 110.793 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.01 81.39 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 121.524 1.482 . . . . 0.0 109.019 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.8 170.28 13.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.05 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.15 8.07 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.453 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.01 10.68 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 18' ' ' VAL . 9.4 m -130.35 94.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 122.869 1.319 . . . . 0.0 109.177 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -144.54 -151.98 0.4 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.35 -1.296 . . . . 38.32 107.549 177.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 19' ' ' THR . 96.7 mt-10 -82.48 -54.32 5.29 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.849 -1.537 . . . . 55.13 106.849 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.35 29.15 7.81 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.402 -0.812 . . . . 0.0 110.762 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.4 150.84 22.21 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.839 -1.163 . . . . 0.0 109.7 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.37 22.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.385 -0.822 . . . . 11.68 110.764 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.46 127.7 41.72 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.88 142.17 21.54 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.374 -1.454 . . . . 12.44 110.947 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.09 155.77 22.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.38 146.84 18.58 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.267 -0.895 . . . . 29.03 109.602 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.71 44.07 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.275 -1.53 . . . . 6.18 109.275 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.33 114.75 22.85 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.513 -0.992 . . . . 9.52 109.454 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.04 108.59 6.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.43 133.69 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.153 1.454 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.82 103.12 15.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.39 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.516 -0.74 . . . . 0.0 111.392 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.3 mt -59.79 -50.46 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.971 -1.08 . . . . 0.0 110.121 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.53 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.17 157.58 43.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.983 -1.073 . . . . 0.0 110.814 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -134.97 65.54 65.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.39 31.64 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.635 1.556 . . . . 0.0 108.966 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.97 -46.56 7.75 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.52 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.268 0.556 . . . . 0.0 110.09 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.36 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 122.709 2.273 . . . . 0.0 109.914 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.75 9.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.816 0 C-N-CA 123.849 0.86 . . . . 0.0 108.849 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.7 m0 -71.89 165.82 23.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.593 -1.317 . . . . 14.29 110.481 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.494 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.9 m0 -129.53 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.356 -0.609 . . . . 11.8 109.356 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -79.01 96.62 5.82 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.504 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.65 55.92 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.379 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.47 150.35 27.08 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.77 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.35 128.49 43.32 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.322 -1.751 . . . . 0.0 107.295 177.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.41 0.98 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 119.643 -1.911 . . . . 0.0 108.03 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.477 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.68 -4.57 4.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.658 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.48 33.9 6.92 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.287 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.77 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.94 164.04 30.01 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 119.654 1.727 . . . . 0.0 111.77 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.64 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.274 1.035 . . . . 0.0 112.583 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.16 156.73 12.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.291 -1.524 . . . . 7.25 109.291 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.38 150.86 43.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.226 -1.161 . . . . 0.0 108.561 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.76 9.04 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.102 . . . . 0.0 109.297 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.28 113.53 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 N-CA-C 108.938 -1.216 . . . . 4.76 108.938 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.6 pttt -60.38 3.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 0.0 110.757 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.7 m-20 -102.03 -7.54 22.24 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.285 -0.885 . . . . 14.84 109.325 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.13 8.22 31.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 10.23 109.506 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.44 156.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.285 -0.885 . . . . 6.97 109.577 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.586 HG11 HD13 ' B' ' 78' ' ' ILE . 29.4 m -106.81 160.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.59 134.27 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.452 -0.78 . . . . 0.0 109.778 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.4 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 98.5 mt -105.13 -63.07 1.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 70.4 m -70.05 151.66 45.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.036 -1.04 . . . . 0.0 109.409 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 65' ' ' SER . 87.8 m-20 -146.6 152.69 39.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 109.311 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.29 1.48 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.299 1.332 . . . . 0.0 109.629 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.61 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.9 124.95 32.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.41 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.76 156.22 28.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -1.112 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.83 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.22 130.81 5.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.29 163.42 36.44 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.052 1.835 . . . . 0.0 108.83 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.596 HG23 ' C ' ' B' ' 84' ' ' ARG . 41.7 mt -135.22 119.85 27.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.983 0.896 . . . . 0.0 109.389 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.42 116.96 3.97 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.11 4.78 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.69 -48.57 8.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -1.067 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.72 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.132 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 53.54 41.3 32.12 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.596 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.3 mmm180 -115.82 143.5 30.86 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.55 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.44 1.427 . . . . 0.0 110.542 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.67 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.95 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.53 61.41 0.32 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.791 -1.193 . . . . 0.0 110.593 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.677 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.67 42.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.67 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.8 158.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 111.294 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.51 115.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.638 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.92 106.07 18.23 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 109.592 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.62 159.48 42.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.11 17.26 4.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.19 25.28 75.85 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.041 -2.024 . . . . 0.0 108.041 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.76 0.65 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.8 0.809 . . . . 0.0 109.732 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.483 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.35 143.52 46.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.58 139.91 33.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.488 -1.382 . . . . 0.0 110.648 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.54 131.99 50.26 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.457 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.21 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.846 -1.158 . . . . 0.0 108.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.89 -26.82 15.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.869 -0.519 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.23 -6.5 31.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.816 -1.177 . . . . 0.0 110.781 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.26 106.25 12.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.818 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.2 m -133.59 175.27 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.329 1.061 . . . . 0.0 111.1 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.87 148.7 46.41 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.37 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.61 1.74 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.82 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.74 -31.78 0.71 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.01 -15.38 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.79 47.5 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.36 109.64 59.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.818 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.05 138.27 39.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.748 1.632 . . . . 0.0 112.147 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.84 56.97 1.78 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.098 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.11 -55.25 1.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.12 30.91 2.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.906 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.93 4.14 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.474 -1.015 . . . . 0.0 109.977 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.41 145.33 24.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 109.412 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.411 -0.806 . . . . 0.0 109.511 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.696 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.61 47.17 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.98 148.36 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.218 -0.926 . . . . 0.0 111.18 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.556 0.693 . . . . 0.0 110.27 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.7 mttm 51.27 22.83 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.465 0.65 . . . . 0.0 109.526 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.46 30.92 20.54 Favored Glycine 0 N--CA 1.481 1.663 0 C-N-CA 119.396 -1.383 . . . . 0.0 109.785 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.6 mt -143.26 142.8 31.48 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 108.79 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.4 152.79 36.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.7 m-85 -153.81 140.27 18.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.2 m -57.57 177.5 0.1 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.366 -1.334 . . . . 0.0 108.486 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.63 -36.06 82.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.417 -0.802 . . . . 0.0 109.349 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.5 m -86.54 -43.8 12.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.745 . . . . 0.0 111.338 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.456 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.87 83.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.722 -1.236 . . . . 0.0 108.089 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.38 14.07 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.55 -44.92 89.23 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.043 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.45 61.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.53 -35.28 46.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.501 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.114 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.43 31.36 16.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.0 m-20 48.59 51.26 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 70.968 -23.396 . . . . 0.0 109.468 179.977 . . . . . . . . 2 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.94 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.99 35.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -1.21 . . . . 0.0 109.583 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.02 148.68 43.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.48 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -66.08 93.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.255 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.25 -54.28 2.0 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.35 74.0 1.38 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.53 158.09 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.36 131.45 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.449 -1.407 . . . . 0.0 111.561 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.92 129.29 45.98 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 13' ' ' TYR . 34.0 m -63.48 154.4 32.44 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.517 1.151 . . . . 0.0 110.594 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.7 mt -114.35 -17.24 11.84 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.23 -1.396 . . . . 10.54 107.23 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.53 145.07 18.54 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.238 -0.914 . . . . 18.39 110.743 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.08 81.41 1.7 Allowed 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.356 1.371 . . . . 0.0 109.058 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.74 170.22 14.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.836 -1.165 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.59 111.11 8.03 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.725 0.774 . . . . 0.0 109.414 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -134.31 111.95 10.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 18' ' ' VAL . 16.1 m -130.27 94.29 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 122.839 1.304 . . . . 0.0 109.13 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.977 HG22 ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.49 -152.09 0.4 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.578 -1.267 . . . . 38.32 107.578 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.977 ' OE1' HG22 ' A' ' 19' ' ' THR . 58.0 mp0 -82.4 -54.31 5.32 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.857 -1.534 . . . . 55.13 106.857 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -109.28 29.16 7.79 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.383 -0.823 . . . . 0.0 110.746 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.52 150.88 22.21 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.823 -1.173 . . . . 0.0 109.678 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.42 111.38 22.37 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.416 -0.803 . . . . 11.68 110.756 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.67 41.58 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.9 142.16 21.52 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.42 -1.425 . . . . 12.44 110.918 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.12 155.82 22.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.93 18.27 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.268 -0.895 . . . . 29.03 109.595 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.1 6.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.345 -1.502 . . . . 6.18 109.345 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.3 114.83 22.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.589 -0.947 . . . . 9.52 109.415 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.99 108.59 5.98 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.41 133.7 49.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 123.154 1.454 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.78 103.08 15.83 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.919 -1.492 . . . . 0.0 107.395 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.502 -0.749 . . . . 0.0 111.468 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.486 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.3 mt -59.74 -50.43 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.917 -1.115 . . . . 0.0 110.201 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.23 157.6 43.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.947 -1.095 . . . . 0.0 110.714 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.55 ' HB3' ' NE1' ' A' ' 44' ' ' TRP . 1.8 mptp? -135.08 65.58 65.24 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.77 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.75 165.32 31.76 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.61 1.54 . . . . 0.0 109.016 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.52 7.78 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.67 -59.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.324 0.583 . . . . 0.0 109.989 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.673 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.6 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.158 0 C-N-CA 122.714 2.276 . . . . 0.0 109.896 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.673 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.6 tp10 131.87 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.802 0.841 . . . . 0.0 108.771 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.536 ' HB2' HD12 ' A' ' 55' ' ' LEU . 16.8 m0 -71.93 165.94 23.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.674 -1.266 . . . . 14.29 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.3 m0 -129.56 145.05 51.51 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.32 -0.622 . . . . 11.8 109.32 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.02 96.62 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.93 128.7 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.921 0.867 . . . . 0.0 110.403 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.45 150.41 27.07 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.78 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.54 43.4 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 117.325 -1.75 . . . . 0.0 107.31 177.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 119.596 -1.94 . . . . 0.0 107.99 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.464 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.49 -4.6 4.17 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.661 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.41 33.81 6.99 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 115.307 -0.861 . . . . 14.41 112.329 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.78 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.1 29.81 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-N 119.603 1.701 . . . . 0.0 111.787 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.56 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.32 1.057 . . . . 0.0 112.468 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.79 12.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.252 -1.539 . . . . 7.25 109.252 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.43 150.88 42.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -1.194 . . . . 0.0 108.608 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.7 8.97 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.955 -1.091 . . . . 0.0 109.297 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.968 -1.205 . . . . 4.76 108.968 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.607 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 16.0 pttp -60.46 3.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 110.648 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.5 m-20 -102.13 -7.52 22.17 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.179 -0.95 . . . . 14.84 109.319 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.09 8.19 31.19 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.242 -0.911 . . . . 10.23 109.427 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 11' ' ' THR . 34.5 m -147.44 156.6 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 6.97 109.513 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.476 HG22 ' N ' ' A' ' 63' ' ' VAL . 12.6 p -106.81 160.72 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 62' ' ' VAL . 56.0 t -107.67 134.25 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.805 . . . . 0.0 109.834 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.2 mt -105.09 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.626 -0.671 . . . . 0.0 109.237 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.48 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 38.8 m -70.0 151.69 45.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.952 -1.092 . . . . 0.0 109.403 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 54.4 p-10 -146.72 152.63 39.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 109.317 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.08 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.59 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.302 1.335 . . . . 0.0 109.681 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.96 82.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.77 125.02 32.2 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.22 28.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -1.128 . . . . 0.0 109.52 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.96 0.2 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.28 130.65 5.29 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.261 -1.14 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.7 Cg_endo -74.19 163.65 36.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.912 1.741 . . . . 0.0 108.922 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.532 HG23 ' C ' ' B' ' 84' ' ' ARG . 64.2 mt -135.39 119.83 26.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 122.087 0.946 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.827 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.5 117.06 4.09 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.016 0.912 . . . . 0.0 109.89 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.513 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.05 4.89 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.827 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.76 -48.5 8.18 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.295 -1.12 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.88 13.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.573 -0.704 . . . . 0.0 109.107 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 53.55 41.14 32.14 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.532 ' C ' HG23 ' B' ' 78' ' ' ILE . 6.8 mtp85 -115.79 143.41 30.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.646 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.39 113.25 1.37 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.485 1.457 . . . . 0.0 110.535 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.669 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.75 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.63 61.55 0.31 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.824 -1.173 . . . . 0.0 110.663 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.07 -101.93 0.15 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.63 120.58 42.05 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.669 HG22 HG21 ' B' ' 86' ' ' ILE . 42.4 t -98.71 158.64 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.472 -0.767 . . . . 0.0 111.211 -177.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.55 116.05 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.624 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.74 106.11 18.25 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 109.629 -179.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.61 159.54 42.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.02 17.28 4.31 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.25 75.92 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.25 -154.88 0.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.747 0.784 . . . . 0.0 109.748 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.484 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.31 143.51 46.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.513 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.528 -1.358 . . . . 0.0 110.594 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.473 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.0 m80 -56.59 131.92 50.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.07 -14.94 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 120.863 -1.148 . . . . 0.0 108.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.78 -26.89 15.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.828 -0.545 . . . . 0.0 110.71 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.06 -6.57 31.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.828 -1.17 . . . . 0.0 110.858 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.471 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.18 106.16 11.99 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.6 m -133.46 175.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.19 0.995 . . . . 0.0 111.203 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.74 45.86 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.303 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.9 28.69 1.75 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.111 -0.993 . . . . 0.0 109.667 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.421 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.83 -31.67 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.343 -0.848 . . . . 0.0 110.097 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.21 4.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.6 47.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 110.173 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.58 59.33 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.0 138.3 39.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.748 1.632 . . . . 0.0 112.13 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.312 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.83 56.94 1.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.159 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.32 1.62 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.34 -0.85 . . . . 0.0 109.01 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 31.07 2.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.946 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.32 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -1.048 . . . . 0.0 109.986 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.52 145.46 24.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.43 169.48 9.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.53 137.71 47.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.07 148.3 28.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.223 -0.923 . . . . 0.0 111.197 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.02 129.31 11.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.34 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.88 1.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.59 30.95 20.12 Favored Glycine 0 N--CA 1.483 1.775 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.713 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.36 142.74 31.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.535 -0.979 . . . . 0.0 108.82 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.47 152.73 36.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.4 m-85 -153.79 140.35 18.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.57 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.495 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.71 -35.92 82.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.4 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.72 -43.69 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.509 -0.744 . . . . 0.0 111.312 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.83 83.46 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.761 -1.212 . . . . 0.0 108.116 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.66 -56.44 13.65 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.7 m-80 -64.51 -44.93 89.36 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.004 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.5 -34.28 61.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.77 -35.4 44.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.218 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 110.091 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.37 31.43 16.52 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.56 51.19 15.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.313 -1.11 . . . . 0.0 109.612 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.475 -39.667 1 CA-C-O 71.024 -23.37 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.76 0.13 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -161.87 35.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -1.194 . . . . 0.0 109.575 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.439 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -72.99 148.68 43.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.123 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.21 93.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.28 -54.39 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.423 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.32 73.86 1.37 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.563 ' N ' ' OG ' ' A' ' 65' ' ' SER . 9.7 t -69.43 158.11 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 31' ' ' MET . 3.3 m -145.31 131.44 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.45 -1.406 . . . . 0.0 111.549 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -99.88 129.27 45.95 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.677 HG22 ' H ' ' A' ' 13' ' ' TYR . 31.8 m -63.42 154.38 32.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.455 1.121 . . . . 0.0 110.602 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.6 mt -114.36 -17.23 11.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.186 -1.412 . . . . 10.54 107.186 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.677 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.53 145.03 18.47 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.126 -0.984 . . . . 18.39 110.765 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 121.43 1.42 . . . . 0.0 109.037 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.79 170.3 13.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.965 -1.084 . . . . 0.0 110.984 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.58 111.01 7.96 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.739 0.78 . . . . 0.0 109.474 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.19 112.0 10.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 18' ' ' VAL . 15.9 m -130.36 94.31 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-O 122.901 1.334 . . . . 0.0 109.126 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.45 -152.07 0.4 Allowed 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.38 -1.282 . . . . 38.32 107.579 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 19' ' ' THR . 96.2 mt-10 -82.47 -54.27 5.33 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.863 -1.532 . . . . 55.13 106.863 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.445 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.33 29.24 7.72 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.375 -0.828 . . . . 0.0 110.741 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.649 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.57 150.94 22.18 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.812 -1.18 . . . . 0.0 109.671 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.469 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.29 22.23 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.42 -0.8 . . . . 11.68 110.757 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.43 127.65 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.8 142.18 21.63 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.425 -1.422 . . . . 12.44 110.904 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.22 155.83 22.31 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 146.93 17.93 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.464 -0.894 . . . . 29.03 109.577 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.62 44.09 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.218 -1.553 . . . . 6.18 109.218 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.84 22.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.592 -0.946 . . . . 9.52 109.449 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.03 108.65 6.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.51 133.74 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.175 1.464 . . . . 0.0 110.53 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.81 102.99 15.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.368 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.507 -0.746 . . . . 0.0 111.607 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' A' ' 47' ' ' LYS . 81.9 mt -59.8 -50.34 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.985 -1.072 . . . . 0.0 110.83 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.09 65.52 64.99 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.785 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -74.83 165.38 31.58 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.618 1.545 . . . . 0.0 108.987 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.93 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.57 -59.27 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.237 0.541 . . . . 0.0 110.136 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.35 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.63 -59.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.693 2.262 . . . . 0.0 109.943 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 70.8 mt-10 131.78 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 123.805 0.842 . . . . 0.0 108.769 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.556 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.8 m0 -71.93 165.92 23.2 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.607 -1.308 . . . . 14.29 110.436 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.467 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.5 m0 -129.57 144.99 51.51 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.338 -0.616 . . . . 11.8 109.338 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -79.01 96.72 5.84 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.493 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.72 55.98 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.907 0.86 . . . . 0.0 110.38 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.52 150.35 27.02 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.781 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.38 128.47 43.34 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.286 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.41 -18.41 1.03 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 119.716 -1.865 . . . . 0.0 107.918 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.55 -4.56 4.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.665 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.39 33.95 6.93 Favored Glycine 0 N--CA 1.481 1.684 0 CA-C-N 115.28 -0.873 . . . . 14.41 112.258 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.781 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.05 29.98 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.648 1.724 . . . . 0.0 111.82 179.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.67 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 122.325 1.059 . . . . 0.0 112.401 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.06 156.79 12.67 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.274 -1.53 . . . . 7.25 109.274 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.39 150.79 43.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.214 -1.168 . . . . 0.0 108.672 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.91 136.77 9.08 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 120.949 -1.094 . . . . 0.0 109.329 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.21 113.52 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 N-CA-C 109.024 -1.183 . . . . 4.76 109.024 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.449 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.35 3.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 110.729 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 57' ' ' PRO . 95.7 m-20 -101.9 -7.71 22.22 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.247 -0.908 . . . . 14.84 109.4 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.0 8.23 30.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.221 -0.925 . . . . 10.23 109.437 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 11' ' ' THR . 33.5 m -147.48 156.48 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.096 -1.002 . . . . 6.97 109.494 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG11 HD13 ' B' ' 78' ' ' ILE . 33.6 m -106.74 160.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.5 t -107.74 134.3 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.372 -0.83 . . . . 0.0 109.701 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 mp -105.06 -63.24 1.25 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.562 -0.711 . . . . 0.0 109.254 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.563 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 11.5 p -70.01 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.024 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 109.372 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.2 1.48 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.53 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.257 1.305 . . . . 0.0 109.656 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.06 82.67 1.78 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.93 124.96 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.81 156.24 28.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -1.114 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.92 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.433 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.44 46.91 0.2 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.21 130.82 5.39 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.312 -1.111 . . . . 0.0 109.396 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.65 35.94 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.876 1.718 . . . . 0.0 108.936 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.496 HG23 ' C ' ' B' ' 84' ' ' ARG . 64.8 mt -135.38 119.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 122.053 0.93 . . . . 0.0 109.44 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 14.8 t -58.46 117.13 4.15 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.872 0.844 . . . . 0.0 109.883 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.518 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -65.0 -0.06 4.97 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.829 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.55 8.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.15 4.94 13.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.496 ' C ' HG23 ' B' ' 78' ' ' ILE . 3.4 mtt180 -116.01 143.3 30.61 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.35 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.412 1.408 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.667 HG21 HG22 ' B' ' 90' ' ' VAL . 21.4 mt -70.98 158.45 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.426 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.54 61.46 0.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.828 -1.17 . . . . 0.0 110.671 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.04 0.15 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.658 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.63 120.59 42.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.667 HG22 HG21 ' B' ' 86' ' ' ILE . 42.2 t -98.72 158.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.41 -0.806 . . . . 0.0 111.286 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.47 HG23 HG22 ' B' ' 100' ' ' VAL . 5.0 t -122.43 116.06 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.634 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.79 106.15 18.27 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.572 -179.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.47 42.74 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.19 4.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.16 76.03 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.19 -154.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.704 0.764 . . . . 0.0 109.747 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.485 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.47 143.5 45.9 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.518 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.6 140.07 33.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.506 -1.371 . . . . 0.0 110.614 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.5 m80 -56.36 131.98 49.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 91' ' ' VAL . 7.4 t -53.33 -14.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 120.843 -1.161 . . . . 0.0 108.323 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.94 15.51 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.804 -0.56 . . . . 0.0 110.683 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.17 -6.52 31.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.936 -1.102 . . . . 0.0 110.835 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.13 106.3 12.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.8 m -133.67 175.22 11.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 111.092 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.526 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.7 148.65 45.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.263 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.85 28.72 1.73 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.57 0.71 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.354 -0.842 . . . . 0.0 110.056 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.4 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.15 -15.55 4.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.75 47.65 0.33 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.55 59.34 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -68.96 138.29 40.03 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.788 1.659 . . . . 0.0 112.101 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.313 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.77 56.91 1.79 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.023 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.18 1.69 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 0.0 109.022 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 30.97 2.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.945 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.34 178.88 4.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -1.041 . . . . 0.0 110.066 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.31 145.41 24.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.509 -0.745 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.33 169.52 9.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 109.624 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.703 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.52 137.77 47.28 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.21 29.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.256 -0.902 . . . . 0.0 111.212 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.36 11.35 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.609 0.719 . . . . 0.0 110.35 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.07 22.92 1.36 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.578 -0.701 . . . . 0.0 109.536 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.37 31.15 20.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.792 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.45 142.74 31.31 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.549 -0.971 . . . . 0.0 108.803 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.42 152.86 36.08 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.725 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.557 ' CE1' HD22 ' B' ' 133' ' ' LEU . 58.3 m-85 -153.82 140.37 18.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.69 177.48 0.11 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.471 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.61 -36.04 82.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 109.294 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 53.7 m -86.66 -43.73 12.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 111.295 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.89 83.38 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.736 -1.228 . . . . 0.0 108.052 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.32 14.47 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.419 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.2 m-80 -64.66 -44.75 89.42 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.48 -34.3 61.3 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.22 44.81 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.351 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.66 -81.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.29 31.6 16.26 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 48.31 51.33 15.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 71.114 -23.327 . . . . 0.0 109.534 179.903 . . . . . . . . 2 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.93 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.98 35.32 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 109.619 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.435 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.08 148.7 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.049 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.12 93.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 0.0 109.394 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.28 2.0 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.38 73.82 1.37 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.39 158.09 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.2 m -145.39 131.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.485 -1.384 . . . . 0.0 111.529 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.92 129.21 45.97 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 13' ' ' TYR . 30.7 m -63.52 154.45 32.44 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.521 1.153 . . . . 0.0 110.584 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.2 mt -114.39 -17.25 11.82 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.173 -1.417 . . . . 10.54 107.173 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.675 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.49 145.03 18.49 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.198 -0.939 . . . . 18.39 110.791 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.04 81.43 1.68 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.385 1.39 . . . . 0.0 109.099 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CG ' ' N ' ' A' ' 16' ' ' SER . 27.8 t80 -71.61 170.23 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.962 -1.087 . . . . 0.0 110.937 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.6 111.09 8.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.776 0.798 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 111.89 10.59 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 18' ' ' VAL . 17.6 m -130.25 94.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-O 122.883 1.325 . . . . 0.0 109.16 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.54 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -144.42 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.575 177.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.54 ' H ' HG22 ' A' ' 19' ' ' THR . 97.5 mt-10 -82.39 -54.34 5.3 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.904 -1.517 . . . . 55.13 106.904 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 17.4 pt-20 -109.26 29.09 7.86 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.451 -0.781 . . . . 0.0 110.703 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.62 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.41 150.89 22.15 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.921 -1.112 . . . . 0.0 109.741 -179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.33 111.4 22.42 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.402 -0.811 . . . . 11.68 110.739 -178.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.6 41.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.89 142.16 21.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.366 -1.459 . . . . 12.44 110.912 -178.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.19 155.8 22.36 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.97 18.2 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.465 -0.894 . . . . 29.03 109.591 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.54 44.2 6.6 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 6.18 109.298 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.37 114.8 22.9 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.725 -0.868 . . . . 9.52 109.389 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.98 108.67 6.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.54 133.66 49.92 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 123.112 1.434 . . . . 0.0 110.585 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.65 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.393 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.16 92.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 111.431 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.48 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.8 mt -59.71 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.894 -1.129 . . . . 0.0 110.259 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.474 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.916 -1.115 . . . . 0.0 110.79 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.555 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.07 65.53 65.13 Favored Pre-proline 0 N--CA 1.486 1.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.794 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.44 31.42 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.653 1.569 . . . . 0.0 108.982 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.06 -46.55 7.73 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.78 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.351 0.596 . . . . 0.0 110.052 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 122.664 2.243 . . . . 0.0 110.023 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 31.4 tt0 131.77 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 C-N-CA 123.814 0.846 . . . . 0.0 108.752 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.548 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.6 m0 -71.87 165.96 23.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.623 -1.298 . . . . 14.29 110.463 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.561 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.1 m0 -129.68 145.06 51.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.233 -0.654 . . . . 11.8 109.233 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.99 96.73 5.83 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.73 55.98 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.89 0.853 . . . . 0.0 110.428 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.52 150.33 27.03 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.789 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.47 128.51 43.47 Favored 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 117.25 -1.78 . . . . 0.0 107.212 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.3 -18.46 0.97 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.775 -1.828 . . . . 0.0 107.995 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.476 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.6 4.29 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.656 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.45 33.82 6.97 Favored Glycine 0 N--CA 1.482 1.761 0 CA-C-N 115.388 -0.824 . . . . 14.41 112.281 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.789 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.91 164.02 30.04 Favored 'General case' 0 N--CA 1.515 2.809 0 CA-C-N 119.796 1.798 . . . . 0.0 111.839 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.59 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 122.309 1.052 . . . . 0.0 112.522 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.11 156.64 12.53 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.255 -1.538 . . . . 7.25 109.255 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.3 150.85 43.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.13 -1.218 . . . . 0.0 108.768 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.62 8.92 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.895 -1.128 . . . . 0.0 109.271 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.048 -1.174 . . . . 4.76 109.048 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.561 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 33.9 pttt -60.38 3.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.8 m120 -102.09 -7.63 22.11 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.183 -0.948 . . . . 14.84 109.273 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 10.23 109.454 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.3 m -147.48 156.64 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.149 -0.969 . . . . 6.97 109.521 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 63' ' ' VAL . 11.3 p -106.77 160.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.435 ' N ' HG22 ' A' ' 62' ' ' VAL . 48.5 t -107.63 134.36 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.5 -0.75 . . . . 0.0 109.767 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -105.11 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.619 -0.676 . . . . 0.0 109.227 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -69.91 151.58 45.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.0 109.435 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -146.54 152.72 39.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 0.0 109.377 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.29 1.48 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.47 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.338 1.358 . . . . 0.0 109.645 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.66 1.78 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.04 32.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.85 156.25 28.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.93 0.2 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.74 5.33 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.337 -1.096 . . . . 0.0 109.378 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.6 Cg_endo -74.14 163.51 36.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.988 1.792 . . . . 0.0 108.87 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.59 HG23 ' C ' ' B' ' 84' ' ' ARG . 48.5 mt -135.35 119.89 27.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 122.081 0.943 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.42 117.01 4.01 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.831 0.824 . . . . 0.0 110.048 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.519 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.93 -0.09 4.91 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.58 -48.7 8.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -1.061 . . . . 0.0 109.375 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.84 13.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.568 -0.708 . . . . 0.0 109.106 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 53.51 41.33 32.11 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.59 ' C ' HG23 ' B' ' 78' ' ' ILE . 42.7 mtp180 -115.89 143.51 30.92 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.54 113.31 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.5 1.467 . . . . 0.0 110.464 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.678 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.78 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.57 61.48 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.809 -1.182 . . . . 0.0 110.646 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.0 0.15 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.674 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.5 120.56 42.06 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.678 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.74 158.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.66 0.743 . . . . 0.0 111.253 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' B' ' 103' ' ' PHE . 5.0 t -122.42 115.96 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.644 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.096 -1.003 . . . . 0.0 109.473 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.55 159.42 42.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.19 17.14 4.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.22 75.94 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.79 0.805 . . . . 0.0 109.754 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.36 143.52 46.12 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.519 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.58 140.0 33.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.66 -1.275 . . . . 0.0 110.58 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.54 132.02 50.37 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.39 -14.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.876 -1.14 . . . . 0.0 108.335 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.82 -26.94 15.45 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.806 -0.559 . . . . 0.0 110.651 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.08 -6.59 31.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.952 -1.092 . . . . 0.0 110.858 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.13 106.26 12.02 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.0 m -133.62 175.17 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.218 1.009 . . . . 0.0 111.18 -177.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.525 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.67 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.259 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.78 1.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.85 -31.75 0.71 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.14 -15.37 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.248 -0.908 . . . . 0.0 110.175 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.66 47.69 0.34 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.851 . . . . 0.0 110.147 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.47 59.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -69.02 138.23 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.706 1.604 . . . . 0.0 112.167 -177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.315 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.76 56.76 1.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.19 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.93 -55.27 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 0.0 109.07 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.08 2.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.93 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.33 178.96 4.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.469 -1.018 . . . . 0.0 109.953 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.45 145.36 24.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.404 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.6 137.64 47.13 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -107.08 148.26 28.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.23 -0.919 . . . . 0.0 111.233 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 129.4 11.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.614 0.721 . . . . 0.0 110.332 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.15 22.86 1.4 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 0.0 109.504 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.95 20.4 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.687 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.4 mt -143.26 142.82 31.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.514 -0.992 . . . . 0.0 108.852 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.48 152.97 35.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.673 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.554 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.9 m-85 -153.92 140.28 18.65 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.61 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.399 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.0 tt0 -63.56 -36.11 82.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.402 -0.811 . . . . 0.0 109.475 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.2 m -86.51 -43.63 12.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.724 . . . . 0.0 111.466 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.77 -43.76 83.15 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.789 -1.194 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.4 13.95 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.6 -44.91 89.1 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.074 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.28 61.22 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.554 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.7 -35.3 45.18 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.354 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.2 m-85 -158.51 -81.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 110.094 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.35 31.41 16.62 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.54 51.16 15.87 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -1.151 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.934 -23.412 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.44 74.92 0.12 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -161.94 35.24 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.253 -1.145 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.442 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.02 148.58 44.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.0 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.22 -54.26 2.0 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.435 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.41 73.94 1.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' N ' ' OG ' ' A' ' 65' ' ' SER . 79.1 t -69.38 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 31' ' ' MET . 3.9 m -145.41 131.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.354 -1.466 . . . . 0.0 111.461 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -99.79 129.19 45.87 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 13' ' ' TYR . 35.4 m -63.44 154.31 32.56 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.51 1.148 . . . . 0.0 110.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.3 mt -114.28 -17.25 11.88 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.225 -1.398 . . . . 10.54 107.225 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.662 ' H ' HG22 ' A' ' 11' ' ' THR . 14.6 m-85 -149.47 145.1 18.63 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.164 -0.96 . . . . 18.39 110.678 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -73.01 81.45 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.444 1.43 . . . . 0.0 109.107 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.78 170.32 13.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.98 -1.075 . . . . 0.0 110.861 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.72 111.1 7.96 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.805 0.812 . . . . 0.0 109.38 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 112.0 10.72 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 18' ' ' VAL . 34.0 m -130.36 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 122.941 1.353 . . . . 0.0 109.222 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 1.031 HG22 ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.512 -1.292 . . . . 38.32 107.512 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 1.031 ' OE1' HG22 ' A' ' 19' ' ' THR . 58.8 mp0 -82.38 -54.47 5.19 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.832 -1.544 . . . . 55.13 106.832 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -109.18 29.22 7.72 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.374 -0.829 . . . . 0.0 110.803 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.53 150.93 22.16 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.036 -1.04 . . . . 0.0 109.761 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.52 22.61 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.517 -0.739 . . . . 11.68 110.655 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.49 127.84 41.86 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.0 142.21 21.48 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.415 -1.428 . . . . 12.44 110.78 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.87 22.4 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 146.92 18.78 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.238 -0.913 . . . . 29.03 109.585 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 44.2 6.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.416 -1.474 . . . . 6.18 109.416 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.452 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.83 22.93 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.543 -0.974 . . . . 9.52 109.331 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.13 108.67 6.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.48 133.66 49.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.155 1.455 . . . . 0.0 110.584 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.78 103.14 15.88 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.41 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.19 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.489 -0.757 . . . . 0.0 111.491 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.4 mt -59.91 -50.31 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.957 -1.09 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.14 65.63 64.94 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.701 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.77 165.41 31.54 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.627 1.551 . . . . 0.0 109.049 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.1 -46.55 7.72 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.77 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.419 0.628 . . . . 0.0 110.059 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.51 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.65 -59.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.547 2.164 . . . . 0.0 109.975 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 71.6 mt-10 131.7 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 123.828 0.851 . . . . 0.0 108.837 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.522 ' HB2' HD12 ' A' ' 55' ' ' LEU . 20.2 m0 -71.87 166.0 22.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.696 -1.252 . . . . 14.29 110.497 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.4 m0 -129.64 144.97 51.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.668 -0.645 . . . . 11.8 109.355 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -78.98 96.68 5.81 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.76 56.0 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.889 0.852 . . . . 0.0 110.321 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.69 150.39 26.79 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.783 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.37 128.56 43.4 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 117.327 -1.749 . . . . 0.0 107.239 178.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.5 1.02 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 119.584 -1.948 . . . . 0.0 108.008 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.472 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.57 4.26 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.662 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.47 33.81 6.97 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-N 115.403 -0.817 . . . . 14.41 112.284 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.783 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.1 29.8 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-N 119.724 1.762 . . . . 0.0 111.792 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.63 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-O 122.356 1.074 . . . . 0.0 112.541 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.71 12.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.294 -1.522 . . . . 7.25 109.294 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.522 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.3 150.78 43.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.278 -1.13 . . . . 0.0 108.596 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.04 136.77 9.02 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 109.269 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 N-CA-C 109.014 -1.187 . . . . 4.76 109.014 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.37 3.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.482 -0.761 . . . . 0.0 110.712 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.7 m-20 -102.01 -7.63 22.18 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.206 -0.934 . . . . 14.84 109.327 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.97 8.13 31.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 10.23 109.527 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.41 156.64 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.193 -0.942 . . . . 6.97 109.483 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.738 HG11 HD13 ' B' ' 78' ' ' ILE . 27.7 m -106.85 160.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.57 134.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.389 -0.819 . . . . 0.0 109.838 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 mp -105.2 -63.18 1.26 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.631 -0.668 . . . . 0.0 109.229 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 14.4 p -70.01 151.54 45.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.037 -1.039 . . . . 0.0 109.521 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 55.7 p-10 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.3 1.48 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.304 1.336 . . . . 0.0 109.667 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.02 82.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.09 32.33 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.71 156.1 29.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.278 -1.131 . . . . 0.0 109.57 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.4 mtt -49.7 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.74 0.2 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.22 130.86 5.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.301 -1.117 . . . . 0.0 109.378 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.41 163.66 35.74 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.85 1.7 . . . . 0.0 108.827 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.738 HD13 HG11 ' A' ' 62' ' ' VAL . 74.6 mt -135.41 119.86 26.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.07 0.938 . . . . 0.0 109.338 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 14.9 t -58.43 116.98 3.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.824 0.821 . . . . 0.0 109.871 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.24 4.92 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.63 -48.65 8.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.361 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.09 4.77 13.72 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 53.57 41.36 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.469 ' C ' HG23 ' B' ' 78' ' ' ILE . 19.7 mtp180 -115.89 143.43 30.77 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.644 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.43 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.442 1.428 . . . . 0.0 110.551 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.661 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.94 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.425 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.44 61.54 0.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.918 -1.114 . . . . 0.0 110.583 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.08 -102.06 0.15 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.64 120.74 42.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.661 HG22 HG21 ' B' ' 86' ' ' ILE . 42.7 t -98.83 158.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.762 0.792 . . . . 0.0 111.141 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.45 115.91 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.641 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 109.548 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.5 42.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.15 17.23 4.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.1 25.42 75.64 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.27 -154.77 0.65 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.712 0.768 . . . . 0.0 109.821 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.478 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.46 143.37 45.85 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.8 m95 -141.48 140.1 33.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.41 -1.431 . . . . 0.0 110.634 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.449 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.5 131.9 49.92 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.6 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 120.894 -1.129 . . . . 0.0 108.336 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.449 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.91 -26.94 15.4 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.71 -0.619 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.21 -6.42 31.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.806 -1.184 . . . . 0.0 110.899 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.29 106.19 12.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.824 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.53 175.25 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.288 1.042 . . . . 0.0 111.167 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.81 148.66 46.28 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.8 28.73 1.71 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.414 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.84 -31.62 0.71 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.349 -0.844 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.22 -15.27 4.19 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.332 -0.855 . . . . 0.0 110.138 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.66 47.67 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.319 -0.863 . . . . 0.0 110.148 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.52 59.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.824 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -69.03 138.22 39.58 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.704 1.603 . . . . 0.0 112.168 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.309 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.79 56.96 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.157 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.01 -55.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 109.082 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.19 30.88 2.76 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.966 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.18 178.84 4.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.479 -1.012 . . . . 0.0 110.03 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.33 145.24 24.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.55 9.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 0.0 109.489 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.6 137.65 47.13 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.03 148.24 28.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.241 -0.912 . . . . 0.0 111.331 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.31 11.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.685 0.755 . . . . 0.0 110.257 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.38 22.83 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.506 -0.746 . . . . 0.0 109.414 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.87 20.59 Favored Glycine 0 N--CA 1.481 1.685 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.79 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.29 142.64 31.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.524 -0.986 . . . . 0.0 108.821 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.91 36.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.739 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.543 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -154.01 140.26 18.54 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.7 m -57.61 177.4 0.1 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.453 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.81 . . . . 0.0 109.383 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.68 -43.79 12.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.434 -0.791 . . . . 0.0 111.354 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.74 83.91 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.867 -1.145 . . . . 0.0 108.213 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.46 13.58 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.4 m-80 -64.52 -44.82 89.66 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.45 -34.49 61.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.543 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.64 -35.19 45.81 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.381 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.7 -81.64 0.05 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 110.085 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.44 31.43 16.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.55 51.28 15.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -1.103 . . . . 0.0 109.556 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.791 -23.48 . . . . 0.0 109.443 -179.981 . . . . . . . . 2 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.81 0.13 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.595 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.03 148.68 43.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.882 . . . . 0.0 109.099 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.11 93.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 109.238 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.31 -54.25 2.0 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.34 74.08 1.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.5 t -69.53 158.07 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.34 131.55 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.463 -1.398 . . . . 0.0 111.528 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.93 129.26 45.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 13' ' ' TYR . 38.5 m -63.42 154.33 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.468 1.128 . . . . 0.0 110.633 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 74.4 mt -114.31 -17.34 11.84 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.219 -1.4 . . . . 10.54 107.219 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.648 ' H ' HG22 ' A' ' 11' ' ' THR . 14.4 m-85 -149.5 145.08 18.57 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.21 -0.931 . . . . 18.39 110.726 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 121.364 1.376 . . . . 0.0 109.042 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.85 170.23 14.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.972 -1.08 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.14 8.04 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.906 0.86 . . . . 0.0 109.358 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.07 10.73 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 18' ' ' VAL . 15.4 m -130.44 94.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 123.039 1.399 . . . . 0.0 109.172 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.672 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.4 m -144.58 -152.11 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.321 -1.309 . . . . 38.32 107.593 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.672 ' H ' HG22 ' A' ' 19' ' ' THR . 79.1 mm-40 -82.37 -54.3 5.33 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.92 -1.511 . . . . 55.13 106.92 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 74.9 mt-10 -109.33 29.17 7.79 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.364 -0.835 . . . . 0.0 110.778 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.39 150.78 22.26 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.756 -1.215 . . . . 0.0 109.83 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.29 111.37 22.38 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.408 -0.807 . . . . 11.68 110.775 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.43 127.71 41.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.0 142.04 21.32 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.374 -1.454 . . . . 12.44 110.848 -178.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.07 155.85 22.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.92 18.49 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.482 -0.887 . . . . 29.03 109.539 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.12 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.284 -1.526 . . . . 6.18 109.284 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.4 114.84 22.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.584 -0.951 . . . . 9.52 109.424 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.07 108.68 6.1 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.54 133.83 49.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 123.231 1.491 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.05 15.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.328 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.545 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.99 92.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.527 -0.733 . . . . 0.0 111.485 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.487 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.6 mt -59.65 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.927 -1.108 . . . . 0.0 110.344 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.66 43.68 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.037 -1.039 . . . . 0.0 110.737 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.02 65.55 65.54 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.75 165.4 31.59 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.61 1.54 . . . . 0.0 109.003 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.07 -46.48 7.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.66 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.352 0.596 . . . . 0.0 110.025 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.8 -47.36 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.734 2.289 . . . . 0.0 109.961 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 67.5 mt-10 131.76 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 C-N-CA 123.881 0.872 . . . . 0.0 108.805 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.551 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.5 m0 -71.85 165.89 23.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.738 -1.226 . . . . 14.29 110.502 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.491 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.6 m0 -129.51 145.03 51.5 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.377 -0.601 . . . . 11.8 109.377 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -78.98 96.71 5.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.9 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.869 0.842 . . . . 0.0 110.429 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.79 150.47 26.61 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.78 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.53 43.4 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 117.28 -1.768 . . . . 0.0 107.325 178.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.45 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.618 -1.926 . . . . 0.0 107.951 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.464 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.71 -4.47 4.31 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.4 33.95 6.92 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 115.379 -0.828 . . . . 14.41 112.224 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.78 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.1 29.79 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.731 1.766 . . . . 0.0 111.87 179.12 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.02 154.65 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.323 1.059 . . . . 0.0 112.408 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.337 -1.505 . . . . 7.25 109.337 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.96 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.31 -1.112 . . . . 0.0 108.684 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.08 136.79 9.02 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.004 -1.06 . . . . 0.0 109.297 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.98 -1.2 . . . . 4.76 108.98 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.46 3.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 110.721 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -101.97 -7.67 22.18 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.147 -0.971 . . . . 14.84 109.391 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.06 8.33 30.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.919 . . . . 10.23 109.483 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.7 m -147.46 156.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 6.97 109.454 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 63' ' ' VAL . 3.8 p -106.76 160.82 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' N ' HG22 ' A' ' 62' ' ' VAL . 45.6 t -107.71 134.26 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.403 -0.811 . . . . 0.0 109.714 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' O ' ' NH2' ' B' ' 84' ' ' ARG . 9.0 mp -105.14 -63.3 1.24 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -69.92 151.59 45.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 49.4 p30 -146.55 152.72 39.41 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.45 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 121.368 1.378 . . . . 0.0 109.7 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.03 82.59 1.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.93 125.14 32.41 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.514 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.09 28.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -1.073 . . . . 0.0 109.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.76 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.3 46.98 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.32 130.79 5.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.286 -1.126 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.21 163.6 36.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.912 1.741 . . . . 0.0 108.847 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.479 ' H ' HE21 ' B' ' 97' ' ' GLN . 30.6 mt -135.43 119.84 26.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 122.17 0.986 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.3 116.96 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.778 0.799 . . . . 0.0 109.897 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.508 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.23 4.91 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.59 -48.74 8.07 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 109.321 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.89 13.76 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 53.44 41.28 32.13 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.459 ' HE ' ' HB3' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -115.82 143.43 30.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.64 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.5 Cg_exo -56.48 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.433 1.422 . . . . 0.0 110.56 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.67 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.91 158.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.426 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.51 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.0 110.577 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.668 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.71 42.46 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.67 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.8 158.62 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.669 0.747 . . . . 0.0 111.245 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.51 116.03 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.622 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.585 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.56 42.58 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 57.94 17.38 4.29 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.32 75.78 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.84 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.479 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.38 143.4 46.03 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.508 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.46 139.97 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.507 -1.371 . . . . 0.0 110.67 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.445 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.38 131.9 49.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.926 -1.109 . . . . 0.0 108.436 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.85 -26.98 15.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.781 -0.574 . . . . 0.0 110.624 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.1 -6.55 31.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.937 -1.102 . . . . 0.0 110.842 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' B' ' 91' ' ' VAL . 24.9 t80 -80.1 106.26 11.99 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.58 175.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.268 1.032 . . . . 0.0 111.172 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.71 45.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.31 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.66 1.74 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.78 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -128.98 -15.57 4.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.385 -0.822 . . . . 0.0 110.208 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.59 0.32 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.52 59.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.06 138.18 39.39 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.699 1.6 . . . . 0.0 112.184 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.326 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.67 56.85 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.194 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.634 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.08 -55.22 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.337 -0.852 . . . . 0.0 108.962 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.22 31.05 2.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.938 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.25 179.07 4.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.578 -0.954 . . . . 0.0 109.949 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.41 24.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 109.305 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.35 169.42 9.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.67 47.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.92 148.29 28.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.264 -0.898 . . . . 0.0 111.25 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.37 11.34 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.584 0.707 . . . . 0.0 110.295 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.14 22.92 1.41 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.664 -0.647 . . . . 0.0 109.448 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.35 31.08 20.39 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.443 -1.361 . . . . 0.0 109.742 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.32 142.71 31.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.547 -0.973 . . . . 0.0 108.778 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.26 152.85 36.38 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.641 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.547 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.9 m-85 -153.9 140.22 18.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.57 177.43 0.1 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.477 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.56 -36.03 82.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.387 -0.82 . . . . 0.0 109.357 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.2 m -86.61 -43.86 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 111.289 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.64 84.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 108.218 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.86 -56.37 14.42 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.55 -44.74 89.83 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.2 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -54.49 -34.37 61.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.547 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.12 44.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.346 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.52 31.32 16.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.409 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.53 51.3 15.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.723 1 CA-C-O 70.819 -23.467 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.29 0.567 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.31 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.02 148.64 43.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.12 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.185 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.26 -54.35 2.0 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.444 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.34 74.0 1.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.514 ' N ' ' OG ' ' A' ' 65' ' ' SER . 10.1 t -69.51 158.13 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.9 m -145.33 131.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.487 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.424 HE21 ' HA2' ' A' ' 28' ' ' GLY . 56.7 tp60 -99.87 129.31 45.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.4 m -63.51 154.36 32.69 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.456 1.122 . . . . 0.0 110.625 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.9 mt -114.31 -17.23 11.86 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.224 -1.398 . . . . 10.54 107.224 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' H ' HG22 ' A' ' 11' ' ' THR . 14.1 m-85 -149.56 145.03 18.45 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.21 -0.931 . . . . 18.39 110.798 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.41 1.67 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 121.425 1.417 . . . . 0.0 109.01 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.71 170.26 13.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.948 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.13 8.06 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.741 0.782 . . . . 0.0 109.452 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.38 112.08 10.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.33 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.888 1.327 . . . . 0.0 109.193 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.509 -1.293 . . . . 38.32 107.509 177.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 19' ' ' THR . 84.2 tt0 -82.49 -54.21 5.37 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.897 -1.52 . . . . 55.13 106.897 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.39 29.31 7.66 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.365 -0.834 . . . . 0.0 110.849 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.57 150.85 22.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.801 -1.187 . . . . 0.0 109.759 -179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -111.34 111.44 22.48 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.411 -0.806 . . . . 11.68 110.714 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.49 127.78 41.8 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.484 ' HE2' ' HG1' ' A' ' 11' ' ' THR . 0.8 OUTLIER -153.02 142.18 21.44 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.382 -1.449 . . . . 12.44 110.819 -178.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.24 155.77 22.32 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.28 146.96 17.83 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.282 -0.886 . . . . 29.03 109.521 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' HA2' HE21 ' A' ' 10' ' ' GLN . . . 84.48 44.11 6.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.35 -1.5 . . . . 6.18 109.35 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.26 114.83 23.01 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.493 -1.004 . . . . 9.52 109.451 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.09 108.63 6.09 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.49 133.64 49.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.179 1.466 . . . . 0.0 110.523 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 103.05 15.8 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.733 -1.576 . . . . 0.0 107.484 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.535 -0.728 . . . . 0.0 111.465 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.493 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.69 -50.46 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.986 -1.072 . . . . 0.0 110.273 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.56 43.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -134.93 65.52 65.88 Favored Pre-proline 0 N--CA 1.486 1.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.791 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.69 165.42 31.59 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.625 1.55 . . . . 0.0 109.008 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.53 7.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.7 m-20 57.69 -59.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.33 0.586 . . . . 0.0 110.017 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 178.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.2 Cg_endo -68.73 -59.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.756 2.304 . . . . 0.0 109.776 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 16.8 pt-20 131.78 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 123.79 0.836 . . . . 0.0 108.784 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.553 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.7 m0 -72.0 165.92 23.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.756 -1.215 . . . . 14.29 110.407 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.3 m0 -129.58 145.07 51.51 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 109.276 -0.639 . . . . 11.8 109.276 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -79.03 96.63 5.83 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.97 128.86 56.08 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.942 0.877 . . . . 0.0 110.441 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.62 150.4 26.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.783 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.52 43.4 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 117.284 -1.766 . . . . 0.0 107.221 177.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.46 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 119.668 -1.895 . . . . 0.0 108.031 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.467 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.57 -4.61 4.27 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.665 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.45 33.89 6.94 Favored Glycine 0 N--CA 1.481 1.691 0 CA-C-N 115.303 -0.862 . . . . 14.41 112.271 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.783 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.12 29.77 Favored 'General case' 0 N--CA 1.515 2.812 0 CA-C-N 119.736 1.768 . . . . 0.0 111.843 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.302 1.048 . . . . 0.0 112.468 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.44 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.22 156.73 12.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.306 -1.518 . . . . 7.25 109.306 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.41 150.85 43.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.271 -1.135 . . . . 0.0 108.685 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.74 9.03 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.765 -1.209 . . . . 0.0 109.354 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.32 113.5 1.15 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.032 -1.18 . . . . 4.76 109.032 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.483 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.19 3.09 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.793 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 10.5 m120 -102.03 -7.67 22.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.095 -1.003 . . . . 14.84 109.337 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -89.11 8.38 30.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.91 . . . . 10.23 109.455 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.48 156.53 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.101 -0.999 . . . . 6.97 109.431 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 63' ' ' VAL . 8.4 p -106.79 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.505 ' N ' HG22 ' A' ' 62' ' ' VAL . 46.6 t -107.67 134.23 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.35 -0.844 . . . . 0.0 109.753 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.17 -63.12 1.26 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.567 -0.708 . . . . 0.0 109.184 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.6 p -70.0 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 50.6 p30 -146.58 152.66 39.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 109.42 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.316 1.344 . . . . 0.0 109.638 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.5 1.75 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.12 32.36 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.434 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.27 28.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.98 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.17 46.82 0.2 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.72 5.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.24 163.64 36.02 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.975 1.783 . . . . 0.0 108.842 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.566 HG23 ' C ' ' B' ' 84' ' ' ARG . 6.4 mt -135.38 119.7 26.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.967 0.889 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.32 116.86 3.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.871 0.843 . . . . 0.0 109.917 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.72 -0.19 4.79 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.62 -48.53 8.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.993 . . . . 0.0 109.443 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.8 13.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 109.147 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 53.47 41.27 32.13 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.566 ' C ' HG23 ' B' ' 78' ' ' ILE . 8.9 mtm105 -115.95 143.39 30.74 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.639 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.42 113.32 1.4 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.409 1.406 . . . . 0.0 110.699 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.668 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.86 158.47 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.56 61.54 0.32 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.858 -1.151 . . . . 0.0 110.593 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.658 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.7 120.69 42.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.668 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.83 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.686 0.755 . . . . 0.0 111.168 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.468 HG23 HG22 ' B' ' 100' ' ' VAL . 4.9 t -122.53 116.01 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.64 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.22 18.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.69 159.53 42.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.21 4.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.14 25.22 75.92 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.2 -154.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.728 0.775 . . . . 0.0 109.783 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.476 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.41 143.37 45.95 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.604 -1.31 . . . . 0.0 110.669 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.503 ' CE1' ' NH2' ' B' ' 84' ' ' ARG . 17.2 m80 -56.56 131.99 50.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG23 ' B' ' 91' ' ' VAL . 7.9 t -53.17 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 120.902 -1.124 . . . . 0.0 108.311 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.79 -27.02 15.43 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.848 -0.532 . . . . 0.0 110.62 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.04 -6.59 31.54 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.886 -1.134 . . . . 0.0 110.841 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.468 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.1 t80 -80.12 106.27 12.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.7 m -133.56 175.34 11.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.272 1.034 . . . . 0.0 111.081 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.68 46.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.312 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.5 1.77 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.7 -31.66 0.72 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.369 -0.832 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.17 -15.42 4.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.375 -0.828 . . . . 0.0 110.133 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.64 47.68 0.34 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.208 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.64 59.59 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.21 138.31 39.23 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.691 1.594 . . . . 0.0 112.126 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.294 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.87 56.95 1.77 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.21 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 108.997 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.97 2.74 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.967 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.25 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -1.011 . . . . 0.0 110.024 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.33 24.86 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.57 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.54 9.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.65 47.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.01 148.26 28.92 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.312 -0.867 . . . . 0.0 111.196 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.31 11.28 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.606 0.717 . . . . 0.0 110.413 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.3 22.84 1.49 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.579 -0.7 . . . . 0.0 109.482 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.47 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.6 mt -143.26 142.74 31.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.487 -1.007 . . . . 0.0 108.762 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.28 152.79 36.37 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.802 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.546 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.82 140.24 18.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.49 177.54 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.341 -1.343 . . . . 0.0 108.388 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.74 -35.99 82.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.382 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.4 m -86.67 -43.65 12.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 0.0 111.464 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.6 -43.76 83.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.797 -1.19 . . . . 0.0 108.255 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.521 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.54 13.17 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.4 m-80 -64.39 -44.98 89.63 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.39 61.25 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.546 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.62 -35.24 45.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.387 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 110.09 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.36 31.48 16.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.413 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.4 51.28 15.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -1.099 . . . . 0.0 109.644 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.708 1 CA-C-O 71.096 -23.335 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.37 74.88 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.6 p -161.93 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.238 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.0 148.67 43.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 t -66.14 93.38 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.02 . . . . 0.0 109.19 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.21 -54.28 2.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.445 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.3 73.97 1.38 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' N ' ' OG ' ' A' ' 65' ' ' SER . 3.7 t -69.39 158.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.46 131.51 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.462 -1.399 . . . . 0.0 111.447 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.0 129.25 46.04 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.2 m -63.45 154.4 32.32 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.505 1.145 . . . . 0.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 84.2 mt -114.39 -17.34 11.8 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.202 -1.407 . . . . 10.54 107.202 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.662 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.4 145.11 18.68 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.24 -0.913 . . . . 18.39 110.79 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.06 81.56 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 121.394 1.396 . . . . 0.0 109.022 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.86 170.39 13.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.853 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.85 0.833 . . . . 0.0 109.338 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.35 111.92 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 18' ' ' VAL . 14.3 m -130.35 94.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 122.93 1.348 . . . . 0.0 109.145 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.52 -152.05 0.4 Allowed 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.392 -1.276 . . . . 38.32 107.611 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.676 ' H ' HG22 ' A' ' 19' ' ' THR . 97.0 mt-10 -82.47 -54.35 5.26 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.813 -1.551 . . . . 55.13 106.813 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.3 29.19 7.77 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.388 -0.82 . . . . 0.0 110.727 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -100.5 150.85 22.24 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.963 -1.086 . . . . 0.0 109.697 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.37 111.55 22.68 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.384 -0.823 . . . . 11.68 110.698 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.59 127.75 41.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.02 142.18 21.43 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.433 -1.417 . . . . 12.44 110.801 -178.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.85 22.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 146.85 18.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.228 -0.92 . . . . 29.03 109.516 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.53 44.26 6.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.302 -1.519 . . . . 6.18 109.302 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.71 22.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.476 -1.014 . . . . 9.52 109.432 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.57 5.95 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.42 133.7 49.74 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 123.088 1.423 . . . . 0.0 110.574 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.83 103.15 15.89 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.374 -178.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.12 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.561 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.2 mt -59.79 -50.3 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.962 -1.086 . . . . 0.0 110.276 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.537 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.28 157.63 43.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.983 -1.073 . . . . 0.0 110.724 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HB3' ' NE1' ' A' ' 44' ' ' TRP . 1.9 mptp? -135.05 65.56 65.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.789 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.39 31.65 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.655 1.57 . . . . 0.0 109.004 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.09 -46.37 7.81 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.58 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 110.044 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.49 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.69 -59.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.107 0 C-N-CA 122.592 2.194 . . . . 0.0 109.922 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 54.2 tt0 131.7 9.38 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 123.882 0.873 . . . . 0.0 108.785 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.0 m0 -71.96 166.01 23.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.73 -1.231 . . . . 14.29 110.436 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.562 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.0 m0 -129.6 145.09 51.52 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.284 -0.635 . . . . 11.8 109.284 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.17 96.64 5.93 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.87 128.76 56.05 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.884 0.849 . . . . 0.0 110.45 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.69 150.36 26.81 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.781 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.35 128.5 43.33 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.297 178.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.41 0.99 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 119.632 -1.918 . . . . 0.0 107.991 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.465 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.64 -4.55 4.31 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.46 33.79 6.99 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 115.25 -0.886 . . . . 14.41 112.306 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.781 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.89 164.11 29.79 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.658 1.729 . . . . 0.0 111.847 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.55 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 122.294 1.045 . . . . 0.0 112.53 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.19 156.85 12.84 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.233 -1.547 . . . . 7.25 109.233 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.42 150.81 43.04 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -1.15 . . . . 0.0 108.644 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.71 9.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.89 -1.131 . . . . 0.0 109.299 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.18 113.57 1.17 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 108.971 -1.204 . . . . 4.76 108.971 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HD2' ' CE2' ' A' ' 44' ' ' TRP . 15.9 pttt -60.41 3.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.479 -0.763 . . . . 0.0 110.679 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -102.16 -7.52 22.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.325 -0.86 . . . . 14.84 109.281 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.13 8.25 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.302 -0.874 . . . . 10.23 109.486 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.44 156.5 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.059 -1.026 . . . . 6.97 109.522 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 63' ' ' VAL . 2.6 p -106.75 160.73 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' HG22 ' A' ' 62' ' ' VAL . 54.4 t -107.72 134.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.449 -0.782 . . . . 0.0 109.699 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.11 -63.21 1.25 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.264 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.7 p -70.01 151.67 45.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 109.415 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.521 ' OD1' ' O ' ' A' ' 65' ' ' SER . 90.2 m-20 -146.67 152.75 39.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.14 -67.44 1.47 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.41 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.364 1.376 . . . . 0.0 109.722 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.54 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.72 124.93 32.07 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.22 29.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -1.157 . . . . 0.0 109.431 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.84 167.85 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.3 -0.875 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.33 46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.74 5.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.306 -1.114 . . . . 0.0 109.312 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.19 163.69 35.97 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.932 1.754 . . . . 0.0 108.854 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.485 ' H ' HE21 ' B' ' 97' ' ' GLN . 27.6 mt -135.46 119.77 26.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 122.05 0.929 . . . . 0.0 109.377 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.825 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.37 117.02 4.0 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.771 0.796 . . . . 0.0 109.995 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.06 4.9 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.825 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.72 -48.55 8.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.07 4.72 13.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.497 -0.752 . . . . 0.0 109.068 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.243 -0.911 . . . . 0.0 108.564 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -115.89 143.39 30.71 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.47 113.37 1.42 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.496 1.464 . . . . 0.0 110.604 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.663 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -71.03 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.49 61.44 0.32 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.898 -1.126 . . . . 0.0 110.733 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.81 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.69 120.56 41.94 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.663 HG22 HG21 ' B' ' 86' ' ' ILE . 42.4 t -98.69 158.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.444 -0.785 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.57 116.07 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.621 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.86 106.03 18.2 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.042 -1.036 . . . . 0.0 109.466 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.57 42.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.29 4.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.08 25.3 75.79 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.82 0.66 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.821 0.819 . . . . 0.0 109.657 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.485 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.39 143.6 46.12 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.67 139.93 33.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.55 -1.343 . . . . 0.0 110.661 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.45 131.94 49.89 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.19 -14.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 120.922 -1.112 . . . . 0.0 108.399 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.77 -26.95 15.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.728 -0.607 . . . . 0.0 110.635 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.24 -6.42 31.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.839 -1.163 . . . . 0.0 110.799 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.32 106.42 12.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.3 m -133.72 175.26 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.259 1.028 . . . . 0.0 111.066 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.8 148.59 46.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.419 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.64 28.54 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.738 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.74 -31.62 0.72 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.075 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.06 -15.41 4.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 110.186 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.68 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.277 -0.89 . . . . 0.0 110.256 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.59 59.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.12 138.3 39.51 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.655 1.57 . . . . 0.0 112.102 -177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.302 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.77 56.94 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.168 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.835 . . . . 0.0 109.023 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.15 31.13 2.73 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.921 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.35 178.95 4.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.587 -0.949 . . . . 0.0 109.901 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.43 145.3 24.87 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.558 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.28 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.49 137.69 47.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.96 148.27 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.253 -0.904 . . . . 0.0 111.189 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.0 129.45 11.38 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.692 0.758 . . . . 0.0 110.237 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 51.02 22.97 1.33 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.561 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.96 20.37 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.32 -1.419 . . . . 0.0 109.698 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.31 142.78 31.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.502 -0.999 . . . . 0.0 108.755 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.34 152.91 36.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.363 -0.836 . . . . 0.0 110.722 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.552 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.99 140.3 18.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.54 177.38 0.1 Allowed 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.344 -1.343 . . . . 0.0 108.415 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.6 -35.98 82.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 109.341 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.66 -43.76 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 111.327 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.74 83.85 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.79 -1.193 . . . . 0.0 108.143 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.52 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.46 13.7 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.424 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.55 -44.7 89.95 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.58 -34.45 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.552 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.59 -35.24 46.07 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.443 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.6 -81.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.47 31.34 16.48 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.406 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.54 51.33 15.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -1.133 . . . . 0.0 109.561 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.801 1 CA-C-O 70.798 -23.477 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.274 0.559 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.99 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.212 -1.17 . . . . 0.0 109.542 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.65 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -66.11 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 109.146 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.31 -54.26 2.0 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.446 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' N ' ' OG ' ' A' ' 65' ' ' SER . 5.2 t -69.41 158.07 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.9 m -145.32 131.53 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.447 -1.408 . . . . 0.0 111.603 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.91 129.22 45.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.9 m -63.45 154.4 32.33 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.501 1.143 . . . . 0.0 110.546 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 8.6 mp -114.41 -17.22 11.82 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.222 -1.399 . . . . 10.54 107.222 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.661 ' H ' HG22 ' A' ' 11' ' ' THR . 14.3 m-85 -149.57 145.08 18.54 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.07 -1.019 . . . . 18.39 110.794 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.06 81.4 1.69 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.479 1.452 . . . . 0.0 109.054 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.77 170.31 13.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.993 -1.067 . . . . 0.0 110.854 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.64 111.13 8.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.839 0.828 . . . . 0.0 109.369 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 112.0 10.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 18' ' ' VAL . 32.8 m -130.27 94.19 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 122.873 1.32 . . . . 0.0 109.238 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -144.43 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.385 -1.28 . . . . 38.32 107.634 177.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.566 ' H ' HG22 ' A' ' 19' ' ' THR . 83.8 tt0 -82.42 -54.33 5.29 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.824 -1.547 . . . . 55.13 106.824 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.1 mt-10 -109.38 29.3 7.68 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.364 -0.835 . . . . 0.0 110.728 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.47 150.79 22.28 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.966 -1.084 . . . . 0.0 109.776 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.25 111.38 22.4 Favored 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.385 -0.822 . . . . 11.68 110.796 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.38 127.63 41.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.93 142.24 21.58 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.385 -1.447 . . . . 12.44 110.839 -178.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.15 155.9 22.36 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 146.95 19.15 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.251 -0.906 . . . . 29.03 109.515 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.11 6.59 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.306 -1.517 . . . . 6.18 109.306 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.68 22.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.47 -1.018 . . . . 9.52 109.385 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.69 6.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.52 133.68 49.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 123.154 1.454 . . . . 0.0 110.504 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.75 103.12 15.86 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.372 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.11 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.534 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.474 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.72 -50.36 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.881 -1.137 . . . . 0.0 110.259 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.51 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.59 43.65 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.973 -1.079 . . . . 0.0 110.736 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.547 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.05 65.54 65.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.79 165.4 31.55 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.628 1.552 . . . . 0.0 108.973 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.52 7.76 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.73 -59.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.309 0.576 . . . . 0.0 110.041 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.78 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 122.621 2.214 . . . . 0.0 109.908 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 67.6 mt-10 131.75 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.853 0.861 . . . . 0.0 108.768 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.558 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.8 m0 -71.85 165.9 23.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.578 -1.326 . . . . 14.29 110.451 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.445 ' C ' HD13 ' A' ' 55' ' ' LEU . 24.9 m0 -129.57 145.03 51.51 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.237 -0.653 . . . . 11.8 109.237 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.99 96.62 5.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.84 56.1 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.928 0.871 . . . . 0.0 110.326 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.69 150.28 26.85 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.78 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.33 128.54 43.35 Favored 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 117.15 -1.82 . . . . 0.0 107.223 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.33 0.99 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 119.579 -1.951 . . . . 0.0 108.045 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.47 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.68 4.46 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.55 33.97 6.86 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 115.309 -0.859 . . . . 14.41 112.261 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.78 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -138.0 164.08 29.95 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 119.645 1.722 . . . . 0.0 111.803 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-O 122.381 1.086 . . . . 0.0 112.417 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.04 156.74 12.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.211 -1.556 . . . . 7.25 109.211 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.34 150.83 43.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.261 -1.141 . . . . 0.0 108.598 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.67 8.91 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.969 -1.082 . . . . 0.0 109.266 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.15 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 N-CA-C 109.09 -1.158 . . . . 4.76 109.09 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.568 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.29 3.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.768 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' PRO . 47.2 p30 -102.1 -7.65 22.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.256 -0.902 . . . . 14.84 109.354 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.181 -0.949 . . . . 10.23 109.497 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.47 156.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.14 -0.975 . . . . 6.97 109.456 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 63' ' ' VAL . 7.5 p -106.78 160.75 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.521 ' N ' HG22 ' A' ' 62' ' ' VAL . 46.5 t -107.67 134.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.49 -0.756 . . . . 0.0 109.765 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.12 -63.27 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.599 -0.688 . . . . 0.0 109.182 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.4 p -69.89 151.59 45.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.062 -1.024 . . . . 0.0 109.491 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -146.59 152.64 39.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.21 -67.36 1.47 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.33 93.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.393 1.395 . . . . 0.0 109.725 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.01 82.48 1.74 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.04 32.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.112 -0.993 . . . . 0.0 109.437 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.18 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -1.121 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.34 46.85 0.2 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.19 130.76 5.37 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.414 -1.051 . . . . 0.0 109.405 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.3 163.57 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.915 1.743 . . . . 0.0 108.881 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.481 ' H ' HE21 ' B' ' 97' ' ' GLN . 29.9 mt -135.38 119.71 26.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-O 122.082 0.944 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.32 117.0 3.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.885 0.85 . . . . 0.0 109.983 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.29 4.96 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.54 -48.52 8.3 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.302 -1.116 . . . . 0.0 109.503 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.1 4.79 13.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 53.59 41.22 32.13 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -115.9 143.34 30.61 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.642 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.44 113.48 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.436 1.424 . . . . 0.0 110.542 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.672 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.93 158.36 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.47 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.872 -1.142 . . . . 0.0 110.687 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -101.96 0.15 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.6 42.14 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.672 HG22 HG21 ' B' ' 86' ' ' ILE . 42.6 t -98.82 158.68 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.736 0.779 . . . . 0.0 111.144 -177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.52 115.99 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.63 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.86 106.05 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 109.558 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.53 42.62 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.627 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.22 17.06 4.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.33 75.79 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.29 -154.7 0.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.63 0.729 . . . . 0.0 109.813 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.481 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.44 143.47 45.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.9 m95 -141.65 140.03 33.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.53 -1.356 . . . . 0.0 110.584 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.48 132.01 50.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.7 t -53.37 -14.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.968 -1.082 . . . . 0.0 108.315 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.83 -26.9 15.46 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.776 -0.577 . . . . 0.0 110.616 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.24 -6.47 31.1 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.94 -1.1 . . . . 0.0 110.787 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.64 175.31 11.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.232 1.015 . . . . 0.0 111.072 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.76 46.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.329 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.96 28.67 1.77 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 109.65 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.417 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.6 0.72 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.354 -0.841 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.14 -15.52 4.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.57 0.32 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.205 -0.934 . . . . 0.0 110.088 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.52 109.65 59.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.19 138.25 39.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.716 1.611 . . . . 0.0 112.099 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.321 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.74 56.94 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.151 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 0.0 109.072 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.27 30.96 2.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.921 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.18 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.58 -0.953 . . . . 0.0 110.04 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.38 145.44 24.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.37 169.48 9.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.47 137.69 47.32 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.14 148.35 28.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.213 -0.929 . . . . 0.0 111.174 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.595 0.712 . . . . 0.0 110.306 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.22 22.95 1.47 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.648 -0.657 . . . . 0.0 109.435 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.627 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.47 30.95 20.41 Favored Glycine 0 N--CA 1.482 1.75 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.499 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.31 142.64 31.39 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.534 -0.98 . . . . 0.0 108.873 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.38 152.76 36.2 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.793 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.2 m-85 -153.8 140.31 18.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.63 177.44 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.414 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.59 -35.9 82.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.4 m -86.65 -43.86 12.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 111.301 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.74 83.73 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.834 -1.167 . . . . 0.0 108.1 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.78 -56.38 14.24 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.64 -44.79 89.34 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.078 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.44 -34.32 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.74 -35.35 44.86 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.279 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.48 -81.64 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.095 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.42 31.42 16.41 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.7 m-20 48.56 51.17 15.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -1.103 . . . . 0.0 109.613 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.977 -23.392 . . . . 0.0 109.455 179.964 . . . . . . . . 2 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.35 74.81 0.12 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.9 35.25 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.057 -1.26 . . . . 0.0 109.58 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.442 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.11 148.67 43.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.142 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -66.06 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.105 -0.997 . . . . 0.0 109.275 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.23 -54.37 2.0 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.441 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.8 m-70 -145.2 73.88 1.38 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.552 ' N ' ' OG ' ' A' ' 65' ' ' SER . 38.6 t -69.38 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.36 131.47 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.458 -1.401 . . . . 0.0 111.549 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -99.8 129.29 45.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 13' ' ' TYR . 35.5 m -63.44 154.45 32.16 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.483 1.135 . . . . 0.0 110.598 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 HG13 ' A' ' 62' ' ' VAL . 87.1 mt -114.37 -17.35 11.81 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.251 -1.388 . . . . 10.54 107.251 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.666 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.044 . . . . 18.39 110.783 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -73.06 81.55 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.438 1.425 . . . . 0.0 108.965 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.5 t80 -71.85 170.4 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.845 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.7 111.04 7.93 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.787 0.803 . . . . 0.0 109.472 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.32 111.93 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 18' ' ' VAL . 10.7 m -130.43 94.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 123.056 1.408 . . . . 0.0 109.147 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.38 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.272 -1.331 . . . . 38.32 107.569 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.693 ' H ' HG22 ' A' ' 19' ' ' THR . 97.3 mt-10 -82.39 -54.39 5.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.923 -1.51 . . . . 55.13 106.923 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.442 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.17 29.01 7.91 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.4 -0.812 . . . . 0.0 110.762 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.629 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -100.4 150.9 22.14 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.863 -1.148 . . . . 0.0 109.787 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.36 111.39 22.4 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.419 -0.801 . . . . 11.68 110.756 -178.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.4 127.68 41.63 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.27 21.67 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.4 -1.437 . . . . 12.44 110.943 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.614 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.82 22.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.87 18.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.242 -0.911 . . . . 29.03 109.617 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.63 44.09 6.61 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.317 -1.513 . . . . 6.18 109.317 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.82 22.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.541 -0.976 . . . . 9.52 109.396 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.06 108.64 6.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.79 49.68 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.192 1.472 . . . . 0.0 110.527 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.477 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.539 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.07 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -0.782 . . . . 0.0 111.53 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.497 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.76 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.968 -1.082 . . . . 0.0 110.267 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.63 43.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.933 -1.105 . . . . 0.0 110.844 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.539 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.03 65.5 65.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.836 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.4 31.51 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.578 1.518 . . . . 0.0 108.96 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.52 7.75 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.59 -59.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.391 0.615 . . . . 0.0 110.141 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.56 -59.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.583 2.188 . . . . 0.0 109.909 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 17.8 pt-20 131.83 9.27 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.892 0.877 . . . . 0.0 108.786 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.571 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.1 m0 -71.77 165.92 23.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.669 -1.27 . . . . 14.29 110.48 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.486 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.4 m0 -129.63 144.99 51.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.243 -0.651 . . . . 11.8 109.243 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -78.93 96.58 5.75 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.498 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.914 0.864 . . . . 0.0 110.373 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.72 150.37 26.75 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.776 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.261 -1.776 . . . . 0.0 107.163 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.37 1.0 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.675 -1.89 . . . . 0.0 108.011 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.457 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.68 -4.59 4.38 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.42 33.88 6.95 Favored Glycine 0 N--CA 1.48 1.627 0 CA-C-N 115.386 -0.825 . . . . 14.41 112.297 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.776 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.14 29.7 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.633 1.717 . . . . 0.0 111.849 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.59 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-O 122.362 1.077 . . . . 0.0 112.434 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.2 156.75 12.73 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.338 -1.505 . . . . 7.25 109.338 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.23 150.89 43.27 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.296 -1.12 . . . . 0.0 108.681 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.71 8.95 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.84 -1.162 . . . . 0.0 109.342 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.22 113.6 1.18 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.074 -1.164 . . . . 4.76 109.074 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.5 pttt -60.37 3.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.487 -0.758 . . . . 0.0 110.603 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.7 m-20 -102.05 -7.66 22.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.144 -0.973 . . . . 14.84 109.323 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.22 30.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 10.23 109.494 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.38 156.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 6.97 109.589 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 12' ' ' LEU . 29.0 m -106.77 160.69 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.2 t -107.59 134.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.411 -0.806 . . . . 0.0 109.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.19 -63.28 1.25 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 13.8 p -69.91 151.61 45.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.983 -1.073 . . . . 0.0 109.418 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -146.59 152.68 39.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.23 1.48 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.254 1.302 . . . . 0.0 109.732 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.7 1.79 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.9 125.09 32.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.86 156.21 28.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -1.181 . . . . 0.0 109.507 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.73 167.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.93 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.75 5.33 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.383 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.522 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.8 35.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.816 1.677 . . . . 0.0 108.828 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.559 HG23 ' C ' ' B' ' 84' ' ' ARG . 61.3 mt -135.52 119.75 26.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 122.072 0.939 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.29 116.94 3.92 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.819 0.818 . . . . 0.0 109.96 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.3 4.96 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.53 -48.62 8.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -1.057 . . . . 0.0 109.455 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.86 13.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.559 ' C ' HG23 ' B' ' 78' ' ' ILE . 29.1 mtp180 -115.91 143.49 30.91 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.511 1.474 . . . . 0.0 110.494 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.655 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.96 158.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.424 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.52 61.48 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 110.615 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.0 -101.93 0.15 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.62 42.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 86' ' ' ILE . 42.5 t -98.77 158.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.419 -0.801 . . . . 0.0 111.195 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.47 ' N ' HG12 ' B' ' 90' ' ' VAL . 5.0 t -122.55 116.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.625 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.033 -1.042 . . . . 0.0 109.622 -179.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.51 42.68 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.637 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.15 4.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.38 25.11 76.16 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.16 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.788 0.804 . . . . 0.0 109.726 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.482 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.35 143.49 46.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.64 139.99 33.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.416 -1.428 . . . . 0.0 110.646 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.465 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.58 131.94 50.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG23 ' B' ' 91' ' ' VAL . 7.8 t -53.16 -14.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.909 -1.119 . . . . 0.0 108.348 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.465 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.83 -26.97 15.44 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 110.638 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.06 -6.6 31.46 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.93 -1.107 . . . . 0.0 110.787 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.24 106.34 12.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.3 m -133.64 175.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.267 1.032 . . . . 0.0 111.088 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.85 148.66 46.45 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.354 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.87 28.77 1.72 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.676 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.413 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.82 -31.62 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.309 -0.87 . . . . 0.0 110.086 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.24 -15.25 4.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.54 47.6 0.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.232 -0.918 . . . . 0.0 110.24 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.59 59.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.12 138.26 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.79 1.66 . . . . 0.0 112.006 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.325 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.038 0.0 OUTLIER -95.77 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.075 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.04 -55.24 1.61 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.001 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.98 2.75 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.947 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.36 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.416 -1.05 . . . . 0.0 109.958 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.53 145.41 24.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.797 . . . . 0.0 109.295 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.39 169.55 9.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.472 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.54 137.66 47.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.96 148.3 28.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.203 -0.936 . . . . 0.0 111.18 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.469 -0.77 . . . . 0.0 110.327 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.31 22.8 1.49 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.637 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 31.02 20.41 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.79 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.37 142.8 31.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.61 -0.936 . . . . 0.0 108.799 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.43 152.82 36.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.331 -0.855 . . . . 0.0 110.673 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.5 m-85 -153.84 140.36 18.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.3 m -57.72 177.55 0.1 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.441 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.67 -35.92 82.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.853 . . . . 0.0 109.436 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.445 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.1 m -86.61 -43.81 12.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 111.349 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.73 83.79 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.738 -1.226 . . . . 0.0 108.177 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.5 13.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.419 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.42 -44.92 89.72 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.184 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.43 -34.36 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.63 -35.35 45.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.384 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.7 m-85 -158.51 -81.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.054 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.46 31.44 16.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.39 51.37 15.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.327 -1.102 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.698 1 CA-C-O 70.992 -23.385 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.309 0.576 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.98 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.91 35.2 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -1.208 . . . . 0.0 109.666 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.62 43.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.296 -0.878 . . . . 0.0 109.139 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.5 t -65.92 93.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -121.26 -54.32 2.0 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.31 73.88 1.37 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 8' ' ' VAL . 3.4 t -69.41 158.13 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 31' ' ' MET . 4.8 m -145.44 131.6 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.48 -1.387 . . . . 0.0 111.513 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -100.03 129.16 46.06 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 13' ' ' TYR . 34.3 m -63.3 154.39 31.84 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.497 1.141 . . . . 0.0 110.617 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 93.1 mt -114.37 -17.28 11.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.211 -1.403 . . . . 10.54 107.211 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.671 ' H ' HG22 ' A' ' 11' ' ' THR . 14.3 m-85 -149.49 145.06 18.54 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 121.133 -0.979 . . . . 18.39 110.794 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -72.87 81.4 1.64 Allowed 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.468 1.445 . . . . 0.0 109.07 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.76 170.33 13.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.923 -1.111 . . . . 0.0 110.91 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.07 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.776 0.798 . . . . 0.0 109.431 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.31 111.96 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 18' ' ' VAL . 19.7 m -130.29 94.25 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 122.9 1.333 . . . . 0.0 109.134 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.817 HG22 ' H ' ' A' ' 20' ' ' GLU . 2.6 m -144.46 -151.98 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.362 -1.29 . . . . 38.32 107.581 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.817 ' H ' HG22 ' A' ' 19' ' ' THR . 76.7 mm-40 -82.5 -54.29 5.3 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.903 -1.518 . . . . 55.13 106.903 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.5 mt-10 -109.3 29.2 7.76 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.53 150.93 22.17 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.907 -1.12 . . . . 0.0 109.741 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.38 22.39 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.342 -0.849 . . . . 11.68 110.82 -178.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.36 127.7 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.03 142.22 21.47 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.327 -1.483 . . . . 12.44 110.851 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.591 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.87 22.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 146.93 18.91 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.255 -0.903 . . . . 29.03 109.492 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.14 6.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.273 -1.531 . . . . 6.18 109.273 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.29 114.79 22.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.652 -0.911 . . . . 9.52 109.436 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.459 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.99 108.57 5.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.489 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.51 133.65 49.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 123.21 1.481 . . . . 0.0 110.549 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.6 102.95 15.69 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.48 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 111.49 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.48 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.85 -50.39 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 120.917 -1.114 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.16 157.62 43.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.99 -1.069 . . . . 0.0 110.831 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.04 65.52 65.35 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.28 31.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.721 1.614 . . . . 0.0 109.027 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.49 7.77 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.67 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.353 0.597 . . . . 0.0 110.037 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.89 -47.54 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.608 2.205 . . . . 0.0 109.996 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.9 pt-20 131.67 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 123.878 0.871 . . . . 0.0 108.806 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.582 ' HB2' HD12 ' A' ' 55' ' ' LEU . 11.7 m0 -71.79 165.91 23.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.712 -1.242 . . . . 14.29 110.527 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.1 m0 -129.46 145.12 51.47 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.633 -0.667 . . . . 11.8 109.302 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.17 96.61 5.92 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -115.92 128.81 56.06 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.966 0.888 . . . . 0.0 110.347 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.63 150.48 26.8 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.785 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.46 128.57 43.51 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 117.275 -1.77 . . . . 0.0 107.216 177.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.44 1.02 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.611 -1.931 . . . . 0.0 107.972 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.58 -4.77 4.43 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.655 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 34.04 6.85 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.438 -0.801 . . . . 14.41 112.215 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.785 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.96 164.11 29.84 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.628 1.714 . . . . 0.0 111.765 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.55 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.305 1.05 . . . . 0.0 112.507 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.14 156.69 12.61 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.324 -1.511 . . . . 7.25 109.324 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.76 43.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.171 -1.194 . . . . 0.0 108.674 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.98 136.75 9.04 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.954 -1.092 . . . . 0.0 109.289 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.12 113.46 1.11 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 N-CA-C 109.052 -1.172 . . . . 4.76 109.052 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.4 pttt -60.36 3.23 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.443 -0.786 . . . . 0.0 110.71 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.3 m120 -102.17 -7.48 22.17 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.3 -0.875 . . . . 14.84 109.326 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.05 8.16 31.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.089 -1.007 . . . . 10.23 109.343 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.45 156.62 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.219 -0.926 . . . . 6.97 109.561 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 63' ' ' VAL . 7.5 p -106.84 160.86 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.506 ' N ' HG22 ' A' ' 62' ' ' VAL . 5.5 p -107.72 134.31 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 64' ' ' LEU . 11.2 mp -105.2 -63.14 1.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.566 -0.709 . . . . 0.0 109.202 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 31.8 m -70.15 151.69 45.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.99 -1.069 . . . . 0.0 109.417 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -146.58 152.67 39.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.32 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.31 1.34 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.58 1.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.79 124.96 32.16 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.94 156.19 28.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -1.134 . . . . 0.0 109.41 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.83 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.28 46.88 0.2 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.27 130.76 5.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.0 109.463 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.15 163.65 36.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.024 1.816 . . . . 0.0 108.811 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.481 ' H ' HE21 ' B' ' 97' ' ' GLN . 74.8 mt -135.47 119.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.073 0.939 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.48 117.05 4.07 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.833 0.825 . . . . 0.0 109.962 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.13 4.97 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.64 -48.6 8.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.372 -1.075 . . . . 0.0 109.422 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.12 4.83 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 53.55 41.26 32.12 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.474 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.0 mmm180 -115.98 143.55 31.08 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.45 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.417 1.411 . . . . 0.0 110.611 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.658 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.89 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.422 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.6 61.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.877 -1.139 . . . . 0.0 110.667 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.08 0.15 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.68 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.71 42.51 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.658 HG22 HG21 ' B' ' 86' ' ' ILE . 43.2 t -98.82 158.72 3.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 111.155 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.6 116.16 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.636 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.89 106.15 18.28 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 109.534 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.53 159.5 42.67 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.23 4.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.22 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.851 -0.793 . . . . 0.0 109.856 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.481 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.48 143.54 45.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.5 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.526 -1.359 . . . . 0.0 110.646 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.455 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.61 132.12 50.82 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.6 t -53.36 -14.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.927 -1.108 . . . . 0.0 108.408 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.455 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.68 -27.18 15.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.778 -0.576 . . . . 0.0 110.589 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -97.94 -6.63 31.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.901 -1.124 . . . . 0.0 110.899 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.15 106.29 12.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.821 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.0 m -133.56 175.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.358 1.075 . . . . 0.0 111.073 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.95 148.7 46.72 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.2 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.65 1.74 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.837 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.43 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.47 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.321 -0.862 . . . . 0.0 110.196 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.23 -15.29 4.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.296 -0.878 . . . . 0.0 110.076 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.61 47.57 0.35 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.794 . . . . 0.0 110.267 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.5 59.05 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.821 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.07 138.23 39.5 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.73 1.62 . . . . 0.0 112.179 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.314 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.8 57.04 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.196 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.629 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.12 -55.29 1.64 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 108.997 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.07 31.0 2.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.922 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.31 178.98 4.13 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.611 -0.935 . . . . 0.0 109.94 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.37 145.3 24.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.564 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.25 169.57 9.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.5 m-85 -132.57 137.65 47.17 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.32 28.85 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.14 -0.975 . . . . 0.0 111.204 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.24 11.2 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.615 0.722 . . . . 0.0 110.324 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.36 22.74 1.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.96 20.32 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.741 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.7 mt -143.25 142.63 31.44 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.608 -0.937 . . . . 0.0 108.873 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.16 152.8 36.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -153.87 140.34 18.76 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.6 m -57.74 177.44 0.11 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.299 -1.361 . . . . 0.0 108.401 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.58 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.58 -35.94 82.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.417 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.71 -43.66 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 111.311 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.466 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.83 -43.55 83.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.817 -1.177 . . . . 0.0 108.206 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.82 -56.37 14.37 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.7 m-80 -64.6 -44.91 89.13 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.009 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.45 -34.35 61.32 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.63 -35.34 45.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.381 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.58 -81.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 110.096 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.4 31.34 16.69 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.48 51.24 15.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -1.084 . . . . 0.0 109.576 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.981 -23.39 . . . . 0.0 109.454 179.915 . . . . . . . . 2 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.84 0.12 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.95 35.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -1.172 . . . . 0.0 109.624 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -72.99 148.6 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.167 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -65.96 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.288 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.41 1.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.23 73.94 1.38 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.46 158.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 31' ' ' MET . 3.9 m -145.34 131.45 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.416 -1.427 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.92 129.22 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.8 m -63.41 154.43 32.1 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.487 1.136 . . . . 0.0 110.572 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.534 HD11 HG23 ' A' ' 62' ' ' VAL . 90.5 mt -114.31 -17.36 11.84 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.274 -1.38 . . . . 10.54 107.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.678 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.51 144.96 18.39 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.16 -0.963 . . . . 18.39 110.803 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.97 81.54 1.65 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.392 1.395 . . . . 0.0 109.024 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.92 170.32 13.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.978 -1.077 . . . . 0.0 110.86 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.63 111.08 7.99 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.831 0.824 . . . . 0.0 109.47 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 111.86 10.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.2 t -130.23 94.35 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.938 1.352 . . . . 0.0 109.2 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.949 HG22 ' H ' ' A' ' 20' ' ' GLU . 4.9 m -144.49 -151.97 0.39 Allowed 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.335 -1.302 . . . . 38.32 107.557 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.949 ' H ' HG22 ' A' ' 19' ' ' THR . 45.6 tp10 -82.41 -54.36 5.27 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.885 -1.524 . . . . 55.13 106.885 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.8 mt-10 -109.38 29.23 7.74 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.447 -0.783 . . . . 0.0 110.712 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.643 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -100.49 150.98 22.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.811 -1.181 . . . . 0.0 109.727 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.443 -0.786 . . . . 11.68 110.765 -178.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.53 127.69 41.77 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.83 142.25 21.68 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.352 -1.467 . . . . 12.44 110.876 -178.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.76 22.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 146.91 18.73 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.227 -0.921 . . . . 29.03 109.452 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.17 6.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.326 -1.51 . . . . 6.18 109.326 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.67 22.72 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.487 -1.008 . . . . 9.52 109.416 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.97 108.69 6.02 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.452 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.59 133.63 50.01 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.201 1.477 . . . . 0.0 110.532 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.71 103.05 15.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.466 -178.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.0 92.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.573 -0.705 . . . . 0.0 111.496 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.4 mt -59.65 -50.52 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.94 -1.1 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.478 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.12 157.67 43.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.991 -1.068 . . . . 0.0 110.788 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.547 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.07 65.6 65.35 Favored Pre-proline 0 N--CA 1.486 1.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.761 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.74 165.34 31.71 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.715 1.61 . . . . 0.0 108.947 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.16 -46.3 7.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.5 m-20 57.62 -59.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.442 0.639 . . . . 0.0 110.054 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.71 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.61 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.128 0 C-N-CA 122.597 2.198 . . . . 0.0 109.968 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.86 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.51 ' HB2' HD12 ' A' ' 55' ' ' LEU . 22.1 m0 -71.81 165.87 23.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.626 -1.296 . . . . 14.29 110.519 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.487 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.8 m0 -129.55 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.286 -0.635 . . . . 11.8 109.286 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.15 96.66 5.92 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -116.0 128.8 56.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.954 0.883 . . . . 0.0 110.378 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.6 150.44 26.86 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.775 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.45 128.58 43.52 Favored 'General case' 0 N--CA 1.509 2.487 0 C-N-CA 117.266 -1.773 . . . . 0.0 107.215 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.5 -18.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.734 -1.854 . . . . 0.0 107.913 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.468 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.55 4.33 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.651 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.35 33.96 6.94 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 115.257 -0.883 . . . . 14.41 112.286 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.775 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.07 29.86 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.745 1.772 . . . . 0.0 111.829 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.97 154.58 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 122.335 1.064 . . . . 0.0 112.52 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.84 12.85 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.236 -1.546 . . . . 7.25 109.236 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.51 150.97 42.76 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.296 -1.12 . . . . 0.0 108.613 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.12 136.67 8.91 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.82 -1.175 . . . . 0.0 109.265 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.04 113.46 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 108.992 -1.195 . . . . 4.76 108.992 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 62.7 pttt -60.33 3.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 110.66 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.3 m-20 -102.01 -7.66 22.15 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.275 -0.891 . . . . 14.84 109.334 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.96 8.11 31.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.239 -0.913 . . . . 10.23 109.56 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 11' ' ' THR . 32.0 m -147.32 156.57 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 6.97 109.542 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.534 HG23 HD11 ' A' ' 12' ' ' LEU . 15.0 t -106.86 160.69 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 10.4 p -107.57 134.34 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.392 -0.818 . . . . 0.0 109.814 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.19 -63.15 1.26 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 33.9 m -70.05 151.68 45.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.956 -1.09 . . . . 0.0 109.503 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -146.75 152.69 39.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.27 1.48 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.52 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.209 1.273 . . . . 0.0 109.637 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.53 1.75 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.05 32.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 156.27 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 109.532 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.92 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.27 46.92 0.2 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.73 5.32 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.283 -1.128 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.519 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.58 36.1 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.872 1.714 . . . . 0.0 108.848 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 62' ' ' VAL . 72.7 mt -135.33 119.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 122.001 0.905 . . . . 0.0 109.379 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.83 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.24 116.88 3.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.75 -0.1 4.73 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.83 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.78 -48.41 8.25 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.361 -1.082 . . . . 0.0 109.397 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.19 4.89 13.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.521 -0.737 . . . . 0.0 109.07 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.487 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.6 mtp-105 -115.94 143.32 30.61 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.8 Cg_exo -56.33 113.25 1.36 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.49 1.46 . . . . 0.0 110.636 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.668 HG21 HG22 ' B' ' 90' ' ' VAL . 21.7 mt -70.9 158.53 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.642 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.425 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.6 61.44 0.32 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.873 -1.142 . . . . 0.0 110.615 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.96 -101.96 0.15 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.677 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.74 120.61 42.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.668 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.67 158.75 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.698 0.761 . . . . 0.0 111.186 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.59 115.92 47.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.634 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.81 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.48 42.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.32 4.35 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.3 75.82 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.8 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.747 0.784 . . . . 0.0 109.684 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.484 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.41 143.4 45.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.46 140.06 33.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.606 -1.309 . . . . 0.0 110.651 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.469 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.5 131.93 50.0 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.9 t -53.17 -14.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.988 -1.07 . . . . 0.0 108.465 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.469 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.8 -26.87 15.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.762 -0.586 . . . . 0.0 110.608 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.14 -6.51 31.37 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.909 -1.119 . . . . 0.0 110.804 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.27 106.31 12.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.58 175.39 11.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.153 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.83 148.69 46.3 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.375 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.74 1.73 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.83 -31.74 0.71 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 110.135 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.08 -15.32 4.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.104 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.63 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.69 59.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.14 138.35 39.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.636 1.558 . . . . 0.0 112.144 -177.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.81 56.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.172 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.621 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.98 -55.35 1.57 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.04 2.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.934 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.96 4.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.429 -1.042 . . . . 0.0 109.977 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.51 145.28 24.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.5 137.72 47.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.06 148.34 28.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.353 -0.842 . . . . 0.0 111.266 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.95 129.31 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.724 . . . . 0.0 110.424 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.97 1.43 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 30.94 20.63 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.77 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.9 mt -143.27 142.66 31.43 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.968 . . . . 0.0 108.853 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.93 36.27 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.735 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.555 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.99 140.28 18.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.1 m -57.54 177.46 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.404 -1.318 . . . . 0.0 108.508 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.64 -35.99 82.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 56.5 m -86.54 -43.79 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 111.426 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.85 83.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.812 -1.18 . . . . 0.0 108.155 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.75 -56.49 13.49 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.2 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.153 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -54.55 -34.29 61.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.71 -35.24 45.19 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.357 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.52 -81.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.45 31.37 16.45 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.57 51.2 15.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -1.09 . . . . 0.0 109.561 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.476 -39.647 1 CA-C-O 70.829 -23.462 . . . . 0.0 109.479 -179.975 . . . . . . . . 2 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.03 35.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -1.102 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.8 ttm-85 -73.01 148.62 44.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.127 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.05 93.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.3 mt -121.19 -54.27 2.01 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.32 74.04 1.38 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.55 157.97 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.2 131.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.365 -1.459 . . . . 0.0 111.553 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -99.9 129.27 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 13' ' ' TYR . 28.3 m -63.47 154.35 32.57 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.499 1.142 . . . . 0.0 110.544 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 91.7 mt -114.3 -17.29 11.86 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.221 -1.4 . . . . 10.54 107.221 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.669 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.48 145.07 18.56 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.154 -0.966 . . . . 18.39 110.768 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.98 81.51 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.345 1.363 . . . . 0.0 109.059 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.4 t80 -71.88 170.3 13.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.912 -1.117 . . . . 0.0 110.821 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.58 111.16 8.07 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.809 0.814 . . . . 0.0 109.389 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.27 111.89 10.61 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 18' ' ' VAL . 23.2 m -130.37 94.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.904 1.335 . . . . 0.0 109.197 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -144.46 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.383 -1.28 . . . . 38.32 107.63 177.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.565 ' H ' HG22 ' A' ' 19' ' ' THR . 97.3 mt-10 -82.41 -54.31 5.31 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.936 -1.505 . . . . 55.13 106.936 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.6 mt-10 -109.25 29.21 7.74 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.47 -0.769 . . . . 0.0 110.827 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.616 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.61 150.92 22.21 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.861 -1.149 . . . . 0.0 109.682 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -111.31 111.43 22.49 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.39 -0.819 . . . . 11.68 110.71 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.45 127.68 41.69 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.92 142.27 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.436 -1.415 . . . . 12.44 110.798 -178.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.32 155.87 22.17 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.94 18.43 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.266 -0.896 . . . . 29.03 109.506 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 44.09 6.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.286 -1.526 . . . . 6.18 109.286 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.87 23.01 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.534 -0.98 . . . . 9.52 109.358 -179.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.22 108.74 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.56 133.75 49.81 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 123.228 1.49 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.86 103.11 15.86 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 113.745 -1.571 . . . . 0.0 107.351 -178.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.495 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.467 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.9 -50.43 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.145 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.17 157.6 43.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.026 -1.046 . . . . 0.0 110.786 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.552 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.01 65.57 65.7 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.767 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.43 31.56 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.567 1.512 . . . . 0.0 109.145 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.11 -46.42 7.78 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.63 -59.43 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.421 0.629 . . . . 0.0 110.071 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.624 2.216 . . . . 0.0 109.899 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 75.2 mt-10 131.86 9.31 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.559 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.8 m0 -71.85 165.91 23.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.619 -1.301 . . . . 14.29 110.385 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.544 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.1 m0 -129.64 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.287 -0.635 . . . . 11.8 109.287 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.99 96.58 5.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.69 55.98 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.91 0.862 . . . . 0.0 110.488 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.5 150.31 27.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.785 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 117.226 -1.789 . . . . 0.0 107.289 177.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.46 1.01 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.652 -1.905 . . . . 0.0 108.013 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.475 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.61 -4.55 4.26 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.655 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.42 33.95 6.92 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-N 115.355 -0.839 . . . . 14.41 112.253 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.785 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.06 29.96 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-N 119.71 1.755 . . . . 0.0 111.859 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.83 154.56 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.231 1.015 . . . . 0.0 112.601 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.17 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.24 -1.544 . . . . 7.25 109.24 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.87 43.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -1.182 . . . . 0.0 108.605 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.06 136.83 9.06 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.075 -1.016 . . . . 0.0 109.225 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.23 113.51 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 108.935 -1.217 . . . . 4.76 108.935 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 25.6 pttm -60.23 2.95 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.453 -0.78 . . . . 0.0 110.798 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.9 m120 -101.96 -7.56 22.29 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 14.84 109.297 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.11 8.34 30.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.289 -0.882 . . . . 10.23 109.481 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.1 m -147.51 156.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.239 -0.913 . . . . 6.97 109.389 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.512 HG22 ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.82 160.78 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.512 ' N ' HG22 ' A' ' 62' ' ' VAL . 73.1 t -107.62 134.22 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.435 -0.791 . . . . 0.0 109.834 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.436 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 97.9 mt -105.14 -63.08 1.26 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.636 -0.665 . . . . 0.0 109.207 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.491 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 19.4 m -70.11 151.55 45.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 65' ' ' SER . 85.6 m-20 -146.43 152.8 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.34 1.47 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.4 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.298 1.332 . . . . 0.0 109.669 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.6 1.77 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.83 124.93 32.15 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.121 -0.987 . . . . 0.0 109.395 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.19 28.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -1.137 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.78 167.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.444 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.39 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.84 5.37 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.346 -1.091 . . . . 0.0 109.291 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.34 163.65 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.941 1.761 . . . . 0.0 108.875 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.556 HG23 ' C ' ' B' ' 84' ' ' ARG . 61.7 mt -135.42 119.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 122.054 0.93 . . . . 0.0 109.313 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.33 116.94 3.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 110.045 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.85 -0.16 4.91 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.55 -48.72 8.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -1.121 . . . . 0.0 109.33 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.01 4.81 13.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 53.62 41.25 32.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.556 ' C ' HG23 ' B' ' 78' ' ' ILE . 5.3 mmm180 -115.95 143.46 30.89 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.416 1.411 . . . . 0.0 110.566 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.667 HG21 HG22 ' B' ' 90' ' ' VAL . 21.3 mt -70.87 158.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.58 61.57 0.32 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.885 -1.134 . . . . 0.0 110.648 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.16 -101.91 0.15 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.66 120.75 42.61 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.667 HG22 HG21 ' B' ' 86' ' ' ILE . 42.7 t -98.89 158.61 3.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.524 -0.735 . . . . 0.0 111.205 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.475 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.6 115.97 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.641 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.7 106.01 18.18 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.687 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.61 42.46 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.92 17.28 4.2 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.24 25.17 76.01 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.14 -154.75 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.776 0.798 . . . . 0.0 109.758 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.482 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.39 143.52 46.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.53 140.01 33.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.462 -1.399 . . . . 0.0 110.644 -177.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.51 131.89 49.9 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.457 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.16 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 120.866 -1.146 . . . . 0.0 108.343 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.11 15.41 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.848 -0.533 . . . . 0.0 110.61 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.13 -6.43 31.56 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 110.746 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.475 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.12 106.24 12.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.821 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.2 m -133.57 175.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 122.219 1.009 . . . . 0.0 111.143 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.71 46.18 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.222 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.7 1.74 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.072 -1.018 . . . . 0.0 109.596 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.8 0.71 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.407 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.36 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.407 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.59 47.75 0.34 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.314 -0.866 . . . . 0.0 110.131 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.57 109.62 59.67 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.821 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.08 138.32 39.67 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.656 1.57 . . . . 0.0 112.059 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.305 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.78 56.87 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.131 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.15 1.69 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.1 30.96 2.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.907 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.35 178.87 4.17 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.411 -1.052 . . . . 0.0 109.953 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.35 145.39 24.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.365 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.42 169.39 9.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 109.504 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.67 47.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.05 148.29 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.256 -0.902 . . . . 0.0 111.22 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.93 129.41 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.09 22.93 1.37 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.491 -0.756 . . . . 0.0 109.531 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.99 20.26 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.4 mt -143.33 142.74 31.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.577 -0.955 . . . . 0.0 108.738 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.81 36.26 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.903 . . . . 0.0 110.721 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.7 m-85 -153.9 140.23 18.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.49 177.48 0.1 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.339 -1.344 . . . . 0.0 108.49 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.65 -36.06 82.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 109.301 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.5 m -86.65 -43.73 12.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.843 . . . . 0.0 111.325 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.72 83.67 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.698 -1.251 . . . . 0.0 108.187 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.7 -56.56 13.03 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.413 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.51 -44.75 89.93 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.139 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.42 61.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.65 -35.22 45.7 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.39 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.62 -81.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.838 . . . . 0.0 110.075 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.33 31.47 16.49 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.422 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.42 51.3 15.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.245 -1.15 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.749 1 CA-C-O 71.145 -23.312 . . . . 0.0 109.454 179.98 . . . . . . . . 2 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.96 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -162.0 35.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.082 -1.246 . . . . 0.0 109.606 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -72.95 148.59 44.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.129 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.0 93.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.277 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 mt -121.37 -54.25 1.99 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.438 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.34 74.1 1.38 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.502 ' N ' ' OG ' ' A' ' 65' ' ' SER . 82.1 t -69.56 158.12 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.39 131.53 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.401 -1.437 . . . . 0.0 111.538 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -99.92 129.23 45.98 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.665 HG22 ' H ' ' A' ' 13' ' ' TYR . 44.1 m -63.45 154.29 32.69 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.513 1.149 . . . . 0.0 110.614 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.3 mt -114.29 -17.3 11.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.155 -1.424 . . . . 10.54 107.155 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.665 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.56 145.04 18.48 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.19 -0.944 . . . . 18.39 110.798 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -73.02 81.47 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.506 1.471 . . . . 0.0 109.036 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.2 t80 -71.78 170.31 13.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.125 . . . . 0.0 110.944 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.0 7.92 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.738 0.78 . . . . 0.0 109.459 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.0 10.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 18' ' ' VAL . 7.5 m -130.33 94.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-O 122.907 1.337 . . . . 0.0 109.26 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.6 m -144.36 -151.93 0.39 Allowed 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.301 -1.318 . . . . 38.32 107.701 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.705 ' H ' HG22 ' A' ' 19' ' ' THR . 96.2 mt-10 -82.51 -54.42 5.2 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.84 -1.541 . . . . 55.13 106.84 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.46 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.4 mt-10 -109.3 29.28 7.69 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.357 -0.839 . . . . 0.0 110.759 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.43 150.89 22.16 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.812 -1.18 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.451 -0.78 . . . . 11.68 110.756 -178.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.39 127.72 41.67 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.99 142.16 21.44 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.386 -1.446 . . . . 12.44 110.905 -178.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.78 22.52 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 146.98 18.09 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.389 -0.924 . . . . 29.03 109.603 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.56 44.18 6.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.248 -1.541 . . . . 6.18 109.248 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.82 22.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.545 -0.973 . . . . 9.52 109.452 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.13 108.66 6.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.46 133.81 49.6 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 123.104 1.431 . . . . 0.0 110.588 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.09 15.84 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.304 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.518 -0.739 . . . . 0.0 111.504 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.486 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 83.1 mt -59.68 -50.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.979 -1.076 . . . . 0.0 110.259 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.55 43.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.03 -1.044 . . . . 0.0 110.844 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.03 65.72 65.91 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.86 165.36 31.58 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.665 1.577 . . . . 0.0 109.003 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.58 -59.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.349 0.595 . . . . 0.0 110.119 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.69 -47.41 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 178.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.68 -59.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 122.562 2.174 . . . . 0.0 110.022 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 29.7 mm-40 131.76 9.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 123.86 0.864 . . . . 0.0 108.729 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.9 m0 -71.79 165.88 23.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.718 -1.239 . . . . 14.29 110.546 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.492 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.1 m0 -129.62 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.661 -0.649 . . . . 11.8 109.263 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.0 96.69 5.83 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.94 128.74 56.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.866 0.841 . . . . 0.0 110.345 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.57 150.36 26.94 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.779 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.41 128.59 43.47 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.27 -1.772 . . . . 0.0 107.181 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.45 -18.37 1.04 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 119.751 -1.843 . . . . 0.0 107.917 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.462 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.53 4.31 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.43 33.86 6.96 Favored Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.331 -0.85 . . . . 14.41 112.271 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.779 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.08 29.86 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.692 1.746 . . . . 0.0 111.762 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.62 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.369 1.081 . . . . 0.0 112.494 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.82 12.82 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.302 -1.519 . . . . 7.25 109.302 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.41 150.94 42.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.218 -1.166 . . . . 0.0 108.629 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.02 136.7 8.97 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.356 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.2 113.52 1.14 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 N-CA-C 109.002 -1.192 . . . . 4.76 109.002 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.3 3.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.842 . . . . 0.0 110.719 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.594 ' OD1' ' NH2' ' B' ' 83' ' ' ARG . 95.8 m-20 -102.07 -7.59 22.16 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.263 -0.898 . . . . 14.84 109.319 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.93 8.09 31.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.269 -0.894 . . . . 10.23 109.533 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.33 156.66 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 6.97 109.49 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 63' ' ' VAL . 2.7 p -106.82 160.83 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 62' ' ' VAL . 8.5 p -107.75 134.27 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.363 -0.836 . . . . 0.0 109.724 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.11 -63.1 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.665 -0.647 . . . . 0.0 109.275 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 13.4 p -69.99 151.54 45.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.027 -1.046 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 44.2 p30 -146.54 152.78 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.221 -0.925 . . . . 0.0 109.337 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.43 1.47 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.338 1.359 . . . . 0.0 109.693 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.0 82.65 1.77 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.04 32.28 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.65 156.35 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.9 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.493 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.8 0.2 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.24 130.78 5.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.271 -1.135 . . . . 0.0 109.431 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.54 36.18 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.958 1.772 . . . . 0.0 108.805 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.527 HG23 ' C ' ' B' ' 84' ' ' ARG . 65.0 mt -135.33 119.78 26.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 122.068 0.937 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.826 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.43 117.09 4.1 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.949 0.881 . . . . 0.0 109.922 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.17 4.94 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.826 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.71 -48.56 8.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.372 -1.075 . . . . 0.0 109.306 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.78 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . 0.594 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 94.2 mtt-85 53.51 41.32 32.12 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.527 ' C ' HG23 ' B' ' 78' ' ' ILE . 3.9 mmm180 -115.87 143.42 30.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.634 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.54 113.3 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.428 1.419 . . . . 0.0 110.596 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.671 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.92 158.42 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.47 61.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 110.682 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.09 0.15 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.49 120.72 42.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.671 HG22 HG21 ' B' ' 86' ' ' ILE . 43.1 t -98.91 158.73 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.73 0.776 . . . . 0.0 111.105 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.64 116.01 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.641 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.89 105.97 18.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.09 -1.007 . . . . 0.0 109.528 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.52 159.64 42.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.22 4.27 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.26 75.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.17 -154.72 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.722 0.772 . . . . 0.0 109.796 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.48 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.5 143.45 45.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.9 m95 -141.58 140.07 33.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.516 -1.365 . . . . 0.0 110.596 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.454 ' C ' ' N ' ' B' ' 101' ' ' GLU . 16.9 m80 -56.66 131.99 50.6 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.15 -14.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.956 -1.09 . . . . 0.0 108.302 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.02 15.45 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.696 -0.627 . . . . 0.0 110.638 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.01 -6.6 31.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.818 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.471 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.12 106.22 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.83 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.204 1.002 . . . . 0.0 111.192 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.7 148.68 45.85 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.329 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.63 1.75 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.66 0.71 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.338 -0.851 . . . . 0.0 110.009 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.36 4.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.392 -0.817 . . . . 0.0 110.165 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.5 109.54 59.34 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.83 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.02 138.19 39.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.804 1.669 . . . . 0.0 112.078 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.78 56.98 1.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.138 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.21 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.9 2.75 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.965 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.2 178.99 4.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.465 -1.021 . . . . 0.0 109.906 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.62 145.37 24.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.761 . . . . 0.0 109.302 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.43 9.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.462 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.705 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.53 137.64 47.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.06 148.33 28.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.262 -0.899 . . . . 0.0 111.173 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.19 11.22 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.607 0.718 . . . . 0.0 110.291 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.39 22.77 1.53 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.4 31.06 20.32 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.729 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.3 mt -143.4 142.71 31.34 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.521 -0.988 . . . . 0.0 108.773 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.9 36.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 110.787 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.548 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.3 m-85 -153.97 140.42 18.75 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.6 177.51 0.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.446 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.73 -35.89 82.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 0.0 109.443 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.1 m -86.69 -43.7 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 111.384 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.7 -43.71 83.6 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.839 -1.163 . . . . 0.0 108.065 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.512 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.84 -56.45 13.9 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.0 m-80 -64.4 -45.03 89.39 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.012 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.34 61.17 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.548 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.66 -35.25 45.57 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.361 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.57 -81.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.51 31.31 16.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.405 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.56 51.3 15.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -1.128 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.744 1 CA-C-O 70.872 -23.442 . . . . 0.0 109.455 179.941 . . . . . . . . 2 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.26 74.93 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -162.0 35.33 0.12 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -1.207 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.434 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.0 148.65 44.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.143 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.15 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -121.37 -54.35 1.99 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.34 74.11 1.38 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -69.52 158.04 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 31' ' ' MET . 3.5 m -145.32 131.48 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.42 -1.425 . . . . 0.0 111.557 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.9 129.25 45.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 13' ' ' TYR . 36.4 m -63.44 154.29 32.64 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.591 1.186 . . . . 0.0 110.546 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 77.2 mt -114.28 -17.22 11.88 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.147 -1.427 . . . . 10.54 107.147 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.661 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.55 145.09 18.57 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.24 -0.913 . . . . 18.39 110.694 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.06 81.53 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 121.372 1.381 . . . . 0.0 109.058 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.29 13.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.015 -1.053 . . . . 0.0 110.896 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.19 8.04 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.857 0.837 . . . . 0.0 109.389 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.97 10.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 18' ' ' VAL . 29.7 m -130.34 94.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-O 122.911 1.339 . . . . 0.0 109.232 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -144.44 -152.05 0.4 Allowed 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 114.377 -1.283 . . . . 38.32 107.618 178.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 19' ' ' THR . 97.2 mt-10 -82.47 -54.27 5.32 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.902 -1.518 . . . . 55.13 106.902 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -109.26 29.23 7.72 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.427 -0.795 . . . . 0.0 110.778 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.569 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.32 150.92 22.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.81 -1.181 . . . . 0.0 109.766 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.51 111.45 22.48 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.401 -0.812 . . . . 11.68 110.695 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.44 127.67 41.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.26 21.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.35 -1.469 . . . . 12.44 110.881 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.605 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.28 155.77 22.27 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 146.95 17.92 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 121.262 -0.899 . . . . 29.03 109.542 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.08 6.65 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.316 -1.514 . . . . 6.18 109.316 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.25 114.78 22.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.522 -0.987 . . . . 9.52 109.54 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.05 108.62 6.04 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.43 133.65 49.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 123.172 1.463 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.74 102.99 15.75 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.459 -178.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.96 92.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.51 -0.744 . . . . 0.0 111.597 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.482 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.78 -50.29 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.993 -1.067 . . . . 0.0 110.248 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.486 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.29 157.6 43.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.055 -1.028 . . . . 0.0 110.779 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.555 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.06 65.58 65.33 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.8 165.41 31.53 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.697 1.598 . . . . 0.0 108.901 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.09 -46.41 7.79 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.62 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.369 0.604 . . . . 0.0 110.069 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.53 0.0 OUTLIER Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.296 -2.185 0 C-N-CA 122.707 2.271 . . . . 0.0 109.874 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.7 pt-20 131.84 9.19 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.898 0 C-N-CA 123.894 0.878 . . . . 0.0 108.754 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.561 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.3 m0 -71.8 165.81 23.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.635 -1.291 . . . . 14.29 110.532 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 19.3 m0 -129.5 144.99 51.5 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.38 -0.6 . . . . 11.8 109.38 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.95 96.73 5.81 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.8 56.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.913 0.863 . . . . 0.0 110.381 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.56 150.44 26.91 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.768 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.46 128.55 43.49 Favored 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 117.282 -1.767 . . . . 0.0 107.203 177.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.41 1.01 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.701 -1.875 . . . . 0.0 107.934 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.47 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.8 -4.4 4.33 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.654 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.46 33.78 6.99 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-N 115.33 -0.85 . . . . 14.41 112.27 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.768 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.79 164.09 29.77 Favored 'General case' 0 N--CA 1.515 2.805 0 CA-C-N 119.783 1.792 . . . . 0.0 111.867 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.0 154.55 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.374 1.083 . . . . 0.0 112.504 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.18 156.66 12.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.267 -1.533 . . . . 7.25 109.267 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.28 150.83 43.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -1.201 . . . . 0.0 108.712 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.99 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.959 -1.088 . . . . 0.0 109.254 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 N-CA-C 108.997 -1.194 . . . . 4.76 108.997 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.501 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 23.8 pttm -60.31 3.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.544 -0.722 . . . . 0.0 110.742 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.657 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 1.0 OUTLIER -102.04 -7.57 22.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.177 -0.952 . . . . 14.84 109.342 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.01 8.27 30.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.255 -0.903 . . . . 10.23 109.487 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -147.59 156.52 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 6.97 109.582 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 63' ' ' VAL . 10.0 p -106.71 160.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 62' ' ' VAL . 11.8 p -107.66 134.26 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.07 -63.23 1.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -70.09 151.67 45.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.922 -1.112 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -146.61 152.74 39.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.196 -0.94 . . . . 0.0 109.385 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.3 1.47 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.27 1.313 . . . . 0.0 109.688 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.24 82.64 1.78 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.06 32.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.2 28.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -1.126 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.21 46.76 0.2 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.17 130.8 5.4 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.21 163.65 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.949 1.766 . . . . 0.0 108.924 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.485 HG23 ' C ' ' B' ' 84' ' ' ARG . 49.0 mt -135.41 119.89 26.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 122.032 0.92 . . . . 0.0 109.425 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.834 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.829 0.823 . . . . 0.0 110.019 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.89 -0.11 4.89 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.834 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.57 8.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -1.094 . . . . 0.0 109.356 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.17 4.77 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . 0.456 HH21 ' HE2' ' A' ' 58' ' ' LYS . 84.3 mtt85 53.62 41.28 32.12 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.485 ' C ' HG23 ' B' ' 78' ' ' ILE . 8.7 mmm180 -115.88 143.48 30.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.646 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.5 Cg_exo -56.51 113.47 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.425 1.417 . . . . 0.0 110.515 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.645 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -71.01 158.47 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.42 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.49 61.4 0.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.887 -1.133 . . . . 0.0 110.688 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.95 -101.88 0.15 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.676 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.65 120.64 42.23 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.645 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.89 158.7 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.755 0.788 . . . . 0.0 111.182 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.53 116.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.634 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.12 18.26 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.057 -1.027 . . . . 0.0 109.552 -179.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.63 42.49 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.634 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.06 17.24 4.32 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.33 75.77 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.35 -154.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.756 0.788 . . . . 0.0 109.658 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.28 143.5 46.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.7 m95 -141.61 140.18 33.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.51 -1.369 . . . . 0.0 110.596 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.446 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.65 132.01 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.466 HG22 HG23 ' B' ' 91' ' ' VAL . 7.8 t -53.24 -14.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.854 -1.153 . . . . 0.0 108.285 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.446 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.97 15.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.743 -0.598 . . . . 0.0 110.594 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.18 -6.47 31.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.903 -1.123 . . . . 0.0 110.769 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.24 106.28 12.14 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.828 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.4 m -133.52 175.31 11.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 122.369 1.08 . . . . 0.0 111.175 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.86 148.71 46.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.343 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.49 1.79 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.71 -31.67 0.72 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.392 -0.818 . . . . 0.0 110.079 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.2 -15.15 4.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.339 -0.851 . . . . 0.0 110.15 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.69 47.46 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.55 109.66 59.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.828 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.07 138.28 39.63 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.673 1.582 . . . . 0.0 112.168 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.327 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.72 56.9 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.212 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.15 -55.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.242 -0.911 . . . . 0.0 108.988 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.94 2.75 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.943 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.88 4.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.54 -0.976 . . . . 0.0 109.963 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.55 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.227 -0.921 . . . . 0.0 109.622 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.59 137.67 47.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.94 148.3 28.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 111.261 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.33 11.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.74 . . . . 0.0 110.318 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.17 22.78 1.39 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.634 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.61 30.8 20.44 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.766 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.21 142.76 31.51 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.56 -0.965 . . . . 0.0 108.851 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.92 35.99 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -153.95 140.23 18.57 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.7 m -57.59 177.43 0.1 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.346 -1.342 . . . . 0.0 108.397 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.52 -36.11 82.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.376 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.9 m -86.57 -43.68 12.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.55 -0.719 . . . . 0.0 111.412 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.78 -43.74 83.18 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.748 -1.22 . . . . 0.0 108.078 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.73 -56.52 13.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.42 -44.85 89.94 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.101 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.57 -34.31 61.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.76 -35.18 44.95 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.366 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.59 -81.71 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.52 31.29 16.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.56 51.28 15.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.714 1 CA-C-O 70.897 -23.43 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.83 0.12 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.93 35.24 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -1.16 . . . . 0.0 109.581 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.07 148.69 43.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.106 -0.996 . . . . 0.0 109.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.13 93.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.268 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.16 -54.32 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.449 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.9 m-70 -145.26 73.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.53 ' N ' ' OG ' ' A' ' 65' ' ' SER . 19.6 t -69.47 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.8 m -145.3 131.44 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.458 -1.401 . . . . 0.0 111.52 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.83 129.28 45.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 13' ' ' TYR . 33.2 m -63.38 154.32 32.36 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.585 1.183 . . . . 0.0 110.532 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.0 mt -114.32 -17.36 11.83 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.125 -1.435 . . . . 10.54 107.125 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.671 ' H ' HG22 ' A' ' 11' ' ' THR . 14.5 m-85 -149.45 145.03 18.52 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.052 -1.03 . . . . 18.39 110.748 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.95 81.38 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.414 1.409 . . . . 0.0 109.031 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.73 170.26 13.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.916 -1.115 . . . . 0.0 110.956 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.12 7.97 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.876 0.846 . . . . 0.0 109.327 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.17 111.91 10.68 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 18' ' ' VAL . 34.0 m -130.38 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 122.983 1.373 . . . . 0.0 109.161 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.635 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.51 -152.01 0.4 Allowed 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.309 -1.314 . . . . 38.32 107.61 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.635 ' H ' HG22 ' A' ' 19' ' ' THR . 97.6 mt-10 -82.36 -54.36 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.967 -1.494 . . . . 55.13 106.967 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.22 29.24 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.424 -0.798 . . . . 0.0 110.769 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.47 150.88 22.19 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.915 -1.116 . . . . 0.0 109.83 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -111.34 111.35 22.33 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.317 -0.864 . . . . 11.68 110.765 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.5 127.64 41.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.96 142.16 21.47 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.36 -1.462 . . . . 12.44 110.861 -178.447 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.16 155.83 22.38 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.99 18.2 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.462 -0.895 . . . . 29.03 109.51 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.52 44.25 6.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.262 -1.535 . . . . 6.18 109.262 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.67 22.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.53 -0.982 . . . . 9.52 109.437 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.92 108.6 5.93 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.55 133.8 49.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.202 1.477 . . . . 0.0 110.561 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.83 103.04 15.8 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.384 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.556 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.588 -0.695 . . . . 0.0 111.543 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.012 -1.055 . . . . 0.0 110.224 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.2 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 110.748 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.556 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.1 65.62 65.19 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.36 31.59 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.693 1.596 . . . . 0.0 108.94 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.08 -46.49 7.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.7 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.366 0.603 . . . . 0.0 110.005 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.55 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.615 2.21 . . . . 0.0 109.965 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 27.4 tt0 131.69 9.1 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.78 0.832 . . . . 0.0 108.795 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.568 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.9 m0 -71.75 165.88 23.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.586 -1.321 . . . . 14.29 110.537 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.536 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.3 m0 -129.58 145.1 51.51 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.321 -0.622 . . . . 11.8 109.321 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -78.99 96.59 5.8 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -115.97 128.77 56.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.011 0.91 . . . . 0.0 110.361 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.59 150.33 26.94 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.789 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.32 128.55 43.34 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 117.299 -1.76 . . . . 0.0 107.266 177.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.43 -18.41 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 119.656 -1.902 . . . . 0.0 107.912 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.69 -4.58 4.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.658 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.49 33.89 6.92 Favored Glycine 0 N--CA 1.481 1.683 0 CA-C-N 115.291 -0.868 . . . . 14.41 112.29 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.789 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.92 164.11 29.81 Favored 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.625 1.713 . . . . 0.0 111.883 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.54 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-O 122.315 1.055 . . . . 0.0 112.484 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.69 12.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 7.25 109.258 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.89 43.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.24 -1.153 . . . . 0.0 108.631 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.73 9.0 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.902 -1.124 . . . . 0.0 109.228 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.1 Cg_exo -51.16 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.217 -0.543 0 N-CA-C 109.061 -1.169 . . . . 4.76 109.061 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 31.3 pttt -60.25 3.01 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.453 -0.779 . . . . 0.0 110.758 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 94.4 m-20 -102.03 -7.62 22.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 14.84 109.27 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.31 30.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.873 . . . . 10.23 109.476 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.47 156.69 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 6.97 109.499 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 63' ' ' VAL . 13.8 p -106.88 160.69 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' N ' HG22 ' A' ' 62' ' ' VAL . 41.7 t -107.61 134.23 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.13 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.613 -0.68 . . . . 0.0 109.239 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 16.4 p -69.99 151.64 45.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 109.462 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -146.65 152.59 39.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.035 . . . . 0.0 109.427 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.36 1.48 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.27 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.464 1.442 . . . . 0.0 109.654 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.74 124.92 32.08 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.73 156.31 28.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.384 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.82 167.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.92 0.2 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.633 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.24 130.74 5.35 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.405 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.24 163.62 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.957 1.772 . . . . 0.0 108.873 178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.483 ' H ' HE21 ' B' ' 97' ' ' GLN . 25.4 mt -135.46 119.76 26.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 122.12 0.962 . . . . 0.0 109.455 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.826 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.32 117.01 3.98 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.869 0.843 . . . . 0.0 109.897 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.1 4.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.826 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.8 -48.48 8.18 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.245 -1.15 . . . . 0.0 109.368 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.13 4.87 13.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . 0.469 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 95.7 mtt-85 53.45 41.49 32.1 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -116.07 143.42 30.9 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.633 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.29 113.39 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.524 1.483 . . . . 0.0 110.592 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.675 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -71.01 158.4 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.429 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.5 61.45 0.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.849 -1.157 . . . . 0.0 110.663 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -102.01 0.15 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.659 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.58 120.7 42.47 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.675 HG22 HG21 ' B' ' 86' ' ' ILE . 43.2 t -98.98 158.74 3.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.507 -0.746 . . . . 0.0 111.151 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.63 115.94 47.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.64 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.72 106.09 18.23 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.57 42.58 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.12 17.12 4.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.09 25.37 75.7 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.77 0.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.857 0.837 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.483 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.45 143.5 45.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.5 140.05 33.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.655 -1.278 . . . . 0.0 110.598 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.45 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.53 131.93 50.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.22 -14.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 120.725 -1.234 . . . . 0.0 108.347 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.82 -27.03 15.42 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.886 -0.509 . . . . 0.0 110.595 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.17 -6.48 31.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.948 -1.095 . . . . 0.0 110.856 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.22 106.31 12.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.829 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.6 175.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.318 1.056 . . . . 0.0 111.065 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.92 148.76 46.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.264 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.89 28.74 1.74 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.428 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.81 -31.68 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.388 -0.82 . . . . 0.0 110.118 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.01 -15.52 4.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.57 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.378 -0.826 . . . . 0.0 110.238 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.5 59.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.829 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.13 138.24 39.32 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.676 1.584 . . . . 0.0 112.111 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.72 56.96 1.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.221 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.17 1.72 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 108.881 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.2 30.99 2.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.944 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.0 OUTLIER -116.29 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.352 -1.087 . . . . 0.0 109.935 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.478 -0.764 . . . . 0.0 109.334 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.39 9.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.84 47.34 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.19 148.31 29.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.22 11.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.604 0.716 . . . . 0.0 110.331 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.42 22.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.638 -0.664 . . . . 0.0 109.413 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.48 Favored Glycine 0 N--CA 1.483 1.815 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.689 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.7 mt -143.33 142.76 31.41 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.646 -0.914 . . . . 0.0 108.865 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.88 36.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.666 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.552 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.92 140.32 18.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.3 m -57.64 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.282 -1.367 . . . . 0.0 108.448 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.97 82.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.78 -43.68 12.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.453 -0.78 . . . . 0.0 111.315 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.71 83.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.67 -1.269 . . . . 0.0 108.133 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.1 t80 -51.8 -56.5 13.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.423 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.0 m-80 -64.58 -44.75 89.69 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.135 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.32 61.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.552 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.29 44.74 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.51 -81.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.026 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.47 31.48 16.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.42 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.7 m-20 48.35 51.31 15.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -1.063 . . . . 0.0 109.563 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.763 1 CA-C-O 70.976 -23.392 . . . . 0.0 109.443 179.971 . . . . . . . . 2 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.332 0.586 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.85 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -161.99 35.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -1.19 . . . . 0.0 109.494 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.07 148.63 43.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.156 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.4 t -66.02 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 0.0 109.282 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.23 -54.36 2.0 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -145.23 73.86 1.38 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.9 t -69.44 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.33 131.58 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.484 -1.385 . . . . 0.0 111.55 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -99.94 129.14 45.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 13' ' ' TYR . 48.9 m -63.37 154.41 32.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.52 1.153 . . . . 0.0 110.598 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 87.8 mt -114.3 -17.38 11.84 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.173 -1.417 . . . . 10.54 107.173 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.651 ' H ' HG22 ' A' ' 11' ' ' THR . 14.5 m-85 -149.43 145.15 18.73 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.177 -0.952 . . . . 18.39 110.706 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.02 81.42 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 121.414 1.41 . . . . 0.0 109.054 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.32 13.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.94 -1.1 . . . . 0.0 110.865 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.449 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.6 111.01 7.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.771 0.796 . . . . 0.0 109.462 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.25 112.07 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.36 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 122.866 1.317 . . . . 0.0 109.071 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.64 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.6 -151.97 0.4 Allowed 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.357 -1.292 . . . . 38.32 107.518 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.64 ' H ' HG22 ' A' ' 19' ' ' THR . 95.9 mt-10 -82.47 -54.33 5.28 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.783 -1.562 . . . . 55.13 106.783 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 71.6 mm-40 -109.35 29.25 7.72 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.366 -0.834 . . . . 0.0 110.701 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.57 150.82 22.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.841 -1.162 . . . . 0.0 109.797 -179.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.32 111.36 22.36 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.295 -0.878 . . . . 11.68 110.804 -178.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.64 41.56 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.91 142.22 21.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.39 -1.443 . . . . 12.44 110.87 -178.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.607 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.82 22.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 146.95 18.5 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.221 -0.925 . . . . 29.03 109.497 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 43.99 6.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.277 -1.529 . . . . 6.18 109.277 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.79 22.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.56 -0.964 . . . . 9.52 109.419 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.06 108.73 6.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.68 49.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 123.179 1.466 . . . . 0.0 110.486 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.75 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.427 -178.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 111.51 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.7 mt -59.73 -50.51 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.994 -1.066 . . . . 0.0 110.194 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.22 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.061 -1.025 . . . . 0.0 110.803 -177.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.02 65.54 65.5 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.83 165.42 31.48 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 109.0 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.13 -46.4 7.78 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.74 -59.53 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.436 0.636 . . . . 0.0 110.018 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.61 2.206 . . . . 0.0 109.922 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 62.2 mt-10 131.74 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 123.845 0.858 . . . . 0.0 108.738 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.545 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.1 m0 -71.74 165.83 23.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.526 -1.359 . . . . 14.29 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.482 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.8 m0 -129.6 145.11 51.52 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.38 -0.6 . . . . 11.8 109.38 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -79.08 96.74 5.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.4 p -115.93 128.76 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.855 0.836 . . . . 0.0 110.36 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.68 150.35 26.82 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.787 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.37 128.49 43.35 Favored 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.172 -1.811 . . . . 0.0 107.212 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.28 -18.45 0.96 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 119.687 -1.883 . . . . 0.0 107.998 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.465 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.61 -4.57 4.29 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.638 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.206 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.787 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.03 29.97 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.773 1.787 . . . . 0.0 111.815 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.303 1.049 . . . . 0.0 112.544 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.21 156.77 12.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.28 -1.528 . . . . 7.25 109.28 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.45 150.88 42.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -1.147 . . . . 0.0 108.657 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.72 9.01 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.029 -1.045 . . . . 0.0 109.27 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.572 ' HB3' HD21 ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.26 113.49 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.068 -1.166 . . . . 4.76 109.068 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.443 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.33 3.21 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 110.78 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.572 HD21 ' HB3' ' A' ' 57' ' ' PRO . 1.1 p30 -102.03 -7.57 22.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 14.84 109.335 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.04 8.21 30.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 10.23 109.536 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.0 m -147.44 156.57 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.942 . . . . 6.97 109.541 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -106.87 160.75 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' B' ' 82' ' ' CYS . 10.5 p -107.61 134.26 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.401 -0.812 . . . . 0.0 109.754 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.05 -63.31 1.24 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.682 . . . . 0.0 109.227 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.447 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 58.3 m -69.95 151.68 45.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.975 -1.078 . . . . 0.0 109.454 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 48.7 p30 -146.58 152.73 39.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 109.356 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.11 -67.28 1.48 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.317 1.344 . . . . 0.0 109.606 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.05 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.72 125.0 32.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.23 28.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.562 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.82 167.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.29 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.23 130.75 5.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 109.366 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.6 Cg_endo -74.16 163.61 36.19 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.946 1.764 . . . . 0.0 108.914 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.512 HG23 ' C ' ' B' ' 84' ' ' ARG . 56.7 mt -135.43 119.74 26.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.081 0.943 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.3 117.05 4.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.22 4.88 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.74 -48.51 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -1.099 . . . . 0.0 109.305 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' CYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 1.6 p -116.12 4.84 13.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 53.54 41.32 32.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.512 ' C ' HG23 ' B' ' 78' ' ' ILE . 43.3 mtp180 -115.86 143.46 30.81 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.64 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.8 Cg_exo -56.32 113.33 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.494 1.463 . . . . 0.0 110.623 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.669 HG21 HG22 ' B' ' 90' ' ' VAL . 21.4 mt -70.95 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.57 61.34 0.32 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.831 -1.168 . . . . 0.0 110.646 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.97 -101.97 0.15 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.656 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.73 42.57 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.669 HG22 HG21 ' B' ' 86' ' ' ILE . 42.5 t -98.81 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.641 0.734 . . . . 0.0 111.298 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.52 115.91 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' ASN . . . . . 0.628 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.81 106.17 18.29 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.062 -1.023 . . . . 0.0 109.481 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.6 159.54 42.63 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.07 17.25 4.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.18 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.724 0.773 . . . . 0.0 109.821 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' GLN . . . . . 0.484 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.43 143.42 45.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.0 m95 -141.44 140.0 33.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.561 -1.337 . . . . 0.0 110.682 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.4 m80 -56.56 131.94 50.18 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 91' ' ' VAL . 7.6 t -53.2 -14.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.701 -1.25 . . . . 0.0 108.32 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.85 15.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.754 -0.591 . . . . 0.0 110.613 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.22 -6.53 31.04 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.26 106.31 12.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.63 175.25 11.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.287 1.041 . . . . 0.0 111.138 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.79 148.69 46.15 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.234 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.79 28.54 1.76 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.73 -31.62 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.432 -0.793 . . . . 0.0 110.149 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.08 -15.38 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 110.156 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.55 0.35 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.28 109.48 58.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.02 138.36 39.97 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.66 1.574 . . . . 0.0 112.077 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.82 56.91 1.78 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.133 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.21 -55.24 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.2 -0.937 . . . . 0.0 108.897 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.12 2.73 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' HIS . . . . . 0.956 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.27 178.88 4.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.483 -1.01 . . . . 0.0 109.987 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.5 145.43 24.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.38 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.563 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.35 169.48 9.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.528 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.6 137.7 47.15 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.96 148.28 28.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.232 -0.918 . . . . 0.0 111.234 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.05 129.34 11.26 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.604 0.716 . . . . 0.0 110.381 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.3 22.78 1.48 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.671 -0.643 . . . . 0.0 109.438 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.9 20.49 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.764 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.4 mt -143.27 142.89 31.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.529 -0.983 . . . . 0.0 108.725 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.84 36.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.685 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.547 ' CE1' HD22 ' B' ' 133' ' ' LEU . 58.5 m-85 -153.89 140.31 18.71 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.65 177.55 0.1 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.26 -1.376 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.67 -36.05 82.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.374 -0.828 . . . . 0.0 109.285 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.7 m -86.61 -43.78 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 0.0 111.333 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.79 83.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.721 -1.237 . . . . 0.0 108.095 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.71 -56.47 13.58 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.211 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.48 -34.29 61.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.547 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.75 -35.23 44.96 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.335 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.33 31.42 16.64 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.53 51.17 15.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -1.109 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.725 1 CA-C-O 70.924 -23.417 . . . . 0.0 109.436 179.924 . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.326 0.584 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.7 p -162.06 35.34 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -1.169 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.06 148.64 43.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.148 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.3 t -66.08 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.117 -0.99 . . . . 0.0 109.246 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.2 -54.26 2.01 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 9' ' ' VAL . 79.2 t -69.43 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 9' ' ' VAL . 3.2 m -145.23 131.51 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.426 -1.421 . . . . 0.0 111.665 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -99.98 129.26 46.02 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.646 HG22 ' H ' ' A' ' 13' ' ' TYR . 52.4 m -63.37 154.28 32.45 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.518 1.152 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 95.9 mt -114.23 -17.35 11.88 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.236 -1.394 . . . . 10.54 107.236 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.646 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.503 2.218 0 C-N-CA 119.463 -0.895 . . . . 18.39 110.699 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.5 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 121.436 1.424 . . . . 0.0 108.983 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.82 170.3 13.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.926 -1.109 . . . . 0.0 110.959 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.12 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.826 0.822 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.93 10.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 18' ' ' VAL . 23.3 m -130.32 94.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.917 1.342 . . . . 0.0 109.187 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.905 HG22 ' H ' ' A' ' 20' ' ' GLU . 4.0 m -144.51 -151.98 0.4 Allowed 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.596 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.905 ' H ' HG22 ' A' ' 19' ' ' THR . 49.8 tp10 -82.42 -54.28 5.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.906 -1.516 . . . . 55.13 106.906 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.443 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.6 mt-10 -109.36 29.12 7.85 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.342 -0.849 . . . . 0.0 110.739 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.41 151.02 22.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.827 -1.171 . . . . 0.0 109.783 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.44 111.38 22.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.38 -0.825 . . . . 11.68 110.773 -178.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.5 127.7 41.75 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' HD2' ' HG1' ' A' ' 11' ' ' THR . 0.8 OUTLIER -152.93 142.12 21.46 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.377 -1.452 . . . . 12.44 110.935 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.81 22.51 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 146.92 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.422 -0.911 . . . . 29.03 109.577 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 11' ' ' THR . . . 84.64 44.05 6.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.315 -1.514 . . . . 6.18 109.315 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.73 22.79 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.509 -0.995 . . . . 9.52 109.396 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.85 108.55 5.86 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.406 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.5 133.77 49.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 123.185 1.469 . . . . 0.0 110.523 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.89 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 113.776 -1.556 . . . . 0.0 107.401 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.558 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.92 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.576 -0.703 . . . . 0.0 111.491 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.7 mt -59.82 -50.33 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.921 -1.112 . . . . 0.0 110.246 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.34 157.65 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.941 -1.099 . . . . 0.0 110.774 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.558 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.16 65.63 64.83 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.766 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.72 165.32 31.79 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.702 1.601 . . . . 0.0 109.07 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.02 -46.5 7.77 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.4 m-20 57.69 -59.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.457 0.646 . . . . 0.0 110.008 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 178.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.74 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.142 0 C-N-CA 122.625 2.217 . . . . 0.0 109.929 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 35.8 mm-40 131.83 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.78 0.832 . . . . 0.0 108.765 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.556 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.3 m0 -71.86 165.84 23.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.64 -1.287 . . . . 14.29 110.464 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.0 m0 -129.54 145.18 51.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.198 -0.667 . . . . 11.8 109.198 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.15 96.79 5.96 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -116.01 128.82 56.03 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.959 0.885 . . . . 0.0 110.361 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.67 150.4 26.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.792 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.62 43.48 Favored 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 117.324 -1.751 . . . . 0.0 107.229 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.51 -18.32 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 119.706 -1.871 . . . . 0.0 107.946 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.459 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.66 -4.64 4.41 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.654 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.687 0 CA-C-N 115.499 -0.773 . . . . 14.41 112.239 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.792 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.93 164.01 30.08 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 119.609 1.704 . . . . 0.0 111.727 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.65 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.76 12.72 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.263 -1.535 . . . . 7.25 109.263 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.39 150.85 43.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.338 -1.095 . . . . 0.0 108.643 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.01 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.782 -1.199 . . . . 0.0 109.316 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.15 113.63 1.19 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 108.912 -1.226 . . . . 4.76 108.912 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.3 pttt -60.52 3.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.671 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.48 ' H ' ' C ' ' A' ' 57' ' ' PRO . 99.5 m-20 -102.05 -7.65 22.13 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.285 -0.884 . . . . 14.84 109.357 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.02 8.31 30.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 10.23 109.454 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.4 m -147.48 156.51 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.094 -1.004 . . . . 6.97 109.487 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.76 160.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' HG22 ' A' ' 62' ' ' VAL . 11.5 p -107.59 134.29 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.43 -0.794 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.12 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.613 -0.679 . . . . 0.0 109.313 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 41.6 m -69.92 151.53 45.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.546 ' OD2' ' NH1' ' B' ' 84' ' ' ARG . 53.4 p-10 -146.63 152.73 39.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.271 -0.893 . . . . 0.0 109.348 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.35 1.48 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.356 1.371 . . . . 0.0 109.688 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.11 82.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.8 124.94 32.14 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 109.301 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.39 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.16 29.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -1.107 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.81 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.85 0.2 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.26 130.85 5.39 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.297 -1.119 . . . . 0.0 109.345 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.29 163.53 36.2 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.031 1.821 . . . . 0.0 108.832 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.507 HG23 ' C ' ' B' ' 84' ' ' ARG . 76.2 mt -135.34 119.85 27.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 122.008 0.909 . . . . 0.0 109.365 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.84 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.809 0.814 . . . . 0.0 109.914 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.82 -0.16 4.86 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.84 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.7 -48.53 8.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.295 -1.121 . . . . 0.0 109.301 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.16 4.78 13.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . 0.456 HH22 ' HE3' ' A' ' 58' ' ' LYS . 83.8 mtt85 53.53 41.25 32.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.546 ' NH1' ' OD2' ' A' ' 66' ' ' ASP . 17.3 mtp180 -115.79 143.39 30.64 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.631 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.37 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.366 1.377 . . . . 0.0 110.615 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.665 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.91 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.702 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.422 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.59 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.877 -1.14 . . . . 0.0 110.55 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.12 -101.8 0.15 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.76 120.63 42.17 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.665 HG22 HG21 ' B' ' 86' ' ' ILE . 42.6 t -98.83 158.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.648 0.737 . . . . 0.0 111.125 -177.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.57 115.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.646 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.73 106.03 18.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 109.624 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.52 42.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.618 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.99 17.34 4.31 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.12 76.09 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.16 -154.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.787 0.803 . . . . 0.0 109.779 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.479 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.48 143.46 45.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.6 139.99 33.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.544 -1.347 . . . . 0.0 110.576 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.46 131.98 50.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.7 t -53.17 -14.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 108.365 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.97 15.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.823 -0.548 . . . . 0.0 110.594 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.05 -6.62 31.45 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.878 -1.139 . . . . 0.0 110.798 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.472 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.1 t80 -80.08 106.3 12.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.8 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.161 0.982 . . . . 0.0 111.192 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.8 148.58 46.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.314 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.78 28.67 1.73 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.77 -31.75 0.71 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.293 -0.879 . . . . 0.0 110.113 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.44 4.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.222 -0.924 . . . . 0.0 110.226 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.65 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.363 -0.836 . . . . 0.0 110.237 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.52 59.18 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -68.99 138.27 39.83 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.825 1.683 . . . . 0.0 112.059 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.8 57.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.132 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.632 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.19 1.69 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 108.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.25 30.98 2.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.954 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.86 4.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.504 -0.998 . . . . 0.0 109.993 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -94.35 145.3 24.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.33 169.45 9.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.78 47.28 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.26 28.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.85 . . . . 0.0 111.188 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.635 0.731 . . . . 0.0 110.334 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.5 mttm 51.39 22.8 1.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.62 -0.675 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.618 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.94 20.4 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.7 mt -143.26 142.81 31.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.46 -1.023 . . . . 0.0 108.848 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.8 36.31 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 110.702 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.555 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.3 m-85 -153.96 140.28 18.61 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.53 177.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.439 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.76 -35.92 82.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -0.814 . . . . 0.0 109.353 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.456 ' O ' ' N ' ' B' ' 132' ' ' GLN . 54.9 m -86.75 -43.52 12.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.543 -0.723 . . . . 0.0 111.384 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.72 -43.82 83.24 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.738 -1.226 . . . . 0.0 108.126 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.65 -56.48 13.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.421 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.6 -44.8 89.46 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.05 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.53 -34.37 61.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.65 -35.26 45.61 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.427 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.36 31.51 16.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.34 51.42 15.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -1.124 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 1 C--O 0.476 -39.651 1 CA-C-O 70.943 -23.408 . . . . 0.0 109.45 -179.965 . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.98 0.12 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -1.217 . . . . 0.0 109.566 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.09 148.67 43.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.4 t -66.07 93.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.19 -54.42 2.0 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.39 74.09 1.38 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.65 158.05 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.39 131.51 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.21 -1.396 . . . . 0.0 111.511 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.01 129.28 46.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 13' ' ' TYR . 30.0 m -63.39 154.37 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.456 1.122 . . . . 0.0 110.636 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.9 mt -114.38 -17.24 11.83 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.205 -1.406 . . . . 10.54 107.205 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.666 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.51 144.98 18.41 Favored Pre-proline 0 N--CA 1.502 2.154 0 C-N-CA 119.474 -0.891 . . . . 18.39 110.793 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.01 81.39 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 121.524 1.482 . . . . 0.0 109.019 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.8 170.28 13.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.021 -1.05 . . . . 0.0 110.984 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.15 8.07 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.453 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.01 10.68 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 18' ' ' VAL . 9.4 m -130.35 94.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 122.869 1.319 . . . . 0.0 109.177 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -144.54 -151.98 0.4 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.35 -1.296 . . . . 38.32 107.549 177.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 19' ' ' THR . 96.7 mt-10 -82.48 -54.32 5.29 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.849 -1.537 . . . . 55.13 106.849 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -109.35 29.15 7.81 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.402 -0.812 . . . . 0.0 110.762 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.4 150.84 22.21 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.839 -1.163 . . . . 0.0 109.7 -179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.37 22.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.385 -0.822 . . . . 11.68 110.764 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.46 127.7 41.72 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.88 142.17 21.54 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.374 -1.454 . . . . 12.44 110.947 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.09 155.77 22.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.38 146.84 18.58 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.267 -0.895 . . . . 29.03 109.602 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.71 44.07 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.275 -1.53 . . . . 6.18 109.275 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.33 114.75 22.85 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.513 -0.992 . . . . 9.52 109.454 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.04 108.59 6.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.401 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.43 133.69 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.153 1.454 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.82 103.12 15.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.39 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.516 -0.74 . . . . 0.0 111.392 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.3 mt -59.79 -50.46 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.971 -1.08 . . . . 0.0 110.121 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.53 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.17 157.58 43.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.983 -1.073 . . . . 0.0 110.814 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -134.97 65.54 65.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.39 31.64 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.635 1.556 . . . . 0.0 108.966 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.97 -46.56 7.75 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.52 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.268 0.556 . . . . 0.0 110.09 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.36 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 122.709 2.273 . . . . 0.0 109.914 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.75 9.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.816 0 C-N-CA 123.849 0.86 . . . . 0.0 108.849 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.7 m0 -71.89 165.82 23.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.593 -1.317 . . . . 14.29 110.481 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.494 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.9 m0 -129.53 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.356 -0.609 . . . . 11.8 109.356 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -79.01 96.62 5.82 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.504 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.65 55.92 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.379 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.47 150.35 27.08 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.77 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.35 128.49 43.32 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.322 -1.751 . . . . 0.0 107.295 177.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.41 0.98 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 119.643 -1.911 . . . . 0.0 108.03 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.477 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.68 -4.57 4.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.658 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.48 33.9 6.92 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.287 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.77 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.94 164.04 30.01 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 119.654 1.727 . . . . 0.0 111.77 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.64 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.274 1.035 . . . . 0.0 112.583 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.16 156.73 12.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.291 -1.524 . . . . 7.25 109.291 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.38 150.86 43.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.226 -1.161 . . . . 0.0 108.561 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.76 9.04 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.102 . . . . 0.0 109.297 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.28 113.53 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 N-CA-C 108.938 -1.216 . . . . 4.76 108.938 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.6 pttt -60.38 3.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 0.0 110.757 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.7 m-20 -102.03 -7.54 22.24 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.285 -0.885 . . . . 14.84 109.325 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.13 8.22 31.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 10.23 109.506 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.44 156.62 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.285 -0.885 . . . . 6.97 109.577 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.586 HG11 HD13 ' B' ' 78' ' ' ILE . 29.4 m -106.81 160.74 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.59 134.27 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.452 -0.78 . . . . 0.0 109.778 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.4 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 98.5 mt -105.13 -63.07 1.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.641 -0.662 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 70.4 m -70.05 151.66 45.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.036 -1.04 . . . . 0.0 109.409 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 65' ' ' SER . 87.8 m-20 -146.6 152.69 39.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 109.311 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.29 1.48 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.42 93.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.299 1.332 . . . . 0.0 109.629 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.61 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.9 124.95 32.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.41 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.76 156.22 28.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -1.112 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.83 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.22 130.81 5.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 109.378 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.29 163.42 36.44 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.052 1.835 . . . . 0.0 108.83 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.596 HG23 ' C ' ' B' ' 84' ' ' ARG . 41.7 mt -135.22 119.85 27.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.983 0.896 . . . . 0.0 109.389 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.42 116.96 3.97 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.11 4.78 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.69 -48.57 8.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -1.067 . . . . 0.0 109.337 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.72 13.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.132 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 53.54 41.3 32.12 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.596 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.3 mmm180 -115.82 143.5 30.86 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.55 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.44 1.427 . . . . 0.0 110.542 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.67 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.95 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.53 61.41 0.32 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.791 -1.193 . . . . 0.0 110.593 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.677 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.67 42.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.67 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.8 158.74 3.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.535 -0.728 . . . . 0.0 111.294 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.51 115.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.638 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.92 106.07 18.23 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 109.592 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.62 159.48 42.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.11 17.26 4.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.19 25.28 75.85 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.041 -2.024 . . . . 0.0 108.041 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.76 0.65 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.8 0.809 . . . . 0.0 109.732 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.483 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.35 143.52 46.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.58 139.91 33.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.488 -1.382 . . . . 0.0 110.648 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.54 131.99 50.26 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.457 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.21 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.846 -1.158 . . . . 0.0 108.377 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.89 -26.82 15.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.869 -0.519 . . . . 0.0 110.615 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.23 -6.5 31.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.816 -1.177 . . . . 0.0 110.781 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.26 106.25 12.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.818 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.2 m -133.59 175.27 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.329 1.061 . . . . 0.0 111.1 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.87 148.7 46.41 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.37 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.61 1.74 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.82 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.74 -31.78 0.71 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.01 -15.38 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.79 47.5 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.36 109.64 59.38 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.818 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.05 138.27 39.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.748 1.632 . . . . 0.0 112.147 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.039 0.0 OUTLIER -95.84 56.97 1.78 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.098 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.11 -55.25 1.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.266 -0.896 . . . . 0.0 108.975 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.12 30.91 2.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.906 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.93 4.14 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.474 -1.015 . . . . 0.0 109.977 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.41 145.33 24.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 109.412 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.411 -0.806 . . . . 0.0 109.511 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.696 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.61 47.17 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.98 148.36 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.218 -0.926 . . . . 0.0 111.18 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.556 0.693 . . . . 0.0 110.27 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.7 mttm 51.27 22.83 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.465 0.65 . . . . 0.0 109.526 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.46 30.92 20.54 Favored Glycine 0 N--CA 1.481 1.663 0 C-N-CA 119.396 -1.383 . . . . 0.0 109.785 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.6 mt -143.26 142.8 31.48 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.516 -0.991 . . . . 0.0 108.79 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.4 152.79 36.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 110.657 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.7 m-85 -153.81 140.27 18.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.2 m -57.57 177.5 0.1 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.366 -1.334 . . . . 0.0 108.486 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.63 -36.06 82.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.417 -0.802 . . . . 0.0 109.349 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.5 m -86.54 -43.8 12.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.745 . . . . 0.0 111.338 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.456 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.87 83.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.722 -1.236 . . . . 0.0 108.089 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.38 14.07 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.55 -44.92 89.23 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.043 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.45 61.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.53 -35.28 46.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.501 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -0.85 . . . . 0.0 110.114 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.43 31.36 16.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.0 m-20 48.59 51.26 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 70.968 -23.396 . . . . 0.0 109.468 179.977 . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.94 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.99 35.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -1.21 . . . . 0.0 109.583 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.02 148.68 43.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.48 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -66.08 93.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.255 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.25 -54.28 2.0 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.35 74.0 1.38 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.53 158.09 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.36 131.45 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.449 -1.407 . . . . 0.0 111.561 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.92 129.29 45.98 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 13' ' ' TYR . 34.0 m -63.48 154.4 32.44 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.517 1.151 . . . . 0.0 110.594 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.7 mt -114.35 -17.24 11.84 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.23 -1.396 . . . . 10.54 107.23 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.53 145.07 18.54 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.238 -0.914 . . . . 18.39 110.743 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.08 81.41 1.7 Allowed 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.356 1.371 . . . . 0.0 109.058 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.74 170.22 14.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.836 -1.165 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.59 111.11 8.03 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.725 0.774 . . . . 0.0 109.414 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -134.31 111.95 10.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 18' ' ' VAL . 16.1 m -130.27 94.29 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 122.839 1.304 . . . . 0.0 109.13 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.977 HG22 ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.49 -152.09 0.4 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.578 -1.267 . . . . 38.32 107.578 177.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.977 ' OE1' HG22 ' A' ' 19' ' ' THR . 58.0 mp0 -82.4 -54.31 5.32 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.857 -1.534 . . . . 55.13 106.857 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -109.28 29.16 7.79 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.383 -0.823 . . . . 0.0 110.746 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.52 150.88 22.21 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.823 -1.173 . . . . 0.0 109.678 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.42 111.38 22.37 Favored 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.416 -0.803 . . . . 11.68 110.756 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.67 41.58 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.9 142.16 21.52 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.42 -1.425 . . . . 12.44 110.918 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.12 155.82 22.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.93 18.27 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.268 -0.895 . . . . 29.03 109.595 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.1 6.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.345 -1.502 . . . . 6.18 109.345 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.3 114.83 22.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.589 -0.947 . . . . 9.52 109.415 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.99 108.59 5.98 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.41 133.7 49.74 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 123.154 1.454 . . . . 0.0 110.584 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.78 103.08 15.83 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.919 -1.492 . . . . 0.0 107.395 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.502 -0.749 . . . . 0.0 111.468 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.486 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.3 mt -59.74 -50.43 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.917 -1.115 . . . . 0.0 110.201 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.23 157.6 43.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.947 -1.095 . . . . 0.0 110.714 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.55 ' HB3' ' NE1' ' A' ' 44' ' ' TRP . 1.8 mptp? -135.08 65.58 65.24 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.77 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.75 165.32 31.76 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.61 1.54 . . . . 0.0 109.016 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.52 7.78 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.67 -59.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.324 0.583 . . . . 0.0 109.989 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.673 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.3 Cg_endo -68.6 -59.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.158 0 C-N-CA 122.714 2.276 . . . . 0.0 109.896 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.673 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.6 tp10 131.87 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.802 0.841 . . . . 0.0 108.771 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.536 ' HB2' HD12 ' A' ' 55' ' ' LEU . 16.8 m0 -71.93 165.94 23.16 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.674 -1.266 . . . . 14.29 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.3 m0 -129.56 145.05 51.51 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.32 -0.622 . . . . 11.8 109.32 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -79.02 96.62 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.93 128.7 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.921 0.867 . . . . 0.0 110.403 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.45 150.41 27.07 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.78 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.54 43.4 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 117.325 -1.75 . . . . 0.0 107.31 177.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 119.596 -1.94 . . . . 0.0 107.99 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.464 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.49 -4.6 4.17 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.661 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.41 33.81 6.99 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 115.307 -0.861 . . . . 14.41 112.329 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.78 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.1 29.81 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-N 119.603 1.701 . . . . 0.0 111.787 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.56 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.32 1.057 . . . . 0.0 112.468 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.79 12.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.252 -1.539 . . . . 7.25 109.252 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.43 150.88 42.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -1.194 . . . . 0.0 108.608 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.7 8.97 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.955 -1.091 . . . . 0.0 109.297 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.968 -1.205 . . . . 4.76 108.968 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.607 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 16.0 pttp -60.46 3.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 110.648 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.5 m-20 -102.13 -7.52 22.17 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.179 -0.95 . . . . 14.84 109.319 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.09 8.19 31.19 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.242 -0.911 . . . . 10.23 109.427 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 11' ' ' THR . 34.5 m -147.44 156.6 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.213 -0.929 . . . . 6.97 109.513 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.476 HG22 ' N ' ' A' ' 63' ' ' VAL . 12.6 p -106.81 160.72 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 62' ' ' VAL . 56.0 t -107.67 134.25 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.411 -0.805 . . . . 0.0 109.834 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.2 mt -105.09 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.626 -0.671 . . . . 0.0 109.237 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.48 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 38.8 m -70.0 151.69 45.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.952 -1.092 . . . . 0.0 109.403 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 54.4 p-10 -146.72 152.63 39.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 109.317 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.08 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.59 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.302 1.335 . . . . 0.0 109.681 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.96 82.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.77 125.02 32.2 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.22 28.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -1.128 . . . . 0.0 109.52 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.96 0.2 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.28 130.65 5.29 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.261 -1.14 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.7 Cg_endo -74.19 163.65 36.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.912 1.741 . . . . 0.0 108.922 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.532 HG23 ' C ' ' B' ' 84' ' ' ARG . 64.2 mt -135.39 119.83 26.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 122.087 0.946 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.827 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.5 117.06 4.09 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.016 0.912 . . . . 0.0 109.89 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.513 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.05 4.89 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.827 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.76 -48.5 8.18 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.295 -1.12 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.88 13.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.573 -0.704 . . . . 0.0 109.107 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 53.55 41.14 32.14 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.532 ' C ' HG23 ' B' ' 78' ' ' ILE . 6.8 mtp85 -115.79 143.41 30.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.646 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.39 113.25 1.37 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.485 1.457 . . . . 0.0 110.535 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.669 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.75 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.63 61.55 0.31 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.824 -1.173 . . . . 0.0 110.663 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.07 -101.93 0.15 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.63 120.58 42.05 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.669 HG22 HG21 ' B' ' 86' ' ' ILE . 42.4 t -98.71 158.64 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.472 -0.767 . . . . 0.0 111.211 -177.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.55 116.05 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.624 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.74 106.11 18.25 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 109.629 -179.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.61 159.54 42.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 58.02 17.28 4.31 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.25 75.92 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.25 -154.88 0.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.747 0.784 . . . . 0.0 109.748 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.484 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.31 143.51 46.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.513 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.528 -1.358 . . . . 0.0 110.594 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.473 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.0 m80 -56.59 131.92 50.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.07 -14.94 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 120.863 -1.148 . . . . 0.0 108.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.78 -26.89 15.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.828 -0.545 . . . . 0.0 110.71 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.06 -6.57 31.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.828 -1.17 . . . . 0.0 110.858 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.471 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.18 106.16 11.99 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.6 m -133.46 175.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.19 0.995 . . . . 0.0 111.203 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.74 45.86 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.303 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.9 28.69 1.75 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.111 -0.993 . . . . 0.0 109.667 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.421 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.83 -31.67 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.343 -0.848 . . . . 0.0 110.097 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.21 4.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.6 47.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.401 -0.812 . . . . 0.0 110.173 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 109.58 59.33 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.0 138.3 39.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.748 1.632 . . . . 0.0 112.13 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.312 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.83 56.94 1.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.159 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.32 1.62 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.34 -0.85 . . . . 0.0 109.01 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 31.07 2.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.946 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.32 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -1.048 . . . . 0.0 109.986 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.52 145.46 24.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.43 169.48 9.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.53 137.71 47.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.07 148.3 28.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.223 -0.923 . . . . 0.0 111.197 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.02 129.31 11.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.34 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.88 1.4 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.59 30.95 20.12 Favored Glycine 0 N--CA 1.483 1.775 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.713 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.36 142.74 31.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.535 -0.979 . . . . 0.0 108.82 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.47 152.73 36.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.4 m-85 -153.79 140.35 18.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.57 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.495 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.71 -35.92 82.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.4 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.72 -43.69 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.509 -0.744 . . . . 0.0 111.312 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.83 83.46 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.761 -1.212 . . . . 0.0 108.116 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.66 -56.44 13.65 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.7 m-80 -64.51 -44.93 89.36 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.004 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.6 tp60 -54.5 -34.28 61.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.77 -35.4 44.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.218 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 110.091 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.37 31.43 16.52 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.56 51.19 15.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.313 -1.11 . . . . 0.0 109.612 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.475 -39.667 1 CA-C-O 71.024 -23.37 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.76 0.13 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -161.87 35.25 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -1.194 . . . . 0.0 109.575 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.439 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -72.99 148.68 43.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.123 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.21 93.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.218 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.28 -54.39 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.423 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.32 73.86 1.37 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.563 ' N ' ' OG ' ' A' ' 65' ' ' SER . 9.7 t -69.43 158.11 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 31' ' ' MET . 3.3 m -145.31 131.44 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.45 -1.406 . . . . 0.0 111.549 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -99.88 129.27 45.95 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.677 HG22 ' H ' ' A' ' 13' ' ' TYR . 31.8 m -63.42 154.38 32.28 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.455 1.121 . . . . 0.0 110.602 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.6 mt -114.36 -17.23 11.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.186 -1.412 . . . . 10.54 107.186 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.677 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.53 145.03 18.47 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.126 -0.984 . . . . 18.39 110.765 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 121.43 1.42 . . . . 0.0 109.037 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.79 170.3 13.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.965 -1.084 . . . . 0.0 110.984 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.58 111.01 7.96 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.739 0.78 . . . . 0.0 109.474 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.19 112.0 10.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 18' ' ' VAL . 15.9 m -130.36 94.31 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-O 122.901 1.334 . . . . 0.0 109.126 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.45 -152.07 0.4 Allowed 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.38 -1.282 . . . . 38.32 107.579 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 19' ' ' THR . 96.2 mt-10 -82.47 -54.27 5.33 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.863 -1.532 . . . . 55.13 106.863 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.445 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.33 29.24 7.72 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.375 -0.828 . . . . 0.0 110.741 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.649 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -100.57 150.94 22.18 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.812 -1.18 . . . . 0.0 109.671 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.469 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.29 22.23 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.42 -0.8 . . . . 11.68 110.757 -178.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.43 127.65 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.8 142.18 21.63 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.425 -1.422 . . . . 12.44 110.904 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.22 155.83 22.31 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 146.93 17.93 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 119.464 -0.894 . . . . 29.03 109.577 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.62 44.09 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.218 -1.553 . . . . 6.18 109.218 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.84 22.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.592 -0.946 . . . . 9.52 109.449 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.03 108.65 6.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.51 133.74 49.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.175 1.464 . . . . 0.0 110.53 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.81 102.99 15.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.368 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.507 -0.746 . . . . 0.0 111.607 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' A' ' 47' ' ' LYS . 81.9 mt -59.8 -50.34 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.985 -1.072 . . . . 0.0 110.83 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.09 65.52 64.99 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.785 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -74.83 165.38 31.58 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.618 1.545 . . . . 0.0 108.987 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.93 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.57 -59.27 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.237 0.541 . . . . 0.0 110.136 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.35 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.63 -59.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.693 2.262 . . . . 0.0 109.943 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 70.8 mt-10 131.78 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 123.805 0.842 . . . . 0.0 108.769 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.556 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.8 m0 -71.93 165.92 23.2 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.607 -1.308 . . . . 14.29 110.436 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.467 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.5 m0 -129.57 144.99 51.51 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.338 -0.616 . . . . 11.8 109.338 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -79.01 96.72 5.84 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.493 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.72 55.98 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.907 0.86 . . . . 0.0 110.38 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.52 150.35 27.02 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.781 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.38 128.47 43.34 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.286 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.41 -18.41 1.03 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 119.716 -1.865 . . . . 0.0 107.918 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.55 -4.56 4.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.665 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.39 33.95 6.93 Favored Glycine 0 N--CA 1.481 1.684 0 CA-C-N 115.28 -0.873 . . . . 14.41 112.258 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.781 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.05 29.98 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 119.648 1.724 . . . . 0.0 111.82 179.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.67 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 122.325 1.059 . . . . 0.0 112.401 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.06 156.79 12.67 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.274 -1.53 . . . . 7.25 109.274 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.39 150.79 43.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.214 -1.168 . . . . 0.0 108.672 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.91 136.77 9.08 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 120.949 -1.094 . . . . 0.0 109.329 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.21 113.52 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 N-CA-C 109.024 -1.183 . . . . 4.76 109.024 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.449 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.35 3.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 110.729 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 57' ' ' PRO . 95.7 m-20 -101.9 -7.71 22.22 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.247 -0.908 . . . . 14.84 109.4 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.0 8.23 30.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.221 -0.925 . . . . 10.23 109.437 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 11' ' ' THR . 33.5 m -147.48 156.48 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.096 -1.002 . . . . 6.97 109.494 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG11 HD13 ' B' ' 78' ' ' ILE . 33.6 m -106.74 160.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.5 t -107.74 134.3 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.372 -0.83 . . . . 0.0 109.701 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 mp -105.06 -63.24 1.25 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.562 -0.711 . . . . 0.0 109.254 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.563 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 11.5 p -70.01 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.024 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 109.372 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.2 1.48 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.53 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.257 1.305 . . . . 0.0 109.656 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.06 82.67 1.78 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.93 124.96 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.81 156.24 28.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -1.114 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.92 167.95 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.433 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.44 46.91 0.2 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.21 130.82 5.39 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.312 -1.111 . . . . 0.0 109.396 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.65 35.94 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.876 1.718 . . . . 0.0 108.936 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.496 HG23 ' C ' ' B' ' 84' ' ' ARG . 64.8 mt -135.38 119.72 26.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 122.053 0.93 . . . . 0.0 109.44 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 14.8 t -58.46 117.13 4.15 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.872 0.844 . . . . 0.0 109.883 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.518 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -65.0 -0.06 4.97 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.829 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.55 8.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.15 4.94 13.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.496 ' C ' HG23 ' B' ' 78' ' ' ILE . 3.4 mtt180 -116.01 143.3 30.61 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.35 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.412 1.408 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.667 HG21 HG22 ' B' ' 90' ' ' VAL . 21.4 mt -70.98 158.45 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.426 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.54 61.46 0.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.828 -1.17 . . . . 0.0 110.671 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.04 0.15 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.658 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.63 120.59 42.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.667 HG22 HG21 ' B' ' 86' ' ' ILE . 42.2 t -98.72 158.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.41 -0.806 . . . . 0.0 111.286 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.47 HG23 HG22 ' B' ' 100' ' ' VAL . 5.0 t -122.43 116.06 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.634 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.79 106.15 18.27 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.572 -179.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.47 42.74 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.19 4.32 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.27 25.16 76.03 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.19 -154.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.704 0.764 . . . . 0.0 109.747 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.485 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.47 143.5 45.9 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.518 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.6 140.07 33.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.506 -1.371 . . . . 0.0 110.614 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.5 m80 -56.36 131.98 49.74 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 91' ' ' VAL . 7.4 t -53.33 -14.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 120.843 -1.161 . . . . 0.0 108.323 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.71 -26.94 15.51 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.804 -0.56 . . . . 0.0 110.683 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.17 -6.52 31.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.936 -1.102 . . . . 0.0 110.835 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.13 106.3 12.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.8 m -133.67 175.22 11.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 111.092 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.526 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.7 148.65 45.93 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.263 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.85 28.72 1.73 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.57 0.71 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.354 -0.842 . . . . 0.0 110.056 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.4 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.15 -15.55 4.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.75 47.65 0.33 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.55 59.34 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -68.96 138.29 40.03 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.788 1.659 . . . . 0.0 112.101 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.313 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.77 56.91 1.79 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.023 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.18 1.69 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 0.0 109.022 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.13 30.97 2.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.945 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.34 178.88 4.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -1.041 . . . . 0.0 110.066 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.31 145.41 24.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.509 -0.745 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.566 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.33 169.52 9.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 109.624 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.703 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.52 137.77 47.28 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.05 148.21 29.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.256 -0.902 . . . . 0.0 111.212 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.36 11.35 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.609 0.719 . . . . 0.0 110.35 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.07 22.92 1.36 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.578 -0.701 . . . . 0.0 109.536 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.37 31.15 20.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.466 -1.349 . . . . 0.0 109.792 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.45 142.74 31.31 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.549 -0.971 . . . . 0.0 108.803 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.42 152.86 36.08 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.725 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.557 ' CE1' HD22 ' B' ' 133' ' ' LEU . 58.3 m-85 -153.82 140.37 18.84 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.69 177.48 0.11 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.471 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.61 -36.04 82.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 109.294 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 53.7 m -86.66 -43.73 12.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 111.295 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.65 -43.89 83.38 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.736 -1.228 . . . . 0.0 108.052 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.32 14.47 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.419 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.2 m-80 -64.66 -44.75 89.42 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.48 -34.3 61.3 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.22 44.81 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.351 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.66 -81.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.29 31.6 16.26 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 48.31 51.33 15.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.473 -39.769 1 CA-C-O 71.114 -23.327 . . . . 0.0 109.534 179.903 . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.93 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.98 35.32 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 109.619 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.435 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.08 148.7 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.049 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.12 93.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 0.0 109.394 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.28 2.0 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.38 73.82 1.37 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.39 158.09 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.2 m -145.39 131.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.485 -1.384 . . . . 0.0 111.529 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.92 129.21 45.97 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 13' ' ' TYR . 30.7 m -63.52 154.45 32.44 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.521 1.153 . . . . 0.0 110.584 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 97.2 mt -114.39 -17.25 11.82 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.173 -1.417 . . . . 10.54 107.173 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.675 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.49 145.03 18.49 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.198 -0.939 . . . . 18.39 110.791 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.04 81.43 1.68 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.385 1.39 . . . . 0.0 109.099 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CG ' ' N ' ' A' ' 16' ' ' SER . 27.8 t80 -71.61 170.23 13.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.962 -1.087 . . . . 0.0 110.937 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.6 111.09 8.01 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.776 0.798 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 111.89 10.59 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 18' ' ' VAL . 17.6 m -130.25 94.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-O 122.883 1.325 . . . . 0.0 109.16 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.54 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -144.42 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.342 -1.299 . . . . 38.32 107.575 177.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.54 ' H ' HG22 ' A' ' 19' ' ' THR . 97.5 mt-10 -82.39 -54.34 5.3 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.904 -1.517 . . . . 55.13 106.904 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 17.4 pt-20 -109.26 29.09 7.86 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.451 -0.781 . . . . 0.0 110.703 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.62 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.41 150.89 22.15 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.921 -1.112 . . . . 0.0 109.741 -179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.33 111.4 22.42 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.402 -0.811 . . . . 11.68 110.739 -178.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.6 41.53 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.89 142.16 21.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.366 -1.459 . . . . 12.44 110.912 -178.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.19 155.8 22.36 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.37 146.97 18.2 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.465 -0.894 . . . . 29.03 109.591 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.54 44.2 6.6 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 6.18 109.298 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.37 114.8 22.9 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.725 -0.868 . . . . 9.52 109.389 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.98 108.67 6.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.54 133.66 49.92 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 123.112 1.434 . . . . 0.0 110.585 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.65 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.393 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.16 92.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 111.431 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.48 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.8 mt -59.71 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.894 -1.129 . . . . 0.0 110.259 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.474 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.916 -1.115 . . . . 0.0 110.79 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.07 65.53 65.13 Favored Pre-proline 0 N--CA 1.486 1.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.794 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.44 31.42 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.653 1.569 . . . . 0.0 108.982 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.06 -46.55 7.73 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.78 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.351 0.596 . . . . 0.0 110.052 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 122.664 2.243 . . . . 0.0 110.023 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 31.4 tt0 131.77 9.24 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 C-N-CA 123.814 0.846 . . . . 0.0 108.752 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.548 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.6 m0 -71.87 165.96 23.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.623 -1.298 . . . . 14.29 110.463 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.561 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 18.1 m0 -129.68 145.06 51.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.233 -0.654 . . . . 11.8 109.233 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.99 96.73 5.83 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.73 55.98 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.89 0.853 . . . . 0.0 110.428 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.52 150.33 27.03 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.789 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.47 128.51 43.47 Favored 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 117.25 -1.78 . . . . 0.0 107.212 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.3 -18.46 0.97 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.775 -1.828 . . . . 0.0 107.995 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.476 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.6 4.29 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.656 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.45 33.82 6.97 Favored Glycine 0 N--CA 1.482 1.761 0 CA-C-N 115.388 -0.824 . . . . 14.41 112.281 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.789 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.91 164.02 30.04 Favored 'General case' 0 N--CA 1.515 2.809 0 CA-C-N 119.796 1.798 . . . . 0.0 111.839 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.86 154.59 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 122.309 1.052 . . . . 0.0 112.522 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.11 156.64 12.53 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.255 -1.538 . . . . 7.25 109.255 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.3 150.85 43.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.13 -1.218 . . . . 0.0 108.768 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.62 8.92 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 120.895 -1.128 . . . . 0.0 109.271 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.048 -1.174 . . . . 4.76 109.048 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.561 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 33.9 pttt -60.38 3.21 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.503 -0.748 . . . . 0.0 110.777 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.8 m120 -102.09 -7.63 22.11 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.183 -0.948 . . . . 14.84 109.273 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 10.23 109.454 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.3 m -147.48 156.64 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.149 -0.969 . . . . 6.97 109.521 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 63' ' ' VAL . 11.3 p -106.77 160.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.435 ' N ' HG22 ' A' ' 62' ' ' VAL . 48.5 t -107.63 134.36 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.5 -0.75 . . . . 0.0 109.767 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -105.11 -63.18 1.25 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.619 -0.676 . . . . 0.0 109.227 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 t -69.91 151.58 45.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.0 109.435 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -146.54 152.72 39.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 0.0 109.377 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.29 1.48 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.47 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.338 1.358 . . . . 0.0 109.645 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.66 1.78 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.04 32.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.85 156.25 28.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.26 46.93 0.2 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.74 5.33 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.337 -1.096 . . . . 0.0 109.378 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.6 Cg_endo -74.14 163.51 36.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.988 1.792 . . . . 0.0 108.87 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.59 HG23 ' C ' ' B' ' 84' ' ' ARG . 48.5 mt -135.35 119.89 27.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 122.081 0.943 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.42 117.01 4.01 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.831 0.824 . . . . 0.0 110.048 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.519 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.93 -0.09 4.91 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.58 -48.7 8.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -1.061 . . . . 0.0 109.375 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.84 13.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.568 -0.708 . . . . 0.0 109.106 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 53.51 41.33 32.11 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.59 ' C ' HG23 ' B' ' 78' ' ' ILE . 42.7 mtp180 -115.89 143.51 30.92 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.54 113.31 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.5 1.467 . . . . 0.0 110.464 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.678 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.78 158.4 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.57 61.48 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.809 -1.182 . . . . 0.0 110.646 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.0 0.15 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.674 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.5 120.56 42.06 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.678 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.74 158.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.66 0.743 . . . . 0.0 111.253 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' B' ' 103' ' ' PHE . 5.0 t -122.42 115.96 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.644 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.096 -1.003 . . . . 0.0 109.473 -178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.55 159.42 42.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.19 17.14 4.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.22 75.94 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.79 0.805 . . . . 0.0 109.754 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.36 143.52 46.12 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.519 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.58 140.0 33.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.66 -1.275 . . . . 0.0 110.58 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.54 132.02 50.37 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.39 -14.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.876 -1.14 . . . . 0.0 108.335 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.82 -26.94 15.45 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.806 -0.559 . . . . 0.0 110.651 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.08 -6.59 31.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.952 -1.092 . . . . 0.0 110.858 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.13 106.26 12.02 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.0 m -133.62 175.17 11.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.218 1.009 . . . . 0.0 111.18 -177.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.525 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.67 46.33 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.259 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.78 1.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.85 -31.75 0.71 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.14 -15.37 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.248 -0.908 . . . . 0.0 110.175 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.66 47.69 0.34 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.851 . . . . 0.0 110.147 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.47 59.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -69.02 138.23 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.706 1.604 . . . . 0.0 112.167 -177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.315 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.76 56.76 1.78 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.19 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.93 -55.27 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.361 -0.837 . . . . 0.0 109.07 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.08 2.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.93 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.33 178.96 4.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.469 -1.018 . . . . 0.0 109.953 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.45 145.36 24.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.404 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.0 p-80 -116.32 169.48 9.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 109.493 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.6 137.64 47.13 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -107.08 148.26 28.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.23 -0.919 . . . . 0.0 111.233 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 129.4 11.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.614 0.721 . . . . 0.0 110.332 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.15 22.86 1.4 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.701 -0.625 . . . . 0.0 109.504 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.95 20.4 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.687 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.4 mt -143.26 142.82 31.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.514 -0.992 . . . . 0.0 108.852 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.48 152.97 35.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.673 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.554 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.9 m-85 -153.92 140.28 18.65 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.61 177.52 0.1 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.399 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.0 tt0 -63.56 -36.11 82.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.402 -0.811 . . . . 0.0 109.475 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.2 m -86.51 -43.63 12.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.724 . . . . 0.0 111.466 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.455 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.77 -43.76 83.15 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.789 -1.194 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.4 13.95 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.6 -44.91 89.1 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.074 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.28 61.22 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.554 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.7 -35.3 45.18 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.354 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.2 m-85 -158.51 -81.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 110.094 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.35 31.41 16.62 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.54 51.16 15.87 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -1.151 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.934 -23.412 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.44 74.92 0.12 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -161.94 35.24 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.253 -1.145 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.02 148.58 44.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.0 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.22 -54.26 2.0 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.435 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.41 73.94 1.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' N ' ' OG ' ' A' ' 65' ' ' SER . 79.1 t -69.38 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 31' ' ' MET . 3.9 m -145.41 131.51 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.354 -1.466 . . . . 0.0 111.461 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -99.79 129.19 45.87 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 13' ' ' TYR . 35.4 m -63.44 154.31 32.56 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.51 1.148 . . . . 0.0 110.537 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 92.3 mt -114.28 -17.25 11.88 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.225 -1.398 . . . . 10.54 107.225 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.662 ' H ' HG22 ' A' ' 11' ' ' THR . 14.6 m-85 -149.47 145.1 18.63 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.164 -0.96 . . . . 18.39 110.678 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -73.01 81.45 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.444 1.43 . . . . 0.0 109.107 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.78 170.32 13.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.98 -1.075 . . . . 0.0 110.861 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.72 111.1 7.96 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.805 0.812 . . . . 0.0 109.38 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 112.0 10.72 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 18' ' ' VAL . 34.0 m -130.36 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 122.941 1.353 . . . . 0.0 109.222 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 1.031 HG22 ' OE1' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.512 -1.292 . . . . 38.32 107.512 178.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 1.031 ' OE1' HG22 ' A' ' 19' ' ' THR . 58.8 mp0 -82.38 -54.47 5.19 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.832 -1.544 . . . . 55.13 106.832 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -109.18 29.22 7.72 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.374 -0.829 . . . . 0.0 110.803 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 1.2 mp0 -100.53 150.93 22.16 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.036 -1.04 . . . . 0.0 109.761 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.52 22.61 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 121.517 -0.739 . . . . 11.68 110.655 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.49 127.84 41.86 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.0 142.21 21.48 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.415 -1.428 . . . . 12.44 110.78 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.87 22.4 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 146.92 18.78 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.238 -0.913 . . . . 29.03 109.585 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 44.2 6.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.416 -1.474 . . . . 6.18 109.416 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.452 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.83 22.93 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.543 -0.974 . . . . 9.52 109.331 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.13 108.67 6.15 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.48 133.66 49.88 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.155 1.455 . . . . 0.0 110.584 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.78 103.14 15.88 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.41 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.19 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.489 -0.757 . . . . 0.0 111.491 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.4 mt -59.91 -50.31 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.957 -1.09 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.14 65.63 64.94 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.701 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.77 165.41 31.54 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.627 1.551 . . . . 0.0 109.049 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.1 -46.55 7.72 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.5 m-20 57.77 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.419 0.628 . . . . 0.0 110.059 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.51 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.65 -59.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.547 2.164 . . . . 0.0 109.975 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 71.6 mt-10 131.7 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 123.828 0.851 . . . . 0.0 108.837 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.522 ' HB2' HD12 ' A' ' 55' ' ' LEU . 20.2 m0 -71.87 166.0 22.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.696 -1.252 . . . . 14.29 110.497 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.4 m0 -129.64 144.97 51.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.668 -0.645 . . . . 11.8 109.355 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -78.98 96.68 5.81 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.95 128.76 56.0 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.889 0.852 . . . . 0.0 110.321 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.69 150.39 26.79 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.783 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.37 128.56 43.4 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 117.327 -1.749 . . . . 0.0 107.239 178.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.5 1.02 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 119.584 -1.948 . . . . 0.0 108.008 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.472 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.59 -4.57 4.26 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.662 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.47 33.81 6.97 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-N 115.403 -0.817 . . . . 14.41 112.284 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.783 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.1 29.8 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-N 119.724 1.762 . . . . 0.0 111.792 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.63 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-O 122.356 1.074 . . . . 0.0 112.541 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.13 156.71 12.63 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.294 -1.522 . . . . 7.25 109.294 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.522 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.3 150.78 43.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.278 -1.13 . . . . 0.0 108.596 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.04 136.77 9.02 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 109.269 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.19 113.55 1.16 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 N-CA-C 109.014 -1.187 . . . . 4.76 109.014 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.37 3.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.482 -0.761 . . . . 0.0 110.712 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' PRO . 97.7 m-20 -102.01 -7.63 22.18 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.206 -0.934 . . . . 14.84 109.327 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.97 8.13 31.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 10.23 109.527 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.41 156.64 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.193 -0.942 . . . . 6.97 109.483 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.738 HG11 HD13 ' B' ' 78' ' ' ILE . 27.7 m -106.85 160.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.57 134.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.389 -0.819 . . . . 0.0 109.838 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 mp -105.2 -63.18 1.26 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.631 -0.668 . . . . 0.0 109.229 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 14.4 p -70.01 151.54 45.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.037 -1.039 . . . . 0.0 109.521 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 55.7 p-10 -146.55 152.67 39.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.3 1.48 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.304 1.336 . . . . 0.0 109.667 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.02 82.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.87 125.09 32.33 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.71 156.1 29.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.278 -1.131 . . . . 0.0 109.57 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.4 mtt -49.7 167.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.74 0.2 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.22 130.86 5.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.301 -1.117 . . . . 0.0 109.378 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.41 163.66 35.74 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.85 1.7 . . . . 0.0 108.827 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.738 HD13 HG11 ' A' ' 62' ' ' VAL . 74.6 mt -135.41 119.86 26.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.07 0.938 . . . . 0.0 109.338 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 14.9 t -58.43 116.98 3.99 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.824 0.821 . . . . 0.0 109.871 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.79 -0.24 4.92 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.63 -48.65 8.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.361 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.09 4.77 13.72 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 53.57 41.36 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.469 ' C ' HG23 ' B' ' 78' ' ' ILE . 19.7 mtp180 -115.89 143.43 30.77 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.644 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.43 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.442 1.428 . . . . 0.0 110.551 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.661 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.94 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.425 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.44 61.54 0.33 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.918 -1.114 . . . . 0.0 110.583 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.08 -102.06 0.15 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.683 -2.167 . . . . 0.0 107.683 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.64 120.74 42.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.661 HG22 HG21 ' B' ' 86' ' ' ILE . 42.7 t -98.83 158.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.762 0.792 . . . . 0.0 111.141 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.45 115.91 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.641 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.102 -0.999 . . . . 0.0 109.548 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.5 42.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.15 17.23 4.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.1 25.42 75.64 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.27 -154.77 0.65 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.712 0.768 . . . . 0.0 109.821 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.478 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.46 143.37 45.85 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.8 m95 -141.48 140.1 33.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.41 -1.431 . . . . 0.0 110.634 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.449 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.5 131.9 49.92 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.6 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 120.894 -1.129 . . . . 0.0 108.336 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.449 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.91 -26.94 15.4 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.71 -0.619 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.21 -6.42 31.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.806 -1.184 . . . . 0.0 110.899 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.29 106.19 12.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.824 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.53 175.25 11.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.288 1.042 . . . . 0.0 111.167 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.81 148.66 46.28 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.333 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.8 28.73 1.71 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.414 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.84 -31.62 0.71 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.349 -0.844 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.22 -15.27 4.19 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.332 -0.855 . . . . 0.0 110.138 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.66 47.67 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.319 -0.863 . . . . 0.0 110.148 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.52 59.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.824 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.5 Cg_endo -69.03 138.22 39.58 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.704 1.603 . . . . 0.0 112.168 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.309 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.79 56.96 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.157 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.01 -55.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 0.0 109.082 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.19 30.88 2.76 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.966 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.18 178.84 4.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.479 -1.012 . . . . 0.0 110.03 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.33 145.24 24.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.55 9.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 0.0 109.489 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.6 137.65 47.13 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.03 148.24 28.96 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.241 -0.912 . . . . 0.0 111.331 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.31 11.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.685 0.755 . . . . 0.0 110.257 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.38 22.83 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.506 -0.746 . . . . 0.0 109.414 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.87 20.59 Favored Glycine 0 N--CA 1.481 1.685 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.79 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.29 142.64 31.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.524 -0.986 . . . . 0.0 108.821 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.91 36.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 110.739 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.543 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -154.01 140.26 18.54 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.7 m -57.61 177.4 0.1 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.453 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.89 82.0 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.81 . . . . 0.0 109.383 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.8 m -86.68 -43.79 12.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.434 -0.791 . . . . 0.0 111.354 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.74 83.91 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.867 -1.145 . . . . 0.0 108.213 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.7 -56.46 13.58 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.4 m-80 -64.52 -44.82 89.66 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.45 -34.49 61.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.543 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.64 -35.19 45.81 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.381 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.7 -81.64 0.05 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 110.085 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.44 31.43 16.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.55 51.28 15.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -1.103 . . . . 0.0 109.556 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.791 -23.48 . . . . 0.0 109.443 -179.981 . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.28 74.81 0.13 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -1.168 . . . . 0.0 109.595 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.03 148.68 43.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.882 . . . . 0.0 109.099 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.11 93.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 109.238 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.31 -54.25 2.0 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.34 74.08 1.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.5 t -69.53 158.07 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.34 131.55 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.463 -1.398 . . . . 0.0 111.528 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.93 129.26 45.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 13' ' ' TYR . 38.5 m -63.42 154.33 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.468 1.128 . . . . 0.0 110.633 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 74.4 mt -114.31 -17.34 11.84 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.219 -1.4 . . . . 10.54 107.219 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.648 ' H ' HG22 ' A' ' 11' ' ' THR . 14.4 m-85 -149.5 145.08 18.57 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.21 -0.931 . . . . 18.39 110.726 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -72.96 81.5 1.65 Allowed 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 121.364 1.376 . . . . 0.0 109.042 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.85 170.23 14.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.972 -1.08 . . . . 0.0 110.88 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.14 8.04 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.906 0.86 . . . . 0.0 109.358 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.07 10.73 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 18' ' ' VAL . 15.4 m -130.44 94.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 123.039 1.399 . . . . 0.0 109.172 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.672 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.4 m -144.58 -152.11 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.321 -1.309 . . . . 38.32 107.593 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.672 ' H ' HG22 ' A' ' 19' ' ' THR . 79.1 mm-40 -82.37 -54.3 5.33 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.92 -1.511 . . . . 55.13 106.92 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 74.9 mt-10 -109.33 29.17 7.79 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.364 -0.835 . . . . 0.0 110.778 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.39 150.78 22.26 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.756 -1.215 . . . . 0.0 109.83 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.29 111.37 22.38 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.408 -0.807 . . . . 11.68 110.775 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.43 127.71 41.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.0 142.04 21.32 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.374 -1.454 . . . . 12.44 110.848 -178.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.07 155.85 22.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.92 18.49 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.482 -0.887 . . . . 29.03 109.539 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.12 6.61 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.284 -1.526 . . . . 6.18 109.284 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.4 114.84 22.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.584 -0.951 . . . . 9.52 109.424 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.07 108.68 6.1 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.54 133.83 49.64 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 123.231 1.491 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.05 15.81 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.328 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.545 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.99 92.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.527 -0.733 . . . . 0.0 111.485 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.487 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.6 mt -59.65 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.927 -1.108 . . . . 0.0 110.344 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.66 43.68 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.037 -1.039 . . . . 0.0 110.737 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.02 65.55 65.54 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.75 165.4 31.59 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.61 1.54 . . . . 0.0 109.003 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.07 -46.48 7.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.66 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.352 0.596 . . . . 0.0 110.025 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.8 -47.36 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.734 2.289 . . . . 0.0 109.961 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 67.5 mt-10 131.76 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 C-N-CA 123.881 0.872 . . . . 0.0 108.805 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.551 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.5 m0 -71.85 165.89 23.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.738 -1.226 . . . . 14.29 110.502 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.491 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.6 m0 -129.51 145.03 51.5 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.377 -0.601 . . . . 11.8 109.377 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -78.98 96.71 5.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.9 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.869 0.842 . . . . 0.0 110.429 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.79 150.47 26.61 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.78 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.39 128.53 43.4 Favored 'General case' 0 N--CA 1.506 2.326 0 C-N-CA 117.28 -1.768 . . . . 0.0 107.325 178.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.45 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 119.618 -1.926 . . . . 0.0 107.951 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.464 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.71 -4.47 4.31 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.4 33.95 6.92 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 115.379 -0.828 . . . . 14.41 112.224 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.78 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.1 29.79 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.731 1.766 . . . . 0.0 111.87 179.12 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.02 154.65 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.323 1.059 . . . . 0.0 112.408 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.337 -1.505 . . . . 7.25 109.337 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.96 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.31 -1.112 . . . . 0.0 108.684 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.08 136.79 9.02 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.004 -1.06 . . . . 0.0 109.297 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.98 -1.2 . . . . 4.76 108.98 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.46 3.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 110.721 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -101.97 -7.67 22.18 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.147 -0.971 . . . . 14.84 109.391 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.06 8.33 30.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.919 . . . . 10.23 109.483 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.7 m -147.46 156.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 6.97 109.454 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 63' ' ' VAL . 3.8 p -106.76 160.82 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' N ' HG22 ' A' ' 62' ' ' VAL . 45.6 t -107.71 134.26 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.403 -0.811 . . . . 0.0 109.714 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' O ' ' NH2' ' B' ' 84' ' ' ARG . 9.0 mp -105.14 -63.3 1.24 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.3 m -69.92 151.59 45.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 49.4 p30 -146.55 152.72 39.41 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.45 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 121.368 1.378 . . . . 0.0 109.7 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.03 82.59 1.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.93 125.14 32.41 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.514 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.09 28.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -1.073 . . . . 0.0 109.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.76 167.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.3 46.98 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.32 130.79 5.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.286 -1.126 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.21 163.6 36.14 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.912 1.741 . . . . 0.0 108.847 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.479 ' H ' HE21 ' B' ' 97' ' ' GLN . 30.6 mt -135.43 119.84 26.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 122.17 0.986 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.3 116.96 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.778 0.799 . . . . 0.0 109.897 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.508 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.23 4.91 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.59 -48.74 8.07 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 109.321 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.89 13.76 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 53.44 41.28 32.13 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.459 ' HE ' ' HB3' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -115.82 143.43 30.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.64 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.5 Cg_exo -56.48 113.42 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.433 1.422 . . . . 0.0 110.56 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.67 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.91 158.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.426 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.51 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.866 -1.146 . . . . 0.0 110.577 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.668 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.67 120.71 42.46 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.67 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.8 158.62 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.669 0.747 . . . . 0.0 111.245 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.51 116.03 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.622 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.585 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.56 42.58 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 8.0 mmt 57.94 17.38 4.29 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.32 75.78 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.84 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.479 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.38 143.4 46.03 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.508 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.46 139.97 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.507 -1.371 . . . . 0.0 110.67 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.445 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.38 131.9 49.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.23 -14.73 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.926 -1.109 . . . . 0.0 108.436 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.85 -26.98 15.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.781 -0.574 . . . . 0.0 110.624 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -98.1 -6.55 31.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.937 -1.102 . . . . 0.0 110.842 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' B' ' 91' ' ' VAL . 24.9 t80 -80.1 106.26 11.99 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.58 175.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.268 1.032 . . . . 0.0 111.172 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.71 45.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.31 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.66 1.74 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.416 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.78 0.71 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -128.98 -15.57 4.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.385 -0.822 . . . . 0.0 110.208 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.59 0.32 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.272 -0.893 . . . . 0.0 110.14 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.48 109.52 59.26 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.06 138.18 39.39 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.699 1.6 . . . . 0.0 112.184 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.326 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.67 56.85 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.194 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.634 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.08 -55.22 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.337 -0.852 . . . . 0.0 108.962 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.22 31.05 2.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.938 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.25 179.07 4.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.578 -0.954 . . . . 0.0 109.949 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.41 24.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.467 -0.771 . . . . 0.0 109.305 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.35 169.42 9.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.285 -0.884 . . . . 0.0 109.483 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.56 137.67 47.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.92 148.29 28.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.264 -0.898 . . . . 0.0 111.25 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.37 11.34 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.584 0.707 . . . . 0.0 110.295 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.14 22.92 1.41 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.664 -0.647 . . . . 0.0 109.448 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.35 31.08 20.39 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.443 -1.361 . . . . 0.0 109.742 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.32 142.71 31.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.547 -0.973 . . . . 0.0 108.778 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.26 152.85 36.38 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.641 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.547 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.9 m-85 -153.9 140.22 18.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.57 177.43 0.1 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.296 -1.362 . . . . 0.0 108.477 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.56 -36.03 82.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.387 -0.82 . . . . 0.0 109.357 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.2 m -86.61 -43.86 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 111.289 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.64 84.12 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 108.218 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.86 -56.37 14.42 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.55 -44.74 89.83 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.2 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -54.49 -34.37 61.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.547 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.12 44.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.346 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.62 -81.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.52 31.32 16.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.409 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.3 m-20 48.53 51.3 15.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -1.109 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.723 1 CA-C-O 70.819 -23.467 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.29 0.567 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.31 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.04 35.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.02 148.64 43.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.12 93.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.185 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -121.26 -54.35 2.0 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.444 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.0 m-70 -145.34 74.0 1.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' N ' ' OG ' ' A' ' 65' ' ' SER . 10.1 t -69.51 158.13 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.9 m -145.33 131.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.487 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.424 HE21 ' HA2' ' A' ' 28' ' ' GLY . 56.7 tp60 -99.87 129.31 45.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.4 m -63.51 154.36 32.69 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.456 1.122 . . . . 0.0 110.625 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.9 mt -114.31 -17.23 11.86 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.224 -1.398 . . . . 10.54 107.224 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' H ' HG22 ' A' ' 11' ' ' THR . 14.1 m-85 -149.56 145.03 18.45 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.21 -0.931 . . . . 18.39 110.798 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.99 81.41 1.67 Allowed 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 121.425 1.417 . . . . 0.0 109.01 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.71 170.26 13.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.948 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.57 111.13 8.06 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.741 0.782 . . . . 0.0 109.452 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.38 112.08 10.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.33 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.888 1.327 . . . . 0.0 109.193 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -144.47 -152.02 0.4 Allowed 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.509 -1.293 . . . . 38.32 107.509 177.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 19' ' ' THR . 84.2 tt0 -82.49 -54.21 5.37 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.897 -1.52 . . . . 55.13 106.897 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.39 29.31 7.66 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.365 -0.834 . . . . 0.0 110.849 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.57 150.85 22.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.801 -1.187 . . . . 0.0 109.759 -179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -111.34 111.44 22.48 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.411 -0.806 . . . . 11.68 110.714 -178.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.49 127.78 41.8 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.484 ' HE2' ' HG1' ' A' ' 11' ' ' THR . 0.8 OUTLIER -153.02 142.18 21.44 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.382 -1.449 . . . . 12.44 110.819 -178.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.24 155.77 22.32 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.28 146.96 17.83 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.282 -0.886 . . . . 29.03 109.521 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' HA2' HE21 ' A' ' 10' ' ' GLN . . . 84.48 44.11 6.66 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.35 -1.5 . . . . 6.18 109.35 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.26 114.83 23.01 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.493 -1.004 . . . . 9.52 109.451 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.09 108.63 6.09 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.49 133.64 49.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.179 1.466 . . . . 0.0 110.523 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 103.05 15.8 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.733 -1.576 . . . . 0.0 107.484 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.535 -0.728 . . . . 0.0 111.465 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.493 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.69 -50.46 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.986 -1.072 . . . . 0.0 110.273 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.19 157.56 43.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -134.93 65.52 65.88 Favored Pre-proline 0 N--CA 1.486 1.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.791 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.69 165.42 31.59 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.625 1.55 . . . . 0.0 109.008 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.53 7.74 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.7 m-20 57.69 -59.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.33 0.586 . . . . 0.0 110.017 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.37 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 178.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.2 Cg_endo -68.73 -59.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.756 2.304 . . . . 0.0 109.776 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 16.8 pt-20 131.78 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 123.79 0.836 . . . . 0.0 108.784 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.553 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.7 m0 -72.0 165.92 23.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.756 -1.215 . . . . 14.29 110.407 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.3 m0 -129.58 145.07 51.51 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 109.276 -0.639 . . . . 11.8 109.276 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -79.03 96.63 5.83 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.97 128.86 56.08 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.942 0.877 . . . . 0.0 110.441 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.62 150.4 26.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.783 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.52 43.4 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 117.284 -1.766 . . . . 0.0 107.221 177.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.34 -18.46 0.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 119.668 -1.895 . . . . 0.0 108.031 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.467 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.57 -4.61 4.27 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.665 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.45 33.89 6.94 Favored Glycine 0 N--CA 1.481 1.691 0 CA-C-N 115.303 -0.862 . . . . 14.41 112.271 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.783 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.12 29.77 Favored 'General case' 0 N--CA 1.515 2.812 0 CA-C-N 119.736 1.768 . . . . 0.0 111.843 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.47 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 122.302 1.048 . . . . 0.0 112.468 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.44 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.22 156.73 12.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.306 -1.518 . . . . 7.25 109.306 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.41 150.85 43.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.271 -1.135 . . . . 0.0 108.685 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.74 9.03 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.765 -1.209 . . . . 0.0 109.354 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.4 Cg_exo -51.32 113.5 1.15 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.032 -1.18 . . . . 4.76 109.032 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.19 3.09 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.775 . . . . 0.0 110.793 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 10.5 m120 -102.03 -7.67 22.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.095 -1.003 . . . . 14.84 109.337 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -89.11 8.38 30.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.91 . . . . 10.23 109.455 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.48 156.53 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.101 -0.999 . . . . 6.97 109.431 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 63' ' ' VAL . 8.4 p -106.79 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.505 ' N ' HG22 ' A' ' 62' ' ' VAL . 46.6 t -107.67 134.23 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.35 -0.844 . . . . 0.0 109.753 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.17 -63.12 1.26 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.567 -0.708 . . . . 0.0 109.184 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.6 p -70.0 151.56 45.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 50.6 p30 -146.58 152.66 39.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 109.42 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.28 1.48 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 93.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.316 1.344 . . . . 0.0 109.638 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.5 1.75 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.12 32.36 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.434 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.27 28.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.58 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.98 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.17 46.82 0.2 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.72 5.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.518 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.24 163.64 36.02 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.975 1.783 . . . . 0.0 108.842 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.566 HG23 ' C ' ' B' ' 84' ' ' ARG . 6.4 mt -135.38 119.7 26.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.967 0.889 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.32 116.86 3.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.871 0.843 . . . . 0.0 109.917 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.72 -0.19 4.79 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.62 -48.53 8.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.993 . . . . 0.0 109.443 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.06 4.8 13.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 109.147 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 53.47 41.27 32.13 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.566 ' C ' HG23 ' B' ' 78' ' ' ILE . 8.9 mtm105 -115.95 143.39 30.74 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.639 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.42 113.32 1.4 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.409 1.406 . . . . 0.0 110.699 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.668 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -70.86 158.47 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.56 61.54 0.32 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.858 -1.151 . . . . 0.0 110.593 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.89 0.15 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.658 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.7 120.69 42.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.668 HG22 HG21 ' B' ' 86' ' ' ILE . 42.9 t -98.83 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.686 0.755 . . . . 0.0 111.168 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.468 HG23 HG22 ' B' ' 100' ' ' VAL . 4.9 t -122.53 116.01 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.64 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.22 18.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.69 159.53 42.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.21 4.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.14 25.22 75.92 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.2 -154.77 0.65 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.728 0.775 . . . . 0.0 109.783 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.476 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.41 143.37 45.95 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.7 m95 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.604 -1.31 . . . . 0.0 110.669 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.503 ' CE1' ' NH2' ' B' ' 84' ' ' ARG . 17.2 m80 -56.56 131.99 50.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG23 ' B' ' 91' ' ' VAL . 7.9 t -53.17 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 120.902 -1.124 . . . . 0.0 108.311 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.79 -27.02 15.43 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.848 -0.532 . . . . 0.0 110.62 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.04 -6.59 31.54 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.886 -1.134 . . . . 0.0 110.841 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.468 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.1 t80 -80.12 106.27 12.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.7 m -133.56 175.34 11.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.272 1.034 . . . . 0.0 111.081 -177.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.75 148.68 46.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.312 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.76 28.5 1.77 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.7 -31.66 0.72 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.369 -0.832 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.17 -15.42 4.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.375 -0.828 . . . . 0.0 110.133 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.64 47.68 0.34 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.208 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.49 109.64 59.59 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.21 138.31 39.23 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.691 1.594 . . . . 0.0 112.126 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.294 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.87 56.95 1.77 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.21 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.222 -0.924 . . . . 0.0 108.997 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.97 2.74 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.967 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.25 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -1.011 . . . . 0.0 110.024 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.46 145.33 24.86 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.57 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.54 9.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 109.559 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.52 137.65 47.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.01 148.26 28.92 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.312 -0.867 . . . . 0.0 111.196 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.31 11.28 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.606 0.717 . . . . 0.0 110.413 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.3 22.84 1.49 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.579 -0.7 . . . . 0.0 109.482 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.47 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.6 mt -143.26 142.74 31.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.487 -1.007 . . . . 0.0 108.762 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.28 152.79 36.37 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.802 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.546 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.82 140.24 18.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.0 m -57.49 177.54 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.341 -1.343 . . . . 0.0 108.388 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.74 -35.99 82.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.382 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.4 m -86.67 -43.65 12.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.611 -0.681 . . . . 0.0 111.464 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.6 -43.76 83.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.797 -1.19 . . . . 0.0 108.255 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.521 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.72 -56.54 13.17 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.4 m-80 -64.39 -44.98 89.63 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.39 61.25 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.546 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.62 -35.24 45.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.387 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 110.09 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.36 31.48 16.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.413 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.4 51.28 15.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -1.099 . . . . 0.0 109.644 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.708 1 CA-C-O 71.096 -23.335 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.37 74.88 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.6 p -161.93 35.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.238 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -73.0 148.67 43.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 t -66.14 93.38 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.069 -1.02 . . . . 0.0 109.19 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.21 -54.28 2.0 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.445 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.3 73.97 1.38 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' N ' ' OG ' ' A' ' 65' ' ' SER . 3.7 t -69.39 158.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.46 131.51 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.462 -1.399 . . . . 0.0 111.447 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.0 129.25 46.04 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.2 m -63.45 154.4 32.32 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.505 1.145 . . . . 0.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 84.2 mt -114.39 -17.34 11.8 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.202 -1.407 . . . . 10.54 107.202 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.662 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.4 145.11 18.68 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 121.24 -0.913 . . . . 18.39 110.79 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -73.06 81.56 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 121.394 1.396 . . . . 0.0 109.022 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.86 170.39 13.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.069 -1.019 . . . . 0.0 110.853 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.85 0.833 . . . . 0.0 109.338 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.35 111.92 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 18' ' ' VAL . 14.3 m -130.35 94.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 122.93 1.348 . . . . 0.0 109.145 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.52 -152.05 0.4 Allowed 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.392 -1.276 . . . . 38.32 107.611 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.676 ' H ' HG22 ' A' ' 19' ' ' THR . 97.0 mt-10 -82.47 -54.35 5.26 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.813 -1.551 . . . . 55.13 106.813 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.3 mt-10 -109.3 29.19 7.77 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.388 -0.82 . . . . 0.0 110.727 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -100.5 150.85 22.24 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.963 -1.086 . . . . 0.0 109.697 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.37 111.55 22.68 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.384 -0.823 . . . . 11.68 110.698 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.59 127.75 41.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -153.02 142.18 21.43 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.433 -1.417 . . . . 12.44 110.801 -178.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.13 155.85 22.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 146.85 18.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.228 -0.92 . . . . 29.03 109.516 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.53 44.26 6.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.302 -1.519 . . . . 6.18 109.302 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.71 22.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.476 -1.014 . . . . 9.52 109.432 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.57 5.95 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.42 133.7 49.74 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 123.088 1.423 . . . . 0.0 110.574 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.83 103.15 15.89 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.374 -178.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.12 92.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.561 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.2 mt -59.79 -50.3 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.962 -1.086 . . . . 0.0 110.276 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.537 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.28 157.63 43.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.983 -1.073 . . . . 0.0 110.724 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HB3' ' NE1' ' A' ' 44' ' ' TRP . 1.9 mptp? -135.05 65.56 65.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.789 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.39 31.65 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.655 1.57 . . . . 0.0 109.004 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.09 -46.37 7.81 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.58 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 110.044 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.49 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.69 -59.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.107 0 C-N-CA 122.592 2.194 . . . . 0.0 109.922 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 54.2 tt0 131.7 9.38 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 123.882 0.873 . . . . 0.0 108.785 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.0 m0 -71.96 166.01 23.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.73 -1.231 . . . . 14.29 110.436 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.562 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.0 m0 -129.6 145.09 51.52 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.284 -0.635 . . . . 11.8 109.284 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.17 96.64 5.93 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.87 128.76 56.05 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.884 0.849 . . . . 0.0 110.45 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.69 150.36 26.81 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.781 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.35 128.5 43.33 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.297 178.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.41 0.99 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 119.632 -1.918 . . . . 0.0 107.991 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.465 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.64 -4.55 4.31 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.46 33.79 6.99 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 115.25 -0.886 . . . . 14.41 112.306 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.781 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.89 164.11 29.79 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.658 1.729 . . . . 0.0 111.847 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.55 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 122.294 1.045 . . . . 0.0 112.53 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.19 156.85 12.84 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.233 -1.547 . . . . 7.25 109.233 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.42 150.81 43.04 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -1.15 . . . . 0.0 108.644 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.98 136.71 9.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.89 -1.131 . . . . 0.0 109.299 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.18 113.57 1.17 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 108.971 -1.204 . . . . 4.76 108.971 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HD2' ' CE2' ' A' ' 44' ' ' TRP . 15.9 pttt -60.41 3.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.479 -0.763 . . . . 0.0 110.679 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.8 m-20 -102.16 -7.52 22.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.325 -0.86 . . . . 14.84 109.281 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -89.13 8.25 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.302 -0.874 . . . . 10.23 109.486 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.44 156.5 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.059 -1.026 . . . . 6.97 109.522 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 63' ' ' VAL . 2.6 p -106.75 160.73 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' HG22 ' A' ' 62' ' ' VAL . 54.4 t -107.72 134.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.449 -0.782 . . . . 0.0 109.699 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.11 -63.21 1.25 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.264 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.7 p -70.01 151.67 45.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 109.415 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.521 ' OD1' ' O ' ' A' ' 65' ' ' SER . 90.2 m-20 -146.67 152.75 39.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.14 -67.44 1.47 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.41 93.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.364 1.376 . . . . 0.0 109.722 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.1 82.54 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.72 124.93 32.07 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.7 156.22 29.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -1.157 . . . . 0.0 109.431 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.84 167.85 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.3 -0.875 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.33 46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.74 5.32 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.306 -1.114 . . . . 0.0 109.312 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.19 163.69 35.97 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.932 1.754 . . . . 0.0 108.854 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.485 ' H ' HE21 ' B' ' 97' ' ' GLN . 27.6 mt -135.46 119.77 26.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 122.05 0.929 . . . . 0.0 109.377 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.825 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.37 117.02 4.0 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.771 0.796 . . . . 0.0 109.995 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.06 4.9 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.825 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.72 -48.55 8.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.07 4.72 13.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.497 -0.752 . . . . 0.0 109.068 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.243 -0.911 . . . . 0.0 108.564 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -115.89 143.39 30.71 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.47 113.37 1.42 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.496 1.464 . . . . 0.0 110.604 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.663 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -71.03 158.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.49 61.44 0.32 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.898 -1.126 . . . . 0.0 110.733 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.81 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.879 -2.088 . . . . 0.0 107.879 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.69 120.56 41.94 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.663 HG22 HG21 ' B' ' 86' ' ' ILE . 42.4 t -98.69 158.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.444 -0.785 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.57 116.07 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.621 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.86 106.03 18.2 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.042 -1.036 . . . . 0.0 109.466 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.57 42.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.29 4.32 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.08 25.3 75.79 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.82 0.66 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.821 0.819 . . . . 0.0 109.657 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.485 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.39 143.6 46.12 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.2 m95 -141.67 139.93 33.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.55 -1.343 . . . . 0.0 110.661 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.464 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.45 131.94 49.89 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.19 -14.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 120.922 -1.112 . . . . 0.0 108.399 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.77 -26.95 15.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.728 -0.607 . . . . 0.0 110.635 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.24 -6.42 31.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.839 -1.163 . . . . 0.0 110.799 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.32 106.42 12.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.3 m -133.72 175.26 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.259 1.028 . . . . 0.0 111.066 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.8 148.59 46.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.419 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.64 28.54 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.738 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.74 -31.62 0.72 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.075 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.06 -15.41 4.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 110.186 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.68 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.277 -0.89 . . . . 0.0 110.256 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.59 59.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.12 138.3 39.51 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.655 1.57 . . . . 0.0 112.102 -177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.302 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.77 56.94 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.168 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.2 1.71 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.835 . . . . 0.0 109.023 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.15 31.13 2.73 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.921 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.35 178.95 4.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.587 -0.949 . . . . 0.0 109.901 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.43 145.3 24.87 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.558 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.2 p-80 -116.28 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.9 m-85 -132.49 137.69 47.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.96 148.27 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.253 -0.904 . . . . 0.0 111.189 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.0 129.45 11.38 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.692 0.758 . . . . 0.0 110.237 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 51.02 22.97 1.33 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.561 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.48 30.96 20.37 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.32 -1.419 . . . . 0.0 109.698 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.5 mt -143.31 142.78 31.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.502 -0.999 . . . . 0.0 108.755 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.34 152.91 36.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.363 -0.836 . . . . 0.0 110.722 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.552 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.99 140.3 18.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.54 177.38 0.1 Allowed 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.344 -1.343 . . . . 0.0 108.415 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.6 -35.98 82.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 109.341 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.66 -43.76 12.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 111.327 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.64 -43.74 83.85 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.79 -1.193 . . . . 0.0 108.143 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.52 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.46 13.7 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.424 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.9 m-80 -64.55 -44.7 89.95 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.58 -34.45 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.552 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.59 -35.24 46.07 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.443 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.6 -81.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.47 31.34 16.48 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.406 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.54 51.33 15.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -1.133 . . . . 0.0 109.561 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.473 -39.801 1 CA-C-O 70.798 -23.477 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.274 0.559 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.99 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -162.0 35.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.212 -1.17 . . . . 0.0 109.542 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.65 43.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -66.11 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 109.146 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.31 -54.26 2.0 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.446 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.39 73.95 1.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' N ' ' OG ' ' A' ' 65' ' ' SER . 5.2 t -69.41 158.07 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.9 m -145.32 131.53 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.447 -1.408 . . . . 0.0 111.603 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.91 129.22 45.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.9 m -63.45 154.4 32.33 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.501 1.143 . . . . 0.0 110.546 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 8.6 mp -114.41 -17.22 11.82 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.222 -1.399 . . . . 10.54 107.222 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.661 ' H ' HG22 ' A' ' 11' ' ' THR . 14.3 m-85 -149.57 145.08 18.54 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.07 -1.019 . . . . 18.39 110.794 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -73.06 81.4 1.69 Allowed 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 121.479 1.452 . . . . 0.0 109.054 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.77 170.31 13.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.993 -1.067 . . . . 0.0 110.854 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.64 111.13 8.02 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.839 0.828 . . . . 0.0 109.369 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 112.0 10.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 18' ' ' VAL . 32.8 m -130.27 94.19 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 122.873 1.32 . . . . 0.0 109.238 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -144.43 -152.0 0.4 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.385 -1.28 . . . . 38.32 107.634 177.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.566 ' H ' HG22 ' A' ' 19' ' ' THR . 83.8 tt0 -82.42 -54.33 5.29 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.824 -1.547 . . . . 55.13 106.824 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.1 mt-10 -109.38 29.3 7.68 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.364 -0.835 . . . . 0.0 110.728 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -100.47 150.79 22.28 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.966 -1.084 . . . . 0.0 109.776 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.25 111.38 22.4 Favored 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.385 -0.822 . . . . 11.68 110.796 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.38 127.63 41.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.93 142.24 21.58 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.385 -1.447 . . . . 12.44 110.839 -178.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.15 155.9 22.36 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 146.95 19.15 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.251 -0.906 . . . . 29.03 109.515 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.11 6.59 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.306 -1.517 . . . . 6.18 109.306 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.68 22.73 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.47 -1.018 . . . . 9.52 109.385 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.96 108.69 6.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.52 133.68 49.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 123.154 1.454 . . . . 0.0 110.504 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.75 103.12 15.86 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.372 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.11 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.534 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.474 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.72 -50.36 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.881 -1.137 . . . . 0.0 110.259 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.59 43.65 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.973 -1.079 . . . . 0.0 110.736 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.05 65.54 65.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.79 165.4 31.55 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.628 1.552 . . . . 0.0 108.973 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.52 7.76 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.73 -59.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.309 0.576 . . . . 0.0 110.041 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.75 -47.32 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.78 -59.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 122.621 2.214 . . . . 0.0 109.908 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 67.6 mt-10 131.75 9.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.853 0.861 . . . . 0.0 108.768 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.558 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.8 m0 -71.85 165.9 23.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.578 -1.326 . . . . 14.29 110.451 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.445 ' C ' HD13 ' A' ' 55' ' ' LEU . 24.9 m0 -129.57 145.03 51.51 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 109.237 -0.653 . . . . 11.8 109.237 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.99 96.62 5.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.84 56.1 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.928 0.871 . . . . 0.0 110.326 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.69 150.28 26.85 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.78 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.33 128.54 43.35 Favored 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 117.15 -1.82 . . . . 0.0 107.223 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.33 0.99 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 119.579 -1.951 . . . . 0.0 108.045 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.47 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.68 4.46 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.66 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.55 33.97 6.86 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 115.309 -0.859 . . . . 14.41 112.261 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.78 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -138.0 164.08 29.95 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 119.645 1.722 . . . . 0.0 111.803 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-O 122.381 1.086 . . . . 0.0 112.417 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.04 156.74 12.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.211 -1.556 . . . . 7.25 109.211 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.34 150.83 43.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.261 -1.141 . . . . 0.0 108.598 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.67 8.91 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.969 -1.082 . . . . 0.0 109.266 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.15 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 N-CA-C 109.09 -1.158 . . . . 4.76 109.09 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.568 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.29 3.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.768 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' PRO . 47.2 p30 -102.1 -7.65 22.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.256 -0.902 . . . . 14.84 109.354 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.03 8.23 30.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.181 -0.949 . . . . 10.23 109.497 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.47 156.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.14 -0.975 . . . . 6.97 109.456 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 63' ' ' VAL . 7.5 p -106.78 160.75 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.521 ' N ' HG22 ' A' ' 62' ' ' VAL . 46.5 t -107.67 134.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.49 -0.756 . . . . 0.0 109.765 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.12 -63.27 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.599 -0.688 . . . . 0.0 109.182 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 15.4 p -69.89 151.59 45.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.062 -1.024 . . . . 0.0 109.491 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -146.59 152.64 39.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.21 -67.36 1.47 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.33 93.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.393 1.395 . . . . 0.0 109.725 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.01 82.48 1.74 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.86 125.04 32.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.112 -0.993 . . . . 0.0 109.437 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.18 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -1.121 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.79 167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.34 46.85 0.2 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.19 130.76 5.37 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.414 -1.051 . . . . 0.0 109.405 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.3 163.57 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.915 1.743 . . . . 0.0 108.881 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.481 ' H ' HE21 ' B' ' 97' ' ' GLN . 29.9 mt -135.38 119.71 26.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-O 122.082 0.944 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.824 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.32 117.0 3.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.885 0.85 . . . . 0.0 109.983 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.78 -0.29 4.96 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.824 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.54 -48.52 8.3 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.302 -1.116 . . . . 0.0 109.503 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.1 4.79 13.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 53.59 41.22 32.13 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -115.9 143.34 30.61 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.642 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.44 113.48 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.436 1.424 . . . . 0.0 110.542 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.672 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.93 158.36 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.47 61.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.872 -1.142 . . . . 0.0 110.687 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -101.96 0.15 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.6 42.14 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.672 HG22 HG21 ' B' ' 86' ' ' ILE . 42.6 t -98.82 158.68 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.736 0.779 . . . . 0.0 111.144 -177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.52 115.99 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.63 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.86 106.05 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 109.558 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.53 42.62 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.627 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.22 17.06 4.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.33 75.79 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.29 -154.7 0.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.63 0.729 . . . . 0.0 109.813 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.481 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.44 143.47 45.93 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.9 m95 -141.65 140.03 33.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.53 -1.356 . . . . 0.0 110.584 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.48 132.01 50.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.7 t -53.37 -14.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.968 -1.082 . . . . 0.0 108.315 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.83 -26.9 15.46 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.776 -0.577 . . . . 0.0 110.616 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -98.24 -6.47 31.1 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.94 -1.1 . . . . 0.0 110.787 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.64 175.31 11.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 122.232 1.015 . . . . 0.0 111.072 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.76 46.05 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.329 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.96 28.67 1.77 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 109.65 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.417 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.6 0.72 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.354 -0.841 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.14 -15.52 4.18 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.89 47.57 0.32 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.205 -0.934 . . . . 0.0 110.088 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.52 109.65 59.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.19 138.25 39.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.716 1.611 . . . . 0.0 112.099 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.321 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.74 56.94 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.151 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.13 -55.14 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 0.0 109.072 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.27 30.96 2.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.921 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.18 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.58 -0.953 . . . . 0.0 110.04 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.38 145.44 24.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.37 169.48 9.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.6 m-85 -132.47 137.69 47.32 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.14 148.35 28.93 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.213 -0.929 . . . . 0.0 111.174 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.26 11.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.595 0.712 . . . . 0.0 110.306 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.22 22.95 1.47 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.648 -0.657 . . . . 0.0 109.435 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.627 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.47 30.95 20.41 Favored Glycine 0 N--CA 1.482 1.75 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.499 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.31 142.64 31.39 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.534 -0.98 . . . . 0.0 108.873 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.38 152.76 36.2 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.793 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.2 m-85 -153.8 140.31 18.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.9 m -57.63 177.44 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.414 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.59 -35.9 82.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.446 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.4 m -86.65 -43.86 12.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 111.301 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.74 83.73 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.834 -1.167 . . . . 0.0 108.1 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.78 -56.38 14.24 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.64 -44.79 89.34 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.078 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.44 -34.32 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.74 -35.35 44.86 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.279 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.48 -81.64 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.095 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.42 31.42 16.41 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.7 m-20 48.56 51.17 15.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -1.103 . . . . 0.0 109.613 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.728 1 CA-C-O 70.977 -23.392 . . . . 0.0 109.455 179.964 . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.35 74.81 0.12 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.9 35.25 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.057 -1.26 . . . . 0.0 109.58 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.11 148.67 43.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.142 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -66.06 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.105 -0.997 . . . . 0.0 109.275 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.5 mt -121.23 -54.37 2.0 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.8 m-70 -145.2 73.88 1.38 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.552 ' N ' ' OG ' ' A' ' 65' ' ' SER . 38.6 t -69.38 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.36 131.47 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.458 -1.401 . . . . 0.0 111.549 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -99.8 129.29 45.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 13' ' ' TYR . 35.5 m -63.44 154.45 32.16 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.483 1.135 . . . . 0.0 110.598 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 HG13 ' A' ' 62' ' ' VAL . 87.1 mt -114.37 -17.35 11.81 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.251 -1.388 . . . . 10.54 107.251 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.666 ' H ' HG22 ' A' ' 11' ' ' THR . 14.0 m-85 -149.49 145.08 18.58 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.03 -1.044 . . . . 18.39 110.783 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -73.06 81.55 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 121.438 1.425 . . . . 0.0 108.965 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.5 t80 -71.85 170.4 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.845 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.5 m -137.7 111.04 7.93 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.787 0.803 . . . . 0.0 109.472 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.32 111.93 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 18' ' ' VAL . 10.7 m -130.43 94.3 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 123.056 1.408 . . . . 0.0 109.147 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.5 m -144.38 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.272 -1.331 . . . . 38.32 107.569 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.693 ' H ' HG22 ' A' ' 19' ' ' THR . 97.3 mt-10 -82.39 -54.39 5.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.923 -1.51 . . . . 55.13 106.923 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.442 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.17 29.01 7.91 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.4 -0.812 . . . . 0.0 110.762 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.629 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -100.4 150.9 22.14 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.863 -1.148 . . . . 0.0 109.787 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.36 111.39 22.4 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.419 -0.801 . . . . 11.68 110.756 -178.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.4 127.68 41.63 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.27 21.67 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.4 -1.437 . . . . 12.44 110.943 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.614 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.82 22.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.87 18.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 121.242 -0.911 . . . . 29.03 109.617 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.63 44.09 6.61 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.317 -1.513 . . . . 6.18 109.317 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.82 22.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.541 -0.976 . . . . 9.52 109.396 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.06 108.64 6.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.79 49.68 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.192 1.472 . . . . 0.0 110.527 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.477 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.539 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.07 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -0.782 . . . . 0.0 111.53 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.497 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.76 -50.41 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.968 -1.082 . . . . 0.0 110.267 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.21 157.63 43.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.933 -1.105 . . . . 0.0 110.844 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.539 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.03 65.5 65.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.836 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.4 31.51 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 121.578 1.518 . . . . 0.0 108.96 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.04 -46.52 7.75 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.59 -59.25 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.391 0.615 . . . . 0.0 110.141 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.66 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 178.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.56 -59.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.583 2.188 . . . . 0.0 109.909 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 17.8 pt-20 131.83 9.27 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 123.892 0.877 . . . . 0.0 108.786 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.571 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.1 m0 -71.77 165.92 23.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.669 -1.27 . . . . 14.29 110.48 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.486 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.4 m0 -129.63 144.99 51.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.243 -0.651 . . . . 11.8 109.243 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -78.93 96.58 5.75 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.498 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.87 56.12 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.914 0.864 . . . . 0.0 110.373 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.72 150.37 26.75 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.776 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 117.261 -1.776 . . . . 0.0 107.163 178.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.37 1.0 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.675 -1.89 . . . . 0.0 108.011 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.457 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.68 -4.59 4.38 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.42 33.88 6.95 Favored Glycine 0 N--CA 1.48 1.627 0 CA-C-N 115.386 -0.825 . . . . 14.41 112.297 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.776 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.14 29.7 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.633 1.717 . . . . 0.0 111.849 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.92 154.59 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-O 122.362 1.077 . . . . 0.0 112.434 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.2 156.75 12.73 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.338 -1.505 . . . . 7.25 109.338 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.23 150.89 43.27 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.296 -1.12 . . . . 0.0 108.681 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.09 136.71 8.95 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.84 -1.162 . . . . 0.0 109.342 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.22 113.6 1.18 Allowed 'Trans proline' 0 C--O 1.216 -0.602 0 N-CA-C 109.074 -1.164 . . . . 4.76 109.074 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.5 pttt -60.37 3.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.487 -0.758 . . . . 0.0 110.603 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 98.7 m-20 -102.05 -7.66 22.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.144 -0.973 . . . . 14.84 109.323 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.22 30.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 10.23 109.494 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.1 m -147.38 156.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 6.97 109.589 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 12' ' ' LEU . 29.0 m -106.77 160.69 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.2 t -107.59 134.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.411 -0.806 . . . . 0.0 109.719 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.19 -63.28 1.25 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 13.8 p -69.91 151.61 45.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.983 -1.073 . . . . 0.0 109.418 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -146.59 152.68 39.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.12 -67.23 1.48 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.254 1.302 . . . . 0.0 109.732 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.7 1.79 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.9 125.09 32.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.86 156.21 28.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -1.181 . . . . 0.0 109.507 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.73 167.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.25 46.93 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.75 5.33 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.383 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.522 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.8 35.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.816 1.677 . . . . 0.0 108.828 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.559 HG23 ' C ' ' B' ' 84' ' ' ARG . 61.3 mt -135.52 119.75 26.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 122.072 0.939 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.29 116.94 3.92 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.819 0.818 . . . . 0.0 109.96 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.3 4.96 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.53 -48.62 8.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -1.057 . . . . 0.0 109.455 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.86 13.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 53.59 41.27 32.12 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.559 ' C ' HG23 ' B' ' 78' ' ' ILE . 29.1 mtp180 -115.91 143.49 30.91 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.6 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.511 1.474 . . . . 0.0 110.494 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.655 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.96 158.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.424 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.52 61.48 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 110.615 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.0 -101.93 0.15 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.704 -2.159 . . . . 0.0 107.704 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.61 120.62 42.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 86' ' ' ILE . 42.5 t -98.77 158.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.419 -0.801 . . . . 0.0 111.195 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.47 ' N ' HG12 ' B' ' 90' ' ' VAL . 5.0 t -122.55 116.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.625 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.85 106.11 18.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.033 -1.042 . . . . 0.0 109.622 -179.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.51 42.68 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.637 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.15 4.29 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.38 25.11 76.16 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.16 -154.83 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.788 0.804 . . . . 0.0 109.726 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.482 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.35 143.49 46.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.4 m95 -141.64 139.99 33.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.416 -1.428 . . . . 0.0 110.646 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.465 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.58 131.94 50.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG23 ' B' ' 91' ' ' VAL . 7.8 t -53.16 -14.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.909 -1.119 . . . . 0.0 108.348 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.465 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.83 -26.97 15.44 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 110.638 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.06 -6.6 31.46 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.93 -1.107 . . . . 0.0 110.787 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.24 106.34 12.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.3 m -133.64 175.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.267 1.032 . . . . 0.0 111.088 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.85 148.66 46.45 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.354 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.87 28.77 1.72 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.676 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.413 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.82 -31.62 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.309 -0.87 . . . . 0.0 110.086 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.24 -15.25 4.18 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.54 47.6 0.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.232 -0.918 . . . . 0.0 110.24 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.44 109.59 59.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.12 138.26 39.42 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.79 1.66 . . . . 0.0 112.006 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.325 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.038 0.0 OUTLIER -95.77 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.075 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.04 -55.24 1.61 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.001 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.98 2.75 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.947 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.36 178.97 4.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.416 -1.05 . . . . 0.0 109.958 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.53 145.41 24.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.797 . . . . 0.0 109.295 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.568 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.39 169.55 9.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.472 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.54 137.66 47.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.96 148.3 28.81 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.203 -0.936 . . . . 0.0 111.18 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.31 11.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.469 -0.77 . . . . 0.0 110.327 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.31 22.8 1.49 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.637 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 31.02 20.41 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.79 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.37 142.8 31.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.61 -0.936 . . . . 0.0 108.799 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.43 152.82 36.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.331 -0.855 . . . . 0.0 110.673 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.5 m-85 -153.84 140.36 18.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.3 m -57.72 177.55 0.1 Allowed 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.299 -1.36 . . . . 0.0 108.441 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.3 tt0 -63.67 -35.92 82.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.853 . . . . 0.0 109.436 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.445 ' O ' ' N ' ' B' ' 132' ' ' GLN . 55.1 m -86.61 -43.81 12.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 111.349 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.66 -43.73 83.79 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.738 -1.226 . . . . 0.0 108.177 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.76 -56.5 13.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.419 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.42 -44.92 89.72 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.184 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.43 -34.36 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.63 -35.35 45.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.384 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.7 m-85 -158.51 -81.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 110.054 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.46 31.44 16.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 48.39 51.37 15.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.327 -1.102 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.475 -39.698 1 CA-C-O 70.992 -23.385 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.309 0.576 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.98 0.12 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.5 p -161.91 35.2 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -1.208 . . . . 0.0 109.666 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.01 148.62 43.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.296 -0.878 . . . . 0.0 109.139 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.5 t -65.92 93.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -121.26 -54.32 2.0 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.31 73.88 1.37 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 8' ' ' VAL . 3.4 t -69.41 158.13 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 31' ' ' MET . 4.8 m -145.44 131.6 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.48 -1.387 . . . . 0.0 111.513 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -100.03 129.16 46.06 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 13' ' ' TYR . 34.3 m -63.3 154.39 31.84 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.497 1.141 . . . . 0.0 110.617 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 93.1 mt -114.37 -17.28 11.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.211 -1.403 . . . . 10.54 107.211 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.671 ' H ' HG22 ' A' ' 11' ' ' THR . 14.3 m-85 -149.49 145.06 18.54 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 121.133 -0.979 . . . . 18.39 110.794 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -72.87 81.4 1.64 Allowed 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.468 1.445 . . . . 0.0 109.07 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.3 t80 -71.76 170.33 13.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.923 -1.111 . . . . 0.0 110.91 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.61 111.07 7.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.776 0.798 . . . . 0.0 109.431 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.31 111.96 10.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 18' ' ' VAL . 19.7 m -130.29 94.25 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 122.9 1.333 . . . . 0.0 109.134 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.817 HG22 ' H ' ' A' ' 20' ' ' GLU . 2.6 m -144.46 -151.98 0.4 Allowed 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.362 -1.29 . . . . 38.32 107.581 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.817 ' H ' HG22 ' A' ' 19' ' ' THR . 76.7 mm-40 -82.5 -54.29 5.3 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.903 -1.518 . . . . 55.13 106.903 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 95.5 mt-10 -109.3 29.2 7.76 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.53 150.93 22.17 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.907 -1.12 . . . . 0.0 109.741 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.31 111.38 22.39 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.342 -0.849 . . . . 11.68 110.82 -178.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.36 127.7 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -153.03 142.22 21.47 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.327 -1.483 . . . . 12.44 110.851 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.591 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.87 22.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 146.93 18.91 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.255 -0.903 . . . . 29.03 109.492 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.59 44.14 6.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.273 -1.531 . . . . 6.18 109.273 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.29 114.79 22.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.652 -0.911 . . . . 9.52 109.436 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.459 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.99 108.57 5.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.489 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.51 133.65 49.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 123.21 1.481 . . . . 0.0 110.549 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.6 102.95 15.69 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.48 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 111.49 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.48 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.85 -50.39 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 120.917 -1.114 . . . . 0.0 110.176 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.16 157.62 43.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.99 -1.069 . . . . 0.0 110.831 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.04 65.52 65.35 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.71 165.28 31.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.721 1.614 . . . . 0.0 109.027 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.02 -46.49 7.77 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.67 -59.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.353 0.597 . . . . 0.0 110.037 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.89 -47.54 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.64 -59.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.608 2.205 . . . . 0.0 109.996 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.9 pt-20 131.67 9.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 123.878 0.871 . . . . 0.0 108.806 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.582 ' HB2' HD12 ' A' ' 55' ' ' LEU . 11.7 m0 -71.79 165.91 23.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.712 -1.242 . . . . 14.29 110.527 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 21.1 m0 -129.46 145.12 51.47 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.633 -0.667 . . . . 11.8 109.302 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.17 96.61 5.92 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -115.92 128.81 56.06 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.966 0.888 . . . . 0.0 110.347 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.63 150.48 26.8 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.785 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.46 128.57 43.51 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 117.275 -1.77 . . . . 0.0 107.216 177.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.38 -18.44 1.02 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 119.611 -1.931 . . . . 0.0 107.972 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.58 -4.77 4.43 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.655 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 34.04 6.85 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.438 -0.801 . . . . 14.41 112.215 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.785 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.96 164.11 29.84 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 119.628 1.714 . . . . 0.0 111.765 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.84 154.55 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.305 1.05 . . . . 0.0 112.507 -177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.14 156.69 12.61 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.324 -1.511 . . . . 7.25 109.324 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.76 43.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.171 -1.194 . . . . 0.0 108.674 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.98 136.75 9.04 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 120.954 -1.092 . . . . 0.0 109.289 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.12 113.46 1.11 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 N-CA-C 109.052 -1.172 . . . . 4.76 109.052 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.4 pttt -60.36 3.23 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.443 -0.786 . . . . 0.0 110.71 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.3 m120 -102.17 -7.48 22.17 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.3 -0.875 . . . . 14.84 109.326 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.05 8.16 31.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.089 -1.007 . . . . 10.23 109.343 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.45 156.62 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.219 -0.926 . . . . 6.97 109.561 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 63' ' ' VAL . 7.5 p -106.84 160.86 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.506 ' N ' HG22 ' A' ' 62' ' ' VAL . 5.5 p -107.72 134.31 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 64' ' ' LEU . 11.2 mp -105.2 -63.14 1.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.566 -0.709 . . . . 0.0 109.202 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 31.8 m -70.15 151.69 45.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.99 -1.069 . . . . 0.0 109.417 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -146.58 152.67 39.31 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.18 -67.3 1.48 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.32 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.31 1.34 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.58 1.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.79 124.96 32.16 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.94 156.19 28.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -1.134 . . . . 0.0 109.41 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.83 167.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.28 46.88 0.2 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.27 130.76 5.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.0 109.463 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.15 163.65 36.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.024 1.816 . . . . 0.0 108.811 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.481 ' H ' HE21 ' B' ' 97' ' ' GLN . 74.8 mt -135.47 119.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.073 0.939 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.48 117.05 4.07 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.833 0.825 . . . . 0.0 109.962 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.94 -0.13 4.97 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.64 -48.6 8.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.372 -1.075 . . . . 0.0 109.422 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.12 4.83 13.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 53.55 41.26 32.12 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.474 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.0 mmm180 -115.98 143.55 31.08 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.45 113.34 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.417 1.411 . . . . 0.0 110.611 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.658 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.89 158.47 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.422 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.6 61.57 0.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.877 -1.139 . . . . 0.0 110.667 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.06 -102.08 0.15 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.68 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.71 42.51 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.658 HG22 HG21 ' B' ' 86' ' ' ILE . 43.2 t -98.82 158.72 3.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 111.155 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.6 116.16 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.636 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.89 106.15 18.28 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 109.534 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.53 159.5 42.67 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.1 17.23 4.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.22 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.851 -0.793 . . . . 0.0 109.856 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.481 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.48 143.54 45.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.5 m95 -141.57 140.05 33.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.526 -1.359 . . . . 0.0 110.646 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.455 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.61 132.12 50.82 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.6 t -53.36 -14.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.927 -1.108 . . . . 0.0 108.408 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.455 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.68 -27.18 15.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.778 -0.576 . . . . 0.0 110.589 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -97.94 -6.63 31.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.901 -1.124 . . . . 0.0 110.899 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.15 106.29 12.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.821 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.0 m -133.56 175.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.358 1.075 . . . . 0.0 111.073 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.95 148.7 46.72 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.2 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.65 1.74 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.158 -0.963 . . . . 0.0 109.837 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.43 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.79 -31.47 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.321 -0.862 . . . . 0.0 110.196 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.4 p -129.23 -15.29 4.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.296 -0.878 . . . . 0.0 110.076 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.61 47.57 0.35 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.794 . . . . 0.0 110.267 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.5 59.05 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.821 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.07 138.23 39.5 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.73 1.62 . . . . 0.0 112.179 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.314 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.8 57.04 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.196 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.629 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.12 -55.29 1.64 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 108.997 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.07 31.0 2.75 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.922 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.31 178.98 4.13 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.611 -0.935 . . . . 0.0 109.94 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.37 145.3 24.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.564 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.3 p-80 -116.25 169.57 9.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.5 m-85 -132.57 137.65 47.17 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.32 28.85 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.14 -0.975 . . . . 0.0 111.204 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.03 129.24 11.2 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.615 0.722 . . . . 0.0 110.324 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.36 22.74 1.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.632 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.96 20.32 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 119.424 -1.369 . . . . 0.0 109.741 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.7 mt -143.25 142.63 31.44 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.608 -0.937 . . . . 0.0 108.873 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.16 152.8 36.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -153.87 140.34 18.76 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.6 m -57.74 177.44 0.11 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.299 -1.361 . . . . 0.0 108.401 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.58 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.58 -35.94 82.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.417 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.71 -43.66 12.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 111.311 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.466 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.83 -43.55 83.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.817 -1.177 . . . . 0.0 108.206 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.82 -56.37 14.37 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.7 m-80 -64.6 -44.91 89.13 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.009 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.45 -34.35 61.32 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.63 -35.34 45.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.381 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.58 -81.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 110.096 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.4 31.34 16.69 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.48 51.24 15.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -1.084 . . . . 0.0 109.576 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.731 1 CA-C-O 70.981 -23.39 . . . . 0.0 109.454 179.915 . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.39 74.84 0.12 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.95 35.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -1.172 . . . . 0.0 109.624 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -72.99 148.6 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.167 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 34.5 t -65.96 93.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.288 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.4 mt -121.29 -54.41 1.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -145.23 73.94 1.38 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.46 158.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 31' ' ' MET . 3.9 m -145.34 131.45 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.416 -1.427 . . . . 0.0 111.564 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.92 129.22 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 13' ' ' TYR . 32.8 m -63.41 154.43 32.1 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.487 1.136 . . . . 0.0 110.572 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.534 HD11 HG23 ' A' ' 62' ' ' VAL . 90.5 mt -114.31 -17.36 11.84 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.274 -1.38 . . . . 10.54 107.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.678 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.51 144.96 18.39 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.16 -0.963 . . . . 18.39 110.803 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.97 81.54 1.65 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.392 1.395 . . . . 0.0 109.024 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.92 170.32 13.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.978 -1.077 . . . . 0.0 110.86 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.63 111.08 7.99 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.831 0.824 . . . . 0.0 109.47 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 111.86 10.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.2 t -130.23 94.35 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.938 1.352 . . . . 0.0 109.2 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.949 HG22 ' H ' ' A' ' 20' ' ' GLU . 4.9 m -144.49 -151.97 0.39 Allowed 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.335 -1.302 . . . . 38.32 107.557 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.949 ' H ' HG22 ' A' ' 19' ' ' THR . 45.6 tp10 -82.41 -54.36 5.27 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.885 -1.524 . . . . 55.13 106.885 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.8 mt-10 -109.38 29.23 7.74 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.447 -0.783 . . . . 0.0 110.712 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.643 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -100.49 150.98 22.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.811 -1.181 . . . . 0.0 109.727 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.43 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 121.443 -0.786 . . . . 11.68 110.765 -178.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.53 127.69 41.77 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.83 142.25 21.68 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.352 -1.467 . . . . 12.44 110.876 -178.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.21 155.76 22.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 146.91 18.73 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.227 -0.921 . . . . 29.03 109.452 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 44.17 6.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.326 -1.51 . . . . 6.18 109.326 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.34 114.67 22.72 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.487 -1.008 . . . . 9.52 109.416 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -72.97 108.69 6.02 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.452 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.59 133.63 50.01 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.201 1.477 . . . . 0.0 110.532 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.71 103.05 15.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.466 -178.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.0 92.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.573 -0.705 . . . . 0.0 111.496 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.4 mt -59.65 -50.52 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.94 -1.1 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.12 157.67 43.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.991 -1.068 . . . . 0.0 110.788 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.07 65.6 65.35 Favored Pre-proline 0 N--CA 1.486 1.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.761 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.74 165.34 31.71 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.715 1.61 . . . . 0.0 108.947 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.16 -46.3 7.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.446 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.5 m-20 57.62 -59.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.442 0.639 . . . . 0.0 110.054 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.71 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.61 -59.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.128 0 C-N-CA 122.597 2.198 . . . . 0.0 109.968 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 18.1 pt-20 131.86 9.22 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.829 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.51 ' HB2' HD12 ' A' ' 55' ' ' LEU . 22.1 m0 -71.81 165.87 23.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.626 -1.296 . . . . 14.29 110.519 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.487 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 20.8 m0 -129.55 145.11 51.5 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.286 -0.635 . . . . 11.8 109.286 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.15 96.66 5.92 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -116.0 128.8 56.02 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.954 0.883 . . . . 0.0 110.378 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.9 tttt -82.6 150.44 26.86 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.775 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.45 128.58 43.52 Favored 'General case' 0 N--CA 1.509 2.487 0 C-N-CA 117.266 -1.773 . . . . 0.0 107.215 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.5 -18.28 1.05 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.734 -1.854 . . . . 0.0 107.913 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.468 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.55 4.33 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.651 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.35 33.96 6.94 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 115.257 -0.883 . . . . 14.41 112.286 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.775 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.86 164.07 29.86 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.745 1.772 . . . . 0.0 111.829 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.97 154.58 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 122.335 1.064 . . . . 0.0 112.52 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.84 12.85 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.236 -1.546 . . . . 7.25 109.236 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.51 150.97 42.76 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.296 -1.12 . . . . 0.0 108.613 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.12 136.67 8.91 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.82 -1.175 . . . . 0.0 109.265 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.04 113.46 1.1 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 108.992 -1.195 . . . . 4.76 108.992 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 62.7 pttt -60.33 3.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 110.66 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 57' ' ' PRO . 96.3 m-20 -102.01 -7.66 22.15 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.275 -0.891 . . . . 14.84 109.334 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.96 8.11 31.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.239 -0.913 . . . . 10.23 109.56 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 11' ' ' THR . 32.0 m -147.32 156.57 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 6.97 109.542 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.534 HG23 HD11 ' A' ' 12' ' ' LEU . 15.0 t -106.86 160.69 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 10.4 p -107.57 134.34 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.392 -0.818 . . . . 0.0 109.814 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.19 -63.15 1.26 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.487 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 33.9 m -70.05 151.68 45.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.956 -1.09 . . . . 0.0 109.503 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -146.75 152.69 39.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.1 -67.27 1.48 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.52 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.209 1.273 . . . . 0.0 109.637 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.97 82.53 1.75 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.05 32.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.69 156.27 29.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 109.532 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.7 mtt -49.92 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.27 46.92 0.2 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.3 130.73 5.32 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.283 -1.128 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.519 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.58 36.1 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.872 1.714 . . . . 0.0 108.848 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.513 HD13 ' CG2' ' A' ' 62' ' ' VAL . 72.7 mt -135.33 119.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 122.001 0.905 . . . . 0.0 109.379 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.83 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.24 116.88 3.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.75 -0.1 4.73 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.83 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.78 -48.41 8.25 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.361 -1.082 . . . . 0.0 109.397 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.19 4.89 13.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.521 -0.737 . . . . 0.0 109.07 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 53.43 41.47 32.11 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.487 ' C ' HG23 ' B' ' 78' ' ' ILE . 2.6 mtp-105 -115.94 143.32 30.61 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.8 Cg_exo -56.33 113.25 1.36 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.49 1.46 . . . . 0.0 110.636 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.668 HG21 HG22 ' B' ' 90' ' ' VAL . 21.7 mt -70.9 158.53 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.642 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.425 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.6 61.44 0.32 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.873 -1.142 . . . . 0.0 110.615 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.96 -101.96 0.15 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.677 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.74 120.61 42.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.668 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.67 158.75 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.698 0.761 . . . . 0.0 111.186 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.59 115.92 47.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.634 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.81 106.11 18.25 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.083 -1.011 . . . . 0.0 109.557 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.48 42.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.32 4.35 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.3 75.82 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.27 -154.8 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.747 0.784 . . . . 0.0 109.684 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.484 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.41 143.4 45.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.46 140.06 33.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.606 -1.309 . . . . 0.0 110.651 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.469 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.5 131.93 50.0 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.9 t -53.17 -14.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.988 -1.07 . . . . 0.0 108.465 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.469 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.8 -26.87 15.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.762 -0.586 . . . . 0.0 110.608 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.14 -6.51 31.37 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.909 -1.119 . . . . 0.0 110.804 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.27 106.31 12.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.58 175.39 11.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.153 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' B' ' 125' ' ' TYR . 1.5 t -62.83 148.69 46.3 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.375 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.74 1.73 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.5 tptm -138.83 -31.74 0.71 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 110.135 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.5 p -129.08 -15.32 4.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.104 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.63 47.58 0.34 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.38 109.69 59.55 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.14 138.35 39.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.636 1.558 . . . . 0.0 112.144 -177.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.81 56.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.172 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.621 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -38.98 -55.35 1.57 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.04 2.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.934 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.96 4.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.429 -1.042 . . . . 0.0 109.977 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.51 145.28 24.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.3 169.42 9.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.0 109.471 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.5 137.72 47.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.06 148.34 28.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.353 -0.842 . . . . 0.0 111.266 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.95 129.31 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.724 . . . . 0.0 110.424 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.15 22.97 1.43 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.41 30.94 20.63 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.77 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.9 mt -143.27 142.66 31.43 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.968 . . . . 0.0 108.853 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.31 152.93 36.27 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.735 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.555 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.99 140.28 18.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.1 m -57.54 177.46 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.404 -1.318 . . . . 0.0 108.508 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.64 -35.99 82.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 56.5 m -86.54 -43.79 12.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 111.426 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.62 -43.85 83.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.812 -1.18 . . . . 0.0 108.155 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.75 -56.49 13.49 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.2 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.153 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -54.55 -34.29 61.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.71 -35.24 45.19 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.357 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.537 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.52 -81.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.047 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.45 31.37 16.45 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.1 m-20 48.57 51.2 15.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -1.09 . . . . 0.0 109.561 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.476 -39.647 1 CA-C-O 70.829 -23.462 . . . . 0.0 109.479 -179.975 . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.91 0.12 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -162.03 35.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -1.102 . . . . 0.0 109.614 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.8 ttm-85 -73.01 148.62 44.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.127 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.05 93.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.3 mt -121.19 -54.27 2.01 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.32 74.04 1.38 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.55 157.97 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -145.2 131.52 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.365 -1.459 . . . . 0.0 111.553 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -99.9 129.27 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 13' ' ' TYR . 28.3 m -63.47 154.35 32.57 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.499 1.142 . . . . 0.0 110.544 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 91.7 mt -114.3 -17.29 11.86 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.221 -1.4 . . . . 10.54 107.221 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.669 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.48 145.07 18.56 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.154 -0.966 . . . . 18.39 110.768 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -72.98 81.51 1.66 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.345 1.363 . . . . 0.0 109.059 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.4 t80 -71.88 170.3 13.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.912 -1.117 . . . . 0.0 110.821 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.58 111.16 8.07 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.809 0.814 . . . . 0.0 109.389 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.27 111.89 10.61 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 18' ' ' VAL . 23.2 m -130.37 94.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.904 1.335 . . . . 0.0 109.197 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -144.46 -152.04 0.4 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.383 -1.28 . . . . 38.32 107.63 177.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.565 ' H ' HG22 ' A' ' 19' ' ' THR . 97.3 mt-10 -82.41 -54.31 5.31 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.936 -1.505 . . . . 55.13 106.936 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.6 mt-10 -109.25 29.21 7.74 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.47 -0.769 . . . . 0.0 110.827 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.616 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.61 150.92 22.21 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.861 -1.149 . . . . 0.0 109.682 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -111.31 111.43 22.49 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.39 -0.819 . . . . 11.68 110.71 -178.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.45 127.68 41.69 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.92 142.27 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.436 -1.415 . . . . 12.44 110.798 -178.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.32 155.87 22.17 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.41 146.94 18.43 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.266 -0.896 . . . . 29.03 109.506 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 44.09 6.59 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.286 -1.526 . . . . 6.18 109.286 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.87 23.01 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.534 -0.98 . . . . 9.52 109.358 -179.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.22 108.74 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.56 133.75 49.81 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 123.228 1.49 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.86 103.11 15.86 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 113.745 -1.571 . . . . 0.0 107.351 -178.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.15 92.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.495 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.0 mt -59.9 -50.43 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.121 -0.987 . . . . 0.0 110.145 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.2 tp10 -147.17 157.6 43.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.026 -1.046 . . . . 0.0 110.786 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.552 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.01 65.57 65.7 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.767 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.68 165.43 31.56 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.567 1.512 . . . . 0.0 109.145 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.11 -46.42 7.78 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 58.9 m-20 57.63 -59.43 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.421 0.629 . . . . 0.0 110.071 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.77 -47.48 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.624 2.216 . . . . 0.0 109.899 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 75.2 mt-10 131.86 9.31 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.559 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.8 m0 -71.85 165.91 23.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.619 -1.301 . . . . 14.29 110.385 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.544 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.1 m0 -129.64 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 109.287 -0.635 . . . . 11.8 109.287 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.99 96.58 5.79 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.89 128.69 55.98 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.91 0.862 . . . . 0.0 110.488 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.5 150.31 27.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.785 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.4 128.53 43.41 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 117.226 -1.789 . . . . 0.0 107.289 177.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.36 -18.46 1.01 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.652 -1.905 . . . . 0.0 108.013 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.475 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.61 -4.55 4.26 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.655 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.42 33.95 6.92 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-N 115.355 -0.839 . . . . 14.41 112.253 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.785 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.95 164.06 29.96 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-N 119.71 1.755 . . . . 0.0 111.859 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.83 154.56 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.231 1.015 . . . . 0.0 112.601 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.17 156.73 12.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.24 -1.544 . . . . 7.25 109.24 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.87 43.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.19 -1.182 . . . . 0.0 108.605 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.06 136.83 9.06 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.075 -1.016 . . . . 0.0 109.225 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.23 113.51 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 108.935 -1.217 . . . . 4.76 108.935 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 25.6 pttm -60.23 2.95 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.453 -0.78 . . . . 0.0 110.798 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 57' ' ' PRO . 9.9 m120 -101.96 -7.56 22.29 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.188 -0.945 . . . . 14.84 109.297 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.11 8.34 30.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.289 -0.882 . . . . 10.23 109.481 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.1 m -147.51 156.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.239 -0.913 . . . . 6.97 109.389 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.512 HG22 ' N ' ' A' ' 63' ' ' VAL . 4.8 p -106.82 160.78 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.512 ' N ' HG22 ' A' ' 62' ' ' VAL . 73.1 t -107.62 134.22 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.435 -0.791 . . . . 0.0 109.834 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.436 ' O ' ' NH1' ' B' ' 84' ' ' ARG . 97.9 mt -105.14 -63.08 1.26 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.636 -0.665 . . . . 0.0 109.207 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.491 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 19.4 m -70.11 151.55 45.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 65' ' ' SER . 85.6 m-20 -146.43 152.8 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.16 -67.34 1.47 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.4 93.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.298 1.332 . . . . 0.0 109.669 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.6 1.77 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.83 124.93 32.15 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.121 -0.987 . . . . 0.0 109.395 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.74 156.19 28.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -1.137 . . . . 0.0 109.529 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.78 167.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.444 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.39 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.31 130.84 5.37 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.346 -1.091 . . . . 0.0 109.291 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.4 Cg_endo -74.34 163.65 35.85 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.941 1.761 . . . . 0.0 108.875 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.556 HG23 ' C ' ' B' ' 84' ' ' ARG . 61.7 mt -135.42 119.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 122.054 0.93 . . . . 0.0 109.313 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.33 116.94 3.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 110.045 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.516 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.85 -0.16 4.91 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.55 -48.72 8.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -1.121 . . . . 0.0 109.33 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.01 4.81 13.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 53.62 41.25 32.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.556 ' C ' HG23 ' B' ' 78' ' ' ILE . 5.3 mmm180 -115.95 143.46 30.89 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.45 113.43 1.45 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.416 1.411 . . . . 0.0 110.566 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.667 HG21 HG22 ' B' ' 90' ' ' VAL . 21.3 mt -70.87 158.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.427 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.58 61.57 0.32 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.885 -1.134 . . . . 0.0 110.648 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.16 -101.91 0.15 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.66 120.75 42.61 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.667 HG22 HG21 ' B' ' 86' ' ' ILE . 42.7 t -98.89 158.61 3.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.524 -0.735 . . . . 0.0 111.205 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.475 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.6 115.97 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.641 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.7 106.01 18.18 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.107 -0.996 . . . . 0.0 109.687 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.61 42.46 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 57.92 17.28 4.2 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.24 25.17 76.01 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.14 -154.75 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.776 0.798 . . . . 0.0 109.758 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.482 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.39 143.52 46.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.516 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.1 m95 -141.53 140.01 33.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.462 -1.399 . . . . 0.0 110.644 -177.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.457 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.3 m80 -56.51 131.89 49.9 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.457 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.16 -14.86 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 O-C-N 120.866 -1.146 . . . . 0.0 108.343 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.457 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.11 15.41 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.848 -0.533 . . . . 0.0 110.61 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.13 -6.43 31.56 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 110.746 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.475 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.0 t80 -80.12 106.24 12.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.821 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.2 m -133.57 175.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-O 122.219 1.009 . . . . 0.0 111.143 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.82 148.71 46.18 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.222 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.88 28.7 1.74 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.072 -1.018 . . . . 0.0 109.596 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.76 -31.8 0.71 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.407 ' O ' ' CB ' ' B' ' 109' ' ' GLU . 31.6 p -129.09 -15.36 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.407 ' CB ' ' O ' ' B' ' 108' ' ' CYS . 4.4 mt-10 71.59 47.75 0.34 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.314 -0.866 . . . . 0.0 110.131 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.57 109.62 59.67 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.821 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.08 138.32 39.67 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.656 1.57 . . . . 0.0 112.059 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.305 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.042 0.0 OUTLIER -95.78 56.87 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.131 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.18 -55.15 1.69 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 108.995 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.1 30.96 2.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.907 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.35 178.87 4.17 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.411 -1.052 . . . . 0.0 109.953 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -94.35 145.39 24.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.365 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.42 169.39 9.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 109.504 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.693 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.67 47.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.05 148.29 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.256 -0.902 . . . . 0.0 111.22 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.93 129.41 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.09 22.93 1.37 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.491 -0.756 . . . . 0.0 109.531 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.49 30.99 20.26 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.4 mt -143.33 142.74 31.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.577 -0.955 . . . . 0.0 108.738 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.81 36.26 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.903 . . . . 0.0 110.721 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.556 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.7 m-85 -153.9 140.23 18.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.6 m -57.49 177.48 0.1 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.339 -1.344 . . . . 0.0 108.49 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.2 tt0 -63.65 -36.06 82.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 109.301 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.5 m -86.65 -43.73 12.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.843 . . . . 0.0 111.325 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.72 83.67 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.698 -1.251 . . . . 0.0 108.187 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.7 -56.56 13.03 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.413 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.51 -44.75 89.93 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.139 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.42 61.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.65 -35.22 45.7 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.39 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.62 -81.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.838 . . . . 0.0 110.075 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.33 31.47 16.49 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.422 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 25.9 m-20 48.42 51.3 15.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.245 -1.15 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.749 1 CA-C-O 71.145 -23.312 . . . . 0.0 109.454 179.98 . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.34 74.96 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.3 p -162.0 35.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.082 -1.246 . . . . 0.0 109.606 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 4' ' ' ARG . 25.9 ttm-85 -72.95 148.59 44.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.129 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -66.0 93.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.277 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 mt -121.37 -54.25 1.99 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.438 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 96.1 m-70 -145.34 74.1 1.38 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.502 ' N ' ' OG ' ' A' ' 65' ' ' SER . 82.1 t -69.56 158.12 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.39 131.53 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.401 -1.437 . . . . 0.0 111.538 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -99.92 129.23 45.98 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.665 HG22 ' H ' ' A' ' 13' ' ' TYR . 44.1 m -63.45 154.29 32.69 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.513 1.149 . . . . 0.0 110.614 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.3 mt -114.29 -17.3 11.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.155 -1.424 . . . . 10.54 107.155 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.665 ' H ' HG22 ' A' ' 11' ' ' THR . 13.9 m-85 -149.56 145.04 18.48 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.19 -0.944 . . . . 18.39 110.798 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -73.02 81.47 1.67 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.506 1.471 . . . . 0.0 109.036 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.2 t80 -71.78 170.31 13.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.125 . . . . 0.0 110.944 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.0 7.92 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.738 0.78 . . . . 0.0 109.459 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.29 112.0 10.68 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 18' ' ' VAL . 7.5 m -130.33 94.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-O 122.907 1.337 . . . . 0.0 109.26 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.6 m -144.36 -151.93 0.39 Allowed 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.301 -1.318 . . . . 38.32 107.701 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.705 ' H ' HG22 ' A' ' 19' ' ' THR . 96.2 mt-10 -82.51 -54.42 5.2 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.84 -1.541 . . . . 55.13 106.84 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 96.4 mt-10 -109.3 29.28 7.69 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.357 -0.839 . . . . 0.0 110.759 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.43 150.89 22.16 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.812 -1.18 . . . . 0.0 109.737 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.34 111.41 22.43 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.451 -0.78 . . . . 11.68 110.756 -178.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.39 127.72 41.67 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.99 142.16 21.44 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.386 -1.446 . . . . 12.44 110.905 -178.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.06 155.78 22.52 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 146.98 18.09 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.389 -0.924 . . . . 29.03 109.603 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.56 44.18 6.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.248 -1.541 . . . . 6.18 109.248 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.36 114.82 22.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.545 -0.973 . . . . 9.52 109.452 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.5 m -73.13 108.66 6.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.46 133.81 49.6 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 123.104 1.431 . . . . 0.0 110.588 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 103.09 15.84 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.304 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.13 92.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.518 -0.739 . . . . 0.0 111.504 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.486 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 83.1 mt -59.68 -50.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.979 -1.076 . . . . 0.0 110.259 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.24 157.55 43.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.03 -1.044 . . . . 0.0 110.844 -177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.03 65.72 65.91 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.86 165.36 31.58 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.665 1.577 . . . . 0.0 109.003 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -91.95 -46.57 7.76 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.2 m-20 57.58 -59.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.349 0.595 . . . . 0.0 110.119 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.636 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.69 -47.41 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 178.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.68 -59.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 122.562 2.174 . . . . 0.0 110.022 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 29.7 mm-40 131.76 9.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 123.86 0.864 . . . . 0.0 108.729 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.56 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.9 m0 -71.79 165.88 23.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.718 -1.239 . . . . 14.29 110.546 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.492 ' CZ2' ' HD2' ' A' ' 58' ' ' LYS . 22.1 m0 -129.62 145.07 51.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.661 -0.649 . . . . 11.8 109.263 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.0 96.69 5.83 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.496 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.94 128.74 56.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.866 0.841 . . . . 0.0 110.345 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.57 150.36 26.94 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.779 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.41 128.59 43.47 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 117.27 -1.772 . . . . 0.0 107.181 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.45 -18.37 1.04 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 119.751 -1.843 . . . . 0.0 107.917 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.462 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.67 -4.53 4.31 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.43 33.86 6.96 Favored Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.331 -0.85 . . . . 14.41 112.271 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.779 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.88 164.08 29.86 Favored 'General case' 0 N--CA 1.516 2.841 0 CA-C-N 119.692 1.746 . . . . 0.0 111.762 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.91 154.62 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.369 1.081 . . . . 0.0 112.494 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.21 156.82 12.82 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.302 -1.519 . . . . 7.25 109.302 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.41 150.94 42.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.218 -1.166 . . . . 0.0 108.629 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.02 136.7 8.97 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.836 -1.165 . . . . 0.0 109.356 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.3 Cg_exo -51.2 113.52 1.14 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 N-CA-C 109.002 -1.192 . . . . 4.76 109.002 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 63.7 pttt -60.3 3.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -0.842 . . . . 0.0 110.719 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.594 ' OD1' ' NH2' ' B' ' 83' ' ' ARG . 95.8 m-20 -102.07 -7.59 22.16 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.263 -0.898 . . . . 14.84 109.319 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.93 8.09 31.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.269 -0.894 . . . . 10.23 109.533 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.33 156.66 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 6.97 109.49 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 63' ' ' VAL . 2.7 p -106.82 160.83 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 62' ' ' VAL . 8.5 p -107.75 134.27 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.363 -0.836 . . . . 0.0 109.724 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.6 tp -105.11 -63.1 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.665 -0.647 . . . . 0.0 109.275 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 13.4 p -69.99 151.54 45.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.027 -1.046 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 44.2 p30 -146.54 152.78 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.221 -0.925 . . . . 0.0 109.337 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.15 -67.43 1.47 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.338 1.359 . . . . 0.0 109.693 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.0 82.65 1.77 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.04 32.28 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.65 156.35 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.9 167.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.89 . . . . 0.0 109.493 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.8 0.2 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.24 130.78 5.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.271 -1.135 . . . . 0.0 109.431 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.52 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.28 163.54 36.18 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.958 1.772 . . . . 0.0 108.805 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.527 HG23 ' C ' ' B' ' 84' ' ' ARG . 65.0 mt -135.33 119.78 26.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 122.068 0.937 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.826 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.43 117.09 4.1 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.949 0.881 . . . . 0.0 109.922 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.51 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.17 4.94 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.826 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.71 -48.56 8.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.372 -1.075 . . . . 0.0 109.306 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.05 4.78 13.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . 0.594 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 94.2 mtt-85 53.51 41.32 32.12 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.527 ' C ' HG23 ' B' ' 78' ' ' ILE . 3.9 mmm180 -115.87 143.42 30.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.634 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.54 113.3 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.428 1.419 . . . . 0.0 110.596 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.671 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -70.92 158.42 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.47 61.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.806 -1.184 . . . . 0.0 110.682 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.98 -102.09 0.15 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.49 120.72 42.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.671 HG22 HG21 ' B' ' 86' ' ' ILE . 43.1 t -98.91 158.73 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.73 0.776 . . . . 0.0 111.105 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.64 116.01 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.641 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.89 105.97 18.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.09 -1.007 . . . . 0.0 109.528 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.52 159.64 42.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.03 17.22 4.27 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.18 25.26 75.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -130.17 -154.72 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.722 0.772 . . . . 0.0 109.796 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.48 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.5 143.45 45.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.51 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 60.9 m95 -141.58 140.07 33.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.516 -1.365 . . . . 0.0 110.596 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.454 ' C ' ' N ' ' B' ' 101' ' ' GLU . 16.9 m80 -56.66 131.99 50.6 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 89' ' ' ARG . 7.8 t -53.15 -14.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.956 -1.09 . . . . 0.0 108.302 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.75 -27.02 15.45 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.696 -0.627 . . . . 0.0 110.638 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -98.01 -6.6 31.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.818 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.471 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.12 106.22 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.83 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.6 175.26 11.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.204 1.002 . . . . 0.0 111.192 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.7 148.68 45.85 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.329 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.83 28.63 1.75 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.89 -31.66 0.71 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.338 -0.851 . . . . 0.0 110.009 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.04 -15.36 4.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.6 0.34 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.392 -0.817 . . . . 0.0 110.165 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.5 109.54 59.34 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.83 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.02 138.19 39.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.804 1.669 . . . . 0.0 112.078 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.308 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.037 0.0 OUTLIER -95.78 56.98 1.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.138 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.09 -55.21 1.64 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.21 30.9 2.75 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.965 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.2 178.99 4.12 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.465 -1.021 . . . . 0.0 109.906 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -94.62 145.37 24.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.761 . . . . 0.0 109.302 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.43 9.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.462 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.705 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.53 137.64 47.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.06 148.33 28.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.262 -0.899 . . . . 0.0 111.173 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.94 129.19 11.22 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.607 0.718 . . . . 0.0 110.291 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.39 22.77 1.53 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.563 -0.711 . . . . 0.0 109.446 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.4 31.06 20.32 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.729 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.3 mt -143.4 142.71 31.34 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.521 -0.988 . . . . 0.0 108.773 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.23 152.9 36.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 110.787 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.548 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.3 m-85 -153.97 140.42 18.75 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.5 m -57.6 177.51 0.1 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.446 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.4 tt0 -63.73 -35.89 82.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 0.0 109.443 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 132' ' ' GLN . 56.1 m -86.69 -43.7 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 111.384 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.463 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.7 -43.71 83.6 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.839 -1.163 . . . . 0.0 108.065 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.512 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.84 -56.45 13.9 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.0 m-80 -64.4 -45.03 89.39 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.012 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 128' ' ' THR . 8.5 tp60 -54.42 -34.34 61.17 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.548 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.66 -35.25 45.57 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.361 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.57 -81.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.51 31.31 16.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.405 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.2 m-20 48.56 51.3 15.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -1.128 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.744 1 CA-C-O 70.872 -23.442 . . . . 0.0 109.455 179.941 . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.26 74.93 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -162.0 35.33 0.12 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -1.207 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.434 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.0 148.65 44.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.143 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.15 93.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -121.37 -54.35 1.99 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -145.34 74.11 1.38 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -69.52 158.04 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 31' ' ' MET . 3.5 m -145.32 131.48 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.42 -1.425 . . . . 0.0 111.557 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -99.9 129.25 45.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 13' ' ' TYR . 36.4 m -63.44 154.29 32.64 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.591 1.186 . . . . 0.0 110.546 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 77.2 mt -114.28 -17.22 11.88 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.147 -1.427 . . . . 10.54 107.147 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.661 ' H ' HG22 ' A' ' 11' ' ' THR . 14.2 m-85 -149.55 145.09 18.57 Favored Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.24 -0.913 . . . . 18.39 110.694 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.06 81.53 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 121.372 1.381 . . . . 0.0 109.058 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.29 13.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.015 -1.053 . . . . 0.0 110.896 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.67 111.19 8.04 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.857 0.837 . . . . 0.0 109.389 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.33 111.97 10.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 18' ' ' VAL . 29.7 m -130.34 94.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-O 122.911 1.339 . . . . 0.0 109.232 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -144.44 -152.05 0.4 Allowed 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 114.377 -1.283 . . . . 38.32 107.618 178.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 19' ' ' THR . 97.2 mt-10 -82.47 -54.27 5.32 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.902 -1.518 . . . . 55.13 106.902 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -109.26 29.23 7.72 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.427 -0.795 . . . . 0.0 110.778 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.569 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -100.32 150.92 22.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.81 -1.181 . . . . 0.0 109.766 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -111.51 111.45 22.48 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.401 -0.812 . . . . 11.68 110.695 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.44 127.67 41.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.85 142.26 21.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.35 -1.469 . . . . 12.44 110.881 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.605 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.28 155.77 22.27 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.3 146.95 17.92 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 121.262 -0.899 . . . . 29.03 109.542 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.55 44.08 6.65 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.316 -1.514 . . . . 6.18 109.316 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.25 114.78 22.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.522 -0.987 . . . . 9.52 109.54 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.3 m -73.05 108.62 6.04 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.2 mtp -105.43 133.65 49.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 123.172 1.463 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.74 102.99 15.75 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.727 -1.579 . . . . 0.0 107.459 -178.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -62.96 92.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.51 -0.744 . . . . 0.0 111.597 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.482 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.78 -50.29 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.993 -1.067 . . . . 0.0 110.248 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.486 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.29 157.6 43.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.055 -1.028 . . . . 0.0 110.779 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.06 65.58 65.33 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.803 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.8 165.41 31.53 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.697 1.598 . . . . 0.0 108.901 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.9 tm-20 -92.09 -46.41 7.79 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.4 m-20 57.62 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.369 0.604 . . . . 0.0 110.069 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.53 0.0 OUTLIER Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.48 -59.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.296 -2.185 0 C-N-CA 122.707 2.271 . . . . 0.0 109.874 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 16.7 pt-20 131.84 9.19 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.898 0 C-N-CA 123.894 0.878 . . . . 0.0 108.754 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.561 ' HB2' HD12 ' A' ' 55' ' ' LEU . 13.3 m0 -71.8 165.81 23.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.635 -1.291 . . . . 14.29 110.532 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 19.3 m0 -129.5 144.99 51.5 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.38 -0.6 . . . . 11.8 109.38 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.95 96.73 5.81 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.5 p -115.96 128.8 56.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.913 0.863 . . . . 0.0 110.381 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 34' ' ' ILE . 71.0 tttt -82.56 150.44 26.91 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.768 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.46 128.55 43.49 Favored 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 117.282 -1.767 . . . . 0.0 107.203 177.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.39 -18.41 1.01 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.701 -1.875 . . . . 0.0 107.934 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.47 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.8 -4.4 4.33 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.654 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.46 33.78 6.99 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-N 115.33 -0.85 . . . . 14.41 112.27 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.768 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.79 164.09 29.77 Favored 'General case' 0 N--CA 1.515 2.805 0 CA-C-N 119.783 1.792 . . . . 0.0 111.867 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.0 154.55 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.374 1.083 . . . . 0.0 112.504 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.18 156.66 12.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.267 -1.533 . . . . 7.25 109.267 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.28 150.83 43.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -1.201 . . . . 0.0 108.712 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.99 136.71 8.99 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.959 -1.088 . . . . 0.0 109.254 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.19 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 N-CA-C 108.997 -1.194 . . . . 4.76 108.997 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.501 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 23.8 pttm -60.31 3.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.544 -0.722 . . . . 0.0 110.742 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.657 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 1.0 OUTLIER -102.04 -7.57 22.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.177 -0.952 . . . . 14.84 109.342 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.01 8.27 30.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.255 -0.903 . . . . 10.23 109.487 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -147.59 156.52 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 6.97 109.582 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 63' ' ' VAL . 10.0 p -106.71 160.83 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 62' ' ' VAL . 11.8 p -107.66 134.26 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.455 -0.778 . . . . 0.0 109.747 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.07 -63.23 1.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.4 m -70.09 151.67 45.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.922 -1.112 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -146.61 152.74 39.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.196 -0.94 . . . . 0.0 109.385 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.2 -67.3 1.47 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.46 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.27 1.313 . . . . 0.0 109.688 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.24 82.64 1.78 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.86 125.06 32.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.8 156.2 28.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -1.126 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.77 167.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.21 46.76 0.2 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.17 130.8 5.4 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.524 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.21 163.65 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.949 1.766 . . . . 0.0 108.924 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.485 HG23 ' C ' ' B' ' 84' ' ' ARG . 49.0 mt -135.41 119.89 26.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 122.032 0.92 . . . . 0.0 109.425 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.834 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.2 t -58.45 117.0 4.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.829 0.823 . . . . 0.0 110.019 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.89 -0.11 4.89 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.834 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.66 -48.57 8.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.341 -1.094 . . . . 0.0 109.356 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.17 4.77 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . 0.456 HH21 ' HE2' ' A' ' 58' ' ' LYS . 84.3 mtt85 53.62 41.28 32.12 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.485 ' C ' HG23 ' B' ' 78' ' ' ILE . 8.7 mmm180 -115.88 143.48 30.87 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.646 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.5 Cg_exo -56.51 113.47 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.425 1.417 . . . . 0.0 110.515 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.645 HG21 HG22 ' B' ' 90' ' ' VAL . 21.5 mt -71.01 158.47 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.42 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.49 61.4 0.32 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.887 -1.133 . . . . 0.0 110.688 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.95 -101.88 0.15 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.676 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.65 120.64 42.23 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.645 HG22 HG21 ' B' ' 86' ' ' ILE . 42.8 t -98.89 158.7 3.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.755 0.788 . . . . 0.0 111.182 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.9 t -122.53 116.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.634 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.87 106.12 18.26 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.057 -1.027 . . . . 0.0 109.552 -179.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 159.63 42.49 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.634 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.06 17.24 4.32 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.15 25.33 75.77 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.35 -154.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.756 0.788 . . . . 0.0 109.658 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.477 ' HG2' HG11 ' B' ' 90' ' ' VAL . 2.8 mt-30 -135.28 143.5 46.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.7 m95 -141.61 140.18 33.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.51 -1.369 . . . . 0.0 110.596 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.446 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.1 m80 -56.65 132.01 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.466 HG22 HG23 ' B' ' 91' ' ' VAL . 7.8 t -53.24 -14.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.854 -1.153 . . . . 0.0 108.285 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.446 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.97 15.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.743 -0.598 . . . . 0.0 110.594 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.18 -6.47 31.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.903 -1.123 . . . . 0.0 110.769 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.3 t80 -80.24 106.28 12.14 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.828 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.4 m -133.52 175.31 11.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 122.369 1.08 . . . . 0.0 111.175 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.86 148.71 46.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.343 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.82 28.49 1.79 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.71 -31.67 0.72 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.392 -0.818 . . . . 0.0 110.079 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.2 -15.15 4.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.339 -0.851 . . . . 0.0 110.15 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.69 47.46 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.55 109.66 59.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.828 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.07 138.28 39.63 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.673 1.582 . . . . 0.0 112.168 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.327 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.72 56.9 1.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.212 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.15 -55.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.242 -0.911 . . . . 0.0 108.988 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.26 30.94 2.75 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.943 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.21 178.88 4.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.54 -0.976 . . . . 0.0 109.963 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 0.0 109.285 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.565 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.26 169.55 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.227 -0.921 . . . . 0.0 109.622 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.59 137.67 47.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.94 148.3 28.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.239 -0.913 . . . . 0.0 111.261 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.33 11.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.74 . . . . 0.0 110.318 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.17 22.78 1.39 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.634 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.61 30.8 20.44 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.766 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' B' ' 123' ' ' LEU . 18.8 mt -143.21 142.76 31.51 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.56 -0.965 . . . . 0.0 108.851 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.92 35.99 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.6 m-85 -153.95 140.23 18.57 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.7 m -57.59 177.43 0.1 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.346 -1.342 . . . . 0.0 108.397 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 53.1 tt0 -63.52 -36.11 82.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.175 -0.953 . . . . 0.0 109.376 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.9 m -86.57 -43.68 12.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.55 -0.719 . . . . 0.0 111.412 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.78 -43.74 83.18 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.748 -1.22 . . . . 0.0 108.078 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.2 t80 -51.73 -56.52 13.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.1 m-80 -64.42 -44.85 89.94 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.101 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.57 -34.31 61.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.76 -35.18 44.95 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.366 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 17.8 m-85 -158.59 -81.71 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.52 31.29 16.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.4 m-20 48.56 51.28 15.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 1 C--O 0.474 -39.714 1 CA-C-O 70.897 -23.43 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.36 74.83 0.12 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.2 p -161.93 35.24 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -1.16 . . . . 0.0 109.581 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.1 ttm-85 -73.07 148.69 43.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.106 -0.996 . . . . 0.0 109.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.13 93.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.268 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -121.16 -54.32 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.449 ' CA ' ' OG ' ' A' ' 65' ' ' SER . 95.9 m-70 -145.26 73.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.53 ' N ' ' OG ' ' A' ' 65' ' ' SER . 19.6 t -69.47 157.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.8 m -145.3 131.44 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.458 -1.401 . . . . 0.0 111.52 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -99.83 129.28 45.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 13' ' ' TYR . 33.2 m -63.38 154.32 32.36 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.585 1.183 . . . . 0.0 110.532 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 96.0 mt -114.32 -17.36 11.83 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.125 -1.435 . . . . 10.54 107.125 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.671 ' H ' HG22 ' A' ' 11' ' ' THR . 14.5 m-85 -149.45 145.03 18.52 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.052 -1.03 . . . . 18.39 110.748 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.95 81.38 1.66 Allowed 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.414 1.409 . . . . 0.0 109.031 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.0 t80 -71.73 170.26 13.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.916 -1.115 . . . . 0.0 110.956 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.7 m -137.73 111.12 7.97 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.876 0.846 . . . . 0.0 109.327 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.17 111.91 10.68 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 18' ' ' VAL . 34.0 m -130.38 94.34 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-O 122.983 1.373 . . . . 0.0 109.161 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.635 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.51 -152.01 0.4 Allowed 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.309 -1.314 . . . . 38.32 107.61 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.635 ' H ' HG22 ' A' ' 19' ' ' THR . 97.6 mt-10 -82.36 -54.36 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.967 -1.494 . . . . 55.13 106.967 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 97.0 mt-10 -109.22 29.24 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.424 -0.798 . . . . 0.0 110.769 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.647 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.47 150.88 22.19 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.915 -1.116 . . . . 0.0 109.83 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -111.34 111.35 22.33 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.317 -0.864 . . . . 11.68 110.765 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.5 127.64 41.7 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.96 142.16 21.47 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.36 -1.462 . . . . 12.44 110.861 -178.447 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.16 155.83 22.38 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 146.99 18.2 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.462 -0.895 . . . . 29.03 109.51 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.52 44.25 6.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.262 -1.535 . . . . 6.18 109.262 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.42 114.67 22.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.53 -0.982 . . . . 9.52 109.437 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.467 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.2 m -72.92 108.6 5.93 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.55 133.8 49.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.202 1.477 . . . . 0.0 110.561 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.83 103.04 15.8 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.384 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.556 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.09 92.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.588 -0.695 . . . . 0.0 111.543 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' HZ3' ' A' ' 36' ' ' LYS . 82.2 mt -59.79 -50.34 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.012 -1.055 . . . . 0.0 110.224 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' CA ' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.2 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 110.748 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.556 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.9 mptp? -135.1 65.62 65.19 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.86 165.36 31.59 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.693 1.596 . . . . 0.0 108.94 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.08 -46.49 7.75 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.0 m-20 57.7 -59.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.366 0.603 . . . . 0.0 110.005 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.85 -47.55 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.6 -59.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.615 2.21 . . . . 0.0 109.965 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 27.4 tt0 131.69 9.1 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.78 0.832 . . . . 0.0 108.795 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.568 ' HB2' HD12 ' A' ' 55' ' ' LEU . 12.9 m0 -71.75 165.88 23.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.586 -1.321 . . . . 14.29 110.537 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.536 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 18.3 m0 -129.58 145.1 51.51 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.321 -0.622 . . . . 11.8 109.321 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -78.99 96.59 5.8 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.6 p -115.97 128.77 56.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.011 0.91 . . . . 0.0 110.361 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.8 tttt -82.59 150.33 26.94 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.789 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.32 128.55 43.34 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 117.299 -1.76 . . . . 0.0 107.266 177.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.43 -18.41 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 119.656 -1.902 . . . . 0.0 107.912 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -64.69 -4.58 4.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.658 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.49 33.89 6.92 Favored Glycine 0 N--CA 1.481 1.683 0 CA-C-N 115.291 -0.868 . . . . 14.41 112.29 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.789 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.92 164.11 29.81 Favored 'General case' 0 N--CA 1.516 2.862 0 CA-C-N 119.625 1.713 . . . . 0.0 111.883 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.89 154.54 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-O 122.315 1.055 . . . . 0.0 112.484 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.18 156.69 12.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 7.25 109.258 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.29 150.89 43.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.24 -1.153 . . . . 0.0 108.631 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.03 136.73 9.0 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.902 -1.124 . . . . 0.0 109.228 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' ASN . 6.1 Cg_exo -51.16 113.54 1.15 Allowed 'Trans proline' 0 C--O 1.217 -0.543 0 N-CA-C 109.061 -1.169 . . . . 4.76 109.061 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 31.3 pttt -60.25 3.01 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.453 -0.779 . . . . 0.0 110.758 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 57' ' ' PRO . 94.4 m-20 -102.03 -7.62 22.18 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 14.84 109.27 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.04 8.31 30.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.873 . . . . 10.23 109.476 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.47 156.69 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 6.97 109.499 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 63' ' ' VAL . 13.8 p -106.88 160.69 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' N ' HG22 ' A' ' 62' ' ' VAL . 41.7 t -107.61 134.23 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.13 -63.14 1.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.613 -0.68 . . . . 0.0 109.239 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 8' ' ' VAL . 16.4 p -69.99 151.64 45.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 109.462 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -146.65 152.59 39.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.035 . . . . 0.0 109.427 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.06 -67.36 1.48 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.27 93.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.464 1.442 . . . . 0.0 109.654 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.09 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.74 124.92 32.08 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -78.73 156.31 28.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.384 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.5 mtt -49.82 167.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.31 46.92 0.2 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.633 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.24 130.74 5.35 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.405 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.5 Cg_endo -74.24 163.62 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.957 1.772 . . . . 0.0 108.873 178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.483 ' H ' HE21 ' B' ' 97' ' ' GLN . 25.4 mt -135.46 119.76 26.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 122.12 0.962 . . . . 0.0 109.455 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.826 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.1 t -58.32 117.01 3.98 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.869 0.843 . . . . 0.0 109.897 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.87 -0.1 4.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.826 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.8 -48.48 8.18 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.245 -1.15 . . . . 0.0 109.368 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.13 4.87 13.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . 0.469 ' NH2' ' OD1' ' A' ' 59' ' ' ASN . 95.7 mtt-85 53.45 41.49 32.1 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -116.07 143.42 30.9 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.633 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.7 Cg_exo -56.29 113.39 1.42 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.524 1.483 . . . . 0.0 110.592 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.675 HG21 HG22 ' B' ' 90' ' ' VAL . 21.6 mt -71.01 158.4 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.429 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.3 pt-20 -160.5 61.45 0.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.849 -1.157 . . . . 0.0 110.663 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.03 -102.01 0.15 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.659 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.8 mtt-85 -112.58 120.7 42.47 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.675 HG22 HG21 ' B' ' 86' ' ' ILE . 43.2 t -98.98 158.74 3.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.507 -0.746 . . . . 0.0 111.151 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.63 115.94 47.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.64 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.72 106.09 18.23 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.59 159.57 42.58 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.629 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.12 17.12 4.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.09 25.37 75.7 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.21 -154.77 0.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.857 0.837 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.483 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.45 143.5 45.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.3 m95 -141.5 140.05 33.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.655 -1.278 . . . . 0.0 110.598 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.45 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.2 m80 -56.53 131.93 50.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 91' ' ' VAL . 7.7 t -53.22 -14.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 O-C-N 120.725 -1.234 . . . . 0.0 108.347 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.6 tp10 -95.82 -27.03 15.42 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.886 -0.509 . . . . 0.0 110.595 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -98.17 -6.48 31.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.948 -1.095 . . . . 0.0 110.856 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.2 t80 -80.22 106.31 12.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.829 HG12 ' CA ' ' B' ' 111' ' ' PRO . 27.4 m -133.6 175.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.318 1.056 . . . . 0.0 111.065 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.92 148.76 46.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.264 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.89 28.74 1.74 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.428 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.81 -31.68 0.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.388 -0.82 . . . . 0.0 110.118 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.01 -15.52 4.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.57 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.378 -0.826 . . . . 0.0 110.238 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.4 109.5 59.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.829 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.3 Cg_endo -69.13 138.24 39.32 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.676 1.584 . . . . 0.0 112.111 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.304 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.04 0.0 OUTLIER -95.72 56.96 1.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.221 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.22 -55.17 1.72 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 108.881 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.2 30.99 2.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.944 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 1.0 OUTLIER -116.29 178.9 4.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.352 -1.087 . . . . 0.0 109.935 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -94.47 145.31 24.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.478 -0.764 . . . . 0.0 109.334 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.561 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.25 169.39 9.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.8 m-85 -132.5 137.84 47.34 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -107.19 148.31 29.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 129.22 11.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.604 0.716 . . . . 0.0 110.331 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.42 22.87 1.58 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.638 -0.664 . . . . 0.0 109.413 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.629 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.42 30.98 20.48 Favored Glycine 0 N--CA 1.483 1.815 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.689 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.7 mt -143.33 142.76 31.41 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.646 -0.914 . . . . 0.0 108.865 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.33 152.88 36.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.666 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.552 ' CE1' HD22 ' B' ' 133' ' ' LEU . 57.8 m-85 -153.92 140.32 18.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 90.3 m -57.64 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.282 -1.367 . . . . 0.0 108.448 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.58 -35.97 82.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 55.6 m -86.78 -43.68 12.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.453 -0.78 . . . . 0.0 111.315 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.464 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.68 -43.71 83.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.67 -1.269 . . . . 0.0 108.133 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.1 t80 -51.8 -56.5 13.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.423 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 44.0 m-80 -64.58 -44.75 89.69 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.135 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.46 -34.32 61.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.552 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.7 mp -78.77 -35.29 44.74 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.1 m-85 -158.51 -81.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.026 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.47 31.48 16.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.42 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.7 m-20 48.35 51.31 15.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -1.063 . . . . 0.0 109.563 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 1 C--O 0.474 -39.763 1 CA-C-O 70.976 -23.392 . . . . 0.0 109.443 179.971 . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.332 0.586 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.38 74.85 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.0 p -161.99 35.42 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -1.19 . . . . 0.0 109.494 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 4' ' ' ARG . 26.0 ttm-85 -73.07 148.63 43.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.156 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' OG ' ' A' ' 65' ' ' SER . 33.4 t -66.02 93.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 0.0 109.282 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.23 -54.36 2.0 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -145.23 73.86 1.38 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' THR . 5.9 t -69.44 158.02 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 m -145.33 131.58 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.484 -1.385 . . . . 0.0 111.55 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -99.94 129.14 45.98 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 13' ' ' TYR . 48.9 m -63.37 154.41 32.03 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.52 1.153 . . . . 0.0 110.598 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 87.8 mt -114.3 -17.38 11.84 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.173 -1.417 . . . . 10.54 107.173 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.651 ' H ' HG22 ' A' ' 11' ' ' THR . 14.5 m-85 -149.43 145.15 18.73 Favored Pre-proline 0 N--CA 1.502 2.167 0 O-C-N 121.177 -0.952 . . . . 18.39 110.706 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -73.02 81.42 1.68 Allowed 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 121.414 1.41 . . . . 0.0 109.054 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 16' ' ' SER . 28.1 t80 -71.78 170.32 13.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.94 -1.1 . . . . 0.0 110.865 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.449 ' N ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 m -137.6 111.01 7.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.771 0.796 . . . . 0.0 109.462 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.25 112.07 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.36 94.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 122.866 1.317 . . . . 0.0 109.071 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.64 HG22 ' H ' ' A' ' 20' ' ' GLU . 1.2 m -144.6 -151.97 0.4 Allowed 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.357 -1.292 . . . . 38.32 107.518 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.64 ' H ' HG22 ' A' ' 19' ' ' THR . 95.9 mt-10 -82.47 -54.33 5.28 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.783 -1.562 . . . . 55.13 106.783 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 71.6 mm-40 -109.35 29.25 7.72 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.366 -0.834 . . . . 0.0 110.701 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -100.57 150.82 22.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.841 -1.162 . . . . 0.0 109.797 -179.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.32 111.36 22.36 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.295 -0.878 . . . . 11.68 110.804 -178.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -95.35 127.64 41.56 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -152.91 142.22 21.57 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.39 -1.443 . . . . 12.44 110.87 -178.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.607 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -84.11 155.82 22.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 146.95 18.5 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.221 -0.925 . . . . 29.03 109.497 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.66 43.99 6.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.277 -1.529 . . . . 6.18 109.277 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -119.35 114.79 22.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.56 -0.964 . . . . 9.52 109.419 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 29' ' ' GLU . 5.4 m -73.06 108.73 6.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtp -105.51 133.68 49.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 123.179 1.466 . . . . 0.0 110.486 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -90.75 103.0 15.75 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.427 -178.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 ' NZ ' ' A' ' 36' ' ' LYS . 2.5 t -63.1 92.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 111.51 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 47' ' ' LYS . 82.7 mt -59.73 -50.51 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.994 -1.066 . . . . 0.0 110.194 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CA ' ' HZ3' ' A' ' 36' ' ' LYS . 9.1 tp10 -147.22 157.65 43.67 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.061 -1.025 . . . . 0.0 110.803 -177.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' NZ ' HG12 ' A' ' 33' ' ' VAL . 1.8 mptp? -135.02 65.54 65.5 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.83 165.42 31.48 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 109.0 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 40' ' ' ASP . 11.8 tm-20 -92.13 -46.4 7.78 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 59.1 m-20 57.74 -59.53 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.436 0.636 . . . . 0.0 110.018 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER 165.78 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 40' ' ' ASP . 1.3 Cg_endo -68.57 -59.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.089 0 C-N-CA 122.61 2.206 . . . . 0.0 109.922 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 62.2 mt-10 131.74 9.28 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 123.845 0.858 . . . . 0.0 108.738 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.545 ' HB2' HD12 ' A' ' 55' ' ' LEU . 14.1 m0 -71.74 165.83 23.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.526 -1.359 . . . . 14.29 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.482 ' NE1' ' HB3' ' A' ' 36' ' ' LYS . 20.8 m0 -129.6 145.11 51.52 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.38 -0.6 . . . . 11.8 109.38 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -79.08 96.74 5.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 15.4 p -115.93 128.76 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.855 0.836 . . . . 0.0 110.36 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 34' ' ' ILE . 70.7 tttt -82.68 150.35 26.82 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.787 ' ND2' ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -96.37 128.49 43.35 Favored 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.172 -1.811 . . . . 0.0 107.212 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -51.28 -18.45 0.96 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 119.687 -1.883 . . . . 0.0 107.998 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.465 ' N ' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -64.61 -4.57 4.29 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.663 ' N ' ' ND2' ' A' ' 48' ' ' ASN . . . 93.5 33.86 6.93 Favored Glycine 0 N--CA 1.481 1.638 0 CA-C-N 115.328 -0.851 . . . . 14.41 112.206 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.787 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -137.85 164.03 29.97 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.773 1.787 . . . . 0.0 111.815 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.9 154.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 122.303 1.049 . . . . 0.0 112.544 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' HD23 ' A' ' 23' ' ' LEU . . . 172.21 156.77 12.76 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.28 -1.528 . . . . 7.25 109.28 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 43' ' ' TRP . 4.4 mm? -72.45 150.88 42.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -1.147 . . . . 0.0 108.657 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.99 136.72 9.01 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.029 -1.045 . . . . 0.0 109.27 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.572 ' HB3' HD21 ' A' ' 59' ' ' ASN . 6.2 Cg_exo -51.26 113.49 1.14 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.068 -1.166 . . . . 4.76 109.068 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.443 ' HD2' ' CZ2' ' A' ' 44' ' ' TRP . 64.5 pttt -60.33 3.21 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 110.78 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.572 HD21 ' HB3' ' A' ' 57' ' ' PRO . 1.1 p30 -102.03 -7.57 22.22 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 14.84 109.335 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.04 8.21 30.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 10.23 109.536 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 11' ' ' THR . 35.0 m -147.44 156.57 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.942 . . . . 6.97 109.541 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -106.87 160.75 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' B' ' 82' ' ' CYS . 10.5 p -107.61 134.26 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.401 -0.812 . . . . 0.0 109.754 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.05 -63.31 1.24 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.61 -0.682 . . . . 0.0 109.227 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.447 ' OG ' ' CG1' ' A' ' 5' ' ' VAL . 58.3 m -69.95 151.68 45.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.975 -1.078 . . . . 0.0 109.454 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 48.7 p30 -146.58 152.73 39.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 109.356 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.11 -67.28 1.48 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.48 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.317 1.344 . . . . 0.0 109.606 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.05 82.54 1.76 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 mt -84.72 125.0 32.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.23 28.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.562 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.82 167.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.29 46.97 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' B' ' 85' ' ' PRO . 2.2 t -155.23 130.75 5.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 109.366 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.525 ' CG ' HG21 ' B' ' 90' ' ' VAL . 5.6 Cg_endo -74.16 163.61 36.19 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.946 1.764 . . . . 0.0 108.914 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.512 HG23 ' C ' ' B' ' 84' ' ' ARG . 56.7 mt -135.43 119.74 26.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.081 0.943 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' B' ' 81' ' ' ALA . 15.0 t -58.3 117.05 4.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.517 ' C ' ' CZ3' ' B' ' 98' ' ' TRP . . . -64.77 -0.22 4.88 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.832 ' HB3' ' SG ' ' B' ' 79' ' ' CYS . . . -86.74 -48.51 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -1.099 . . . . 0.0 109.305 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' CYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 1.6 p -116.12 4.84 13.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 53.54 41.32 32.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.512 ' C ' HG23 ' B' ' 78' ' ' ILE . 43.3 mtp180 -115.86 143.46 30.81 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.64 ' HB3' HG11 ' B' ' 76' ' ' VAL . 5.8 Cg_exo -56.32 113.33 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.494 1.463 . . . . 0.0 110.623 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.669 HG21 HG22 ' B' ' 90' ' ' VAL . 21.4 mt -70.95 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.428 ' N ' HG22 ' B' ' 86' ' ' ILE . 2.2 pt-20 -160.57 61.34 0.32 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.831 -1.168 . . . . 0.0 110.646 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.97 -101.97 0.15 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.656 ' CG ' HH11 ' B' ' 89' ' ' ARG . 2.9 mtt-85 -112.58 120.73 42.57 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.669 HG22 HG21 ' B' ' 86' ' ' ILE . 42.5 t -98.81 158.61 3.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.641 0.734 . . . . 0.0 111.298 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' B' ' 103' ' ' PHE . 4.8 t -122.52 115.91 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ASN . . . . . 0.628 HD22 ' N ' ' B' ' 92' ' ' ASN . 0.8 OUTLIER -89.81 106.17 18.29 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.062 -1.023 . . . . 0.0 109.481 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.6 159.54 42.63 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.633 ' SD ' ' O ' ' B' ' 122' ' ' GLY . 7.9 mmt 58.07 17.25 4.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.11 25.34 75.74 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.18 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.724 0.773 . . . . 0.0 109.821 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' GLN . . . . . 0.484 HE21 ' H ' ' B' ' 78' ' ' ILE . 2.8 mt-30 -135.43 143.42 45.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' TRP . . . . . 0.517 ' CZ3' ' C ' ' B' ' 80' ' ' GLY . 61.0 m95 -141.44 140.0 33.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.561 -1.337 . . . . 0.0 110.682 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' HIS . . . . . 0.458 ' C ' ' N ' ' B' ' 101' ' ' GLU . 17.4 m80 -56.56 131.94 50.18 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 91' ' ' VAL . 7.6 t -53.2 -14.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.701 -1.25 . . . . 0.0 108.32 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' B' ' 99' ' ' HIS . 12.5 tp10 -95.86 -26.85 15.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.754 -0.591 . . . . 0.0 110.613 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.22 -6.53 31.04 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' B' ' 91' ' ' VAL . 25.4 t80 -80.26 106.31 12.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' B' ' 111' ' ' PRO . 26.9 m -133.63 175.25 11.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.287 1.041 . . . . 0.0 111.138 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' B' ' 126' ' ' CYS . 1.5 t -62.79 148.69 46.15 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.234 178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 124' ' ' ALA . . . -91.79 28.54 1.76 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.425 ' N ' ' SG ' ' B' ' 105' ' ' CYS . 13.4 tptm -138.73 -31.62 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.432 -0.793 . . . . 0.0 110.149 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.08 -15.38 4.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.31 -0.869 . . . . 0.0 110.156 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.63 47.55 0.35 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.28 109.48 58.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' B' ' 104' ' ' VAL . 5.4 Cg_endo -69.02 138.36 39.97 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.66 1.574 . . . . 0.0 112.077 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . 1.301 ' CG ' ' CB ' ' B' ' 112' ' ' PHE 1.041 0.0 OUTLIER -95.82 56.91 1.78 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.133 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' B' ' 111' ' ' PRO . 10.8 mp -39.21 -55.24 1.7 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.2 -0.937 . . . . 0.0 108.897 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.16 31.12 2.73 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.956 ' HB2' ' HB3' ' B' ' 112' ' ' PHE . 0.9 OUTLIER -116.27 178.88 4.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.483 -1.01 . . . . 0.0 109.987 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -94.5 145.43 24.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.38 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.563 ' C ' ' CD1' ' B' ' 118' ' ' TYR . 11.1 p-80 -116.35 169.48 9.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.528 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' B' ' 118' ' ' TYR . 3.7 m-85 -132.6 137.7 47.15 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -106.96 148.28 28.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.232 -0.918 . . . . 0.0 111.234 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.05 129.34 11.26 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.604 0.716 . . . . 0.0 110.381 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 51.3 22.78 1.48 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.671 -0.643 . . . . 0.0 109.438 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.633 ' O ' ' SD ' ' B' ' 94' ' ' MET . . . 86.5 30.9 20.49 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.764 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' B' ' 123' ' ' LEU . 18.4 mt -143.27 142.89 31.51 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.529 -0.983 . . . . 0.0 108.725 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 106' ' ' ALA . . . -76.46 152.84 36.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.685 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.547 ' CE1' HD22 ' B' ' 133' ' ' LEU . 58.5 m-85 -153.89 140.31 18.71 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' B' ' 105' ' ' CYS . 91.1 m -57.65 177.55 0.1 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.26 -1.376 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 118' ' ' TYR . 52.9 tt0 -63.67 -36.05 82.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.374 -0.828 . . . . 0.0 109.285 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 54.7 m -86.61 -43.78 12.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 0.0 111.333 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' B' ' 133' ' ' LEU . 32.5 m170 -66.67 -43.79 83.56 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.721 -1.237 . . . . 0.0 108.095 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' B' ' 118' ' ' TYR . 5.3 t80 -51.71 -56.47 13.58 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' B' ' 135' ' ' GLY . 43.8 m-80 -64.52 -44.81 89.7 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.211 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -54.48 -34.29 61.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.547 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.8 mp -78.75 -35.23 44.96 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.335 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 133' ' ' LEU . 18.0 m-85 -158.59 -81.6 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -0.809 . . . . 0.0 110.137 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' B' ' 131' ' ' ASN . . . 87.33 31.42 16.64 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' OH ' ' B' ' 130' ' ' TYR . 26.6 m-20 48.53 51.17 15.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -1.109 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 1 C--O 0.474 -39.725 1 CA-C-O 70.924 -23.417 . . . . 0.0 109.436 179.924 . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_